patient	NN	O
recorded	VBD	O
as	IN	O
having	VBG	O
no	DT	O
known	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM
to	TO	O
drugs	NNS	B-TREATMENT

chief	NN	O
complaint:	NN	O
recent	JJ	B-PROBLEM
mild	JJ	I-PROBLEM
angina	NN	I-PROBLEM
with	IN	O
exertion	NN	O

emergency	NN	B-TREATMENT
cabg	NN	I-TREATMENT
x	$	O
3	CD	O
(	(	O
2017-06-13	JJ	O
)(	NNP	O
lima	NN	B-TREATMENT
to	TO	I-TREATMENT
lad	VB	I-TREATMENT
,	,	O
svg	VB	B-TREATMENT
to	TO	I-TREATMENT
ramus	VB	I-TREATMENT
,	,	O
svg	VB	B-TREATMENT
to	TO	I-TREATMENT
om	VB	I-TREATMENT
)	)	O

61	CD	O
yo	JJ	O
african-american-hispanic	JJ	O
male	NN	O
had	VBD	O
abnormal	JJ	B-PROBLEM
ekg	RB	I-PROBLEM
found	VBN	O
as	IN	O
part	NN	O
of	IN	O
pre-op	JJ	B-TEST
eval.	NN	I-TEST
for	IN	O
ventral	JJ	B-TREATMENT
hernia	NN	I-TREATMENT
repair	NN	I-TREATMENT
.	.	O

had	VBD	O
subsequent	JJ	O
abnormal	JJ	B-PROBLEM
stress	NN	I-PROBLEM
test	NN	I-PROBLEM
and	CC	O
pefusion	NN	B-TEST
imaging	NN	I-TEST
showed	VBD	O
ef	JJ	B-TEST
38%	CD	O
with	IN	O
perfusion	NN	B-PROBLEM
defects	NNS	I-PROBLEM
.	.	O

echo	JJ	B-TEST
prior	RB	O
to	TO	O
scheduled	VBN	B-TEST
cath	NN	I-TEST
showed	VBD	O
mild	JJ	B-PROBLEM
lvh	NN	I-PROBLEM
,	,	O
inferior	JJ	B-PROBLEM
hk	NN	I-PROBLEM
,	,	O
ef	RB	B-TEST
40%	CD	O
,	,	O
mild	JJ	B-PROBLEM
mr	NN	I-PROBLEM
,	,	O
mild	JJ	B-PROBLEM
lae	NN	I-PROBLEM
.	.	O

cath	NN	B-TEST
at	IN	O
kindred/north	NN	O
shore	NN	O
today	NN	O
showed	VBD	O
80%	CD	B-PROBLEM
lm	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
with	IN	O
normal	JJ	O
lad	NN	O
,	,	O
cx	NN	O
,	,	O
rca	NN	O
.	.	O

severe	JJ	B-PROBLEM
systolic	NN	I-PROBLEM
htn	NN	I-PROBLEM
also	RB	O
noted	VBD	O
.	.	O

transferred	VBN	O
in	IN	O
urgently	RB	O
for	IN	O
cabg	NN	B-TREATMENT
with	IN	O
dr.	JJ	O
howard	NN	O
.	.	O

ventral	JJ	B-PROBLEM
hernia	NN	I-PROBLEM

htn	NN	B-PROBLEM
elev.	NN	B-PROBLEM
chol.	NN	I-PROBLEM
right	RB	B-PROBLEM
facial	JJ	I-PROBLEM
droop	NN	I-PROBLEM
with	IN	O
metal	NN	B-TREATMENT
plate	NN	I-TREATMENT
secondary	NN	O
to	TO	O
gsw	VB	B-PROBLEM
to	TO	O
face	VB	B-TREATMENT
right	JJ	I-TREATMENT
nephrectomy	NN	I-TREATMENT

2017-06-14	JJ	O
02:06am	CD	O
blood	NN	B-TEST

wbc	SYM	B-TEST
-	:	O
9.4	CD	O
rbc	NN	B-TEST
-	:	O
3.61*	CD	O
hgb	NN	B-TEST
-	:	O
10.4*	CD	O
hct	NN	B-TEST
-	:	O
29.9*	CD	O
mcv	SYM	B-TEST
-	:	O
83	CD	O
mch	SYM	B-TEST
-	:	O
28.8	CD	O
mchc	SYM	B-TEST
-	:	O
34.8	CD	O
rdw	NN	B-TEST
-	:	O
14.3	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
154	CD	O

2017-06-17	JJ	O
05:14am	CD	O
blood	NN	B-TEST

hct	SYM	B-TEST
-	:	O
25.2*	CD	O

2017-06-14	JJ	O
02:06am	CD	O
blood	NN	B-TEST

plt	NN	B-TEST
ct	SYM	I-TEST
-	:	O
154	CD	O

2017-06-13	JJ	O
08:05pm	CD	O
blood	NN	B-TEST

pt	SYM	B-TEST
-	:	O
13.6*	CD	O
ptt	NN	B-TEST
-	:	O
33.3	CD	O
inr	NN	B-TEST
(	(	O
pt	NN	B-TEST
)	)	O
-	:	O
1.2*	CD	O

2017-06-17	JJ	O
05:14am	CD	O
blood	NN	B-TEST

urean	JJ	B-TEST
-	:	O
25*	CD	O
creat	NN	B-TEST
-	:	O
1.0	CD	O
k	SYM	B-TEST
-	:	O
3.9	CD	O

2017-06-15	JJ	O
02:02pm	CD	O
blood	NN	B-TEST

mg	SYM	B-TEST
-	:	O
2.1	CD	O

two	CD	B-TEST
view	NN	I-TEST
chest	NN	I-TEST
,	,	O
2017-06-17	JJ	O

status	NN	O
post	NN	O
coronary	JJ	B-TREATMENT
bypass	NN	I-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

there	EX	O
has	VBZ	O
been	VBN	O
removal	NN	O
of	IN	O
a	DT	B-TREATMENT
swan-ganz	JJ	I-TREATMENT
catheter	NN	I-TREATMENT
and	CC	O
placement	NN	O
of	IN	O
a	DT	B-TREATMENT
right	JJ	I-TREATMENT
internal	JJ	I-TREATMENT
jugular	NN	I-TREATMENT
vascular	NN	I-TREATMENT
catheter	NN	I-TREATMENT
,	,	O
with	IN	O
the	DT	O
tip	NN	O
terminating	NN	O
in	IN	O
the	DT	O
proximal	JJ	O
right	JJ	O
atrium	NN	O
just	RB	O
below	IN	O
the	DT	O
junction	NN	O
with	IN	O
the	DT	O
superior	JJ	O
vena	NN	O
cava	NN	O
.	.	O

previously	RB	O
reported	VBN	O
interstitial	JJ	B-PROBLEM
edema	NN	I-PROBLEM
has	VBZ	O
resolved	VBN	O
.	.	O

there	EX	O
has	VBZ	O
been	VBN	O
interval	JJ	O
improvement	NN	O
in	IN	O
left	JJ	B-PROBLEM
basilar	JJ	I-PROBLEM
atelectasis	NN	I-PROBLEM
.	.	O

right	RB	B-PROBLEM
basilar	JJ	I-PROBLEM
atelectasis	NN	I-PROBLEM
has	VBZ	O
slightly	RB	O
worsened	VBN	O
.	.	O

bilateral	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
are	VBP	O
unchanged	JJ	O
.	.	O

1.	CD	O
vascular	JJ	B-TREATMENT
catheter	NN	I-TREATMENT
tip	NN	I-TREATMENT
terminates	NNS	O
in	IN	O
proximal	JJ	O
right	JJ	O
atrium	NN	O
.	.	O

2.	CD	O
bibasilar	JJ	B-PROBLEM
minor	JJ	I-PROBLEM
atelectasis	NN	I-PROBLEM
,	,	O
worse	JJR	O
on	IN	O
the	DT	O
right	NN	O
and	CC	O
improved	VBN	O
on	IN	O
the	DT	O
left	NN	O
.	.	O

persistent	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
.	.	O

the	DT	O
left	JJ	O
atrium	NN	O
is	VBZ	O
mildly	RB	B-PROBLEM
dilated	VBN	I-PROBLEM
.	.	O

no	DT	O
spontaneous	JJ	B-PROBLEM
echo	NN	I-PROBLEM
contrast	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
in	IN	O
the	DT	O
body	NN	O
of	IN	O
the	DT	O
left	JJ	O
atrium	NN	O
.	.	O

no	DT	O
spontaneous	JJ	B-PROBLEM
echo	NN	I-PROBLEM
contrast	NN	I-PROBLEM
or	CC	O
thrombus	NN	B-PROBLEM
is	VBZ	O
seen	VBN	O
in	IN	O
the	DT	O
body	NN	O
of	IN	O
the	DT	O
left	JJ	O
atrium	NN	O
or	CC	O
left	VBN	O
atrial	JJ	O
appendage	NN	O
.	.	O

no	DT	O
mass/thrombus	NN	B-PROBLEM
is	VBZ	O
seen	VBN	O
in	IN	O
the	DT	O
left	JJ	O
atrium	NN	O
or	CC	O
left	VBN	O
atrial	JJ	O
appendage	NN	O
.	.	O

no	DT	O
atrial	JJ	B-PROBLEM
septal	NN	I-PROBLEM
defect	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
by	IN	O
2d	CD	B-TEST
or	CC	O
color	NN	B-TEST
doppler	NN	I-TEST
.	.	O

there	EX	O
is	VBZ	O
mild	JJ	B-PROBLEM
symmetric	JJ	I-PROBLEM
left	VBD	I-PROBLEM
ventricular	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
with	IN	O
normal	JJ	O
cavity	NN	O
size	NN	O
.	.	O

there	EX	O
is	VBZ	O
mild	JJ	B-PROBLEM
symmetric	JJ	I-PROBLEM
left	VBD	I-PROBLEM
ventricular	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
.	.	O

no	DT	O
left	VBD	B-PROBLEM
ventricular	JJ	I-PROBLEM
aneurysm	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
.	.	O

there	EX	O
is	VBZ	O
mild	JJ	B-PROBLEM
regional	JJ	I-PROBLEM
left	VBD	I-PROBLEM
ventricular	JJ	I-PROBLEM
systolic	JJ	I-PROBLEM
dysfunction	NN	I-PROBLEM
.	.	O

overall	JJ	B-TEST
left	VBD	I-TEST
ventricular	JJ	I-TEST
systolic	JJ	I-TEST
function	NN	I-TEST
is	VBZ	O
mildly	RB	B-PROBLEM
depressed	JJ	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
ventricular	JJ	B-PROBLEM
septal	NN	I-PROBLEM
defect	NN	I-PROBLEM
.	.	O

resting	VBG	B-PROBLEM
regional	JJ	I-PROBLEM
wall	NN	I-PROBLEM
motion	NN	I-PROBLEM
abnormalities	NNS	I-PROBLEM
include	VBP	O
mild	JJ	B-PROBLEM
inferior	JJ	I-PROBLEM
hypokinesis	NN	I-PROBLEM
.	.	O

the	DT	O
right	JJ	O
ventricular	NN	O
cavity	NN	O
is	VBZ	O
mildly	RB	B-PROBLEM
dilated	VBN	I-PROBLEM
.	.	O

there	EX	O
are	VBP	O
simple	JJ	B-PROBLEM
atheroma	NN	I-PROBLEM
in	IN	O
the	DT	O
aortic	JJ	O
root	NN	O
.	.	O

there	EX	O
are	VBP	O
simple	JJ	B-PROBLEM
atheroma	NN	I-PROBLEM
in	IN	O
the	DT	O
ascending	NN	O
aorta	NN	O
.	.	O

there	EX	O
are	VBP	O
simple	JJ	B-PROBLEM
atheroma	NN	I-PROBLEM
in	IN	O
the	DT	O
aortic	JJ	O
arch	NN	O
.	.	O

there	EX	O
are	VBP	O
simple	JJ	B-PROBLEM
atheroma	NN	I-PROBLEM
in	IN	O
the	DT	O
descending	NN	O
thoracic	NN	O
aorta	NN	O
.	.	O

the	DT	O
aortic	JJ	O
valve	NN	O
leaflets	NNS	O
are	VBP	O
mildly	RB	B-PROBLEM
thickened	VBN	I-PROBLEM
.	.	O

no	DT	O
masses	NNS	B-PROBLEM
or	CC	O
vegetations	NNS	B-PROBLEM
are	VBP	O
seen	VBN	O
on	IN	O
the	DT	O
aortic	JJ	O
valve	NN	O
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
aortic	JJ	B-PROBLEM
valve	NN	I-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

trace	NN	B-PROBLEM
aortic	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
.	.	O

the	DT	O
mitral	JJ	O
valve	NN	O
leaflets	NNS	O
are	VBP	O
mildly	RB	B-PROBLEM
thickened	VBN	I-PROBLEM
.	.	O

no	DT	O
mass	NN	B-PROBLEM
or	CC	O
vegetation	NN	B-PROBLEM
is	VBZ	O
seen	VBN	O
on	IN	O
the	DT	O
mitral	JJ	O
valve	NN	O
.	.	O

trivial	JJ	B-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
pericardial	JJ	B-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

preserved	VBN	O
lv	JJ	O
systolic	JJ	O
function	NN	O
on	IN	O
phenylephrine	NN	B-TREATMENT
.	.	O

lvef	RB	B-TEST
now	RB	O
50%	CD	O
.	.	O

trace	NN	B-PROBLEM
mr	NN	I-PROBLEM
,	,	O
ai	VBP	B-PROBLEM
as	IN	O
described	NN	O
.	.	O

i	NN	O
certify	VBP	O
that	IN	O
i	NN	O
was	VBD	O
present	JJ	O
for	IN	O
this	DT	B-TREATMENT
procedure	NN	I-TREATMENT
in	IN	O
compliance	NN	O
with	IN	O
hcfa	JJ	O
regulations	NNS	O
.	.	O

admitted	VBN	O
directly	RB	O
to	TO	O
or	CC	O
from	IN	O
ambulance	NN	O
transfer	NN	O
and	CC	O
underwent	JJ	O
cabg	NN	B-TREATMENT
x3	NN	O
with	IN	O
dr.	JJ	O
howard	NN	O
on	IN	O
06-13	NN	O
.	.	O

transferred	VBN	O
to	TO	O
the	DT	O
csru	NN	O
in	IN	O
stable	JJ	O
condition	NN	O
on	IN	O
phenylephrine	NN	B-TREATMENT
and	CC	O
propofol	JJ	B-TREATMENT
drips	NNS	I-TREATMENT
.	.	O

extubated	VBN	O
early	RB	O
the	DT	O
next	JJ	O
morning	NN	O
and	CC	O
chest	NN	B-TREATMENT
tubes	NNS	I-TREATMENT
removed	VBD	O
.	.	O

gentle	JJ	B-TREATMENT
diuresis	NN	I-TREATMENT
and	CC	O
beta	NN	B-TREATMENT
blockade	NN	I-TREATMENT
started	VBD	O
,	,	O
and	CC	O
he	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
floor	NN	O
to	TO	O
begin	VB	O
increasing	VBG	O
his	PRP$	O
activity	NN	O
level	NN	O
.	.	O

foley	NN	B-TREATMENT
removed	VBD	O
on	IN	O
pod	NN	O
#2	NN	O
and	CC	O
had	VBD	O
scattered	VBN	B-PROBLEM
rales	NNS	I-PROBLEM
with	IN	O
temp	JJ	B-TEST
101.2	CD	O
.	.	O

afebrile	IN	B-PROBLEM
the	DT	O
next	JJ	O
day	NN	O
and	CC	O
pacing	NN	B-TREATMENT
wires	NNS	I-TREATMENT
removed	VBD	O
without	IN	O
incident	NN	O
.	.	O

bisoprolol	NN	B-TREATMENT
5	CD	O
mg	JJ	O
daily	JJ	O
crestor	NN	B-TREATMENT
20	CD	O
mg	JJ	O
daily	JJ	O

hctz	NN	B-TREATMENT
25	CD	O
mg	JJ	O
daily	JJ	O
lisinopril	VBZ	B-TREATMENT
40	CD	O
mg	JJ	O
daily	JJ	O

1.	CD	O
metoprolol	JJ	B-TREATMENT
tartrate	NN	I-TREATMENT
25	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

2.	CD	O
potassium	NN	B-TREATMENT
chloride	NN	I-TREATMENT
10	CD	O
meq	NN	O
capsule	NN	O
,	,	O
sustained	VBD	O
release	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
capsule	NN	O
,	,	O
sustained	VBD	O
release	NN	O
po	NN	O
q12h	NN	O
(	(	O
every	DT	O
12	CD	O
hours	NNS	O
)	)	O
for	IN	O
7	CD	O
days	NNS	O
.	.	O

3.	CD	O
docusate	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
100	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

4.	CD	O
ranitidine	NN	B-TREATMENT
hcl	NN	I-TREATMENT
150	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

5.	CD	O
aspirin	JJ	B-TREATMENT
81	CD	O
mg	JJ	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

6.	CD	O
oxycodone-acetaminophen	JJ	B-TREATMENT
5-325	JJ	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
1-2	JJ	O
tablets	NNS	O
po	JJ	O
every	DT	O
4-6	JJ	O
hours	NNS	O
as	IN	O
needed	VBN	O
for	IN	O
pain	NN	B-PROBLEM
.	.	O

7.	CD	O
rosuvastatin	NN	B-TREATMENT
20	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

8.	CD	O
furosemide	JJ	B-TREATMENT
20	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
for	IN	O
7	CD	O
days	NNS	O
.	.	O

cad	NN	B-PROBLEM

htn	JJ	B-PROBLEM
ventral	JJ	B-PROBLEM
hernia	NN	I-PROBLEM
right	RB	B-TREATMENT
nephrectomy	JJ	I-TREATMENT
s/p	RB	O
right	JJ	B-TREATMENT
facial	NN	I-TREATMENT
plating	NN	I-TREATMENT

discharge	NN	O
instructions	NNS	O
:	:	O
may	MD	O
shower	VB	O
,	,	O
no	DT	O
bathing	NN	O
or	CC	O
swimming	NN	O
for	IN	O
1	CD	O
month	NN	O
no	DT	O
creams	NN	B-TREATMENT
,	,	O
lotions	NNS	B-TREATMENT
or	CC	O
powders	NNS	B-TREATMENT
to	TO	O
any	DT	B-PROBLEM
incisions	NNS	I-PROBLEM
no	DT	O
driving	NN	O
for	IN	O
1	CD	O
month	NN	O
no	DT	O
lifting	VBG	O
>	RB	O
10	CD	O
#	#	O
for	IN	O
10	CD	O
weeks	NNS	O

chest	NN	B-PROBLEM
pain	NN	I-PROBLEM

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
91	CD	O
yo	NN	O
woman	NN	O
with	IN	O
h/o	JJ	O
htn	NNS	B-PROBLEM
who	WP	O
came	VBD	O
from	IN	O
bridgewater	NN	O
state	NN	O
hospital	NN	O
rehab	NN	O
with	IN	O
substernal	JJ	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
after	IN	O
exercise	NN	O
.	.	O

after	IN	O
returning	VBG	O
to	TO	O
her	PRP$	O
room	NN	O
she	PRP	O
w	VBD	O
noted	JJ	O
sscp	NN	B-PROBLEM
without	IN	O
radiation	NN	O
.	.	O

no	DT	O
nausea	NN	B-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
,	,	O
diaphoresis	NN	B-PROBLEM
.	.	O

they	PRP	O
did	VBD	O
an	DT	B-TEST
ecg	NN	I-TEST
at	IN	O
bridgewater	NN	O
state	NN	O
hospital	NN	O
rehab	NN	O
which	WDT	O
demonstarted	VBD	O
new	JJ	B-PROBLEM
st	JJ	I-PROBLEM
depressions	NNS	I-PROBLEM
in	IN	I-PROBLEM
v1-v4	NN	I-PROBLEM
.	.	O

she	PRP	O
received	VBD	O
asa	RB	B-TREATMENT
81	CD	O
mg	NNS	O
x	JJ	O
2	CD	O
and	CC	O
nitro	JJ	B-TREATMENT
sl	NN	I-TREATMENT
x	VBD	O
2	CD	O
with	IN	O
partial	JJ	O
relief	NN	O
at	IN	O
nursing	NN	O
home	NN	O
.	.	O

on	IN	O
presentation	NN	O
to	TO	O
providence	VB	O
behavioral	JJ	O
health	NN	O
hospital	NN	O
amanda	NN	O
,	,	O
her	PRP$	B-TEST
vitals	NNS	I-TEST
were	VBD	O
hr	JJ	B-TEST
68	CD	O
,	,	O
bp	NN	B-TEST
142/68	CD	O
,	,	O
rr	NN	B-TEST
28	CD	O
,	,	O
o2	PRP	B-TEST
sat	VBD	I-TEST
100%	CD	O
ra	NN	O
.	.	O

exam	NN	B-TEST
was	VBD	O
notable	JJ	O
for	IN	O
rrr	NN	O
with	IN	O
no	DT	O
murmur	NN	B-PROBLEM
,	,	O
bibasilar	JJ	B-PROBLEM
crackles	NNS	I-PROBLEM
,	,	O
guaiac	JJ	B-TEST
negative	NN	O
.	.	O

ekg	NN	B-TEST
showed	VBD	O
sinus	JJ	B-PROBLEM
brady	NN	I-PROBLEM
,	,	O
with	IN	O
old	JJ	B-PROBLEM
lad	NN	I-PROBLEM
and	CC	I-PROBLEM
new	JJ	I-PROBLEM
st	NN	I-PROBLEM
depressions	NNS	I-PROBLEM
in	IN	I-PROBLEM
v1-v4	NN	I-PROBLEM
.	.	O

troponin	NN	B-TEST
was	VBD	O
0.07	CD	O
.	.	O

she	PRP	O
received	VBD	O
asa	RB	B-TREATMENT
,	,	O
nitro	RB	B-TREATMENT
sl	JJ	I-TREATMENT
then	RB	O
gtt	NN	O
,	,	O
morphine	NN	B-TREATMENT
,	,	O
metoprolol	NN	B-TREATMENT
,	,	O
and	CC	O
heparin	NN	B-TREATMENT
gtt	NN	I-TREATMENT
.	.	O

cardiology	NN	O
discussed	VBD	O
cath	NN	B-TEST
however	RB	O
,	,	O
patient	NN	O
's	POS	O
family	NN	O
turned	VBD	O
down	RB	O
.	.	O

transferred	VBN	O
to	TO	O
ccu	VB	O
for	IN	O
further	JJ	B-TREATMENT
management	NN	I-TREATMENT
and	CC	O
observation	NN	O
.	.	O

htn	NN	B-PROBLEM

hearing	VBG	B-PROBLEM
difficulty	NN	I-PROBLEM

blindness	JJ	B-PROBLEM
02-26	JJ	O
macular	JJ	B-PROBLEM
degeneration	NN	I-PROBLEM

r	NN	B-PROBLEM
ankle	NN	I-PROBLEM
fx	NN	I-PROBLEM
2002	CD	O

s/p	NN	O
hysterectomy	NN	B-TREATMENT

t	NN	B-TEST
97.8	CD	O
,	,	O
hr	NN	B-TEST
53	CD	O
,	,	O
bp	NN	B-TEST
156/58	CD	O
,	,	O
rr	NN	B-TEST
16	CD	O
,	,	O
o2	PRP	B-TEST
sat	VBD	I-TEST
94%	CD	O
on	IN	O
2.5	CD	O
l	NN	O

nad	RB	B-PROBLEM
,	,	O
awake	NN	O
,	,	O
alert	NN	O
,	,	O
blind	NN	B-PROBLEM
,	,	O
able	JJ	O
to	TO	O
hear	VB	O
loud	JJ	O
voices	NNS	O
at	IN	O
l	NN	O
ear	NN	O

jvp	NN	B-TEST
11	CD	O
cm	NN	O

reg	NN	O
rate	NN	O
,	,	O
nl	CC	O
s1	NN	O
&	CC	O
s2	NN	O
,	,	O
no	DT	O
m/r/g	NN	B-PROBLEM

crackles	NNS	B-PROBLEM
at	IN	I-PROBLEM
base	NN	I-PROBLEM
and	CC	I-PROBLEM
mid-lungs	NNS	I-PROBLEM
bilaterally	RB	I-PROBLEM

soft	JJ	O
,	,	O
nt	JJ	B-PROBLEM
,	,	O
nd	JJ	B-PROBLEM
,	,	O
bs	JJ	O
present	NN	O
,	,	O
no	DT	O
masses	NNS	B-PROBLEM

trace	NN	B-PROBLEM
ankle	NN	I-PROBLEM
edema	NN	I-PROBLEM
bilaterally	RB	I-PROBLEM

wbc	SYM	B-TEST
-	:	O
11.4*	CD	O
rbc	NN	B-TEST
-	:	O
3.61*	CD	O
hgb	NN	B-TEST
-	:	O
11.4*	CD	O
hct	NN	B-TEST
-	:	O
32.6*	CD	O
mcv	SYM	B-TEST
-	:	O
90	CD	O
mch	SYM	B-TEST
-	:	O
31.7	CD	O

mchc	SYM	B-TEST
-	:	O
35.1*	CD	O
rdw	NN	B-TEST
-	:	O
14.7	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
281	CD	O

glucose	JJ	B-TEST
-	:	O
124*	CD	O
urean	JJ	B-TEST
-	:	O
30*	CD	O
creat	NN	B-TEST
-	:	O
1.3*	CD	O
na	SYM	B-TEST
-	:	O
137	CD	O
k	SYM	B-TEST
-	:	O
4.2	CD	O
cl	NN	B-TEST
-	:	O
102	CD	O
hco3	NN	B-TEST
-	:	O
27	CD	O

angap	SYM	B-TEST
-	:	O
12	CD	O

ck	NN	B-TEST
(	(	O
cpk	NN	B-TEST
)	)	O
-	:	O
42	CD	O
ctropnt	NN	B-TEST
-	:	O
0.07*	CD	O

ekg	NN	B-TEST
:	:	O

sinus	NN	B-PROBLEM
brady	JJ	I-PROBLEM
@	VBZ	O
48	CD	O
bpm	NN	O
,	,	O
lad	NN	O
,	,	O
lvh	NN	B-PROBLEM
,	,	O
rbbb	NN	B-PROBLEM
,	,	O
q	JJ	B-PROBLEM
wave	VBP	I-PROBLEM
in	IN	I-PROBLEM
i	NN	I-PROBLEM
,	,	O
st	JJ	B-PROBLEM
depressions	NNS	I-PROBLEM
in	IN	I-PROBLEM
v1-v4	NN	I-PROBLEM
,	,	O
st	JJ	B-PROBLEM
elevation	NN	I-PROBLEM
in	IN	I-PROBLEM
iii	NN	I-PROBLEM
,	,	O
avf	NN	B-PROBLEM
,	,	O
twi	NN	B-PROBLEM
in	IN	I-PROBLEM
iii	NN	I-PROBLEM
,	,	O
v5	NN	O
.	.	O

cxr	JJ	B-TEST
10-07	NNS	O
:	:	O

there	EX	O
is	VBZ	O
slight	JJ	B-PROBLEM
worsening	NN	I-PROBLEM
of	IN	O
the	DT	B-PROBLEM
still	RB	I-PROBLEM
mild	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
pneumothorax	NN	B-PROBLEM
.	.	O

small	JJ	B-PROBLEM
right	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
is	VBZ	O
stable	JJ	O
.	.	O

echo	NN	B-TEST
:	:	O

lvef	NN	B-TEST
>70%	NN	O
,	,	O
la	FW	B-TEST
6.1	CD	O
cm	NN	O
,	,	O
no	DT	O
regional	JJ	B-PROBLEM
wall	NN	I-PROBLEM
motion	NN	I-PROBLEM
abnormality	NN	I-PROBLEM
.	.	O

cardiac	JJ	B-TEST
enzymes	NNS	I-TEST

2015-10-05	JJ	O
09:00pm	CD	O
blood	NN	B-TEST

ck	NN	B-TEST
(	(	O
cpk	NN	B-TEST
)	)	O
-	:	O
1471*	CD	O
ck-mb	JJ	B-TEST
-	:	O
207*	CD	O
mb	NN	B-TEST
indx	NN	I-TEST
-	:	O
14.1*	CD	O
ctropnt	NN	B-TEST
-	:	O
6.00*	CD	O

2015-10-06	JJ	O
04:47pm	CD	O
blood	NN	B-TEST

ck	NN	B-TEST
(	(	O
cpk	NN	B-TEST
)	)	O
-	:	O
1288*	CD	O
ck-mb	JJ	B-TEST
-	:	O
158*	CD	O
mb	NN	B-TEST
indx	NN	I-TEST
-	:	O
12.3*	CD	O
ctropnt	NN	B-TEST
-	:	O
6.88*	CD	O

2015-10-07	JJ	O
07:30am	CD	O
blood	NN	B-TEST

ck	NN	B-TEST
(	(	O
cpk	NN	B-TEST
)	)	O
-	:	O
627*	CD	O
ck-mb	JJ	B-TEST
-	:	O
55*	CD	O
mb	NN	B-TEST
indx	NN	I-TEST
-	:	O
8.8*	CD	O
ctropnt	NN	B-TEST
-	:	O
4.46*	CD	O

labs	NNS	B-TEST
on	IN	O
discharge	NN	O
2015-10-08	CD	O
08:35am	CD	O

wbc	SYM	B-TEST
-	:	O
13.8*	CD	O
rbc	NN	B-TEST
-	:	O
3.39*	CD	O
hgb	NN	B-TEST
-	:	O
10.7*	CD	O
hct	NN	B-TEST
-	:	O
30.2*	CD	O
mcv	SYM	B-TEST
-	:	O
89	CD	O
mch	SYM	B-TEST
-	:	O
31.5	CD	O

mchc	SYM	B-TEST
-	:	O
35.3*	CD	O
rdw	NN	B-TEST
-	:	O
14.8	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
214	CD	O

glucose	JJ	B-TEST
-	:	O
120*	CD	O
urean	JJ	B-TEST
-	:	O
30*	CD	O
creat	NN	B-TEST
-	:	O
1.2*	CD	O
na	SYM	B-TEST
-	:	O
134	CD	O
k	SYM	B-TEST
-	:	O
4.2	CD	O
cl	NN	B-TEST
-	:	O
100	CD	O
hco3	NN	B-TEST
-	:	O
25	CD	O

angap	SYM	B-TEST
-	:	O
13	CD	O

calcium	NN	B-TEST
-	:	O
8.7	CD	O
phos	NN	B-TEST
-	:	O
2.5*	CD	O
mg	SYM	B-TEST
-	:	O
2.1	CD	O

90	CD	O
year-old	JJ	O
woman	NN	O
with	IN	O
h/o	NN	O
of	IN	O
htn	NN	B-PROBLEM
p/w	JJ	O
substernal	JJ	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
shortly	RB	O
after	IN	O
exercise	NN	O
at	IN	O
nursing	NN	O
home	NN	O
,	,	O
with	IN	O
ekg	JJ	B-TEST
showing	VBG	O
st	JJ	B-PROBLEM
depressions	NNS	I-PROBLEM
in	IN	I-PROBLEM
v1-v4	NN	I-PROBLEM
and	CC	O
troponin	NN	B-TEST
0.07.	CD	O

likely	JJ	O
nstemi	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
's	POS	O
family	NN	O
refused	VBD	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
catheterization	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
asa	RB	B-TREATMENT
,	,	O
plavix	NN	B-TREATMENT
,	,	O
heparin	NN	B-TREATMENT
drip	NN	I-TREATMENT
x	VBD	O
24	CD	O
hours	NNS	O
,	,	O
nitro	JJ	B-TREATMENT
drip	NN	I-TREATMENT
,	,	O
atorvastatin	NN	B-TREATMENT
,	,	O
metoprolol	NN	B-TREATMENT
,	,	O
and	CC	O
lisinopril	NN	B-TREATMENT
.	.	O

her	PRP$	B-PROBLEM
chest	JJS	I-PROBLEM
pain	NN	I-PROBLEM
was	VBD	O
controlled	VBN	O
with	IN	O
morphine	NN	B-TREATMENT
.	.	O

her	PRP$	B-TEST
sbp	NN	I-TEST
remained	VBD	O
in	IN	O
the	DT	O
160s-170s	NNS	O
on	IN	O
hospital	JJ	O
day	NN	O
1	CD	O
and	CC	O
she	PRP	O
was	VBD	O
gently	RB	O
diuresed	VBN	O
.	.	O

on	IN	O
hospital	JJ	O
day	NN	O
2	CD	O
she	PRP	O
experienced	VBD	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
with	IN	O
hr	NN	B-TEST
in	IN	O
the	DT	O
140s	CD	O
.	.	O

her	PRP$	B-TREATMENT
metoprolol	NN	I-TREATMENT
dose	NN	I-TREATMENT
was	VBD	O
increased	VBN	O
from	IN	O
25	CD	O
mg	NNS	O
po	RB	O
bid	VBD	O
to	TO	O
50	CD	O
mg	NNS	O
po	RB	O
bid	VBD	O
then	RB	O
75	CD	O
mg	NNS	O
po	JJ	O
tid	NN	O
.	.	O

her	PRP$	B-TEST
hr	NN	I-TEST
decreased	VBN	O
to	TO	O
70s-80s	NNS	O
.	.	O

her	PRP$	B-TEST
bp	NN	I-TEST
remained	VBD	O
stable	JJ	O
.	.	O

an	DT	B-TEST
echo	NN	I-TEST
showed	VBD	O
that	IN	O
she	PRP	O
had	VBD	O
preserved	VBN	O
ef	RB	O
and	CC	O
no	DT	O
wall	NN	B-PROBLEM
motion	NN	I-PROBLEM
abnormalities	NNS	I-PROBLEM
.	.	O

we	PRP	O
decided	VBD	O
given	VBN	O
her	PRP$	O
age	NN	O
that	IN	O
she	PRP	O
would	MD	O
not	RB	O
be	VB	O
a	DT	O
good	JJ	O
candidate	NN	O
for	IN	O
cardioversion	NN	B-TREATMENT
for	IN	O
her	PRP$	B-PROBLEM
afib	JJ	I-PROBLEM
nor	CC	O
would	MD	O
she	PRP	O
be	VB	O
a	DT	O
good	JJ	O
candidate	NN	O
for	IN	O
coumadin	NN	B-TREATMENT
.	.	O

therefore	IN	O
we	PRP	O
will	MD	O
continue	VB	O
rate	NN	O
control	NN	O
with	IN	O
metoprolol	NN	B-TREATMENT
this	DT	O
can	MD	O
be	VB	O
titrated	VBN	O
if	IN	O
needed	VBN	O
,	,	O
and	CC	O
aspirin	NN	B-TREATMENT
and	CC	O
plavix	NN	B-TREATMENT
for	IN	O
anti-coagulation	NN	B-TREATMENT
.	.	O

she	PRP	O
should	MD	O
also	RB	O
continue	VB	O
on	IN	O
lipitor	NN	B-TREATMENT
and	CC	O
lisinopril	NN	B-TREATMENT
.	.	O

she	PRP	O
should	MD	O
have	VB	O
her	PRP$	B-TEST
chem	NN	I-TEST
7	CD	I-TEST
checked	VBD	O
next	JJ	O
week	NN	O
given	VBN	O
the	DT	O
start	NN	O
of	IN	O
her	PRP$	B-TREATMENT
new	JJ	I-TREATMENT
meds	NNS	I-TREATMENT
.	.	O

will	MD	O
also	RB	O
need	VB	O
lft	NN	B-TEST
's	POS	I-TEST
checked	VBN	O
in	IN	O
3-6	JJ	O
months	NNS	O
.	.	O

bilateral	JJ	B-PROBLEM
crackles	NNS	I-PROBLEM
at	IN	I-PROBLEM
bases	NNS	I-PROBLEM
and	CC	I-PROBLEM
midlungs	NNS	I-PROBLEM
,	,	O
elevated	VBD	B-PROBLEM
jvp	NN	I-PROBLEM
,	,	O
trace	NN	B-PROBLEM
bilateral	JJ	I-PROBLEM
ankle	NN	I-PROBLEM
edema	NN	I-PROBLEM
,	,	O
and	CC	O
cxr	NN	B-TEST
with	IN	O
diffuse	NN	B-PROBLEM
opacities	NNS	I-PROBLEM
suggest	VBP	O
possible	JJ	O
pulmonary	JJ	B-PROBLEM
edema	NN	I-PROBLEM
,	,	O
likely	RB	O
secondary	JJ	O
to	TO	O
acute	VB	B-PROBLEM
mi	NN	I-PROBLEM
.	.	O

her	PRP$	B-TEST
o2	NN	I-TEST
sat	NN	I-TEST
was	VBD	O
stable	JJ	O
at	IN	O
94-97%	CD	O
on	IN	O
2.5l	CD	O
of	IN	O
supplemental	JJ	B-TREATMENT
o2	NN	I-TREATMENT
.	.	O

she	PRP	O
experienced	VBD	O
no	DT	O
respiratory	NN	B-PROBLEM
difficulty	NN	I-PROBLEM
during	IN	O
the	DT	O
hospital	NN	O
stay	NN	O
.	.	O

her	PRP$	B-TEST
cxr	NN	I-TEST
prior	RB	O
to	TO	O
discharge	VB	O
showed	JJ	O
mild	JJ	B-PROBLEM
pulm	NN	I-PROBLEM
edema	NN	I-PROBLEM
and	CC	O
thus	RB	O
was	VBD	O
given	VBN	O
40	CD	O
of	IN	O
lasix	NN	B-TREATMENT
prior	NN	O
to	TO	O
going	VBG	O
to	TO	O
rehab	VB	O
.	.	O

she	PRP	O
can	MD	O
be	VB	O
given	VBN	O
prn	JJ	O
lasix	NN	B-TREATMENT
for	IN	O
weight	JJ	B-PROBLEM
gain	NN	I-PROBLEM
or	CC	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

*	JJ	O
leukocytosis-	JJ	B-PROBLEM
she	PRP	O
developed	VBD	O
mild	RB	B-PROBLEM
elevated	VBN	I-PROBLEM
wbc	NN	I-PROBLEM
.	.	O

ua	JJ	B-TEST
had	VBD	O
12-14	NNS	O

wbc	NN	B-TEST
's	POS	I-TEST
,	,	O
few	JJ	B-PROBLEM
bacteria	NNS	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
initially	RB	O
started	VBN	O
on	IN	O
bactrim	NN	B-TREATMENT
,	,	O
but	CC	O
this	DT	O
was	VBD	O
stopped	VBN	O
as	IN	O
she	PRP	O
was	VBD	O
afebrile	RB	B-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
a	DT	B-TEST
culture	NN	I-TEST
pending	VBG	O
which	WDT	O
needs	VBZ	O
to	TO	O
be	VB	O
followed	VBN	O
up	RP	O
at	IN	O
the	DT	O
nursing	NN	O
home	NN	O
and	CC	O
treated	VBD	O
if	IN	O
positive	JJ	B-PROBLEM
.	.	O

tylenol	NN	B-TREATMENT
prn	NN	O
lisinopril	VBD	B-TREATMENT
5	CD	O
mg	NN	O
po	NN	O
qd	NN	O
protonix	VBD	B-TREATMENT
20	CD	O
mg	NN	O
po	NN	O
qd	JJ	O
artifical	JJ	B-TREATMENT
tears	NNS	I-TREATMENT
bid	VBD	O
metoprolol	RB	B-TREATMENT
25	CD	O
mg	JJ	O
po	NN	O
bid	NN	O

1.	CD	O
senna	JJ	B-TREATMENT
8.6	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

2.	CD	O
docusate	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
100	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
constipation	NN	B-PROBLEM
.	.	O

3.	CD	O
aspirin	JJ	B-TREATMENT
325	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

4.	CD	O
clopidogrel	NN	B-TREATMENT
75	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

5.	CD	O
atorvastatin	JJ	B-TREATMENT
80	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

6.	CD	O
pantoprazole	JJ	B-TREATMENT
40	CD	O
mg	JJ	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
0.5	CD	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
q24h	NN	O
(	(	O
every	DT	O
24	CD	O
hours	NNS	O
)	)	O
.	.	O

7.	CD	O
polyvinyl	NN	B-TREATMENT
alcohol	RB	I-TREATMENT
1.4	CD	O
%	NN	O
drops	JJ	O
sig	NN	O
:	:	O
1-2	JJ	O
drops	NNS	O
ophthalmic	JJ	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

8.	CD	O
lisinopril	JJ	B-TREATMENT
10	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

9.	CD	O
metoprolol	JJ	B-TREATMENT
tartrate	NN	I-TREATMENT
25	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
three	CD	O
(	(	O
3	CD	O
)	)	O
tablet	NN	O
po	NN	O
tid	NN	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

10.	CD	O
acetaminophen	JJ	B-TREATMENT
325	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

11.	CD	O
maalox	JJ	B-TREATMENT
225-200	JJ	O
mg/5	NN	O
ml	NN	O
suspension	NN	O
sig	NN	O
:	:	O
five	CD	O
(	(	O
5	CD	O
)	)	O
ml	NN	O
po	NN	O
every	DT	O
six	CD	O
(	(	O
6	CD	O
)	)	O
hours	NNS	O
as	IN	O
needed	VBN	O
for	IN	O
indigestion	NN	B-PROBLEM
.	.	O

12.	CD	O
lasix	JJ	B-TREATMENT
40	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
once	RB	O
a	DT	O
day	NN	O
as	IN	O
needed	VBN	O
for	IN	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
or	CC	O
wheezing	NN	B-PROBLEM
:	:	O

can	MD	O
give	VB	O
40	CD	O
lasix	NN	B-TREATMENT
po	NN	O
if	IN	O
having	VBG	O
any	DT	O
weight	JJ	B-PROBLEM
gain	NN	I-PROBLEM
or	CC	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

nstemi	NN	B-PROBLEM

atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM

htn	NN	B-PROBLEM

patient	NN	O
without	IN	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
and	CC	O
bp	NN	B-TEST
stable	JJ	O
.	.	O

please	VB	O
take	VB	O
all	DT	B-TREATMENT
medications	NNS	I-TREATMENT
as	IN	O
instructed	VBN	O
.	.	O

she	PRP	O
has	VBZ	O
been	VBN	O
started	VBN	O
on	IN	O
several	JJ	B-TREATMENT
new	JJ	I-TREATMENT
medications	NNS	I-TREATMENT
which	WDT	O
are	VBP	O
important	JJ	O
to	TO	O
protect	VB	O
her	PRP$	O
heart	NN	O
.	.	O

if	IN	O
the	DT	O
patient	NN	O
experiences	VBZ	O
any	DT	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
,	,	O
fevers	NNS	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
,	,	O
please	VB	O
return	NN	O
to	TO	O
the	DT	O
emergency	NN	O
room	NN	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
1,770	JJ	O
gram	NN	O
male	NN	O
infant	NN	O
born	VBN	O
by	IN	O
stat	JJ	B-TREATMENT
cesarean	JJ	I-TREATMENT
section	NN	I-TREATMENT
for	IN	O
fetal	JJ	B-PROBLEM
bradycardia	NN	I-PROBLEM
at	IN	O
30-6/7	JJ	O
weeks	NNS	O
gestation	NN	O
to	TO	O
a	DT	O
29-year-old	JJ	O
gravida	NN	O
3	CD	O
,	,	O
para	VBZ	O
0	CD	O
now	RB	O
1	CD	O
mother	NN	O
.	.	O

the	DT	O
pregnancy	NN	O
was	VBD	O
unremarkable	JJ	O
until	IN	O
2015-06-01	JJ	O
when	WRB	O
the	DT	O
mother	NN	O
presented	VBD	O
to	TO	O
shriner	VB	O
's	POS	O
hospital	NN	O
for	IN	O
crippled	JJ	O
children	NNS	O
for	IN	O
increased	VBN	B-PROBLEM
blood	NN	I-PROBLEM
pressure	NN	I-PROBLEM
and	CC	O
proteinuria	NN	B-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
charles	NNS	O
river	VB	O
hospital	NN	O
and	CC	O
was	VBD	O
treated	VBN	O
with	IN	O
magnesium	NN	B-TREATMENT
sulfate	NN	I-TREATMENT
and	CC	O
betamethasone	NN	B-TREATMENT
.	.	O

the	DT	O
morning	NN	O
of	IN	O
admission	NN	O
the	DT	O
mother	NN	O
developed	VBD	O
vaginal	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
and	CC	O
fetal	JJ	B-PROBLEM
bradycardia	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
.	.	O

therefore	RB	O
,	,	O
a	DT	B-TREATMENT
stat	JJ	I-TREATMENT
cesarean	JJ	I-TREATMENT
section	NN	I-TREATMENT
was	VBD	O
performed	VBN	O
.	.	O

the	DT	O
infant	NN	O
emerged	VBD	O
limp	NN	B-PROBLEM
and	CC	O
without	IN	O
spontaneous	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
effort	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
given	VBN	O
bag	JJ	B-TREATMENT
mask	NN	I-TREATMENT
ventilation	NN	I-TREATMENT
with	IN	O
good	JJ	O
response	NN	O
.	.	O

apgar	NN	B-TEST
scores	NNS	I-TEST
were	VBD	O
6	CD	O
at	IN	O
one	CD	O
minute	NN	O
and	CC	O
8	CD	O
at	IN	O
five	CD	O
minutes	NNS	O
.	.	O

o+	NN	O
,	,	O
hepatitis	NN	B-TEST
b	NN	I-TEST
surface	NN	I-TEST
antigen	NN	I-TEST
negative	JJ	O
,	,	O

rpr	NN	B-TEST
nonreactive	JJ	O
,	,	O
rubella	NN	B-PROBLEM
immune	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
in	IN	O
mild	NN	B-PROBLEM
to	TO	I-PROBLEM
moderate	VB	I-PROBLEM
respiratory	NN	I-PROBLEM
distress	NN	I-PROBLEM
.	.	O

neck	NN	O
was	VBD	O
supple	RB	O
without	IN	O
masses	NNS	B-PROBLEM
or	CC	O
defects	NNS	B-PROBLEM
.	.	O

the	DT	O
lungs	NNS	O
were	VBD	O
coarse	JJ	B-PROBLEM
bilaterally	RB	I-PROBLEM
with	IN	O
moderate	JJ	B-PROBLEM
retractions	NNS	I-PROBLEM
.	.	O

the	DT	B-TEST
cardiovascular	JJ	I-TEST
examination	NN	I-TEST
revealed	VBD	O
s1	NN	B-TEST
and	CC	O
s2	NN	B-TEST
regular	NN	O
,	,	O
no	DT	O
murmurs	NN	B-PROBLEM
,	,	O
2+	CD	B-TEST
femoral	JJ	I-TEST
pulses	NNS	I-TEST
.	.	O

the	DT	O
abdomen	NNS	O
was	VBD	O
benign	JJ	O
,	,	O
flat	JJ	O
,	,	O
nontender	FW	B-PROBLEM
,	,	O
nondistended	VBD	B-PROBLEM
,	,	O
no	DT	O
hepatosplenomegaly	NN	B-PROBLEM
.	.	O

hips	NNS	O
were	VBD	O
stable	JJ	O
without	IN	O
clunk	NN	B-PROBLEM
.	.	O

the	DT	O
skin	NN	O
was	VBD	O
without	IN	O
lesions	NNS	B-PROBLEM
.	.	O

the	DT	B-TEST
neurological	JJ	I-TEST
examination	NN	I-TEST
was	VBD	O
appropriate	JJ	O
for	IN	O
age	NN	O
with	IN	O
normal	JJ	O
tone	NN	O
and	CC	O
strength	NN	O
and	CC	O
appropriate	JJ	O
reflexes	NNS	O
.	.	O

he	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
some	DT	B-PROBLEM
apnea	NN	I-PROBLEM
and	CC	O
bradycardic	JJ	B-PROBLEM
spells	NNS	I-PROBLEM
of	IN	I-PROBLEM
prematurity	NN	I-PROBLEM
and	CC	O
was	VBD	O
therefore	RB	O
started	VBN	O
on	IN	O
caffeine	NN	B-TREATMENT
.	.	O

with	IN	O
the	DT	O
initiation	NN	O
of	IN	O
caffeine	NN	B-TREATMENT
therapy	NN	I-TREATMENT
the	DT	O
patient	NN	O
has	VBZ	O
had	VBN	O
no	DT	O
more	RBR	O
apnea	NN	B-PROBLEM
or	CC	O
bradycardic	JJ	B-PROBLEM
events	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
initially	RB	O
started	VBN	O
on	IN	O
nasal	NN	B-TREATMENT
prong	JJ	I-TREATMENT
cpap	NN	I-TREATMENT
at	IN	O
6	CD	O
and	CC	O
required	VBD	O
additional	JJ	B-TREATMENT
oxygen	NN	I-TREATMENT
to	TO	O
35%	CD	O
.	.	O

however	RB	O
by	IN	O
24	CD	O
hours	NNS	O
he	PRP	O
transitioned	VBD	O
to	TO	O
low-flow	JJ	B-TREATMENT
nasal	JJ	I-TREATMENT
cannula	NN	I-TREATMENT
and	CC	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
five	CD	O
transitioned	VBN	O
to	TO	O
room	NN	O
air	NN	O
where	WRB	O
he	PRP	O
currently	RB	O
remains	VBZ	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
initially	RB	O
maintained	VBN	O
on	IN	O
intravenous	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
only	RB	O
and	CC	O
when	WRB	O
his	PRP$	B-PROBLEM
respiratory	NN	I-PROBLEM
distress	NN	I-PROBLEM
resolved	VBD	O
he	PRP	O
was	VBD	O
transitioned	VBN	O
to	TO	O
enteral	JJ	B-TREATMENT
feeds	NNS	I-TREATMENT
.	.	O

the	DT	O
morning	NN	O
of	IN	O
transfer	NN	O
his	PRP$	B-TREATMENT
iv	NN	I-TREATMENT
came	VBD	O
out	RB	O
so	RB	O
he	PRP	O
has	VBZ	O
just	RB	O
been	VBN	O
advanced	VBN	O
to	TO	O
120	CD	O
cc	NNS	O
per	IN	O
kg	FW	O
per	IN	O
day	NN	O
of	IN	O
pe-20	NN	B-TREATMENT
and	CC	O
his	PRP$	O
tolerating	VBG	O
these	DT	B-TREATMENT
pg	JJ	I-TREATMENT
feedings	NNS	I-TREATMENT
without	IN	O
difficulty	NN	O
.	.	O

last	JJ	B-TEST
set	NN	I-TEST
of	IN	I-TEST
electrolytes	NNS	I-TEST
on	IN	O
06-08	NN	O
,	,	O
dol3	NN	O
:	:	O

na	RB	B-TEST
145	CD	O
,	,	O
k	VBD	B-TEST
4.3	CD	O
,	,	O
cl	NN	B-TEST
110	CD	O
,	,	O
tco2	VBD	B-TEST
25	CD	O
.	.	O

his	PRP$	B-TEST
admission	NN	I-TEST
complete	JJ	I-TEST
blood	NN	I-TEST
count	NN	I-TEST
was	VBD	O
notable	JJ	O
for	IN	O
a	DT	B-TEST
white	JJ	I-TEST
count	NN	I-TEST
of	IN	O
11.8	CD	O
,	,	O
25	CD	B-TEST
polys	NN	I-TEST
and	CC	O
no	DT	O
bands	NNS	B-PROBLEM
.	.	O

hematocrit	NN	B-TEST
was	VBD	O
45	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
270	CD	O
.	.	O

he	PRP	O
developed	VBD	O
physiologic	JJ	B-PROBLEM
hyperbilirubinemia	NN	I-PROBLEM
(	(	O
peak	JJ	B-TEST
bili	NN	I-TEST
8.6/0.3	CD	O
on	IN	O
06-08	NN	O
,	,	O
dol3	NN	O
)	)	O
for	IN	O
which	WDT	O
he	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
a	DT	B-TREATMENT
single	JJ	I-TREATMENT
phototherapy	NN	I-TREATMENT
.	.	O

his	PRP$	B-TEST
most	RBS	I-TEST
recent	JJ	I-TEST
bilirubin	NN	I-TEST
was	VBD	O
6.6	CD	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
six	CD	O
,	,	O
the	DT	O
day	NN	O
of	IN	O
discharge	NN	O
,	,	O
and	CC	O
his	PRP$	B-TREATMENT
phototherapy	NN	I-TREATMENT
was	VBD	O
discontinued.	NN	O
he	PRP	O
will	MD	O
need	VB	O
a	DT	B-TEST
rebound	NN	I-TEST
bilirubin	NN	I-TEST
level	NN	I-TEST
in	IN	O
am	VBP	O
.	.	O

blood	NN	B-TEST
culture	NN	I-TEST
was	VBD	O
sent	VBN	O
but	CC	O
he	PRP	O
was	VBD	O
never	RB	O
started	VBN	O
on	IN	O
antibiotics	NNS	B-TREATMENT
.	.	O

the	DT	B-TEST
blood	NN	I-TEST
culture	NN	I-TEST
remained	VBD	O
sterile	JJ	O
.	.	O

he	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
an	DT	B-PROBLEM
erythematous	JJ	I-PROBLEM
perianal	JJ	I-PROBLEM
rash	NN	I-PROBLEM
and	CC	O
for	IN	O
this	DT	O
was	VBD	O
started	VBN	O
on	IN	O
nystatin	NN	B-TREATMENT
powder	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
not	RB	O
had	VBN	O
an	DT	O
cmed	VBN	B-TEST
examination	NN	I-TEST
or	CC	O
hearing	JJ	B-TEST
test	NN	I-TEST
.	.	O

feeds	NNS	B-TREATMENT
at	IN	O
discharge	NN	O
are	VBP	O
pe-20	JJ	B-TREATMENT
currently	RB	O
at	IN	O
120	CD	O
cc	NN	O
per	IN	O
kg	FW	O
per	IN	O
day	NN	O
due	JJ	O
to	TO	O
advance	VB	O
15	CD	O
cc	NN	O
per	IN	O
kg	FW	O
per	IN	O
day	NN	O
to	TO	O
a	DT	O
total	NN	O
of	IN	O
150	CD	O
cc	NNS	O
per	IN	O
kg	FW	O
per	IN	O
day	NN	O
.	.	O

caffeine	NN	B-TREATMENT
12	CD	O
mg	NN	O
pg	NN	O
q	NN	O
day.	NN	O
he	PRP	O
has	VBZ	O
not	RB	O
had	VBN	O
his	PRP$	O
06-10	JJ	O
dose	NN	O
.	.	O

he	PRP	O
is	VBZ	O
due	JJ	O
to	TO	O
have	VB	O
his	PRP$	B-TEST
state	NN	I-TEST
screen	NN	I-TEST
sent	VBD	O
today	NN	O
.	.	O

synagis	NN	B-TREATMENT
rsv	NN	I-TREATMENT
prophylaxis	NN	I-TREATMENT
should	MD	O
be	VB	O
considered	VBN	O
from	IN	O
october	VBN	O
through	IN	O
april	NN	O
for	IN	O
infants	NNS	O
who	WP	O
meet	VBP	O
any	DT	O
of	IN	O
the	DT	O
following	JJ	O
criteria	NNS	O
:	:	O

3.	CD	O
with	IN	O
chronic	JJ	B-PROBLEM
lung	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

influenza	JJ	B-TREATMENT
vaccination	NN	I-TREATMENT
should	MD	O
be	VB	O
considered	VBN	O
annually	RB	O
in	IN	O
the	DT	O
fall	NN	O
for	IN	O
preterm	JJ	O
infants	NNS	O
with	IN	O
chronic	JJ	B-PROBLEM
lung	NN	I-PROBLEM
disease	NN	I-PROBLEM
once	IN	O
they	PRP	O
reach	VBP	O
six	CD	O
months	NNS	O
of	IN	O
age	NN	O
.	.	O

before	IN	O
this	DT	O
age	NN	O
,	,	O
the	DT	O
family	NN	O
and	CC	O
other	JJ	O
caregivers	NNS	O
should	MD	O
be	VB	O
considered	VBN	O
for	IN	O
immunization	NN	B-TREATMENT
against	IN	O
influenza	NN	B-PROBLEM
to	TO	O
protect	VB	O
the	DT	O
infant	NN	O
.	.	O

1.	CD	O
prematurity	NN	B-PROBLEM
at	IN	O
30-6/7	JJ	O
weeks	NNS	O
.	.	O

2.	CD	O
rule	NN	O
out	IN	O
sepsis	NN	B-PROBLEM
,	,	O
off	RB	O
antibiotics	NNS	B-TREATMENT
.	.	O

3.	CD	O
apnea	NN	B-PROBLEM
and	CC	O
bradycardia	NN	B-PROBLEM
of	IN	O
prematurity	NN	B-PROBLEM
.	.	O

4.	CD	O
hyperbilirubinemia	NN	B-PROBLEM
.	.	O

5.	CD	O
feeding	JJ	B-PROBLEM
immaturity	NN	I-PROBLEM
.	.	O

sulfonamides	NNS	B-TREATMENT
/	VBP	O
penicillins	NNS	B-TREATMENT
/	JJ	O
tetracyclines	NNS	B-TREATMENT
/	VBP	O
azithromycin	JJ	B-TREATMENT
/	NNP	O
iodine	NN	B-TREATMENT
/	NNP	O
shellfish	JJ	O
/	NNP	O
ace	NN	B-TREATMENT
inhibitors	NNS	I-TREATMENT
/	VBP	O
ciprofloxacin	NN	B-TREATMENT

chronic	JJ	B-PROBLEM
prostatitis	NN	I-PROBLEM

turp	NN	B-TREATMENT

justin	NN	O
searle	VBD	O
a	DT	O
60-year-old	JJ	O
man	NN	O
with	IN	O
a	DT	O
long	JJ	O
history	NN	O
of	IN	O
chronic	JJ	B-PROBLEM
prostatitis	NN	I-PROBLEM
status	NN	O
post	NN	O
two	CD	B-TREATMENT
transurethral	JJ	I-TREATMENT
resection	NN	I-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
prostate	NN	I-TREATMENT
procedures	NNS	O
in	IN	O
2007	CD	O
and	CC	O
1998	CD	O
.	.	O

he	PRP	O
also	RB	O
has	VBZ	O
a	DT	O
diagnosis	NN	O
of	IN	O
interstitial	JJ	B-PROBLEM
cystitis	NN	I-PROBLEM
and	CC	O
more	RBR	O
significantly	RB	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
with	IN	O
a	DT	B-TEST
recent	JJ	I-TEST
catheterization	NN	I-TEST
,	,	O
supraventricular	JJ	B-PROBLEM
tachycardia	NN	I-PROBLEM
,	,	O
and	CC	O
a	DT	B-PROBLEM
progressive	JJ	I-PROBLEM
mitochondrial	NN	I-PROBLEM
myopathy	NN	I-PROBLEM
.	.	O

he	PRP	O
has	VBZ	O
had	VBN	O
symptoms	NNS	B-PROBLEM
of	IN	O
dribbling	NN	B-PROBLEM
,	,	O
stress	NN	B-PROBLEM
incontinence	NN	I-PROBLEM
,	,	O
hematuria	NN	B-PROBLEM
,	,	O
but	CC	O
has	VBZ	O
no	DT	O
dysuria	NN	B-PROBLEM
.	.	O

1.	CD	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
(	(	O
s/p	JJ	O
stents	NNS	B-TREATMENT
to	TO	I-TREATMENT
lad	VB	I-TREATMENT
and	CC	I-TREATMENT
3rd	CD	I-TREATMENT
om	NN	I-TREATMENT
)	)	O

2.	CD	O
supraventricular	JJ	B-PROBLEM
tachycardia	NN	I-PROBLEM
(	(	O
on	IN	O
a	DT	B-TREATMENT
beta	NN	I-TREATMENT
blocker	NN	I-TREATMENT
)	)	O
.	.	O

3.	CD	O
mitochondrial	JJ	B-PROBLEM
myopathy	NN	I-PROBLEM
.	.	O

4.	CD	O
history	NN	O
of	IN	O
orthostasis	NN	B-PROBLEM
with	IN	O
tilt	JJ	B-TEST
table	JJ	I-TEST
testing	VBG	I-TEST
done	VBN	O
in	IN	O
the	DT	O
past	NN	O
.	.	O

5.	CD	O
status	NN	O
post	NN	O
transurethral	JJ	B-TREATMENT
resection	NN	I-TREATMENT
of	IN	I-TREATMENT
prostate	JJ	I-TREATMENT
times	NNS	O
two	CD	O
(	(	O
in	IN	O
2007	CD	O
and	CC	O
1998	CD	O
)	)	O
.	.	O

6.	CD	O
interstitial	JJ	B-PROBLEM
cystitis	NN	I-PROBLEM
.	.	O

7.	CD	O
pericarditis	NN	B-PROBLEM
.	.	O

8.	CD	O
hypertension	NN	B-PROBLEM
.	.	O

9.	CD	O
hypercholesterolemia	NN	B-PROBLEM
.	.	O

10.	CD	O
gastrointestinal	JJ	B-PROBLEM
bleed	NN	I-PROBLEM

father	NN	O
had	VBD	O
mi	VBN	B-PROBLEM
at	IN	O
42	CD	O

mother	NN	O
died	VBD	O
of	IN	O
mi	NN	B-PROBLEM
at	IN	O
76	CD	O

nad	NN	B-PROBLEM

rrr	NN	O
,	,	O
no	DT	O
m/r/g	NN	B-PROBLEM

abd	NN	O
:	:	O
soft	JJ	O
,	,	O
+distension	NN	B-PROBLEM
with	IN	O
tympany	NN	B-PROBLEM
,	,	O
no	DT	O
hsm	NN	B-PROBLEM
,	,	O
hyperactive	JJ	B-PROBLEM
bs	NN	I-PROBLEM

ext	NN	O
:	:	O
no	DT	O
c/c/e	NN	B-PROBLEM

ecg	NN	B-TEST
:	:	O

nsr	NN	B-TEST
at	IN	O
62	CD	O
,	,	O
nl	RB	O
axis	NN	O
,	,	O
nl	JJ	O
intervals	NNS	O
,	,	O
q	NN	B-PROBLEM
waves	NNS	I-PROBLEM
in	IN	I-PROBLEM
iii	NN	I-PROBLEM
,	,	O
avr	NN	B-TEST
,	,	I-TEST
v1	NN	B-TEST
.	.	O

twi	NN	B-PROBLEM
's	POS	O
in	IN	O
iii	NN	O
,	,	O
v1	NN	O
.	.	O

glucose	JJ	B-TEST
-	:	O
94	CD	O
urea	JJ	B-TEST
n	SYM	I-TEST
-	:	O
22*	CD	O
creat	NN	B-TEST
-	:	O
1.4*	CD	O
sodium	NN	B-TEST
-	:	O
142	CD	O

potassium	NN	B-TEST
-	:	O
5.9*	CD	O
chloride	NN	B-TEST
-	:	O
108	CD	O
total	JJ	B-TEST
co2	NN	I-TEST
-	:	O
23	CD	O
anion	NN	B-TEST
gap	NN	I-TEST
-	:	O
17	CD	O

calcium	NN	B-TEST
-	:	O
9.7	CD	O
phosphate	NN	B-TEST
-	:	O
3.9	CD	O
magnesium	NN	B-TEST
-	:	O
1.9	CD	O

wbc	SYM	B-TEST
-	:	O
7.5	CD	O
rbc	NN	B-TEST
-	:	O
5.09	CD	O
hgb	NN	B-TEST
-	:	O
15.4	CD	O
hct	NN	B-TEST
-	:	O
43.7	CD	O
mcv	SYM	B-TEST
-	:	O
86	CD	O

mch	SYM	B-TEST
-	:	O
30.2	CD	O
mchc	SYM	B-TEST
-	:	O
35.2*	CD	O
rdw	NN	B-TEST
-	:	O
13.6	CD	O

plt	NN	B-TEST
count	NN	I-TEST
-	:	O
257#	CD	O

pt	SYM	B-TEST
-	:	O
12.2	CD	O
ptt	NN	B-TEST
-	:	O
23.8	CD	O
inr	NN	B-TEST
(	(	I-TEST
pt	NN	I-TEST
)	)	I-TEST
-	:	O
0.9	CD	O

on	IN	O
hd2	NN	O
,	,	O
cardiac	JJ	B-TEST
clearance	NN	I-TEST
was	VBD	O
obtained	VBN	O
by	IN	O
dr.	JJ	O
sanchez	NN	O
.	.	O

patient	NN	O
tolerated	VBD	O
procedure	NN	B-TREATMENT
on	IN	O
2018-03-05	JJ	O
and	CC	O
was	VBD	O
transferred	VBN	O
to	TO	O

icu	NN	O
for	IN	O
24hr	CD	O
post-op	JJ	O
cardiac	JJ	B-TEST
monitoring	NN	I-TEST
.	.	O

catheter	NN	B-TREATMENT
was	VBD	O
removed	VBN	O
.	.	O

he	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
pyridium	NN	B-TREATMENT
.	.	O

1.	CD	O
hydroxyzine	NN	B-TREATMENT
hcl	NN	I-TREATMENT
10	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

2.	CD	O
atorvastatin	JJ	B-TREATMENT
calcium	NN	I-TREATMENT
20	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

3.	CD	O
ezetimibe	JJ	B-TREATMENT
10	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

4.	CD	O
simethicone	NN	B-TREATMENT
80	CD	O
mg	NN	O
tablet	NN	O
,	,	O
chewable	JJ	O
sig	NN	O
:	:	O
0.5-1	JJ	O
tablet	NN	O
,	,	O
chewable	JJ	O
po	NN	O
qid	NN	O
(	(	O
4	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
indigestion/gas	NN	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

5.	CD	O
aluminum-magnesium	JJ	B-TREATMENT
hydroxide	JJ	I-TREATMENT
225-200	JJ	O
mg/5	NN	O
ml	NN	O
suspension	NN	O
sig	NN	O
:	:	O
15-30	JJ	O
mls	NN	O
po	NN	O
qid	NN	O
(	(	O
4	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
indigestion	NN	B-PROBLEM
.	.	O

6.	CD	O
atenolol	JJ	B-TREATMENT
100	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

7.	CD	O
hyoscyamine	JJ	B-TREATMENT
sulfate	NN	I-TREATMENT
0.125	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
qid	NN	O
(	(	O
4	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

8.	CD	O
phenazopyridine	NN	B-TREATMENT
hcl	NN	I-TREATMENT
100	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
tid	NN	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
for	IN	O
3	CD	O
days	NNS	O
.	.	O

chronic	JJ	B-PROBLEM
prostatitis	NN	I-PROBLEM

interstitial	JJ	B-PROBLEM
cystitis	NN	I-PROBLEM

go	VB	O
to	TO	O
an	DT	O
emergency	NN	O
room	NN	O
if	IN	O
you	PRP	O
experience	VBP	O
symptoms	NNS	B-PROBLEM
including	VBG	O
,	,	O
but	CC	O
not	RB	O
necessarily	RB	O
limited	VBN	O
to	TO	O
:	:	O
new	JJ	B-PROBLEM
and	CC	I-PROBLEM
continuing	VBG	I-PROBLEM
nausea	NN	I-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
,	,	O
fevers	NNS	B-PROBLEM
(	(	O
>101.5	NNP	O
f	NN	O
)	)	O
,	,	O
chills	NNS	B-PROBLEM
,	,	O
or	CC	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

proceed	NN	O
to	TO	O
the	DT	O
er/ew/monica	NN	O
if	IN	O
your	PRP$	B-PROBLEM
wound	NN	I-PROBLEM
becomes	RB	O
red	JJ	B-PROBLEM
,	,	O
swollen	VBN	B-PROBLEM
,	,	O
warm	JJ	B-PROBLEM
,	,	O
or	CC	O
produces	VBZ	O
pus	NN	B-PROBLEM
.	.	O

you	PRP	O
may	MD	O
remove	VB	O
your	PRP$	B-TREATMENT
dressings	NNS	I-TREATMENT
2	CD	O
days	NNS	O
after	IN	O
your	PRP$	B-TREATMENT
surgery	NN	I-TREATMENT
if	IN	O
they	PRP	O
were	VBD	O
not	RB	O
removed	VBN	O
in	IN	O
the	DT	O
hospital	NN	O
.	.	O

leave	VB	O
the	DT	B-TREATMENT
steri	JJ	I-TREATMENT
strips	NNS	I-TREATMENT
on	IN	O
until	IN	O
they	PRP	O
begin	VBP	O
to	TO	O
peel	VB	O
,	,	O
then	RB	O
you	PRP	O
may	MD	O
remove	VB	O
them.	NN	O
staples	NNS	B-TREATMENT
and	CC	O
stitches	NNS	B-TREATMENT
will	MD	O
remain	VB	O
until	IN	O
your	PRP$	O
follow-up	JJ	O
appointment	NN	O
.	.	O

if	IN	O
you	PRP	O
experience	VBP	O
clear	JJ	B-PROBLEM
drainage	NN	I-PROBLEM
from	IN	O
your	PRP$	B-PROBLEM
wounds	NNS	I-PROBLEM
,	,	O
cover	VB	O
them	PRP	O
with	IN	O
a	DT	B-TREATMENT
clean	JJ	I-TREATMENT
dressing	NN	I-TREATMENT
and	CC	O
stop	VB	O
showering	NN	O
until	IN	O
the	DT	B-PROBLEM
drainage	NN	I-PROBLEM
subsides	VBZ	O
for	IN	O
at	IN	O
least	JJS	O
2	CD	O
days	NNS	O
.	.	O

no	DT	O
driving	VBG	O
while	IN	O
taking	VBG	O
pain	JJ	B-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

narcotics	NNS	B-TREATMENT
can	MD	O
cause	VB	O
constipation	NN	B-PROBLEM
.	.	O

please	VB	O
take	VB	O
an	DT	B-TREATMENT
over	IN	I-TREATMENT
the	DT	I-TREATMENT
counter	JJ	I-TREATMENT
stool	NN	I-TREATMENT
softener	NN	I-TREATMENT
such	JJ	O
as	IN	O
colace	NN	B-TREATMENT
or	CC	O
a	DT	B-TREATMENT
gentle	JJ	I-TREATMENT
laxative	NN	I-TREATMENT
such	JJ	O
as	IN	O
milk	NN	B-TREATMENT
of	IN	I-TREATMENT
magnesia	NN	I-TREATMENT
if	IN	O
you	PRP	O
experience	VBP	O
constipation	NN	B-PROBLEM
.	.	O

you	PRP	O
may	MD	O
take	VB	O
showers	NNS	O
(	(	O
no	DT	O
baths	NN	O
)	)	O
after	IN	O
your	PRP$	B-TREATMENT
dressings	NNS	I-TREATMENT
have	VBP	O
been	VBN	O
removed	VBN	O
from	IN	O
your	PRP$	B-PROBLEM
wounds	NNS	I-PROBLEM
.	.	O

continue	VB	O
taking	VBG	O
your	PRP$	B-TREATMENT
home	NN	I-TREATMENT
medications	NNS	I-TREATMENT
unless	IN	O
otherwise	RB	O
contraindicated	VBN	O
and	CC	O
follow	VB	O
up	RP	O
with	IN	O
pcp	NN	O
.	.	O

mr.	NN	O
jackson	NN	O
is	VBZ	O
a	DT	O
63-year-old	JJ	O
male	NN	O
with	IN	O
squamous	JJ	B-PROBLEM
cell	NN	I-PROBLEM
carcinoma	NN	I-PROBLEM
of	IN	O
the	DT	O
floor	NN	O
of	IN	O
mouth	NN	O
(	(	O
stage	NN	B-PROBLEM
t2	RB	I-PROBLEM
n0	RB	I-PROBLEM
)	)	O
that	WDT	O
was	VBD	O
biopsied	VBN	O
by	IN	O
his	PRP$	O
dentist	NN	O
.	.	O

pathology	NN	B-TEST
was	VBD	O
reviewed	VBN	O
revealing	VBG	O
invasive	JJ	B-PROBLEM
squamous	JJ	I-PROBLEM
cell	NN	I-PROBLEM
carcinoma	NN	I-PROBLEM
.	.	O

he	PRP	O
presented	VBD	O
on	IN	O
2016-11-21	JJ	O
for	IN	O
resection	NN	B-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
admitted	VBN	O
on	IN	O
2016-11-21	JJ	O
following	VBG	O
his	PRP$	B-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

he	PRP	O
underwent	VBD	O
a	DT	B-TREATMENT
joint	JJ	I-TREATMENT
procedure	NN	I-TREATMENT
by	IN	O
otolaryngology	NN	O
and	CC	O
plastic	NN	O
surgery	NN	O
.	.	O

includes	VBZ	O
hypertension	NN	B-PROBLEM
and	CC	O
chronic	JJ	B-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

polypectomy	NN	B-TREATMENT
in	IN	O
2011	CD	O
,	,	O
tooth	DT	B-TREATMENT
extraction	NN	I-TREATMENT
(	(	O
all	DT	O
)	)	O
in	IN	O
1980	CD	O
,	,	O
and	CC	O
hernia	NN	B-PROBLEM
in	IN	O
1977	CD	O
.	.	O

tomato	NN	O
(	(	O
causing	VBG	O
anaphylaxis	NN	B-PROBLEM
)	)	O
and	CC	O
tetanus	$	B-TREATMENT
shot	NN	I-TREATMENT
.	.	O

triamterene/hydrochlorothiazide	RB	B-TREATMENT
37.5/25	CD	O
mg	NN	O
one	CD	O
tablet	NN	O
by	IN	O
mouth	NN	O
once	RB	O
daily	JJ	O
and	CC	O
lorazepam	JJ	B-TREATMENT
1	CD	O
mg	NN	O
three	CD	O
times	NNS	O
daily	RB	O
as	IN	O
needed	VBN	O
(	(	O
for	IN	O
anxiety	NN	B-PROBLEM
)	)	O
.	.	O

1.	CD	O
tracheostomy	NN	B-TREATMENT
.	.	O

2.	CD	O
diagnostic	JJ	B-TEST
laryngoscopy	NN	I-TEST
and	CC	O
biopsy	NN	B-TEST
.	.	O

3.	CD	O
bilateral	JJ	B-TREATMENT
supraomohyoid	NN	I-TREATMENT
neck	NN	I-TREATMENT
dissection	NN	I-TREATMENT
.	.	O

4.	CD	O
resection	NN	B-TREATMENT
of	IN	O
floor	NN	O
of	IN	O
mouth	JJ	B-PROBLEM
tumor	NN	I-PROBLEM
.	.	O

frozen	JJ	B-TEST
section	NN	I-TEST
sent	VBD	O
to	TO	O
pathology	VB	O
revealing	VBG	O
invasive	JJ	B-PROBLEM
squamous	JJ	I-PROBLEM
cell	NN	I-PROBLEM
carcinoma	NN	I-PROBLEM
.	.	O

no	DT	O
complications	NNS	B-PROBLEM
.	.	O

the	DT	O
plastic	NN	O
team	NN	O
then	RB	O
took	VBD	O
over	RP	O
for	IN	O
reconstruction	NN	B-TREATMENT
consisting	NN	O
of	IN	O
radial	JJ	B-TREATMENT
forearm	NN	I-TREATMENT
free	JJ	I-TREATMENT
flap	NN	I-TREATMENT
to	TO	O
floor	NN	O
of	IN	O
mouth	NN	O
.	.	O

total	JJ	B-TREATMENT
intravenous	JJ	I-TREATMENT
fluids	NNS	I-TREATMENT
of	IN	O
7300	CD	O
cc	NN	O
.	.	O

estimated	VBN	B-PROBLEM
blood	NN	I-PROBLEM
loss	NN	I-PROBLEM
of	IN	O
300	CD	O
cc	NN	O
.	.	O

urine	JJ	B-TEST
output	NN	I-TEST
of	IN	O
900	CD	O
cc	NN	O
.	.	O

no	DT	O
complications	NNS	B-PROBLEM
.	.	O

in	IN	O
addition	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
prepared	VBN	O
for	IN	O
an	DT	B-TREATMENT
attempted	JJ	I-TREATMENT
percutaneous	JJ	I-TREATMENT
endoscopic	NN	I-TREATMENT
gastrostomy	NN	I-TREATMENT
tube	NN	I-TREATMENT
.	.	O

the	DT	B-TREATMENT
percutaneous	JJ	I-TREATMENT
endoscopic	NN	I-TREATMENT
gastrostomy	NN	I-TREATMENT
was	VBD	O
unsuccessful	JJ	O
,	,	O
and	CC	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
was	VBD	O
converted	VBN	O
to	TO	O
an	DT	B-TREATMENT
open	JJ	I-TREATMENT
gastrostomy	NN	I-TREATMENT
tube	NN	I-TREATMENT
which	WDT	O
then	RB	O
proceeded	VBD	O
without	IN	O
complications	NNS	B-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
sedated	VBN	O
and	CC	O
ventilated	VBN	O
by	IN	O
his	PRP$	B-TREATMENT
tracheostomy	NN	I-TREATMENT
6	CD	I-TREATMENT
cuff	NN	I-TREATMENT
shiley	NN	I-TREATMENT
tube	NN	I-TREATMENT
.	.	O

he	PRP	O
had	VBD	O
three	CD	O
westwood-pocasset	NN	B-TREATMENT
drains	NNS	I-TREATMENT
-	:	O
two	CD	O
in	IN	O
the	DT	O
neck	NN	O
and	CC	O
one	CD	O
in	IN	O
his	PRP$	O
right	JJ	O
arm	NN	O
.	.	O

g-tube	NN	B-TREATMENT
was	VBD	O
to	TO	O
gravity	NN	O
,	,	O
foley	NN	B-TREATMENT
to	TO	O
gravity	NN	O
,	,	O
left	VBD	B-TREATMENT
radial	JJ	I-TREATMENT
a-line	NN	I-TREATMENT
.	.	O

the	DT	B-TREATMENT
flap	NN	I-TREATMENT
was	VBD	O
pink	VBN	O
with	IN	O
a	DT	B-TEST
strong	JJ	I-TEST
doppler	NN	I-TEST
signal	NN	I-TEST
.	.	O

he	PRP	O
underwent	JJ	O
flap	JJ	B-TEST
checks	NNS	I-TEST
every	DT	O
15	CD	O
minutes	NNS	O
initially	RB	O
with	IN	O
a	DT	B-TREATMENT
dextran	JJ	I-TREATMENT
infusion	NN	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
placed	VBN	O
on	IN	O
unasyn	JJ	B-TREATMENT
3	CD	O
grams	NNS	O
iv	VBP	B-TREATMENT
q.6h.	NN	O

nothing	NN	O
by	IN	O
mouth	NN	O
initially	RB	O
with	IN	O
morphine	NN	B-TREATMENT
as	IN	O
needed	VBN	O
for	IN	O
pain	NN	B-PROBLEM
and	CC	O
ativan	NN	B-TREATMENT
around	IN	O
the	DT	O
clock	NN	O
for	IN	O
delirium	NN	B-TREATMENT
tremens	NNS	I-TREATMENT
prophylaxis	NN	I-TREATMENT
.	.	O

in	IN	O
addition	NN	O
,	,	O
he	PRP	O
received	VBD	O
metoprolol	JJ	B-TREATMENT
q.4.h.	NN	O
,	,	O
a	DT	B-TREATMENT
regular	JJ	I-TREATMENT
insulin	NN	I-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT
,	,	O
and	CC	O
adequate	JJ	O
gastrointestinal	JJ	O
prophylaxis	NN	O
with	IN	O
protonix	NN	B-TREATMENT
.	.	O

postoperative	JJ	B-TEST
laboratories	NNS	I-TEST
revealed	VBD	O
sodium	NN	B-TEST
was	VBD	O
134	CD	O
,	,	O
potassium	NN	B-TEST
was	VBD	O
4.1	CD	O
,	,	O
chloride	NN	B-TEST
was	VBD	O
102	CD	O
,	,	O
bicarbonate	NN	B-TEST
was	VBD	O
28	CD	O
,	,	O
blood	NN	B-TEST
urea	JJ	I-TEST
nitrogen	NN	I-TEST
was	VBD	O
18	CD	O
,	,	O
creatinine	NN	B-TEST
was	VBD	O
0.8	CD	O
,	,	O
and	CC	O
glucose	NN	B-TEST
was	VBD	O
148	CD	O
.	.	O

calcium	NN	B-TEST
was	VBD	O
7.6	CD	O
.	.	O

magnesium	NN	B-TEST
was	VBD	O
2.2	CD	O
.	.	O

complete	JJ	B-TEST
blood	NN	I-TEST
count	NN	I-TEST
revealed	VBD	O
white	JJ	B-TEST
count	NN	I-TEST
was	VBD	O
5.4	CD	O
,	,	O
hematocrit	NN	B-TEST
was	VBD	O
31.3	CD	O
,	,	O
and	CC	O
platelets	NNS	B-TEST
were	VBD	O
160	CD	O
.	.	O

alt	NN	B-TEST
was	VBD	O
14	CD	O
,	,	O
ast	NN	B-TEST
was	VBD	O
31	CD	O
,	,	O
alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
was	VBD	O
42	CD	O
,	,	O
total	JJ	B-TEST
bilirubin	NN	I-TEST
was	VBD	O
0.9	CD	O
,	,	O
albumin	NN	B-TEST
was	VBD	O
2.2	CD	O
.	.	O

a	DT	B-TEST
chest	JJ	I-TEST
x-ray	NN	I-TEST
postoperatively	RB	O
showed	VBD	O
clear	JJ	O
lung	NN	O
fields	NNS	O
.	.	O

tracheostomy	NN	B-TREATMENT
tube	NN	I-TREATMENT
in	IN	O
good	JJ	O
position	NN	O
.	.	O

no	DT	O
pneumothorax	NN	B-PROBLEM
.	.	O

cmed	VBN	O
csru	NN	O
and	CC	O
plastic	NN	O
surgery	NN	O
flap	NN	B-TEST
checks	NNS	I-TEST
,	,	O
tracheostomy	EX	B-TREATMENT
care	NN	I-TREATMENT
,	,	O
and	CC	O
westwood-pocasset	JJ	B-TREATMENT
management.	NN	I-TREATMENT

lopressor	NN	B-TREATMENT
5	CD	O
intravenously	RB	O
q.4.h.	JJ	O

nebulizers	NNS	B-TREATMENT
as	IN	O
needed	VBN	O
,	,	O
weaning	VBG	O
from	IN	O
ventilation	NN	B-TREATMENT
.	.	O

medications	NNS	B-TREATMENT
per	IN	O
gastrostomy	NN	B-TREATMENT
tube	NN	I-TREATMENT
on	IN	O
postoperative	JJ	O
day	NN	O
one	CD	O
.	.	O

foley	NN	B-TREATMENT
catheter	NN	I-TREATMENT
for	IN	O
strict	JJ	B-TEST
monitoring	NN	I-TEST
of	IN	I-TEST
ins	NNS	I-TEST
and	CC	I-TEST
outs	NNS	I-TEST
.	.	O

hematocrit	NN	B-TEST
stable	JJ	O
.	.	O

unasyn	NN	B-TREATMENT
for	IN	O
antibiotic	JJ	B-TREATMENT
coverage	NN	I-TREATMENT
.	.	O

flap	NN	B-TEST
checks	NNS	I-TEST
carried	VBD	O
out	RP	O
q.2h.	NN	O
initially	RB	O
in	IN	O
the	DT	O
surgical	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
showing	VBG	O
positive	JJ	B-PROBLEM
biphasic	JJ	I-PROBLEM
doppler	NN	I-PROBLEM
signals	NNS	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
weaned	VBN	O
from	IN	O
ventilation	NN	B-TREATMENT
on	IN	O
postoperative	JJ	O
day	NN	O
one	CD	O
to	TO	O
pressure	VB	B-TREATMENT
support	NN	I-TREATMENT
ventilation	NN	I-TREATMENT
and	CC	O
then	RB	O
to	TO	O
spontaneous	JJ	O
breathing	VBG	O
on	IN	O
postoperative	JJ	O
day	NN	O
two	CD	O
.	.	O

his	PRP$	B-TEST
westwood-pocasset	NN	I-TEST
output	NN	I-TEST
for	IN	O
postoperative	JJ	O
day	NN	O
one	CD	O
on	IN	O
the	DT	O
left	NN	O
was	VBD	O
60	CD	O
,	,	O
right	RB	O
neck	NN	O
93	CD	O
,	,	O
in	IN	O
the	DT	O
arm	NN	O
20	CD	O
.	.	O

tube	NN	B-TREATMENT
feedings	NNS	I-TREATMENT
were	VBD	O
started	VBN	O
48	CD	O
hours	NNS	O
after	IN	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
.	.	O

the	DT	O
cuff	NN	O
on	IN	O
his	PRP$	B-TREATMENT
tracheostomy	NN	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
put	VBN	O
down	RP	O
on	IN	O
11-23	JJ	O
,	,	O
postoperative	JJ	O
day	NN	O
two	CD	O
which	WDT	O
he	PRP	O
tolerated	VBD	O
well	RB	O
with	IN	O
minimal	JJ	B-PROBLEM
secretions	NNS	I-PROBLEM
and	CC	O
a	DT	O
strong	JJ	O
adequate	JJ	O
cough	NN	O
.	.	O

his	PRP$	B-TREATMENT
tube	NN	I-TREATMENT
feedings	NNS	I-TREATMENT
were	VBD	O
advanced	VBN	O
.	.	O

he	PRP	O
continued	VBD	O
with	IN	O
pulmonary	JJ	B-TREATMENT
toilet	NN	I-TREATMENT
and	CC	O
q.2h.	NN	B-TEST
flap	NN	I-TEST
checks	NNS	I-TEST
.	.	O

the	DT	B-TREATMENT
westwood-pocasset	NN	I-TREATMENT
in	IN	I-TREATMENT
his	PRP$	I-TREATMENT
right	JJ	I-TREATMENT
arm	NN	I-TREATMENT
was	VBD	O
removed	VBN	O
on	IN	O
2016-11-25	JJ	O
.	.	O

his	PRP$	B-TREATMENT
tracheostomy	NN	I-TREATMENT
was	VBD	O
changed	VBN	O
to	TO	O
a	DT	B-TREATMENT
6	CD	I-TREATMENT
cuffless	NN	I-TREATMENT
shiley	NN	I-TREATMENT
on	IN	O
2016-11-26	JJ	O
and	CC	O
sutures	NNS	B-TREATMENT
in	IN	O
place	NN	O
with	IN	O
a	DT	B-TREATMENT
3-0	JJ	I-TREATMENT
silk	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
tolerated	VBD	O
this	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
.	.	O

mrs.	NN	O
wisniewski	NN	O
is	VBZ	O
a	DT	O
45-year-old	JJ	O
woman	NN	O
with	IN	O
multiple	JJ	B-PROBLEM
familial	JJ	I-PROBLEM
cavernous	JJ	I-PROBLEM
hemangiomas	NN	I-PROBLEM
.	.	O

she	PRP	O
developed	VBD	O
an	DT	B-PROBLEM
ear	JJ	I-PROBLEM
ache	NN	I-PROBLEM
,	,	O
for	IN	O
which	WDT	O
she	PRP	O
saw	VBD	O
her	PRP	O
primary	JJ	O
care	NN	O
physician	NN	O
,	,	O
evelyn	NN	O
was	VBD	O
prescribed	VBN	O
cortisone	JJ	B-TREATMENT
drops	NNS	I-TREATMENT
.	.	O

a	DT	O
few	JJ	O
days	NNS	O
later	RB	O
she	PRP	O
complained	VBD	O
of	IN	O
dizziness	NN	B-PROBLEM
.	.	O

this	DT	O
was	VBD	O
mostly	RB	O
described	VBN	O
as	IN	O
feeling	VBG	O
unsteady	JJ	B-PROBLEM
on	IN	I-PROBLEM
her	PRP$	I-PROBLEM
feet	NNS	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
seen	VBN	O
again	RB	O
by	IN	O
primary	JJ	O
care	NN	O
physician	NN	O
,	,	O
roderick	NN	O
since	IN	O
she	PRP	O
had	VBD	O
complaints	NNS	O
of	IN	O
dizziness	NN	B-PROBLEM
,	,	O
as	RB	O
well	RB	O
as	IN	O
a	DT	O
new	JJ	O
complaint	NN	O
of	IN	O
decreased	JJ	B-PROBLEM
hearing	NN	I-PROBLEM
and	CC	O
the	DT	O
sensation	NN	O
of	IN	O
static	JJ	B-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
ears	NNS	I-PROBLEM
,	,	O
meniere	EX	B-PROBLEM
's	POS	I-PROBLEM
disease	NN	I-PROBLEM
was	VBD	O
considered	VBN	O
.	.	O

she	PRP	O
was	VBD	O
given	VBN	O
an	DT	B-TREATMENT
oral	JJ	I-TREATMENT
prednisone	NN	I-TREATMENT
taper	NN	I-TREATMENT
.	.	O

this	DT	B-PROBLEM
unsteady	JJ	I-PROBLEM
gait	NN	I-PROBLEM
progressed	VBN	O
,	,	O
and	CC	O
then	RB	O
she	PRP	O
subsequently	RB	O
started	VBD	O
to	TO	O
develop	VB	O
a	DT	B-PROBLEM
pins	NNS	I-PROBLEM
and	CC	I-PROBLEM
needle	JJ	I-PROBLEM
feeling	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
face	NN	I-PROBLEM
,	,	I-PROBLEM
hands	NNS	I-PROBLEM
and	CC	I-PROBLEM
feet	NNS	I-PROBLEM
bilaterally	RB	I-PROBLEM
.	.	O

her	PRP$	O
hearing	NN	O
got	VBD	O
progressively	RB	B-PROBLEM
worse	JJR	I-PROBLEM
and	CC	O
the	DT	B-PROBLEM
sound	NN	I-PROBLEM
of	IN	I-PROBLEM
static	JJ	I-PROBLEM
increased	VBN	O
.	.	O

she	PRP	O
was	VBD	O
very	RB	B-PROBLEM
fatigued	VBN	I-PROBLEM
.	.	O

at	IN	O
an	DT	O
outside	JJ	O
hospital	NN	O
,	,	O
head	NN	B-TEST
ct	NN	I-TEST
revealed	VBD	O
a	DT	B-PROBLEM
1.5	CD	I-PROBLEM
cm	NN	I-PROBLEM
diameter	NN	I-PROBLEM
hyperdense	NN	I-PROBLEM
mass	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
pons	NNS	I-PROBLEM
,	,	O
slightly	RB	O
off	IN	O
center	NN	O
to	TO	O
the	DT	O
right	NN	O
.	.	O

notable	JJ	O
for	IN	O
multiple	JJ	B-PROBLEM
cavernous	JJ	I-PROBLEM
hemangiomas	NN	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
had	VBN	O
at	IN	B-PROBLEM
least	JJS	I-PROBLEM
two	CD	I-PROBLEM
bleeding	VBG	I-PROBLEM
episodes	NNS	I-PROBLEM
in	IN	O
the	DT	O
past	NN	O
,	,	O
mostly	RB	O
described	VBN	O
as	IN	O
being	VBG	O
accompanied	VBN	O
by	IN	O
generalized	JJ	B-PROBLEM
weakness	NN	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
had	VBN	O
at	IN	B-PROBLEM
least	JJS	I-PROBLEM
two	CD	I-PROBLEM
generalized	JJ	I-PROBLEM
seizures	NNS	I-PROBLEM
in	IN	O
the	DT	O
past	JJ	O
,	,	O
but	CC	O
she	PRP	O
has	VBZ	O
not	RB	O
had	VBN	O
one	CD	O
since	IN	O
she	PRP	O
was	VBD	O
26	CD	O
years	NNS	O
old	JJ	O
.	.	O

she	PRP	O
was	VBD	O
never	RB	O
on	IN	O
an	DT	B-TREATMENT
anticonvulsant	JJ	I-TREATMENT
due	JJ	O
to	TO	O
her	PRP$	O
former	JJ	O
beliefs	NN	O
as	IN	O
n.	JJ	O
derk	NN	O
scientist	NN	O
.	.	O

prednisone	NN	B-TREATMENT
taper	NN	I-TREATMENT
as	IN	O
above	NN	O
.	.	O

strong	JJ	O
maternal	JJ	O
history	NN	O
of	IN	O
hemangiomas	NN	B-PROBLEM
.	.	O

temperature	NN	B-TEST
99.2	CD	O
.	.	O

pulse	RB	B-TEST
60	CD	O
.	.	O

blood	NN	B-TEST
pressure	NN	I-TEST
120/80	CD	O
.	.	O

respiratory	NN	B-TEST
rate	NN	I-TEST
14	CD	O
.	.	O

in	IN	O
general	JJ	O
,	,	O
she	PRP	O
was	VBD	O
a	DT	O
thin	JJ	O
well-appearing	JJ	O
woman	NN	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

sclera	NN	O
were	VBD	O
anicteric	JJ	B-PROBLEM
.	.	O

cardiovascular	JJ	B-TEST
exam	NN	I-TEST
revealed	VBD	O
a	DT	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
with	IN	O
no	DT	O
murmurs	NNS	B-PROBLEM
,	,	O
rubs	NNS	B-PROBLEM
or	CC	O
gallops	NNS	B-PROBLEM
.	.	O

abdomen	NNS	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
and	CC	O
distended	VBD	B-PROBLEM
.	.	O

extremities	NNS	O
showed	VBD	O
no	DT	O
edema	NN	B-PROBLEM
.	.	O

neurologically	RB	O
,	,	O
she	PRP	O
was	VBD	O
awoken	VBN	O
from	IN	O
sleep	NN	O
by	IN	O
voice	NN	O
,	,	O
cooperative	JJ	O
,	,	O
but	CC	O
mildly	RB	B-PROBLEM
drowsy	NNS	I-PROBLEM
.	.	O

she	PRP	O
became	VBD	O
more	RBR	O
alert	JJ	O
during	IN	O
the	DT	O
remainder	NN	O
of	IN	O
the	DT	B-TEST
exam	NN	I-TEST
.	.	O

speech	NN	O
was	VBD	O
fluent	JJ	O
but	CC	O
slow	JJ	B-PROBLEM
,	,	O
and	CC	O
there	RB	O
was	VBD	O
long	JJ	B-PROBLEM
response	NN	I-PROBLEM
latencies	NNS	I-PROBLEM
before	IN	O
she	PRP	O
would	MD	O
initiate	VB	O
speech	NN	O
.	.	O

she	PRP	O
otherwise	RB	O
had	VBD	O
normal	JJ	O
spontaneous	JJ	O
movements	NNS	O
and	CC	O
facial	JJ	O
expression	NN	O
and	CC	O
did	VBD	O
not	RB	O
appear	VB	O
to	TO	O
be	VB	O
abulic	JJ	B-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
dysarthria	NN	B-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
any	DT	B-PROBLEM
special	JJ	I-PROBLEM
neglect	NN	I-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
sustained	VBN	B-PROBLEM
gaze	JJ	I-PROBLEM
holding	VBG	I-PROBLEM
nystagmus	NN	I-PROBLEM
in	IN	O
both	DT	O
horizontal	JJ	O
directions	NNS	O
.	.	O

there	EX	O
was	VBD	O
no	DT	O
rotary	JJ	B-PROBLEM
component	NN	I-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
a	DT	B-PROBLEM
mildly	RB	I-PROBLEM
widened	VBN	I-PROBLEM
right	RB	I-PROBLEM
palpable	JJ	I-PROBLEM
fissure	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
decreased	VBN	B-PROBLEM
excursion	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
mouth	NN	I-PROBLEM
and	CC	O
flattening	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
nasolabial	JJ	I-PROBLEM
fold	NN	I-PROBLEM
(	(	I-PROBLEM
mild	JJ	I-PROBLEM
)	)	I-PROBLEM
.	.	O

light	JJ	O
touch	NN	O
was	VBD	O
subjectively	RB	B-PROBLEM
abnormal	JJ	I-PROBLEM
on	IN	O
both	DT	O
sides	NNS	O
of	IN	O
the	DT	O
face	NN	O
.	.	O

hearing	NN	O
was	VBD	O
diminished	VBN	B-PROBLEM
for	IN	O
conversational	JJ	O
speech	NN	O
.	.	O

there	EX	O
was	VBD	O
a	DT	B-PROBLEM
mild	JJ	I-PROBLEM
left	JJ	I-PROBLEM
pronator	NN	I-PROBLEM
drift	NN	I-PROBLEM
.	.	O

finger	NN	B-TEST
tapping	VBG	I-TEST
and	CC	O
rapid	JJ	B-TEST
alternating	VBG	I-TEST
movements	NNS	I-TEST
were	VBD	O
slow	JJ	B-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
and	CC	O
she	PRP	O
had	VBD	O
trouble	NN	B-PROBLEM
isolating	VBG	I-PROBLEM
individual	JJ	I-PROBLEM
finger	NN	I-PROBLEM
movements	NNS	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
mild	JJ	B-PROBLEM
finger-to-nose	JJ	I-PROBLEM
dysmetria	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
.	.	O

power	NN	O
was	VBD	O
mildly	RB	B-PROBLEM
diminished	VBN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
finger	NN	I-PROBLEM
extensors	NNS	I-PROBLEM
and	CC	O
hand	NN	O
intrinsics	NNS	O
on	IN	O
the	DT	O
left	NN	O
,	,	O
otherwise	RB	O
,	,	O
power	NN	O
was	VBD	O
full	JJ	O
throughout	IN	O
.	.	O

reflexes	NNS	B-TEST
were	VBD	O
brisk	VBN	O
in	IN	O
the	DT	O
legs	NN	O
with	IN	O
4-5	JJ	O
beats	NNS	O
of	IN	O
clonus	NN	B-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
ankles	NNS	I-PROBLEM
bilaterally	RB	I-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
bilateral	JJ	B-PROBLEM
upgoing	NN	I-PROBLEM
toes	NNS	I-PROBLEM
.	.	O

she	PRP	O
made	VBD	O
mistakes	NNS	B-PROBLEM
with	IN	I-PROBLEM
position	NN	I-PROBLEM
sense	NN	I-PROBLEM
,	,	O
roughly	RB	O
at	IN	O
chance	NN	O
level	NN	O
with	IN	O
both	DT	O
great	JJ	O
toes	NNS	O
and	CC	O
the	DT	O
left	NN	O
first	RB	O
finger	NN	O
,	,	O
position	NN	O
sense	NN	O
in	IN	O
the	DT	O
right	JJ	O
limb	NN	O
seems	VBZ	O
preserved	VBN	O
.	.	O

gait	NN	O
was	VBD	O
wide	JJ	B-PROBLEM
based	VBN	I-PROBLEM
,	,	O
very	RB	B-PROBLEM
unsteady	JJ	I-PROBLEM
,	,	O
veering	VBG	O
to	TO	O
the	DT	O
left	NN	O
and	CC	O
to	TO	O
the	DT	O
right	NN	O
.	.	O

she	PRP	O
retropulsed	VBD	B-PROBLEM
and	CC	O
would	MD	O
have	VB	O
pitched	VBN	O
backwards	NNS	O
without	IN	O
the	DT	O
assistance	NN	O
of	IN	O
the	DT	O
examiner	NN	O
.	.	O

white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
7.8	CD	O
with	IN	O
86%	CD	O
polymorphonuclear	JJ	B-TEST
cells	NNS	I-TEST
,	,	O
11.1	CD	O
lymphocytes	NNS	B-TEST
,	,	O
hemoglobin	NN	B-TEST
14.3	CD	O
,	,	O
hematocrit	NN	B-TEST
40.5	CD	O
,	,	O
mcv	FW	B-TEST
88	CD	O
,	,	O
inr	NN	B-TEST
1.0	CD	O
,	,	O
ptt	NN	B-TEST
24.7	CD	O
,	,	O
pt	NN	B-TEST
12.3	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
295,000	CD	O
,	,	O
glucose	RB	B-TEST
81	CD	O
,	,	O
bun	NN	B-TEST
15	CD	O
,	,	O
creatinine	NN	B-TEST
0.8	CD	O
,	,	O
sodium	NN	B-TEST
142	CD	O
,	,	O
potassium	NN	B-TEST
4.2	CD	O
,	,	O
chloride	RB	B-TEST
104	CD	O
,	,	O
co2	NN	B-TEST
26	CD	O
,	,	O
calcium	NN	B-TEST
9.3	CD	O
,	,	O
phosphate	NN	B-TEST
4.8	CD	O
,	,	O
magnesium	NN	B-TEST
2.3	CD	O
.	.	O

mri	NN	B-TEST
of	IN	I-TEST
the	DT	I-TEST
brain	NN	I-TEST
revealed	VBD	O
multiple	JJ	B-PROBLEM
foci	JJ	I-PROBLEM
susceptibility	NN	I-PROBLEM
artifact	NN	I-PROBLEM
within	IN	I-PROBLEM
the	DT	I-PROBLEM
brain	NN	I-PROBLEM
.	.	O

these	DT	O
were	VBD	O
seen	VBN	O
best	JJS	O
in	IN	O
gradient	NN	B-TEST
echocardiogram	NN	I-TEST
images	NNS	I-TEST
.	.	O

there	EX	O
was	VBD	O
a	DT	O
large	JJ	O
focus	NN	O
of	IN	O
subacute	JJ	B-PROBLEM
blood	NN	I-PROBLEM
products	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
mid	NN	I-PROBLEM
to	TO	I-PROBLEM
low	JJ	I-PROBLEM
pons	NNS	I-PROBLEM
suggesting	VBG	O
recent	JJ	B-PROBLEM
hemorrhage	NN	I-PROBLEM
into	IN	I-PROBLEM
a	DT	I-PROBLEM
cavernous	JJ	I-PROBLEM
angioma	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
some	DT	B-PROBLEM
mild	JJ	I-PROBLEM
surrounding	VBG	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

there	EX	O
are	VBP	O
also	RB	O
tiny	JJ	B-PROBLEM
foci	NNS	I-PROBLEM
artifact	NN	I-PROBLEM
within	IN	I-PROBLEM
the	DT	I-PROBLEM
cerebellum	NN	I-PROBLEM
and	CC	I-PROBLEM
base	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
pons	NNS	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
a	DT	O
larger	JJR	O
area	NN	O
of	IN	O
susceptibility	NN	B-PROBLEM
artifact	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
temporal	JJ	I-PROBLEM
lobe	NN	I-PROBLEM
,	,	I-PROBLEM
right	JJ	I-PROBLEM
frontal	NN	I-PROBLEM
lobe	NN	I-PROBLEM
,	,	I-PROBLEM
and	CC	I-PROBLEM
the	DT	I-PROBLEM
splenius	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
corpus	NN	I-PROBLEM
collasum	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
mild	JJ	B-PROBLEM
enhancement	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
pontine	NN	I-PROBLEM
hemorrhagic	JJ	I-PROBLEM
mass	NN	I-PROBLEM
but	CC	O
none	NN	O
elsewhere	RB	O
.	.	O

there	EX	O
was	VBD	O
no	DT	O
areas	NNS	B-PROBLEM
of	IN	I-PROBLEM
restricted	JJ	I-PROBLEM
diffusion	NN	I-PROBLEM
to	TO	O
indicate	VB	O
infarction	NN	B-PROBLEM
.	.	O

mra	NN	B-TEST
of	IN	I-TEST
the	DT	I-TEST
brain	NN	I-TEST
was	VBD	O
unremarkable	JJ	O
.	.	O

there	EX	O
was	VBD	O
no	DT	O
communication	NN	O
>.......<	VBZ	O
in	IN	O
the	DT	O
visualized	JJ	O
vessels	NNS	O
and	CC	O
the	DT	O
angiomas	NN	B-PROBLEM
.	.	O

follow-up	JJ	B-TEST
ct	NN	I-TEST
was	VBD	O
obtained	VBN	O
the	DT	O
second	JJ	O
day	NN	O
of	IN	O
admission	NN	O
.	.	O

there	EX	O
was	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
developing	VBG	B-PROBLEM
hydrocephalus	NN	I-PROBLEM
,	,	O
which	WDT	O
was	VBD	O
a	DT	O
concern	NN	O
due	JJ	O
to	TO	O
the	DT	B-PROBLEM
surrounding	VBG	I-PROBLEM
edema	NN	I-PROBLEM
,	,	O
and	CC	O
possible	JJ	O
suppression	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
fourth	JJ	I-PROBLEM
ventricle	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
significant	JJ	B-PROBLEM
change	NN	I-PROBLEM
in	IN	I-PROBLEM
size	NN	I-PROBLEM
of	IN	O
the	DT	B-PROBLEM
subacute	JJ	I-PROBLEM
pontine	NN	I-PROBLEM
hemorrhage	NN	I-PROBLEM
.	.	O

mrs.	NN	O
wisniewski	NN	O
is	VBZ	O
a	DT	O
45	CD	O
-	:	O
year-old	JJ	O
woman	NN	O
with	IN	O
a	DT	O
strong	JJ	O
family	NN	O
history	NN	O
of	IN	O
cavernous	JJ	B-PROBLEM
angiomas	NNS	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
had	VBD	O
several	JJ	B-PROBLEM
prior	RB	I-PROBLEM
bleeding	VBG	I-PROBLEM
events	NNS	I-PROBLEM
and	CC	O
presented	VBN	O
with	IN	O
a	DT	B-PROBLEM
subacute	NN	I-PROBLEM
bleed	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
mid	NN	I-PROBLEM
to	TO	I-PROBLEM
lower	JJR	I-PROBLEM
pons	NNS	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
relatively	RB	O
central	JJ	O
in	IN	O
location	NN	O
,	,	O
with	IN	O
only	RB	O
a	DT	B-PROBLEM
slight	JJ	I-PROBLEM
right-sided	JJ	I-PROBLEM
predominance	NN	I-PROBLEM
.	.	O

her	PRP$	B-TEST
physical	JJ	I-TEST
examination	NN	I-TEST
remained	VBD	O
relatively	RB	O
unchanged	JJ	O
,	,	O
with	IN	O
resolution	NN	O
of	IN	O
the	DT	B-PROBLEM
subtle	NN	I-PROBLEM
left	VBD	I-PROBLEM
hand	NN	I-PROBLEM
weakness	NN	I-PROBLEM
and	CC	O
right	JJ	B-PROBLEM
facial	JJ	I-PROBLEM
weakness	NN	I-PROBLEM
.	.	O

her	PRP$	O
gait	NN	O
remained	VBD	O
severely	RB	B-PROBLEM
ataxic	JJ	I-PROBLEM
,	,	O
likely	JJ	O
secondary	JJ	O
to	TO	O
sensory	JJ	B-PROBLEM
deafferentation	NN	I-PROBLEM
,	,	O
as	RB	O
well	RB	O
as	IN	O
involvement	NN	O
of	IN	O
crossing	VBG	B-PROBLEM
pontine	JJ	I-PROBLEM
cerebellar	JJ	I-PROBLEM
fibers	NNS	I-PROBLEM
.	.	O

therefore	RB	O
,	,	O
it	PRP	O
was	VBD	O
recommended	VBN	O
that	IN	O
she	PRP	O
have	VBP	O
aggressive	JJ	B-TREATMENT
physical	JJ	I-TREATMENT
therapy	NN	I-TREATMENT
at	IN	O
an	DT	O
acute	JJ	O
rehabilitation	NN	O
center	NN	O
.	.	O

we	PRP	O
will	MD	O
arrange	VB	O
to	TO	O
have	VB	O
a	DT	O
copy	NN	O
of	IN	O
the	DT	B-TEST
mri	NN	I-TEST
scans	VBZ	I-TEST
sent	VBN	O
to	TO	O
him	PRP	O
.	.	O

1.	CD	O
familial	JJ	B-PROBLEM
cavernous	JJ	I-PROBLEM
hemangiomas	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
a	DT	B-PROBLEM
subacute	NN	I-PROBLEM
pontine	NN	I-PROBLEM
hemorrhage	NN	I-PROBLEM
.	.	O

2.	CD	O
severe	JJ	B-PROBLEM
gait	NN	I-PROBLEM
ataxia	NN	I-PROBLEM
.	.	O

1.	CD	O
gabapentin	NN	B-TREATMENT
100	CD	O
mg	NN	O
po	NN	O
t.i.d.	NN	O
for	IN	O
paresthesias	NN	B-PROBLEM
.	.	O

2.	CD	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
po	NN	O
b.i.d.	NN	O

3.	CD	O
zantac	NN	B-TREATMENT
150	CD	O
mg	NN	O
po	NN	O
b.i.d.	NN	O

4.	CD	O
prednisone	NN	B-TREATMENT
taper	NN	I-TREATMENT
completed	VBN	O
.	.	O

this	DT	O
is	VBZ	O
an	DT	O
85	CD	O
year	NN	O
old	JJ	O
man	NN	O
initially	RB	O
admitted	VBN	O
to	TO	O
the	DT	O
plastic	NN	O
surgery	NN	O
service	NN	O
for	IN	O
evaluation	NN	B-TEST
of	IN	O
a	DT	B-PROBLEM
left	JJ	I-PROBLEM
facial	JJ	I-PROBLEM
mass	NN	I-PROBLEM
.	.	O

his	PRP$	O
past	JJ	O
medical	JJ	O
history	NN	O
is	VBZ	O
significant	JJ	O
for	IN	O
prostate	NN	B-PROBLEM
cancer	NN	I-PROBLEM
,	,	O
benign	JJ	B-PROBLEM
prostatic	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
,	,	O
hypothyroidism	NN	B-PROBLEM
,	,	O
status	NN	O
post	NN	O
radiation	NN	B-TREATMENT
for	IN	O
non	JJ	B-PROBLEM
hodgkin	NN	I-PROBLEM
's	POS	I-PROBLEM
lymphoma	NN	I-PROBLEM
,	,	O
chronic	JJ	B-PROBLEM
painless	NN	I-PROBLEM
hematuria	NN	I-PROBLEM
,	,	O
degenerative	JJ	B-PROBLEM
joint	NN	I-PROBLEM
disease	NN	I-PROBLEM
and	CC	O
history	NN	O
of	IN	O
a	DT	B-PROBLEM
murmur	NN	I-PROBLEM
.	.	O

last	JJ	O
colonoscopy	NN	B-TEST
,	,	O
five	CD	O
years	NNS	O
ago	RB	O
.	.	O

dementia	NN	B-PROBLEM
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

1.	CD	O
levothyroxine	NN	B-TREATMENT
.	.	O

2.	CD	O
lasix	NN	B-TREATMENT
.	.	O

3.	CD	O
proscar	NN	B-TREATMENT
.	.	O

4.	CD	O
aeroseb	NN	B-TREATMENT
.	.	O

5.	CD	O
ancef	NN	B-TREATMENT
.	.	O

on	IN	O
examination	NN	B-TEST
,	,	O
he	PRP	O
is	VBZ	O
afebrile	JJ	B-PROBLEM
.	.	O

vital	JJ	B-TEST
signs	NNS	I-TEST
,	,	O
stable	JJ	O
.	.	O

elderly	JJ	O
man	NN	O
,	,	O
somewhat	RB	B-PROBLEM
cachectic	JJ	I-PROBLEM
.	.	O

head	NN	O
,	,	O
eyes	NNS	O
,	,	O
ears	NNS	O
,	,	O
nose	RB	O
and	CC	O
throat	NN	O
,	,	O
polypoid	JJ	B-PROBLEM
lesion	NN	I-PROBLEM
just	RB	O
inferior	RB	O
to	TO	O
the	DT	O
left	NN	O
zygoma	NN	O
,	,	O
elevated	VBD	O
superiorly	RB	O
,	,	O
with	IN	O
visible	JJ	B-PROBLEM
bone	NN	I-PROBLEM
.	.	O

no	DT	O
exudate	NN	B-PROBLEM
.	.	O

minimal	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
.	.	O

clear	JJ	O
to	TO	O
auscultation	NN	B-TEST
.	.	O

nontender	NN	B-PROBLEM
,	,	O
nondistended	VBN	B-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
initially	RB	O
admitted	VBN	O
to	TO	O
cmed	VB	O
for	IN	O
resection	NN	B-TREATMENT
and	CC	O
repair	NN	B-TREATMENT
of	IN	O
this	DT	B-PROBLEM
left	JJ	I-PROBLEM
facial	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
.	.	O

he	PRP	O
also	RB	O
had	VBD	O
consults	NNS	O
from	IN	O
urology	NN	O
for	IN	O
his	PRP$	B-PROBLEM
hematuria	NN	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
medicine	NN	O
preoperatively	RB	O
and	CC	O
cmed	VBD	O
ccu	NN	O
.	.	O

he	PRP	O
went	VBD	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
on	IN	O
2016-03-10	JJ	O
with	IN	O
urology	NN	O
for	IN	O
hematuria	NN	B-PROBLEM
where	WRB	O
he	PRP	O
had	VBD	O
a	DT	B-TREATMENT
cystoscopy	JJ	I-TREATMENT
transurethral	JJ	I-TREATMENT
resection	NN	I-TREATMENT
of	IN	I-TREATMENT
prostate	JJ	I-TREATMENT
placement	NN	I-TREATMENT
.	.	O

he	PRP	O
then	RB	O
went	VBD	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
on	IN	O
2016-03-14	JJ	O
where	WRB	O
he	PRP	O
had	VBD	O
resection	NN	B-TREATMENT
of	IN	O
the	DT	B-PROBLEM
left	JJ	I-PROBLEM
face	NN	I-PROBLEM
squamous	JJ	I-PROBLEM
cell	NN	I-PROBLEM
cancer	NN	I-PROBLEM
by	IN	O
dr.	JJ	O
langhorne	NN	O
and	CC	O
split	NN	B-TREATMENT
thickness	NN	I-TREATMENT
and	CC	I-TREATMENT
full	JJ	I-TREATMENT
thickness	NN	I-TREATMENT
skin	VBD	I-TREATMENT
grafting	NN	I-TREATMENT
of	IN	O
the	DT	B-PROBLEM
defects	NNS	I-PROBLEM
on	IN	O
2016-03-14	JJ	O
.	.	O

he	PRP	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
with	IN	O
no	DT	O
complications	NNS	B-PROBLEM
except	IN	O
postoperatively	RB	O
,	,	O
his	PRP$	O
voice	NN	O
was	VBD	O
hoarse	NN	B-PROBLEM
.	.	O

on	IN	O
scoping	VBG	B-TEST
him	PRP	O
he	PRP	O
had	VBD	O
significant	JJ	B-PROBLEM
supraglottic	JJ	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
kept	VBN	O
in	IN	O
the	DT	O
unit	NN	O
for	IN	O
observation	NN	B-TEST
of	IN	I-TEST
his	PRP$	I-TEST
airway	NN	I-TEST
and	CC	O
b.i.d.	NN	O
laryngoscopy	NN	B-TEST
.	.	O

this	DT	O
revealed	VBD	O
some	DT	B-PROBLEM
supraglottic	JJ	I-PROBLEM
edema	NN	I-PROBLEM
which	WDT	O
revealed	VBD	O
with	IN	O
time	NN	O
,	,	O
without	IN	O
further	JJ	B-TREATMENT
intervention	NN	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
followed	VBN	O
by	IN	O
plastic	NN	O
surgery	NN	O
for	IN	O
his	PRP$	B-TREATMENT
split	NN	I-TREATMENT
thickness	NN	I-TREATMENT
skin	NN	I-TREATMENT
graft	NN	I-TREATMENT
and	CC	O
his	PRP$	B-TREATMENT
bolster	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
on	IN	O
postoperative	JJ	O
day	NN	O
#5	IN	O
with	IN	O
good	JJ	O
take	VB	O
up	IN	O
of	IN	O
his	PRP$	B-TREATMENT
skin	NN	I-TREATMENT
graft	NN	I-TREATMENT
.	.	O

urology	NN	O
also	RB	O
followed	VBD	O
him	PRP	O
and	CC	O
kept	VBD	O
him	PRP	O
on	IN	O
antibiotics	NNS	B-TREATMENT
until	IN	O
postoperative	JJ	O
day	NN	O
#7	NNP	O
at	IN	O
which	WDT	O
point	NN	O
antibiotics	NNS	B-TREATMENT
were	VBD	O
discontinued	VBN	O
.	.	O

foley	NN	B-TREATMENT
was	VBD	O
also	RB	O
discontinued	VBN	O
.	.	O

he	PRP	O
is	VBZ	O
being	VBG	O
discharged	VBN	O
to	TO	O
rehabilitation	VB	O
to	TO	O
follow	VB	O
up	RP	O
for	IN	O
xrt	NNP	B-TREATMENT
given	VBN	O
the	DT	O
fact	NN	O
that	IN	O
his	PRP$	B-TEST
pathology	NN	I-TEST
revealed	VBD	O
squamous	JJ	B-PROBLEM
cell	NN	I-PROBLEM
cancer	NN	I-PROBLEM
extending	VBG	O
deep	JJ	O
to	TO	O
the	DT	O
margin	NN	O
as	RB	O
well	RB	O
as	IN	O
positive	JJ	B-PROBLEM
level	NN	I-PROBLEM
ii	NN	I-PROBLEM
nodes	NNS	I-PROBLEM
.	.	O

dr.	NN	O
navarrete	NN	O
has	VBZ	O
been	VBN	O
e-mailed	JJ	O
and	CC	O
his	PRP$	O
secretary	NN	O
contacted	VBD	O
for	IN	O
as	RB	O
soon	RB	O
as	IN	O
possible	JJ	O
appointment	NN	O
for	IN	O
xrt	NN	B-TREATMENT
follow	VBP	O
up	RP	O
.	.	O

keflex	JJ	B-TREATMENT
/	NNP	O
heparin	NN	B-TREATMENT
agents	NNS	I-TREATMENT

chief	JJ	O
complaint	NN	O
:	:	O
pt	NN	O
sent	VBD	O
to	TO	O
er	VB	O
after	IN	O
routine	JJ	O
f/u	NN	O
for	IN	O
ue	JJ	B-PROBLEM
dvt	NN	I-PROBLEM
with	IN	O
vascular	JJ	O
surgery	NN	O
.	.	O

in	IN	O
er	JJ	O
c/o	NN	O
dyspnea	NN	B-PROBLEM
and	CC	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
mental	JJ	B-PROBLEM
status	NN	I-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

avr	NN	B-TREATMENT
(	(	I-TREATMENT
tissue	NN	I-TREATMENT
)	)	I-TREATMENT
05-14	NN	O

s/p	JJ	O
avr	JJ	B-TREATMENT
05-14	NN	O
.	.	O

postop	JJ	O
course	NN	O
c/b	NN	O
right	JJ	B-PROBLEM
upper	JJ	I-PROBLEM
extremity	NN	I-PROBLEM
dvt	NN	I-PROBLEM
and	CC	O
postop	JJ	B-PROBLEM
afib	NN	I-PROBLEM
.	.	O

at	IN	O
that	DT	O
time	NN	O
had	VBD	O
ue	JJ	B-TEST
duplex	NN	I-TEST
which	WDT	O
revealed	VBD	O
rue	NN	B-PROBLEM
dvt	NN	I-PROBLEM
involving	VBG	O
ij	NN	O
,	,	O
axillary	JJ	O
,	,	O
subclav	JJ	O
,	,	O
brachial	JJ	O
,	,	O
and	CC	O
basilic	JJ	O
veins	NNS	O
.	.	O

then	RB	O
referred	VBD	O
to	TO	O
er	VB	O
for	IN	O
tx	NN	B-TREATMENT

s/p	NN	O
avr	NN	B-TREATMENT
(	(	O
#27	NNP	O
pericardial	NN	O
)	)	O

post-op	JJ	B-PROBLEM
afib	NN	I-PROBLEM

htn	NN	B-PROBLEM

renal	JJ	B-PROBLEM
calculi	NN	I-PROBLEM

?	.	O
sleep	JJ	B-PROBLEM
apnea	NN	I-PROBLEM

seasonal	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM

s/p	NN	O
2	CD	B-TREATMENT
surgs.	NN	I-TREATMENT
for	IN	O
spermatocele	NN	B-PROBLEM

s/p	JJ	O
oral	JJ	B-TREATMENT
surgery	NN	I-TREATMENT

non-contributory	NN	O
for	IN	O
premature	NN	B-PROBLEM
cad	NN	I-PROBLEM
;	:	O
father	CC	O
had	VBD	O
mi	VBN	B-PROBLEM
in	IN	O
his	PRP$	O
70	CD	O
's	POS	O

admission	NN	B-TEST
pe	NN	I-TEST

vs	NN	B-TEST
:	:	O
hr	NN	B-TEST
103	CD	O
bp	NN	B-TEST
162/69	CD	O
rr	NN	B-TEST
14	CD	O
sat	VBD	B-TEST
92%	CD	O
ra	NN	O

neuro	NN	O
:	:	O
mae	NN	O
,	,	O
follows	VBZ	O
commands	NNS	O
,	,	O
slightly	RB	B-PROBLEM
confused	VBD	I-PROBLEM

heent	NN	O
:	:	O
perrl/eomi	NN	O
,	,	O
no	DT	O
jvd	NN	B-PROBLEM

cv	NN	O
:	:	O
rrr	JJ	O
s1-s2	NN	O
,	,	O
no	DT	O
murmur	NN	B-PROBLEM
.	.	O

abdm	NN	O
:	:	O
soft	JJ	O
nt	NNS	B-PROBLEM
/	VBP	O
nd	JJ	B-PROBLEM
/	NNP	O
nabs	NN	O

ext	NN	O
:	:	O
+	JJ	O
distal	JJ	B-TEST
pulses	NNS	I-TEST
,	,	O
no	DT	O
edema	NN	B-PROBLEM

discharge	NN	B-TEST
pe	NN	I-TEST

vs	NN	B-TEST
:	:	O
t	NN	B-TEST
99	CD	O
hr	NN	B-TEST
68	CD	O
bp	NN	B-TEST
113/72	CD	O
rr	NN	B-TEST
18	CD	O
sat	VBD	B-TEST
98%	CD	O
ra	NN	O

cv:rrr	JJ	O
s1-s2	NN	O
,	,	O
no	DT	O
mrg	NN	B-PROBLEM

abdm	NN	O
:	:	O
soft	JJ	O
,	,	O
nt/nd/nabs	JJ	B-PROBLEM

ext	NN	O
:	:	O
warm	NN	O
well	RB	O
perfused	VBD	O
no	DT	O
cce	NN	B-PROBLEM

glucose	JJ	B-TEST
-	:	O
193	CD	O
*	JJ	O
urea	JJ	B-TEST
n	SYM	I-TEST
-	:	O
23	CD	O
*	NN	O
creat	NN	B-TEST
-	:	O
1.2	CD	O
sodium	NN	B-TEST
-	:	O
138	CD	O
potassium	NN	B-TEST
-	:	O
4.6	CD	O
chloride	NN	B-TEST
-	:	O
101	CD	O
total	JJ	B-TEST
co2	NN	I-TEST
-	:	O
21	CD	O
*	JJ	O
anion	NN	B-TEST
gap	NN	I-TEST
-	:	O
21	CD	O
*	NN	O

calcium	NN	B-TEST
-	:	O
8.8	CD	O
phosphate	NN	B-TEST
-	:	O
3.9	CD	O
magnesium	NN	B-TEST
-	:	O
2.4	CD	O

pt	SYM	B-TEST
-	:	O
15.0	CD	O
*	NN	O
ptt	NN	B-TEST
-	:	O
107.1	CD	O
*	JJ	O
inr	NN	B-TEST
(	(	I-TEST
pt	JJ	I-TEST
)-	JJ	I-TEST
1.3	CD	O
*	NN	O

wbc	SYM	B-TEST
-	:	O
13.3	CD	O
*#	NN	O
rbc	NN	B-TEST
-	:	O
3.45	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
10.6	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
30.5	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
88	CD	O
mch	SYM	B-TEST
-	:	O
30.6	CD	O
mchc	SYM	B-TEST
-	:	O
34.7	CD	O
rdw	NN	B-TEST
-	:	O
12.7	CD	O

blood	NN	B-TEST
wbc	SYM	I-TEST
-	:	O
12.9	CD	O
*	NN	O
rbc	NN	B-TEST
-	:	O
3.37	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
10.4	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
29.4	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
87	CD	O
mch	SYM	B-TEST
-	:	O
30.8	CD	O
mchc	SYM	B-TEST
-	:	O
35.3	CD	O
*	NN	O
rdw	NN	B-TEST
-	:	O
13.3	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
345	CD	O

blood	NN	B-TEST
pt	SYM	I-TEST
-	:	O
39.1	CD	O
*	JJ	O
inr	NN	B-TEST
(	(	I-TEST
pt	JJ	I-TEST
)-	JJ	I-TEST
4.4	CD	O
*	NN	O

blood	NN	B-TEST
heparin	NN	I-TEST
dependent	JJ	I-TEST
antibodies	NNS	I-TEST
-	:	O
positive	JJ	O

pt	NN	O
admitted	VBD	O
05-24	CD	O
from	IN	O
er	NN	O
after	IN	O
positive	JJ	B-PROBLEM
rue	NN	I-PROBLEM
dvt	NN	I-PROBLEM
finding	VBG	O
in	IN	O
vascular	JJ	O
lab	NN	O
.	.	O

during	IN	O
er	JJ	B-TEST
evaluation	NN	I-TEST
pt	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
some	DT	O
degree	NN	O
of	IN	O
dyspnea	NN	B-PROBLEM
as	RB	O
well	RB	O
as	IN	O
mental	JJ	B-PROBLEM
status	NN	I-PROBLEM
changes	NNS	I-PROBLEM
,	,	O
including	VBG	O
loss	NN	B-PROBLEM
of	IN	I-PROBLEM
short	JJ	I-PROBLEM
term	NN	I-PROBLEM
memory	NN	I-PROBLEM
and	CC	O
brief	JJ	B-PROBLEM
unresponsive	JJ	I-PROBLEM
period	NN	I-PROBLEM
after	IN	O
one	CD	O
dose	NN	O
of	IN	O
iv	JJ	B-TREATMENT
benadry	NN	I-TREATMENT
and	CC	O
steroids	NNS	B-TREATMENT
prior	RB	O
to	TO	O
ct	VB	B-TEST
scan	JJ	I-TEST
.	.	O

the	DT	B-TEST
ct	NN	I-TEST
was	VBD	O
negative	JJ	O
for	IN	O
cva	NN	B-PROBLEM
but	CC	O
positive	JJ	O
for	IN	O
pulmonary	JJ	B-PROBLEM
embolism	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
csru	VB	O
for	IN	O
evaluation	NN	B-TEST
.	.	O

neurology	NN	O
was	VBD	O
consulted	VBN	O
and	CC	O
the	DT	O
pt	NN	O
also	RB	O
had	VBD	O
mri	NNS	B-TEST
which	WDT	O
was	VBD	O
negative	JJ	O
.	.	O

the	DT	O
pt	NN	O
was	VBD	O
begun	VBN	O
on	IN	O
heparin	NN	B-TREATMENT
gtt	NN	I-TREATMENT
and	CC	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
platelet	VBN	B-PROBLEM
drop	NN	I-PROBLEM
>	NN	O
50%	CD	O
after	IN	O
infusion	NN	B-TREATMENT
began	VBD	O
,	,	O
hepain	NN	B-TREATMENT
was	VBD	O
d/c	JJ	O
'd.	NNS	O

argatroban	NN	B-TREATMENT
was	VBD	O
started	VBN	O
abd	RP	O
a	DT	B-TEST
hit	NN	I-TEST
panel	NN	I-TEST
was	VBD	O
sent	VBN	O
,	,	O
hit	VBD	B-TEST
panel	NN	I-TEST
was	VBD	O
positive	JJ	B-PROBLEM
.	.	O

by	IN	O
the	DT	O
following	JJ	O
mornig	NN	O
all	DT	B-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
changes	NNS	I-PROBLEM
had	VBD	O
cleared	VBN	O
and	CC	O
the	DT	O
pt	NN	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
floors	NNS	O
for	IN	O
continued	JJ	O
care	NN	O
.	.	O

over	IN	O
the	DT	O
next	JJ	O
several	JJ	O
days	NNS	O
the	DT	O
patient	NN	O
was	VBD	O
maintained	VBN	O
on	IN	O
argatrobanwhile	JJ	B-TREATMENT
coumadin	NN	B-TREATMENT
therapy	NN	I-TREATMENT
was	VBD	O
initiated	VBN	O
.	.	O

on	IN	O
hd#6	PDT	O
the	DT	O
pt	NN	O
had	VBD	O
a	DT	B-TEST
therapeudic	JJ	I-TEST
inr	NN	I-TEST
(	(	O
4.4	CD	O
)	)	O
off	IN	O
argatroban	NN	B-TREATMENT
and	CC	O
wad	NN	O
discharged	VBD	O
home	NN	O
.	.	O

he	PRP	O
was	VBD	O
to	TO	O
have	VB	O
f/u	VBN	O
inr	JJ	B-TEST
check	NN	I-TEST
with	IN	O
dr	JJ	O
lewis	NNS	O
on	IN	O
05-31	NN	O
.	.	O

asa	RB	B-TREATMENT
81	CD	O
'	''	O

atorvastatin	RB	B-TREATMENT
10	CD	O
'	''	O

lisinopril	RB	B-TREATMENT
5	CD	O
'	''	O

lopressor	NN	B-TREATMENT
50	CD	O
"	NN	O

amiodarone	RB	B-TREATMENT
200	CD	O
'	''	O

1.	CD	O
aspirin	JJ	B-TREATMENT
81	CD	O
mg	JJ	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

2.	CD	O
atorvastatin	JJ	B-TREATMENT
10	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

3.	CD	O
metoprolol	JJ	B-TREATMENT
tartrate	NN	I-TREATMENT
50	CD	O
mg	NN	O
tablet	NN	O
sig	VB	O
:one	NN	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

4.	CD	O
amoxicillin-pot	JJ	B-TREATMENT
clavulanate	NN	I-TREATMENT
875-125	JJ	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
for	IN	O
10	CD	O
days	NNS	O
.	.	O

5.	CD	O
amiodarone	NN	B-TREATMENT
200	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

6.	CD	O
warfarin	JJ	B-TREATMENT
2	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
1.5	CD	O
tablets	NNS	O
po	RB	O
as	IN	O
directed	VBN	O
:	:	O
3	CD	O
mg	RBS	O
1943-05-29	JJ	O
and	CC	O
6/1	CD	O
then	RB	O
as	IN	O
directed	VBN	O
by	IN	O
dr	JJ	O
mace	NN	O
.	.	O

discharge	NN	O
diagnosis	NN	O
:	:	O
s/p	JJ	O
avr	IN	B-TREATMENT
05-14	NN	O
(	(	O
tissue	NN	O
)	)	O
readmitted	VBD	O
05-24	JJ	O
w/	NN	O
pulmonary	JJ	B-PROBLEM
embolism	NN	I-PROBLEM
,	,	O
rue	JJ	B-PROBLEM
dvt	NN	I-PROBLEM
,	,	O
hit	VBD	B-PROBLEM
positive	JJ	I-PROBLEM

pmh	NN	O
:	:	O
htn	NN	B-PROBLEM
,	,	O
renal	JJ	B-PROBLEM
calculi	NN	I-PROBLEM
,	,	O
sleep	JJ	B-PROBLEM
apnea	NN	I-PROBLEM
,	,	O

discharge	NN	O
instructions	NNS	O
:	:	O
keep	VB	O
wounds	NNS	B-PROBLEM
clean	JJ	O
and	CC	O
dry	JJ	O
.	.	O

take	VB	O
all	DT	B-TREATMENT
medications	NNS	I-TREATMENT
as	IN	O
prescribed	NN	O
.	.	O

follow-up	JJ	B-TEST
inr	NN	I-TEST
to	TO	O
be	VB	O
drawn	VBN	O
06-01	JJ	O
,	,	O
by	IN	O
dr	JJ	O
lewis	JJ	O
@	NN	O
597-4427	JJ	O

haldol	NN	B-TREATMENT
/	NNP	O
compazine	NN	B-TREATMENT
/	NNP	O
phenergan	NN	B-TREATMENT
/	NNP	O
tigan	NN	B-TREATMENT
/	NNP	O
flagyl	NN	B-TREATMENT

chest	NN	B-PROBLEM
pain	NN	I-PROBLEM

removal	NN	B-TREATMENT
of	IN	I-TREATMENT
tunneled	JJ	I-TREATMENT
cath	NN	I-TREATMENT
(	(	O
previously	RB	O
used	VBN	O
for	IN	O
tpn	NN	B-TREATMENT
)	)	O

54	CD	O
yo	NNS	O
f	JJ	O
with	IN	O
crohn	NN	B-PROBLEM
's	POS	I-PROBLEM
s/p	JJ	O
ileostomy	NN	B-TREATMENT
and	CC	O
subsequent	JJ	O
short	JJ	B-PROBLEM
gut	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
with	IN	O
port-a-cath	JJ	B-TREATMENT
placement	NN	I-TREATMENT
for	IN	O
tpn	NN	B-TREATMENT
who	WP	O
presents	VBZ	O
with	IN	O
progressive	JJ	B-PROBLEM
right	NN	I-PROBLEM
sided	VBD	I-PROBLEM
chest	JJS	I-PROBLEM
pain	NN	I-PROBLEM
that	WDT	O
comes	VBZ	O
in	IN	O
waves	NNS	O
.	.	O

the	DT	O
pt	NN	O
reports	NNS	O
sharp	JJ	B-PROBLEM
10/10	CD	I-PROBLEM
chest	JJS	I-PROBLEM
pain	NN	I-PROBLEM
under	IN	I-PROBLEM
the	DT	I-PROBLEM
right	NN	I-PROBLEM
breast	NN	I-PROBLEM
which	WDT	O
is	VBZ	O
getting	VBG	O
progressively	RB	O
worse	JJR	O
.	.	O

the	DT	B-PROBLEM
pain	NN	I-PROBLEM
is	VBZ	O
worsened	VBN	O
with	IN	O
deep	JJ	O
inspiration	NN	O
or	CC	O
movement	NN	O
.	.	O

it	PRP	O
is	VBZ	O
associated	VBN	O
with	IN	O
sob	NN	B-PROBLEM
as	RB	O
well	RB	O
as	IN	O
fevers	NNS	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
.	.	O

the	DT	O
pt	NN	O
denies	VBZ	O
abd	RB	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
n/v	NN	B-PROBLEM
or	CC	O
increased	JJ	B-PROBLEM
ostomy	NN	I-PROBLEM
output	NN	I-PROBLEM
.	.	O

given	VBN	O
her	PRP$	B-PROBLEM
fever	NN	I-PROBLEM
,	,	O
sx	NN	B-PROBLEM
of	IN	I-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
sob	NN	B-PROBLEM
as	RB	O
well	RB	O
as	IN	O
an	DT	B-PROBLEM
elevated	JJ	I-PROBLEM
wbc	NN	I-PROBLEM
count	NN	I-PROBLEM
,	,	O
she	PRP	O
was	VBD	O
initially	RB	O
thought	VBN	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
pna	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
therefore	RB	O
given	VBN	O
ceftriaxone	NN	B-TREATMENT
1	CD	O
g	NN	O
iv	NN	O
x1	NNP	O
and	CC	O
azithromycin	RB	B-TREATMENT
500	CD	O
mg	NNS	O
po	JJ	O
x1	NN	O
in	IN	O
the	DT	O
deanna	NN	O
.	.	O

as	IN	O
the	DT	B-TEST
cxr	NN	I-TEST
was	VBD	O
without	IN	O
any	DT	O
evidence	NN	O
of	IN	O
pna	NN	B-PROBLEM
,	,	O
or	CC	O
ptx	NN	B-PROBLEM
,	,	O
the	DT	O
pt	NN	O
subsequently	RB	O
received	VBD	O
a	DT	B-TEST
cta	NN	I-TEST
to	TO	O
evaluate	VB	O
for	IN	O
pe	NN	B-PROBLEM
which	WDT	O
revealed	VBD	O
multifocal	JJ	B-PROBLEM
bilateral	JJ	I-PROBLEM
pna	NN	I-PROBLEM
but	CC	O
no	DT	O
pe	NN	B-PROBLEM
.	.	O

at	IN	O
this	DT	O
time	NN	O
,	,	O
she	PRP	O
was	VBD	O
given	VBN	O
vancomycin	RB	B-TREATMENT
1	CD	O
g	NNS	O
iv	JJ	O
x1	NNP	O
.	.	O

she	PRP	O
was	VBD	O
also	RB	O
given	VBN	O
morphine	NN	B-TREATMENT
2	CD	O
mg	NN	O
x3	NN	O
,	,	O
4	CD	O
mg	NN	O
iv	NN	O
x2	NNP	O
,	,	O
dolasetron	VBZ	B-TREATMENT
12.5	CD	O
mg	NN	O
x2	NN	O
and	CC	O
ativan	$	B-TREATMENT
1	CD	O
mg	NN	O
iv	NN	O
x1	NN	O
.	.	O

1.	CD	O
crohn	NN	B-PROBLEM
's	POS	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
dx	NN	O
1974	CD	O
s/p	NN	O
three	CD	B-TREATMENT
bowel	NN	I-TREATMENT
resections	NNS	I-TREATMENT
and	CC	O
eventual	JJ	B-TREATMENT
ileostomy	NN	I-TREATMENT
,	,	O
resulting	VBG	O
in	IN	O
short	JJ	B-PROBLEM
gut	NN	I-PROBLEM
syndrome	NN	I-PROBLEM

2.	CD	O
restless	JJ	B-PROBLEM
leg	NN	I-PROBLEM
syndrome	NN	I-PROBLEM

3.	CD	O
?	.	O
parkinsons	NNS	B-PROBLEM
vs.	IN	O
eps	JJ	B-PROBLEM
side	NN	I-PROBLEM
effects	NNS	I-PROBLEM
from	IN	O
risperdal	NN	B-TREATMENT

4.	CD	O
chronic	JJ	B-PROBLEM
idiopathic	JJ	I-PROBLEM
pancreatitis	NN	I-PROBLEM
,	,	O
as	IN	O
demonstrated	VBN	O
on	IN	O
ct	NN	B-TEST
in	IN	O
09-01	JJ	O

5.	CD	O
arthritis	NN	B-PROBLEM
s/p	NN	O
"	NNP	B-TREATMENT
pin	NN	I-TREATMENT
placement	NN	I-TREATMENT
"	NN	I-TREATMENT
in	IN	I-TREATMENT
left	JJ	I-TREATMENT
foot	NN	I-TREATMENT
05-01	NN	O

6.	CD	O
degenerative	JJ	B-PROBLEM
disc	NN	I-PROBLEM
disease	NN	I-PROBLEM
s/p	VBD	O
two	CD	B-TREATMENT
back	JJ	I-TREATMENT
surgeries	NNS	I-TREATMENT
in	IN	O
80	CD	O
's	POS	O

7.	CD	O
benzo	NN	B-TREATMENT
and	CC	O
opiod	JJ	B-TREATMENT
addiction	NN	O

8.	CD	O
paranoia	JJ	B-PROBLEM
/	NNP	O
depression	NN	B-PROBLEM
,	,	O
h/o	JJ	O
auditory	NN	B-PROBLEM
hallucinations	NNS	I-PROBLEM
,	,	O
?	.	O
mania	NN	B-PROBLEM

9.	CD	O
port-a-cath	JJ	B-TREATMENT
placement	NN	I-TREATMENT
for	IN	O
iv	JJ	B-TREATMENT
hydration	NN	I-TREATMENT
in	IN	O
setting	VBG	O
of	IN	O
short	JJ	B-PROBLEM
gut	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
,	,	O
complicated	VBN	O
by	IN	O
clotting	VBG	B-PROBLEM
x	JJ	O
4	CD	O
,	,	O
requiring	VBG	O
replacement	NN	B-TREATMENT

abd	NN	B-TEST
ct	NN	I-TEST
performed	VBD	O
09-01	JJ	O
showed	JJ	O
multiple	JJ	B-PROBLEM
calcifications	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
body	NN	I-PROBLEM
and	CC	I-PROBLEM
tail	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
pancreas	NNS	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
larger	JJR	I-PROBLEM
cystic	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
tail	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
pancreas	NNS	I-PROBLEM
.	.	O

a	DT	B-PROBLEM
second	JJ	I-PROBLEM
9	CD	I-PROBLEM
mm	NN	I-PROBLEM
cystic	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
in	IN	O
the	DT	O
head	NN	O
of	IN	O
the	DT	O
pancreas	NNS	O
.	.	O

these	DT	O
findings	NNS	O
are	VBP	O
consistent	JJ	O
with	IN	O
chronic	JJ	B-PROBLEM
pancreatitis	NN	I-PROBLEM
with	IN	O
pseudocyst	NN	B-PROBLEM
formation	NN	I-PROBLEM

social	JJ	O
history:	NN	O
lives	VBZ	O
w/	IN	O
her	PRP$	O
husband	NN	O
in	IN	O
john	JJ	O
area	NN	O
;	:	O
smokes	VBZ	O
05-04	JJ	O
cig	NN	O
/d	NNP	O
(	(	O
30	CD	O
pack	NN	O
year	NN	O
history	NN	O
);	NNP	O
no	DT	O
alcohol	NN	O
or	CC	O
recreational	JJ	O
drug	NN	O
use	NN	O
,	,	O
has	VBZ	O
had	VBN	O
addiction	NN	O
to	TO	O
benzodiazepines	NNS	B-TREATMENT
and	CC	O
opioids	NNS	B-TREATMENT
in	IN	O
the	DT	O
past	NN	O

mother-crohn	NN	B-PROBLEM
's	POS	I-PROBLEM
;	:	O
daugher-ibs	JJ	B-PROBLEM
,	,	O
colitis	NN	B-PROBLEM
;	:	O
mother	CC	O
--	:	O
breast	NN	B-PROBLEM
ca	MD	I-PROBLEM
,;	VB	O

father	SYM	O
-	:	O
stephanie	JJ	B-PROBLEM
tumor	NN	I-PROBLEM
,	,	O
no	DT	O
dm	NN	B-PROBLEM
,	,	O
no	DT	O
cad	NN	B-PROBLEM

v	NN	B-TEST
:	:	O
101.4	CD	O
,	,	O
102	CD	O
,	,	O
167/54	CD	O
->	NN	O
159/77	CD	O
,	,	O
24	CD	O
->	NN	O
16	CD	O
,	,	O
98%	CD	O
ra	NN	O
->	VBD	O
96%	CD	O
ra	NN	O

cv	NN	O
:	:	O
rrr	NN	O
,	,	O
s1	NN	O
,	,	O
s2	NN	B-PROBLEM
distant	NN	I-PROBLEM

chest	NN	O
:	:	O
crackles	NNS	B-PROBLEM
at	IN	I-PROBLEM
right	JJ	I-PROBLEM
base	NN	I-PROBLEM
with	IN	O
dec.	NNP	B-PROBLEM
air	NN	I-PROBLEM
movement	NN	I-PROBLEM
.	.	O

tender	NN	B-PROBLEM
over	IN	I-PROBLEM
right	JJ	I-PROBLEM
chest	NN	I-PROBLEM

abd	NN	O
:	:	O
obese	JJ	B-PROBLEM
,	,	O
multiple	JJ	B-PROBLEM
surgical	JJ	I-PROBLEM
scars	NNS	I-PROBLEM
.	.	O

ileostomy	NN	B-TREATMENT
bag	NN	I-TREATMENT
present	NN	O
with	IN	O
gas	NN	O
and	CC	O
stool	NN	O
.	.	O

absomen	NNS	O
soft	JJ	O
,	,	O
tender	NN	B-PROBLEM
to	TO	O
palpation	NN	B-TEST
over	IN	I-TEST
ruq	NN	I-TEST
,	,	O
but	CC	O
no	DT	O
guarding	NN	B-PROBLEM
or	CC	O
rebound	NN	B-PROBLEM

ext	NN	O
:	:	O
tr	NN	B-PROBLEM
edema	NN	I-PROBLEM
,	,	O
2+	CD	O
dp	NN	B-TEST
bilaterally	RB	I-TEST

glucose	JJ	B-TEST
-	:	O
208	CD	O
*	JJ	O
urea	JJ	B-TEST
n	SYM	I-TEST
-	:	O
21	CD	O
*	NN	O
creat	NN	B-TEST
-	:	O
1.3	CD	O
*	JJ	O
sodium	NN	B-TEST
-	:	O
138	CD	O
potassium	NN	B-TEST
-	:	O
4.2	CD	O
chloride	NN	B-TEST
-	:	O
104	CD	O
total	JJ	B-TEST
co2	NN	I-TEST
-	:	O
23	CD	O
anion	NN	B-TEST
gap	NN	I-TEST
-	:	O
15	CD	O

ck	NN	B-TEST
(	(	I-TEST
cpk	JJ	I-TEST
)-	CD	I-TEST
31	CD	O

ctropnt	NN	B-TEST
-<	VBZ	O
0.01	CD	O

wbc	SYM	B-TEST
-	:	O
14.4	CD	O
*#	NN	O
rbc	NN	B-TEST
-	:	O
3.82	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
11.5	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
33.5	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
88	CD	O
mch	SYM	B-TEST
-	:	O
30.2	CD	O
mchc	SYM	B-TEST
-	:	O
34.5	CD	O
rdw	NN	B-TEST
-	:	O
14.7	CD	O

neuts	NNS	B-TEST
-	:	O
78.0	CD	O
*	NN	O
lymphs	SYM	B-TEST
-	:	O
17.0	CD	O
*	JJ	O
monos	NNS	B-TEST
-	:	O
4.6	CD	O
eos	SYM	B-TEST
-	:	O
0.3	CD	O
basos	SYM	B-TEST
-	:	O
0.1	CD	O

plt	NN	B-TEST
count	NN	I-TEST
-	:	O
128	CD	O
*	NN	O

pt	SYM	B-TEST
-	:	O
12.3	CD	O
ptt	NN	B-TEST
-	:	O
26.1	CD	O
inr	NN	B-TEST
(	(	I-TEST
pt	JJ	I-TEST
)-	CD	I-TEST
1.0	CD	O

cta	NN	B-TEST
2013-12-24	JJ	O
-	:	O
impression	NN	O
:	:	O

1.	CD	O
no	DT	O
definite	NN	B-PROBLEM
pulmonary	JJ	I-PROBLEM
embolism	NN	I-PROBLEM
is	VBZ	O
identified	VBN	O
.	.	O

2.	CD	O
peripheral	JJ	B-PROBLEM
patchy	NN	I-PROBLEM
opacities	NNS	I-PROBLEM
are	VBP	O
seen	VBN	O
bilaterally	RB	O
,	,	O
most	JJS	O
consistent	JJ	O
with	IN	O
multifocal	JJ	B-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

cxr	NN	B-TEST
2013-12-24	JJ	O
-	:	O
there	EX	O
are	VBP	O
faint	JJ	B-PROBLEM
ill-defined	JJ	I-PROBLEM
opacities	NNS	I-PROBLEM
within	IN	O
the	DT	O
right	NN	O
lower	RBR	O
lung	NN	O
zone	NN	O
and	CC	O
left	VBD	O
upper	JJ	O
lung	NN	O
zone	NN	O
could	MD	O
represent	VB	O
a	DT	B-PROBLEM
multifocal	JJ	I-PROBLEM
pneumonic	NN	I-PROBLEM
process	NN	I-PROBLEM
.	.	O

cxr	NN	B-TEST
2014-01-02	JJ	O
-	:	O
impression	NN	O
:	:	O

multilobar	NN	B-PROBLEM
pneumonia	NN	I-PROBLEM
with	IN	O
interval	JJ	B-PROBLEM
worsening	VBG	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
lung	NN	I-PROBLEM
but	CC	O
slight	JJ	O
improvement	NN	O
in	IN	O
the	DT	O
right	NN	O
lower	JJR	O
lobe	NN	O
.	.	O

head	NN	B-TEST
ct	NN	I-TEST
2014-01-09	JJ	O
-	:	O
ordered	VBN	O
to	TO	O
evaluate	VB	O
for	IN	O
changes	NNS	O
to	TO	O
explain	VB	O
delta	JJ	B-PROBLEM
ms	NN	I-PROBLEM

left	JJ	B-PROBLEM
parietal	JJ	I-PROBLEM
subcortical	JJ	I-PROBLEM
hypodensity	NN	I-PROBLEM
,	,	O
likely	JJ	O
ischemic	NN	B-PROBLEM
.	.	O

no	DT	O
definite	NN	B-PROBLEM
changes	NNS	I-PROBLEM
since	IN	O
the	DT	B-TEST
mr	NN	I-TEST
of	IN	O
in	IN	O
2011-05-15	JJ	O
.	.	O

cxr	NN	B-TEST
2014-01-09	JJ	O

54	CD	O
yo	NNS	O
f	JJ	O
with	IN	O
crohn	NN	B-PROBLEM
's	POS	I-PROBLEM
disease	NN	I-PROBLEM
s/p	VBD	O
ileostomy	NN	B-TREATMENT
with	IN	O
subsequent	JJ	O
short	JJ	B-PROBLEM
gut	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
with	IN	O
port-o-cath	NN	B-TREATMENT
for	IN	O
tpn	JJ	B-TREATMENT
presents	NNS	O
with	IN	O
acute	JJ	B-PROBLEM
onset	VBN	I-PROBLEM
pleuritic	JJ	I-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
with	IN	O
fever	NN	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
,	,	O
and	CC	O
sob	NN	B-PROBLEM
.	.	O

1.	CD	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
/	NN	O
fever	NN	B-PROBLEM
/	NNP	O
chills	NNS	B-PROBLEM
:	:	O

the	DT	B-PROBLEM
acute	JJ	I-PROBLEM
onset	NN	I-PROBLEM
of	IN	I-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
was	VBD	O
initially	RB	O
very	RB	O
concerning	VBG	O
for	IN	O
a	DT	B-PROBLEM
pe	NN	I-PROBLEM
,	,	O
however	RB	O
the	DT	B-TEST
chest	JJS	I-TEST
ct	NN	I-TEST
demonstrated	VBD	O
multifocal	JJ	B-PROBLEM
consolidation	NN	I-PROBLEM
consistent	NN	O
with	IN	O
a	DT	B-PROBLEM
bacterial	JJ	I-PROBLEM
pna	NN	I-PROBLEM
.	.	O

this	DT	O
is	VBZ	O
consistent	JJ	O
with	IN	O
the	DT	O
remainder	NN	O
of	IN	O
the	DT	O
pt	NN	O
's	POS	O
history	NN	O
including	VBG	O
fever	NN	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
,	,	O
sob	NN	B-PROBLEM
and	CC	O
an	DT	B-PROBLEM
elevated	JJ	I-PROBLEM
wbc	NN	I-PROBLEM
count	NN	I-PROBLEM
.	.	O

the	DT	O
pt	NN	O
was	VBD	O
given	VBN	O
ceftriaxone	NN	B-TREATMENT
/	NN	O
azithromycin	NN	B-TREATMENT
/	NNP	O
vancomycin	NN	B-TREATMENT
in	IN	O
deanna	NN	O
.	.	O

blood	NN	B-TEST
,	,	I-TEST
urine	JJ	I-TEST
and	CC	I-TEST
sputum	JJ	I-TEST
culutres	NNS	I-TEST
were	VBD	O
sent	VBN	O
.	.	O

pt	NN	B-TEST
's	POS	I-TEST
blood	NN	I-TEST
cultures	NNS	I-TEST
came	VBD	O
back	RB	O
positive	JJ	O
for	IN	O
staph	NN	B-PROBLEM
aureus	NN	I-PROBLEM
and	CC	O
enterococcus	NN	B-PROBLEM
,	,	O
both	DT	O
were	VBD	O
pansensitive	JJ	O
.	.	O

sputum	JJ	B-TEST
culture	NN	I-TEST
also	RB	O
returned	VBD	O
with	IN	O
staph.	NN	B-PROBLEM
aureus	NN	I-PROBLEM
.	.	O

ceftriaxone	NN	B-TREATMENT
and	CC	O
azithro	NN	B-TREATMENT
were	VBD	O
discontinued	VBN	O
,	,	O
and	CC	O
vacomycin	NN	B-TREATMENT
was	VBD	O
continued	VBN	O
.	.	O

pt	NN	O
initially	RB	O
was	VBD	O
hypoxic	JJ	B-PROBLEM
requiring	VBG	O
nrb	NN	B-TREATMENT
for	IN	O
o2	JJ	B-TEST
sat	NN	I-TEST
of	IN	O
94%	CD	O
,	,	O
with	IN	O
any	DT	O
attempt	NN	O
to	TO	O
wean	VB	O
she	PRP	O
would	MD	O
desat	VB	O
.	.	O

pt	NN	O
was	VBD	O
intubated	VBN	O
prior	RB	O
to	TO	O
tunneled	VB	B-TREATMENT
catheter	NN	I-TREATMENT
removal	NN	I-TREATMENT
,	,	O
see	VBP	O
below	IN	O
.	.	O

(	(	O
the	DT	B-TREATMENT
tunneled	VBN	I-TREATMENT
catheter	NN	I-TREATMENT
later	RBR	O
came	VBD	O
back	RB	O
for	IN	O
negative	JJ	O
for	IN	O
culture.	NN	B-TEST
)	)	O

earlier	RBR	O
that	DT	O
day	NN	O
pt	VB	O
had	VBD	O
a	DT	B-TEST
chest	NN	I-TEST
x	NN	I-TEST
ray	NN	I-TEST
which	WDT	O
showed	VBD	O
diffuse	IN	B-PROBLEM
infiltrative	JJ	I-PROBLEM
process	NN	I-PROBLEM
concerning	VBG	O
for	IN	O
ards	NNS	B-PROBLEM
.	.	O

post	NN	O
procedure	NN	B-TREATMENT
pt	NN	O
remained	VBD	O
intubated	VBN	B-TREATMENT
on	IN	O
ardsnet	NN	B-TREATMENT
protocol	NN	I-TREATMENT
.	.	O

she	PRP	O
self	PRP	O
extubated	VBD	O
the	DT	O
first	JJ	O
day	NN	O
and	CC	O
was	VBD	O
reintubated	VBN	O
without	IN	O
any	DT	B-PROBLEM
complications	NNS	I-PROBLEM
.	.	O

her	PRP$	B-PROBLEM
o2	JJ	I-PROBLEM
requirement	NN	I-PROBLEM
improved	VBN	O
on	IN	O
the	DT	B-TREATMENT
vent	NN	I-TREATMENT
over	IN	O
the	DT	O
next	JJ	O
few	JJ	O
days	NNS	O
and	CC	O
she	PRP	O
was	VBD	O
weaned	VBN	O
off	RP	O
the	DT	B-TREATMENT
vent	NN	I-TREATMENT
on	IN	O
2013-01-01	JJ	O
.	.	O

after	IN	O
extubation	NN	O
her	PRP$	B-PROBLEM
o2	JJ	I-PROBLEM
requirement	NN	I-PROBLEM
was	VBD	O
down	RB	O
to	TO	O
1l	CD	B-TREATMENT
nc	NNS	I-TREATMENT
with	IN	O
sats	NNS	B-TEST
in	IN	O
mid	JJ	O
90s	CD	O
.	.	O

the	DT	O
patient	NN	O
remained	VBD	O
afebrile	JJ	B-PROBLEM
when	WRB	O
she	PRP	O
transferred	VBD	O
to	TO	O
the	DT	O
medicine	NN	O
service	NN	O
.	.	O

she	PRP	O
was	VBD	O
weaned	VBN	O
off	RP	O
the	DT	B-TREATMENT
oxygen	NN	I-TREATMENT
and	CC	O
for	IN	O
the	DT	O
remainder	NN	O
of	IN	O
her	PRP$	O
course	NN	O
her	PRP$	B-TEST
o2sats	NNS	I-TEST
were	VBD	O
stable	JJ	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
completed	VBN	O
her	PRP$	B-TREATMENT
antibiotic	JJ	I-TREATMENT
course	NN	I-TREATMENT
while	IN	O
in	IN	O
house	NN	O
.	.	O

2.	CD	O
hx	NN	O
of	IN	O
multiple	JJ	B-PROBLEM
port-o-cath	JJ	I-PROBLEM
clots	NNS	I-PROBLEM
:	:	O

although	IN	O
the	DT	O
pt	NN	O
is	VBZ	O
on	IN	O
warfarin	NN	B-TREATMENT
chronically	RB	O
,	,	O
her	PRP	B-TEST
inr	NN	I-TEST
was	VBD	O
subtherapeutic	JJ	O
.	.	O

goal	NN	O
inr	JJ	B-TEST
01-31	NN	O
.	.	O

initially	RB	O
coumadin	NN	B-TREATMENT
was	VBD	O
increased	VBN	O
,	,	O
however	RB	O
given	VBN	O
concern	NN	O
for	IN	O
infected	JJ	B-PROBLEM
line	NN	I-PROBLEM
,	,	O
general	JJ	O
surgery	NN	O
was	VBD	O
consulted	VBN	O
who	WP	O
removed	VBD	O
the	DT	B-TREATMENT
line	NN	I-TREATMENT
in	IN	O
the	DT	O
icu	NN	O
.	.	O

3.	CD	O
arf	NN	B-PROBLEM
:	:	O

pt	NNS	O
initially	RB	O
with	IN	O
mild	JJ	B-PROBLEM
ari	NN	I-PROBLEM
,	,	O
this	DT	O
was	VBD	O
thought	VBN	O
to	TO	O
be	VB	O
due	JJ	O
to	TO	O
dehydration	NN	B-PROBLEM
,	,	O
after	IN	O
initial	JJ	B-TREATMENT
volume	NN	I-TREATMENT
repletion	NN	I-TREATMENT
her	PRP$	O
renal	JJ	O
function	NN	O
improved	VBD	O
to	TO	O
her	PRP$	O
baseline	NN	O
.	.	O

the	DT	O
pt	NN	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
paranoia	NN	B-PROBLEM
/	NNP	O
depression	NN	B-PROBLEM
.	.	O

on	IN	O
admission	NN	O
she	PRP	O
was	VBD	O
taking	VBG	O
quetiapine	JJ	B-TREATMENT
300	CD	O
mg	NN	O
qhs	NN	O
and	CC	O
clonazepam	NN	B-TREATMENT
1	CD	O
mg	NN	O
qam	NN	O
,	,	O
1	CD	O
mg	NN	O
q3pm	NN	O
,	,	O
2	CD	O
mg	NN	O
po	NN	O
qhs	NN	O
.	.	O

quetiapine	NN	B-TREATMENT
was	VBD	O
continued	VBN	O
however	RB	O
clonipin	NN	B-TREATMENT
was	VBD	O
initially	RB	O
held	VBN	O
when	WRB	O
she	PRP	O
was	VBD	O
intubated	VBN	B-TREATMENT
on	IN	O
fentynyl	NN	B-TREATMENT
/	NN	O
versed	VBD	B-TREATMENT
.	.	O

this	DT	O
was	VBD	O
restarted	VBN	O
post	NN	O
extubation	NN	B-TREATMENT
.	.	O

her	PRP$	O
course	NN	O
later	RB	O
became	VBD	O
complicated	VBN	O
by	IN	O
visual	JJ	B-PROBLEM
and	CC	I-PROBLEM
auditory	JJ	I-PROBLEM
hallucinations	NNS	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
unable	JJ	B-PROBLEM
to	TO	I-PROBLEM
sleep	VB	I-PROBLEM
at	IN	O
night	NN	O
,	,	O
often	RB	O
pacing	VBG	O
the	DT	O
halls	NNS	O
.	.	O

she	PRP	O
required	VBD	O
a	DT	B-TREATMENT
1:1	CD	I-TREATMENT
sitter	NN	I-TREATMENT
.	.	O

they	PRP	O
felt	VBD	O
that	IN	O
her	PRP$	O
presentation	NN	O
was	VBD	O
secondary	JJ	O
to	TO	O
delirium	VB	B-PROBLEM
and	CC	O
was	VBD	O
multifactorial	JJ	O
.	.	O

they	PRP	O
attributed	VBD	O
it	PRP	O
to	TO	O
polypharmacy	VB	B-PROBLEM
,	,	O
recent	JJ	B-PROBLEM
infection	NN	I-PROBLEM
(	(	I-PROBLEM
pneumonia	NN	I-PROBLEM
)	)	I-PROBLEM
and	CC	O
insomnia	NN	B-PROBLEM
.	.	O

a	DT	B-TEST
head	NN	I-TEST
ct	NN	I-TEST
was	VBD	O
done	VBN	O
which	WDT	O
ruled	VBD	O
out	RP	O
any	DT	B-PROBLEM
acute	JJ	I-PROBLEM
processes	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
refused	VBD	O
an	DT	B-TEST
lp	NN	I-TEST
.	.	O

they	PRP	O
made	VBD	O
recommendations	NNS	O
for	IN	O
adjustments	NNS	O
to	TO	O
her	PRP$	B-TREATMENT
anti-psychotic	JJ	I-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

at	IN	O
discharge	PDT	O
the	DT	O
patient	NN	O
was	VBD	O
on	IN	O
clonazepam	NN	B-TREATMENT
1	CD	O
mg	NN	O
tid	NN	O
,	,	O
seroquel	JJ	B-TREATMENT
300	CD	O
bid	NN	O
and	CC	O
neurontin	$	B-TREATMENT
600	CD	O
qam	NN	O
,	,	O
1200	CD	O
qpm	NN	O
and	CC	O
1200	CD	O
qhs	NN	O
.	.	O

the	DT	O
kindred	VBN	O
hospital	NN	O
hospital	NN	O
course	NN	O
was	VBD	O
prolonged	VBN	O
because	IN	O
of	IN	O
her	PRP$	B-PROBLEM
delirium	NN	I-PROBLEM
.	.	O

5.	CD	O
?	.	O
parkinson	NN	B-PROBLEM
's	POS	I-PROBLEM
disease	NN	I-PROBLEM
/	FW	O
akithesia	NN	B-PROBLEM
:	:	O

the	DT	O
patient	NN	O
was	VBD	O
maintained	VBN	O
sinemet	NN	B-TREATMENT
.	.	O

6.	CD	O
pain	NN	B-PROBLEM
:	:	O

in	IN	O
addition	NN	O
to	TO	O
her	PRP$	B-PROBLEM
usual	JJ	I-PROBLEM
neuropathy	JJ	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
the	DT	O
pt	NN	O
initially	RB	O
appeared	VBD	O
to	TO	O
have	VB	O
significant	JJ	B-PROBLEM
pain	NN	I-PROBLEM
from	IN	O
the	DT	B-PROBLEM
multi-focal	JJ	I-PROBLEM
pna	NN	I-PROBLEM
as	IN	O
well	RB	O
.	.	O

(	(	O
home	NN	B-TREATMENT
regimen	NNS	I-TREATMENT
,	,	O
gabapentin	NN	B-TREATMENT
800	CD	O
mg	NN	O
po	NN	O
qam	NN	O
,	,	O
1600	CD	O
mg	NN	O
po	NN	O
q3pm	NN	O
,	,	O
1600	CD	O
mg	NN	O
po	NN	O
qhs	NN	O
.	.	O

this	DT	O
was	VBD	O
held	VBN	O
in	IN	O
the	DT	O
icu	NN	O
and	CC	O
she	PRP	O
was	VBD	O
given	VBN	O
diluadid	JJ	B-TREATMENT
prn	NN	O
for	IN	O
pain	NN	B-TREATMENT
control	NN	I-TREATMENT
.	.	O

the	DT	B-TREATMENT
patient	NN	I-TREATMENT
's	POS	I-TREATMENT
narcotic	JJ	I-TREATMENT
and	CC	O
cmed	VBD	B-TREATMENT
ccu	NNS	I-TREATMENT
regimen	NNS	I-TREATMENT
was	VBD	O
evaluated	VBN	O
by	IN	O
psychiatry	NN	O
during	IN	O
her	PRP$	B-PROBLEM
delirium	NN	I-PROBLEM
.	.	O

given	VBN	O
her	PRP$	O
hx	NN	O
of	IN	O
ileostomy	JJ	B-TREATMENT
secondary	JJ	O
to	TO	O
crohn	VB	B-PROBLEM
's	POS	I-PROBLEM
disease	NN	I-PROBLEM
and	CC	O
resultant	JJ	O
short	JJ	B-PROBLEM
gut	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
,	,	O
the	DT	O
pt	NN	O
requires	VBZ	O
nutritional	JJ	B-TREATMENT
support	NN	I-TREATMENT
via	IN	O
tpn	NN	B-TREATMENT
.	.	O

after	IN	O
removal	NN	O
of	IN	O
tunneled	JJ	B-TREATMENT
line	NN	I-TREATMENT
pt	NN	O
was	VBD	O
given	VBN	O
tube	RP	B-TREATMENT
feeds	NNS	I-TREATMENT
while	IN	O
she	PRP	O
was	VBD	O
intubated	VBN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
transitioned	VBN	O
to	TO	O
a	DT	B-TREATMENT
low	JJ	I-TREATMENT
fat	NN	I-TREATMENT
,	,	I-TREATMENT
low	JJ	I-TREATMENT
residue	JJ	I-TREATMENT
diet	NN	I-TREATMENT
.	.	O

ppx	NN	O
:	:	O
ppi	NN	B-TREATMENT
and	CC	O
heparin	NN	B-TREATMENT
sc	NN	I-TREATMENT

1.	CD	O
quetiapine	JJ	B-TREATMENT
300	CD	O
mg	NN	O
qhs	NN	O

2.	CD	O
clonazepam	NN	B-TREATMENT
1	CD	O
mg	NN	O
qam	NN	O
,	,	O
1	CD	O
mg	NN	O
q3pm	NN	O
,	,	O
2	CD	O
mg	NN	O
po	NN	O
qhs	NN	O

3.	CD	O
ferrous	JJ	B-TREATMENT
sulfate	NN	I-TREATMENT
325	CD	O
po	JJ	O
daily	JJ	O

4.	CD	O
carbidopa-levodopa	JJ	B-TREATMENT
25-250	JJ	O
mg	NN	O
po	NN	O
5	CD	O
times	NNS	O
per	IN	O
day	NN	O
.	.	O

5.	CD	O
gabapentin	NN	B-TREATMENT
800	CD	O
mg	NN	O
po	NN	O
qam	NN	O
,	,	O
1600	CD	O
mg	NN	O
po	NN	O
q3pm	NN	O
,	,	O
1600	CD	O
mg	NN	O
po	NN	O
qhs	NN	O

6.	CD	O
heparin	NN	B-TREATMENT
lock	NN	I-TREATMENT
flush	VBD	I-TREATMENT
10	CD	O
unit	NN	O
/	JJ	O
ml	JJ	O
daily	RB	O
as	IN	O
needed	VBN	O
.	.	O

7.	CD	O
saline	NN	B-TREATMENT
flush	NN	I-TREATMENT

8.	CD	O
prevacid	JJ	B-TREATMENT
30	CD	O
mg	NN	O
po	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

9.	CD	O
vistaril	JJ	B-TREATMENT
50	CD	O
mg	NN	O
once	RB	O
a	DT	O
day	NN	O
as	IN	O
needed	VBN	O
for	IN	O
nausea	NN	B-PROBLEM
.	.	O

10.	CD	O
zofran	NN	B-TREATMENT
4	CD	O
mg	NN	O
po	NN	O
once	RB	O
a	DT	O
day	NN	O
as	IN	O
needed	VBN	O
for	IN	O
nausea	NN	B-PROBLEM
.	.	O

11.	CD	O
vitamin	JJ	B-TREATMENT
b-12	NN	I-TREATMENT
1,000	CD	O
mcg	NN	O
/	NNP	O
ml	VBZ	O
one	CD	O
injection	NN	O
every	DT	O
other	JJ	O
week	NN	O
.	.	O

12.	CD	O
vicodin	JJ	B-TREATMENT
5-500	JJ	O
mg	NN	O
1-2	JJ	O
tablets	NNS	O
po	VBP	O
every	DT	O
six	CD	O
(	(	O
6	CD	O
)	)	O
hours	NNS	O
prn	VBP	O

13.	CD	O
warfarin	JJ	B-TREATMENT
1	CD	O
mg	NN	O
po	NN	O
hs	NN	O
.	.	O

14.	CD	O
tpn	NN	B-TREATMENT

1.	CD	O
amylase-lipase-protease	JJ	B-TREATMENT
33,200	CD	O
-	:	O
10,000	CD	O
-	:	O
37,500	CD	O
unit	NN	O
capsule	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
four	CD	O
(	(	O
4	CD	O
)	)	O
cap	NN	O
po	NN	O
w/	NN	O
meals	NNS	O
and	CC	O
snacks	NNS	O
(	(	O
)	)	O
.	.	O

2.	CD	O
carbidopa-levodopa	JJ	B-TREATMENT
25	CD	O
-	:	O
250	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	$	O
5	CD	O
times	NNS	O
a	DT	O
day	NN	O
(	(	O
)	)	O
.	.	O

3.	CD	O
pramipexole	JJ	B-TREATMENT
0.125	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
tid	NN	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

4.	CD	O
clonazepam	NN	B-TREATMENT
1	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
tid	NN	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

5.	CD	O
ferrous	JJ	B-TREATMENT
sulfate	NN	I-TREATMENT
300	CD	O
mg	NN	O
/	VBD	O
5	CD	O
ml	NN	O
liquid	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
po	NN	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

6.	CD	O
nystatin	JJ	B-TREATMENT
100,000	CD	O
unit	NN	O
/	JJ	O
g	NN	O
cream	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
appl	RB	O
topical	JJ	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

7.	CD	O
lansoprazole	JJ	B-TREATMENT
30	CD	O
mg	NN	O
capsule	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

8.	CD	O
quetiapine	JJ	B-TREATMENT
100	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
three	CD	O
(	(	O
3	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

9.	CD	O
propranolol	JJ	B-TREATMENT
10	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

10.	CD	O
neurontin	JJ	B-TREATMENT
300	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
three	CD	O
(	(	O
3	CD	O
)	)	O
capsule	NN	O
po	VBD	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
:	:	O
take	VB	O
2	CD	O
tabs	NNS	O
in	IN	O
the	DT	O
morining	NN	O
,	,	O
4	CD	O
tabs	NN	O
in	IN	O
the	DT	O
afternoon	NN	O
,	,	O
and	CC	O
4	CD	O
tabs	NNS	O
in	IN	O
the	DT	O
evening	NN	O
.	.	O

pneumonia	NN	B-PROBLEM

you	PRP	O
are	VBP	O
to	TO	O
return	VB	O
to	TO	O
the	DT	O
hospital	NN	O
immediately	RB	O
if	IN	O
you	PRP	O
should	MD	O
experience	VB	O
any	DT	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
fevers	NNS	B-PROBLEM
or	CC	O
any	DT	B-PROBLEM
other	JJ	I-PROBLEM
worrisome	JJ	I-PROBLEM
symptom	NN	I-PROBLEM
.	.	O

please	NN	O
continue	VB	O
taking	VBG	O
your	PRP$	B-TREATMENT
medications	NNS	I-TREATMENT
as	IN	O
prescribed	NN	O
.	.	O

patient	NN	O
recorded	VBD	O
as	IN	O
having	VBG	O
no	DT	O
known	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM
to	TO	O
drugs	NNS	B-TREATMENT

shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM

coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
x3	NNP	O
(	(	O
left	VBD	B-TREATMENT
internal	JJ	I-TREATMENT
mammary	JJ	I-TREATMENT
->	NN	I-TREATMENT
left	VBD	I-TREATMENT
anterior	JJ	I-TREATMENT
descending	NN	I-TREATMENT
,	,	O
saphaneous	JJ	B-TREATMENT
vein	NN	I-TREATMENT
graft	NN	I-TREATMENT
->	NNP	I-TREATMENT
obtuse	IN	I-TREATMENT
marginal	JJ	I-TREATMENT
,	,	O
saphaneous	JJ	B-TREATMENT
vein	NN	I-TREATMENT
graft	NN	I-TREATMENT
->	NNP	I-TREATMENT
posterior	NN	I-TREATMENT
descending	VBG	I-TREATMENT
artery	NN	I-TREATMENT
)	)	O
2018-10-25	CD	O

67	CD	O
y/o	NNS	O
male	JJ	O
with	IN	O
worsening	VBG	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath.	NN	I-PROBLEM
had	VBD	O
abnormal	JJ	B-PROBLEM
ett	NN	I-PROBLEM
and	CC	O
referred	VBD	O
for	IN	O
cath	NN	B-TEST
.	.	O

cath	NN	B-TEST
revealed	VBD	O
severe	JJ	B-PROBLEM
3	CD	I-PROBLEM
vessel	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

then	RB	O
referred	VBN	O
for	IN	O
surgical	JJ	B-TREATMENT
intervention	NN	I-TREATMENT
.	.	O

carpal	JJ	B-PROBLEM
tunnel	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
,	,	O
hypertension	NN	B-PROBLEM
,	,	O
hyperlipidemia	NN	B-PROBLEM
,	,	O
arthritis	NN	B-PROBLEM
,	,	O
h/o	NN	O
bell's	NN	B-PROBLEM
palsy	NN	I-PROBLEM
,	,	O
hoh	NN	B-PROBLEM
,	,	O
s/p	JJ	O
tonsillectomy	NN	B-TREATMENT

father	NN	O
with	IN	O
mi	NN	B-PROBLEM
in	IN	O
50	CD	O
's	POS	O
and	CC	O
underwent	JJ	O
cabg	NN	B-TREATMENT
.	.	O

vs	NN	B-TEST
:	:	O
65	CD	O
20	CD	O
160/100	CD	O
5	CD	O
'	POS	O
7	CD	O
"	JJ	O
180	CD	O
#	#	O

general	JJ	O
:	:	O
wd/wn	NN	O
male	NN	O
in	IN	O
nad	NN	B-PROBLEM

heent	NN	O
:	:	O
eomi	NN	O
,	,	O
perrl	NN	O
,	,	O
nc/at	NN	B-PROBLEM

neck	NN	O
:	:	O
supple	NN	O
,	,	O
from	IN	O
,	,	O
-	:	O
jvd	NN	B-PROBLEM
,	,	O
-	:	O
carotid	NN	B-PROBLEM
bruits	NNS	I-PROBLEM

chest	NN	O
:	:	O
ctab	NN	O
-	:	O
w/r/r	NN	B-PROBLEM

heart	NN	O
:	:	O
rrr	NN	O
-	:	O
c/r/m/g	NN	B-PROBLEM

abd	NN	O
:	:	O
soft	JJ	O
,	,	O
nt/nd	JJ	B-PROBLEM
+bs	NN	O

ext	NN	O
:	:	O
warm	NN	O
,	,	O
well-perfused	JJ	O
-	:	O
edema	NN	B-PROBLEM
,	,	O
-	:	O
varicosities	NNS	B-PROBLEM

echo	JJ	B-TEST
10-25	JJ	O
:	:	O
pre-bypass	NN	O
:	:	O
left	VBD	B-TEST
ventricular	JJ	I-TEST
wall	NN	I-TEST
thicknesses	NNS	I-TEST
are	VBP	O
normal	JJ	O
.	.	O

the	DT	B-TEST
left	NN	I-TEST
ventricular	JJ	I-TEST
cavity	NN	I-TEST
size	NN	I-TEST
is	VBZ	O
normal	JJ	O
.	.	O

there	EX	O
is	VBZ	O
mild	JJ	B-PROBLEM
inferior	JJ	I-PROBLEM
wall	NN	I-PROBLEM
hypokinesis	NN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
akinesis	JJ	B-PROBLEM
/	JJ	O
dyskinesis	NN	B-PROBLEM
and	CC	O
thinning	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
mid	NN	I-PROBLEM
to	TO	I-PROBLEM
distal	VB	I-PROBLEM
inferior	JJ	I-PROBLEM
septum	NN	I-PROBLEM
and	CC	O
the	DT	O
apex	NN	O
.	.	O

overall	JJ	B-TEST
left	VBD	I-TEST
ventricular	JJ	I-TEST
systolic	JJ	I-TEST
function	NN	I-TEST
is	VBZ	O
mildly	RB	B-PROBLEM
depressed	JJ	I-PROBLEM
.	.	O

right	RB	B-TEST
ventricular	JJ	I-TEST
chamber	NN	I-TEST
size	NN	I-TEST
and	CC	O
free	JJ	B-TEST
wall	NN	I-TEST
motion	NN	I-TEST
are	VBP	O
normal	JJ	O
.	.	O

the	DT	O
descending	VBG	O
thoracic	NN	O
aorta	NN	O
is	VBZ	O
mildly	RB	B-PROBLEM
dilated	VBN	I-PROBLEM
.	.	O

there	EX	O
are	VBP	O
simple	JJ	B-PROBLEM
atheroma	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
descending	NN	I-PROBLEM
thoracic	NN	I-PROBLEM
aorta	NN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
aortic	JJ	B-PROBLEM
valve	NN	I-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

no	DT	O
aortic	JJ	B-PROBLEM
regurgitation	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
.	.	O

the	DT	O
mitral	JJ	O
valve	NN	O
leaflets	NNS	O
are	VBP	O
mildly	RB	B-PROBLEM
thickened	VBN	I-PROBLEM
.	.	O

trivial	JJ	B-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
.	.	O

post-bypass	NN	B-TREATMENT
:	:	O
lv	NN	B-TEST
and	CC	I-TEST
rv	NN	I-TEST
function	NN	I-TEST
is	VBZ	O
unchanged	JJ	O
.	.	O

cxr	JJ	B-TEST
10-30	JJ	O
:	:	O
left	VBD	B-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
atelectasis	NN	I-PROBLEM
has	VBZ	O
partially	RB	O
cleared	VBN	O
.	.	O

mild	JJ	B-PROBLEM
postoperative	JJ	I-PROBLEM
widening	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
cardiomediastinal	JJ	I-PROBLEM
silhouette	NN	I-PROBLEM
is	VBZ	O
stable	JJ	O
.	.	O

no	DT	O
pneumothorax	NN	B-PROBLEM
.	.	O

2018-10-25	JJ	O
11:15	CD	O
am	VBP	O
blood	NN	B-TEST
wbc	NN	B-TEST
-	:	O
18.3	CD	O
*#	NN	O
rbc	NN	B-TEST
-	:	O
3.42	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
10.9	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
31.6	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
92	CD	O
mch	SYM	B-TEST
-	:	O
31.7	CD	O
mchc	SYM	B-TEST
-	:	O
34.4	CD	O
rdw	NN	B-TEST
-	:	O
13.3	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
134	CD	O
*	NN	O

2018-10-31	JJ	O
06:25	CD	O
am	VBP	O
blood	NN	B-TEST
wbc	NN	B-TEST
-	:	O
13.6	CD	O
*	NN	O
rbc	NN	B-TEST
-	:	O
2.72	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
8.6	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
24.6	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
91	CD	O
mch	SYM	B-TEST
-	:	O
31.7	CD	O
mchc	SYM	B-TEST
-	:	O
35.0	CD	O
rdw	NN	B-TEST
-	:	O
14.0	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
314	CD	O

2018-10-25	JJ	O
11:15	CD	O
am	VBP	O
blood	NN	B-TEST
pt	NN	B-TEST
-	:	O
13.3	CD	O
*	NN	O
ptt	NN	B-TEST
-	:	O
30.0	CD	O
inr(pt)	JJ	B-TEST
-	:	O
1.2	CD	O
*	NN	O

2018-10-29	JJ	O
06:50	CD	O
am	VBP	O
blood	NN	B-TEST
pt	NN	B-TEST
-	:	O
11.9	CD	O
inr(pt)	JJ	B-TEST
-	:	O
1.0	CD	O

2018-10-25	JJ	O
12:36	CD	O
pm	NN	O
blood	NN	B-TEST
urean	JJ	B-TEST
-	:	O
17	CD	O
creat	NN	B-TEST
-	:	O
0.7	CD	O
cl	NN	B-TEST
-	:	O
111	CD	O
*	NN	O
hco3	NN	B-TEST
-	:	O
23	CD	O

2018-10-31	JJ	O
06:25	CD	O
am	VBP	O
blood	NN	B-TEST
glucose	JJ	B-TEST
-	:	O
91	CD	O
urean	JJ	B-TEST
-	:	O
19	CD	O
creat	NN	B-TEST
-	:	O
0.8	CD	O
na	SYM	B-TEST
-	:	O
134	CD	O
k	SYM	B-TEST
-	:	O
4.0	CD	O
cl	NN	B-TEST
-	:	O
98	CD	O
hco3	NN	B-TEST
-	:	O
26	CD	O
angap	NN	B-TEST
-	:	O
14	CD	O

mr.	NN	O
kammerer	NNP	O
was	VBD	O
a	DT	O
same	JJ	O
day	NN	O
admit	NN	O
and	CC	O
on	IN	O
10-25	NNS	O
was	VBD	O
brought	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
where	WRB	O
he	PRP	O
underwent	VBD	O
a	DT	B-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
x	VBD	O
3	CD	O
.	.	O

he	PRP	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
and	CC	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
csru	NN	O
for	IN	O
invasive	JJ	B-TEST
monitoring	NN	I-TEST
in	IN	O
stable	JJ	O
condition	NN	O
.	.	O

later	RB	O
on	IN	O
op	NNS	O
day	NN	O
he	PRP	O
was	VBD	O
weaned	VBN	O
from	IN	O
sedation	NN	B-TREATMENT
,	,	O
awoke	VBD	O
neurologically	RB	O
intact	JJ	O
,	,	O
and	CC	O

beta	NN	B-TREATMENT
blockers	NNS	I-TREATMENT
and	CC	O
diuretics	NNS	B-TREATMENT
were	VBD	O
initiated	VBN	O
on	IN	O
post-op	JJ	O
day	NN	O
one	CD	O
.	.	O

he	PRP	O
was	VBD	O
diuresed	VBN	B-TREATMENT
towards	IN	O
his	PRP$	B-TEST
pre-op	JJ	I-TEST
weight	NN	I-TEST
.	.	O

he	PRP	O
did	VBD	O
have	VB	O
burst	NN	B-PROBLEM
of	IN	I-PROBLEM
atrial	JJ	I-PROBLEM
fibrillation	NN	I-PROBLEM
and	CC	O
was	VBD	O
started	VBN	O
on	IN	O
a	DT	B-TREATMENT
amiodarone	NN	I-TREATMENT
gtt	NN	I-TREATMENT
.	.	O

his	PRP$	B-TREATMENT
beta	NN	I-TREATMENT
blockers	NNS	I-TREATMENT
were	VBD	O
also	RB	O
titrated	VBN	O
for	IN	O
maximal	JJ	B-TREATMENT
bp	NN	I-TREATMENT
and	CC	I-TREATMENT
hr	NN	I-TREATMENT
control	NN	I-TREATMENT
.	.	O

chest	NN	B-TREATMENT
tubes	NNS	I-TREATMENT
were	VBD	O
removed	VBN	O
on	IN	O
post-op	JJ	O
day	NN	O
two	CD	O
and	CC	O
epicardial	JJ	B-TREATMENT
pacing	NN	I-TREATMENT
wires	NNS	I-TREATMENT
on	IN	O
post-op	JJ	O
day	NN	O
three	CD	O
.	.	O

over	IN	O
the	DT	O
next	JJ	O
several	JJ	O
days	NNS	O
he	PRP	O
continued	VBD	O
to	TO	O
improve	VB	O
his	PRP$	O
ambulation	NN	O
and	CC	O
mobility	NN	O
with	IN	O
physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

he	PRP	O
had	VBD	O
no	DT	O
further	JJ	B-PROBLEM
episodes	NNS	I-PROBLEM
of	IN	I-PROBLEM
afib	NN	I-PROBLEM
while	IN	O
on	IN	O
po	NN	B-TREATMENT
amiodarone	NN	I-TREATMENT
.	.	O

on	IN	O
post-op	JJ	O
day	NN	O
five	CD	O
he	PRP	O
appeared	VBD	O
to	TO	O
have	VB	O
left	VBN	B-PROBLEM
arm	JJ	I-PROBLEM
phlebitis	NN	I-PROBLEM
and	CC	O
was	VBD	O
started	VBN	O
on	IN	O
antibiotics	NNS	B-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
discharged	VBN	O
home	NN	O
on	IN	O
post-op	JJ	O
day	NN	O
six	CD	O
with	IN	O
antibiotics	NNS	B-TREATMENT
and	CC	O
appropriate	JJ	B-TREATMENT
meds	NNS	I-TREATMENT
.	.	O

he	PRP	O
will	MD	O
have	VB	O
vna	NN	B-TREATMENT
services	NNS	I-TREATMENT
and	CC	O
make	VB	O
the	DT	O
appropriate	JJ	O
follow-up	JJ	O
appointments	NNS	O
.	.	O

aspirin	RB	B-TREATMENT
81	CD	O
mg	NN	O
qd	NN	O
,	,	O
toprol	NN	B-TREATMENT
xl	VBD	O
50	CD	O
mg	NN	O
qd	NN	O
,	,	O
mvi	NN	B-TREATMENT
,	,	O
flexeril	VBP	B-TREATMENT
10	CD	O
mg	NN	O
qhs	NN	O
,	,	O
plavix	VBP	B-TREATMENT
75	CD	O
mg	NN	O
qd	NN	O
(	(	O
last	JJ	O
on	IN	O
10-18	NNS	O
)	)	O

1.	CD	O
docusate	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
100	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

2.	CD	O
aspirin	JJ	B-TREATMENT
81	CD	O
mg	JJ	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

3.	CD	O
ranitidine	NN	B-TREATMENT
hcl	NN	I-TREATMENT
150	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

4.	CD	O
oxycodone	CD	B-TREATMENT
-	:	I-TREATMENT
acetaminophen	NN	I-TREATMENT
5-325	JJ	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
1-2	JJ	O
tablets	NNS	O
po	VBP	O
q4h	NN	O
(	(	O
every	DT	O
4	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
pain	NN	B-PROBLEM
.	.	O

5.	CD	O
atorvastatin	JJ	B-TREATMENT
10	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

6.	CD	O
amiodarone	NN	B-TREATMENT
200	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
):	JJ	O
please	NN	O
take	VB	O
400	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
until	IN	O
11-02	JJ	O
then	RB	O
decrease	NN	O
to	TO	O
400	CD	O
mg	NN	O
once	RB	O
a	DT	O
day	NN	O
for	IN	O
1	CD	O
week	NN	O
and	CC	O
then	RB	O
decrease	VB	O
to	TO	O
200	CD	O
mg	NN	O
once	RB	O
a	DT	O
day	NN	O
.	.	O

7.	CD	O
metoprolol	JJ	B-TREATMENT
succinate	NN	I-TREATMENT
50	CD	O
mg	NN	O
tablet	NN	O
sustained	VBD	O
release	NN	O
24	CD	O
hr	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
sustained	VBD	O
release	NN	O
24	CD	O
hr	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

8.	CD	O
ferrous	JJ	B-TREATMENT
gluconate	NN	I-TREATMENT
300	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

9.	CD	O
ascorbic	JJ	B-TREATMENT
acid	RB	I-TREATMENT
500	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

10.	CD	O
cephalexin	NN	B-TREATMENT
500	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
q6h	NN	O
(	(	O
every	DT	O
6	CD	O
hours	NNS	O
)	)	O
for	IN	O
6	CD	O
days	NNS	O
:	:	O
please	VB	O
complete	JJ	O
full	JJ	O
course	NN	O
.	.	O

11.	CD	O
furosemide	JJ	B-TREATMENT
20	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
once	RB	O
a	DT	O
day	NN	O
for	IN	O
2	CD	O
weeks	NNS	O
.	.	O

12.	CD	O
potassium	NN	B-TREATMENT
chloride	NN	I-TREATMENT
10	CD	O
meq	NN	O
capsule	NN	O
,	,	O
sustained	VBD	O
release	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
,	,	O
sustained	VBD	O
release	NN	O
po	NN	O
daily	RB	O
(	(	O
daily	JJ	O
)	)	O
for	IN	O
2	CD	O
weeks	NNS	O
.	.	O

13.	CD	O
lisinopril	JJ	B-TREATMENT
5	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
0.5	CD	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
s/p	VBD	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
x3	NN	O

pmh	NN	O
:	:	O
carpal	JJ	B-PROBLEM
tunnel	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
,	,	O
hypertension	NN	B-PROBLEM
,	,	O
hyperlipidemia	NN	B-PROBLEM
,	,	O
arthritis	NN	B-PROBLEM

monitor	NN	O
wounds	NNS	B-PROBLEM
for	IN	O
infection	NN	B-PROBLEM
-	:	O
redness	NN	B-PROBLEM
,	,	O
drainage	NN	B-PROBLEM
,	,	O
or	CC	O
increased	VBD	B-PROBLEM
pain	NN	I-PROBLEM

report	NN	O
any	DT	B-PROBLEM
fever	RB	I-PROBLEM
greater	JJR	I-PROBLEM
than	IN	I-PROBLEM
101	CD	I-PROBLEM

report	NN	O
any	DT	B-PROBLEM
weight	JJ	I-PROBLEM
gain	NN	I-PROBLEM
of	IN	O
greater	JJR	O
than	IN	O
2	CD	O
pounds	NNS	O
in	IN	O
24	CD	O
hours	NNS	O
or	CC	O
5	CD	O
pounds	NNS	O
in	IN	O
a	DT	O
week	NN	O

no	DT	O
creams	NN	B-TREATMENT
,	,	O
lotions	NNS	B-TREATMENT
,	,	O
powders	NNS	B-TREATMENT
,	,	O
or	CC	O
ointments	NNS	B-TREATMENT
to	TO	O
incisions	NNS	B-PROBLEM

left	JJ	O
arm	NN	O
continue	NN	O
with	IN	O
elevation	NN	B-TREATMENT
,	,	O
ice	NN	B-TREATMENT
,	,	O
and	CC	O
complete	JJ	O
all	DT	B-TREATMENT
antibiotics	NNS	I-TREATMENT

for	IN	O
surgical	JJ	B-PROBLEM
incision	NN	I-PROBLEM
and	CC	O
left	VBD	O
arm	NN	O

this	DT	O
is	VBZ	O
an	DT	O
83	CD	O
year	NN	O
old	JJ	O
woman	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
who	WP	O
presents	VBZ	O
with	IN	O
slurred	JJ	B-PROBLEM
speech	NN	I-PROBLEM
when	WRB	O
dehydrated	VBN	B-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
paraplegia	VBN	B-PROBLEM
secondary	JJ	O
to	TO	O
htlv	VB	B-PROBLEM
exposure	NN	I-PROBLEM
while	IN	O
on	IN	O
vacation	NN	O
in	IN	O
the	DT	O
bahamas	NN	O
six	CD	O
years	NNS	O
ago	RB	O
.	.	O

she	PRP	O
presented	VBD	O
with	IN	O
three	CD	O
days	NNS	O
of	IN	O
general	JJ	B-PROBLEM
malaise	NN	I-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
cough	JJ	B-PROBLEM
productive	NN	O
of	IN	O
white	JJ	B-PROBLEM
sputum	NN	I-PROBLEM
.	.	O

she	PRP	O
awoke	VBD	O
with	IN	O
nausea	NN	B-PROBLEM
on	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
and	CC	O
pleuritic	JJ	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
some	DT	B-PROBLEM
difficulty	NN	I-PROBLEM
talking	VBG	O
and	CC	O
grasping	VBG	O
right	JJ	O
hand	NN	O
.	.	O

she	PRP	O
came	VBD	O
to	TO	O
the	DT	O
emergency	NN	O
department	NN	O
on	IN	O
the	DT	O
2011-03-10	JJ	O
,	,	O
with	IN	O
temperature	NN	B-TEST
of	IN	O
99.0	CD	O
f	NNS	O
.;	JJ	O
blood	NN	B-TEST
pressure	NN	I-TEST
of	IN	O
97/50	CD	O
;	:	O
heart	NN	B-TEST
rate	NN	I-TEST
100	CD	O
;	:	O
respirations	NNS	B-TEST
27	CD	O
;	:	O
o2	JJ	B-TEST
saturation	NN	I-TEST
84%	CD	O
on	IN	O
room	NN	O
air	NN	O
and	CC	O
94%	CD	O
on	IN	O
two	CD	O
liters	NNS	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
coarse	VBN	B-PROBLEM
rhonchi	NNS	I-PROBLEM
on	IN	O
examination	NN	B-TEST
.	.	O

chest	JJS	B-TEST
x-ray	NN	I-TEST
revealed	VBD	O
mild	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

chest	NN	B-TEST
ct	NN	I-TEST
scan	NN	I-TEST
was	VBD	O
negative	JJ	O
for	IN	O
pulmonary	JJ	B-PROBLEM
embolism	NN	I-PROBLEM
but	CC	O
positive	JJ	O
for	IN	O
consolidation	NN	B-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
levofloxacin	NN	B-TREATMENT
but	CC	O
the	DT	O
patient	NN	O
became	VBD	O
hypotensive	JJ	B-PROBLEM
at	IN	O
that	DT	O
point	NN	O
with	IN	O
blood	NN	B-TEST
pressure	NN	I-TEST
of	IN	O
70/45	CD	O
and	CC	O
received	VBD	O
a	DT	B-TREATMENT
normal	JJ	I-TREATMENT
saline	NN	I-TREATMENT
bolus	NN	I-TREATMENT
to	TO	O
boost	VB	O
her	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
to	TO	O
99/60	CD	O
;	:	O
however	RB	O
the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
medical	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
for	IN	O
overnight	JJ	B-TEST
observation	NN	I-TEST
because	IN	O
of	IN	O
her	PRP$	B-PROBLEM
somnolence	NN	I-PROBLEM
and	CC	O
hypotension	NN	B-PROBLEM
.	.	O

1.	CD	O
positive	JJ	B-PROBLEM
lupus	NN	I-PROBLEM
anti-coagulant	NN	I-PROBLEM
.	.	O

2.	CD	O
basilar	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

3.	CD	O
prior	JJ	B-PROBLEM
transient	NN	I-PROBLEM
ischemic	JJ	I-PROBLEM
attacks	NNS	I-PROBLEM
.	.	O

4.	CD	O
right	JJ	B-TREATMENT
medial	JJ	I-TREATMENT
malleolus	NN	I-TREATMENT
repair	NN	I-TREATMENT
in	IN	O
2004-08-05	JJ	O
.	.	O

5.	CD	O
paraplegia	JJ	B-PROBLEM
secondary	JJ	O
to	TO	O
htlv	VB	B-PROBLEM
from	IN	O
a	DT	O
trip	NN	O
to	TO	O
the	DT	O
bahamas	NN	O
five	CD	O
to	TO	O
six	CD	O
years	NNS	O
ago	RB	O
.	.	O

6.	CD	O
hypertension	NN	B-PROBLEM
.	.	O

7.	CD	O
chronic	JJ	B-PROBLEM
diarrhea	NN	I-PROBLEM
with	IN	O
multiple	JJ	O
admissions	NNS	O
for	IN	O
dehydration	NN	B-PROBLEM
with	IN	O
most	RBS	O
recent	JJ	O
one	CD	O
on	IN	O
2011-02-26	JJ	O
.	.	O

8.	CD	O
venous	JJ	B-PROBLEM
stasis	NN	I-PROBLEM
.	.	O

9.	CD	O
depression	NN	B-PROBLEM
.	.	O

10.	CD	O
seizure	NN	B-PROBLEM
history	NN	I-PROBLEM
on	IN	O
neurontin	NN	B-TREATMENT
.	.	O

11.	CD	O
left	VBD	B-TREATMENT
cmed	VBN	I-TREATMENT
cataract	JJ	I-TREATMENT
surgery	NN	I-TREATMENT
in	IN	O
2009-10-05	JJ	O
.	.	O

12.	CD	O
chronic	JJ	B-PROBLEM
muscle	NN	I-PROBLEM
spasms	NNS	I-PROBLEM
.	.	O

penicillin	NN	B-TREATMENT
for	IN	O
which	WDT	O
she	PRP	O
reports	VBZ	O
a	DT	B-PROBLEM
rash	NN	I-PROBLEM
and	CC	O
dyspepsia	NN	B-PROBLEM
when	WRB	O
taking	VBG	O
uncoated	JJ	B-TREATMENT
aspirin	NN	I-TREATMENT
.	.	O

she	PRP	O
has	VBZ	O
a	DT	O
questionable	JJ	O
sensitivity	NN	B-PROBLEM
to	TO	O
iodine	VB	B-TREATMENT
.	.	O

1.	CD	O
enteric-coated	JJ	B-TREATMENT
aspirin	NN	I-TREATMENT
.	.	O

2.	CD	O
aggrenox	NN	B-TREATMENT
.	.	O

3.	CD	O
zanaflex	NN	B-TREATMENT
.	.	O

4.	CD	O
neurontin	JJ	B-TREATMENT
300	CD	O
mg	NN	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
.	.	O

5.	CD	O
celexa	NN	B-TREATMENT
10	CD	O
mg	JJ	O
daily	RB	O
.	.	O

on	IN	O
admission	NN	B-TEST
examination	NN	I-TEST
she	PRP	O
was	VBD	O
a	DT	O
well	NN	O
developed	NN	O
,	,	O
well	RB	O
nourished	JJ	O
female	NN	O
in	IN	O
no	DT	O
apparent	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

her	PRP$	O
lungs	NNS	O
revealed	VBD	O
coarse	JJ	B-PROBLEM
bilateral	JJ	I-PROBLEM
rhonchi	NN	I-PROBLEM
from	IN	O
base	NN	O
to	TO	O
midline	VB	O
.	.	O

cardiovascular	JJ	B-TEST
examination	NN	I-TEST
is	VBZ	O
notable	JJ	O
for	IN	O
a	DT	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
;	:	O
no	DT	O
murmurs	NN	B-PROBLEM
,	,	O
rubs	NN	B-PROBLEM
or	CC	O
gallops	NNS	B-PROBLEM
.	.	O

abdomen	NNS	O
is	VBZ	O
soft	JJ	O
and	CC	O
obese	JJ	B-PROBLEM
,	,	O
nontender	NN	B-PROBLEM
.	.	O

extremities	NNS	O
notable	JJ	O
for	IN	O
two	CD	B-PROBLEM
plus	CC	I-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
edema	NN	I-PROBLEM
and	CC	O
the	DT	O
ankles	NNS	O
were	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
in	IN	O
pressure	NN	B-TREATMENT
stockings	NNS	I-TREATMENT
.	.	O

white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
were	VBD	O
11.8	CD	O
,	,	O
hematocrit	NN	B-TEST
31.5	CD	O
,	,	O
platelets	NNS	B-TEST
151	CD	O
.	.	O

chem-7	NN	B-TEST
was	VBD	O
a	DT	B-TEST
sodium	NN	I-TEST
of	IN	O
140	CD	O
,	,	O
potassium	NN	B-TEST
of	IN	O
3.0	CD	O
,	,	O
chloride	RB	B-TEST
108	CD	O
,	,	O
bicarbonate	NN	B-TEST
24	CD	O
,	,	O
bun	NN	B-TEST
22	CD	O
,	,	O
creatinine	NN	B-TEST
1.0	CD	O
and	CC	O
glucose	JJ	B-TEST
117	CD	O
.	.	O

the	DT	O
patient	NN	O
also	RB	O
had	VBD	O
a	DT	B-TEST
head	NN	I-TEST
ct	NN	I-TEST
scan	JJ	I-TEST
in	IN	O
the	DT	O
emergency	NN	O
department	NN	O
before	IN	O
coming	VBG	O
to	TO	O
the	DT	O
unit	NN	O
which	WDT	O
reported	VBD	O
no	DT	O
recent	JJ	B-PROBLEM
bleed	NN	I-PROBLEM
and	CC	O
no	DT	O
change	NN	B-PROBLEM
from	IN	O
a	DT	B-TEST
prior	JJ	I-TEST
ct	NN	I-TEST
scan	JJ	I-TEST
done	VBN	O
on	IN	O
2011-03-04	JJ	O
.	.	O

ekg	NN	B-TEST
is	VBZ	O
notable	JJ	O
for	IN	O
sinus	JJ	B-PROBLEM
tachycardia	NN	I-PROBLEM
at	IN	O
100	CD	O
beats	NNS	O
per	IN	O
minute	NN	O
,	,	O
normal	JJ	O
axis	NN	O
.	.	O

.....	RB	O
done	VBN	O
on	IN	O
02-24	NN	O
,	,	O
notable	JJ	O
for	IN	O
mid-basilar	JJ	B-PROBLEM
artery	NN	I-PROBLEM
high-grade	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

after	IN	O
transfer	NN	O
to	TO	O
the	DT	O
floor	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
levofloxacin	NN	B-TREATMENT
for	IN	O
a	DT	O
ten	NN	O
to	TO	O
14	CD	O
day	NN	O
course	NN	O
for	IN	O
presumptive	JJ	O
pneumonia	NN	B-PROBLEM
.	.	O

due	JJ	O
to	TO	O
her	PRP$	B-PROBLEM
chronic	JJ	I-PROBLEM
diarrhea	NN	I-PROBLEM
she	PRP	O
was	VBD	O
repleted	VBN	O
with	IN	O
intravenous	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
.	.	O

for	IN	O
her	PRP$	B-PROBLEM
depression	NN	I-PROBLEM
,	,	O
continued	VBD	O
on	IN	O
citalopram	NN	B-TREATMENT
10	CD	O
mg	JJ	O
daily	RB	O
.	.	O

for	IN	O
her	PRP$	B-PROBLEM
paraplegia	NN	I-PROBLEM
and	CC	O
associated	JJ	O
muscle	NN	B-PROBLEM
spasticity	NN	I-PROBLEM
she	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
her	PRP$	B-TREATMENT
zanaflex	NN	I-TREATMENT
.	.	O

for	IN	O
deep	JJ	B-TREATMENT
vein	NN	I-TREATMENT
thrombosis	NN	I-TREATMENT
prophylaxis	NN	I-TREATMENT
she	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
subcutaneous	JJ	B-TREATMENT
heparin	NNS	I-TREATMENT
and	CC	O
for	IN	O
gastrointestinal	JJ	B-TREATMENT
prophylaxis	NN	I-TREATMENT
she	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
protonix	NN	B-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
also	RB	O
evaluated	VBN	O
by	IN	O
physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
and	CC	O
speech	NN	B-TREATMENT
and	CC	O
swallow	NN	B-TREATMENT
because	IN	O
of	IN	O
some	DT	O
report	NN	O
of	IN	O
dysphagia	NN	B-PROBLEM
.	.	O

physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
felt	VBD	O
that	IN	O
the	DT	O
patient	NN	O
was	VBD	O
cleared	VBN	O
for	IN	O
transfer	NN	O
home	NN	O
with	IN	O
services	NNS	O
.	.	O

occupational	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
was	VBD	O
also	RB	O
in	IN	O
agreement	NN	O
with	IN	O
the	DT	O
patient	NN	O
's	POS	O
disposition	NN	O
home	NN	O
with	IN	O
services	NNS	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
able	JJ	O
to	TO	O
advance	VB	O
her	PRP$	O
diet	JJ	O
well	NN	O
from	IN	O
liquids	NNS	O
to	TO	O
solids	NNS	O
,	,	O
however	RB	O
,	,	O
she	PRP	O
was	VBD	O
plagued	VBN	O
with	IN	O
a	DT	B-PROBLEM
persistent	JJ	I-PROBLEM
cough	NN	I-PROBLEM
and	CC	O
some	DT	B-PROBLEM
low	JJ	I-PROBLEM
grade	NN	I-PROBLEM
fevers	NNS	I-PROBLEM
to	TO	O
99.0	CD	O
f	NNS	O
.	.	O

speech	NN	B-TREATMENT
and	CC	O
swallow	NN	B-TREATMENT
evaluated	VBD	O
the	DT	O
patient	NN	O
at	IN	O
bedside	NN	O
and	CC	O
recommended	VBD	O
advancing	VBG	O
to	TO	O
regular	VB	O
diet	JJ	O
with	IN	O
regular	JJ	O
consistency	NN	O
and	CC	O
saw	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
any	DT	B-PROBLEM
dysphagia	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
some	DT	O
question	NN	O
regarding	VBG	O
restarting	NN	O
of	IN	O
the	DT	B-TREATMENT
patient	NN	I-TREATMENT
's	POS	I-TREATMENT
coumadin	NN	I-TREATMENT
given	VBN	O
her	PRP$	B-PROBLEM
positive	JJ	I-PROBLEM
lupus	NN	I-PROBLEM
anti-coagulant	JJ	I-PROBLEM
status	NN	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
the	DT	O
presence	NN	O
of	IN	O
her	PRP$	B-PROBLEM
basilar	JJ	I-PROBLEM
artery	NN	I-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
discharged	VBN	O
on	IN	O
the	DT	O
2011-03-15	JJ	O
on	IN	O
the	DT	B-TREATMENT
following	JJ	I-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

1.	CD	O
levofloxacin	JJ	B-TREATMENT
250	CD	O
mg	JJ	O
q.	NNS	O
day	NN	O
for	IN	O
ten	JJ	O
days	NNS	O
.	.	O

2.	CD	O
aspirin	JJ	B-TREATMENT
/	NNP	O
dipyridamole	NN	B-TREATMENT
25/200	CD	O
mg	NN	O
capsules	NNS	O
taken	VBN	O
two	CD	O
times	NNS	O
a	DT	O
day	NN	O
.	.	O

3.	CD	O
neurontin	JJ	B-TREATMENT
300	CD	O
mg	NN	O
taken	VBN	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
.	.	O

4.	CD	O
subcutaneous	JJ	B-TREATMENT
heparin	NN	I-TREATMENT
taken	VBN	O
5000	CD	O
units	NNS	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

5.	CD	O
albuterol	NN	B-TREATMENT
multiple	NN	I-TREATMENT
dose	NN	I-TREATMENT
inhalers	NNS	I-TREATMENT
,	,	O
one	CD	O
to	TO	O
two	CD	O
puffs	NNS	O
q.	RB	O
six	CD	O
hours	NNS	O
as	IN	O
needed	VBN	O
.	.	O

6.	CD	O
atrovent	JJ	B-TREATMENT
multiple	NN	I-TREATMENT
dose	NN	I-TREATMENT
inhalers	NNS	I-TREATMENT
,	,	O
one	CD	O
to	TO	O
two	CD	O
puffs	NNS	O
q.	RB	O
six	CD	O
hours	NNS	O
as	IN	O
needed	VBN	O
.	.	O

7.	CD	O
citalopram	NN	B-TREATMENT
10	CD	O
mg	NN	O
q.	JJ	O
day	NN	O
.	.	O

8.	CD	O
lisinopril	JJ	B-TREATMENT
2.5	CD	O
mg	NN	O
once	RB	O
a	DT	O
day	NN	O
.	.	O

9.	CD	O
trazodone	NN	B-TREATMENT
25	CD	O
mg	NN	O
q.	JJ	O
h.s.	NN	O
p.r.n.	NN	O

10.	CD	O
protonix	JJ	B-TREATMENT
40	CD	O
mg	JJ	O
q.	JJ	O
day	NN	O
.	.	O

11.	CD	O
zanaflex	JJ	B-TREATMENT
2	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

12.	CD	O
tylenol	JJ	B-TREATMENT
325	CD	O
mg	NN	O
,	,	O
one	CD	O
to	TO	O
two	CD	O
tablets	NNS	O
q.	RB	O
four	CD	O
to	TO	O
six	CD	O
hours	NNS	O
p.r.n.	VBP	O

13.	CD	O
the	DT	O
patient	NN	O
was	VBD	O
also	RB	O
discharged	VBN	O
with	IN	O
the	DT	O
restarting	NN	O
of	IN	O
warfarin	$	B-TREATMENT
2	CD	O
mg	JJ	O
daily	RB	O
.	.	O

1.	CD	O
she	PRP	O
was	VBD	O
instructed	VBN	O
to	TO	O
have	VB	O
blood	VBN	B-TEST
drawn	VBN	O
by	IN	O
the	DT	O
visiting	NN	O
nurses	VBZ	O
association	VBP	O
the	DT	O
day	NN	O
after	IN	O
discharge	NN	O
and	CC	O
then	RB	O
a	DT	O
few	JJ	O
days	NNS	O
after	IN	O
discharge	VBP	O
the	DT	O
same	JJ	O
week	NN	O
to	TO	O
have	VB	O
inr	NN	B-TEST
.	.	O

will	MD	O
also	RB	O
have	VB	O
inr	NN	B-TEST
checked	VBN	O
at	IN	O
once	RB	O
weekly	JJ	O
until	IN	O
target	NN	O
of	IN	O
inr	NN	B-TEST
of	IN	O
2.0	CD	O
to	TO	O
3.0	CD	O
is	VBZ	O
reached	VBN	O
.	.	O

2.	CD	O
the	DT	O
patient	NN	O
was	VBD	O
instructed	VBN	O
to	TO	O
contact	VB	O
dr.	JJ	O
ralph	NN	O
at	IN	O
(	(	O
428	CD	O
)	)	O
678-6930	CD	O
,	,	O
who	WP	O
is	VBZ	O
covering	VBG	O
for	IN	O
her	PRP$	O
primary	JJ	O
care	NN	O
physician	NN	O
,	,	O
dr.	NN	O
erika	FW	O
witt	NN	O
,	,	O
to	TO	O
adjust	VB	O
her	PRP$	B-TREATMENT
dosages	NNS	I-TREATMENT
based	VBN	O
on	IN	O
the	DT	B-TEST
inr	NN	I-TEST
levels	NNS	I-TEST
.	.	O

4.	CD	O
she	PRP	O
was	VBD	O
also	RB	O
instructed	VBN	O
to	TO	O
follow-up	JJ	O
with	IN	O
dr.	JJ	O
reid	NN	O
from	IN	O
neurology	NN	O
within	IN	O
a	DT	O
month	NN	O
at	IN	O
(	(	O
382	CD	O
)	)	O
716	CD	O
4151	CD	O
,	,	O
given	VBN	O
her	PRP$	B-PROBLEM
neurological	JJ	I-PROBLEM
deficits	NNS	I-PROBLEM
during	IN	O
this	DT	O
presentation	NN	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
47	CD	O
-	:	O
year-old	JJ	O
male	NN	O
with	IN	O
a	DT	O
past	JJ	O
medical	JJ	O
history	NN	O
of	IN	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
status	NN	B-TREATMENT
post	NN	I-TREATMENT
2-vessel	JJ	I-TREATMENT
percutaneous	JJ	I-TREATMENT
transluminal	JJ	I-TREATMENT
coronary	NN	I-TREATMENT
angioplasty	NN	I-TREATMENT
in	IN	O
2005	CD	O
,	,	O
3-vessel	JJ	B-TREATMENT
percutaneous	JJ	I-TREATMENT
transluminal	JJ	I-TREATMENT
coronary	NN	I-TREATMENT
angioplasty	NN	I-TREATMENT
in	IN	O
2009	CD	O
,	,	O
hypertension	NN	B-PROBLEM
,	,	O
new	JJ	B-PROBLEM
onset	VBN	I-PROBLEM
type	NN	I-PROBLEM
2	CD	I-PROBLEM
diabetes	NNS	I-PROBLEM
,	,	O
and	CC	O
hypercholesterolemia	NN	B-PROBLEM
who	WP	O
presents	VBZ	O
with	IN	O
the	DT	O
sudden	JJ	O
onset	NN	O
of	IN	O
substernal	JJ	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
status	NN	O
post	NN	O
exercise	NN	O
.	.	O

the	DT	O
patient	NN	O
presented	VBD	O
to	TO	O
bournewood	VB	O
hospital	NN	O
on	IN	O
the	DT	O
morning	NN	O
of	IN	O
admission	NN	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
substernal	JJ	B-PROBLEM
burning	NN	I-PROBLEM
without	IN	O
radiation	NN	O
which	WDT	O
developed	VBD	O
while	IN	O
doing	VBG	O
exercise	NN	O
.	.	O

the	DT	B-PROBLEM
pain	NN	I-PROBLEM
became	VBD	O
worse	JJR	O
over	IN	O
the	DT	O
next	JJ	O
few	JJ	O
minutes	NNS	O
to	TO	O
07-12	JJ	O
and	CC	O
increased	VBD	O
to	TO	O
10-12	JJ	O
while	IN	O
he	PRP	O
was	VBD	O
in	IN	O
the	DT	O
ambulance	NN	O
.	.	O

his	PRP$	B-TREATMENT
nitroglycerin	JJ	I-TREATMENT
patch	NN	I-TREATMENT
did	VBD	O
not	RB	O
help	VB	O
,	,	O
and	CC	O
he	PRP	O
only	RB	O
had	VBD	O
slight	JJ	O
relief	NN	O
with	IN	O
sublingual	JJ	B-TREATMENT
nitroglycerin	NN	I-TREATMENT
times	NNS	O
three	CD	O
.	.	O

in	IN	O
addition	NN	O
,	,	O
he	PRP	O
had	VBD	O
slight	JJ	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
but	CC	O
denies	VBZ	O
headache	NN	B-PROBLEM
,	,	O
change	NN	B-PROBLEM
in	IN	I-PROBLEM
vision	NN	I-PROBLEM
,	,	O
dizziness	NN	B-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
,	,	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
change	NN	B-PROBLEM
in	IN	I-PROBLEM
bowel	NN	I-PROBLEM
or	CC	I-PROBLEM
urinary	JJ	I-PROBLEM
habits	NNS	I-PROBLEM
,	,	O
or	CC	O
fevers	NNS	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
,	,	O
and	CC	O
sweats	NNS	B-PROBLEM
.	.	O

in	IN	O
the	DT	O
emergency	NN	O
department	NN	O
he	PRP	O
received	VBD	O
aspirin	RB	B-TREATMENT
,	,	O
nitroglycerin	JJ	B-TREATMENT
drip	NN	I-TREATMENT
,	,	O
heparin	NN	B-TREATMENT
drip	NN	I-TREATMENT
,	,	O
dilaudid	NN	B-TREATMENT
,	,	O
and	CC	O
tnk	NN	B-TREATMENT
with	IN	O
decreased	VBN	O
in	IN	O
his	PRP$	B-PROBLEM
pain	NN	I-PROBLEM
but	CC	O
without	IN	O
resolution	NN	O
of	IN	O
symptoms	NNS	B-PROBLEM
.	.	O

electrocardiogram	NN	B-TEST
at	IN	O
that	DT	O
time	NN	O
showed	VBD	O
st	JJ	B-PROBLEM
elevations	NNS	I-PROBLEM
and	CC	O
j	NN	B-PROBLEM
point	NN	I-PROBLEM
elevations	NNS	I-PROBLEM
in	IN	I-PROBLEM
v2	NN	I-PROBLEM
through	IN	I-PROBLEM
v4	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
transferred	VBN	O
to	TO	O
sturdy	VB	O
memorial	NN	O
where	WRB	O
he	PRP	O
underwent	JJ	O
catheterization	NN	B-TEST
.	.	O

catheterization	NN	B-TEST
results	NNS	I-TEST
showed	VBD	O
100%	CD	B-PROBLEM
occlusion	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
proximal	JJ	I-PROBLEM
left	VBD	I-PROBLEM
anterior	JJ	I-PROBLEM
descending	VBG	I-PROBLEM
artery	NN	I-PROBLEM
and	CC	O
50%	CD	B-PROBLEM
stenosis	NN	I-PROBLEM
of	IN	I-PROBLEM
first	JJ	I-PROBLEM
diagonal	NN	I-PROBLEM
.	.	O

angio-jet	JJ	B-TREATMENT
percutaneous	JJ	I-TREATMENT
transluminal	JJ	I-TREATMENT
coronary	NN	I-TREATMENT
angioplasty	NN	I-TREATMENT
and	CC	O
stenting	NN	B-TREATMENT
was	VBD	O
performed	VBN	O
on	IN	O
proximal	JJ	O
left	VBN	O
anterior	JJ	O
descending	VBG	O
artery	NN	O
and	CC	O
the	DT	B-TREATMENT
percutaneous	JJ	I-TREATMENT
transluminal	JJ	I-TREATMENT
coronary	NN	I-TREATMENT
angioplasty	NN	I-TREATMENT
was	VBD	O
performed	VBN	O
on	IN	O
first	JJ	O
diagonal	JJ	O
with	IN	O
good	JJ	O
results	NNS	O
.	.	O

an	DT	B-TREATMENT
intra-aortic	JJ	I-TREATMENT
balloon	NN	I-TREATMENT
pump	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
at	IN	O
this	DT	O
time	NN	O
as	RB	O
well	RB	O
.	.	O

1.	CD	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
;	:	O
the	DT	O
patient	NN	O
is	VBZ	O
status	NN	B-TREATMENT
post	NN	I-TREATMENT
percutaneous	JJ	I-TREATMENT
transluminal	JJ	I-TREATMENT
coronary	NN	I-TREATMENT
angioplasty	NN	I-TREATMENT
times	NNS	O
three	CD	O
in	IN	O
2009	CD	O
at	IN	O
clinton	JJ	O
hospital	NN	O
;	:	O
the	DT	O
patient	NN	O
is	VBZ	O
status	NN	B-TREATMENT
post	NN	I-TREATMENT
percutaneous	JJ	I-TREATMENT
transluminal	JJ	I-TREATMENT
coronary	NN	I-TREATMENT
angioplasty	JJ	I-TREATMENT
times	NNS	O
two	CD	O
in	IN	O
2005	CD	O
at	IN	O
waltham/weston	JJ	O
hospital	NN	O
.	.	O

2.	CD	O
type	NN	B-PROBLEM
2	CD	I-PROBLEM
diabetes	NNS	I-PROBLEM
.	.	O

3.	CD	O
hypercholesterolemia	NN	B-PROBLEM
.	.	O

4.	CD	O
hypertension	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
's	POS	O
father	NN	O
died	VBD	O
of	IN	O
a	DT	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
at	IN	O
age	NN	O
40	CD	O
,	,	O
and	CC	O
a	DT	O
brother	NN	O
who	WP	O
died	VBD	O
of	IN	O
a	DT	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
at	IN	O
age	NN	O
40	CD	O
.	.	O

diltiazem	RB	B-TREATMENT
180	CD	O
mg	NNS	O
p.o.	JJ	O
q.d.	NN	O
,	,	O
lipitor	NN	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
,	,	O
glyset	VBD	B-TREATMENT
25	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
,	,	O
prevacid	VBP	B-TREATMENT
30	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
,	,	O
metoprolol	FW	B-TREATMENT
50	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O
,	,	O
glucophage	NN	B-TREATMENT
500	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

allergies	NNS	B-PROBLEM
included	VBD	O
penicillin	NN	B-TREATMENT
and	CC	O
iodine	NN	B-TREATMENT
.	.	O

temperature	NN	B-TEST
maximum	JJ	I-TEST
98.7	CD	O
,	,	O
temperature	NN	B-TEST
current	JJ	I-TEST
98.3	CD	O
,	,	O
pulse	RB	B-TEST
ranged	VBD	O
from	IN	O
82	CD	O
to	TO	O
92	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
104	CD	O
to	TO	O
124/67	CD	O
to	TO	O
74	CD	O
with	IN	O
a	DT	O
mean	NN	O
of	IN	O
86	CD	O
to	TO	O
99	CD	O
,	,	O
respiratory	JJ	B-TEST
rate	NN	I-TEST
of	IN	O
11	CD	O
to	TO	O
16	CD	O
,	,	O
oxygen	NN	B-TEST
saturation	NN	I-TEST
94%	CD	O
to	TO	O
98%	CD	O
on	IN	O
2	CD	O
liters	NNS	O
.	.	O

pulmonary	JJ	B-TEST
artery	NN	I-TEST
pressure	NN	I-TEST
was	VBD	O
29/15	CD	O
with	IN	O
a	DT	O
mean	NN	O
of	IN	O
22	CD	O
.	.	O

cardiac	JJ	B-TEST
output	NN	I-TEST
was	VBD	O
7	CD	O
(	(	O
that	WDT	O
was	VBD	O
on	IN	O
6	CD	O
of	IN	O
dopamine	NN	B-TREATMENT
)	)	O
.	.	O

intra-aortic	JJ	B-TEST
balloon	NN	I-TEST
pump	NN	I-TEST
augmented	VBD	I-TEST
systole	NN	I-TEST
was	VBD	O
109	CD	O
,	,	O
augmented	VBD	B-TEST
diastole	NN	I-TEST
was	VBD	O
111	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
lying	VBG	O
flat	JJ	O
in	IN	O
no	DT	O
apparent	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

no	DT	O
lymphadenopathy	NN	B-PROBLEM
.	.	O

lungs	NNS	O
were	VBD	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
,	,	O
anteriorly	RB	O
and	CC	O
laterally	RB	O
.	.	O

cardiovascular	NN	O
revealed	VBD	O
jugular	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
distention	NN	I-PROBLEM
not	RB	O
appreciated	VBN	O
.	.	O

carotids	NNS	O
had	VBD	O
normal	JJ	O
upstroke	JJ	O
and	CC	O
normal	JJ	O
volume	NN	O
with	IN	O
bilateral	JJ	B-PROBLEM
bruits	NNS	I-PROBLEM
.	.	O

no	DT	O
s3	NN	B-PROBLEM
or	CC	O
s4	NN	B-PROBLEM
.	.	O

no	DT	O
murmurs	NN	B-PROBLEM
,	,	O
rubs	NN	B-PROBLEM
or	CC	O
gallops	NNS	B-PROBLEM
.	.	O

abdomen	NNS	O
had	VBD	O
decreased	VBN	B-PROBLEM
bowel	NN	I-PROBLEM
sounds	NNS	I-PROBLEM
,	,	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
and	CC	O
nondistended	VBD	B-PROBLEM
.	.	O

no	DT	O
hepatosplenomegaly	NN	B-PROBLEM
.	.	O

extremities	NNS	O
had	VBD	O
no	DT	O
edema	NN	B-PROBLEM
.	.	O

the	DT	O
right	JJ	O
groin	NN	O
revealed	VBD	O
intra-aortic	JJ	B-TREATMENT
balloon	NN	I-TREATMENT
pump	NN	I-TREATMENT
site	NN	O
and	CC	O
pulmonary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
catheterization	NN	I-TREATMENT
site	NN	O
were	VBD	O
clean	JJ	O
,	,	O
dry	JJ	O
and	CC	O
intact	JJ	O
without	IN	O
tenderness	NN	B-PROBLEM
.	.	O

dorsalis	NN	B-TEST
pedis	NN	I-TEST
pulses	NNS	I-TEST
were	VBD	O
2+	CD	O
bilaterally	RB	O
.	.	O

neurologic	JJ	B-TEST
examination	NN	I-TEST
revealed	VBD	O
alert	JJ	O
and	CC	O
oriented	VBD	O
times	NNS	O
three	CD	O
.	.	O

laboratories	NNS	B-TEST
on	IN	O
admission	NN	O
revealed	VBN	O
white	JJ	B-TEST
count	NN	I-TEST
7.8	CD	O
,	,	O
hematocrit	NN	B-TEST
was	VBD	O
41.7	CD	O
,	,	O
platelets	NNS	B-TEST
of	IN	O
252	CD	O
,	,	O
mcv	FW	B-TEST
89	CD	O
,	,	O
rdw	VBD	B-TEST
12.7	CD	O
.	.	O

chem-7	NN	B-TEST
revealed	VBD	O
sodium	NN	B-TEST
of	IN	O
136	CD	O
,	,	O
potassium	NN	B-TEST
4.7	CD	O
,	,	O
chloride	RB	B-TEST
103	CD	O
,	,	O
bicarbonate	NN	B-TEST
22	CD	O
,	,	O
bun	NN	B-TEST
16	CD	O
,	,	O
creatinine	NN	B-TEST
0.8	CD	O
,	,	O
glucose	VBD	B-TEST
284	CD	O
.	.	O

pt	NN	B-TEST
14.2	CD	O
,	,	O
ptt	NN	B-TEST
108.5	CD	O
,	,	O
inr	RB	B-TEST
1.3	CD	O
.	.	O

creatine	NN	B-TEST
kinase	NN	I-TEST
at	IN	O
11	CD	O
a.m.	NN	O
was	VBD	O
83	CD	O
,	,	O
at	IN	O
5	CD	O
p.m.	NN	O
was	VBD	O
3021	CD	O
.	.	O

arterial	JJ	B-TEST
blood	NN	I-TEST
gas	NN	I-TEST
at	IN	O
11	CD	O
a.m.	NN	O
was	VBD	O
7.33/46/115	CD	O
.	.	O

creatine	NN	B-TEST
kinases	NNS	I-TEST
trended	VBD	O
from	IN	O
11:15	CD	O
on	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
from	IN	O
83	CD	O
to	TO	O
3021	CD	O
at	IN	O
5	CD	O
p.m.	NN	O
to	TO	O
3450	CD	O
at	IN	O
11	CD	O
p.m.	NN	O
,	,	O
to	TO	O
1734	CD	O
at	IN	O
5:30	CD	O
a.m.	RB	O
on	IN	O
11-07	JJ	O
,	,	O
to	TO	O
1277	CD	O
at	IN	O
11:30	CD	O
a.m.	RB	O
on	IN	O
11-07	JJ	O
,	,	O
to	TO	O
83	CD	O
at	IN	O
9:30	CD	O
a.m.	RB	O
on	IN	O
11-11	NNS	O
.	.	O

electrocardiogram	NN	B-TEST
post	NN	O
catheterization	NN	B-TEST
showed	VBD	O
continued	JJ	B-PROBLEM
st	JJ	I-PROBLEM
elevations	NNS	I-PROBLEM
and	CC	O
j	NN	B-PROBLEM
point	NN	I-PROBLEM
elevations	NNS	I-PROBLEM
in	IN	I-PROBLEM
v2	NN	I-PROBLEM
through	IN	I-PROBLEM
v3	NN	I-PROBLEM
.	.	O

post	NN	B-TEST
catheterization	NN	I-TEST
echocardiogram	NN	I-TEST
showed	VBD	O
an	DT	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
of	IN	O
30%	CD	O
,	,	O
moderate	JJ	B-PROBLEM
systolic	JJ	I-PROBLEM
dysfunction	NN	I-PROBLEM
,	,	O
basal	NN	B-PROBLEM
anterior	JJ	I-PROBLEM
hypokinesis	NN	I-PROBLEM
,	,	O
mid	JJ	B-PROBLEM
anterior	JJ	I-PROBLEM
akinesis	NN	I-PROBLEM
,	,	O
basal	JJ	B-PROBLEM
anteroseptal	JJ	I-PROBLEM
hypokinesis	NN	I-PROBLEM
,	,	O
mid	JJ	B-PROBLEM
anteroseptal	JJ	I-PROBLEM
akinesis	NN	I-PROBLEM
.	.	O

anterior	JJ	B-PROBLEM
apex	NN	I-PROBLEM
akinesis	NN	I-PROBLEM
,	,	O
inferior	JJ	B-PROBLEM
apex	NN	I-PROBLEM
akinesis	NN	I-PROBLEM
,	,	O
and	CC	O
apex	JJ	B-PROBLEM
akinesis	NN	I-PROBLEM
.	.	O

the	DT	O
was	VBD	O
trace	JJ	B-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
and	CC	O
trace	NN	B-PROBLEM
tricuspid	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

this	DT	O
is	VBZ	O
a	DT	O
47	CD	O
-	:	O
year-old	JJ	O
male	NN	O
with	IN	O
a	DT	O
past	JJ	O
medical	JJ	O
history	NN	O
of	IN	O
type	NN	B-PROBLEM
2	CD	I-PROBLEM
diabetes	NNS	I-PROBLEM
,	,	O
high	JJ	B-PROBLEM
cholesterol	NN	I-PROBLEM
,	,	O
hypertension	NN	B-PROBLEM
,	,	O
and	CC	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
status	NN	B-TREATMENT
post	NN	I-TREATMENT
percutaneous	JJ	I-TREATMENT
transluminal	JJ	I-TREATMENT
coronary	NN	I-TREATMENT
angioplasty	JJ	I-TREATMENT
times	NNS	O
two	CD	O
,	,	O
who	WP	O
presented	VBD	O
with	IN	O
acute	JJ	B-PROBLEM
coronary	JJ	I-PROBLEM
syndrome	NN	I-PROBLEM
refractory	NN	O
to	TO	O
medical	JJ	B-TREATMENT
treatment	NN	I-TREATMENT
and	CC	O
tnk	NN	B-TREATMENT
,	,	O
now	RB	O
status	NN	B-TREATMENT
post	NN	I-TREATMENT
angio-jet	RB	I-TREATMENT
percutaneous	JJ	I-TREATMENT
transluminal	JJ	I-TREATMENT
coronary	NN	I-TREATMENT
angioplasty	NN	I-TREATMENT
and	CC	O
stent	NN	B-TREATMENT
of	IN	I-TREATMENT
proximal	JJ	I-TREATMENT
left	VBD	I-TREATMENT
anterior	JJ	I-TREATMENT
descending	VBG	I-TREATMENT
artery	NN	I-TREATMENT
and	CC	O
percutaneous	JJ	B-TREATMENT
transluminal	JJ	I-TREATMENT
coronary	JJ	I-TREATMENT
angioplasty	NN	I-TREATMENT
of	IN	O
first	JJ	O
diagonal	JJ	O
with	IN	O
intra-aortic	JJ	B-TREATMENT
balloon	NN	I-TREATMENT
pump	NN	I-TREATMENT
placement	NN	I-TREATMENT
.	.	O

dopamine	NN	B-TREATMENT
was	VBD	O
discontinued	VBN	O
on	IN	O
day	NN	O
one	CD	O
.	.	O

the	DT	B-TREATMENT
intra-aortic	JJ	I-TREATMENT
balloon	NN	I-TREATMENT
pump	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
on	IN	O
day	NN	O
two	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
heparin	NN	B-TREATMENT
throughout	IN	O
his	PRP$	O
hospital	NN	O
course	NN	O
and	CC	O
transitioned	VBD	O
to	TO	O
coumadin	VB	B-TREATMENT
on	IN	O
hospital	JJ	O
day	NN	O
four	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
lipitor	NN	B-TREATMENT
and	CC	O
aspirin	NN	B-TREATMENT
,	,	O
and	CC	O
plavix	NN	B-TREATMENT
was	VBD	O
added	VBN	O
and	CC	O
will	MD	O
be	VB	O
continued	VBN	O
for	IN	O
30	CD	O
days	NNS	O
post	VBN	O
catheterization	NN	B-TEST
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
lopressor	NN	B-TREATMENT
and	CC	O
captopril	NN	B-TREATMENT
throughout	IN	O
his	PRP$	O
hospital	NN	O
course	NN	O
,	,	O
and	CC	O
changed	VBD	O
to	TO	O

zestril	NN	B-TREATMENT
10	CD	O
mg	NN	O
q.d.	NN	O
and	CC	O
atenolol	$	B-TREATMENT
25	CD	O
mg	NN	O
q.d.	NN	O
at	IN	O
discharge	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
discharged	VBN	O
to	TO	O
the	DT	O
medical	JJ	O
floor	NN	O
on	IN	O
hospital	NN	O
day	NN	O
three	CD	O
and	CC	O
discharged	VBD	O
from	IN	O
the	DT	O
hospital	NN	O
once	RB	O
his	PRP$	B-TEST
inr	NN	I-TEST
was	VBD	O
within	IN	O
the	DT	O
2	CD	O
to	TO	O
2.5	CD	O
range	NN	O
.	.	O

primary	JJ	O
care	NN	O
physician	NN	O
was	VBD	O
to	TO	O
check	VB	O
inr	NN	B-TEST
and	CC	O
titrate	NN	O
zestril	NN	B-TREATMENT
up	RB	O
and	CC	O
atenolol	RB	B-TREATMENT
as	IN	O
tolerated	VBN	O
.	.	O

1.	CD	O
lipitor	NN	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

2.	CD	O
aspirin	JJ	B-TREATMENT
325	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

3.	CD	O
plavix	JJ	B-TREATMENT
75	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
times	NNS	O
30	CD	O
days	NNS	O
.	.	O

4.	CD	O
prevacid	JJ	B-TREATMENT
30	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

5.	CD	O
atenolol	JJ	B-TREATMENT
25	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

6.	CD	O
zestril	NN	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

7.	CD	O
glyset	NN	B-TREATMENT
25	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

8.	CD	O
glucophage	NN	B-TREATMENT
500	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

9.	CD	O
coumadin	NN	B-TREATMENT
5	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

medicine	NN	B-TREATMENT

patient	NN	O
recorded	VBD	O
as	IN	O
having	VBG	O
no	DT	O
known	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM
to	TO	I-PROBLEM
drugs	NNS	I-PROBLEM

shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM

endotracheal	JJ	B-TREATMENT
intubation	NN	I-TREATMENT

central	JJ	B-TREATMENT
venous	JJ	I-TREATMENT
catheter	NN	I-TREATMENT
and	CC	O
swan	NN	B-TREATMENT
ganz	NN	I-TREATMENT
catheter	NN	I-TREATMENT
placement	NN	I-TREATMENT

arterial	JJ	B-TREATMENT
line	NN	I-TREATMENT
placement	NN	I-TREATMENT

right	RB	B-TREATMENT
sided	VBN	I-TREATMENT
thoracentesis	NN	I-TREATMENT

70	CD	O
y/o	NNS	O
male	JJ	O
with	IN	O
h/o	JJ	O
cad	NN	B-PROBLEM
s/p	NN	B-TREATMENT
lad	VBD	I-TREATMENT
ptca	JJ	I-TREATMENT
33	CD	O
yrs	NN	O
ago	RB	O
,	,	O
copd	NN	B-PROBLEM
,	,	O
t2dm	NN	B-PROBLEM
,	,	O
and	CC	O
aicd	VBP	B-PROBLEM
pocket	NN	I-PROBLEM
infection	NN	I-PROBLEM
who	WP	O
presented	VBD	O
to	TO	O
the	DT	O
juan	NN	O
on	IN	O
2017-09-03	JJ	O
with	IN	O
worsening	VBG	B-PROBLEM
sob	JJ	I-PROBLEM
x	JJ	O
5	CD	O
days	NNS	O
and	CC	O
feeling	VBG	O
"	NNP	O
cloudy	NN	O
."	NN	O

the	DT	O
patient	NN	O
was	VBD	O
currently	RB	O
at	IN	O
hubbard	JJ	O
regional	JJ	O
hospital	NN	O
and	CC	O
began	VBD	O
to	TO	O
develop	VB	O
worsening	VBG	B-PROBLEM
sob	NN	I-PROBLEM
for	IN	O
the	DT	O
past	JJ	O
5	CD	O
days	NNS	O
.	.	O

this	DT	O
am	VBP	O
while	IN	O
talking	VBG	O
with	IN	O
his	PRP$	O
daughter	NN	O
on	IN	O
the	DT	O
phone	NN	O
,	,	O
he	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
desaturate	VB	O
into	IN	O
the	DT	O
high	JJ	O
80s	CD	O
and	CC	O
he	PRP	O
was	VBD	O
brought	VBN	O
to	TO	O
the	DT	O
the	DT	O
hospital	NN	O
for	IN	O
orthopedics	NNS	O
juan	NN	O
for	IN	O
further	JJ	B-TEST
evaluation	NN	I-TEST
.	.	O

the	DT	O
patient	NN	O
states	VBZ	O
that	IN	O
he	PRP	O
has	VBZ	O
felt	VBN	O
"	NNP	O
cloudy	NN	B-PROBLEM
"	NNP	O
of	IN	O
late	JJ	O
which	WDT	O
seems	VBZ	O
to	TO	O
relate	VB	O
to	TO	O
his	PRP$	B-PROBLEM
worsening	VBG	I-PROBLEM
sob	NN	I-PROBLEM
.	.	O

he	PRP	O
is	VBZ	O
not	RB	O
ambulatory	JJ	O
and	CC	O
is	VBZ	O
very	RB	B-PROBLEM
deconditioned	JJ	I-PROBLEM
secondary	JJ	O
to	TO	O
several	JJ	B-PROBLEM
complications	NNS	I-PROBLEM
within	IN	O
the	DT	O
past	JJ	O
two	CD	O
months	NNS	O
related	VBN	O
to	TO	O
an	DT	B-PROBLEM
aicd	NN	I-PROBLEM
pocket	NN	I-PROBLEM
infection	NN	I-PROBLEM
.	.	O

he	PRP	O
denies	VBZ	O
any	DT	B-PROBLEM
cp	NN	I-PROBLEM
,	,	O
n/v/d	RB	B-PROBLEM
,	,	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
or	CC	O
ha	NN	B-PROBLEM
.	.	O

in	IN	O
the	DT	O
juan	NN	O
,	,	O
his	PRP$	B-TEST
vs	NN	I-TEST
were	VBD	O
97.8	CD	O
150/80	CD	O
88	CD	O
12	CD	O
89-94%	JJ	O
3l	CD	B-TREATMENT
nc	NN	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
given	VBN	O
percocet	NN	B-TREATMENT
for	IN	O
back	RB	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
lasix	VBZ	B-TREATMENT
80	CD	O
mg	NN	O
iv	NN	O
,	,	O
and	CC	O
combivent	NN	B-TREATMENT
neb	NN	I-TREATMENT
.	.	O

for	IN	O
unclear	JJ	O
reasons	NNS	O
,	,	O
he	PRP	O
was	VBD	O
placed	VBN	O
on	IN	O
a	DT	B-TREATMENT
nrb	NN	I-TREATMENT
in	IN	O
the	DT	O
juan	NN	O
.	.	O

he	PRP	O
was	VBD	O
quickly	RB	O
weaned	VBN	O
to	TO	O
3l	CD	B-TREATMENT
o2	NN	I-TREATMENT
via	IN	O
nc	NN	B-TREATMENT
,	,	O
o2	JJ	B-TEST
sats	NNS	I-TEST
100%	CD	O
.	.	O

-	:	O
aicd	NN	B-PROBLEM
pocket	NN	I-PROBLEM
infection	NN	I-PROBLEM
c/b	NN	O
mssa	NN	B-PROBLEM
bacteremia	NN	I-PROBLEM
,	,	O
pericardial	JJ	B-PROBLEM
effusion	NN	I-PROBLEM
s/p	VBD	B-TEST
mediastinal	JJ	I-TEST
exploration	NN	I-TEST
,	,	O
evacuation	NN	B-TREATMENT
of	IN	O
pericardial	JJ	B-PROBLEM
effusion	NN	I-PROBLEM
&	CC	O
hematoma	NN	B-PROBLEM
(	(	O
2017-07-24	CD	O
)	)	O

-	:	O
ischemic	NN	B-PROBLEM
colitis	NN	I-PROBLEM
and	CC	O
ischemic	JJ	B-PROBLEM
liver	NN	I-PROBLEM
2017-06-22	JJ	O
(	(	O
post	FW	O
air	NN	B-PROBLEM
embolism	NN	I-PROBLEM
from	IN	O
post	NN	O
mediastinal	JJ	B-TEST
exploration	NN	I-TEST
)	)	O

-	:	O
cad	NN	B-PROBLEM
s/p	NN	B-TREATMENT
lad	VBD	I-TREATMENT
ptca	JJ	I-TREATMENT
33	CD	O
years	NNS	O
ago	RB	O

-	:	O
t2dm	NN	B-PROBLEM
c/b	NN	O
neuropathy	JJ	B-PROBLEM
and	CC	O
nephropathy	JJ	B-PROBLEM

-	:	O
copd	NN	B-PROBLEM

-	:	O
hypothyroidism	NN	B-PROBLEM

-	:	O
cva	NN	B-PROBLEM

-	:	O
s/p	NN	B-TREATMENT
bovine	NN	I-TREATMENT
avr	NN	I-TREATMENT
1999	CD	O

-	:	O
hyperlipidemia	NN	B-PROBLEM

-	:	O
gerd	NN	B-PROBLEM

-	:	O
chronic	NN	B-PROBLEM
lbp	NN	I-PROBLEM

-	:	O
lumbar	NN	B-PROBLEM
sympathectomy	NN	I-PROBLEM

sister	NN	O
with	IN	O
diabetes	NNS	B-PROBLEM
.	.	O

97.6	CD	O
95/48	CD	O
71	CD	O
98%	CD	O
4l	CD	B-TREATMENT
nc	NN	I-TREATMENT

slight	JJ	B-PROBLEM
confustion	NN	I-PROBLEM
with	IN	O
place	NN	O
but	CC	O
oriented	VBN	O
with	IN	O
some	DT	O
re-direction	NN	O
.	.	O

jvd	NN	B-PROBLEM
difficult	JJ	O
to	TO	O
access	NN	O
02-23	NN	O
increased	VBD	B-PROBLEM
neck	RB	I-PROBLEM
girth	NN	I-PROBLEM
.	.	O

s1	NN	O
,	,	O
s2	NN	O
with	IN	O
grade	JJ	B-PROBLEM
ii/vi	NN	I-PROBLEM
sem	NN	I-PROBLEM
.	.	O
+s3	NN	B-PROBLEM
.	.	O

crackles	NNS	B-PROBLEM
halfway	VBP	I-PROBLEM
up	RP	I-PROBLEM
lung	NN	I-PROBLEM
fields	NNS	I-PROBLEM
b/l	NN	I-PROBLEM
.	.	O

soft	JJ	O
,	,	O
nt/nd	JJ	B-PROBLEM
with	IN	O
normoactive	JJ	O
bs	NN	O
.	.	O

2+	CD	O
pitting	VBG	B-PROBLEM
edema	NN	I-PROBLEM
to	TO	I-PROBLEM
knees	VB	I-PROBLEM
b/l	NN	I-PROBLEM
.	.	O

2017-09-03	JJ	O
pt	NN	B-TEST
-	:	O
13.8	CD	O
*	NN	O
ptt	NN	B-TEST
-	:	O
33.1	CD	O
inr	NN	B-TEST
(	(	I-TEST
pt	JJ	I-TEST
)-	JJ	I-TEST
1.2	CD	O
*	NN	O

2017-09-03	JJ	O
plt	NN	B-TEST
count	NN	I-TEST
-	:	O
124	CD	O
*	NN	O

2017-09-03	JJ	O
hypochrom	NN	B-TEST
-	:	O
2+	CD	O
anisocyt	SYM	B-TEST
-	:	O
1+	CD	O
macrocyt	SYM	B-TEST
-	:	O
2+	CD	O

2017-09-03	JJ	O
neuts	NNS	B-TEST
-	:	O
79.5	CD	O
*	NN	O
lymphs	SYM	B-TEST
-	:	O
9.9	CD	O
*	JJ	O
monos	NNS	B-TEST
-	:	O
4.9	CD	O
eos	SYM	B-TEST
-	:	O
5.4	CD	O
*	NN	O
basos	SYM	B-TEST
-	:	O
0.2	CD	O

2017-09-03	JJ	O
wbc	NN	B-TEST
-	:	O
9.1	CD	O
rbc	NN	B-TEST
-	:	O
2.77	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
8.8	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
27.2	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
99	CD	O
*	NN	O
mch	SYM	B-TEST
-	:	O
31.9	CD	O
mchc	SYM	B-TEST
-	:	O
32.4	CD	O
rdw	NN	B-TEST
-	:	O
18.0	CD	O
*	NN	O

2017-09-03	JJ	O
ck	NN	B-TEST
-	:	I-TEST
mb	NN	I-TEST
-	:	O
not	RB	O
done	VBN	O
probnp	NN	B-TEST
-	:	O
2656	CD	O
*	NN	O

2017-09-03	JJ	O
ck	NN	B-TEST
(	(	I-TEST
cpk	JJ	I-TEST
)-	JJ	I-TEST
16	CD	O
*	NN	O

2017-09-03	JJ	O
glucose	JJ	B-TEST
-	:	O
206	CD	O
*	JJ	O
urea	JJ	B-TEST
n	SYM	I-TEST
-	:	O
28	CD	O
*	NN	O
creat	NN	B-TEST
-	:	O
1.8	CD	O
*	JJ	O
sodium	NN	B-TEST
-	:	O
135	CD	O
potassium	NN	B-TEST
-	:	O
4.1	CD	O
chloride	NN	B-TEST
-	:	O
85	CD	O
*	JJ	O
total	NN	B-TEST
co2	NN	I-TEST
-	:	O
42	CD	O
*	JJ	O
anion	NN	B-TEST
gap	NN	I-TEST
-	:	O
12	CD	O

2017-09-03	JJ	O
ck	NN	B-TEST
-	:	I-TEST
mb	NN	I-TEST
-	:	O
not	RB	O
done	VBN	O
ctropnt	NN	B-TEST
-	:	O
0.22	CD	O
*	NN	O

2017-09-03	JJ	O
ck	NN	B-TEST
(	(	I-TEST
cpk	JJ	I-TEST
)-	CD	I-TEST
38	CD	O

inr	NN	B-TEST
3.5	CD	O
,	,	O
pt	NN	B-TEST
32.5	CD	O
,	,	O
ptt	VBD	B-TEST
41	CD	O

1.	CD	O
cxr	NN	B-TEST
(	(	I-TEST
pa/lateral	JJ	I-TEST
)	)	I-TEST
2017-09-03	JJ	O

congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
with	IN	O
bilateral	JJ	B-PROBLEM
effusions	NNS	I-PROBLEM
(	(	O
r	NN	O
>	NNP	O
l	NN	O
)	)	O
,	,	O
with	IN	O
possible	JJ	O
underlying	VBG	B-PROBLEM
consolidation	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
rll	NN	I-PROBLEM
and	CC	O
to	TO	O
a	DT	O
lesser	JJR	O
degree	NN	O
the	DT	O
rml	NN	O
and	CC	O
lll	NN	O
.	.	O

2.	CD	O
cxr	JJ	B-TEST
2017-09-04	JJ	O

compared	VBN	O
to	TO	O
pa	VB	B-TEST
and	CC	I-TEST
lateral	JJ	I-TEST
chest	NN	I-TEST
of	IN	O
the	DT	O
prior	JJ	O
day	NN	O
.	.	O

right-sided	JJ	B-TREATMENT
picc	NN	I-TREATMENT
line	NN	I-TREATMENT
with	IN	O
its	PRP$	O
tip	NN	O
in	IN	O
the	DT	O
distal	JJ	O
svc	NN	O
.	.	O

the	DT	O
heart	NN	O
is	VBZ	O
markedly	RB	B-PROBLEM
enlarged	VBN	I-PROBLEM
.	.	O

there	EX	O
remains	VBZ	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
right	NN	I-PROBLEM
and	CC	I-PROBLEM
small	JJ	I-PROBLEM
left	VBD	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
,	,	O
not	RB	O
significantly	RB	O
changed	VBN	O
.	.	O

patient	NN	O
remains	VBZ	O
in	IN	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
,	,	O
though	IN	O
it	PRP	O
may	MD	O
be	VB	O
slightly	RB	O
improved	VBN	O
compared	VBN	O
to	TO	O
the	DT	B-TEST
prior	JJ	I-TEST
study	NN	I-TEST
.	.	O

underlying	VBG	B-PROBLEM
infectious	JJ	I-PROBLEM
consolidation	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	NN	I-PROBLEM
lower	RBR	I-PROBLEM
lobe	NN	I-PROBLEM
not	RB	O
excluded	VBN	O
.	.	O

3.	CD	O
echo	JJ	B-TEST
2017-09-04	JJ	O

the	DT	O
left	JJ	O
atrium	NN	O
is	VBZ	O
mildly	RB	B-PROBLEM
dilated	VBN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
mild	JJ	B-PROBLEM
symmetric	JJ	I-PROBLEM
left	VBD	I-PROBLEM
ventricular	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
.	.	O

lv	JJ	B-TEST
systolic	JJ	I-TEST
function	NN	I-TEST
appears	VBZ	O
depressed	JJ	B-PROBLEM
.	.	O

resting	VBG	B-PROBLEM
regional	JJ	I-PROBLEM
wall	NN	I-PROBLEM
motion	NN	I-PROBLEM
abnormalities	NNS	I-PROBLEM
include	VBP	O
inferior	JJ	B-PROBLEM
and	CC	I-PROBLEM
inferolateral	JJ	I-PROBLEM
hypokinesis	NN	I-PROBLEM
.	.	O

right	RB	O
ventricular	JJ	O
chamber	NN	O
size	NN	O
is	VBZ	O
normal	JJ	O
and	CC	O
free	JJ	O
wall	NN	O
motion	NN	O
may	MD	O
be	VB	O
mildly	RB	B-PROBLEM
impaired	JJ	I-PROBLEM
.	.	O

the	DT	O
aortic	JJ	O
root	NN	O
is	VBZ	O
mildly	RB	B-PROBLEM
dilated	VBN	I-PROBLEM
.	.	O

the	DT	O
ascending	VBG	O
aorta	NN	O
is	VBZ	O
mildly	RB	B-PROBLEM
dilated	VBN	I-PROBLEM
.	.	O

the	DT	O
aortic	JJ	O
valve	NN	O
leaflets	NNS	O
are	VBP	O
mildly	RB	B-PROBLEM
thickened	VBN	I-PROBLEM
.	.	O

a	DT	B-TREATMENT
bioprosthetic	JJ	I-TREATMENT
aortic	JJ	I-TREATMENT
valve	NN	I-TREATMENT
prosthesis	NN	I-TREATMENT
is	VBZ	O
present	JJ	O
.	.	O

the	DT	B-TREATMENT
aortic	JJ	I-TREATMENT
prosthesis	NN	I-TREATMENT
leaflets	NNS	I-TREATMENT
appear	VBP	O
to	TO	O
move	VB	O
normally	RB	O
.	.	O

the	DT	O
transaortic	JJ	O
gradient	NN	O
is	VBZ	O
normal	JJ	O
for	IN	O
this	DT	B-TREATMENT
prosthesis	NN	I-TREATMENT
.	.	O

the	DT	O
mitral	JJ	O
valve	NN	O
leaflets	NNS	O
are	VBP	O
mildly	RB	B-PROBLEM
thickened	VBN	I-PROBLEM
.	.	O

the	DT	B-TEST
left	NN	I-TEST
ventricular	JJ	I-TEST
inflow	JJ	I-TEST
pattern	NN	I-TEST
suggests	VBZ	O
a	DT	B-PROBLEM
restrictive	JJ	I-PROBLEM
filling	NN	I-PROBLEM
abnormality	NN	I-PROBLEM
,	,	O
with	IN	O
elevated	JJ	B-PROBLEM
left	VBD	I-PROBLEM
atrial	JJ	I-PROBLEM
pressure	NN	I-PROBLEM
.	.	O

transmitral	JJ	B-TEST
doppler	NN	I-TEST
and	CC	O
tissue	NN	B-TEST
velocity	NN	I-TEST
imaging	VBG	I-TEST
are	VBP	O
consistent	JJ	O
with	IN	O
grade	JJ	B-PROBLEM
iii/iv	NN	I-PROBLEM
(	(	I-PROBLEM
severe	JJ	I-PROBLEM
)	)	I-PROBLEM
left	VBD	I-PROBLEM
ventricular	JJ	I-PROBLEM
diastolic	JJ	I-PROBLEM
dysfunction	NN	I-PROBLEM
.	.	O

the	DT	O
tricuspid	JJ	O
valve	NN	O
leaflets	NNS	O
are	VBP	O
mildly	RB	B-PROBLEM
thickened	VBN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
mild	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
systolic	JJ	I-PROBLEM
hypertension	NN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
pericardial	JJ	B-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

compared	VBN	O
with	IN	O
the	DT	B-TEST
prior	JJ	I-TEST
study	NN	I-TEST
(	(	O
images	NNS	O
reviewed	VBN	O
)	)	O
of	IN	O
2017-08-14	JJ	O
,	,	O
ventricular	JJ	O
function	NN	O
is	VBZ	O
now	RB	O
similar.	JJ	O

ef	DT	B-TEST
35-40%	JJ	O
.	.	O

4.	CD	O
echo	JJ	B-TEST
2017-09-14	JJ	O

the	DT	O
left	JJ	O
atrium	NN	O
is	VBZ	O
mildly	RB	B-PROBLEM
dilated	VBN	I-PROBLEM
.	.	O

overall	JJ	B-TEST
left	VBD	I-TEST
ventricular	JJ	I-TEST
systolic	JJ	I-TEST
function	NN	I-TEST
cannot	NN	O
be	VB	O
reliably	RB	O
assessed	VBN	O
.	.	O

the	DT	O
aortic	JJ	O
valve	NN	O
leaflets	NNS	O
are	VBP	O
mildly	RB	B-PROBLEM
thickened	VBN	I-PROBLEM
.	.	O

the	DT	O
mitral	JJ	O
valve	NN	O
leaflets	NNS	O
are	VBP	O
mildly	RB	B-PROBLEM
thickened	VBN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
pericardial	JJ	B-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

compared	VBN	O
with	IN	O
the	DT	B-TEST
prior	JJ	I-TEST
study	NN	I-TEST
(	(	O
images	NNS	O
reviewed	VBN	O
)	)	O
of	IN	O
2017-09-04	JJ	O
,	,	O
there	EX	O
is	VBZ	O
probably	RB	O
no	DT	O
significant	JJ	O
change	NN	O
.	.	O

all	DT	B-TEST
cultures	NNS	I-TEST
,	,	O
including	VBG	O
bcx	NN	B-TEST
,	,	O
ucx	JJ	B-TEST
,	,	O
pleural	JJ	B-TEST
fluid	NN	I-TEST
culture	NN	I-TEST
,	,	O
and	CC	O
wound	JJ	B-TEST
culture	NN	I-TEST
have	VBP	O
been	VBN	O
negative	JJ	O
.	.	O

5.	CD	O
ct	JJ	B-TEST
chest	JJ	I-TEST
2017-09-16	JJ	O
:	:	O

1.	CD	O
increasing	VBG	B-PROBLEM
large	JJ	I-PROBLEM
right-sided	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
and	CC	O
pulmonary	JJ	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

scattered	VBN	B-PROBLEM
parenchymal	JJ	I-PROBLEM
opacities	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
represent	NN	O
superimposed	VBN	B-PROBLEM
infection	NN	I-PROBLEM
vs	NN	O
atelectasis	NN	B-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
evidence	NN	O
of	IN	O
abscess	NN	B-PROBLEM
.	.	O

6.	CD	O
2017-09-28	JJ	O
chest	NN	B-TEST
x	NN	I-TEST
ray	NN	I-TEST
:	:	O

single	JJ	B-TEST
ap	DT	I-TEST
view	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
chest	NN	I-TEST
.	.	O

there	EX	O
has	VBZ	O
been	VBN	O
almost	RB	O
complete	JJ	O
resolution	NN	O
of	IN	O
pulmonary	JJ	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

a	DT	B-PROBLEM
small	JJ	I-PROBLEM
right	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
has	VBZ	O
decreased	VBN	O
in	IN	O
size	NN	O
.	.	O

mild	JJ	B-PROBLEM
cardiomegaly	NN	I-PROBLEM
is	VBZ	O
stable	JJ	O
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
pneumothorax	NN	B-PROBLEM
.	.	O

right	JJ	B-TREATMENT
pic	NN	I-TREATMENT
catheter	NN	I-TREATMENT
tip	NN	I-TREATMENT
ends	VBZ	O
in	IN	O
the	DT	O
lower	JJR	O
svc	NN	O
.	.	O

patient	NN	O
is	VBZ	O
post	JJ	O
median	JJ	B-TREATMENT
sternotomy	NN	I-TREATMENT
.	.	O

almost	RB	O
complete	JJ	O
resolution	NN	O
of	IN	O
pulmonary	JJ	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

7.	CD	O
2017-09-29	JJ	O
ct	NNS	B-TEST
head	NN	I-TEST
:	:	O

there	EX	O
is	VBZ	O
no	DT	O
evidence	NN	O
of	IN	O
intraaxial	JJ	B-PROBLEM
or	CC	I-PROBLEM
extraaxial	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
,	,	O
mass	NN	B-PROBLEM
effect	NN	I-PROBLEM
,	,	O
shift	NN	B-PROBLEM
of	IN	I-PROBLEM
normally	RB	I-PROBLEM
midline	JJ	I-PROBLEM
structures	NNS	I-PROBLEM
,	,	O
or	CC	O
acute	VB	B-PROBLEM
major	JJ	I-PROBLEM
or	CC	I-PROBLEM
minor	JJ	I-PROBLEM
vascular	JJ	I-PROBLEM
territorial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

the	DT	O
ventricles	NNS	O
and	CC	O
sulci	NNS	O
are	VBP	O
mildly	RB	B-PROBLEM
prominent	JJ	I-PROBLEM
,	,	O
but	CC	O
stable	JJ	O
in	IN	O
size	NN	O
and	CC	O
appearance	NN	O
.	.	O

again	RB	O
seen	VBN	O
are	VBP	O
subtle	JJ	B-PROBLEM
hypodensities	NNS	I-PROBLEM
within	IN	I-PROBLEM
the	DT	I-PROBLEM
periventricular	JJ	I-PROBLEM
white	JJ	I-PROBLEM
matter	NN	I-PROBLEM
which	WDT	O
is	VBZ	O
an	DT	O
indication	NN	O
of	IN	O
chronic	JJ	B-PROBLEM
microvascular	JJ	I-PROBLEM
ischemic	JJ	I-PROBLEM
changes	NNS	I-PROBLEM
,	,	O
stable	JJ	O
.	.	O

extensive	JJ	B-PROBLEM
carotid	NN	I-PROBLEM
artery	NN	I-PROBLEM
calcifications	NNS	I-PROBLEM
are	VBP	O
identified	VBN	O
.	.	O

no	DT	O
evidence	NN	O
of	IN	O
acute	NN	B-PROBLEM
or	CC	I-PROBLEM
chronic	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

stable	JJ	B-PROBLEM
microvascular	JJ	I-PROBLEM
ischemic	JJ	I-PROBLEM
changes	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
periventricular	JJ	I-PROBLEM
white	JJ	I-PROBLEM
matter	NN	I-PROBLEM
.	.	O

8.	CD	O
2017-09-30	JJ	O
eeg	NN	B-TEST
:	:	O

abnormal	JJ	B-PROBLEM
eeg	NN	I-PROBLEM
due	JJ	O
to	TO	O
the	DT	B-PROBLEM
moderately	RB	I-PROBLEM
slow	JJ	I-PROBLEM
posterior	NN	I-PROBLEM
background	NN	I-PROBLEM
and	CC	O
occasional	JJ	O
bursts	NNS	O
of	IN	O
generalized	JJ	B-PROBLEM
slowing	NN	I-PROBLEM
.	.	O

these	DT	O
findings	NNS	O
indicate	VBP	O
a	DT	B-PROBLEM
widespread	JJ	I-PROBLEM
encephalopathic	JJ	I-PROBLEM
condition	NN	I-PROBLEM
affecting	VBG	O
both	DT	O
cortical	JJ	O
and	CC	O
subcortical	JJ	O
structures	NNS	O
.	.	O

medications	NNS	B-TREATMENT
,	,	O
metabolic	JJ	B-PROBLEM
disturbances	NNS	I-PROBLEM
,	,	O
and	CC	O
infection	NN	B-PROBLEM
are	VBP	O
among	IN	O
the	DT	O
most	RBS	O
common	JJ	O
causes	NNS	O
.	.	O

no	DT	O
prominent	JJ	B-PROBLEM
focal	JJ	I-PROBLEM
abnormalities	NNS	I-PROBLEM
were	VBD	O
evident	JJ	O
,	,	O
and	CC	O
there	EX	O
were	VBD	O
no	DT	O
epileptiform	NN	B-PROBLEM
features	VBZ	I-PROBLEM
.	.	O

the	DT	B-TEST
cardiac	JJ	I-TEST
monitor	NN	I-TEST
showed	VBD	O
occasional	JJ	B-PROBLEM
irregularities	NNS	I-PROBLEM
in	IN	O
a	DT	B-TREATMENT
paced	JJ	I-TREATMENT
rhythm	NN	I-TREATMENT
.	.	O

70	CD	O
y/o	NNS	O
male	JJ	O
with	IN	O
h/o	JJ	O
cad	NN	B-PROBLEM
,	,	O
t2dm	NN	B-PROBLEM
,	,	O
hyperlipidemia	NN	B-PROBLEM
,	,	O
and	CC	O
copd	NN	B-PROBLEM
who	WP	O
presented	VBD	O
to	TO	O
the	DT	O
juan	NN	O
on	IN	O
2017-09-03	JJ	O
with	IN	O
worsening	VBG	B-PROBLEM
sob	JJ	I-PROBLEM
x	JJ	O
5	CD	O
days	NNS	O
from	IN	O
morton	NNP	O
hospital	NN	O
&	CC	O
medical	JJ	O
center	NN	O
.	.	O

pt.	NN	O
was	VBD	O
initially	RB	O
admitted	VBN	O
to	TO	O
ccu	VB	O
on	IN	O
2017-09-03	JJ	O
,	,	O
transferred	VBN	O
to	TO	O
pendleton	VB	O
on	IN	O
2017-09-05	JJ	O
,	,	O
triggered	VBN	O
on	IN	O
2017-09-10	JJ	O
for	IN	O
hypotension	NN	B-PROBLEM
with	IN	O
bp	JJ	B-TEST
67/38	CD	O
and	CC	O
transferred	VBD	O
back	RB	O
to	TO	O
ccu	VB	O
on	IN	O
2017-09-10	JJ	O
.	.	O

he	PRP	O
remained	VBD	O
fluid	NN	B-PROBLEM
overloaded	VBN	I-PROBLEM
and	CC	O
a	DT	B-TREATMENT
swan	NN	I-TREATMENT
catheter	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
.	.	O

pump	NN	B-TREATMENT

the	DT	O
patient	NN	O
was	VBD	O
initially	RB	O
admitted	VBN	O
for	IN	O
likely	JJ	O
chf	JJ	B-PROBLEM
exacerbation	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
a	DT	B-TREATMENT
lasix	NN	I-TREATMENT
gtt	NN	I-TREATMENT
the	DT	O
night	NN	O
of	IN	O
admission	NN	O
with	IN	O
a	DT	O
good	JJ	O
response	NN	O
.	.	O

after	IN	O
several	JJ	O
days	NNS	O
,	,	O
he	PRP	O
became	VBD	O
hypotensive	JJ	B-PROBLEM
and	CC	O
triggered	VBD	O
for	IN	O
bps	NN	B-TEST
60s/30s	CD	O
.	.	O

he	PRP	O
was	VBD	O
given	VBN	O
ivf	NN	B-TREATMENT
without	IN	O
an	DT	O
adequate	JJ	O
response	NN	O
in	IN	O
his	PRP$	B-TEST
pressures	NNS	I-TEST
.	.	O

he	PRP	O
was	VBD	O
transferred	VBN	O
back	RB	O
to	TO	O
the	DT	O
ccu	NN	O
and	CC	O
started	VBD	O
on	IN	O
a	DT	B-TREATMENT
dopamine	NN	I-TREATMENT
gtt	NN	I-TREATMENT
.	.	O

he	PRP	O
diuresed	VBD	O
well	RB	O
on	IN	O
the	DT	B-TREATMENT
dopamine	NN	I-TREATMENT
gtt	NN	I-TREATMENT
and	CC	O
his	PRP$	B-TEST
bp	NN	I-TEST
was	VBD	O
supported	VBN	O
.	.	O

gradually	RB	O
,	,	O
the	DT	B-TREATMENT
dopamine	NN	I-TREATMENT
gtt	NN	I-TREATMENT
was	VBD	O
weaned	VBN	O
.	.	O

however	RB	O
,	,	O
he	PRP	O
still	RB	O
appeared	VBD	O
volume	NN	B-PROBLEM
overloaded	VBN	I-PROBLEM
with	IN	O
minimal	JJ	O
improvement	NN	O
in	IN	O
his	PRP$	B-PROBLEM
oxygen	NN	I-PROBLEM
requirement	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
swan	NN	I-TEST
was	VBD	O
placed	VBN	O
for	IN	O
a	DT	O
more	RBR	O
accurate	JJ	O
picture	NN	O
of	IN	O
his	PRP$	O
volume	NN	O
status	NN	O
and	CC	O
he	PRP	O
was	VBD	O
volume	NN	B-PROBLEM
overloaded	VBN	I-PROBLEM
by	IN	O
swan	JJ	B-TEST
numbers	NNS	I-TEST
with	IN	O
an	DT	B-PROBLEM
elevated	JJ	I-PROBLEM
pad	NN	I-PROBLEM
and	CC	O
elevated	VBD	B-PROBLEM
cvp	NN	I-PROBLEM
without	IN	O
an	DT	B-TEST
obtainable	JJ	I-TEST
wedge	NN	I-TEST
pressure	NN	I-TEST
.	.	O

he	PRP	O
also	RB	O
had	VBD	O
a	DT	B-PROBLEM
high	JJ	I-PROBLEM
co	NN	I-PROBLEM
and	CC	O
low	JJ	B-PROBLEM
svr	NN	I-PROBLEM
suggestive	NN	O
of	IN	O
sepsis	NN	B-PROBLEM
,	,	O
but	CC	O
he	PRP	O
never	RB	O
had	VBD	O
an	DT	B-PROBLEM
elevated	VBN	I-PROBLEM
wbc	NN	I-PROBLEM
and	CC	O
was	VBD	O
afebrile	NN	B-PROBLEM
during	IN	O
his	PRP$	O
entire	JJ	O
hospital	NN	O
admission	NN	O
with	IN	O
negative	JJ	O
blood	NN	B-TEST
,	,	I-TEST
urine	NN	I-TEST
,	,	I-TEST
wound	NN	I-TEST
,	,	I-TEST
and	CC	I-TEST
pleural	JJ	I-TEST
fluid	NN	I-TEST
cultures	NNS	I-TEST
.	.	O

the	DT	B-TREATMENT
lasix	NN	I-TREATMENT
drip	NN	I-TREATMENT
was	VBD	O
eventually	RB	O
changed	VBN	O
to	TO	O
iv	VB	B-TREATMENT
lasix	JJ	I-TREATMENT
boluses	NNS	I-TREATMENT
,	,	O
with	IN	O
a	DT	B-TREATMENT
net	JJ	I-TREATMENT
diuresis	NN	I-TREATMENT
of	IN	O
over	IN	O
36	CD	O
liters	NNS	O
for	IN	O
the	DT	O
hospital	NN	O
stay	NN	O
.	.	O

he	PRP	O
was	VBD	O
then	RB	O
transitioned	VBN	O
to	TO	O
oral	JJ	B-TREATMENT
lasix	NN	I-TREATMENT
for	IN	O
maintainence	NN	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
an	DT	B-TEST
echo	NN	I-TEST
on	IN	O
2017-09-04	JJ	O
with	IN	O
the	DT	O
results	NNS	O
above	IN	O
in	IN	O
detail	NN	O
.	.	O

it	PRP	O
was	VBD	O
unchanged	JJ	O
in	IN	O
comparison	NN	O
to	TO	O
2017-08-14	JJ	O
with	IN	O
similar	JJ	O
ventricular	JJ	B-TEST
function	NN	I-TEST
and	CC	O
inferior	JJ	B-PROBLEM
and	CC	I-PROBLEM
inferolateral	JJ	I-PROBLEM
hypokinesis	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
another	DT	B-TEST
echo	NN	I-TEST
on	IN	O
2017-09-14	JJ	O
with	IN	O
no	DT	O
new	JJ	O
changes	NNS	O
.	.	O

at	IN	O
discharge	PDT	O
the	DT	O
patient	NN	O
was	VBD	O
thought	VBN	O
to	TO	O
be	VB	O
euvolemic	JJ	O
,	,	O
satting	VBG	O
well	RB	O
on	IN	O
room	NN	O
air	NN	O
and	CC	O
without	IN	O
peripheral	JJ	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

his	PRP$	B-TEST
dry	JJ	I-TEST
weight	NN	I-TEST
is	VBZ	O
70.4	CD	O
kg	NN	O
.	.	O

ischemia	NN	B-PROBLEM

the	DT	O
patient	NN	O
had	VBD	O
an	DT	B-PROBLEM
initial	JJ	I-PROBLEM
troponin	NN	I-PROBLEM
bump	NN	I-PROBLEM
on	IN	O
admission	NN	O
which	WDT	O
was	VBD	O
most	RBS	O
likely	JJ	O
secondary	JJ	O
to	TO	O
chf	VB	B-PROBLEM
exacerbation	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
aspirin	NN	B-TREATMENT
,	,	O
metoprolol	NN	B-TREATMENT
and	CC	O
lipitor	NN	B-TREATMENT
with	IN	O
no	DT	O
further	JJ	B-PROBLEM
issues	NNS	I-PROBLEM
.	.	O

rhythm	NN	B-TEST

the	DT	O
patient	NN	O
is	VBZ	O
completely	RB	B-PROBLEM
pacer-dependent	JJ	I-PROBLEM
,	,	O
being	VBG	O
epicardially	RB	B-TREATMENT
paced	VBN	I-TREATMENT
at	IN	O
70	CD	O
.	.	O

he	PRP	O
is	VBZ	O
on	IN	O
amiodarone	NN	B-TREATMENT
for	IN	O
post-op	JJ	B-PROBLEM
afib	NN	I-PROBLEM
and	CC	O
this	DT	O
was	VBD	O
continued	VBN	O
this	DT	O
entire	JJ	O
admission	NN	O
.	.	O

his	PRP$	B-TEST
underlying	JJ	I-TEST
rhythm	NN	I-TEST
is	VBZ	O
atrial	JJ	B-PROBLEM
flutter	NN	I-PROBLEM
;	:	O
it	PRP	O
was	VBD	O
unclear	JJ	O
whether	IN	O
he	PRP	O
had	VBD	O
previously	RB	O
been	VBN	O
cardioverted	VBN	O
.	.	O

anti-coagulation	NN	B-TREATMENT
was	VBD	O
started	VBN	O
with	IN	O
warfarin	NN	B-TREATMENT
5	CD	O
mg	NN	O
with	IN	O
a	DT	O
goal	NN	O
of	IN	O
2-3	JJ	O
and	CC	O
a	DT	O
plan	NN	O
for	IN	O
cardioversion	NN	B-TREATMENT
in	IN	O
6	CD	O
weeks	NNS	O
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
inr	NN	I-TEST
became	VBD	O
supratherapeutic	JJ	B-PROBLEM
and	CC	O
coumadin	NN	B-TREATMENT
was	VBD	O
held	VBN	O
.	.	O

his	PRP$	B-TREATMENT
coumadin	NN	I-TREATMENT
was	VBD	O
transitioned	VBN	O
to	TO	O
2	CD	O
mg	NNS	O
and	CC	O
then	RB	O
1	CD	O
mg	NNS	O
.	.	O

his	PRP$	B-TEST
inr	NN	I-TEST
continued	VBD	O
to	TO	O
flucuate	VB	O
.	.	O

his	PRP$	B-TEST
inr	NN	I-TEST
will	MD	O
have	VB	O
to	TO	O
be	VB	O
monitored	VBN	O
closely	RB	O
unitl	JJ	O
his	PRP$	B-TEST
levels	NNS	I-TEST
are	VBP	O
stable	JJ	O
.	.	O

his	PRP$	O
inr	NN	B-TEST
goal	NN	O
is	VBZ	O
02-24	JJ	O
.	.	O

2#	CD	O
sob	NN	B-PROBLEM
on	IN	O
admission	NN	O
:	:	O

likely	RB	O
due	JJ	O
to	TO	O
chf	VB	B-PROBLEM
exacerbation	NN	I-PROBLEM
,	,	O
with	IN	O
diuresis	NN	B-TREATMENT
of	IN	O
over	IN	O
36	CD	O
l	NN	O
during	IN	O
his	PRP$	O
admission	NN	O
.	.	O

he	PRP	O
had	VBD	O
4	CD	B-TREATMENT
surgeries	NNS	I-TREATMENT
(	(	O
3	CD	B-TREATMENT
cardiac	NN	I-TREATMENT
surgeries	NNS	I-TREATMENT
)	)	O
earlier	RBR	O
in	IN	O
the	DT	O
summer	NN	O
,	,	O
so	IN	O
it	PRP	O
is	VBZ	O
likely	JJ	O
that	IN	O
he	PRP	O
required	VBD	O
copious	JJ	B-TREATMENT
ivf	JJ	I-TREATMENT
hydration	NN	I-TREATMENT
surrounding	VBG	O
these	DT	B-TREATMENT
procedures	NNS	I-TREATMENT
which	WDT	O
may	MD	O
have	VB	O
been	VBN	O
the	DT	O
cause	NN	O
of	IN	O
his	PRP$	B-PROBLEM
massive	JJ	I-PROBLEM
fluid	NN	I-PROBLEM
overload	NN	I-PROBLEM
.	.	O

it	PRP	O
appears	VBZ	O
that	IN	O
his	PRP$	O
diet	NN	O
was	VBD	O
regulated	VBN	O
at	IN	O
rehab	NN	O
but	CC	O
there	EX	O
is	VBZ	O
concern	NN	O
for	IN	O
medication	NN	B-PROBLEM
non-compliance	NN	I-PROBLEM
at	IN	O
rehab	NN	O
,	,	O
per	IN	O
previous	JJ	O
discharge	NN	O
summaries	NNS	O
.	.	O

on	IN	O
discharge	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
maintained	VBN	O
on	IN	O
standing	VBG	B-TREATMENT
diuretics	NNS	I-TREATMENT
as	RB	O
well	RB	O
as	IN	O
prn	NN	B-TREATMENT
nebs	NN	I-TREATMENT
and	CC	O
inh	NN	B-TREATMENT
copd	NN	I-TREATMENT
meds	NNS	I-TREATMENT
.	.	O

3#	CD	O
metabolic	JJ	B-PROBLEM
alkalosis	NN	I-PROBLEM
/	NN	O
hypochloremia	NN	B-PROBLEM
:	:	O

etiology	NN	O
most	RBS	O
likely	JJ	O
a	DT	O
combination	NN	O
of	IN	O
contraction	NN	B-PROBLEM
alkalosis	NN	I-PROBLEM
and	CC	O
/	NN	O
or	CC	O
post-hypercapnia	NN	B-PROBLEM
.	.	O

this	DT	O
acutely	RB	O
worsened	VBN	O
on	IN	O
2017-09-18	JJ	O
,	,	O
when	WRB	O
the	DT	O
patient	NN	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
mental	JJ	B-PROBLEM
status	NN	I-PROBLEM
changes	NNS	I-PROBLEM
and	CC	O
an	DT	B-TEST
abg	NN	I-TEST
revealed	VBD	O
a	DT	B-TEST
co2	NN	I-TEST
of	IN	O
over	IN	O
100	CD	O
,	,	O
likley	NN	O
due	JJ	O
to	TO	O
a	DT	B-PROBLEM
depressed	JJ	I-PROBLEM
respiratory	NN	I-PROBLEM
drive	NN	I-PROBLEM
secondary	JJ	O
to	TO	O
sedatives	VB	B-TREATMENT
given	VBN	O
for	IN	O
agitation	NN	B-PROBLEM
on	IN	O
top	NN	O
of	IN	O
a	DT	B-PROBLEM
preexisting	JJ	I-PROBLEM
alkalosis	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
therefore	RB	O
intubated	JJ	B-TREATMENT
for	IN	O
ventilation	NN	B-TREATMENT
,	,	O
and	CC	O
continued	VBD	O
to	TO	O
be	VB	O
diuresed	VBN	O
.	.	O

his	PRP$	B-TEST
co2	NN	I-TEST
improved	VBD	O
and	CC	O
he	PRP	O
was	VBD	O
extubated	VBN	B-TREATMENT
after	IN	O
a	DT	O
few	JJ	O
days	NNS	O
.	.	O

all	DT	B-TREATMENT
sedating	JJ	I-TREATMENT
medications	NNS	I-TREATMENT
were	VBD	O
held	VBN	O
and	CC	O
serial	JJ	B-TEST
abgs	NN	I-TEST
were	VBD	O
trended	VBN	O
to	TO	O
follow	VB	O
the	DT	O
resolution	NN	O
of	IN	O
the	DT	B-PROBLEM
metabolic	JJ	I-PROBLEM
alkalosis	NN	I-PROBLEM
.	.	O

4#	CD	O
pleural	JJ	B-PROBLEM
effusions	NNS	I-PROBLEM
:	:	O
s/p	NN	B-TREATMENT
right	JJ	I-TREATMENT
thoracentesis	NN	I-TREATMENT
on	IN	O
2017-09-06	CD	O
,	,	O
1600	CD	O
ml	NN	O
of	IN	O
serosanguinous	JJ	B-PROBLEM
fluid	NNS	I-PROBLEM
removed	VBN	O
from	IN	O
right	JJ	O
pleural	JJ	O
space	NN	O
.	.	O

gram	NN	B-TEST
stain	NN	I-TEST
and	CC	O
cultures	NNS	B-TEST
were	VBD	O
negative	JJ	O
,	,	O
cytology	NN	B-TEST
was	VBD	O
negative	JJ	O
.	.	O

the	DT	B-PROBLEM
right	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
slowly	RB	O
re-accumulated	JJ	O
after	IN	O
tap	NN	B-TREATMENT
but	CC	O
resolved	VBD	O
after	IN	O
continued	JJ	B-TREATMENT
diuresis	NN	I-TREATMENT
.	.	O

repeat	NN	B-TEST
cxr	NN	I-TEST
showed	VBD	O
improvement	NN	O
of	IN	O
the	DT	B-PROBLEM
effusion	NN	I-PROBLEM
and	CC	O
on	IN	O
discharge	NN	O
he	PRP	O
had	VBD	O
been	VBN	O
breathing	VBG	O
well	RB	O
on	IN	O
room	NN	O
air	NN	O
without	IN	O
complications	NNS	B-PROBLEM

5#	CD	O
t2dm	NN	B-PROBLEM
:	:	O

the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
glargine	NN	B-TREATMENT
for	IN	O
tighter	JJR	O
glycemic	JJ	O
control	NN	O
and	CC	O
was	VBD	O
covered	VBN	O
with	IN	O
an	DT	B-TREATMENT
insulin	NN	I-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
monitored	VBN	O
with	IN	O
qid	NN	B-TEST
fingersticks	NNS	I-TEST
.	.	O

his	PRP$	B-TEST
blood	NN	I-TEST
sugars	NNS	I-TEST
were	VBD	O
in	IN	O
the	DT	O
100s	CD	O
on	IN	O
discharge	NN	O
.	.	O

6#	CD	O
hyperlipidemia	NN	B-PROBLEM
:	:	O

the	DT	O
patient	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
his	PRP$	B-TREATMENT
statin	NN	I-TREATMENT
.	.	O

7#	CD	O
copd	NN	B-PROBLEM
:	:	O

the	DT	O
patient	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
nebs	NNS	B-TREATMENT

8#	CD	O
ms	JJ	B-PROBLEM
changes	NNS	I-PROBLEM
:	:	O

the	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
baseline	NN	B-PROBLEM
dementia	NN	I-PROBLEM
which	WDT	O
was	VBD	O
confounded	VBN	O
by	IN	O
delerium	NN	B-PROBLEM
in	IN	O
the	DT	O
face	NN	O
of	IN	O
metabolic	JJ	B-PROBLEM
abnormalities	NNS	I-PROBLEM
.	.	O

neurology	NN	O
was	VBD	O
also	RB	O
consulted	VBN	O
and	CC	O
a	DT	B-TEST
head	NN	I-TEST
ct	NN	I-TEST
showed	VBD	O
old	JJ	B-PROBLEM
lacunar	JJ	I-PROBLEM
infarcts	NNS	I-PROBLEM
but	CC	O
no	DT	O
acute	JJ	O
causes	NNS	O
for	IN	O
a	DT	B-PROBLEM
change	NN	I-PROBLEM
in	IN	I-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
.	.	O

an	DT	B-TEST
eeg	NN	I-TEST
showed	VBD	O
mild	JJ	B-PROBLEM
encephalopathy	JJ	I-PROBLEM
,	,	O
but	CC	O
no	DT	O
other	JJ	O
findings	NNS	O
.	.	O

his	PRP$	O
mental	JJ	O
status	NN	O
did	VBD	O
clear	JJ	O
somewhat	RB	O
with	IN	O
the	DT	O
addition	NN	O
of	IN	O
standing	VBG	B-TREATMENT
lactulose	NN	I-TREATMENT
;	:	O
he	PRP	O
was	VBD	O
discharged	VBN	O
on	IN	O
this	DT	B-TREATMENT
medication	NN	I-TREATMENT
.	.	O

9#	CD	O
hypothyroidism	NN	B-PROBLEM
:	:	O

the	DT	O
patient	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
his	PRP$	O
outpatient	NN	O
dose	NN	O
of	IN	O
levothyroxine	NN	B-TREATMENT
.	.	O

10#	CD	O
?	.	O
uti	NN	B-PROBLEM
:	:	O

the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
levofloxacin	NN	B-TREATMENT
at	IN	O
newton-wellesley	JJ	O
hospital	NN	O
for	IN	O
a	DT	O
question	NN	O
of	IN	O
uti	NN	B-PROBLEM
based	VBN	O
on	IN	O
u/a	JJ	B-TEST
positive	JJ	O
for	IN	O
wbc	NN	B-TEST
.	.	O

ucx	NN	B-TEST
during	IN	O
this	DT	O
hospitalization	NN	O
were	VBD	O
negative	JJ	O
and	CC	O
levofloxacin	NN	B-TREATMENT
was	VBD	O
d/c	JJ	O
'd	MD	O
.	.	O

11#	CD	O
chronic	JJ	B-PROBLEM
lower	JJR	I-PROBLEM
back	RB	I-PROBLEM
pain	NN	I-PROBLEM
:	:	O

the	DT	O
patient	NN	O
was	VBD	O
treated	VBN	O
with	IN	O
a	DT	B-TREATMENT
lidocaine	JJ	I-TREATMENT
patch	NN	I-TREATMENT
and	CC	O
percocet	NN	B-TREATMENT
prn	NN	O
.	.	O

stronger	JJR	B-TREATMENT
narcotics	NNS	I-TREATMENT
were	VBD	O
avoided	VBN	O
given	VBN	O
somnolence	NN	B-PROBLEM
and	CC	O
ms	NN	B-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

12#	CD	O
wound	NN	B-TREATMENT
care	NN	I-TREATMENT
:	:	O

the	DT	O
patient	NN	O
has	VBZ	O
left	VBN	B-PROBLEM
chest	NN	I-PROBLEM
wound	NN	I-PROBLEM
and	CC	O
left	VBD	B-PROBLEM
gluteal	JJ	I-PROBLEM
pressure	NN	I-PROBLEM
ulcer	NN	I-PROBLEM
.	.	O

for	IN	O
the	DT	B-PROBLEM
left	JJ	I-PROBLEM
gluteal	NN	I-PROBLEM
pressure	NN	I-PROBLEM
ulcer	NN	I-PROBLEM
,	,	O
they	PRP	O
recommended	VBD	O
gentle	JJ	B-TREATMENT
cleansing	VBG	I-TREATMENT
with	IN	O
normal	JJ	B-TREATMENT
saline	NN	I-TREATMENT
or	CC	O
commercial	JJ	B-TREATMENT
wound	NN	I-TREATMENT
cleaner	JJR	I-TREATMENT
,	,	O
thin	JJ	O
layer	NN	O
of	IN	O
duoderm	JJ	B-TREATMENT
gel	NN	I-TREATMENT
,	,	O
air	NN	O
dry	JJ	O
,	,	O
allevyn	JJ	B-TREATMENT
foam	NN	I-TREATMENT
adhesive	NN	I-TREATMENT
over	IN	O
the	DT	O
site	NN	O
,	,	O
and	CC	O
change	NN	O
every	DT	O
2	CD	O
days	NNS	O
or	CC	O
prn	NN	O
.	.	O

for	IN	O
the	DT	B-PROBLEM
left	JJ	I-PROBLEM
chest	NN	I-PROBLEM
wound	NN	I-PROBLEM
,	,	O
they	PRP	O
recommended	VBD	O
cleansing	VBG	O
with	IN	O
commercial	JJ	B-TREATMENT
wound	NN	I-TREATMENT
cleanser	NN	I-TREATMENT
,	,	O
pat	NN	O
dry	NN	O
,	,	O
pack	NN	B-TREATMENT
aquacel	NN	I-TREATMENT
ag	IN	I-TREATMENT
rope	NN	I-TREATMENT
and	CC	O
moisten	NN	O
with	IN	O
saline	NN	B-TREATMENT
,	,	O
cover	NN	O
with	IN	O
dry	JJ	B-TREATMENT
gauze	NN	I-TREATMENT
and	CC	O
change	NN	O
daily	RB	O
.	.	O

he	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
finsateride	NN	B-TREATMENT
on	IN	O
the	DT	O
day	NN	O
prior	RB	O
to	TO	O
admission	NN	O
.	.	O

until	IN	O
then	RB	O
,	,	O
his	PRP$	B-TREATMENT
foley	NN	I-TREATMENT
should	MD	O
remain	VB	O
in	IN	O
place	NN	O
.	.	O

levothyroxine	NN	B-TREATMENT
100	CD	O
mcg	NN	O
po	NNS	O
daily	RB	O

duloxetine	NN	B-TREATMENT
20	CD	O
mg	NN	O
po	NN	O
qhs	NN	O

ondansetron	NN	B-TREATMENT
prn	NN	O

percocet	NN	B-TREATMENT
1	CD	O
tab	NN	O
prn	NN	O

senna	NN	B-TREATMENT
prn	NN	O

colace	NN	B-TREATMENT
prn	NN	O

lasix	RB	B-TREATMENT
80	CD	O
mg	JJ	O
po	NN	O
bid	NN	O

lactulose	JJ	B-TREATMENT
prn	NN	O

lidocaine	NN	B-TREATMENT
patch	NN	I-TREATMENT

nystatin	JJ	B-TREATMENT
powder	NN	I-TREATMENT

gabapentin	NN	B-TREATMENT
300	CD	O
mg	NN	O
po	NN	O
tid	NN	O

alb	NN	B-TREATMENT
nebs	NN	I-TREATMENT

fluticasone	NN	B-TREATMENT
/	CD	O
salmeterol	NN	B-TREATMENT

tiotropium	NN	B-TREATMENT
bromide	NN	I-TREATMENT

spironolactone	NN	B-TREATMENT
25	CD	O
mg	NN	O
po	NNS	O
daily	RB	O

epoetin	NN	B-TREATMENT
4000	CD	O
units	NNS	O
mwf	VBP	O

riss	NN	B-TREATMENT

amiodarone	RB	B-TREATMENT
200	CD	O
mg	NNS	O
po	JJ	O
daily	JJ	O

calcium	NN	B-TREATMENT
acetate	NN	I-TREATMENT
667	CD	O
mg	NN	O
po	NN	O
tid	NN	O

subq	NN	B-TREATMENT
heparin	NN	I-TREATMENT

pantoprazole	JJ	B-TREATMENT
40	CD	O
mg	JJ	O
po	NNS	O
daily	RB	O

simvastatin	NN	B-TREATMENT
40	CD	O
mg	NN	O
po	NN	O
qhs	NN	O

asa	RB	B-TREATMENT
81	CD	O
mg	NNS	O
po	JJ	O
daily	JJ	O

mvi	NN	B-TREATMENT

tylenol	NN	B-TREATMENT
prn	NN	O

1.	CD	O
docusate	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
100	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
tid	NN	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
constipation	NN	B-PROBLEM
.	.	O

2.	CD	O
levothyroxine	JJ	B-TREATMENT
100	CD	O
mcg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

3.	CD	O
duloxetine	JJ	B-TREATMENT
20	CD	O
mg	NN	O
capsule	NN	O
,	,	O
delayed	VBN	O
release(	NN	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
qhs	NN	O
(	(	O
once	RB	O
a	DT	O
day	NN	O
(	(	O
at	IN	O
bedtime	NN	O
)	)	O
)	)	O
.	.	O

4.	CD	O
lactulose	JJ	B-TREATMENT
10	CD	O
g	NN	O
/	VBD	O
15	CD	O
ml	NN	O
syrup	NN	O
sig	NN	O
:	:	O
thirty	NN	O
(	(	O
30	CD	O
)	)	O
ml	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

5.	CD	O
fluticasone	NN	B-TREATMENT
-	:	O
salmeterol	NN	B-TREATMENT
100-50	JJ	O
mcg	NN	O
/	NNP	O
dose	JJ	O
disk	NN	O
with	IN	O
device	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
disk	NN	O
with	IN	O
device	JJ	O
inhalation	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

6.	CD	O
tiotropium	NN	B-TREATMENT
bromide	NN	I-TREATMENT
18	CD	O
mcg	NN	O
capsule	NN	O
,	,	O
w/	JJ	O
inhalation	NN	B-TREATMENT
device	NN	I-TREATMENT
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
cap	NN	O
inhalation	NN	O
daily	RB	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

7.	CD	O
amiodarone	NN	B-TREATMENT
200	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

8.	CD	O
calcium	NN	B-TREATMENT
acetate	NN	I-TREATMENT
667	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
tid	NN	O
w/meals	NNS	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
with	IN	O
meals	NNS	O
)	)	O
.	.	O

9.	CD	O
oxycodone	CD	B-TREATMENT
-	:	O
acetaminophen	NN	B-TREATMENT
5-325	JJ	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
1-2	JJ	O
tablets	NNS	O
po	JJ	O
q4-6h	JJ	O
(	(	O
every	DT	O
4	CD	O
to	TO	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
pain	NN	B-PROBLEM
.	.	O

10.	CD	O
multivitamin	NN	B-TREATMENT
capsule	NN	I-TREATMENT
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
cap	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

11.	CD	O
miconazole	JJ	B-TREATMENT
nitrate	RB	I-TREATMENT
2	CD	O
%	NN	O
powder	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
appl	RB	O
topical	JJ	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

12.	CD	O
aspirin	JJ	B-TREATMENT
81	CD	O
mg	JJ	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

13.	CD	O
simvastatin	JJ	B-TREATMENT
40	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
qhs	NN	O
(	(	O
once	RB	O
a	DT	O
day	NN	O
(	(	O
at	IN	O
bedtime	NN	O
)	)	O
)	)	O
.	.	O

14.	CD	O
pantoprazole	JJ	B-TREATMENT
40	CD	O
mg	JJ	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

15.	CD	O
lidocaine	JJ	B-TREATMENT
5	CD	O
%(	JJ	O
700	CD	O
mg	NN	O
/	NNP	O
patch	NN	O
)	)	O
adhesive	JJ	O
patch	NN	O
,	,	O
medicated	VBN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
adhesive	JJ	O
patch	NN	O
,	,	O
medicated	VBD	O
topical	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

16.	CD	O
furosemide	JJ	B-TREATMENT
40	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

17.	CD	O
ferrous	JJ	B-TREATMENT
sulfate	NN	I-TREATMENT
325	CD	O
(	(	O
65	CD	O
)	)	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

18.	CD	O
epoetin	JJ	B-TREATMENT
alfa	RB	I-TREATMENT
4,000	CD	O
unit/ml	JJ	O
solution	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
injection	NN	O
qmowefr	NN	O
(	(	O
monday	JJ	O
-	:	O
wednesday	JJ	O
-	:	O
friday	NN	O
)	)	O
.	.	O

19.	CD	O
spironolactone	NN	B-TREATMENT
25	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

20.	CD	O
albuterol	NN	B-TREATMENT
90	CD	O
mcg/actuation	NN	O
aerosol	NN	O
sig	NN	O
:	:	O
4-6	JJ	O
puffs	NNS	O
inhalation	NN	O
q6h	NN	O
(	(	O
every	DT	O
6	CD	O
hours	NNS	O
)	)	O
.	.	O

21.	CD	O
metoprolol	JJ	B-TREATMENT
succinate	NN	I-TREATMENT
25	CD	O
mg	NN	O
tablet	NN	O
sustained	VBD	O
release	NN	O
24hr	CD	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
sustained	VBD	O
release	NN	O
24hr	CD	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

22.	CD	O
finasteride	JJ	B-TREATMENT
5	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

23.	CD	O
gabapentin	NN	B-TREATMENT
300	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

24.	CD	O
warfarin	JJ	B-TREATMENT
1	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
at	IN	O
bedtime	NN	O
:	:	O
please	NN	O
monitor	NN	O
inr	NN	B-TEST
with	IN	O
goal	NN	O
02-24	NN	O
.	.	O

congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
exacerbation	NN	I-PROBLEM

coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM

hypertension	NN	B-PROBLEM

type	NN	B-PROBLEM
2	CD	I-PROBLEM
diabetes	NNS	I-PROBLEM
mellitus	VBP	I-PROBLEM

chronic	JJ	B-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM

the	DT	O
patient	NN	O
was	VBD	O
discharged	VBN	O
hemodynamicallly	RB	O
stable	JJ	O
,	,	O
afebrile	JJ	B-PROBLEM
with	IN	O
appropriate	JJ	O
follow	VBP	O
up	RP	O
.	.	O

during	IN	O
this	DT	O
admission	NN	O
you	PRP	O
have	VBP	O
been	VBN	O
treated	VBN	O
for	IN	O
a	DT	B-PROBLEM
chf	JJ	I-PROBLEM
exacerbation	NN	I-PROBLEM
.	.	O

1.	CD	O
please	JJ	O
take	VB	O
all	DT	B-TREATMENT
medications	NNS	I-TREATMENT
as	IN	O
prescribed	NN	O
.	.	O

3.	CD	O
please	NN	O
call	VB	O
your	PRP$	O
pcp	NN	O
c.	NN	O
lettinga	NN	O
or	CC	O
seek	VB	O
medical	JJ	O
attention	NN	O
in	IN	O
the	DT	O
juan	NN	O
if	IN	O
you	PRP	O
experience	VBP	O
worsening	VBG	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
dizziness	NN	B-PROBLEM
,	,	O
passing	VBG	B-PROBLEM
out	RP	I-PROBLEM
,	,	O
or	CC	O
any	DT	B-PROBLEM
other	JJ	I-PROBLEM
concerning	NN	I-PROBLEM
symptom	NN	I-PROBLEM
.	.	O

medicine	NN	B-TREATMENT

sulfonamides	NNS	B-TREATMENT

transfer	NN	O
from	IN	O
athol	JJ	O
memorial	JJ	O
hospital	NN	O
for	IN	O
acute	NN	O
on	IN	O
chronic	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
distress	NN	I-PROBLEM
.	.	O

lumbar	NN	B-TEST
puncture	NN	I-TEST
on	IN	O
08-16	NN	O

mr.	NN	O
lockley	NN	O
is	VBZ	O
a	DT	O
73	CD	O
yo	NN	O
male	NN	O
with	IN	O
a	DT	O
complicated	VBN	O
past	JJ	O
medical	JJ	O
history	NN	O
,	,	O
recently	RB	O
discharged	VBN	O
from	IN	O
st.	NN	O
margaret	NN	O
's	POS	O
center	NN	O
for	IN	O
women	NNS	O
&	CC	O
infants	NNS	O
on	IN	O
08-02	NN	O
following	VBG	O
a	DT	O
prolonged	JJ	O
admission	NN	O
for	IN	O
stemi	NN	B-PROBLEM
,	,	O
respiratory	JJ	B-PROBLEM
failure	NN	I-PROBLEM
felt	VBD	O
secondary	JJ	O
to	TO	O
pulmonary	JJ	B-PROBLEM
edema	NN	I-PROBLEM
requiring	VBG	O
intubation	NN	O
and	CC	O
subsequent	JJ	B-TREATMENT
tracheostomy	NN	I-TREATMENT
02-22	JJ	O
failure	NN	B-PROBLEM
to	TO	I-PROBLEM
wean	VB	I-PROBLEM
,	,	O
sepsis	NN	B-PROBLEM
and	CC	O
c.difficile	NN	B-PROBLEM
colitis	NN	I-PROBLEM
treated	VBN	O
with	IN	O
vancomycin	NN	B-TREATMENT
and	CC	O
flagyl	NN	B-TREATMENT
with	IN	O
a	DT	O
course	NN	O
of	IN	O
levophed	JJ	B-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
discharged	VBN	O
to	TO	O
athol	VB	O
memorial	JJ	O
hospital	NN	O
for	IN	O
continued	JJ	B-TREATMENT
weaning	NN	I-TREATMENT
.	.	O

per	IN	O
dr.	NN	O
john	NN	O
c.	NN	O
corrigan	JJ	O
mental	JJ	O
health	NN	O
center	NN	O
,	,	O
patient	NN	O
remained	VBD	O
ventilator	JJ	B-PROBLEM
dependent	NN	I-PROBLEM
,	,	O
intermittently	RB	O
on	IN	O
ps	NN	B-TREATMENT
20/5	CD	O
and	CC	O
back	RB	O
on	IN	O
ac	NN	B-TREATMENT
15/5/500/0.35	CD	O
on	IN	O
08-08	NN	O
.	.	O

at	IN	O
osh	RBS	O
,	,	O
sputum	NN	B-TEST
cultures	NNS	I-TEST
grew	VBD	O
pseudomonas	NNS	B-PROBLEM
and	CC	O
mrsa	NN	B-PROBLEM
,	,	O
and	CC	O
he	PRP	O
was	VBD	O
restarted	VBN	O
on	IN	O
zosyn	NN	B-TREATMENT
(	(	O
08-08	JJ	O
)	)	O
and	CC	O
vancomycin	$	B-TREATMENT
(	(	O
08-09	JJ	O
).	NN	O

he	PRP	O
completed	VBD	O
his	PRP$	O
course	NN	O
of	IN	O
vancomycin	NN	B-TREATMENT
on	IN	O
2017-08-10	JJ	O
.	.	O

however	RB	O
,	,	O
today	NN	O
around	IN	O
17:45	CD	O
,	,	O
while	IN	O
being	VBG	O
moved	VBN	O
by	IN	O
the	DT	O
nursing	NN	O
staff	NN	O
,	,	O
mr.	NN	O
lockley	NNP	O
bosche	NN	O
started	VBD	O
coughing	VBG	B-PROBLEM
.	.	O

he	PRP	O
then	RB	O
became	VBD	O
dusky	JJ	B-PROBLEM
and	CC	O
cyanotic	JJ	B-PROBLEM
,	,	O
and	CC	O
stopped	VBD	B-PROBLEM
breathing	VBG	I-PROBLEM
on	IN	O
his	PRP$	O
own	JJ	O
.	.	O

a	DT	O
code	NN	O
was	VBD	O
called	VBN	O
,	,	O
+	NNP	O
pulse	NN	B-TEST
.	.	O

patient	NN	O
placed	VBN	O
on	IN	O
fio2	JJ	B-TREATMENT
100%	CD	O
.	.	O

vitals	NNS	B-TEST
reportedly	RB	O
hr	VBD	B-TEST
88-98	CD	O
,	,	O
bp	VBZ	B-TEST
150/80	CD	O
.	.	O

abg	RB	B-TEST
done	VBN	O
on	IN	O
fio2	NN	B-TREATMENT
100%	CD	O
7.36/66/417/98%	CD	O
.	.	O

at	IN	O
vencor	JJ	O
hospital	NN	O
,	,	O
bp	NN	B-PROBLEM
dropped	VBD	I-PROBLEM
to	TO	O
90	CD	O
,	,	O
and	CC	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
ns	NN	B-TREATMENT
ivf	NN	I-TREATMENT
,	,	O
with	IN	O
improvement	NN	O
in	IN	O
bp	NN	B-TEST
.	.	O

ekg	NN	B-TEST
without	IN	O
acute	JJ	B-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
st.	VB	O
margaret	NN	O
's	POS	O
center	NN	O
for	IN	O
women	NNS	O
&	CC	O
infants	NNS	O
john	NN	O
for	IN	O
further	JJ	B-TREATMENT
management	NN	I-TREATMENT
on	IN	O
ac	NN	B-TEST
,	,	O
rr	NN	B-TEST
15	CD	O
,	,	O
peep	RB	B-TEST
5	CD	O
,	,	O
vt	FW	B-TEST
500	CD	O
,	,	O
fi02	RB	B-TEST
1.0	CD	O
.	.	O

in	IN	O
john	NN	O
,	,	O
bp	NN	B-TEST
80/60	CD	O
,	,	O
hr	VBD	B-TEST
80	CD	O
.	.	O

continued	VBN	O
on	IN	O
ivf	NN	B-TREATMENT
(	(	O
received	VBN	O
total	JJ	O
2300	CD	O
cc	NN	O
)	)	O
,	,	O
with	IN	O
improved	JJ	O
bp	NN	B-TEST
to	TO	O
sbp	VB	B-TEST
105-118	JJ	O
.	.	O

stool	NN	B-TEST
sent	VBD	O
for	IN	O
c.diff	NN	B-PROBLEM
and	CC	O
given	VBN	O
flagyl	NNS	B-TREATMENT
500	CD	O
mg	NNS	O
po	JJ	O
x	VBP	O
1	CD	O
dose	NN	O
.	.	O

1.	CD	O
non-small	JJ	B-PROBLEM
cell	NN	I-PROBLEM
lung	NN	I-PROBLEM
cancer	NN	I-PROBLEM
s/p	NN	B-TREATMENT
xrt	NNP	I-TREATMENT
and	CC	O
chemotherapy	NN	B-TREATMENT
in	IN	O
french	JJ	O
guiana	NN	O
,	,	O
s/p	RB	B-TREATMENT
right	JJ	I-TREATMENT
pneumonectomy	NN	I-TREATMENT
in	IN	O
2016-09-21	JJ	O
for	IN	O
recurrence	NN	B-PROBLEM
.	.	O

chronic	JJ	B-PROBLEM
left	VBD	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

2.	CD	O
sss	NN	B-PROBLEM
status	NN	B-TREATMENT
post	NN	I-TREATMENT
pm/icd	NN	I-TREATMENT
placement	NN	I-TREATMENT

3.	CD	O
copd/bronchiectasis	NN	B-PROBLEM

4.	CD	O
hypertension	NN	B-PROBLEM

5.	CD	O
cad	NN	B-PROBLEM
,	,	O
with	IN	O
known	VBN	O
to	TO	O
rca	VB	O
.	.	O

6.	CD	O
chf	NN	B-PROBLEM
with	IN	O
ef	JJ	B-TEST
25%	CD	O
on	IN	O
last	JJ	B-TEST
echo	NN	I-TEST
on	IN	O
2017-07-19	JJ	O

7.	CD	O
bph	NN	B-PROBLEM

8.	CD	O
depression	NN	B-PROBLEM

9.	CD	O
left	VBD	B-PROBLEM
femoral	JJ	I-PROBLEM
av	JJ	I-PROBLEM
fistula	NN	I-PROBLEM
2017-04-19	JJ	O

10.	CD	O
recent	JJ	B-PROBLEM
mrsa	NN	I-PROBLEM
pneumonia	NN	I-PROBLEM
and	CC	O
sepsis	NN	B-PROBLEM
2017-07-21	JJ	O
,	,	O
treated	VBN	O
with	IN	O
vancomycin	NN	B-TREATMENT

11.	CD	O
c.	NN	B-PROBLEM
difficile	NN	I-PROBLEM
colitis	NN	I-PROBLEM
treated	VBN	O
with	IN	O
flagyl	NN	B-TREATMENT
(	(	O
completed	VBN	O
08-10	NN	O
)	)	O

12.	CD	O
status	NN	B-TREATMENT
post	NN	I-TREATMENT
peg	NN	I-TREATMENT
tube	NN	I-TREATMENT
placement	NN	I-TREATMENT
2017-07-21	JJ	O

13.	CD	O
status	NN	B-TREATMENT
post	NN	I-TREATMENT
tracheostomy	IN	I-TREATMENT
2017-07-21	JJ	O
02-22	JJ	O
failure	NN	B-PROBLEM
to	TO	I-PROBLEM
wean	VB	I-PROBLEM

14.	CD	O
status	NN	B-TREATMENT
post	NN	I-TREATMENT
partial	JJ	I-TREATMENT
colectomy	NN	I-TREATMENT
1972	CD	O

opens	NNS	O
eyes	NNS	O
spontaneously	RB	O
,	,	O
withdraws	NNS	O
to	TO	O
painful	JJ	B-TEST
stimulus	NN	I-TEST
.	.	O

bp	JJ	B-TEST
90s-118/47-59	CD	O
,	,	O
hr	JJR	B-TEST
80-90s	CD	O
.	.	O

ac	NN	B-TEST
,	,	O
rr	NN	B-TEST
15	CD	O
,	,	O
peep	RB	B-TEST
5	CD	O
,	,	O
vt	FW	B-TEST
500	CD	O
cc	NN	O
,	,	O
fio2	JJ	B-TEST
1.0	CD	O
.	.	O

intubated	VBN	B-TREATMENT
,	,	O
opens	VBZ	O
eyes	NNS	O
,	,	O
responds	VBZ	O
to	TO	O
painful	JJ	B-TEST
stimulus	NN	I-TEST
.	.	O

pupils	NNS	B-PROBLEM
minimally	RB	I-PROBLEM
reactive	VBP	I-PROBLEM
.	.	O

sclera	NN	B-PROBLEM
anicteric	NN	I-PROBLEM
.	.	O

unable	JJ	O
to	TO	O
assess	VB	O
jvp	NN	B-TEST
.	.	O

bronchial	JJ	B-PROBLEM
breathing	NN	I-PROBLEM
over	IN	I-PROBLEM
right	JJ	I-PROBLEM
hemithorax	NN	I-PROBLEM
.	.	O

ronchorous	JJ	B-PROBLEM
breath	NN	I-PROBLEM
sounds	VBZ	I-PROBLEM
left	JJ	I-PROBLEM
chest	NN	I-PROBLEM
.	.	O

limited	JJ	B-TEST
examination	NN	I-TEST
.	.	O

+	JJ	O
s4	NN	B-PROBLEM
.	.	O

no	DT	O
murmur	NN	B-PROBLEM
appreciated	VBD	O
.	.	O

peg	NN	B-TREATMENT
in	IN	O
place	NN	O
,	,	O
site	NN	O
without	IN	O
drainage	NN	B-PROBLEM
.	.	O

bs	NN	O
present	NN	O
,	,	O
hypoactive	NN	B-PROBLEM
.	.	O

no	DT	O
grimacing	VBG	B-PROBLEM
with	IN	O
palpation	NN	B-TEST
.	.	O

foley	NN	B-TREATMENT
in	IN	O
place	NN	O
.	.	O

2+	CD	B-PROBLEM
edema	JJ	I-PROBLEM
both	DT	I-PROBLEM
upper	JJ	I-PROBLEM
extremities	NNS	I-PROBLEM
,	,	O
sacral	JJ	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

cool	JJ	B-PROBLEM
extremities	NNS	I-PROBLEM
.	.	O

limited	JJ	B-TEST
examination	NN	I-TEST
.	.	O

withdraws	NNS	O
to	TO	O
painful	JJ	B-TEST
stimulus	NN	I-TEST
.	.	O

wbc	SYM	B-TEST
-	:	O
4.9	CD	O
rbc	NN	B-TEST
-	:	O
2.92	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
8.8	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
26.2	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
90	CD	O
mch	SYM	B-TEST
-	:	O
30.1	CD	O
mchc	SYM	B-TEST
-	:	O
33.5	CD	O
rdw	NN	B-TEST
-	:	O
18.5	CD	O
*	NN	O
neuts	NNS	B-TEST
-	:	O
86.5	CD	O
*	NN	O
lymphs	SYM	B-TEST
-	:	O
7.5	CD	O
*	JJ	O
monos	NNS	B-TEST
-	:	O
4.7	CD	O
eos	SYM	B-TEST
-	:	O
1.2	CD	O
basos	SYM	B-TEST
-	:	O
0.1	CD	O
plt	NN	B-TEST
count	NN	I-TEST
-	:	O
145	CD	O
*	NN	O
glucose	VBD	B-TEST
-	:	O
91	CD	O
urea	JJ	B-TEST
n	SYM	I-TEST
-	:	O
21	CD	O
*	NN	O
creat	NN	B-TEST
-	:	O
0.6	CD	O
sodium	NN	B-TEST
-	:	O
143	CD	O
potassium	NN	B-TEST
-	:	O
4.2	CD	O
chloride	NN	B-TEST
-	:	O
106	CD	O
total	JJ	B-TEST
co2	NN	I-TEST
-	:	O
32	CD	O
anion	NN	B-TEST
gap	NN	I-TEST
-	:	O
9	CD	O
lactate	JJ	B-TEST
-	:	O
1.4	CD	O
k+	SYM	B-TEST
-	:	O
3.9	CD	O

abg	NN	B-TEST
:	:	O

2017-08-14	JJ	O
07:30	CD	O
pm	NN	O
type	NN	O
-	:	O
art	NN	B-TEST
po2	VBZ	I-TEST
-	:	O
468	CD	O
*	NN	O
pco2	NN	B-TEST
-	:	O
44	CD	O
ph	NN	B-TEST
-	:	O
7.50	CD	O
*	JJ	O
total	NN	B-TEST
co2	NN	I-TEST
-	:	O
36	CD	O
*	JJ	O
base	NN	B-TEST
xs	NNP	I-TEST
-	:	O
10	CD	O
intubated	JJ	B-TREATMENT
-	:	O
intubated	JJ	B-TREATMENT

ekg	NN	B-TEST
(	(	O
at	IN	O
athol	RB	O
memorial	JJ	O
hospital	NN	O
,	,	O
17:11	CD	O
)	)	O
:	:	O

atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
,	,	O
occasional	JJ	B-TREATMENT
v-paced	JJ	I-TREATMENT
,	,	O
rate	NN	B-TEST
74	CD	O
.	.	O

old	JJ	B-PROBLEM
twi	JJ	I-PROBLEM
v4-6	NN	I-PROBLEM
.	.	O

ekg	NN	B-TEST
in	IN	O
john	NN	O
:	:	O

afib	NN	B-PROBLEM
,	,	O
occasional	JJ	B-TREATMENT
v-paced	JJ	I-TREATMENT
,	,	O
rate	NN	B-TEST
83	CD	O
bpm	NN	O
.	.	O

long	RB	B-PROBLEM
qt	JJ	I-PROBLEM
interval	NN	I-PROBLEM
(	(	O
qtc	JJ	B-TEST
462	CD	O
ms	NN	O
).	NN	O

st	JJ	B-PROBLEM
depressions	NNS	I-PROBLEM
v4	VBP	I-PROBLEM
,	,	I-PROBLEM
5	CD	I-PROBLEM
.	.	O

mild	JJ	B-PROBLEM
st	JJ	I-PROBLEM
elevation	NN	I-PROBLEM
in	IN	I-PROBLEM
v3	NN	I-PROBLEM
.	.	O

old	JJ	B-PROBLEM
twi	JJ	I-PROBLEM
v4-6	NN	I-PROBLEM
.	.	O

2017-08-14	JJ	O
cxr	NN	B-TEST
:	:	O

ett	NN	B-TREATMENT
in	IN	O
correct	JJ	O
position	NN	O
.	.	O

pm	NN	B-TREATMENT
wires	NNS	I-TREATMENT
in	IN	O
good	JJ	O
position	NN	O
.	.	O

s/p	RB	B-TREATMENT
right	JJ	I-TREATMENT
pneumonectomy	NN	I-TREATMENT
.	.	O

blunting	NN	B-PROBLEM
of	IN	I-PROBLEM
left	NN	I-PROBLEM
cpa	NN	I-PROBLEM
likely	JJ	O
effusion	NN	B-PROBLEM
.	.	O

new	JJ	B-PROBLEM
lower	JJR	I-PROBLEM
left	JJ	I-PROBLEM
lateral	JJ	I-PROBLEM
cw	NN	I-PROBLEM
opacity	NN	I-PROBLEM
,	,	O
likely	RB	O
loculated	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
fluid	NN	I-PROBLEM
.	.	O

2017-07-19	JJ	O
echo	NN	B-TEST
:	:	O

left-to-right	JJ	B-PROBLEM
shunt	NN	I-PROBLEM
across	IN	I-PROBLEM
the	DT	I-PROBLEM
interatrial	JJ	I-PROBLEM
septum	NN	I-PROBLEM
.	.	O

lvef	RB	B-TEST
25%	CD	O
.	.	O

resting	VBG	B-TEST
wma	JJ	I-TEST
include	VBP	O
mid	NNS	B-PROBLEM
to	TO	I-PROBLEM
distal	JJ	I-PROBLEM
septal	JJ	I-PROBLEM
akinesis	NN	I-PROBLEM
,	,	O
apical	JJ	B-PROBLEM
akinesis	NN	I-PROBLEM
,	,	O
inferior	JJ	B-PROBLEM
akinesis/hypokinesis	NN	I-PROBLEM
,	,	O
and	CC	O
mid	NN	B-PROBLEM
to	TO	I-PROBLEM
distal	JJ	I-PROBLEM
anterolateral	JJ	I-PROBLEM
hypokinesis	NN	I-PROBLEM
/	JJ	O
akinesis	NN	B-PROBLEM
.	.	O

no	DT	O
definite	JJ	O
apical	JJ	B-PROBLEM
thrombus	NN	I-PROBLEM
seen	VBN	O
(	(	O
cannot	JJ	O
exclude	NN	O
).	NN	O

01-22+	JJ	O
ar	NN	B-PROBLEM
.	.	O

trivial	JJ	B-PROBLEM
mr	NN	I-PROBLEM
.	.	O

1+	CD	O
tr	NN	B-PROBLEM
.	.	O

2017-08-16	JJ	O
ct	NN	B-TEST
head	NN	I-TEST
:	:	O

new	JJ	B-PROBLEM
rounded	VBD	I-PROBLEM
low-density	JJ	I-PROBLEM
area	NN	I-PROBLEM
measuring	VBG	O
2.5	CD	O
cm	NN	O
in	IN	O
left	JJ	O
basal	NN	O
ganglia	NNS	O
,	,	O
which	WDT	O
partially	RB	O
extends	VBZ	O
to	TO	O
the	DT	O
left	NN	O
thalamus	NN	O
,	,	O
probably	RB	O
representing	VBG	O
subacute	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

on	IN	O
this	DT	B-TEST
head	NN	I-TEST
ct	NN	I-TEST
without	IN	O
contrast	NN	O
,	,	O
the	DT	B-TEST
evaluation	NN	I-TEST
is	VBZ	O
limited	VBN	O
.	.	O

2017-08-16	JJ	O
cta	NN	B-TEST
chest	NN	I-TEST
:	:	O

no	DT	O
evidence	NN	O
for	IN	O
pulmonary	JJ	B-PROBLEM
embolism	NN	I-PROBLEM
.	.	O

findings	NNS	O
consistent	NN	O
with	IN	O
failure	NN	B-PROBLEM
or	CC	O
fluid	NN	B-PROBLEM
overload	NN	I-PROBLEM
.	.	O

development	NN	O
of	IN	O
small	JJ	B-PROBLEM
loculated	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
fluid	NN	I-PROBLEM
collection	NN	I-PROBLEM
along	IN	I-PROBLEM
the	DT	I-PROBLEM
periphery	NN	I-PROBLEM
of	IN	O
the	DT	O
left	NN	O
major	JJ	O
fissure	NN	O
or	CC	O
so-called	JJ	B-PROBLEM
pseudotumor	NN	I-PROBLEM
,	,	O
consistent	JJ	O
with	IN	O
the	DT	B-TEST
recent	JJ	I-TEST
chest	NN	I-TEST
x-ray	NN	I-TEST
.	.	O

unchanged	JJ	O
appearance	NN	O
of	IN	O
right	JJ	B-TREATMENT
pneumonectomy	NN	I-TREATMENT
.	.	O

2017-08-16	JJ	O
echo	NN	B-TEST
:	:	O

overall	JJ	B-TEST
lvef	NN	I-TEST
is	VBZ	O
difficult	JJ	O
to	TO	O
assess	VB	O
due	JJ	O
to	TO	O
poor	JJ	O
echo	JJ	B-TEST
windows	NNS	I-TEST
although	IN	O
the	DT	B-TEST
basal	NN	I-TEST
lv	VBZ	I-TEST
appeas	JJ	O
hyperdynamic	NN	B-PROBLEM
without	IN	O
regional	JJ	B-PROBLEM
contraction	NN	I-PROBLEM
abnormality	NN	I-PROBLEM
(	(	O
suspect	JJ	O
significant	JJ	O
improvement	NN	O
compared	VBN	O
to	TO	O
prior	VB	B-TEST
study	NN	I-TEST
dated	VBN	O
2017-07-18	CD	O
).	NNS	O

no	DT	O
masses	NNS	B-PROBLEM
or	CC	O
thrombi	NNS	B-PROBLEM
are	VBP	O
seen	VBN	O
in	IN	O
the	DT	O
left	JJ	O
ventricle	NN	O
(	(	O
due	JJ	O
to	TO	O
poor	JJ	O
echo	JJ	B-TEST
windows	NNS	I-TEST
cannot	VBP	O
fully	RB	O
exclude	VBP	O
).	NNS	O

the	DT	O
ascending	VBG	O
aorta	NN	O
is	VBZ	O
mildly	RB	B-PROBLEM
dilated	VBN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
aortic	JJ	B-PROBLEM
valve	NN	I-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

mild	NN	B-PROBLEM
(	(	I-PROBLEM
1+	CD	I-PROBLEM
)	)	I-PROBLEM
aortic	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
.	.	O

trivial	JJ	B-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
.	.	O

the	DT	B-TEST
left	NN	I-TEST
ventricular	JJ	I-TEST
inflow	JJ	I-TEST
pattern	NN	I-TEST
suggests	VBZ	O
impaired	JJ	B-PROBLEM
relaxation	NN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
pericardial	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

there	EX	O
are	VBP	O
no	DT	O
echocardiographic	JJ	B-TEST
signs	NNS	I-TEST
of	IN	O
tamponade	NN	B-PROBLEM

2017-08-17	JJ	O
eeg	NN	B-TEST
:	:	O

markedly	RB	B-PROBLEM
abnormal	JJ	I-PROBLEM
portable	JJ	I-PROBLEM
eeg	NN	I-PROBLEM
due	JJ	O
to	TO	O
the	DT	B-PROBLEM
voltage	NN	I-PROBLEM
suppression	NN	I-PROBLEM
over	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
hemisphere	NN	I-PROBLEM
and	CC	O
due	JJ	O
to	TO	O
the	DT	B-PROBLEM
bursts	NNS	I-PROBLEM
of	IN	I-PROBLEM
generalized	JJ	I-PROBLEM
slowing	NN	I-PROBLEM
and	CC	O
right	NN	B-PROBLEM
hemisphere	RB	I-PROBLEM
slowing	VBG	I-PROBLEM
.	.	O

the	DT	B-PROBLEM
first	JJ	I-PROBLEM
abnormality	NN	I-PROBLEM
raises	VBZ	O
the	DT	O
possibility	NN	O
of	IN	O
material	NN	B-PROBLEM
(	(	I-PROBLEM
such	JJ	I-PROBLEM
as	IN	I-PROBLEM
subdural	JJ	I-PROBLEM
fluid	NN	I-PROBLEM
)	)	I-PROBLEM
interposed	VBD	I-PROBLEM
between	IN	I-PROBLEM
the	DT	I-PROBLEM
brain	NN	I-PROBLEM
and	CC	O
recording	VBG	O
electrodes	NNS	O
or	CC	O
widespread	JJ	B-PROBLEM
cortical	JJ	I-PROBLEM
dysfunction	NN	I-PROBLEM
on	IN	I-PROBLEM
that	DT	I-PROBLEM
side	NN	I-PROBLEM
.	.	O

the	DT	B-PROBLEM
generalized	JJ	I-PROBLEM
slowing	NN	I-PROBLEM
indicates	VBZ	O
a	DT	B-PROBLEM
non	NN	I-PROBLEM
specific	JJ	I-PROBLEM
dysfunction	NN	I-PROBLEM
in	IN	I-PROBLEM
midline	JJ	I-PROBLEM
structures	NNS	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
also	RB	O
evidence	NN	O
of	IN	O
subcortical	JJ	B-PROBLEM
dysfunction	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
side	NN	I-PROBLEM
.	.	O

no	DT	O
epileptiform	NN	B-PROBLEM
features	NNS	I-PROBLEM
were	VBD	O
seen	VBN	O
.	.	O

2017-08-17	JJ	O
stool	NN	B-TEST
clostridium	NN	I-TEST
difficile	NN	I-TEST
toxin	NN	I-TEST
assay	VBP	I-TEST
-	:	O
pending	NN	O

2017-08-16	JJ	O
csf	NN	O
;	:	O
spinal	JJ	B-TEST
fluid	NN	I-TEST
gram	NN	I-TEST
stain	VBP	I-TEST
-	:	O
neg	NN	O
fluid	JJ	B-TEST
culture	NN	I-TEST
-	:	O
neg	NN	O
;	:	O
fungal	JJ	B-TEST
culture	NN	I-TEST
-	:	O
pending	NN	O
;	:	O
acid	CC	B-TEST
fast	JJ	I-TEST
culture	NN	I-TEST
-	:	O
pending	NN	O
;	:	O
viral	JJ	B-TEST
culture	NN	I-TEST
-	:	O
pending	NN	O

2017-08-15	JJ	O
sputum	NN	B-TEST
culture	NN	I-TEST
-	:	O
preliminary	JJ	O
{	(	O
pseudomonas	JJ	B-PROBLEM
aeruginosa	NN	I-PROBLEM
}	)	O

2017-08-15	JJ	O
blood	NN	B-TEST
culture	NN	I-TEST
ngtd	NN	O

2017-08-15	JJ	O
urine	JJ	B-TEST
culture	NN	I-TEST
-	:	O
final	JJ	O

2017-08-15	JJ	O
blood	NN	B-TEST
culture	NN	I-TEST
ngtd	NN	O

mr.	NN	O
lockley	NN	O
was	VBD	O
admitted	VBN	O
with	IN	O
respiratory	JJ	B-PROBLEM
failure	NN	I-PROBLEM
,	,	O
thought	VBN	O
to	TO	O
be	VB	O
related	VBN	O
to	TO	O
mucus	VB	B-PROBLEM
plugging	NN	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
a	DT	B-PROBLEM
pseudomonal	JJ	I-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

however	RB	O
,	,	O
the	DT	O
issue	NN	O
that	WDT	O
dominated	VBD	O
the	DT	O
admission	NN	O
was	VBD	O
his	PRP$	B-PROBLEM
recent	JJ	I-PROBLEM
acute	JJ	I-PROBLEM
decline	NN	I-PROBLEM
in	IN	I-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
thoroughly	RB	O
evaluated	VBN	O
by	IN	O
neurology	NN	O
and	CC	O
underwent	JJ	O
head	NN	B-TEST
ct	NN	I-TEST
,	,	O
mri	NN	B-TEST
,	,	O
lp	NN	B-TEST
,	,	O
and	CC	O
eeg	NN	B-TEST
.	.	O

this	DT	B-TEST
work-up	JJ	I-TEST
demonstrated	VBD	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
left	NN	I-PROBLEM
basal	NN	I-PROBLEM
ganglia	JJ	I-PROBLEM
infarct	NN	I-PROBLEM
,	,	O
likely	JJ	O
cardioembolic	NN	B-PROBLEM
.	.	O

however	RB	O
,	,	O
they	PRP	O
felt	VBD	O
this	DT	O
event	NN	O
could	MD	O
not	RB	O
account	VB	O
for	IN	O
his	PRP$	B-PROBLEM
new	JJ	I-PROBLEM
,	,	I-PROBLEM
severe	JJ	I-PROBLEM
global	JJ	I-PROBLEM
deficit	NN	I-PROBLEM
;	:	O
this	DT	O
was	VBD	O
thought	VBN	O
to	TO	O
be	VB	O
secondary	JJ	O
to	TO	O
a	DT	B-PROBLEM
more	RBR	I-PROBLEM
pervasive	JJ	I-PROBLEM
process	NN	I-PROBLEM
,	,	O
likely	RB	O
anoxic	JJ	B-PROBLEM
encephalopathy	NNS	I-PROBLEM
,	,	O
for	IN	O
which	WDT	O
the	DT	O
prognosis	NN	O
is	VBZ	O
extremely	RB	O
grim	JJ	O
.	.	O

the	DT	O
end	NN	O
result	NN	O
of	IN	O
these	DT	O
discussion	NN	O
was	VBD	O
that	IN	O
the	DT	O
patient	NN	O
's	POS	O
wishes	NNS	O
would	MD	O
not	RB	O
be	VB	O
consistent	JJ	O
with	IN	O
this	DT	O
new	JJ	O
level	NN	O
of	IN	O
functioning	VBG	O
from	IN	O
which	WDT	O
he	PRP	O
had	VBD	O
little	JJ	O
hope	NN	O
of	IN	O
recovery	NN	O
;	:	O
the	DT	O
family	NN	O
decided	VBD	O
to	TO	O
make	VB	O
him	PRP	O
comfort	VB	B-TREATMENT
measures	NNS	I-TREATMENT
only	RB	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
disconnected	VBN	O
from	IN	O
the	DT	B-TREATMENT
ventilator	NN	I-TREATMENT
and	CC	O
all	DT	B-TREATMENT
medications	NNS	I-TREATMENT
beyond	IN	O
a	DT	B-TREATMENT
morphine	JJ	I-TREATMENT
drip	NN	I-TREATMENT
were	VBD	O
stopped	VBN	O
,	,	O
and	CC	O
he	PRP	O
expired	VBD	O
shortly	RB	O
thereafter	RB	O
.	.	O

jevity	NN	B-TREATMENT
1.2	CD	O
65	CD	O
ml	NN	O
/	FW	O
hour	NN	O
continuous	JJ	O
with	IN	O
water	NN	O
240	CD	O
cc	NN	O
q	NN	O
8	CD	O
hours	NNS	O

lasix	RB	B-TREATMENT
40	CD	O
mg	NNS	O
iv	JJ	O
qam	NN	O
(	(	O
given	VBN	O
08-14	NN	O
)	)	O

vancomycin	NN	B-TREATMENT
1	CD	O
gm	NN	O
iv	NN	O
q	VBD	O
36	CD	O
hours	NNS	O
(	(	O
last	JJ	O
dose	NN	O
at	IN	O
2000	CD	O
on	IN	O
08-13	NN	O
)	)	O
.	.	O

asa	RB	B-TREATMENT
325	CD	O
mg	NNS	O
po	JJ	O
qd	NN	O

lansoprazole	JJ	B-TREATMENT
30	CD	O
mg	NN	O
po	NN	O
qam	NN	O

heparin	NN	B-TREATMENT
5000	CD	O
units	NNS	O
sc	VBD	O
tid	NN	O

zosyn	NN	B-TREATMENT
4.5	CD	O
gm	NN	O
iv	NN	O
q	VBD	O
8	CD	O
hours	NNS	O
(	(	O
last	JJ	O
dose	NN	O
on	IN	O
08-14	NN	O
at	IN	O
1400	CD	O
)	)	O
,	,	O
started	VBD	O
08-08	CD	O
.	.	O

metoprolol	NN	B-TREATMENT
37.5	CD	O
mg	NN	O
q	NN	O
12	CD	O
hours	NNS	O
(	(	O
last	JJ	O
dose	NN	O
07/25	CD	O
in	IN	O
am	VBP	O
)	)	O

protein	NN	B-TREATMENT
/	VBZ	I-TREATMENT
soy	JJ	I-TREATMENT
supplement	NN	I-TREATMENT
2	CD	O
scoops	NNS	O
q	RB	O
12	CD	O
hours	NNS	O

ipratropium	NN	B-TREATMENT
/	NNP	O
albuterol	NN	B-TREATMENT
inhaler	NN	I-TREATMENT
4	CD	O
puffs	NNS	O
qid	NN	O

completed	VBN	O
course	NN	O
of	IN	O
flagyl	JJ	B-TREATMENT
07-25	JJ	O
-->	JJ	O
08-10	NN	O
.	.	O

anoxic	NN	B-PROBLEM
encephalopathy	NN	I-PROBLEM

acute	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
failure	NN	I-PROBLEM

chronic	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
failure	NN	I-PROBLEM

pseudomonal	JJ	B-PROBLEM
pneumonia	NN	I-PROBLEM

volume	NN	B-PROBLEM
overload	NN	I-PROBLEM

chronic	JJ	B-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM

bronchiectasis	NN	B-PROBLEM

hyponatremia	NN	B-PROBLEM

anemia	NN	B-PROBLEM
of	IN	I-PROBLEM
chronic	JJ	I-PROBLEM
disease	NN	I-PROBLEM

1.	CD	O
non-small	JJ	B-PROBLEM
cell	NN	I-PROBLEM
lung	NN	I-PROBLEM
cancer	NN	I-PROBLEM
s/p	NN	B-TREATMENT
xrt	NNP	I-TREATMENT
and	CC	O
chemotherapy	NN	B-TREATMENT
in	IN	O
western	JJ	O
sahara	NN	O
,	,	O
s/p	RB	B-TREATMENT
right	JJ	I-TREATMENT
pneumonectomy	NN	I-TREATMENT
in	IN	O
2016-09-21	JJ	O
for	IN	O
recurrence	NN	B-PROBLEM
.	.	O

chronic	JJ	B-PROBLEM
left	VBD	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

2.	CD	O
sick	JJ	B-PROBLEM
sinus	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
status	NN	B-TREATMENT
post	NN	I-TREATMENT
pm/icd	NN	I-TREATMENT
placement	NN	I-TREATMENT

3.	CD	O
copd/bronchiectasis	NN	B-PROBLEM

4.	CD	O
hypertension	NN	B-PROBLEM

5.	CD	O
cad	NN	B-PROBLEM
,	,	O
with	IN	O
known	VBN	O
to	TO	O
rca	VB	O
.	.	O

6.	CD	O
chf	NN	B-PROBLEM
with	IN	O
ef	JJ	B-TEST
25%	CD	O
on	IN	O
last	JJ	B-TEST
echo	NN	I-TEST
on	IN	O
2017-07-19	JJ	O

7.	CD	O
bph	NN	B-PROBLEM

8.	CD	O
depression	NN	B-PROBLEM

9.	CD	O
left	VBD	B-PROBLEM
femoral	JJ	I-PROBLEM
av	JJ	I-PROBLEM
fistula	NN	I-PROBLEM
2017-04-19	JJ	O

10.	CD	O
recent	JJ	B-PROBLEM
mrsa	NN	I-PROBLEM
pneumonia	NN	I-PROBLEM
and	CC	O
sepsis	NN	B-PROBLEM
2017-07-21	JJ	O
,	,	O
treated	VBN	O
with	IN	O
vancomycin	NN	B-TREATMENT

11.	CD	O
c.	NN	B-PROBLEM
difficile	NN	I-PROBLEM
colitis	NN	I-PROBLEM
treated	VBN	O
with	IN	O
flagyl	NN	B-TREATMENT
(	(	O
completed	VBN	O
08-10	NN	O
)	)	O

12.	CD	O
status	NN	B-TREATMENT
post	NN	I-TREATMENT
peg	NN	I-TREATMENT
tube	NN	I-TREATMENT
placement	NN	I-TREATMENT
2017-07-21	JJ	O

13.	CD	O
status	NN	B-TREATMENT
post	NN	I-TREATMENT
tracheostomy	IN	I-TREATMENT
2017-07-21	JJ	O
02-22	JJ	O
failure	NN	B-PROBLEM
to	TO	I-PROBLEM
wean	VB	I-PROBLEM

14.	CD	O
status	NN	B-TREATMENT
post	NN	I-TREATMENT
partial	JJ	I-TREATMENT
colectomy	NN	I-TREATMENT
1972	CD	O

medicine	NN	B-TREATMENT

losartan	JJ	B-TREATMENT
/	NNP	O
aspirin	NN	B-TREATMENT
/	VBD	O
lisinopril-hctz	JJ	B-TREATMENT

chief	JJ	O
complaint	NN	O
:	:	O
fever	NN	B-PROBLEM

intubation	NN	B-TREATMENT
for	IN	O
airway	NN	B-TREATMENT
protection	NN	I-TREATMENT
tunneled	VBD	B-TREATMENT
line	NN	I-TREATMENT
change	NN	I-TREATMENT
over	IN	I-TREATMENT
wire	NN	I-TREATMENT
2019-01-08	JJ	O

69	CD	O
y/o	JJ	O
female	NN	O
wtih	NN	O
pmh	NN	O
significant	JJ	O
for	IN	O
esrd	NN	B-PROBLEM
on	IN	O
hd	NN	B-TREATMENT
,	,	O
type	NN	B-PROBLEM
2	CD	I-PROBLEM
dm	NN	I-PROBLEM
,	,	O
and	CC	O
recent	JJ	B-PROBLEM
pe	NN	I-PROBLEM
resulting	VBG	O
in	IN	O
pea	NN	B-PROBLEM
arrest	NN	I-PROBLEM
admitted	VBN	O
through	IN	O
the	DT	O
juan	NN	O
with	IN	O
sepsis	NN	B-PROBLEM
of	IN	O
unknown	JJ	O
etiology	NN	O
.	.	O

pt	NN	O
was	VBD	O
recently	RB	O
admitted	VBN	O
to	TO	O
the	DT	O
hospital	NN	O
for	IN	O
orthopedics	NNS	O
from	IN	O
12-07	JJ	O
thorugh	IN	O
12-14	JJ	O
with	IN	O
hypotension	NN	B-PROBLEM
thought	VBN	O
to	TO	O
be	VB	O
secondary	JJ	O
to	TO	O
overdiuresis	VB	B-PROBLEM
at	IN	O
hd.	NN	B-TREATMENT

however	RB	O
,	,	O
a	DT	B-PROBLEM
septic	JJ	I-PROBLEM
component	NN	I-PROBLEM
to	TO	O
the	DT	B-PROBLEM
hypotension	NN	I-PROBLEM
was	VBD	O
also	RB	O
considered	VBN	O
as	IN	O
the	DT	O
pt	NN	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
citrobacter	NN	B-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
urine	NN	I-PROBLEM
and	CC	O
c	VB	B-PROBLEM
diff	NN	I-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
stool	NN	I-PROBLEM
.	.	O

her	PRP$	O
son	NN	O
reports	NNS	O
that	IN	O
she	PRP	O
then	RB	O
developed	VBD	O
a	DT	B-PROBLEM
headache	NN	I-PROBLEM
and	CC	O
fevers	NNS	B-PROBLEM
started	VBD	O
three	CD	O
days	NNS	O
ago	RB	O
which	WDT	O
were	VBD	O
treated	VBN	O
with	IN	O
tylenol	NN	B-TREATMENT
.	.	O

then	RB	O
,	,	O
this	DT	O
morning	NN	O
she	PRP	O
developed	VBD	O
fatigue	NN	B-PROBLEM
and	CC	O
did	VBD	O
not	RB	O
eat	VB	O
well	RB	O
.	.	O

he	PRP	O
son	VBZ	O
also	RB	O
notes	NNS	O
that	IN	O
she	PRP	O
appeared	VBD	O
to	TO	O
be	VB	O
working	VBG	B-PROBLEM
hard	JJ	I-PROBLEM
to	TO	I-PROBLEM
breath	VB	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
febrile	JJ	B-PROBLEM
to	TO	O
101.9	CD	O
and	CC	O
received	VBD	O
levoflox	NNS	B-TREATMENT
and	CC	O
vancomycin	NN	B-TREATMENT
.	.	O

pt	NN	O
was	VBD	O
then	RB	O
sent	VBN	O
to	TO	O
the	DT	O
the	DT	O
hospital	NN	O
for	IN	O
orthopedics	NNS	O
juan	NN	O
for	IN	O
further	JJ	B-TEST
evaluation	NN	I-TEST
.	.	O

per	IN	O
notes	NNS	O
,	,	O
pt	NN	O
denied	VBD	O
sob	NN	B-PROBLEM
,	,	O
cp	NN	B-PROBLEM
,	,	O
and	CC	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
prior	RB	O
to	TO	O
intubation	NN	B-TREATMENT
.	.	O

she	PRP	O
did	VBD	O
complain	NN	O
of	IN	O
a	DT	B-PROBLEM
left	JJ	I-PROBLEM
frontal	JJ	I-PROBLEM
headache	NN	I-PROBLEM
.	.	O

in	IN	O
the	DT	O
juan	NN	O
,	,	O
the	DT	B-TEST
pt	NN	I-TEST
's	POS	I-TEST
vs	NN	I-TEST
were	VBD	O
singificant	JJ	O
for	IN	O
a	DT	B-PROBLEM
fever	NN	I-PROBLEM
of	IN	O
103.8	CD	O
,	,	O
tachycardia	NN	B-PROBLEM
in	IN	O
the	DT	O
130s-150s	JJ	O
,	,	O
and	CC	O
initial	JJ	B-PROBLEM
hypertensive	NN	I-PROBLEM
in	IN	O
the	DT	O
140s	CD	O
.	.	O

her	PRP$	B-TEST
oxygen	NN	I-TEST
saturation	NN	I-TEST
was	VBD	O
96%	CD	O
on	IN	O
ra	NN	O
but	CC	O
she	PRP	O
was	VBD	O
tachypneic	JJ	B-PROBLEM
to	TO	O
31	CD	O
.	.	O

she	PRP	O
was	VBD	O
obtunded	VBN	B-PROBLEM
and	CC	O
was	VBD	O
thus	RB	O
intubated	VBN	B-TREATMENT
for	IN	O
airway	NN	B-TREATMENT
protection	NN	I-TREATMENT
.	.	O

post-intubation	NN	O
,	,	O
the	DT	B-TEST
pt	NN	I-TEST
's	POS	I-TEST
bp	NN	I-TEST
acutely	RB	O
dropped	VBD	O
to	TO	O
58/19	CD	O
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
propofol	NN	B-TREATMENT
.	.	O

when	WRB	O
this	DT	B-TREATMENT
medication	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
,	,	O
her	PRP$	B-TEST
bp	NN	I-TEST
came	VBD	O
back	RB	O
up	IN	O
to	TO	O
the	DT	O
70s-90s	JJ	O
/	JJ	O
30s-50s	NNS	O
.	.	O

pt	NN	O
was	VBD	O
then	RB	O
initiated	VBN	O
on	IN	O
the	DT	B-TREATMENT
sepsis	NN	I-TREATMENT
protocol	NN	I-TREATMENT
.	.	O

in	IN	O
the	DT	O
juan	NN	O
,	,	O
she	PRP	O
received	VBD	O
vancomycin	NN	B-TREATMENT
,	,	O
levofloxacin	NN	B-TREATMENT
,	,	O
flagyl	NN	B-TREATMENT
,	,	O
and	CC	O
cefepime	NN	B-TREATMENT
(	(	O
2	CD	O
gm	NN	O
).	NN	O

she	PRP	O
received	VBD	O
a	DT	O
total	NN	O
of	IN	O
4	CD	O
liters	NNS	O
of	IN	O
ns	JJ	B-TREATMENT
then	RB	O
was	VBD	O
started	VBN	O
on	IN	O
levophed	NN	B-TREATMENT
for	IN	O
continued	JJ	B-PROBLEM
hypotension	NN	I-PROBLEM
.	.	O

pt	NN	O
is	VBZ	O
now	RB	O
transferred	VBN	O
to	TO	O
the	DT	O
ficu	NN	O
for	IN	O
further	JJ	B-TREATMENT
care	NN	I-TREATMENT
.	.	O

per	IN	O
pt	NN	O
's	POS	O
son	NN	O
,	,	O
she	PRP	O
is	VBZ	O
bedbound	VBN	B-PROBLEM
at	IN	O
baseline	NN	O
due	JJ	O
to	TO	O
her	PRP$	B-PROBLEM
multiple	JJ	I-PROBLEM
le	JJ	I-PROBLEM
femur	NN	I-PROBLEM
fractures	NNS	I-PROBLEM
.	.	O

1.	CD	O
type	NN	B-PROBLEM
2	CD	I-PROBLEM
diabetes	NNS	I-PROBLEM
mellitus	VBP	I-PROBLEM

2.	CD	O
diabetic	JJ	B-PROBLEM
nephropathy	JJ	I-PROBLEM
resulting	VBG	O
in	IN	O
esrd	NN	B-PROBLEM
for	IN	O
which	WDT	O
she	PRP	O
is	VBZ	O
on	IN	O
hd	NN	B-TREATMENT
.	.	O

pt	NN	O
was	VBD	O
due	JJ	O
for	IN	O
hd	NN	B-TREATMENT
but	CC	O
missed	VBD	O
it	PRP	O
secondary	JJ	O
to	TO	O
her	PRP$	B-PROBLEM
illness	NN	I-PROBLEM
.	.	O

she	PRP	O
normally	RB	O
receives	VBZ	O
hd	NN	B-TREATMENT
on	IN	O
mon	NN	O
,	,	O
wed	VBN	O
,	,	O
and	CC	O
fri	NN	O
.	.	O

3.	CD	O
status	NN	B-PROBLEM
post	NN	I-PROBLEM
left	VBD	I-PROBLEM
femur	JJ	I-PROBLEM
fracture	NN	I-PROBLEM

4.	CD	O
hyponatremia	NN	B-PROBLEM

5.	CD	O
hypercholesterolemia	NN	B-PROBLEM

6.	CD	O
unsteady	JJ	B-PROBLEM
gait	NN	I-PROBLEM

7.	CD	O
cataracts	NNS	B-PROBLEM

8.	CD	O
back	RB	B-PROBLEM
pain	NN	I-PROBLEM

9.	CD	O
hypertension	NN	B-PROBLEM

10.	CD	O
anemia	NN	B-PROBLEM
of	IN	I-PROBLEM
chronic	JJ	I-PROBLEM
disease	NN	I-PROBLEM

11.	CD	O
s/p	JJ	B-TREATMENT
l	NN	I-TREATMENT
shoulder	NN	I-TREATMENT
hemiarthroplasty	NN	I-TREATMENT
following	VBG	O
a	DT	B-PROBLEM
left	JJ	I-PROBLEM
humeral	JJ	I-PROBLEM
fracuture	NN	I-PROBLEM
in	IN	O
2018-11-10-	JJ	O
dumas	NN	O
was	VBD	O
complicated	VBN	O
by	IN	O
a	DT	B-PROBLEM
pea	NN	I-PROBLEM
arrest	NN	I-PROBLEM
secondary	JJ	O
to	TO	O
pe	VB	B-PROBLEM
.	.	O

12.	CD	O
pe	JJ	B-PROBLEM
2018-11-17	JJ	O
leading	VBG	O
to	TO	O
pea	VB	B-PROBLEM
arrest	NN	I-PROBLEM

ac	RB	O
500	CD	O
/	JJ	O
15	CD	O
/	JJ	O
.50	NNP	O
/	NNP	O
peep	VBZ	B-TREATMENT
5	CD	O

gen	NN	O
-	:	O
sedated	VBN	B-TREATMENT
and	CC	O
intubated	VBN	B-TREATMENT
.	.	O

anicteric	JJ	B-PROBLEM
sclera	NN	I-PROBLEM
.	.	O

no	DT	O
m,r,g	NN	B-PROBLEM
.	.	O

abdomen	NNS	O
-	:	O
obese	NN	B-PROBLEM
.	.	O

nt	NN	B-PROBLEM
.	.	O

nd	NN	B-PROBLEM
.	.	O

extremities	NNS	O
-	:	O
feet	NNS	B-PROBLEM
mildly	RB	I-PROBLEM
cool	VBP	I-PROBLEM
.	.	O

2+	CD	B-TEST
dp	NN	I-TEST
pulses	NNS	I-TEST
bilaterally	RB	I-TEST
.	.	O

2+	CD	B-PROBLEM
pitting	VBG	I-PROBLEM
edema	JJ	I-PROBLEM
bilateral	JJ	I-PROBLEM
le	NN	I-PROBLEM
.	.	O

skin	JJ	B-PROBLEM
breakdown	NN	I-PROBLEM
between	IN	I-PROBLEM
toes	NNS	I-PROBLEM
.	.	O

pressure	NN	B-PROBLEM
ulcers	NNS	I-PROBLEM
under	IN	I-PROBLEM
bilateral	JJ	I-PROBLEM
le	NN	I-PROBLEM
right	RB	O
above	IN	O
the	DT	O
ankles	NNS	O
.	.	O

do	VB	O
not	RB	O
appear	VB	O
infected	VBN	B-PROBLEM
.	.	O

question	NN	O
mild	NN	B-PROBLEM
erythema	NN	I-PROBLEM
and	CC	O
warmth	NN	B-PROBLEM
of	IN	I-PROBLEM
left	JJ	I-PROBLEM
le	NN	I-PROBLEM
.	.	O

neuro	SYM	O
-	:	O
sedated	VBN	B-PROBLEM
.	.	O

lactate	NN	B-TEST
-	:	O
1.8	CD	O

crp	SYM	B-TEST
-	:	O
46.2	CD	O
*	NN	O

sed	VBN	B-TEST
rate	NN	I-TEST
-	:	O
33	CD	O
*	NN	O

type	SYM	O
-	:	O
mix	NN	B-TEST
temp	SYM	I-TEST
-	:	O
35.6	CD	O
rates	NNS	B-TEST
-/	VBP	O
15	CD	O
tidal	JJ	B-TEST
vol	NN	I-TEST
-	:	O
500	CD	O
peep	JJ	B-TREATMENT
-	:	O
5	CD	O
o2	SYM	B-TEST
-	:	O
50	CD	O
po2	NN	B-TEST
-	:	O
34	CD	O
*	NN	O
pco2	NN	B-TEST
-	:	O
39	CD	O
ph	NN	B-TEST
-	:	O
7.32	CD	O
*	JJ	O
total	NN	B-TEST
co2	NN	I-TEST
-	:	O
21	CD	O
base	NN	B-TEST
xs	NNP	I-TEST
-	:	O
-6	NN	O

-	:	O
assist	NN	O
/	JJ	O
con	NN	O
intubated	VBD	B-TREATMENT
-	:	O
intubated	VBN	B-TREATMENT

lactate	NN	B-TEST
-	:	O
1.6	CD	O

glucose	JJ	B-TEST
-	:	O
210	CD	O
*	JJ	O
urea	JJ	B-TEST
n	SYM	I-TEST
-	:	O
29	CD	O
*	NN	O
creat	NN	B-TEST
-	:	O
3.2	CD	O
*	JJ	O
sodium	NN	B-TEST
-	:	O
139	CD	O
potassium	NN	B-TEST
-	:	O
3.9	CD	O
chloride	NN	B-TEST
-	:	O
112	CD	O
*	JJ	O
total	NN	B-TEST
co2	NN	I-TEST
-	:	O
17	CD	O
*	JJ	O
anion	NN	B-TEST
gap	NN	I-TEST
-	:	O
14	CD	O

calcium	NN	B-TEST
-	:	O
6.2	CD	O
*	NN	O
phosphate	NN	B-TEST
-	:	O
1.7	CD	O
*	JJ	O
magnesium	NN	B-TEST
-	:	O
0.9	CD	O
*	NN	O

cortisol	SYM	B-TEST
-	:	O
10.3	CD	O

wbc	SYM	B-TEST
-	:	O
9.0	CD	O
rbc	NN	B-TEST
-	:	O
2.93	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
9.0	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
29.7	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
101	CD	O
*	NN	O
mch	SYM	B-TEST
-	:	O
30.8	CD	O
mchc	SYM	B-TEST
-	:	O
30.4	CD	O
*	NN	O
rdw	NN	B-TEST
-	:	O
24.1	CD	O
*	NN	O

neuts	NNS	B-TEST
-	:	O
65.2	CD	O
lymphs	SYM	B-TEST
-	:	O
25.2	CD	O
monos	NNS	B-TEST
-	:	O
6.0	CD	O
eos	SYM	B-TEST
-	:	O
3.3	CD	O
basos	SYM	B-TEST
-	:	O
0.4	CD	O

hypochrom	SYM	B-TEST
-	:	O
3+	CD	O
anisocyt	SYM	B-TEST
-	:	O
3+	CD	O
poikilocy	NN	B-TEST
-	:	O
1+	CD	O
macrocyt	SYM	B-TEST
-	:	O
3+	CD	O
microcyt	SYM	B-TEST
-	:	O
1+	CD	O

plt	NN	B-TEST
count	NN	I-TEST
-	:	O
177	CD	O

cortisol	SYM	B-TEST
-	:	O
9.3	CD	O

2018-12-26	JJ	O
08:28	CD	O
pm	NN	B-TEST
urine	NN	I-TEST

color	NN	B-TEST
-	:	O
yellow	NN	O
appear	VBP	B-TEST
-	:	O
slhazy	JJ	O
sp	NN	O
barajas	SYM	O
-	:	O
1.005	CD	O

2018-12-26	JJ	O
08:28	CD	O
pm	NN	B-TEST
urine	NN	I-TEST

blood	NN	B-TEST
-	:	O
lge	NN	B-TEST
nitrite	JJ	I-TEST
-	:	O
neg	NN	O
protein	SYM	B-TEST
-	:	O
500	CD	O
glucose	JJ	B-TEST
-	:	O
tr	NN	O
ketone	NN	B-TEST
-	:	O
neg	NN	O
bilirubin	SYM	B-TEST
-	:	O
neg	NN	O
urobilngn	JJ	B-TEST
-	:	O
neg	NN	O
ph	SYM	B-TEST
-	:	O
7.0	CD	O
leuk	SYM	B-TEST
-	:	O
neg	NN	O

2018-12-26	JJ	O
08:28	CD	O
pm	NN	B-TEST
urine	NN	I-TEST

rbc	LS	B-TEST
-	:	O
225	CD	O
*	NN	O
wbc	SYM	B-TEST
-	:	O
8	CD	O
*	NN	O
bacteria	NNS	B-TEST
-	:	O
none	NN	O
yeast	SYM	B-TEST
-	:	O
none	NN	O
epi	SYM	B-TEST
-	:	O
<	NN	O
1	CD	O

ck	NN	B-TEST
(	(	I-TEST
cpk	JJ	I-TEST
)-	JJ	I-TEST
350	CD	O
*	NN	O

ck	SYM	B-TEST
-	:	O
mb	NN	B-TEST
-	:	O
3	CD	O
ctropnt	NN	B-TEST
-	:	O
0.40	CD	O
*	NN	O

micro	NN	O
:	:	O
sputum	JJ	B-TEST
12-27	NNS	O
:	:	O
grm	NN	B-TEST
stn	NN	I-TEST
and	CC	O
cx	NN	B-TEST
negative	JJ	O

infl	VB	B-TEST
a	DT	I-TEST
and	CC	I-TEST
b	JJ	I-TEST
12-27	JJ	O
:	:	O
negative	JJ	O

csf	NN	B-TEST
grm	NN	I-TEST
stn	NN	I-TEST
/	NNP	O
cx	NN	B-TEST
:	:	O
negative	JJ	O

urine	JJ	B-TEST
cx	JJ	I-TEST
12-26	JJ	O
:	:	O
>	JJ	O
100k	CD	O
vre	NN	B-PROBLEM
likely	RB	O
colonized	VBN	O
,	,	O
01-03	JJ	O
yest	NN	O
and	CC	O
vre	NN	B-PROBLEM

c	NNS	B-TEST
diff	JJ	I-TEST
neg	NNS	O
:	:	O
12-28	JJ	O
,	,	O
12-31	JJ	O
,	,	O
01-01	JJ	O
,	,	O
01-02	JJ	O
.	.	O

bld	NN	B-TEST
cx	NN	I-TEST
12-26	JJ	O
,	,	O
12-27	JJ	O
,	,	O
12-28	JJ	O
,	,	O
12-31	JJ	O
-	:	O
ng	NN	O
.	.	O

catheter	NN	B-TREATMENT
tip	NN	I-TREATMENT
01-05	CD	O
,	,	O
ng	NN	B-TREATMENT
.	.	O

c.	NN	B-TEST
diff	NN	I-TEST
b	SYM	I-TEST
-	:	O
negative	JJ	O

tunnled	VBN	B-TREATMENT
catheter	NN	I-TREATMENT
tip	NN	I-TREATMENT
01-08	JJ	O
-	:	O
ngtd	NN	O

herpes	NNS	B-TEST
simplex	JJ	I-TEST
virus	NN	I-TEST
pcr	SYM	I-TEST
-	:	O
pnd	NN	O

69	CD	O
y/o	JJ	O
female	NN	O
wtih	NN	O
pmh	NN	B-PROBLEM
significant	JJ	O
for	IN	O
esrd	NN	B-PROBLEM
on	IN	O
hd	NN	B-TREATMENT
,	,	O
type	NN	B-PROBLEM
2	CD	I-PROBLEM
dm	NN	I-PROBLEM
,	,	O
and	CC	O
recent	JJ	B-PROBLEM
pe	NN	I-PROBLEM
resulting	VBG	O
in	IN	O
pea	NN	B-PROBLEM
arrest	NN	I-PROBLEM
admitted	VBN	O
through	IN	O
the	DT	O
juan	NN	O
with	IN	O
sepsis	NN	B-PROBLEM
of	IN	O
unknown	JJ	O
etiology	NN	O
.	.	O

1.	CD	O
sepsis	NN	B-PROBLEM
/	VBD	O
id-	JJ	O
started	VBN	O
on	IN	O
sepsis	NN	B-TREATMENT
protocol	NN	I-TREATMENT
.	.	O

unclear	JJ	O
etiology	NN	O
headache	NN	B-PROBLEM
over	IN	O
the	DT	O
three	CD	O
days	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
in	IN	O
association	NN	O
with	IN	O
fever	NN	B-PROBLEM
was	VBD	O
concerning	VBG	O
for	IN	O
a	DT	O
cns	NN	O
etiology	NN	O
.	.	O

covered	VBN	O
broadly	RB	O
with	IN	O
vancomycin	NN	B-TREATMENT
,	,	O
flagyl	NN	B-TREATMENT
,	,	O
and	CC	O
cefipime	NN	B-TREATMENT
.	.	O

given	VBN	O
stress	NN	B-TREATMENT
dose	JJ	I-TREATMENT
steroids	NNS	I-TREATMENT
empirically	RB	O
and	CC	O
sanchez	VB	B-TEST
stim	NN	I-TEST
showed	VBD	O
cortisol	NN	B-TEST
of	IN	O
9.3	CD	O
-->	JJ	O
10.3	CD	O
therefore	RB	O
steroids	NNS	B-TREATMENT
continued	VBD	O
.	.	O

cxr	NN	B-TEST
,	,	O
lp	NN	B-TEST
,	,	O
ua	JJ	B-TEST
and	CC	O
abdominal	JJ	B-TEST
ct	NN	I-TEST
showed	VBD	O
no	DT	O
sign	NN	O
of	IN	O
infection	NN	B-PROBLEM
.	.	O

picc	NN	B-TREATMENT
line	NN	I-TREATMENT
was	VBD	O
removed	VBN	O
empirically	RB	O
.	.	O

tip	NN	B-TREATMENT
could	MD	O
not	RB	O
be	VB	O
cultured	VBN	O
due	JJ	O
to	TO	O
contamination	NN	B-PROBLEM
.	.	O

cultures	NNS	B-TEST
drawn	VBN	O
off	RP	O
the	DT	B-TREATMENT
hd	NN	I-TREATMENT
cath	NN	I-TREATMENT
are	VBP	O
negative	JJ	O
to	TO	O
date	NN	O
.	.	O

patient	NN	B-PROBLEM
's	POS	I-PROBLEM
le	JJ	I-PROBLEM
ulcers	NNS	I-PROBLEM
appear	VBP	O
chronic	JJ	O
and	CC	O
do	VBP	O
not	RB	O
appear	VB	O
to	TO	O
be	VB	O
the	DT	O
source	NN	O
of	IN	O
infection	NN	B-PROBLEM
.	.	O

her	PRP$	O
left	JJ	O
knee	NN	O
is	VBZ	O
slightly	RB	B-PROBLEM
erythematous	JJ	I-PROBLEM
compared	VBN	O
to	TO	O
the	DT	O
right	NN	O
but	CC	O
not	RB	O
impressive	JJ	O
.	.	O

nasal	JJ	B-TEST
washings	NNS	I-TEST
for	IN	O
influenza	NN	B-PROBLEM
were	VBD	O
negative	JJ	O
;	:	O
culture	NN	B-TEST
pending	NN	O
.	.	O

steroids	NNS	B-TREATMENT
were	VBD	O
discontinued	VBN	O
.	.	O

on	IN	O
12-18	JJ	O
flagyl	NN	B-TREATMENT
and	CC	O
cefepime	NN	B-TREATMENT
were	VBD	O
discontinued	VBN	O
as	IN	O
all	DT	B-TEST
culture	NN	I-TEST
data	NNS	I-TEST
negative	JJ	O
to	TO	O
date	NN	O
.	.	O

plan	NN	O
to	TO	O
continue	VB	O
vancomycin	NN	B-TREATMENT
for	IN	O
08-19	JJ	O
day	NN	O
course	NN	O
to	TO	O
treat	VB	O
empiric	JJ	B-PROBLEM
line	NN	I-PROBLEM
infection	NN	I-PROBLEM
.	.	O

urine	JJ	B-TEST
culture	NN	I-TEST
came	VBD	O
back	RB	O
positive	JJ	O
for	IN	O
vre	NN	B-PROBLEM
,	,	O
however	RB	O
,	,	O
since	IN	O
patient	NN	O
improved	VBN	O
without	IN	O
treatement	NN	B-TREATMENT
(	(	O
ie	JJ	O
linezolid	NN	B-TREATMENT
)	)	O
initially	RB	O
.	.	O

on	IN	O
the	DT	O
floor	NN	O
the	DT	B-TREATMENT
vancomycin	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
as	IN	O
the	DT	B-TEST
catheter	NN	I-TEST
tip	JJ	I-TEST
culture	NN	I-TEST
was	VBD	O
negative	JJ	O
.	.	O

id	NN	O
was	VBD	O
consulted	VBN	O
who	WP	O
suggested	VBD	O
broad	JJ	B-TREATMENT
spectrum	NN	I-TREATMENT
antibiotics	NNS	I-TREATMENT
if	IN	O
she	PRP	O
were	VBD	O
to	TO	O
spike	VB	B-PROBLEM
.	.	O

when	WRB	O
pt	NN	O
spiked	VBD	O
a	DT	B-PROBLEM
temperature	NN	I-PROBLEM
and	CC	O
became	VBD	O
hypotensive	JJ	B-PROBLEM
she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
linezolid	NN	B-TREATMENT
was	VBD	O
started	VBN	O
for	IN	O
presumed	JJ	O
vre	JJ	B-PROBLEM
infection	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
urine	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
also	RB	O
started	VBN	O
on	IN	O
fluconazole	NN	B-TREATMENT
for	IN	O
yeast	NN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
urine	NN	I-PROBLEM
,	,	O
to	TO	O
be	VB	O
treated	VBN	O
with	IN	O
fluconazole	NN	B-TREATMENT
for	IN	O
total	JJ	O
7	CD	O
days	NNS	O
.	.	O

she	PRP	O
was	VBD	O
given	VBN	O
flagyl	NN	B-TREATMENT
for	IN	O
presumed	JJ	O
c.	NN	B-PROBLEM
diff.	NN	I-PROBLEM
colitis	NN	I-PROBLEM
,	,	O
however	RB	O
this	DT	O
was	VBD	O
stopped	VBN	O
when	WRB	O
c.	NN	B-TEST
diff	NN	I-TEST
b	NN	I-TEST
toxin	NN	I-TEST
came	VBD	O
back	RB	O
negative	JJ	O
on	IN	O
2019-01-10	JJ	O
.	.	O

the	DT	B-TREATMENT
tunneled	JJ	I-TREATMENT
catheter	NN	I-TREATMENT
line	NN	I-TREATMENT
was	VBD	O
changed	VBN	O
over	IN	O
a	DT	B-TREATMENT
wire	NN	I-TREATMENT
and	CC	O
the	DT	B-TEST
tip	NN	I-TEST
was	VBD	O
also	RB	O
negative	JJ	O
.	.	O

2.	CD	O
respiratory	JJ	O
-	:	O
intubated	VBN	B-TREATMENT
for	IN	O
airway	NN	B-TREATMENT
protection	NN	I-TREATMENT
due	JJ	O
to	TO	O
change	VB	B-PROBLEM
in	IN	I-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
.	.	O

extubated	VBN	B-TREATMENT
12-28	JJ	O
with	IN	O
no	DT	O
incident	NN	O
.	.	O

3.	CD	O
ecg	NN	B-PROBLEM
changes	NNS	I-PROBLEM
-	:	O
patient	NN	O
had	VBD	O
an	DT	O
episode	NN	O
of	IN	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
during	IN	O
her	PRP$	O
hospital	NN	O
stay	NN	O
that	WDT	O
was	VBD	O
both	DT	O
right	JJ	O
and	CC	O
left	VBD	O
sided	VBN	O
with	IN	O
no	DT	O
radiation	NN	O
and	CC	O
no	DT	O
associated	VBN	B-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O

ecg	NN	B-TEST
showed	VBD	O
new	JJ	B-PROBLEM
diffuse	NN	I-PROBLEM
twi	NN	I-PROBLEM
in	IN	I-PROBLEM
all	DT	I-PROBLEM
leads	NNS	I-PROBLEM
.	.	O

cardiac	JJ	B-TEST
enzymes	NNS	I-TEST
were	VBD	O
cycled	VBN	O
and	CC	O
were	VBD	O
normal	JJ	O
.	.	O

echo	NN	B-TEST
was	VBD	O
obtained	VBN	O
which	WDT	O
showed	VBD	O
wma	NNS	B-PROBLEM
and	CC	O
ef	NN	B-TEST
of	IN	O
35-40%	JJ	O
.	.	O

pt	NN	O
was	VBD	O
note	RB	O
started	VBN	O
on	IN	O
asa	NN	B-TREATMENT
as	IN	O
she	PRP	O
does	VBZ	O
not	RB	O
tolerate	VB	O
this	DT	O
well	NN	O
,	,	O
bb	NN	B-TREATMENT
was	VBD	O
also	RB	O
not	RB	O
started	VBD	O
given	VBN	O
sbps	NN	B-TEST
in	IN	O
the	DT	O
110s	CD	O
.	.	O

statin	NN	B-TREATMENT
was	VBD	O
also	RB	O
deffered	VBN	O
.	.	O

she	PRP	O
may	MD	O
be	VB	O
started	VBN	O
on	IN	O
asa	NN	B-TREATMENT
,	,	O
bb	NN	B-TREATMENT
,	,	O
statin	NN	B-TREATMENT
by	IN	O
pcp	NN	O
as	IN	O
stephen	NN	O
.	.	O

4.	CD	O
shoulder	NN	B-PROBLEM
fracture	NN	I-PROBLEM
-	:	O
patient	NN	O
is	VBZ	O
s/p	PDT	B-PROBLEM
a	DT	I-PROBLEM
left	JJ	I-PROBLEM
hip	NN	I-PROBLEM
fracture	NN	I-PROBLEM
(	(	O
decision	NN	O
not	RB	O
to	TO	O
operate	VB	O
)	)	O
and	CC	O
a	DT	B-PROBLEM
left	JJ	I-PROBLEM
shoulder	NN	I-PROBLEM
fracture	NN	I-PROBLEM
with	IN	O
hemiarthroplasty	JJ	B-TREATMENT
11-14	NNS	O
.	.	O

patient	NN	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
new	JJ	I-PROBLEM
humerus	NN	I-PROBLEM
fracture	NN	I-PROBLEM
distal	NN	I-PROBLEM
to	TO	I-PROBLEM
the	DT	I-PROBLEM
hardware	NN	I-PROBLEM
on	IN	O
film	NN	B-TEST
this	DT	O
admission	NN	O
.	.	O

assumed	VBN	O
to	TO	O
be	VB	O
secondary	JJ	O
to	TO	O
trauma	VB	B-PROBLEM
when	WRB	O
moving	VBG	O
patient	NN	O
into	IN	O
ambulance	NN	O
.	.	O

cmed	JJ	O
service	NN	O
was	VBD	O
consulted	VBN	O
and	CC	O
recommended	VBN	O
wtd	NN	B-TREATMENT
woulnd	NN	I-TREATMENT
care	NN	I-TREATMENT
and	CC	O
sling	NN	B-TREATMENT
at	IN	O
all	DT	O
times	NNS	O
.	.	O

wound	NN	B-TREATMENT
care	NN	I-TREATMENT
should	MD	O
be	VB	O
continued	VBN	O
as	IN	O
described	NN	O
after	IN	O
discharge	NN	O
.	.	O

5.	CD	O
type	NN	B-PROBLEM
2	CD	I-PROBLEM
dm	NN	I-PROBLEM
-	:	O
patient	NN	O
was	VBD	O
initially	RB	O
covered	VBN	O
with	IN	O
an	DT	B-TREATMENT
insulin	NN	I-TREATMENT
drip	NN	I-TREATMENT
while	IN	O
septic	JJ	B-PROBLEM
and	CC	O
then	RB	O
transitioned	VBD	O
back	RB	O
to	TO	O
insulin	VB	B-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT
.	.	O

6.	CD	O
esrd	NN	B-PROBLEM
on	IN	O
hd	NN	B-TREATMENT
-	:	O
pt	NN	O
has	VBZ	O
esrd	VBN	B-PROBLEM
secondary	JJ	O
to	TO	O
her	PRP$	B-PROBLEM
dm	NN	I-PROBLEM
and	CC	O
is	VBZ	O
on	IN	O
hd	NN	B-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
dialysed	VBN	O
but	CC	O
was	VBD	O
slightly	RB	B-PROBLEM
limited	VBN	I-PROBLEM
by	IN	O
hypotension	NN	B-PROBLEM
.	.	O

her	PRP$	B-TREATMENT
dialysis	NN	I-TREATMENT
was	VBD	O
managed	VBN	O
by	IN	O
renal	JJ	O
service	NN	O
in	IN	O
house	NN	O
.	.	O

7.	CD	O
pe	NN	B-PROBLEM
(	(	O
11-14	JJ	O
)-	NN	O
on	IN	O
heparin	NN	B-TREATMENT
drip	NN	I-TREATMENT
.	.	O

restared	VBN	O
coumadin	NN	B-TREATMENT
on	IN	O
12-29	JJ	O
.	.	O

heparin	NN	B-TREATMENT
discontinued	VBN	O
on	IN	O
01-01	NN	O
when	WRB	O
inr	NN	B-TEST
was	VBD	O
2.0	CD	O
.	.	O

coumadin	NN	B-TREATMENT
was	VBD	O
stopped	VBN	O
and	CC	O
she	PRP	O
received	VBD	O
ffp	NN	B-TREATMENT
for	IN	O
tunneled	JJ	B-TREATMENT
line	NN	I-TREATMENT
change	NN	I-TREATMENT
over	IN	I-TREATMENT
a	DT	I-TREATMENT
wire	NN	I-TREATMENT
.	.	O

coumadin	NN	B-TREATMENT
was	VBD	O
restarted	VBN	O
at	IN	O
a	DT	O
dose	NN	O
of	IN	O
2	CD	O
mg	NN	O
qhs	NN	O
.	.	O

this	DT	O
should	MD	O
be	VB	O
titrated	VBN	O
after	IN	O
discharge	NN	O
for	IN	O
inr	JJ	B-TEST
goal	NN	I-TEST
of	IN	O
2-3	JJ	O
.	.	O

8.	CD	O
pvd	NN	B-PROBLEM
:	:	O

dry	JJ	B-PROBLEM
gangrene	NN	I-PROBLEM
of	IN	I-PROBLEM
toes	NNS	I-PROBLEM
bilaterally	RB	I-PROBLEM
w/	VBP	O
necrosis	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
heels	NNS	I-PROBLEM
and	CC	I-PROBLEM
posterior	JJ	I-PROBLEM
calf	NN	I-PROBLEM
.	.	O

continue	NN	O
to	TO	O
monitor	VB	B-TEST
for	IN	O
sign	NN	O
of	IN	O
infection	NN	B-PROBLEM
.	.	O

on	IN	O
vit	NN	B-TREATMENT
c.	NN	I-TREATMENT
and	CC	O
zinc	NN	B-TREATMENT
as	RB	O
well	RB	O
to	TO	O
aid	VB	O
w/	NN	O
wound	IN	O
healing	NN	O
.	.	O

wound	NN	O
care	NN	O
consult	NN	O
given	VBN	O
anasarca	NN	B-TREATMENT
to	TO	O
prevent	VB	O
decub	NN	B-PROBLEM
.	.	O

9.	CD	O
left	VBD	O
ue	JJ	O
markedly	RB	O
more	RBR	B-PROBLEM
edematous	JJ	I-PROBLEM
than	IN	O
right	JJ	O
ue	NN	O
,	,	O
this	DT	O
could	MD	O
be	VB	O
from	IN	O
fracture	NN	B-PROBLEM
,	,	O
or	CC	O
there	EX	O
could	MD	O
be	VB	O
a	DT	B-PROBLEM
clot	NN	I-PROBLEM
,	,	O
an	DT	B-PROBLEM
abscess	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
area	NN	I-PROBLEM
also	RB	O
a	DT	O
possiblity	NN	O
.	.	O

ultrasound	NN	B-TEST
without	IN	O
clot	NN	B-PROBLEM
.	.	O

continue	VB	O
elevation	NN	B-TREATMENT
and	CC	O
tight	JJ	B-TREATMENT
dressing	VBG	I-TREATMENT
to	TO	I-TREATMENT
lue	VB	I-TREATMENT
>	NN	O

10.	CD	O
access	NN	O
-	:	O
left	VBD	B-TREATMENT
ij	JJ	I-TREATMENT
placed	VBN	O
12-26	JJ	O
in	IN	O
juan	NN	O
was	VBD	O
discontinued	VBN	O
during	IN	O
the	DT	O
hospitilization	NN	O
.	.	O

right	JJ	B-TREATMENT
dialysis	NN	I-TREATMENT
catheter	NN	I-TREATMENT
(	(	O
2018-11-05	JJ	O
)	)	O
was	VBD	O
changed	VBN	O
over	IN	O
a	DT	B-TREATMENT
wire	NN	I-TREATMENT
2019-01-08	JJ	O
.	.	O

picc	JJ	B-TREATMENT
line	NN	I-TREATMENT
placed	VBN	O
2019-01-08	CD	O
,	,	O
this	DT	O
should	MD	O
be	VB	O
discontinued	VBN	O
immediately	RB	O
after	IN	O
pt	NN	O
finishes	VBZ	O
the	DT	B-TREATMENT
linezolid	JJ	I-TREATMENT
course	NN	I-TREATMENT
.	.	O

1.	CD	O
ascorbic	JJ	B-TREATMENT
acid	RB	I-TREATMENT
500	CD	O
mg	NNS	O
bid	NN	O

2.	CD	O
folic	JJ	B-TREATMENT
acid	RB	I-TREATMENT
1	CD	O
mg	NNS	O
daily	RB	O

3.	CD	O
humulin	JJ	B-TREATMENT
insulin	NN	I-TREATMENT
2	CD	O
units	NNS	O
qam	RB	O

4.	CD	O
riss	NN	B-TREATMENT

5.	CD	O
pantoprazole	JJ	B-TREATMENT
40	CD	O
mg	NNS	O
bid	NN	O

6.	CD	O
neutra	JJ	B-TREATMENT
phos	NN	I-TREATMENT
2	CD	O
tabs	NNS	O
bid	NN	O

7.	CD	O
vitamin	NN	B-TREATMENT
b	NN	I-TREATMENT
complex	JJ	I-TREATMENT
1	CD	O
tab	JJ	O
daily	RB	O

8.	CD	O
coumadin	SYM	B-TREATMENT
-	:	O
dose	NN	O
unknown	JJ	O

9.	CD	O
tylenol	JJ	B-TREATMENT
650	CD	O
mg	NN	O
q4h	NN	O
prn	NN	O

10.	CD	O
ondansetron	$	B-TREATMENT
4	CD	O
mg	NN	O
q6h	NN	O
prn	NN	O

1.	CD	O
ascorbic	JJ	B-TREATMENT
acid	RB	I-TREATMENT
500	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

2.	CD	O
folic	JJ	B-TREATMENT
acid	RB	I-TREATMENT
1	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

3.	CD	O
zinc	NN	B-TREATMENT
sulfate	NN	I-TREATMENT
220	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

4.	CD	O
acetaminophen	JJ	B-TREATMENT
325	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
1-2	JJ	O
tablets	NNS	O
po	JJ	O
q4-6h	JJ	O
(	(	O
every	DT	O
4	CD	O
to	TO	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

5.	CD	O
papain	NN	B-TREATMENT
-	:	I-TREATMENT
urea	JJ	I-TREATMENT
544	CD	O
287	CD	O
0616	CD	O
unit	NN	O
-	:	O
mg	NN	O
/	JJ	O
g	NN	O
ointment	JJ	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
appl	RB	O
topical	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

6.	CD	O
ipratropium	NN	B-TREATMENT
bromide	RB	I-TREATMENT
0.02	CD	O
%	NN	O
solution	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
inhalation	NN	O
q4h	NN	O
(	(	O
every	DT	O
4	CD	O
hours	NNS	O
)	)	O
.	.	O

7.	CD	O
calcium	NN	B-TREATMENT
acetate	NN	I-TREATMENT
667	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
tid	NN	O
w/	NN	O
meals	NNS	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
with	IN	O
meals	NNS	O
)	)	O
.	.	O

8.	CD	O
metoprolol	JJ	B-TREATMENT
tartrate	NN	I-TREATMENT
25	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
0.5	CD	O
tablet	NN	O
po	NN	O
tid	NN	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
:	:	O
hold	NN	O
for	IN	O
sbp	JJ	O
<	NN	O
100	CD	O
,	,	O
hr	NN	O
<	VBD	O
60	CD	O
.	.	O

9.	CD	O
fluconazole	JJ	B-TREATMENT
200	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
q24h	NN	O
(	(	O
every	DT	O
24	CD	O
hours	NNS	O
)	)	O
for	IN	O
2	CD	O
days	NNS	O
.	.	O

10.	CD	O
insulin	NN	B-TREATMENT
regular	JJ	I-TREATMENT
human	JJ	I-TREATMENT
300	CD	O
unit	NN	O
/	VBD	O
3	CD	O
ml	JJ	O
insulin	NN	O
pen	JJ	O
sig	NN	O
:	:	O
as	IN	O
directed	VBN	O
subcutaneous	JJ	O
four	CD	O
times	NNS	O
a	DT	O
day	NN	O
:	:	O
please	NN	O
administer	RB	O
8	CD	O
units	NNS	O
glargine	VBP	B-TREATMENT
at	IN	O
dinner	NN	O
and	CC	O
regular	JJ	B-TREATMENT
insulin	NN	I-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT
as	IN	O
prescribed	NN	O
.	.	O

11.	CD	O
warfarin	JJ	B-TREATMENT
2	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
hs	NN	O
(	(	O
at	IN	O
bedtime	NN	O
)	)	O
:	:	O
titrate	NN	O
dose	NN	O
to	TO	O
goal	NN	O
inr	JJ	B-TEST
03-15	NN	O
.	.	O

12.	CD	O
linezolid	JJ	B-TREATMENT
600	CD	O
mg	NN	O
iv	NN	O
q12h	NN	O

13.	CD	O
heparin	JJ	B-TREATMENT
flush	NN	I-TREATMENT
picc	NN	I-TREATMENT
(	(	O
100	CD	O
units	NNS	O
/	NNP	O
ml	NN	O
)	)	O
2	CD	O
ml	JJ	O
iv	JJ	O
daily	JJ	O
:	:	O
prn	NN	O
10	CD	O
ml	NN	O
ns	NN	O
followed	VBN	O
by	IN	O
2	CD	O
ml	NNS	O
of	IN	O
100	CD	O
units	NNS	O
/	VBP	O
ml	JJ	O
heparin	NN	B-TREATMENT
(	(	O
200	CD	O
units	NNS	O
heparin	RB	B-TREATMENT
)	)	O
each	DT	O
lumen	JJ	B-TREATMENT
daily	JJ	O
and	CC	O
prn	NN	O
.	.	O

14.	CD	O
heparin	JJ	B-TREATMENT
flush	NN	I-TREATMENT
cvl	NN	I-TREATMENT
(	(	O
100	CD	O
units	NNS	O
/	NNP	O
ml	NN	O
)	)	O
1	CD	O
ml	JJ	O
iv	JJ	O
daily	JJ	O
:	:	O
prn	NN	O

10ml	CD	O
ns	NN	B-TREATMENT
followed	VBN	O
by	IN	O
1ml	CD	O
of	IN	O
100	CD	O
units/ml	JJ	O
heparin	NN	B-TREATMENT
(	(	O
100	CD	O
units	NNS	O
heparin	RB	B-TREATMENT
)	)	O
each	DT	O
lumen	NNS	B-TREATMENT
qd	VBP	O
and	CC	O
prn	VBP	O
.	.	O

15.	CD	O
dolasetron	NN	B-TREATMENT
mesylate	NN	I-TREATMENT
12.5	CD	O
mg	NN	O
iv	NN	O
q8h	NN	O
:	:	O
prn	NN	O

16.	CD	O
medication	NN	B-TREATMENT

please	VB	O
complete	VB	O
a	DT	O
total	JJ	O
14	CD	O
day	NN	O
course	NN	O
of	IN	O
linezolid	JJ	B-TREATMENT
.	.	O

stop	NN	O
linezolid	NN	B-TREATMENT
on	IN	O
2019-01-17	JJ	O
.	.	O

the	DT	B-TREATMENT
picc	JJ	I-TREATMENT
line	NN	I-TREATMENT
should	MD	O
be	VB	O
discontinued	VBN	O
promptly	RB	O
after	IN	O
the	DT	B-TREATMENT
linezolid	JJ	I-TREATMENT
course	NN	I-TREATMENT
is	VBZ	O
completed	VBN	O
.	.	O

sepsis	NN	B-PROBLEM
-?	CD	O
source	NN	O

chronic	JJ	B-PROBLEM
kidney	NN	I-PROBLEM
disease	NN	I-PROBLEM
-	:	O
on	IN	O
hemodialysis	NN	B-TREATMENT
type	NN	B-PROBLEM
2	CD	I-PROBLEM
diabetes	NNS	I-PROBLEM
hypercholestrolemia	JJ	B-PROBLEM
anemia	NN	B-PROBLEM
of	IN	I-PROBLEM
chornic	JJ	I-PROBLEM
disease	NN	I-PROBLEM
h/o	NN	O
pe	NN	B-PROBLEM
,	,	O
s/p	JJ	B-PROBLEM
pea	NN	I-PROBLEM
arrest	IN	I-PROBLEM
11-14	NN	O

you	PRP	O
were	VBD	O
admitted	VBN	O
with	IN	O
low	JJ	B-PROBLEM
blood	NN	I-PROBLEM
pressure	NN	I-PROBLEM
and	CC	O
fevers	NNS	B-PROBLEM
likely	RB	O
due	JJ	O
to	TO	O
an	DT	B-PROBLEM
infection	NN	I-PROBLEM
.	.	O

although	IN	O
there	EX	O
was	VBD	O
never	RB	O
any	DT	B-PROBLEM
bacteria	NNS	I-PROBLEM
isolated	VBN	O
from	IN	O
the	DT	B-TEST
blood	NN	I-TEST
you	PRP	O
had	VBD	O
some	DT	B-PROBLEM
bacteria	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
urine	NN	I-PROBLEM
which	WDT	O
you	PRP	O
are	VBP	O
being	VBG	O
treated	VBN	O
for	IN	O
.	.	O

it	PRP	O
is	VBZ	O
important	JJ	O
that	IN	O
you	PRP	O
complete	VBP	O
the	DT	B-TREATMENT
antibiotic	JJ	I-TREATMENT
course	NN	I-TREATMENT
as	IN	O
prescribed	NN	O
.	.	O

please	NN	O
continue	VB	O
to	TO	O
take	VB	O
all	DT	B-TREATMENT
medications	NNS	I-TREATMENT
as	IN	O
prescirbed	NN	O
and	CC	O
follow	VB	O
up	RP	O
with	IN	O
all	DT	O
your	PRP$	O
appointments	NNS	O
.	.	O

if	IN	O
you	PRP	O
have	VBP	O
chest	VBN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
diahrrea	NN	B-PROBLEM
or	CC	O
fevers	NNS	B-PROBLEM
please	VBP	O
contact	VB	O
your	PRP$	O
pcp	NN	O
.	.	O

robert	VB	O
the	DT	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
gets	VBZ	O
worse	JJR	O
please	NN	O
return	VB	O
to	TO	O
emergency	NN	O
room	NN	O
.	.	O

if	IN	O
you	PRP	O
have	VBP	O
fevers	NNS	B-PROBLEM
please	VB	O
contact	VB	O
your	PRP$	O
pcp	NN	O
or	CC	O
return	NN	O
to	TO	O
the	DT	O
emergency	NN	O
room	NN	O
.	.	O

medicine	NN	B-TREATMENT

this	DT	O
is	VBZ	O
a	DT	O
59	CD	O
year	NN	O
old	JJ	O
male	NN	O
with	IN	O
a	DT	O
past	JJ	O
medical	JJ	O
history	NN	O
significant	JJ	O
for	IN	O
an	DT	B-TREATMENT
atrioseptal	JJ	I-TREATMENT
defect	NN	I-TREATMENT
repair	NN	I-TREATMENT
at	IN	O
age	NN	O
18	CD	O
,	,	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
with	IN	O
an	DT	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
of	IN	O
45%	CD	O
and	CC	O
a	DT	B-PROBLEM
recent	JJ	I-PROBLEM
cardiac	JJ	I-PROBLEM
myocardial	NN	I-PROBLEM
infarction	NN	I-PROBLEM
,	,	O
pulmonary	JJ	B-PROBLEM
hypertension	NN	I-PROBLEM
and	CC	O
mitral	JJ	B-PROBLEM
regurgitation	NN	I-PROBLEM
,	,	O
and	CC	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
seen	VBN	O
by	IN	O
his	PRP$	O
primary	JJ	O
care	NN	O
physician	JJ	O
the	DT	O
day	NN	O
before	IN	O
admission	NN	O
and	CC	O
complained	VBN	O
of	IN	O
two	CD	O
weeks	NNS	O
of	IN	O
increasing	VBG	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
and	CC	O
fatigue	NN	B-PROBLEM
,	,	O
weight	VBD	B-PROBLEM
gain	NN	I-PROBLEM
and	CC	O
abdominal	JJ	B-PROBLEM
fullness	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
sent	VBN	O
to	TO	O
the	DT	O
emergency	NN	O
department	NN	O
for	IN	O
further	JJ	B-TEST
evaluation	NN	I-TEST
.	.	O

the	DT	O
patient	NN	O
reported	VBD	O
feeling	NN	O
at	IN	O
his	PRP$	O
baseline	NN	O
with	IN	O
chronic	JJ	B-PROBLEM
mild	NNS	I-PROBLEM
dyspnea	VBP	I-PROBLEM
on	IN	O
exertion	NN	O
until	IN	O
two	CD	O
weeks	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
.	.	O

during	IN	O
this	DT	O
period	NN	O
he	PRP	O
had	VBD	O
also	RB	O
been	VBN	O
weaned	VBN	O
off	IN	O
of	IN	O
his	PRP$	B-TREATMENT
digoxin	NN	I-TREATMENT
starting	VBG	O
early	JJ	O
in	IN	O
february	JJ	O
.	.	O

over	IN	O
the	DT	O
two	CD	O
weeks	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
he	PRP	O
had	VBD	O
noticed	VBN	O
an	DT	B-PROBLEM
increasing	VBG	I-PROBLEM
heart	NN	I-PROBLEM
rate	NN	I-PROBLEM
from	IN	O
his	PRP$	O
baseline	NN	O
in	IN	O
the	DT	O
60s	CD	O
to	TO	O
a	DT	B-TEST
heart	NN	I-TEST
rate	NN	I-TEST
in	IN	O
the	DT	O
120s	CD	O
.	.	O

he	PRP	O
had	VBD	O
also	RB	O
some	DT	B-PROBLEM
increased	VBD	I-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
10	CD	I-PROBLEM
pound	NN	I-PROBLEM
weight	VBD	I-PROBLEM
gain	NN	I-PROBLEM
and	CC	O
new	JJ	O
three	CD	O
to	TO	O
four	CD	O
pillow	NN	B-PROBLEM
orthopnea	NN	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
dry	JJ	I-PROBLEM
cough	NN	I-PROBLEM
.	.	O

he	PRP	O
denied	VBD	O
fevers	NNS	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
or	CC	O
vomiting	NN	B-PROBLEM
,	,	O
chest	VBP	B-PROBLEM
pain	NN	I-PROBLEM
or	CC	O
diaphoresis	NN	B-PROBLEM
.	.	O

atrioseptal	JJ	B-TREATMENT
defect	NN	I-TREATMENT
repair	NN	I-TREATMENT
in	IN	O
1970	CD	O
,	,	O
cardiomyopathy	NN	B-PROBLEM
,	,	O
right-sided	JJ	B-PROBLEM
congestive	JJ	I-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
,	,	O
pulmonary	JJ	B-PROBLEM
hypertension	NN	I-PROBLEM
,	,	O
history	NN	O
of	IN	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
and	CC	O
atrial	JJ	B-PROBLEM
flutter	NN	I-PROBLEM
,	,	O
history	NN	O
of	IN	O
prostate	NN	B-PROBLEM
cancer	NN	I-PROBLEM
,	,	O
status	NN	B-TREATMENT
post	NN	I-TREATMENT
brachytherapy	NN	I-TREATMENT
,	,	O
history	NN	O
of	IN	O
rectal	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
,	,	O
obstructive	JJ	B-PROBLEM
sleep	NN	I-PROBLEM
apnea	NN	I-PROBLEM
on	IN	O
cpap	NN	B-TREATMENT
.	.	O

ace	NN	B-TREATMENT
inhibitors	NNS	I-TREATMENT
,	,	O
possible	JJ	O
allergy	NN	B-PROBLEM
to	TO	O
barium	NN	B-TREATMENT
reported	VBN	O
by	IN	O
the	DT	O
patient	NN	O
during	IN	O
a	DT	B-TREATMENT
barium	NN	I-TREATMENT
swallow	JJ	I-TREATMENT
25	CD	O
years	NNS	O
ago	RB	O
.	.	O

digoxin	NN	B-TREATMENT
0.125	CD	O
,	,	O
discontinued	VBD	O
one	CD	O
month	NN	O
prior	RB	O
to	TO	O
admission	NN	O
,	,	O
toprol	NN	B-TREATMENT
xl	VBD	I-TREATMENT
100	CD	O
mg	JJ	O
daily	RB	O
,	,	O
trazodone	NN	B-TREATMENT
50	CD	O
mg	NN	O
once	RB	O
daily	JJ	O
,	,	O
lipitor	JJ	B-TREATMENT
10	CD	O
mg	JJ	O
daily	RB	O
,	,	O
diovan	VBZ	B-TREATMENT
40	CD	O
mg	JJ	O
daily	RB	O
,	,	O
atrovent	JJ	B-TREATMENT
/	NNP	O
albuterol	NN	B-TREATMENT
prn	NN	O
,	,	O
pulmicort	NN	B-TREATMENT
,	,	O
coumadin	VBP	B-TREATMENT
2.5	CD	O
mg	JJ	O
daily	RB	O
,	,	O
vitamin	FW	B-TREATMENT
e	NN	I-TREATMENT
,	,	O
vitamin	FW	B-TREATMENT
c	NN	I-TREATMENT
,	,	O
iron	NN	B-TREATMENT
supplement	NN	I-TREATMENT
.	.	O

white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
10.5	CD	O
,	,	O
hematocrit	NN	B-TEST
38.1	CD	O
,	,	O
platelets	NNS	B-TEST
254	CD	O
,	,	O
inr	RB	B-TEST
1.8	CD	O
.	.	O

sodium	NN	B-TEST
140	CD	O
,	,	O
potassium	NN	B-TEST
5.2	CD	O
,	,	O
bun	NN	B-TEST
38	CD	O
,	,	O
creatinine	NN	B-TEST
.7	NN	O
,	,	O
tsh	NN	B-TEST
1.8	CD	O
,	,	O
digoxin	NN	B-TEST
level	NN	I-TEST
less	JJR	O
than	IN	O
0.2	CD	O
.	.	O

serial	JJ	B-TEST
cardiac	JJ	I-TEST
enzymes	NNS	I-TEST
negative	JJ	O
.	.	O

alt	RB	B-TEST
14	CD	O
,	,	O
ast	RB	B-TEST
31	CD	O
,	,	O
alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
283	CD	O
,	,	O
total	JJ	B-TEST
bilirubin	NN	I-TEST
1.0	CD	O
,	,	O
amylase	NN	B-TEST
71	CD	O
,	,	O
glucose	JJ	B-TEST
tolerance	NN	I-TEST
test	NN	I-TEST
317	CD	O
.	.	O

electrocardiogram	NN	B-TEST
showed	VBD	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
with	IN	O
rapid	JJ	B-PROBLEM
ventricular	JJ	I-PROBLEM
response	NN	I-PROBLEM
and	CC	O
atrial	JJ	B-PROBLEM
flutter	NN	I-PROBLEM
.	.	O

echocardiogram	NN	B-TEST
showed	VBD	O
moderate	JJ	B-PROBLEM
dilated	VBN	I-PROBLEM
left	JJ	I-PROBLEM
atrium	NN	I-PROBLEM
,	,	O
no	DT	O
atrioseptal	JJ	B-PROBLEM
defect	NN	I-PROBLEM
,	,	O
severe	JJ	B-PROBLEM
global	JJ	I-PROBLEM
left	VBD	I-PROBLEM
ventricular	JJ	I-PROBLEM
hypokinesis	NN	I-PROBLEM
with	IN	O
severe	JJ	B-PROBLEM
left	VBN	I-PROBLEM
ventricular	JJ	I-PROBLEM
systolic	JJ	I-PROBLEM
function	NN	I-PROBLEM
and	CC	O
moderately	RB	B-PROBLEM
dilated	VBD	I-PROBLEM
right	JJ	I-PROBLEM
ventricle	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
global	JJ	B-PROBLEM
hypokinesis	NN	I-PROBLEM
apical	JJ	I-PROBLEM
throughout	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
ventricle	NN	I-PROBLEM
and	CC	O
abnormal	JJ	B-PROBLEM
septal	JJ	I-PROBLEM
motion	NN	I-PROBLEM
consistent	NN	O
with	IN	O
right	JJ	B-PROBLEM
ventricular	NN	I-PROBLEM
volume	NN	I-PROBLEM
overload	NN	I-PROBLEM
.	.	O

moderate	NN	B-PROBLEM
to	TO	I-PROBLEM
severe	VB	I-PROBLEM
3+	CD	I-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
and	CC	O
3+	CD	B-PROBLEM
tricuspid	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
along	IN	O
with	IN	O
moderate	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
early	JJ	I-PROBLEM
systolic	JJ	I-PROBLEM
hypertension	NN	I-PROBLEM
.	.	O

of	IN	O
note	NN	O
,	,	O
this	DT	B-TEST
echocardiogram	NN	I-TEST
was	VBD	O
performed	VBN	O
when	WRB	O
the	DT	O
patient	NN	O
was	VBD	O
tachycardiac	JJ	B-PROBLEM
.	.	O

1.	CD	O
hypotension	NN	B-PROBLEM
-	:	O
the	DT	O
patient	NN	O
was	VBD	O
initially	RB	O
mildly	RB	B-PROBLEM
hypotensive	JJ	I-PROBLEM
with	IN	O
systolic	JJ	B-TEST
blood	NN	I-TEST
pressures	NNS	I-TEST
in	IN	O
the	DT	O
80s	CD	O
.	.	O

upon	IN	O
admission	NN	O
it	PRP	O
was	VBD	O
unclear	JJ	O
whether	IN	O
or	CC	O
not	RB	O
the	DT	O
patient	NN	O
was	VBD	O
volume	NN	B-PROBLEM
overloaded	VBD	I-PROBLEM
or	CC	O
volume	NN	B-PROBLEM
depleted	VBN	I-PROBLEM
.	.	O

initially	RB	O
he	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
intravenous	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
with	IN	O
a	DT	O
dramatic	JJ	O
response	NN	O
in	IN	O
his	PRP$	B-TEST
systolic	JJ	I-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
.	.	O

however	RB	O
,	,	O
subsequent	VBD	O
it	PRP	O
was	VBD	O
determined	VBN	O
that	IN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
hypotension	NN	I-PROBLEM
may	MD	O
have	VB	O
been	VBN	O
related	VBN	O
to	TO	O
his	PRP$	B-PROBLEM
rapid	JJ	I-PROBLEM
ventricular	JJ	I-PROBLEM
response	NN	I-PROBLEM
and	CC	O
right	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

therefore	RB	O
the	DT	O
focus	NN	O
of	IN	O
treatment	NN	B-TREATMENT
was	VBD	O
changed	VBN	O
to	TO	O
controlling	VBG	O
his	PRP$	B-TEST
rate	NN	I-TEST
.	.	O

2.	CD	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
-	:	O
the	DT	B-TREATMENT
patient	NN	I-TREATMENT
's	POS	I-TREATMENT
digoxin	NN	I-TREATMENT
had	VBD	O
been	VBN	O
weaned	VBN	O
off	RP	O
prior	JJ	O
to	TO	O
his	PRP$	O
admission	NN	O
.	.	O

it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
this	DT	O
potentially	RB	O
had	VBD	O
lead	VBN	O
to	TO	O
his	PRP$	B-PROBLEM
atrial	JJ	I-PROBLEM
flutter	NN	I-PROBLEM
and	CC	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
with	IN	O
rapid	JJ	B-PROBLEM
ventricular	JJ	I-PROBLEM
response	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
loaded	VBN	O
once	RB	O
again	RB	O
with	IN	O
digoxin	NN	B-TREATMENT
and	CC	O
his	PRP$	B-TREATMENT
beta	NN	I-TREATMENT
blocker	NN	I-TREATMENT
was	VBD	O
increased	VBN	O
to	TO	O
100	CD	O
mg	NN	O
of	IN	O
lopressor	NN	B-TREATMENT
,	,	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
.	.	O

in	IN	O
addition	NN	O
the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
verapamil	NN	B-TREATMENT
since	IN	O
his	PRP$	B-TEST
heart	NN	I-TEST
rate	NN	I-TEST
had	VBD	O
remained	VBN	O
mildly	RB	B-PROBLEM
tachycardiac	JJ	I-PROBLEM
in	IN	O
the	DT	O
low	JJ	O
100s	CD	O
.	.	O

3.	CD	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
-	:	O
during	IN	O
the	DT	O
initial	JJ	O
course	NN	O
of	IN	O
the	DT	O
patient	NN	O
's	POS	O
admission	NN	O
,	,	O
it	PRP	O
was	VBD	O
unclear	JJ	O
as	IN	O
to	TO	O
whether	IN	O
or	CC	O
not	RB	O
he	PRP	O
was	VBD	O
volume	NN	B-PROBLEM
overloaded	VBD	I-PROBLEM
or	CC	O
volume	NN	B-PROBLEM
depleted	VBN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
initially	RB	O
treated	VBN	O
with	IN	O
intravenous	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
,	,	O
however	RB	O
,	,	O
subsequently	RB	O
he	PRP	O
was	VBD	O
diuresed	VBN	O
when	WRB	O
he	PRP	O
became	VBD	O
symptomatic	JJ	B-PROBLEM
and	CC	O
short	JJ	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

chest	JJS	B-TEST
x-rays	NNS	I-TEST
revealed	VBD	O
evidence	NN	O
of	IN	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

the	DT	O
decision	NN	O
was	VBD	O
made	VBN	O
to	TO	O
have	VB	O
the	DT	O
patient	NN	O
undergo	VBZ	O
a	DT	B-TEST
cardiac	JJ	I-TEST
catheterization	NN	I-TEST
to	TO	O
fully	RB	O
evaluate	VB	O
the	DT	O
hemodynamics	NNS	O
to	TO	O
determine	VB	O
the	DT	O
etiology	NN	O
of	IN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

in	IN	O
addition	NN	O
,	,	O
plans	NNS	O
were	VBD	O
made	VBN	O
to	TO	O
evaluate	VB	O
the	DT	O
patient	NN	O
's	POS	O
cardiac	JJ	O
arteries	NNS	O
to	TO	O
determine	VB	O
if	IN	O
he	PRP	O
had	VBD	O
any	DT	O
component	NN	O
of	IN	O
ischemic	JJ	B-PROBLEM
cardiomyopathy	NN	I-PROBLEM
.	.	O

4.	CD	O
abnormal	JJ	B-TEST
liver	NN	I-TEST
function	NN	I-TEST
tests	VBZ	I-TEST
-	:	O
the	DT	O
patient	NN	O
had	VBD	O
an	DT	B-PROBLEM
isolated	VBN	I-PROBLEM
,	,	I-PROBLEM
elevated	JJ	I-PROBLEM
alkaline	NN	I-PROBLEM
phosphatase	NN	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
confirmatory	JJ	I-PROBLEM
elevation	NN	I-PROBLEM
in	IN	O
his	PRP$	B-TEST
gamma	NN	I-TEST
glutamyl	NN	I-TEST
transferase	NN	I-TEST
.	.	O

an	DT	B-TEST
ultrasound	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
right	JJ	I-TEST
upper	JJ	I-TEST
quadrant	NN	I-TEST
did	VBD	O
not	RB	O
reveal	VB	O
any	DT	B-PROBLEM
cholelithiasis	NN	I-PROBLEM
or	CC	O
cholecystitis	NN	B-PROBLEM
,	,	O
however	RB	O
,	,	O
an	DT	B-PROBLEM
irregular	JJ	I-PROBLEM
hepatic	JJ	I-PROBLEM
contour	NN	I-PROBLEM
was	VBD	O
seen	VBN	O
which	WDT	O
is	VBZ	O
suggestive	JJ	O
of	IN	O
underlying	VBG	B-PROBLEM
chronic	JJ	I-PROBLEM
liver	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
some	DT	O
concern	NN	O
that	IN	O
the	DT	O
patient	NN	O
may	MD	O
have	VB	O
a	DT	B-PROBLEM
partial	JJ	I-PROBLEM
biliary	JJ	I-PROBLEM
obstruction	NN	I-PROBLEM
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
sent	VBN	O
for	IN	O
an	DT	B-TEST
magnetic	JJ	I-TEST
resonance	NN	I-TEST
cholangiopancreatography	NN	I-TEST
to	TO	O
further	JJ	O
evaluate	VB	O
the	DT	O
biliary	JJ	O
system	NN	O
.	.	O

magnetic	JJ	B-TEST
resonance	NN	I-TEST
cholangiopancreatography	NN	I-TEST
did	VBD	O
not	RB	O
reveal	VB	O
any	DT	O
evidence	NN	O
of	IN	O
biliary	JJ	B-PROBLEM
dilatation	NN	I-PROBLEM
or	CC	O
of	IN	O
any	DT	B-PROBLEM
obstructing	VBG	I-PROBLEM
pancreatic	JJ	I-PROBLEM
mass	NN	I-PROBLEM
.	.	O

again	RB	O
seen	VBN	O
was	VBD	O
a	DT	B-PROBLEM
slightly	RB	I-PROBLEM
irregular	JJ	I-PROBLEM
contour	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
liver	NN	I-PROBLEM
with	IN	O
dilated	JJ	B-PROBLEM
hepatic	JJ	I-PROBLEM
veins	NNS	I-PROBLEM
suggesting	VBG	O
chronic	JJ	B-PROBLEM
hepatic	JJ	I-PROBLEM
vascular	JJ	I-PROBLEM
congestion	NN	I-PROBLEM
.	.	O

it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
he	PRP	O
may	MD	O
have	VB	O
had	VBD	O
some	DT	O
component	NN	O
of	IN	O
vascular	JJ	B-PROBLEM
congestion	NN	I-PROBLEM
from	IN	O
his	PRP$	B-PROBLEM
congestive	JJ	I-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
possibly	RB	O
some	DT	B-PROBLEM
mild	JJ	I-PROBLEM
cirrhotic	JJ	I-PROBLEM
changes	NNS	I-PROBLEM
secondary	VBP	O
to	TO	O
his	PRP$	O
previous	JJ	O
alcohol	NN	O
use	NN	O
.	.	O

he	PRP	O
did	VBD	O
not	RB	O
sleep	VB	O
at	IN	O
all	PDT	O
the	DT	O
night	NN	O
before	IN	O
and	CC	O
was	VBD	O
extremely	RB	B-PROBLEM
fatigued	VBN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
walking	VBG	O
in	IN	O
the	DT	O
hall	NN	O
,	,	O
dragging	VBG	O
his	PRP$	B-TREATMENT
intravenous	JJ	I-TREATMENT
pole	NN	I-TREATMENT
when	WRB	O
he	PRP	O
tripped	VBD	O
over	IN	O
the	DT	O
foot	NN	O
of	IN	O
the	DT	O
pole	NN	O
and	CC	O
lost	VBD	O
his	PRP$	O
balance	NN	O
.	.	O

his	PRP$	B-TEST
neurological	JJ	I-TEST
examination	NN	I-TEST
at	IN	O
that	DT	O
time	NN	O
was	VBD	O
nonfocal	JJ	O
and	CC	O
the	DT	O
head	NN	O
was	VBD	O
atraumatic	JJ	B-PROBLEM
without	IN	O
any	DT	O
evidence	NN	O
of	IN	O
a	DT	B-PROBLEM
hematoma	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
computerized	JJ	I-TEST
axial	JJ	I-TEST
tomography	NN	I-TEST
scan	NN	I-TEST
of	IN	I-TEST
his	PRP$	I-TEST
head	NN	I-TEST
at	IN	O
that	DT	O
time	NN	O
did	VBD	O
not	RB	O
reveal	VB	O
any	DT	B-PROBLEM
extra	JJ	I-PROBLEM
or	CC	I-PROBLEM
intracranial	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
.	.	O

6.	CD	O
rectal	JJ	B-PROBLEM
bleeding	VBG	I-PROBLEM
-	:	O
the	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
rectal	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
,	,	O
ever	RB	O
since	IN	O
his	PRP$	B-TREATMENT
brachytherapy	NN	I-TREATMENT
for	IN	O
his	PRP$	B-PROBLEM
prostate	NN	I-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
been	VBN	O
treated	VBN	O
with	IN	O
argon	NN	B-TREATMENT
laser	NN	I-TREATMENT
therapy	NN	I-TREATMENT
in	IN	O
the	DT	O
past	NN	O
for	IN	O
his	PRP$	B-PROBLEM
rectal	JJ	I-PROBLEM
bleeding	NN	I-PROBLEM
and	CC	O
it	PRP	O
is	VBZ	O
recommended	VBN	O
that	IN	O
he	PRP	O
follow	VB	O
up	RP	O
with	IN	O
his	PRP$	O
gastroenterologist	NN	O
for	IN	O
repeat	NN	B-TREATMENT
argon	NN	I-TREATMENT
laser	NN	I-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

internal	JJ	B-TREATMENT
medicine	NN	I-TREATMENT

her	PRP$	O
renal	JJ	O
function	NN	O
significantly	RB	O
improved	VBN	O
,	,	O
and	CC	O
her	PRP$	B-TEST
discharge	NN	I-TEST
creatinine	NN	I-TEST
was	VBD	O
3.1	CD	O
.	.	O

of	IN	O
note	NN	O
,	,	O
her	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
significantly	RB	O
improved	VBN	O
in	IN	O
the	DT	O
120s-130s	JJ	O
which	WDT	O
assured	VBD	O
better	JJR	O
perfusion	NN	O
in	IN	O
her	PRP$	O
kidneys	NNS	O
.	.	O

she	PRP	O
received	VBD	O
intermittent	JJ	O
doses	NNS	O
of	IN	O
lasix	NN	B-TREATMENT
to	TO	O
assure	VB	O
overall	JJ	O
negative	JJ	O
intakes	NNS	O
and	CC	O
outputs	NNS	O
.	.	O

she	PRP	O
progressed	VBD	O
beautifully	RB	O
with	IN	O
physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
and	CC	O
occupational	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
and	CC	O
was	VBD	O
able	JJ	O
to	TO	O
ambulate	VB	O
with	IN	O
assistance	NN	O
.	.	O

she	PRP	O
has	VBZ	O
very	RB	B-PROBLEM
mild	JJ	I-PROBLEM
left	VBD	I-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
pain	NN	I-PROBLEM
which	WDT	O
is	VBZ	O
largely	RB	O
unchanged	JJ	O
.	.	O

1.	CD	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

2.	CD	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

3.	CD	O
acute	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

4.	CD	O
acute	JJ	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

5.	CD	O
osteomyelitis	NN	B-PROBLEM
.	.	O

6.	CD	O
diabetes	NNS	B-PROBLEM
mellitus	NN	I-PROBLEM
.	.	O

1.	CD	O
amiodarone	NN	B-TREATMENT
200	CD	O
mg	NN	O
p.o.	NN	O
q	JJ	O
day	NN	O
.	.	O

2.	CD	O
warfarin	JJ	B-TREATMENT
3	CD	O
mg	NN	O
p.o.	NN	O
q	VBD	O
h.s.	NN	O

3.	CD	O
renagel	NN	B-TREATMENT
1600	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O

4.	CD	O
aspirin	JJ	B-TREATMENT
325	CD	O
mg	NN	O
p.o.	NN	O
q	JJ	O
day	NN	O
.	.	O

5.	CD	O
miconazole	JJ	B-TREATMENT
powder	NN	I-TREATMENT
2%	CD	O
t.i.d.	NN	O

6.	CD	O
levofloxacin	JJ	B-TREATMENT
250	CD	O
mg	NN	O
p.o.	NN	O
q48	NN	O
hours	NNS	O
for	IN	O
the	DT	O
next	JJ	O
five	CD	O
weeks	NNS	O
for	IN	O
osteomyelitis	NN	B-PROBLEM
.	.	O

7.	CD	O
flagyl	JJ	B-TREATMENT
500	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O
for	IN	O
the	DT	O
next	JJ	O
five	CD	O
weeks	NNS	O
for	IN	O
osteomyelitis	NN	B-PROBLEM
.	.	O

8.	CD	O
protonix	JJ	B-TREATMENT
40	CD	O
mg	NN	O
p.o.	NN	O
q	JJ	O
day	NN	O
.	.	O

9.	CD	O
magnesium	NN	B-TREATMENT
oxide	RB	I-TREATMENT
800	CD	O
mg	NNS	O
p.o.	JJ	O
b.i.d.	NN	O

10.	CD	O
epogen	NN	B-TREATMENT
5000	CD	O
units	NNS	O
two	CD	O
times	NNS	O
weekly	RB	O
,	,	O
on	IN	O
monday	NN	O
and	CC	O
thursday	NN	O
.	.	O

11.	CD	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

12.	CD	O
lasix	JJ	B-TREATMENT
80	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

13.	CD	O
nph	JJ	B-TREATMENT
insulin	NN	I-TREATMENT
7	CD	O
units	NNS	O
in	IN	O
the	DT	O
morning	NN	O
and	CC	O
5	CD	O
units	NNS	O
at	IN	O
night	NN	O
.	.	O

14.	CD	O
regular	JJ	B-TREATMENT
insulin	NN	I-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT
.	.	O

tape	NN	O
/	VBZ	O
benadryl	NN	B-TREATMENT

chest	NN	B-PROBLEM
discomfort	NN	I-PROBLEM

2015-10-30	JJ	O
left	VBD	B-TREATMENT
carotid	NN	I-TREATMENT
stenting	NN	I-TREATMENT

2015-11-02	JJ	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
x	$	O
2	CD	O
(	(	O
lima	NN	B-TREATMENT
to	TO	I-TREATMENT
lad	VB	I-TREATMENT
,	,	O
svg	VB	B-TREATMENT
to	TO	I-TREATMENT
om	VB	I-TREATMENT
)	)	O

ms.	NN	O
bridge	NN	O
is	VBZ	O
a	DT	O
74	CD	O
y/o	NN	O
female	NN	O
admitted	VBD	O
to	TO	O
outside	JJ	O
hospital	NN	O
on	IN	O
2015-10-21	JJ	O
with	IN	O
chest	JJS	B-PROBLEM
discomfort	NN	I-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
and	CC	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

initial	JJ	B-TEST
ekg	NN	I-TEST
showed	VBD	O
st	JJ	B-PROBLEM
depressions	NNS	I-PROBLEM
,	,	O
but	CC	O
cardiac	JJ	B-TEST
enzymes	NNS	I-TEST
were	VBD	O
not	RB	O
elevated	VBN	B-PROBLEM
.	.	O

she	PRP	O
eventually	RB	O
underwent	VBD	O
a	DT	B-TEST
cardiac	JJ	I-TEST
cath	NN	I-TEST
to	TO	O
assess	VB	O
coronary	JJ	B-PROBLEM
disease	NN	I-PROBLEM
which	WDT	O
revealed	VBD	O
three	CD	B-PROBLEM
vessel	NN	I-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
then	RB	O
transferred	VBN	O
to	TO	O
the	DT	O
hospital	NN	O
for	IN	O
orthopedics	NNS	O
for	IN	O
surgical	JJ	B-TREATMENT
intervention	NN	I-TREATMENT
.	.	O

coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
hypertension	NN	B-PROBLEM
,	,	O
hyperlipidemia	NN	B-PROBLEM
,	,	O
diabetes	VBZ	B-PROBLEM
mellitus	NN	I-PROBLEM
,	,	O
hypothyroid	NN	B-PROBLEM
,	,	O
h/o	JJ	O
bilateral	JJ	B-PROBLEM
dvt	NN	I-PROBLEM
's	POS	I-PROBLEM
(	(	O
on	IN	O
chronic	NN	B-TREATMENT
coumadin	NN	I-TREATMENT
therapy	NN	I-TREATMENT
),	NNP	O
pleural	JJ	B-PROBLEM
disorder	NN	I-PROBLEM
?	.	O
sarcoidosis	NN	B-PROBLEM
,	,	O
gastritis	NN	B-PROBLEM
,	,	O
b12	JJ	B-PROBLEM
deficiency	NN	I-PROBLEM
,	,	O
chronic	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
,	,	O
s/p	JJ	O
appendectomy	NN	B-TREATMENT
,	,	O
s/p	JJ	O
lap	NN	B-TREATMENT
cholectomy	NN	I-TREATMENT
,	,	O
s/p	JJ	O
total	JJ	B-TREATMENT
abdominal	JJ	I-TREATMENT
hysterectomy	NN	I-TREATMENT

mother	NN	O
died	VBD	O
of	IN	O
mi	NN	B-PROBLEM
at	IN	O
age	NN	O
55	CD	O
.	.	O

brother	NN	O
w/	NN	O
cad	NN	B-PROBLEM
since	IN	O
age	NN	O
40	CD	O
and	CC	O
died	VBD	O
in	IN	O
70	CD	O
's	POS	O
after	IN	O
cardiac	JJ	B-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

son	NN	O
died	VBD	O
at	IN	O
14	CD	O
d/t	NN	O
asd	NN	B-PROBLEM
.	.	O

gen	NN	O
:	:	O
nad	NN	B-PROBLEM

neck	NN	O
:	:	O
supple	NN	O
,	,	O
-	:	O
jvd	NN	B-PROBLEM
,	,	O
-	:	O
bruits	NNS	B-PROBLEM

heart	NN	O
:	:	O
rrr	NN	O
-	:	O
c/r/m/g	NN	B-PROBLEM

lungs	NNS	O
:	:	O
ctab	NN	O
,	,	O
coarse	NN	B-PROBLEM

abd	NN	O
:	:	O
soft	JJ	O
,	,	O
nt/nt	JJ	B-PROBLEM
+	NN	O
bs	NN	O

ext	NN	O
:	:	O
cool	NN	O
,	,	O
1	CD	O
+	NN	O
pedal	NN	B-TEST
pulses	NNS	I-TEST
,	,	O
-	:	O
varicosities	NNS	B-PROBLEM
,	,	O
-	:	O
edema	NN	B-PROBLEM

some	DT	B-PROBLEM
rashes	NNS	I-PROBLEM
on	IN	I-PROBLEM
acw	NN	I-PROBLEM
around	IN	O
ekg	JJ	B-TREATMENT
leads	NNS	I-TREATMENT

cnis	JJ	B-TEST
10-29	NNS	O
:	:	O

1.	CD	O
60-69%	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
internal	JJ	I-PROBLEM
carotid	NN	I-PROBLEM
artery	NN	I-PROBLEM
.	.	O

2.	CD	O
80-99%	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
internal	JJ	I-PROBLEM
carotid	NN	I-PROBLEM
artery	NN	I-PROBLEM
.	.	O

echo	JJ	B-TEST
11-02	JJ	O
:	:	O
pre-bypass	NN	O
:	:	O
left	VBD	O
ventricular	JJ	O
wall	NN	O
thickness	NN	O
,	,	O
cavity	NN	O
size	NN	O
,	,	O
and	CC	O
systolic	JJ	O
function	NN	O
are	VBP	O
normal	JJ	O
(	(	O
lvef>55%	JJ	B-TEST
).	NN	O

resting	VBG	B-PROBLEM
regional	JJ	I-PROBLEM
wall	NN	I-PROBLEM
motion	NN	I-PROBLEM
abnormalities	NNS	I-PROBLEM
include	VBP	O
mild	JJ	B-PROBLEM
apical	JJ	I-PROBLEM
hypokinesis	NN	I-PROBLEM
.	.	O

the	DT	O
aortic	JJ	O
valve	NN	O
leaflets	NNS	O
(	(	O
3	CD	O
)	)	O
appear	VBP	O
structurally	RB	O
normal	JJ	O
with	IN	O
good	JJ	O
leaflet	NN	O
excursion	NN	O
and	CC	O
no	DT	O
aortic	JJ	B-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

the	DT	O
mitral	JJ	O
valve	NN	O
appears	VBZ	O
structurally	RB	O
normal	JJ	O
with	IN	O
trivial	JJ	B-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

there	EX	O
are	VBP	O
complex	JJ	B-PROBLEM
(>	$	I-PROBLEM
4	CD	I-PROBLEM
mm	NN	I-PROBLEM
)	)	I-PROBLEM
atheroma	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
descending	NN	I-PROBLEM
thoracic	NN	I-PROBLEM
aorta	NN	I-PROBLEM
.	.	O

mild	JJ	B-PROBLEM
tricuspid	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

trivial	JJ	B-PROBLEM
mr	NN	I-PROBLEM
.	.	O

ct	JJ	B-TEST
11-04	JJ	O
:	:	O
no	DT	O
acute	JJ	B-PROBLEM
intracranial	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
.	.	O

findings	NNS	O
consistent	JJ	O
with	IN	O
small	JJ	B-PROBLEM
vessel	NNS	I-PROBLEM
ischemic	JJ	I-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

mri	NN	B-TEST
would	MD	O
be	VB	O
more	RBR	O
sensitive	JJ	O
for	IN	O
the	DT	O
detection	NN	O
of	IN	O
acute	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

ct	NN	B-TEST
angiogram	NN	I-TEST
demonstrates	VBZ	O
no	DT	O
stenosis	NN	B-PROBLEM
or	CC	O
aneurysm	NN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
intracranial	JJ	I-PROBLEM
circulation	NN	I-PROBLEM
.	.	O

slight	JJ	B-PROBLEM
irregularity	NN	I-PROBLEM
of	IN	O
the	DT	O
origin	NN	O
of	IN	O
the	DT	O
right	JJ	O
vertebral	JJ	O
artery	NN	O
may	MD	O
be	VB	O
atherosclerotic	JJ	B-PROBLEM
in	IN	O
nature	NN	O
.	.	O

normal	JJ	O
contrast	NN	O
enhancement	NN	O
seen	VBN	O
in	IN	O
the	DT	B-TREATMENT
left	JJ	I-TREATMENT
common/internal	JJ	I-TREATMENT
carotid	NN	I-TREATMENT
artery	NN	I-TREATMENT
stent	NN	I-TREATMENT
.	.	O

mild	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
proximal	JJ	I-PROBLEM
right	JJ	I-PROBLEM
internal	JJ	I-PROBLEM
carotid	NN	I-PROBLEM
artery	NN	I-PROBLEM
.	.	O

4	CD	B-PROBLEM
mm	NN	I-PROBLEM
left	VBD	I-PROBLEM
upper	JJ	I-PROBLEM
lobe	NN	I-PROBLEM
lung	NN	I-PROBLEM
nodule	NN	I-PROBLEM
.	.	O

in	IN	O
the	DT	O
absence	NN	O
of	IN	O
history	NN	O
of	IN	O
malignancy	NN	B-PROBLEM
,	,	O
this	DT	O
is	VBZ	O
statistically	RB	O
benign	JJ	O
.	.	O

cxr	JJ	B-TEST
11-06	JJ	O
:	:	O
allowing	VBG	O
for	IN	O
technical	JJ	O
changes	NNS	O
,	,	O
no	DT	O
major	JJ	B-PROBLEM
adverse	JJ	I-PROBLEM
interval	NN	I-PROBLEM
change	NN	I-PROBLEM
has	VBZ	O
occurred	VBN	O
.	.	O

bibasilar	JJ	B-PROBLEM
subsegmental	JJ	I-PROBLEM
atelectasis	NN	I-PROBLEM
together	RB	O
with	IN	O
bilateral	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
appear	VBP	O
relatively	RB	O
unchanged	JJ	O
.	.	O

left-sided	JJ	B-TREATMENT
subclavian	JJ	I-TREATMENT
line	NN	I-TREATMENT
is	VBZ	O
unchanged	JJ	O
in	IN	O
position	NN	O
.	.	O

there	EX	O
is	VBZ	O
evidence	NN	O
of	IN	O
prior	JJ	B-TREATMENT
cardiac	JJ	I-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

2015-11-13	JJ	O
06:15	CD	O
am	VBP	O
blood	NN	O
wbc	NN	B-TEST
-	:	O
8.8	CD	O
rbc	NN	B-TEST
-	:	O
2.79	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
8.6	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
25.4	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
91	CD	O
mch	SYM	B-TEST
-	:	O
30.9	CD	O
mchc	SYM	B-TEST
-	:	O
33.8	CD	O
rdw	NN	B-TEST
-	:	O
15.6	CD	O
*	JJ	O
plt	NN	B-TEST
ct	SYM	I-TEST
-	:	O
583	CD	O
*	NN	O

2015-11-12	JJ	O
06:00	CD	O
am	VBP	O
blood	NN	O
wbc	NN	B-TEST
-	:	O
7.7	CD	O
rbc	NN	B-TEST
-	:	O
2.73	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
8.3	CD	O
*	NN	O
hct	NN	B-TEST
-	:	I-TEST
25.1	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
92	CD	O
mch	SYM	B-TEST
-	:	O
30.4	CD	O
mchc	SYM	B-TEST
-	:	O
33.1	CD	O
rdw	NN	B-TEST
-	:	O
15.5	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
528	CD	O
*	NN	O

2015-11-13	JJ	O
06:15	CD	O
am	VBP	O
blood	NN	O
plt	NN	B-TEST
ct	VBD	I-TEST
-	:	O
583	CD	O
*	NN	O

2015-11-13	JJ	O
06:15	CD	O
am	VBP	O
blood	NN	O
pt	NN	B-TEST
-	:	O
18.0	CD	O
*	NN	O
ptt	NN	B-TEST
-	:	O
62.3	CD	O
*	NN	O
inr(pt)	NN	B-TEST
-	:	O
1.7	CD	O
*	NN	O

2015-11-12	JJ	O
06:00	CD	O
am	VBP	O
blood	NN	O
pt	NN	B-TEST
-	:	O
15.5	CD	O
*	NN	O
ptt	NN	B-TEST
-	:	O
62.4	CD	O
*	NN	O
inr(pt)	NN	B-TEST
-	:	O
1.4	CD	O
*	NN	O

2015-11-11	JJ	O
05:45	CD	O
am	VBP	O
blood	NN	O
pt	NN	B-TEST
-	:	O
14.5	CD	O
*	NN	O
ptt	NN	B-TEST
-	:	O
51.4	CD	O
*	NN	O
inr(pt)	NN	B-TEST
-	:	O
1.3	CD	O
*	NN	O

2015-11-13	JJ	O
06:15	CD	O
am	VBP	O
blood	NN	O
glucose	JJ	B-TEST
-	:	O
96	CD	O
urean	JJ	B-TEST
-	:	O
20	CD	O
creat	NN	B-TEST
-	:	O
1.6	CD	O
*	NN	O
na	SYM	B-TEST
-	:	O
141	CD	O
k	SYM	B-TEST
-	:	O
4.3	CD	O
cl	NN	B-TEST
-	:	O
106	CD	O
hco3	NN	B-TEST
-	:	O
24	CD	O
angap	NN	B-TEST
-	:	O
15	CD	O

2015-11-12	JJ	O
06:00	CD	O
am	VBP	O
blood	NN	O
glucose	JJ	B-TEST
-	:	O
85	CD	O
urean	JJ	B-TEST
-	:	O
19	CD	O
creat	NN	B-TEST
-	:	O
1.6	CD	O
*	NN	O
na	SYM	B-TEST
-	:	O
140	CD	O
k	SYM	B-TEST
-	:	I-TEST
4.4	CD	O
cl	NN	B-TEST
-	:	O
105	CD	O
hco3	NN	B-TEST
-	:	O
24	CD	O
angap	NN	B-TEST
-	:	I-TEST
15	CD	O

2015-11-11	JJ	O
05:45	CD	O
am	VBP	O
blood	NN	O
creat	NN	B-TEST
-	:	O
1.6	CD	O
*	NN	O
k	SYM	B-TEST
-	:	O
4.7	CD	O

2015-10-28	JJ	O
03:30	CD	O
pm	NN	O
blood	NN	O
glucose	VB	B-TEST
-	:	O
98	CD	O
urean	JJ	B-TEST
-	:	O
26	CD	O
*	NN	O
creat	NN	B-TEST
-	:	O
1.6	CD	O
*	NN	O
na	SYM	B-TEST
-	:	O
140	CD	O
k	SYM	B-TEST
-	:	O
4.6	CD	O
cl	NN	B-TEST
-	:	O
104	CD	O
hco3	NN	B-TEST
-	:	O
27	CD	O
angap	NN	B-TEST
-	:	O
14	CD	O

ms.	NN	O
bridge	NN	O
was	VBD	O
admitted	VBN	O
from	IN	O
osh	NN	O
for	IN	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

she	PRP	O
underwent	JJ	O
usual	JJ	B-TEST
pre-operative	JJ	I-TEST
testing	VBG	I-TEST
along	IN	O
with	IN	O
carotid	NN	B-TEST
ultrasound	NN	I-TEST
.	.	O

cnis	NN	B-TEST
revealed	VBD	O
carotid	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
and	CC	O
she	PRP	O
ultimately	RB	O
underwent	JJ	O
left	VBD	B-TREATMENT
carotid	JJ	I-TREATMENT
stenting	NN	I-TREATMENT
by	IN	O
vascular	JJ	O
surgery	NN	O
on	IN	O
10-30	NNS	O
.	.	O

on	IN	O
11-02	JJ	O
she	PRP	O
was	VBD	O
brought	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
where	WRB	O
she	PRP	O
underwent	VBD	O
a	DT	B-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
x	VBD	O
2	CD	O
.	.	O

she	PRP	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
and	CC	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
csru	NN	O
for	IN	O
invasive	JJ	B-TEST
monitoring	NN	I-TEST
in	IN	O
stable	JJ	O
condition	NN	O
.	.	O

later	RB	O
on	IN	O
op	JJ	O
day	NN	O
sedation	NN	B-TREATMENT
was	VBD	O
weaned	VBN	O
,	,	O
she	PRP	O
awoke	VBD	O
neurologically	RB	O
intact	JJ	O
and	CC	O
was	VBD	O
extubated	VBN	B-TREATMENT
.	.	O

on	IN	O
post-op	JJ	O
day	NN	O
one	CD	O
chest	NN	B-TREATMENT
tubes	NNS	I-TREATMENT
were	VBD	O
removed	VBN	O
and	CC	O
beta	JJ	B-TREATMENT
blockers	NNS	I-TREATMENT
and	CC	O
diuretics	NNS	B-TREATMENT
were	VBD	O
initiated	VBN	O
.	.	O

early	RB	O
on	IN	O
post-op	JJ	O
day	NN	O
two	CD	O
ms.	NN	O
bridge	NN	O
had	VBD	O
an	DT	O
episode	NN	O
of	IN	O
aphasia	NN	B-PROBLEM
.	.	O

she	PRP	O
underwent	VBD	O
an	DT	B-TEST
immediate	JJ	I-TEST
head	NN	I-TEST
ct	NN	I-TEST
and	CC	O
neuro	JJ	O
consult	NN	O
and	CC	O
was	VBD	O
transferred	VBN	O
back	RB	O
to	TO	O
the	DT	O
csru	NN	O
.	.	O

ct	NN	B-TEST
was	VBD	O
negative	JJ	O
and	CC	O
she	PRP	O
returned	VBD	O
to	TO	O
baseline	VB	O
neuro	JJ	O
status	NN	O
without	IN	O
deficits	NNS	B-PROBLEM
by	IN	O
arrival	NN	O
to	TO	O
csru	VB	O
.	.	O

neurology	NN	O
concluded	VBD	O
episode	NN	B-PROBLEM
was	VBD	O
most	RBS	O
concerning	VBG	O
for	IN	O
tia	NN	B-PROBLEM
.	.	O

epicardial	JJ	B-TREATMENT
pacing	NN	I-TREATMENT
wires	NNS	I-TREATMENT
were	VBD	O
removed	VBN	O
on	IN	O
post-op	JJ	O
day	NN	O
four	CD	O
.	.	O

after	IN	O
remaining	VBG	O
stable	JJ	O
in	IN	O
the	DT	O
csru	NN	O
for	IN	O
several	JJ	O
days	NNS	O
without	IN	O
change	NN	B-PROBLEM
in	IN	I-PROBLEM
neuro	NN	I-PROBLEM
status	NN	I-PROBLEM
she	PRP	O
was	VBD	O
transferred	VBN	O
back	RB	O
to	TO	O
the	DT	O
sdu	NN	O
on	IN	O
post-op	JJ	O
day	NN	O
four	CD	O
.	.	O

she	PRP	O
was	VBD	O
then	RB	O
started	VBN	O
on	IN	O
heparin	NN	B-TREATMENT
with	IN	O
transition	NN	O
to	TO	O
coumadin	VB	B-TREATMENT
(	(	O
goal	NN	O
inr	NN	B-TEST
of	IN	O
2-3	JJ	O
secondary	JJ	O
to	TO	O
h/o	VB	O
bilateral	JJ	B-PROBLEM
dvt	NN	I-PROBLEM
's).	NN	O

complications	NNS	B-PROBLEM
.	.	O

meds	NNS	B-TREATMENT
at	IN	O
home	NN	O
:	:	O
coumadin	NN	B-TREATMENT
,	,	O
levoxyl	NN	B-TREATMENT
,	,	O
folate	NN	B-TREATMENT
,	,	O
colace	NN	B-TREATMENT
,	,	O
byetta	NN	B-TREATMENT
,	,	O
verapamil	NN	B-TREATMENT
,	,	O
lisinopril	NN	B-TREATMENT
,	,	O
pravachol	NN	B-TREATMENT
,	,	O
nexium	NN	B-TREATMENT
,	,	O
lasix	NN	B-TREATMENT
,	,	O
celexa	NN	B-TREATMENT

meds	NNS	B-TREATMENT
at	IN	O
transfer	NN	O
:	:	O
levoxyl	NN	B-TREATMENT
,	,	O
celexa	NN	B-TREATMENT
,	,	O
folate	NN	B-TREATMENT
,	,	O
lopressor	NN	B-TREATMENT
,	,	O
colace	NN	B-TREATMENT
,	,	O
riss	NN	B-TREATMENT
,	,	O
b12	NN	B-TREATMENT
,	,	O
protonix	NN	B-TREATMENT
,	,	O
lasix	NN	B-TREATMENT
,	,	O
zocor	NN	B-TREATMENT
,	,	O
verapamil	NN	B-TREATMENT
,	,	O
lovenox	NN	B-TREATMENT
,	,	O
lisinopril	NN	B-TREATMENT

1.	CD	O
aspirin	JJ	B-TREATMENT
81	CD	O
mg	JJ	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

2.	CD	O
pantoprazole	JJ	B-TREATMENT
40	CD	O
mg	JJ	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
q24h	NN	O
(	(	O
every	DT	O
24	CD	O
hours	NNS	O
).	VBP	O

3.	CD	O
levothyroxine	JJ	B-TREATMENT
125	CD	O
mcg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

4.	CD	O
simvastatin	JJ	B-TREATMENT
40	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

5.	CD	O
citalopram	NN	B-TREATMENT
20	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
0.5	CD	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

6.	CD	O
clopidogrel	NN	B-TREATMENT
75	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

7.	CD	O
ferrous	JJ	B-TREATMENT
gluconate	NN	I-TREATMENT
300	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

8.	CD	O
ascorbic	JJ	B-TREATMENT
acid	RB	I-TREATMENT
500	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

9.	CD	O
folic	JJ	B-TREATMENT
acid	RB	I-TREATMENT
1	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

10.	CD	O
metoprolol	JJ	B-TREATMENT
tartrate	NN	I-TREATMENT
25	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

11.	CD	O
docusate	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
100	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

12.	CD	O
coumadin	NN	B-TREATMENT
5	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
once	RB	O
a	DT	O
day	NN	O
:	:	O
check	VB	O
inr	JJ	B-TEST
11-15	JJ	O
with	IN	O
results	NNS	O
called	VBN	O
to	TO	O
dr.	VB	O
lynn	NN	O
.	.	O

13.	CD	O
tramadol	JJ	B-TREATMENT
50	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
q4-6h	NN	O
(	(	O
every	DT	O
4	CD	O
to	TO	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

14.	CD	O
lasix	JJ	B-TREATMENT
40	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
once	RB	O
a	DT	O
day	NN	O
:	:	O
40	CD	O
mg	NNS	O
daily	JJ	O
x	RB	O
1	CD	O
week	NN	O
then	RB	O
40	CD	O
mg	NNS	O
every	DT	O
other	JJ	O
day	NN	O
as	IN	O
prior	JJ	O
to	TO	O
surgery	NN	B-TREATMENT
.	.	O

coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
s/p	VBD	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
x	VBD	O
2	CD	O

post-operative	JJ	B-PROBLEM
transient	NN	I-PROBLEM
ischemic	JJ	I-PROBLEM
attack	NN	I-PROBLEM

carotid	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
s/p	NN	O
left	VBD	B-TREATMENT
carotid	NN	I-TREATMENT
stenting	NN	I-TREATMENT

pmh	NN	O
:	:	O
hypertension	NN	B-PROBLEM
,	,	O
hyperlipidemia	NN	B-PROBLEM
,	,	O
diabetes	VBZ	B-PROBLEM
mellitus	NN	I-PROBLEM
,	,	O
hypothyroid	NN	B-PROBLEM
,	,	O
h/o	JJ	O
bilateral	JJ	B-PROBLEM
dvt	NN	I-PROBLEM
's,	POS	I-PROBLEM
pleural	JJ	B-PROBLEM
disorder	NN	I-PROBLEM
?	.	O
sarcoidosis	NN	B-PROBLEM
,	,	O
gastritis	NN	B-PROBLEM
,	,	O
b12	JJ	B-PROBLEM
deficiency	NN	I-PROBLEM
,	,	O
chronic	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
,	,	O
s/p	JJ	O
appendectomy	NN	B-TREATMENT
,	,	O
s/p	JJ	O
lap	NN	B-TREATMENT
cholectomy	NN	I-TREATMENT
,	,	O
s/p	JJ	O
total	JJ	B-TREATMENT
abdominal	JJ	I-TREATMENT
hysterectomy	NN	I-TREATMENT

no	DT	O
creams	NN	B-TREATMENT
,	,	O
lotions	NNS	B-TREATMENT
or	CC	O
ointments	NNS	B-TREATMENT
to	TO	O
incisions	NNS	B-PROBLEM
.	.	O

no	DT	O
lifting	VBG	O
more	JJR	O
than	IN	O
10	CD	O
lbs	NN	O
for	IN	O
at	IN	O
least	JJS	O
10	CD	O
weeks	NNS	O
from	IN	O
the	DT	O
date	NN	O
of	IN	O
surgery	NN	B-TREATMENT
.	.	O

monitor	NN	O
wounds	NNS	B-PROBLEM
for	IN	O
signs	NNS	B-PROBLEM
of	IN	I-PROBLEM
infection	NN	I-PROBLEM
.	.	O
please	VB	O
call	JJ	O
with	IN	O
any	DT	O
concerns	NNS	O
or	CC	O
questions	NNS	O
.	.	O

briefly	NN	O
,	,	O
this	DT	O
is	VBZ	O
a	DT	O
57-year-old	JJ	O
gentleman	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
copd	NN	B-PROBLEM
,	,	O
status	NN	O
post	NN	O
intubation	NN	B-TREATMENT
six	CD	O
years	NNS	O
ago	RB	O
but	CC	O
not	RB	O
on	IN	O
home	NN	B-TREATMENT
02	CD	I-TREATMENT
with	IN	O
recent	JJ	O
fev1	JJ	B-TEST
27%	CD	O
of	IN	O
predicted	VBN	O
value	NN	O
,	,	O
and	CC	O
fev1/fvc	VB	B-TEST
ratio	NN	I-TEST
56%	CD	O
of	IN	O
hypercholesterolemia	NN	B-PROBLEM
,	,	O
who	WP	O
was	VBD	O
admitted	VBN	O
for	IN	O
copd	JJ	B-PROBLEM
exacerbation	NN	I-PROBLEM
and	CC	O
worsening	NN	O
of	IN	O
upper	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
tract	JJ	I-PROBLEM
infection	NN	I-PROBLEM
symptoms	NNS	I-PROBLEM
for	IN	O
a	DT	O
week	NN	O
prior	RB	O
to	TO	O
admission	NN	O
.	.	O

he	PRP	O
was	VBD	O
afebrile	JJ	B-PROBLEM
with	IN	O
stable	JJ	O
vital	JJ	O
signs	NNS	O
on	IN	O
presentation	NN	O
to	TO	O

he	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
p.o.	NN	B-TREATMENT
steroids	NNS	I-TREATMENT
and	CC	O
to	TO	O
cmed	VB	O
for	IN	O
management	NN	B-TREATMENT
of	IN	O
copd	JJ	B-PROBLEM
exacerbation	NN	I-PROBLEM
but	CC	O
he	PRP	O
appeared	VBD	O
in	IN	O
more	RBR	B-PROBLEM
respiratory	JJ	I-PROBLEM
distress	NN	I-PROBLEM
overnight	NN	O
and	CC	O
was	VBD	O
started	VBN	O
on	IN	O
iv	NN	B-TREATMENT
solu-medrol	NN	I-TREATMENT
and	CC	O
more	JJR	B-TREATMENT
frequent	JJ	I-TREATMENT
nebulizers	NNS	I-TREATMENT
for	IN	O
copd	NN	B-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
also	RB	O
started	VBN	O
on	IN	O
antibiotics	NNS	B-TREATMENT
for	IN	O
possible	JJ	O
bronchitis	NN	B-PROBLEM
or	CC	O
community-acquired	JJ	B-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

given	VBN	O
his	PRP$	B-PROBLEM
tenuous	JJ	I-PROBLEM
respiratory	NN	I-PROBLEM
status	NN	I-PROBLEM
,	,	O
he	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
ficu	NN	O
with	IN	O
closer	JJR	B-TEST
observation	NN	I-TEST
.	.	O

he	PRP	O
did	VBD	O
not	RB	O
require	VB	O
intubation	NN	B-TREATMENT
and	CC	O
improved	VBN	O
with	IN	O
q.	JJ	O
two	CD	O
hour	NN	O
nebulizers	NNS	B-TREATMENT
and	CC	O
chest	JJS	B-TREATMENT
pt	NN	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
again	RB	O
transferred	VBN	O
to	TO	O
the	DT	O
cmed	JJ	O
service	NN	O
for	IN	O
further	JJ	B-TREATMENT
management	NN	I-TREATMENT
of	IN	O
his	PRP$	B-PROBLEM
copd	NN	I-PROBLEM
exacerbation	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
p.o.	NN	B-TREATMENT
prednisone	NN	I-TREATMENT
and	CC	O
frequent	JJ	B-TREATMENT
nebulizers	NNS	I-TREATMENT
for	IN	O
copd	NN	B-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
evaluated	VBN	O
by	IN	O
the	DT	O
physical	JJ	O
therapist	NN	O
in	IN	O
the	DT	O
hospital	NN	O
and	CC	O
was	VBD	O
found	VBN	O
to	TO	O
desaturate	VB	B-PROBLEM
to	TO	O
84%	CD	O
with	IN	O
ambulating	VBG	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

therefore	RB	O
,	,	O
home	NN	B-TREATMENT
02	CD	I-TREATMENT
was	VBD	O
recommended	VBN	O
on	IN	O
discharge	NN	O
.	.	O

1.	CD	O
chronic	JJ	B-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
exacerbation	NN	I-PROBLEM
.	.	O

2.	CD	O
bronchitis	NN	B-PROBLEM
.	.	O

3.	CD	O
community-acquired	JJ	B-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

4.	CD	O
rule	NN	O
out	IN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

1.	CD	O
flovent	JJ	B-TREATMENT
two	CD	O
puffs	NNS	O
b.i.d.	VBP	O

2.	CD	O
levofloxacin	JJ	B-TREATMENT
500	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
for	IN	O
another	DT	O
11	CD	O
days	NNS	O
for	IN	O
a	DT	O
total	NN	O
of	IN	O
a	DT	O
14	CD	O
day	NN	O
course	NN	O
.	.	O

3.	CD	O
albuterol	NN	B-TREATMENT
inhaler	NN	I-TREATMENT
one	CD	O
to	TO	O
two	CD	O
puffs	NNS	O
q.	RB	O
four	CD	O
to	TO	O
six	CD	O
hours	NNS	O
p.r.n.	VBP	O

4.	CD	O
aspirin	JJ	B-TREATMENT
81	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

5.	CD	O
salmeterol	NN	B-TREATMENT
one	CD	O
to	TO	O
two	CD	O
puffs	NNS	O
b.i.d.	VBP	O

6.	CD	O
oxygen	NN	B-TREATMENT
2	CD	I-TREATMENT
liters	NNS	I-TREATMENT
nasal	JJ	I-TREATMENT
cannula	NN	I-TREATMENT
with	IN	O
ambulating	VBG	O
as	IN	O
needed	VBN	O
.	.	O

7.	CD	O
prednisone	NN	B-TREATMENT
taper	NN	I-TREATMENT
with	IN	O
40	CD	O
mg	NNS	O
p.o.	JJ	O
q.d.	NNS	O
for	IN	O
two	CD	O
days	NNS	O
,	,	O
30	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
for	IN	O
two	CD	O
days	NNS	O
,	,	O
20	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
for	IN	O
two	CD	O
days	NNS	O
,	,	O
10	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
for	IN	O
two	CD	O
days	NNS	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
47	CD	O
year	NN	O
old	JJ	O
male	NN	O
,	,	O
with	IN	O
end	JJ	B-PROBLEM
stage	NN	I-PROBLEM
liver	JJ	I-PROBLEM
disease	NN	I-PROBLEM
secondary	JJ	O
to	TO	O
hepatitis	VB	B-PROBLEM
c	JJ	I-PROBLEM
cirrhosis	NN	I-PROBLEM
diagnosed	VBD	O
about	IN	O
5	CD	O
years	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
undergone	JJ	O
treatment	NN	B-TREATMENT
with	IN	O
interferon	NN	B-TREATMENT
and	CC	O
ribavirin	NN	B-TREATMENT
.	.	O

he	PRP	O
had	VBD	O
been	VBN	O
admitted	VBN	O
to	TO	O
the	DT	O
st.	NN	O
margaret	NN	O
's	POS	O
center	NN	O
for	IN	O
women	NNS	O
&	CC	O
infants	NNS	O
multiple	JJ	O
times	NNS	O
early	RB	O
in	IN	O
2013	CD	O
for	IN	O
management	NN	B-TREATMENT
of	IN	O
encephalopathy	NN	B-PROBLEM
and	CC	O
ascites	NNS	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
been	VBN	O
discharged	VBN	O
from	IN	O
the	DT	O
st.	NN	O
margaret	NN	O
's	POS	O
center	NN	O
for	IN	O
women	NNS	O
&	CC	O
infants	NNS	O
on	IN	O
2013-05-06	JJ	O
,	,	O
but	CC	O
was	VBD	O
readmitted	VBN	O
on	IN	O
2013-05-09	JJ	O
when	WRB	O
noted	VBN	O
to	TO	O
have	VB	O
worsening	VBG	B-PROBLEM
renal	JJ	I-PROBLEM
function	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
serum	JJ	I-TEST
creatinine	NN	I-TEST
on	IN	O
the	DT	O
day	NN	O
of	IN	O
discharge	NN	O
,	,	O
on	IN	O
2013-05-06	JJ	O
,	,	O
was	VBD	O
1.9	CD	O
,	,	O
but	CC	O
was	VBD	O
noted	VBN	O
to	TO	O
increase	VB	O
to	TO	O

3.2	CD	O
on	IN	O
2013-05-08	JJ	O
,	,	O
and	CC	O
was	VBD	O
further	RB	B-PROBLEM
elevated	VBN	I-PROBLEM
to	TO	O
3.6	CD	O
on	IN	O
2013-05-09	JJ	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
with	IN	O
concern	NN	O
for	IN	O
hepatorenal	JJ	B-PROBLEM
syndrome	NN	I-PROBLEM
.	.	O

1.	CD	O
hepatitis	NN	B-PROBLEM
c	NN	I-PROBLEM
cirrhosis	NN	I-PROBLEM
for	IN	O
which	WDT	O
the	DT	O
patient	NN	O
was	VBD	O
on	IN	O
the	DT	O
liver	NN	O
transplant	JJ	O
list	NN	O
.	.	O

2.	CD	O
hypertension	NN	B-PROBLEM
.	.	O

3.	CD	O
nephrolithiasis	NN	B-PROBLEM
.	.	O

4.	CD	O
hemorrhoids	NNS	B-PROBLEM
.	.	O

5.	CD	O
knee	NN	B-TREATMENT
surgeries	NNS	I-TREATMENT
.	.	O

6.	CD	O
back	RB	B-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

1.	CD	O
miconazole	JJ	B-TREATMENT
nitrate	JJ	I-TREATMENT
powder	NN	I-TREATMENT
tid	NN	O
prn	NN	O
for	IN	O
groin	NN	B-PROBLEM
rash	NN	I-PROBLEM
.	.	O

2.	CD	O
protonix	JJ	B-TREATMENT
40	CD	O
mg	JJ	O
po	NN	O
bid	NN	O
.	.	O

3.	CD	O
lactulose	JJ	B-TREATMENT
30	CD	O
ml	NN	O
tid	NN	O
(	(	O
titrated	VBN	O
to	TO	O
4	CD	O
to	TO	O
5	CD	O
bowel	NN	O
movements	NNS	O
qd	NN	O
)	)	O
.	.	O

4.	CD	O
vancomycin	NN	B-TREATMENT
1	CD	O
gm	JJ	O
iv	JJ	O
bid	NN	O
.	.	O

as	IN	O
previously	RB	O
mentioned	VBN	O
,	,	O
the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
creatinine	NN	I-TEST
at	IN	O
the	DT	O
time	NN	O
of	IN	O
admission	NN	O
was	VBD	O
up	RB	O
to	TO	O
3.6	CD	O
from	IN	O
1.9	CD	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
his	PRP$	O
discharge	NN	O
3	CD	O
days	NNS	O
prior	RB	O
.	.	O

over	IN	O
the	DT	O
following	JJ	O
5	CD	O
days	NNS	O
,	,	O
the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
creatinine	NN	I-TEST
improved	VBN	O
marginally	RB	O
to	TO	O
2.7	CD	O
.	.	O

optimization	NN	O
of	IN	O
his	PRP$	B-TEST
fluid	NN	I-TEST
balance	NN	I-TEST
was	VBD	O
managed	VBN	O
by	IN	O
the	DT	O
medical	JJ	O
service	NN	O
in	IN	O
consultation	NN	O
with	IN	O
hepatology	NN	O
and	CC	O
renal	NN	O
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
inr	NN	I-TEST
on	IN	O
admission	NN	O
was	VBD	O
2.4	CD	O
,	,	O
with	IN	O
his	PRP$	B-TEST
pt	NN	I-TEST
level	NN	I-TEST
being	VBG	O
18.9	CD	O
.	.	O

the	DT	O
patient	NN	O
periodically	RB	O
required	JJ	O
transfusions	NNS	B-TREATMENT
of	IN	O
fresh	JJ	B-TREATMENT
frozen	JJ	I-TREATMENT
plasma	NN	I-TREATMENT
,	,	O
as	RB	O
well	RB	O
as	IN	O
platelets	NNS	B-TREATMENT
and	CC	O
red	JJ	B-TREATMENT
cells	NNS	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
thrombocytopenic	JJ	B-PROBLEM
with	IN	O
a	DT	B-TEST
platelet	NN	I-TEST
count	NN	I-TEST
of	IN	O
49	CD	O
on	IN	O
the	DT	O
23	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
vancomycin	NN	B-TREATMENT
therapy	NN	I-TREATMENT
for	IN	O
his	PRP$	B-PROBLEM
previously	RB	I-PROBLEM
diagnosed	VBN	I-PROBLEM
methicillin	NN	I-PROBLEM
resistant	NN	I-PROBLEM
,	,	I-PROBLEM
coagulase	NN	I-PROBLEM
negative	JJ	I-PROBLEM
staph	NN	I-PROBLEM
bacteremia	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
's	POS	O
nutrition	NN	O
was	VBD	O
suboptimal	JJ	O
,	,	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
tube	NN	B-TREATMENT
feeding	NN	I-TREATMENT
.	.	O

the	DT	O
patient	JJ	O
underwent	JJ	O
diagnostic	JJ	O
and	CC	O
therapeutic	JJ	B-TREATMENT
paracentesis	NN	I-TREATMENT
on	IN	O
2013-05-16	JJ	O
,	,	O
2013-05-21	JJ	O
,	,	O
and	CC	O
2013-05-24	JJ	O
.	.	O

he	PRP	O
had	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
spontaneous	JJ	B-PROBLEM
bacterial	JJ	I-PROBLEM
peritonitis	NN	I-PROBLEM
.	.	O

on	IN	O
2013-05-25	JJ	O
,	,	O
a	DT	O
liver	NN	O
became	VBD	O
available	JJ	O
for	IN	O
transplant	NN	B-TREATMENT
to	TO	O
the	DT	O
patient	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
and	CC	O
underwent	JJ	O
an	DT	B-TREATMENT
orthotopic	NN	I-TREATMENT
liver	NN	I-TREATMENT
transplant	NN	I-TREATMENT
.	.	O

in	IN	O
order	NN	O
to	TO	O
aid	NN	O
in	IN	O
optimization	NN	O
of	IN	O
the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
fluid	NN	I-TEST
status	NN	I-TEST
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
on	IN	O
continuous	JJ	B-TREATMENT
baker	NN	I-TREATMENT
baker	NN	I-TREATMENT
dialysis	NN	I-TREATMENT
during	IN	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
.	.	O

his	PRP$	B-PROBLEM
estimated	VBN	I-PROBLEM
blood	NN	I-PROBLEM
loss	NN	I-PROBLEM
was	VBD	O
2	CD	O
liters	NNS	O
.	.	O

the	DT	O
patient	NN	O
received	VBD	O
5	CD	O
liters	NNS	O
of	IN	O
crystalloid	NN	B-TREATMENT
,	,	O
9	CD	O
units	NNS	O
of	IN	O
fresh	JJ	B-TREATMENT
frozen	JJ	I-TREATMENT
plasma	NN	I-TREATMENT
,	,	O
9	CD	O
units	NNS	O
of	IN	O
red	JJ	B-TREATMENT
cells	NNS	I-TREATMENT
,	,	O
6	CD	O
units	NNS	O
of	IN	O
platelets	NNS	B-TREATMENT
,	,	O
as	RB	O
well	RB	O
as	IN	O
1	CD	O
liter	NN	O
of	IN	O
cell	NN	B-TREATMENT
saver	NN	I-TREATMENT
.	.	O

the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
proceeded	VBD	O
without	IN	O
complications	NNS	B-PROBLEM
,	,	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
while	IN	O
still	RB	O
intubated	VBN	B-TREATMENT
following	VBG	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
.	.	O

by	IN	O
postop	JJ	O
day	NN	O
1	CD	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
awake	RB	O
,	,	O
in	IN	O
no	DT	O
distress	NN	B-PROBLEM
,	,	O
and	CC	O
appeared	VBD	O
lucid	RB	O
prior	JJ	O
to	TO	O
extubation	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
extubated	VBN	O
on	IN	O
postop	JJ	O
day	NN	O
1	CD	O
without	IN	O
any	DT	B-PROBLEM
problems	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
on	IN	O
a	DT	B-TREATMENT
lasix	JJ	I-TREATMENT
drip	NN	I-TREATMENT
to	TO	O
aid	NN	O
in	IN	O
diuresis	NN	B-TREATMENT
,	,	O
and	CC	O
was	VBD	O
ultimately	RB	O
converted	VBN	O
to	TO	O
oral	JJ	B-TREATMENT
lasix	NN	I-TREATMENT
on	IN	O
postop	JJ	O
day	NN	O
1	CD	O
.	.	O

the	DT	B-TREATMENT
patient	NN	I-TREATMENT
's	POS	I-TREATMENT
pain	NN	I-TREATMENT
control	NN	I-TREATMENT
was	VBD	O
with	IN	O
morphine	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
required	VBD	O
2	CD	O
units	NNS	O
of	IN	O
fresh	JJ	B-TREATMENT
frozen	JJ	I-TREATMENT
plasma	NN	I-TREATMENT
on	IN	O
the	DT	O
night	NN	O
following	VBG	O
surgery	NN	B-TREATMENT
,	,	O
and	CC	O
1	CD	O
unit	NN	O
of	IN	O
platelets	NNS	B-TREATMENT
on	IN	O
postop	JJ	O
day	NN	O
1	CD	O
,	,	O
but	CC	O
otherwise	RB	O
required	JJ	O
no	DT	O
blood	NN	B-TREATMENT
products	NNS	I-TREATMENT
following	VBG	O
the	DT	B-TREATMENT
liver	NN	I-TREATMENT
transplant	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
advanced	VBN	O
per	IN	O
protocol	NN	O
to	TO	O
an	DT	B-TREATMENT
immunosuppressive	JJ	I-TREATMENT
regimen	NN	I-TREATMENT
of	IN	O
prednisone	NN	B-TREATMENT
,	,	O
neoral	JJ	B-TREATMENT
,	,	O
and	CC	O
cellcept	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
started	VBD	O
ambulating	VBG	O
with	IN	O
the	DT	O
assistance	NN	O
of	IN	O
physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
following	VBG	O
transfer	NN	O
to	TO	O
the	DT	O
surgical	JJ	O
floor	NN	O
.	.	O

the	DT	O
patient	NN	O
's	POS	O
appetite	NN	O
improved	VBD	O
significantly	RB	O
,	,	O
and	CC	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
the	DT	O
patient	NN	O
was	VBD	O
on	IN	O
a	DT	O
regular	JJ	O
diet	NN	O
with	IN	O
no	DT	O
tube	NN	B-TREATMENT
feed	VBD	I-TREATMENT
supplements	NNS	I-TREATMENT
deemed	VBN	O
necessary	JJ	O
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
liver	JJ	I-TEST
function	NN	I-TEST
tests	NNS	I-TEST
all	DT	O
improved	VBN	O
appropriately	RB	O
by	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
.	.	O

the	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
surgical	JJ	I-PROBLEM
incision	NN	I-PROBLEM
was	VBD	O
also	RB	O
healing	VBG	O
well	RB	O
by	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
with	IN	O
no	DT	O
evidence	NN	O
of	IN	O
infection	NN	B-PROBLEM
.	.	O

1.	CD	O
bactrim	JJ	B-TREATMENT
single	JJ	I-TREATMENT
strength	NN	I-TREATMENT
1	CD	O
tablet	NN	O
po	NN	O
qd	NN	O
.	.	O

2.	CD	O
protonix	JJ	B-TREATMENT
40	CD	O
mg	NN	O
po	NN	O
qd	NN	O
.	.	O

3.	CD	O
metoprolol	JJ	B-TREATMENT
25	CD	O
mg	JJ	O
po	NN	O
bid	NN	O
.	.	O

4.	CD	O
fluconazole	JJ	B-TREATMENT
200	CD	O
mg	NN	O
po	NN	O
qd	NN	O
.	.	O

5.	CD	O
cellcept	VBD	B-TREATMENT
1	CD	O
gm	JJ	O
po	NN	O
bid	NN	O
.	.	O

6.	CD	O
prednisone	NN	B-TREATMENT
20	CD	O
mg	NN	O
po	NN	O
qd	NN	O
.	.	O

7.	CD	O
dilaudid	JJ	B-TREATMENT
prn	NN	O
.	.	O

8.	CD	O
neoral	JJ	B-TREATMENT
500	CD	O
mg	JJ	O
po	NN	O
bid	NN	O
.	.	O

9.	CD	O
valcyte	JJ	B-TREATMENT
450	CD	O
mg	NN	O
po	NN	O
qod	NN	O
.	.	O

10.	CD	O
lasix	JJ	B-TREATMENT
40	CD	O
mg	JJ	O
bid	NN	O
x	VBZ	O
21	CD	O
days	NNS	O
.	.	O

11.	CD	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
po	NN	O
bid	NN	O
.	.	O

liver	RB	B-TREATMENT
transplant	NN	I-TREATMENT
on	IN	O
2013-05-25	JJ	O
.	.	O

cadaveric	JJ	B-TREATMENT
pancreas	JJ	I-TREATMENT
transplantation	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
37	CD	O
year	NN	O
old	JJ	O
lady	NN	O
with	IN	O
type	JJ	B-PROBLEM
1	CD	I-PROBLEM
diabetes	NNS	I-PROBLEM
mellitus	RB	I-PROBLEM
,	,	O
who	WP	O
is	VBZ	O
four	CD	O
months	NNS	O
postcadaveric	JJ	B-TREATMENT
kidney	NN	I-TREATMENT
transplantation	NN	I-TREATMENT
and	CC	O
now	RB	O
has	VBZ	O
good	JJ	O
graft	NN	O
function	NN	O
.	.	O

she	PRP	O
presents	VBZ	O
for	IN	O
cadaveric	JJ	B-TREATMENT
pancreas	JJ	I-TREATMENT
transplantation	NN	I-TREATMENT
.	.	O

her	PRP$	B-PROBLEM
diabetes	NNS	I-PROBLEM
mellitus	NN	I-PROBLEM
has	VBZ	O
been	VBN	O
complicated	VBN	O
by	IN	O
retinopathy	NN	B-PROBLEM
and	CC	O
nephropathy	JJ	B-PROBLEM
as	RB	O
well	RB	O
as	IN	O
peripheral	JJ	B-PROBLEM
neuropathy	NN	I-PROBLEM
.	.	O

she	PRP	O
takes	VBZ	O
14	CD	O
units	NNS	O
of	IN	O
nph	JJ	B-TREATMENT
insulin	NN	I-TREATMENT
twice	RB	O
a	DT	O
day	NN	O
supplementing	VBG	O
with	IN	O
a	DT	B-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT
.	.	O

on	IN	O
examination	NN	B-TEST
,	,	O
she	PRP	O
is	VBZ	O
in	IN	O
no	DT	O
apparent	JJ	B-PROBLEM
distress	NN	I-PROBLEM
and	CC	O
is	VBZ	O
alert	JJ	O
and	CC	O
oriented	VBN	O
.	.	O

her	PRP$	B-TEST
chest	NN	I-TEST
and	CC	I-TEST
cardiovascular	JJ	I-TEST
examinations	NNS	I-TEST
are	VBP	O
unremarkable	JJ	O
.	.	O

she	PRP	O
is	VBZ	O
afebrile	JJ	B-PROBLEM
with	IN	O
stable	JJ	O
vital	JJ	O
signs	NNS	O
.	.	O

her	PRP$	O
abdomen	NNS	O
is	VBZ	O
soft	JJ	O
and	CC	O
nontender	NN	B-PROBLEM
with	IN	O
a	DT	B-PROBLEM
well	NN	I-PROBLEM
healed	VBN	I-PROBLEM
left	VBD	I-PROBLEM
lower	RBR	I-PROBLEM
quadrant	JJ	I-PROBLEM
incision	NN	I-PROBLEM
from	IN	O
her	PRP$	B-TREATMENT
kidney	NN	I-TREATMENT
transplantation	NN	I-TREATMENT
.	.	O

she	PRP	O
underwent	JJ	O
cadaveric	JJ	B-TREATMENT
pancreas	NNS	I-TREATMENT
transplantation	NN	I-TREATMENT
without	IN	O
complication	NN	B-PROBLEM
.	.	O

she	PRP	O
received	VBD	O
induction	NN	B-TREATMENT
therapy	NN	I-TREATMENT
with	IN	O
thymoglobulin	JJ	B-TREATMENT
intraoperative	JJ	O
and	CC	O
postoperatively	RB	O
for	IN	O
five	CD	O
days	NNS	O
.	.	O

she	PRP	O
was	VBD	O
kept	VBN	O
on	IN	O
a	DT	B-TREATMENT
similar	JJ	I-TREATMENT
immunosuppressive	JJ	I-TREATMENT
regimen	NNS	I-TREATMENT
as	IN	O
with	IN	O
her	PRP$	B-TREATMENT
kidney	NN	I-TREATMENT
transplant	NN	I-TREATMENT
.	.	O

she	PRP	O
is	VBZ	O
to	TO	O
continue	VB	O
monitoring	VBG	O
her	PRP$	B-TEST
blood	NN	I-TEST
sugar	NN	I-TEST
twice	RB	O
a	DT	O
day	NN	O
.	.	O

she	PRP	O
has	VBZ	O
undergone	JJ	O
full	JJ	O
teaching	NN	O
in	IN	O
regards	NNS	O
to	TO	O
immunosuppressant	VB	B-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

in	IN	O
addition	NN	O
,	,	O
she	PRP	O
will	MD	O
take	VB	O
valganciclovir	NN	B-TREATMENT
for	IN	O
three	CD	O
months	NNS	O
posttransplant	VBP	O
.	.	O

1.	CD	O
status	NN	O
post	NN	O
cadaveric	JJ	B-TREATMENT
pancreas	NN	I-TREATMENT
transplant	NN	I-TREATMENT
.	.	O

2.	CD	O
type	NN	B-PROBLEM
1	CD	I-PROBLEM
diabetes	NNS	I-PROBLEM
mellitus	NN	I-PROBLEM
.	.	O

3.	CD	O
end	NN	B-PROBLEM
stage	NN	I-PROBLEM
renal	JJ	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
kidney	NN	B-TREATMENT
transplantation	NN	I-TREATMENT
.	.	O

penicillins	NNS	B-TREATMENT
/	VBP	O
sulfonamides	NNS	B-TREATMENT

benzo	NN	B-PROBLEM
overdose	NN	I-PROBLEM

intubation	NN	B-TREATMENT
for	IN	I-TREATMENT
airway	NN	I-TREATMENT
protection	NN	I-TREATMENT

ms.	NN	O
franklin	NN	O
is	VBZ	O
a	DT	O
34	CD	O
-	:	O
year-old	JJ	O
woman	NN	O
with	IN	O
bipolar	JJ	B-PROBLEM
disorder	NN	I-PROBLEM
and	CC	O
group	NN	O
home	NN	O
resident	NN	O
who	WP	O
by	IN	O
way	NN	O
of	IN	O
ems	NNS	O
for	IN	O
apparent	JJ	B-PROBLEM
alprazolam	NN	I-PROBLEM
overdose	NN	I-PROBLEM
.	.	O

in	IN	O
the	DT	O
st.	NN	O
margaret	NN	O
's	POS	O
center	NN	O
for	IN	O
women	NNS	O
&	CC	O
infants	NNS	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
lethargic	JJ	B-PROBLEM
and	CC	O
unable	JJ	O
to	TO	O
give	VB	O
a	DT	O
history	NN	O
.	.	O

she	PRP	O
was	VBD	O
promptly	RB	O
intubated	VBN	O
for	IN	O
airway	NN	O
protection	NN	O
and	CC	O
in	IN	O
order	NN	O
to	TO	O
administer	VB	O
charcoal	NN	B-TREATMENT
.	.	O

patient	NN	O
was	VBD	O
found	VBN	O
at	IN	O
group	NN	O
home	NN	O
in	IN	O
am	VBP	O
laying	VBG	O
on	IN	O
floor	NN	O
by	IN	O
bed	NN	O
unresponsive	JJ	B-PROBLEM
,	,	O
last	JJ	O
seen	VBN	O
awake	RB	O
8	CD	O
hours	NNS	O
prior	RB	O
at	IN	O
dinner	NN	O
.	.	O

group	NN	O
home	NN	O
states	NNS	O
that	WDT	O
patient	VBP	O
"	NN	O
may	MD	O
have	VB	O
taken	VBN	O
too	RB	O
many	JJ	O
xanax	NNS	B-TREATMENT
.	.	O

patient	NN	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
suicidal	JJ	B-PROBLEM
ideations	NNS	I-PROBLEM
and	CC	O
self	JJ	B-PROBLEM
mutilation	NN	I-PROBLEM
.	.	O

later	RB	O
patient	JJ	O
told	VBD	O
cmed	VBN	O
ccu	NN	O
that	IN	O
she	PRP	O
was	VBD	O
feeling	VBG	O
down	RB	O
and	CC	O
impulsively	RB	O
ingested	JJ	O
5	CD	O
days	NNS	O
worth	IN	O
of	IN	O
medications	NNS	B-TREATMENT
,	,	O
she	PRP	O
states	VBZ	O
that	IN	O
her	PRP$	O
intent	NN	O
at	IN	O
that	DT	O
time	NN	O
was	VBD	O
to	TO	O
end	VB	O
her	PRP$	O
life	NN	O
.	.	O

1.	CD	O
bipolar	JJ	B-PROBLEM
disorder	NN	I-PROBLEM
.	.	O

2.	CD	O
asthma	NN	B-PROBLEM
.	.	O

3.	CD	O
posttraumatic	JJ	B-PROBLEM
stress	NN	I-PROBLEM
disorder	NN	I-PROBLEM
.	.	O

4.	CD	O
gerd	NN	B-PROBLEM

5.	CD	O
chronic	JJ	B-PROBLEM
constipation	NN	I-PROBLEM
from	IN	O
laxative	JJ	B-PROBLEM
abuse	NN	I-PROBLEM
.	.	O

two	CD	O
sisters	NNS	O
with	IN	O
h/o	JJ	O
depression	NN	B-PROBLEM
and	CC	O
suicidality	NN	B-PROBLEM
.	.	O

vs	NN	B-TEST
95.4	CD	O
hr	NN	B-TEST
62	CD	O
bp	NN	B-TEST
99/70	CD	O
rr	NN	B-TEST
20	CD	O
o2sat	VBD	B-TEST
100%	CD	O

intubated	VBN	B-TREATMENT
and	CC	O
sedated	VBN	B-TREATMENT

atnc	NN	B-PROBLEM
,	,	O
pupils	NNS	O
dialted	VBD	O
at	IN	O
5	CD	O
mm	NNS	O
but	CC	O
minimally	RB	B-PROBLEM
reactive	JJ	I-PROBLEM
,	,	O
anicteric	JJ	B-PROBLEM

rr	NN	O
nl	CC	O
s1	NN	O
s2	NN	O
no	DT	O
m	NN	B-PROBLEM

soft	JJ	O
,	,	O
nd	JJ	B-PROBLEM
,	,	O
hypoactive	JJ	B-PROBLEM
bowel	NN	I-PROBLEM
sounds	NNS	I-PROBLEM

wwp	NN	B-PROBLEM
,	,	O
multiple	JJ	B-PROBLEM
linear	JJ	I-PROBLEM
scars	NNS	I-PROBLEM
and	CC	O
burns	NNS	B-PROBLEM
on	IN	I-PROBLEM
hands	NNS	I-PROBLEM
and	CC	I-PROBLEM
arms	NNS	I-PROBLEM

sedated	VBN	B-TREATMENT
,	,	O
dtrs	NN	B-TEST
:	:	O

no	DT	O
rashes	NNS	B-PROBLEM
or	CC	O
petechiae	NN	B-PROBLEM
,	,	O
linear	JJ	B-PROBLEM
and	CC	I-PROBLEM
burn	JJ	I-PROBLEM
scars	NNS	I-PROBLEM
as	IN	O
above	IN	O

wbc	SYM	B-TEST
-	:	O
9.4	CD	O
#	#	O
rbc	NN	B-TEST
-	:	O
4.75	CD	O
hgb	NN	B-TEST
-	:	O
14.7	CD	O
hct	NN	B-TEST
-	:	O
42.2	CD	O
mcv	SYM	B-TEST
-	:	O
89	CD	O
mch	SYM	B-TEST
-	:	O
30.9	CD	O
mchc	SYM	B-TEST
-	:	O
34.8	CD	O
rdw	NN	B-TEST
-	:	O
13.6	CD	O

plt	NN	B-TEST
count	NN	I-TEST
-	:	O
330	CD	O

neuts	NNS	B-TEST
-	:	O
73.0	CD	O
*	NN	O
lymphs	SYM	B-TEST
-	:	O
21.8	CD	O
monos	NNS	B-TEST
-	:	O
3.8	CD	O
eos	SYM	B-TEST
-	:	O
1.1	CD	O
basos	SYM	B-TEST
-	:	O
0.3	CD	O

asa	SYM	B-TEST
-	:	O
neg	NN	O
ethanol	SYM	B-TEST
-	:	O
neg	NN	O
acetmnphn	SYM	B-TEST
-	:	O
neg	NN	O
bnzodzpn	SYM	B-TEST
-	:	O
neg	NN	O
barbitrt	SYM	B-TEST
-	:	O
neg	JJ	O
tricyclic	JJ	B-TEST
-	:	O
pos	NN	O

lithium	NN	B-TEST
-	:	O
less	JJR	O
than	IN	O

digoxin	NN	B-TEST
-<	VBZ	O
0.2	CD	O
*	NN	O

glucose	JJ	B-TEST
-	:	O
116	CD	O
*	JJ	O
urea	JJ	B-TEST
n	SYM	I-TEST
-	:	O
14	CD	O
creat	NN	B-TEST
-	:	O
1.0	CD	O
sodium	NN	B-TEST
-	:	O
137	CD	O
potassium	NN	B-TEST
-	:	O
4.5	CD	O
chloride	NN	B-TEST
-	:	O
105	CD	O
total	JJ	B-TEST
co2	NN	I-TEST
-	:	O
20	CD	O
*	JJ	O
anion	NN	B-TEST
gap	NN	I-TEST
-	:	O
17	CD	O

calcium	NN	B-TEST
-	:	O
9.7	CD	O
phosphate	NN	B-TEST
-	:	O
3.7	CD	O
magnesium	NN	B-TEST
-	:	O
2.1	CD	O

alt	NN	B-TEST
(	(	I-TEST
sgpt	JJ	I-TEST
)-	JJ	I-TEST
21	CD	O
ast	NN	B-TEST
(	(	I-TEST
sgot	JJ	I-TEST
)-	JJ	O
40	CD	O
alk	NN	B-TEST
phos	NN	I-TEST
-	:	O
70	CD	O
amylase	NN	B-TEST
-	:	O
59	CD	O
tot	NN	B-TEST
bili	SYM	I-TEST
-	:	O
0.4	CD	O

lipase	NN	B-TEST
-	:	O
66	CD	O
*	NN	O

2014-04-23	JJ	O
08:00	CD	O
am	VBP	O
urine	JJ	B-TEST

blood	NN	B-TEST
-	:	O
neg	NN	O
nitrite	JJ	B-TEST
-	:	O
neg	NN	O
protein	SYM	B-TEST
-	:	O
neg	NN	O
glucose	JJ	B-TEST
-	:	O
neg	NN	O
ketone	NN	B-TEST
-	:	O
tr	NN	O
bilirubin	SYM	B-TEST
-	:	O
neg	NN	O
urobilngn	JJ	B-TEST
-	:	O
neg	NN	O
ph	SYM	B-TEST
-	:	O
6.5	CD	O
leuk	SYM	B-TEST
-	:	O
neg	NN	O

2014-04-23	JJ	O
08:13	CD	O
am	VBP	O
urine	JJ	B-TEST
bnzodzpn	NN	B-TEST
-	:	O
pos	NN	O
barbitrt	SYM	B-TEST
-	:	O
neg	NN	O
opiates	VBZ	B-TEST
-	:	O
neg	NN	O
cocaine	NN	B-TEST
-	:	O
neg	NN	O
amphetmn	SYM	B-TEST
-	:	O
neg	NN	O
mthdone	NN	B-TEST
-	:	O
neg	NN	O

ck	NN	B-TEST
(	(	I-TEST
cpk	JJ	I-TEST
)-	JJ	I-TEST
4713	CD	O
*	NN	O

2014-04-23	JJ	O
03:45	CD	O
pm	NN	O
urine	NN	B-TEST

ucg	JJ	B-TEST
-	:	O
negative	JJ	O

d-dimer	JJ	B-TEST
-	:	O
7998	CD	O
*	NN	O

cxr	NN	B-TEST
:	:	O

probable	JJ	O
ateletasis	NN	B-PROBLEM
of	IN	I-PROBLEM
lingula	NN	I-PROBLEM
,	,	O
consistent	JJ	O
with	IN	O
pneumonitis	NN	B-PROBLEM

ekg	NN	B-TEST
:	:	O

nsr	JJ	O
r	NN	B-TEST
60	CD	O
normal	JJ	O
axis	NN	O
,	,	O
intervals	NNS	O
,	,	O
incomplete	JJ	B-PROBLEM
rbbb	NN	I-PROBLEM
,	,	O
flat	JJ	B-PROBLEM
t	NN	I-PROBLEM
avl	NN	I-PROBLEM
,	,	O
v2	NN	O
,	,	O
twi	NN	B-PROBLEM
v1	NN	I-PROBLEM

ct	NN	B-TEST
chest	JJS	I-TEST
-	:	O
shows	VBZ	O
bilateral	JJ	B-PROBLEM
segmental	NN	I-PROBLEM
,	,	I-PROBLEM
subsegmental	JJ	I-PROBLEM
pes	NNS	I-PROBLEM

b/l	NN	B-TEST
le	NN	I-TEST
lenis	SYM	I-TEST
-	:	O
negative	JJ	O

patient	NN	O
was	VBD	O
intubated	VBN	O
in	IN	O
john	NN	O
for	IN	O
airway	NN	O
protection	NN	O
and	CC	O
administation	NN	O
of	IN	O
charcoal	NN	B-TREATMENT
.	.	O

toxicology	NN	O
consulted	VBN	O
and	CC	O
felt	VBD	O
that	DT	O
patient	NN	O
most	RBS	O
likely	JJ	O
had	VBD	O
benzo	VBN	B-PROBLEM
overdose	RB	I-PROBLEM
.	.	O

abg	NN	B-TEST
revealed	VBD	O
widened	VBD	B-PROBLEM
a-a	JJ	I-PROBLEM
gradient	NN	I-PROBLEM
so	IN	O
a	DT	B-TEST
d-dimer	NN	I-TEST
was	VBD	O
sent	VBN	O
which	WDT	O
was	VBD	O
elevated	VBN	B-PROBLEM
.	.	O

patient	NN	O
had	VBD	O
cta	NN	B-TEST
which	WDT	O
showed	VBD	O
bilateral	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
embolisms	NNS	I-PROBLEM
.	.	O

patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
heparin	NN	B-TREATMENT
drip	NN	I-TREATMENT
and	CC	O
bilateral	JJ	B-TEST
lower	JJR	I-TEST
extremeties	NNS	I-TEST
were	VBD	O
done	VBN	O
which	WDT	O
were	VBD	O
negative	JJ	O
for	IN	O
dvt	NN	B-PROBLEM
.	.	O

overnight	NN	O
in	IN	O
the	DT	O
icu	JJ	O
patient	NN	O
was	VBD	O
noticed	VBN	O
to	TO	O
have	VB	O
painful	JJ	B-PROBLEM
bullae	NN	I-PROBLEM
on	IN	I-PROBLEM
hands	NNS	I-PROBLEM
and	CC	I-PROBLEM
arm	NN	I-PROBLEM
along	IN	O
with	IN	O
swelling	NN	B-PROBLEM
.	.	O

dermatology	NN	O
and	CC	O
plastic	NN	O
surgery	NN	O
were	VBD	O
consulted	VBN	O
who	WP	O
felt	VBD	O
that	IN	O
symptoms	NNS	B-PROBLEM
were	VBD	O
due	JJ	O
to	TO	O
trauma	VB	B-PROBLEM
;	:	O
it	PRP	O
was	VBD	O
not	RB	O
felt	VBN	O
that	IN	O
patient	NN	O
had	VBD	O
compartment	JJ	B-PROBLEM
syndrome	NN	I-PROBLEM
.	.	O

patient	NN	O
was	VBD	O
gradually	RB	O
put	VBN	O
back	RP	O
on	IN	O
her	PRP$	B-TREATMENT
outpatient	JJ	I-TREATMENT
xanax	NN	I-TREATMENT
dose	NN	I-TREATMENT
of	IN	O
1	CD	O
mg	NNS	O
qid	NN	O
and	CC	O
clozaril	NN	B-TREATMENT
was	VBD	O
restarted	VBN	O
.	.	O

plastic	NN	O
did	VBD	O
not	RB	O
feel	VB	O
that	IN	O
patient	NN	O
had	VBD	O
any	DT	B-PROBLEM
compartment	JJ	I-PROBLEM
syndrome	NN	I-PROBLEM
and	CC	O
recommended	VBD	O
aggresive	JJ	B-TREATMENT
upper	JJ	I-TREATMENT
extremity	NN	I-TREATMENT
elevation	NN	I-TREATMENT
for	IN	O
swelling	VBG	B-TREATMENT
reduction	NN	I-TREATMENT
.	.	O

while	IN	O
on	IN	O
the	DT	O
floor	NN	O
patient	NN	O
's	POS	O
hands	NNS	O
improved	VBN	O
with	IN	O
good	JJ	O
range	NN	O
of	IN	O
motion	NN	O
of	IN	O
left	JJ	O
hand	NN	O
,	,	O
however	RB	O
jones	VBZ	O
some	DT	B-PROBLEM
poor	JJ	I-PROBLEM
range	NN	I-PROBLEM
of	IN	I-PROBLEM
motion	NN	I-PROBLEM
of	IN	O
right	NN	O
.	.	O

x-ray	NN	B-TEST
of	IN	I-TEST
the	DT	I-TEST
hands	NNS	I-TEST
and	CC	I-TEST
wrist	NN	I-TEST
were	VBD	O
obtained	VBN	O
which	WDT	O
were	VBD	O
negative	JJ	O
.	.	O

patient	NN	O
seen	VBN	O
by	IN	O
pt	NN	O
and	CC	O
ot	NN	O
who	WP	O
recommended	VBD	O
hand	NN	B-TREATMENT
exercises	NNS	I-TREATMENT
and	CC	O
splints	NNS	B-TREATMENT
for	IN	O
patient	NN	O
.	.	O

patient	NN	O
was	VBD	O
put	VBN	O
on	IN	O
coumadin	NN	B-TREATMENT
that	WDT	O
was	VBD	O
bridged	VBN	O
with	IN	O
lovenox	JJ	B-TREATMENT
unti	JJ	O
linr	JJ	B-TREATMENT
theraputic	JJ	I-TREATMENT
01-23	NN	O
.	.	O

patient	NN	O
conitnued	VBN	O
to	TO	O
have	VB	O
si	VBN	B-PROBLEM
while	IN	O
on	IN	O
floor	NN	O
and	CC	O
was	VBD	O
transferred	VBN	O
to	TO	O
psychiatry	VB	O
.	.	O

while	IN	O
on	IN	O
the	DT	O
floor	NN	O
patient	NN	B-TEST
's	POS	I-TEST
urinalysis	JJ	I-TEST
suggestive	NN	O
of	IN	O
uti	JJ	B-PROBLEM
and	CC	O
was	VBD	O
put	VBN	O
on	IN	O
6	CD	O
day	NN	O
course	NN	O
of	IN	O
levofloxacin	NN	B-TREATMENT
.	.	O

propanolol	NN	B-TREATMENT
xl	VBZ	I-TREATMENT
80	CD	O
mg	NN	O
qd	NN	O

modifinal	JJ	B-TREATMENT
100	CD	O
mg	NN	O
po	NN	O
qd	NN	O

lamictal	JJ	B-TREATMENT
100	CD	O
mg	JJ	O
po	NN	O
bid	NN	O

alprazolam	RB	B-TREATMENT
1	CD	O
mg	NNS	O
po	JJ	O
qid	NN	O

senna	NN	B-TREATMENT

trazadone	NN	B-TREATMENT
200	CD	O
mg	NN	O
po	NN	O
qhs	NN	O

clomipramine	NN	B-TREATMENT
100	CD	O
mg	NN	O
po	NN	O
qhs	NN	O

pantopraozle	RB	B-TREATMENT
40	CD	O
mg	NNS	O
po	JJ	O
qd	NN	O

clozapine	NN	B-TREATMENT
300	CD	O
mg	NN	O
po	NN	O
qhs	NN	O

folate	NN	B-TREATMENT
1	CD	O
mg	NN	O
po	NN	O
qd	NN	O

multivitamin	NN	B-TREATMENT

1.	CD	O
acetaminophen	JJ	B-TREATMENT
325	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
1-2	JJ	O
tablets	NNS	O
po	JJ	O
q4-6h	JJ	O
(	(	O
every	DT	O
4	CD	O
to	TO	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

2.	CD	O
lamotrigine	JJ	B-TREATMENT
100	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

3.	CD	O
pantoprazole	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
40	CD	O
mg	NN	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
q24h	NN	O
(	(	O
every	DT	O
24	CD	O
hours	NNS	O
)	)	O
.	.	O

4.	CD	O
folic	JJ	B-TREATMENT
acid	RB	I-TREATMENT
1	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

5.	CD	O
multivitamin	NN	B-TREATMENT
capsule	NN	I-TREATMENT
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
cap	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

6.	CD	O
senna	JJ	B-TREATMENT
8.6	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

7.	CD	O
clozapine	NN	B-TREATMENT
25	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
hs	NN	O
(	(	O
at	IN	O
bedtime	NN	O
)	)	O
.	.	O

8.	CD	O
warfarin	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
3	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
at	IN	O
bedtime	NN	O
.	.	O

9.	CD	O
docusate	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
100	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

10.	CD	O
trazodone	NN	B-TREATMENT
hcl	NN	I-TREATMENT
100	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
po	NN	O
hs	NN	O
(	(	O
at	IN	O
bedtime	NN	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

11.	CD	O
alprazolam	JJ	B-TREATMENT
1	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
qid	NN	O
(	(	O
4	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

12.	CD	O
levofloxacin	JJ	B-TREATMENT
500	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
q24h	NN	O
(	(	O
every	DT	O
24	CD	O
hours	NNS	O
)	)	O
for	IN	O
3	CD	O
days	NNS	O
.	.	O

13.	CD	O
bisacodyl	NN	B-TREATMENT
5	CD	O
mg	NN	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
daily	JJ	O
(	(	O
daily	RB	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

14.	CD	O
nicotine	JJ	B-TREATMENT
14	CD	O
mg	NN	O
/	VBD	O
24	CD	O
hr	NN	O
patch	NN	O
24	CD	O
hr	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
patch	NN	O
24	CD	O
hr	NN	O
transdermal	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

benzodiazapine	NN	B-PROBLEM
overdose	NN	I-PROBLEM

traumatic	JJ	B-PROBLEM
/	NNP	I-PROBLEM
pressure	NN	I-PROBLEM
bullae	NN	I-PROBLEM

bipolar	JJ	B-PROBLEM
disorder	NN	I-PROBLEM

stable	JJ	O
-	:	O
swelling	VBG	B-PROBLEM
in	IN	I-PROBLEM
hands	NNS	I-PROBLEM
reduced	VBN	O
and	CC	O
range	NN	O
of	IN	O
motion	NN	O
continue	NN	O
to	TO	O
improve	VB	O
.	.	O

please	NN	O
continue	VB	O
to	TO	O
take	VB	O
coumadin	NN	B-TREATMENT
as	IN	O
directed	VBN	O
by	IN	O
your	PRP$	O
doctors	NNS	O
until	IN	O
told	VBN	O
to	TO	O
stop	VB	O
for	IN	O
clots	NNS	B-PROBLEM
found	VBN	O
in	IN	O
your	PRP$	O
lungs	NNS	O
.	.	O

please	NN	O
continue	VB	O
to	TO	O
take	VB	O
antibiotics	NNS	B-TREATMENT
as	IN	O
directed	VBN	O
for	IN	O
urinary	JJ	B-PROBLEM
tract	NN	I-PROBLEM
infection	NN	I-PROBLEM
for	IN	O
3	CD	O
more	JJR	O
days	NNS	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
55	CD	O
-	:	O
year-old	JJ	O
male	NN	O
with	IN	O
recently	RB	B-PROBLEM
diagnosed	VBN	I-PROBLEM
abdominal	JJ	I-PROBLEM
carcinomatosis	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
bloating	NN	B-PROBLEM
and	CC	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
omental	JJ	I-PROBLEM
mass	NN	I-PROBLEM
.	.	O

biopsy	NN	B-TEST
revealed	VBD	O
adenocarcinoma	NN	B-PROBLEM
.	.	O

histochemical	JJ	B-TEST
stains	NNS	I-TEST
are	VBP	O
consistent	JJ	O
with	IN	O
hepatobiliary	JJ	O
origin	NN	O
.	.	O

endoscopies	NNS	B-TEST
were	VBD	O
negative	JJ	O
except	IN	O
for	IN	O
an	DT	B-PROBLEM
extrinsic	JJ	I-PROBLEM
mass	NN	I-PROBLEM
present	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
stomach	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
presents	VBZ	O
with	IN	O
increased	JJ	B-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
poor	JJ	B-PROBLEM
oral	JJ	I-PROBLEM
intake	NN	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
generalized	VBN	B-PROBLEM
weakness	NN	I-PROBLEM
.	.	O

on	IN	O
presentation	NN	O
,	,	O
the	DT	O
patient	NN	O
denied	VBD	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
and	CC	O
cough	NN	B-PROBLEM
.	.	O

1.	CD	O
benign	JJ	B-PROBLEM
prostatic	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
.	.	O

2.	CD	O
osteoarthritis	NN	B-PROBLEM
.	.	O

3.	CD	O
gastrointestinal	JJ	B-PROBLEM
adenocarcinoma	NN	I-PROBLEM
(	(	O
as	IN	O
noted	VBN	O
in	IN	O
history	NN	O
of	IN	O
present	JJ	O
illness	NN	O
)	)	O
.	.	O

colace	NN	B-TREATMENT
,	,	O
senna	NN	B-TREATMENT
,	,	O
dulcolax	NN	B-TREATMENT
,	,	O
tylenol	NN	B-TREATMENT
,	,	O
oxycodone	NN	B-TREATMENT
as	IN	O
needed	VBN	O
,	,	O
ambien	NN	B-TREATMENT
,	,	O
and	CC	O
protonix	NN	B-TREATMENT
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

mother	NN	O
had	VBD	O
adrenal	JJ	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

father	NN	O
had	VBD	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

review	NN	B-TEST
of	IN	I-TEST
systems	NNS	I-TEST
was	VBD	O
significant	JJ	O
for	IN	O
progressive	JJ	B-PROBLEM
abdominal	JJ	I-PROBLEM
discomfort	NN	I-PROBLEM
,	,	O
decreased	VBD	B-PROBLEM
oral	JJ	I-PROBLEM
intake	NN	I-PROBLEM
,	,	O
and	CC	O
weakness	NN	B-PROBLEM
in	IN	O
the	DT	O
past	JJ	O
nine	CD	O
weeks	NNS	O
.	.	O

physical	JJ	B-TEST
examination	NN	I-TEST
revealed	VBD	O
temperature	NN	B-TEST
was	VBD	O
96.9	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
was	VBD	O
121	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
was	VBD	O
122/86	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
was	VBD	O
22	CD	O
,	,	O
and	CC	O
oxygen	NN	B-TEST
saturation	NN	I-TEST
was	VBD	O
96%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

in	IN	O
general	JJ	O
,	,	O
the	DT	O
patient	NN	O
looked	VBD	O
acutely	RB	B-PROBLEM
and	CC	I-PROBLEM
chronically	RB	I-PROBLEM
ill	VB	I-PROBLEM
.	.	O

head	NN	B-TEST
,	,	I-TEST
eyes	NNS	I-TEST
,	,	I-TEST
ears	NNS	I-TEST
,	,	I-TEST
nose	RB	I-TEST
,	,	I-TEST
and	CC	I-TEST
throat	NN	I-TEST
examination	NN	I-TEST
revealed	VBD	O
the	DT	O
oropharynx	NN	O
was	VBD	O
clear	JJ	O
.	.	O

sclerae	NN	O
were	VBD	O
anicteric	JJ	B-PROBLEM
.	.	O

cardiovascular	JJ	B-TEST
examination	NN	I-TEST
revealed	VBD	O
tachycardic	JJ	B-PROBLEM
first	JJ	I-PROBLEM
heart	NN	I-PROBLEM
sound	NN	I-PROBLEM
and	CC	I-PROBLEM
second	JJ	I-PROBLEM
heart	NN	I-PROBLEM
sound	NN	I-PROBLEM
.	.	O

no	DT	O
murmurs	NN	B-PROBLEM
,	,	O
rubs	NN	B-PROBLEM
,	,	O
or	CC	O
gallops	NNS	B-PROBLEM
.	.	O

lungs	NNS	O
revealed	VBD	O
decreased	JJ	B-PROBLEM
breath	NN	I-PROBLEM
sounds	NNS	I-PROBLEM
and	CC	O
dullness	NN	B-PROBLEM
to	TO	O
percussion	NN	B-TEST
in	IN	O
the	DT	O
left	NN	O
lung	NN	O
base	NN	O
.	.	O

the	DT	O
abdomen	NNS	O
was	VBD	O
distended	VBN	B-PROBLEM
and	CC	O
firm	NN	B-PROBLEM
.	.	O

extremity	NN	B-TEST
examination	NN	I-TEST
revealed	VBD	O
no	DT	O
clubbing	NN	B-PROBLEM
,	,	O
cyanosis	NN	B-PROBLEM
,	,	O
or	CC	O
edema	NN	B-PROBLEM
.	.	O

this	DT	O
was	VBD	O
a	DT	O
55	CD	O
-	:	O
year-old	JJ	O
gentleman	NN	O
with	IN	O
recently	RB	B-PROBLEM
diagnosed	VBN	I-PROBLEM
abdominal	JJ	I-PROBLEM
carcinomatosis	NN	I-PROBLEM
admitted	VBN	O
with	IN	O
increased	JJ	B-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
poor	JJ	B-PROBLEM
oral	JJ	I-PROBLEM
intake	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
o-cmed	JJ	O
service	NN	O
for	IN	O
further	JJ	B-TREATMENT
management	NN	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
placed	VBN	O
on	IN	O
a	DT	B-TREATMENT
patient-controlled	JJ	I-TREATMENT
analgesia	NN	I-TREATMENT
for	IN	O
pain	NN	B-TREATMENT
control	NN	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
administered	VBN	O
intravenous	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
and	CC	O
oral	JJ	O
diet	NN	O
as	IN	O
tolerated	VBN	O
.	.	O

on	IN	O
the	DT	O
night	NN	O
of	IN	O
05-01	NN	O
,	,	O
the	DT	O
patient	NN	O
complained	VBD	O
of	IN	O
increased	JJ	B-PROBLEM
vomiting	NN	I-PROBLEM
.	.	O

he	PRP	O
also	RB	O
complained	VBD	O
of	IN	O
increased	JJ	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
and	CC	O
"	NNP	O
difficulty	NN	B-PROBLEM
catching	VBG	I-PROBLEM
his	PRP$	I-PROBLEM
breath	NN	I-PROBLEM
."	NN	O

on	IN	O
room	NN	O
air	NN	O
,	,	O
the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
oxygen	NN	I-TEST
saturation	NN	I-TEST
was	VBD	O
80%	CD	O
.	.	O

his	PRP$	B-TEST
saturation	NN	I-TEST
increased	VBD	O
to	TO	O
87%	CD	O
on	IN	O
a	DT	B-TREATMENT
nonrebreather	NN	I-TREATMENT
.	.	O

a	DT	B-TEST
chest	NN	I-TEST
x-ray	NN	I-TEST
disclosed	VBD	O
a	DT	B-PROBLEM
left	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
bolused	VBN	O
with	IN	O
intravenous	JJ	B-TREATMENT
heparin	NNS	I-TREATMENT
due	JJ	O
to	TO	O
concern	NN	O
for	IN	O
pulmonary	JJ	B-PROBLEM
embolism	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
became	VBD	O
more	RBR	O
comfortable	JJ	O
being	VBG	O
seated	VBN	O
upright	JJ	O
with	IN	O
nebulizer	JJ	B-TREATMENT
treatments	NNS	I-TREATMENT
.	.	O

an	DT	B-TEST
angiogram	NN	I-TEST
was	VBD	O
done	VBN	O
which	WDT	O
disclosed	VBD	O
possible	JJ	O
subsegmental	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
emboli	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
upper	JJ	I-PROBLEM
lobes	NN	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
infiltrates	NNS	B-PROBLEM
consistent	JJ	O
with	IN	O
aspiration	NN	B-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
placed	VBN	O
on	IN	O
flagyl	NN	B-TREATMENT
and	CC	O
levaquin	NN	B-TREATMENT
for	IN	O
treatment	NN	B-TREATMENT
of	IN	O
pneumonia	NN	B-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
heparin	NN	B-TREATMENT
for	IN	O
treatment	NN	B-TREATMENT
of	IN	O
the	DT	B-PROBLEM
pulmonary	JJ	I-PROBLEM
emboli	NN	I-PROBLEM
.	.	O

while	IN	O
in	IN	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
increasing	VBG	B-PROBLEM
abdominal	JJ	I-PROBLEM
distention	NN	I-PROBLEM
.	.	O

on	IN	O
05-03	PDT	O
the	DT	O
patient	NN	O
underwent	VBD	O
an	DT	B-TEST
abdominal	JJ	I-TEST
ultrasound	NN	I-TEST
with	IN	O
paracentesis	NN	B-TREATMENT
,	,	O
and	CC	O
5	CD	O
liters	NNS	O
of	IN	O
fluid	NN	B-PROBLEM
were	VBD	O
removed	VBN	O
.	.	O

due	JJ	O
to	TO	O
persistent	JJ	B-PROBLEM
gastric	JJ	I-PROBLEM
secretions	NNS	I-PROBLEM
,	,	O
an	DT	B-TREATMENT
nasogastric	JJ	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
for	IN	O
decompression	NN	B-TREATMENT
.	.	O

octreotide	NN	B-TREATMENT
was	VBD	O
initiated	VBN	O
in	IN	O
an	DT	O
attempt	NN	O
to	TO	O
decrease	VB	O
the	DT	B-PROBLEM
gastric	JJ	I-PROBLEM
secretions	NNS	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
noted	VBN	O
not	RB	O
have	VB	O
an	DT	B-PROBLEM
increasing	VBG	I-PROBLEM
left-sided	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

a	DT	B-TREATMENT
thoracentesis	NN	I-TREATMENT
was	VBD	O
done	VBN	O
with	IN	O
removal	NN	B-TREATMENT
of	IN	O
1.5	CD	O
liters	NNS	O
of	IN	O
fluid	NN	B-PROBLEM
.	.	O

a	DT	B-TREATMENT
paracentesis	NN	I-TREATMENT
was	VBD	O
repeated	VBN	O
with	IN	O
removal	NN	B-TREATMENT
of	IN	O
2.5	CD	O
liters	NNS	O
of	IN	O
fluid	NN	B-PROBLEM
.	.	O

the	DT	O
family	NN	O
decided	VBD	O
to	TO	O
pursue	VB	O
comfort	NN	B-TREATMENT
measures	NNS	I-TREATMENT
.	.	O

morphine	NN	B-TREATMENT
was	VBD	O
administered	VBN	O
to	TO	O
insure	VB	O
patient	NN	O
's	POS	O
comfort	NN	O
.	.	O

1.	CD	O
gastrointestinal	JJ	B-PROBLEM
adenocarcinoma	NN	I-PROBLEM
;	:	O
primary	JJ	O
unknown	NN	O
(	(	O
likely	JJ	O
hepatobiliary	NN	O
)	)	O
.	.	O

2.	CD	O
aspiration	NN	B-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

3.	CD	O
pulmonary	JJ	B-PROBLEM
emboli	NN	I-PROBLEM
.	.	O

4.	CD	O
hypoxia	NN	B-PROBLEM
.	.	O

5.	CD	O
dehydration	NN	B-PROBLEM
.	.	O

6.	CD	O
ileus	NN	B-PROBLEM
.	.	O

erythromycin	JJ	B-TREATMENT
base	NN	I-TREATMENT

syncope	NN	B-PROBLEM
.	.	O

45m	CD	O
w/no	JJ	O
pmh	NN	O
presented	VBN	O
to	TO	O
chelseahospital	VB	O
after	IN	O
a	DT	B-PROBLEM
syncopal	JJ	I-PROBLEM
episode	NN	I-PROBLEM
on	IN	O
the	DT	O
morning	NN	O
of	IN	O
admission	NN	O
.	.	O

pt	NN	O
was	VBD	O
preparing	VBG	O
lunch	NN	O
when	WRB	O
suddenly	RB	O
felt	VBD	O
lightheaded	JJ	B-PROBLEM
/	NN	O
faint	NN	B-PROBLEM
and	CC	O
immediately	RB	O
fell	VBD	O
to	TO	O
the	DT	O
kitchen	NN	O
floor	NN	O
face	NN	O
first	RB	O
.	.	O

he	PRP	O
denies	VBZ	O
loc	NN	B-PROBLEM
.	.	O

immediately	RB	O
there	EX	O
after	IN	O
he	PRP	O
was	VBD	O
very	RB	B-PROBLEM
short	JJ	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
felt	VBD	O
lightheaded	VBN	B-PROBLEM
again	RB	O
and	CC	O
called	VBD	O
911	CD	O
.	.	O

at	IN	O
springfield	NN	O
,	,	O
ct	NN	B-TEST
chest	NN	I-TEST
was	VBD	O
positive	JJ	O
for	IN	O
saddle	JJ	B-PROBLEM
pe	NN	I-PROBLEM
.	.	O

vs	NNS	B-TEST
were	VBD	O
with	IN	O
stable	JJ	O
bps	NN	O
,	,	O
tachy	NN	B-PROBLEM
to	TO	O
110-120	CD	O
,	,	O
sat	VBD	B-TEST
98%	CD	O
ra	NN	O
.	.	O

he	PRP	O
received	VBD	O
lovenox	JJ	B-TREATMENT
91	CD	O
mg	NN	O
sc	NN	O
prior	RB	O
to	TO	O
transport	VB	O
and	CC	O
was	VBD	O
transferred	VBN	O
to	TO	O
arbour	VB	O
hospital	NN	O
for	IN	O
further	JJ	O
care	NN	O
.	.	O

he	PRP	O
was	VBD	O
essentially	RB	B-PROBLEM
bed	VBN	I-PROBLEM
bound	NN	I-PROBLEM
for	IN	O
3	CD	O
days	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
,	,	O
unable	JJ	B-PROBLEM
to	TO	I-PROBLEM
ambulate	VB	I-PROBLEM
.	.	O

he	PRP	O
started	VBD	O
to	TO	O
notice	VB	O
inflammation	NN	B-PROBLEM
of	IN	I-PROBLEM
his	PRP$	I-PROBLEM
l	NN	I-PROBLEM
calf	NN	I-PROBLEM
/	NNP	I-PROBLEM
leg	VBZ	I-PROBLEM
worse	JJR	O
2	CD	O
days	NNS	O
prior	RB	O
to	TO	O
presentation	NN	O
.	.	O

in	IN	O
this	DT	O
2	CD	O
week	NN	O
interval	NN	O
he	PRP	O
denied	VBD	O
having	VBG	O
cp	NN	B-PROBLEM
/	NNP	O
chest	NN	B-PROBLEM
discomfort	NN	I-PROBLEM
or	CC	O
difficulty	NN	B-PROBLEM
breathing	NN	I-PROBLEM
,	,	O
no	DT	O
cough	NN	B-PROBLEM
or	CC	O
hemoptysis	NN	B-PROBLEM
.	.	O

no	DT	O
f/c/	NN	B-PROBLEM
sweats	NNS	B-PROBLEM
.	.	O

pt	RB	O
denied	VBD	O
any	DT	B-PROBLEM
bleeding	NN	I-PROBLEM
or	CC	I-PROBLEM
clotting	VBG	I-PROBLEM
disorders	NNS	I-PROBLEM
and	CC	O
has	VBZ	O
never	RB	O
had	VBD	O
a	DT	B-PROBLEM
clot	NN	I-PROBLEM
in	IN	O
the	DT	O
past	NN	O
.	.	O

left	VBN	B-PROBLEM
knee	JJ	I-PROBLEM
injury	NN	I-PROBLEM
.	.	O

seasonal	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

htn	NN	B-PROBLEM
,	,	O
dm	NN	B-PROBLEM

copd	NN	B-PROBLEM
,	,	O
prostate	NN	B-PROBLEM
ca	MD	I-PROBLEM

-	:	O
grandfather	NN	O
died	VBD	O
of	IN	O
mi	NN	B-PROBLEM
at	IN	O
age	NN	O
75	CD	O

vs	NN	B-TEST
:	:	O
99.4	CD	O
hr	NN	B-TEST
111	CD	O
bp	NN	B-TEST
110/64	CD	O
rr16	NN	B-TEST
97%	CD	O
2lnc	CD	B-TREATMENT

gen	NN	O
:	:	O
nad	NN	B-PROBLEM
,	,	O
pleasant	JJ	O
speaking	NN	O
in	IN	O
full	JJ	O
sentences	NNS	O

heent	NN	O
:	:	O
mmm	NN	O
,	,	O
op	JJ	O
clear	JJ	O
,	,	O
dried	VBD	B-PROBLEM
blood	NN	I-PROBLEM
in	IN	I-PROBLEM
nasal	JJ	I-PROBLEM
mucosa	NN	I-PROBLEM

resp	NN	O
:	:	O
ctabl	NN	O
,	,	O
no	DT	O
crackles	NNS	B-PROBLEM
,	,	O
no	DT	O
wheezing	NN	B-PROBLEM
or	CC	O
rhonchi	VB	B-PROBLEM

cv	NN	O
:	:	O
reg	NN	O
,	,	O
tachy	JJ	B-PROBLEM
nml	NN	O
s1	NN	O
,	,	O
s2	NN	O
,	,	O
no	DT	O
m/r/g	NN	B-PROBLEM

abd	NN	O
:	:	O
soft	JJ	O
nd/nt	NNS	B-PROBLEM
+bs	VBP	O

ext	NN	O
:	:	O
l	NN	B-PROBLEM
leg/calf	NN	I-PROBLEM
swollen	NN	I-PROBLEM
,	,	O
+	NNP	O
johnson	NNP	B-TEST
sign	NN	I-TEST
,	,	O
not	RB	O
tense	VB	B-PROBLEM
,	,	O
no	DT	O
cord	NN	O
palpable	NN	O
,	,	O
l	JJ	O
knee	NN	O
w/	VBP	O
medial	JJ	B-PROBLEM
meniscus	NN	I-PROBLEM
area	NN	I-PROBLEM
inflammed	VBD	I-PROBLEM
,	,	O
not	RB	O
warm	JJ	B-PROBLEM
,	,	O
no	DT	O
crepitus	NN	B-PROBLEM
,	,	O
feet-2+dp	JJ	B-TEST
pulses	NNS	I-TEST
b/l	NN	O

1.	CD	O
ct	NN	B-TEST
of	IN	I-TEST
head	NN	I-TEST
without	IN	I-TEST
contrast	NN	I-TEST
:	:	O

no	DT	O
evidence	NN	O
of	IN	O
acute	JJ	B-PROBLEM
intracranial	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
or	CC	O
fractures	NNS	B-PROBLEM
.	.	O

2.	CD	O
echo	NN	B-TEST

the	DT	B-TEST
estimated	VBN	I-TEST
right	JJ	I-TEST
atrial	JJ	I-TEST
pressure	NN	I-TEST
is	VBZ	O
16-20	JJ	O
mmhg	NN	O
.	.	O

left	VBN	B-TEST
ventricular	JJ	I-TEST
wall	NN	I-TEST
thicknesses	NNS	I-TEST
are	VBP	O
normal	JJ	O
.	.	O

the	DT	B-TEST
left	NN	I-TEST
ventricular	JJ	I-TEST
cavity	NN	I-TEST
is	VBZ	O
small	JJ	O
.	.	O

left	VBD	B-TEST
ventricular	JJ	I-TEST
systolic	JJ	I-TEST
function	NN	I-TEST
is	VBZ	O
hyperdynamic	JJ	B-PROBLEM
(	(	O
ef	JJ	B-TEST
>	NNP	O
75%	CD	O
)	)	O
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
ventricular	JJ	B-PROBLEM
septal	NN	I-PROBLEM
defect	NN	I-PROBLEM
.	.	O

the	DT	O
right	JJ	O
ventricular	NN	O
cavity	NN	O
is	VBZ	O
mildly	RB	B-PROBLEM
dilated	VBN	I-PROBLEM
.	.	O

right	RB	B-TEST
ventricular	JJ	I-TEST
systolic	JJ	I-TEST
function	NN	I-TEST
is	VBZ	O
borderline	JJ	O
normal	JJ	O
.	.	O

the	DT	O
aortic	JJ	O
valve	NN	O
leaflets	NNS	O
(	(	O
3	CD	O
)	)	O
appear	VBP	O
structurally	RB	O
normal	JJ	O
with	IN	O
good	JJ	O
leaflet	NN	O
excursion	NN	O
and	CC	O
no	DT	O
aortic	JJ	B-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
mitral	JJ	B-PROBLEM
valve	NN	I-PROBLEM
prolapse	NN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
moderate	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
systolic	JJ	I-PROBLEM
hypertension	NN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
pericardial	JJ	B-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

impression	NN	O
:	:	O
mildly	RB	B-PROBLEM
dilated	VBD	I-PROBLEM
right	JJ	I-PROBLEM
ventricle	NN	I-PROBLEM
;	:	O
small	JJ	B-PROBLEM
,	,	I-PROBLEM
hyperdynamic	JJ	I-PROBLEM
left	VBD	I-PROBLEM
ventricle	NN	I-PROBLEM
;	:	O
at	IN	O
least	JJS	O
moderate	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
hypertension	NN	I-PROBLEM

3.	CD	O
bilateral	JJ	B-TEST
leni	NN	I-TEST
's	POS	I-TEST

no	DT	O
evidence	NN	O
of	IN	O
dvt	NN	B-PROBLEM
in	IN	I-PROBLEM
either	DT	I-PROBLEM
lower	JJR	I-PROBLEM
limb	NN	I-PROBLEM
.	.	O

osh	JJ	B-TEST
imaging	NN	I-TEST
:	:	O

-	:	O
saddle	NN	B-PROBLEM
pe	NN	I-PROBLEM
,	,	O
no	DT	O
cd	NN	O
or	CC	O
report	NN	O
sent	VBD	O

ekg	NN	B-TEST
:	:	O

-	:	O
sinus	NN	B-PROBLEM
tach	NN	I-PROBLEM
,	,	O
normal	JJ	O
axis	NN	O
hr	VBD	B-TEST
119	CD	O
st	JJ	B-PROBLEM
depression	NN	I-PROBLEM
v3-v5	NN	I-PROBLEM
;	:	O
s1q3t3	NN	B-PROBLEM
,	,	O
p-pulmonale	JJ	B-PROBLEM
.	.	O

01-11	JJ	O
mri	NN	B-TEST
left	VBD	I-TEST
knee	JJ	I-TEST
w/o	NN	I-TEST
contrast	NN	I-TEST

1.	CD	O
bucket	NN	B-PROBLEM
handle	JJ	I-PROBLEM
medial	JJ	I-PROBLEM
meniscal	JJ	I-PROBLEM
tear	NN	I-PROBLEM
with	IN	O
flipped	JJ	B-PROBLEM
fragment	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
intercondylar	JJ	I-PROBLEM
notch	NN	I-PROBLEM
.	.	O

complex	JJ	B-PROBLEM
tear	NN	I-PROBLEM
involving	VBG	O
the	DT	O
posterior	JJ	O
ellison	NN	O
and	CC	O
body	NN	O
.	.	O

2.	CD	O
moderate	JJ	B-PROBLEM
knee	NNS	I-PROBLEM
joint	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
with	IN	O
possible	JJ	O
ganglion	NN	B-PROBLEM
cyst	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
insertion	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
pcl	NN	I-PROBLEM
.	.	O

3.	CD	O
discoid	JJ	B-PROBLEM
lateral	JJ	I-PROBLEM
meniscus	NN	I-PROBLEM
.	.	O

mr.	NN	O
anders	NNS	O
was	VBD	O
admitted	VBN	O
for	IN	O
anticoagulation	NN	B-TREATMENT
and	CC	O
hemodynamic	JJ	B-TEST
monitoring	NN	I-TEST
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
saddle	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
embolus	NN	I-PROBLEM
and	CC	O
left	VBD	B-PROBLEM
knee	JJ	I-PROBLEM
injury	NN	I-PROBLEM
.	.	O

#.	JJ	O
pe	NN	B-PROBLEM
:	:	O

given	VBN	O
no	DT	O
other	JJ	O
risk	NN	O
factors	NNS	O
or	CC	O
likely	JJ	O
causes	NNS	O
,	,	O
the	DT	O
most	RBS	O
likely	JJ	O
etiology	NN	O
for	IN	O
his	PRP$	B-PROBLEM
embolus	NN	I-PROBLEM
is	VBZ	O
dvt	VBN	B-PROBLEM
from	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
leg	NN	I-PROBLEM
.	.	O

he	PRP	O
has	VBZ	O
no	DT	O
known	VBN	B-PROBLEM
clotting	VBG	I-PROBLEM
disorder	NN	I-PROBLEM
but	CC	O
did	VBD	O
have	VB	O
trauma	NN	B-PROBLEM
to	TO	I-PROBLEM
leg	VB	I-PROBLEM
prompting	VBG	O
immobility	NN	B-PROBLEM
and	CC	O
stasis	NN	B-PROBLEM
.	.	O

he	PRP	O
remained	VBD	O
hemodynmically	RB	O
stable	JJ	O
throughout	IN	O
his	PRP$	O
hospitalization	NN	O
and	CC	O
did	VBD	O
not	RB	O
have	VB	O
an	DT	B-PROBLEM
oxygen	NN	I-PROBLEM
requirement	NN	I-PROBLEM
upon	IN	O
discharge	NN	O
.	.	O

given	VBN	O
no	DT	O
evidence	NN	O
of	IN	O
hemodynamic	JJ	B-PROBLEM
instability	NN	I-PROBLEM
,	,	O
lysis	NN	B-TREATMENT
was	VBD	O
not	RB	O
required	VBN	O
.	.	O

he	PRP	O
was	VBD	O
anticoagulated	VBN	O
with	IN	O
heparin	NN	B-TREATMENT
and	CC	O
coumadin	NN	B-TREATMENT
.	.	O

he	PRP	O
will	MD	O
need	VB	O
to	TO	O
follow	VB	O
up	RP	O
with	IN	O
hematology	NN	O
for	IN	O
an	DT	B-TEST
outpatient	JJ	I-TEST
thrombophilia	NN	I-TEST
work-up	NN	I-TEST
(	(	O
not	RB	O
done	VBN	O
as	RB	O
inpatient	JJ	O
as	IN	O
results	NNS	O
would	MD	O
not	RB	O
change	VB	O
acute	JJ	B-TREATMENT
management	NN	I-TREATMENT
of	IN	O
pe	NN	B-PROBLEM
).	NN	O

he	PRP	O
will	MD	O
also	RB	O
require	VB	O
close	RB	O
follow	VB	O
up	RP	O
with	IN	O
his	PRP$	O
primary	JJ	O
care	NN	O
provider	NN	O
for	IN	O
coumadin	NN	B-TREATMENT
management	NN	I-TREATMENT
.	.	O

duration	NN	O
of	IN	O
his	PRP$	B-TREATMENT
coumadin	NN	I-TREATMENT
therapy	NN	I-TREATMENT
to	TO	O
be	VB	O
determined	VBN	O
by	IN	O
hematology	NN	O
,	,	O
but	CC	O
likely	JJ	O
to	TO	O
be	VB	O
at	IN	O
least	JJS	O
6	CD	O
months	NNS	O
in	IN	O
duration	NN	O
.	.	O

#.	JJ	O
syncope	NN	B-PROBLEM
:	:	O

in	IN	O
setting	VBG	O
of	IN	O
pe	NN	B-PROBLEM
.	.	O

remainder	NN	O
of	IN	O
his	PRP$	B-TEST
cardiac	JJ	I-TEST
workup	NN	I-TEST
was	VBD	O
negative	JJ	O
.	.	O

he	PRP	O
did	VBD	O
have	VB	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
troponin	NN	I-PROBLEM
leak	NN	I-PROBLEM
,	,	O
felt	VBD	O
to	TO	O
be	VB	O
related	VBN	O
to	TO	O
right	JJ	B-PROBLEM
heart	NN	I-PROBLEM
strain	NN	I-PROBLEM
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
p-pulmonale	JJ	B-PROBLEM
related	VBN	O
to	TO	O
clot	VB	B-PROBLEM
burden	NN	I-PROBLEM
.	.	O

his	PRP$	B-TEST
tronponin	NN	I-TEST
quickly	RB	O
trended	VBD	O
down	RB	O
and	CC	O
he	PRP	O
did	VBD	O
not	RB	O
have	VB	O
ekg	JJ	B-TEST
evidence	NN	O
of	IN	O
ischemia	NN	B-PROBLEM
.	.	O

an	DT	B-TEST
echo	NN	I-TEST
did	VBD	O
not	RB	O
reveal	VB	O
any	DT	B-PROBLEM
wall	NN	I-PROBLEM
motion	NN	I-PROBLEM
abnormalities	NNS	I-PROBLEM
related	VBN	O
to	TO	O
ischemia	NN	B-PROBLEM
.	.	O

#.	JJ	O
hematocrit	NN	B-TEST
:	:	O

dropped	VBD	O
from	IN	O
42.7	CD	O
to	TO	O
36	CD	O
in	IN	O
setting	NN	O
of	IN	O
anticoagulation	NN	B-TREATMENT
for	IN	O
saddle	JJ	B-PROBLEM
pe	NN	I-PROBLEM
and	CC	O
iv	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
.	.	O

no	DT	O
active	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
noted	VBD	O
.	.	O

pt	NN	O
asymptomatic	NN	B-PROBLEM
.	.	O

#.	JJ	O
l	NN	B-PROBLEM
knee	JJ	I-PROBLEM
injury	NN	I-PROBLEM
:	:	O

given	VBN	O
his	PRP$	O
history	NN	O
and	CC	O
physical	JJ	B-TEST
exam	NN	I-TEST
,	,	O
mr.	NN	O
anders	NNS	O
presented	VBD	O
with	IN	O
an	DT	B-PROBLEM
injury	NN	I-PROBLEM
most	RBS	O
consistent	JJ	O
with	IN	O
meniscal	JJ	B-PROBLEM
tear	NN	I-PROBLEM
.	.	O

in	IN	O
order	NN	O
to	TO	O
facilitate	VB	O
therapy	NN	B-TREATMENT
and	CC	O
to	TO	O
promote	VB	O
mobility	NN	O
,	,	O
an	DT	B-TEST
mri	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
knee	NN	I-TEST
was	VBD	O
done	VBN	O
.	.	O

he	PRP	O
was	VBD	O
seen	VBN	O
by	IN	O
physical	JJ	O
therapy	NN	O
and	CC	O
will	MD	O
need	VB	O
to	TO	O
follow	VB	O
up	RP	O
with	IN	O
orthopaedics	NNS	O
upon	IN	O
discharge	NN	O
for	IN	O
repeat	NN	B-TEST
evaluation	NN	I-TEST
.	.	O

-	:	O
claritin	NN	B-TREATMENT
prn	NN	O

-	:	O
flonase	NN	B-TREATMENT
prn	NN	O

pulmonary	JJ	B-PROBLEM
embolus	NN	I-PROBLEM

left	VBN	B-PROBLEM
knee	JJ	I-PROBLEM
meniscal	JJ	I-PROBLEM
tear	NN	I-PROBLEM

you	PRP	O
were	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
hospital	NN	O
for	IN	O
a	DT	B-PROBLEM
pulmonary	JJ	I-PROBLEM
embolism	NN	I-PROBLEM
.	.	O

you	PRP	O
were	VBD	O
treated	VBN	O
with	IN	O
blood	NN	B-TREATMENT
thinners	NNS	I-TREATMENT
.	.	O

you	PRP	O
have	VBP	O
been	VBN	O
started	VBN	O
on	IN	O
an	DT	B-TREATMENT
oral	JJ	I-TREATMENT
blood	NN	I-TREATMENT
thinner	NN	I-TREATMENT
called	VBN	O
coumadin	NN	B-TREATMENT
(	(	I-TREATMENT
warfarin	JJ	I-TREATMENT
).	NN	O

please	NN	O
continue	VB	O
to	TO	O
take	VB	O
this	DT	B-TREATMENT
medication	NN	I-TREATMENT
as	IN	O
prescribed	NN	O
.	.	O

you	PRP	O
must	MD	O
have	VB	O
your	PRP$	B-TEST
inr	NN	I-TEST
(	(	O
blood	NN	B-TEST
levels	NNS	I-TEST
)	)	O
checked	VBD	O
on	IN	O
a	DT	O
regular	JJ	O
basis	NN	O
until	IN	O
your	PRP$	B-TEST
inr	NN	I-TEST
levels	NNS	I-TEST
remain	VBP	O
01-19	JJ	O
.	.	O

the	DT	B-TEST
mri	NN	I-TEST
of	IN	I-TEST
your	PRP$	I-TEST
knee	NN	I-TEST
showed	VBD	O
a	DT	B-PROBLEM
meniscal	JJ	I-PROBLEM
tear	NN	I-PROBLEM
.	.	O

please	NN	O
schedule	NN	O
an	DT	O
appointment	NN	O
with	IN	O
your	PRP$	O
orthopedic	JJ	O
surgeon	NN	O
to	TO	O
determine	VB	O
a	DT	O
plan	NN	O
for	IN	O
treatment	NN	B-TREATMENT
.	.	O

please	VB	O
return	NN	O
to	TO	O
the	DT	O
hospital	NN	O
if	IN	O
you	PRP	O
experience	VBP	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
lightheadedness	NN	B-PROBLEM
or	CC	O
dizziness	NN	B-PROBLEM
.	.	O

this	DT	O
is	VBZ	O
a	DT	O
55-year-old	JJ	O
female	NN	O
with	IN	O
multiple	JJ	O
prior	JJ	O
admissions	NNS	O
for	IN	O
pneumonia	NN	B-PROBLEM
,	,	O
copd	NN	B-PROBLEM
,	,	O
asthma	JJ	B-PROBLEM
exacerbation	NN	I-PROBLEM
,	,	O
over	IN	O
3	CD	O
weeks	NNS	O
of	IN	O
upper	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
like	IN	I-PROBLEM
infection	NN	I-PROBLEM
unremitting	VBG	O
with	IN	O
increased	JJ	B-TREATMENT
nebulizer	NN	I-TREATMENT
treatments	NNS	I-TREATMENT
at	IN	O
home	NN	O
.	.	O

the	DT	O
patient	NN	O
saw	VBD	O
her	PRP$	O
pcp	NN	O
and	CC	O
was	VBD	O
known	VBN	O
to	TO	O
have	VB	O
an	DT	B-TEST
oxygen	NN	I-TEST
saturation	NN	I-TEST
of	IN	O
82	CD	O
to	TO	O
85	CD	O
percent	NN	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

in	IN	O
the	DT	O
emergency	NN	O
department	NN	O
,	,	O
the	DT	O
patient	NN	O
received	VBD	O
zithromax	NN	B-TREATMENT
,	,	O
ceftriaxone	NN	B-TREATMENT
,	,	O
and	CC	O
flagyl	NN	B-TREATMENT
.	.	O

chest	JJS	B-TEST
x-ray	NN	I-TEST
was	VBD	O
remarkable	JJ	O
for	IN	O
a	DT	O
questionable	JJ	O
left	NN	B-PROBLEM
lower	RBR	I-PROBLEM
lobe	NN	I-PROBLEM
infiltrate	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
received	VBD	O
nebulizer	JJ	B-TREATMENT
treatment	NN	I-TREATMENT
with	IN	O
oxygen	NN	B-TEST
saturations	NNS	I-TEST
increasing	VBG	O
up	RB	O
to	TO	O
98	CD	O
percent	NN	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

asthma	NN	B-PROBLEM
/	NNP	O
copd	NN	B-PROBLEM
on	IN	O
bipap	NN	B-TREATMENT
,	,	O
history	NN	O
of	IN	O
intubation	NN	B-TREATMENT
.	.	O

restrictive	JJ	B-PROBLEM
lung	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

chronic	JJ	B-PROBLEM
inflammatory	NN	I-PROBLEM
demyelinating	VBG	I-PROBLEM
polyradiculopathy	NN	I-PROBLEM
.	.	O

gastritis	NN	B-PROBLEM
and	CC	O
duodenitis	NN	B-PROBLEM
.	.	O

question	NN	O
of	IN	O
tyrone	NN	B-PROBLEM
esophagus	NN	I-PROBLEM
.	.	O

chronic	JJ	B-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

neurogenic	JJ	B-PROBLEM
bladder	NN	I-PROBLEM
.	.	O

chronic	JJ	B-PROBLEM
muscle	NN	I-PROBLEM
spasms	NNS	I-PROBLEM
.	.	O

coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
status	NN	O
post	NN	O
negative	JJ	O
stress	NN	B-TEST
echo	NN	I-TEST
on	IN	O
10-12	NNS	O
.	.	O

history	NN	O
of	IN	O
syncope	NN	B-PROBLEM
.	.	O

adrenal	JJ	B-PROBLEM
insufficiency	NN	I-PROBLEM
.	.	O

hypercholesterolemia	NN	B-PROBLEM
.	.	O

depression	NN	B-PROBLEM
and	CC	O
anxiety	NN	B-PROBLEM
.	.	O

hyperthyroidism	NN	B-PROBLEM
.	.	O

igg	JJ	B-PROBLEM
deficiency	NN	I-PROBLEM
.	.	O

status	NN	O
post	NN	O
cholecystectomy	NN	B-TREATMENT
and	CC	O
appendectomy	NN	B-TREATMENT
.	.	O

anemia	NN	B-PROBLEM
of	IN	O
chronic	JJ	B-PROBLEM
disease	NN	I-PROBLEM
.	.	O

azmacort	NN	B-TREATMENT
,	,	O
clindamycin	NN	B-TREATMENT
,	,	O
versed	VBD	B-TREATMENT
,	,	O
fentanyl	NN	B-TREATMENT
,	,	O
and	CC	O
morphine	NN	B-TREATMENT
.	.	O

married	VBN	O
with	IN	O
children	NNS	O
,	,	O
wheelchair	NN	B-PROBLEM
bound	NN	I-PROBLEM
mostly	RB	O
.	.	O

from	IN	O
admission	NN	O
,	,	O
vital	JJ	B-TEST
signs	NNS	I-TEST
98.3	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
128/74	CD	O
,	,	O
68	CD	O
to	TO	O
112	CD	O
is	VBZ	O
her	PRP$	B-TEST
heart	NN	I-TEST
rate	NN	I-TEST
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
24	CD	O
,	,	O
100	CD	O
percent	NN	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

she	PRP	O
is	VBZ	O
a	DT	O
chronically	RB	O
ill-appearing	JJ	O
female	NN	O
,	,	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

cardiac	JJ	B-TEST
exam	NN	I-TEST
:	:	O

pulmonary	JJ	B-TEST
exam	NN	I-TEST
:	:	O

diffuse	NN	B-PROBLEM
bronchial	JJ	I-PROBLEM
breath	NN	I-PROBLEM
sounds	NNS	I-PROBLEM
,	,	O
no	DT	O
wheezes	NN	B-PROBLEM
.	.	O

abdominal	JJ	B-TEST
exam	NN	I-TEST
:	:	O

extremity	NN	B-TEST
exam	NN	I-TEST
:	:	O

no	DT	O
edema	NN	B-PROBLEM
.	.	O

left	VBD	B-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
and	CC	I-PROBLEM
left	VBD	I-PROBLEM
upper	JJ	I-PROBLEM
extremity	NN	I-PROBLEM
weaker	NN	I-PROBLEM
at	IN	O
3/5	CD	O
compared	VBN	O
to	TO	O
right	VB	O
upper	JJ	O
extremity	NN	O
and	CC	O
right	JJ	O
lower	JJR	O
extremity	NN	O
,	,	O
chronic	JJ	O
according	VBG	O
to	TO	O
the	DT	O
patient	NN	O
.	.	O

1.	CD	O
vitamin	NN	B-TREATMENT
d	NN	I-TREATMENT
400	CD	O
mg	NN	O
q.d.	NN	O

2.	CD	O
levoxyl	JJ	B-TREATMENT
50	CD	O
mcg	NN	O
q.d.	NN	O

3.	CD	O
baclofen	NN	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O

4.	CD	O
florinef	JJ	B-TREATMENT
0.1	CD	O
mg	NN	O
p.o.	NN	O
q.a.m.	NN	O

5.	CD	O
klonopin	NN	B-TREATMENT
2	CD	O
mg	NN	O
t.i.d.	NN	O

6.	CD	O
buspar	NN	B-TREATMENT
10	CD	O
mg	NN	O
t.i.d.	NN	O

7.	CD	O
zanaflex	JJ	B-TREATMENT
8	CD	O
mg	NN	O
q.4	NN	O
h.	NN	O

8.	CD	O
oxazepam	JJ	B-TREATMENT
30	CD	O
mg	NN	O
p.r.n.	NN	O

9.	CD	O
singulair	NN	B-TREATMENT
10	CD	O
mg	NN	O
q.p.m.	NN	O

10.	CD	O
lipitor	NN	B-TREATMENT
10	CD	O
mg	NN	O
q.p.m.	NN	O

11.	CD	O
ativan	JJ	B-TREATMENT
2	CD	O
mg	NN	O
p.r.n.	NN	O

12.	CD	O
protonix	JJ	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

13.	CD	O
sucralfate	JJ	B-TREATMENT
2	CD	O
mg	NN	O
b.i.d.	NN	O

14.	CD	O
albuterol	JJ	B-TREATMENT
nebulizer	JJ	I-TREATMENT
q.03-14	NN	O
h.	NN	O
p.r.n.	NN	O

15.	CD	O
pamidronate	NN	B-TREATMENT
30	CD	O
mg	NN	O
iv	NN	O
every	DT	O
month	NN	O
.	.	O

shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
maintained	VBN	O
on	IN	O
albuterol	NN	B-TREATMENT
nebulizer	NN	I-TREATMENT
treatments	NNS	I-TREATMENT
and	CC	O
ipratropium	JJ	B-TREATMENT
nebulizer	NN	I-TREATMENT
treatments	NNS	I-TREATMENT
,	,	O
as	IN	O
this	DT	O
was	VBD	O
apparently	RB	O
thought	VBN	O
to	TO	O
be	VB	O
related	VBN	O
to	TO	O
her	PRP$	B-PROBLEM
chronic	JJ	I-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

given	VBN	O
the	DT	O
presence	NN	O
of	IN	O
consolidation	NN	B-PROBLEM
on	IN	O
chest	JJS	B-TEST
x-ray	NN	I-TEST
,	,	O
however	RB	O
,	,	O
and	CC	O
previous	JJ	O
history	NN	O
of	IN	O
pneumonia	NN	B-PROBLEM
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
maintained	VBN	O
on	IN	O
antibiotics	NNS	B-TREATMENT
of	IN	O
zithromax	NN	B-TREATMENT
500	CD	O
mg	JJ	O
daily	JJ	O
and	CC	O
ceftriaxone	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
also	RB	O
started	VBN	O
on	IN	O
solu-medrol	NN	B-TREATMENT
iv	NN	I-TREATMENT
for	IN	O
active	JJ	B-PROBLEM
airway	NN	I-PROBLEM
disease	NN	I-PROBLEM
component	NN	I-PROBLEM
of	IN	O
her	PRP$	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
maintained	VBN	O
on	IN	O
supplemental	JJ	B-TREATMENT
oxygen	NN	I-TREATMENT
and	CC	O
sputum	NN	O
production	NN	O
was	VBD	O
maximized	VBN	O
with	IN	O
the	DT	O
help	NN	O
of	IN	O
an	DT	B-TREATMENT
acapella	NN	I-TREATMENT
device	NN	I-TREATMENT
and	CC	O
respiratory	NN	B-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

mucomyst	NN	B-TREATMENT
was	VBD	O
also	RB	O
considered	VBN	O
as	IN	O
a	DT	B-TREATMENT
mucolytic	JJ	I-TREATMENT
component	NN	I-TREATMENT
towards	NNS	O
secretions	NNS	B-PROBLEM
.	.	O

adrenal	JJ	B-PROBLEM
insufficiency	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
maintained	VBN	O
on	IN	O
iv	NN	B-TREATMENT
solu	NN	I-TREATMENT
-	:	I-TREATMENT
medrol	NN	I-TREATMENT
60	CD	O
mg	NN	O
q.	NN	O
8	CD	O
h.	NN	O

chest	NN	B-PROBLEM
soreness	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
describes	VBZ	O
chest	JJS	B-PROBLEM
discomfort	NN	I-PROBLEM
without	IN	O
any	DT	B-PROBLEM
significant	JJ	I-PROBLEM
ekg	NN	I-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
maintained	VBN	O
on	IN	O
percocet	NN	B-TREATMENT
p.r.n.	NN	O
for	IN	O
pain	NN	B-TREATMENT
relief	NN	I-TREATMENT
.	.	O

there	EX	O
was	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
acute	JJ	B-PROBLEM
rib	NN	I-PROBLEM
factors	NNS	I-PROBLEM
on	IN	O
her	PRP$	B-TEST
chest	JJS	I-TEST
x-ray	NN	I-TEST
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
maintained	VBN	O
on	IN	O
ppi	NN	B-TREATMENT
for	IN	O
reflux	JJ	B-PROBLEM
disease	NN	I-PROBLEM
and	CC	O
known	VBN	B-PROBLEM
gastritis	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
neurogenic	JJ	B-PROBLEM
bladder	NN	I-PROBLEM
and	CC	O
,	,	O
therefore	RB	O
,	,	O
she	PRP	O
required	VBD	O
a	DT	B-TREATMENT
foley	JJ	I-TREATMENT
catheterization	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
on	IN	O
levoxyl	NN	B-TREATMENT
at	IN	O
home	NN	O
as	IN	O
her	PRP$	O
home	NN	O
dose	NN	O
for	IN	O
hyperthyroidism	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
transferred	VBN	O
on	IN	O
the	DT	O
evening	NN	O
of	IN	O
2012-05-22	JJ	O
to	TO	O
the	DT	O
icu	NN	O
given	VBN	O
persistent	JJ	B-PROBLEM
carbon	NN	I-PROBLEM
dioxide	NN	I-PROBLEM
retention	NN	I-PROBLEM
and	CC	O
respiratory	JJ	B-PROBLEM
acidosis	NN	I-PROBLEM
and	CC	O
the	DT	B-PROBLEM
intermittent	JJ	I-PROBLEM
mental	NN	I-PROBLEM
status	NN	I-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
had	VBN	O
abg	VBN	B-TEST
on	IN	O
the	DT	O
floor	NN	O
,	,	O
which	WDT	O
prompted	VBD	O
her	PRP	O
to	TO	O
transfer	VB	O
to	TO	O
the	DT	O
icu	NN	O
.	.	O

her	PRP$	B-TEST
ph	NN	I-TEST
was	VBD	O
7.23	CD	O
,	,	O
pco2	NN	B-TEST
73	CD	O
,	,	O
po2	RB	B-TEST
146	CD	O
on	IN	O
a	DT	B-TREATMENT
nonrebreather	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
bipap	VBN	B-TREATMENT
initiated	VBN	O
once	IN	O
she	PRP	O
reached	VBD	O
the	DT	O
unit	NN	O
,	,	O
but	CC	O
did	VBD	O
not	RB	O
tolerate	VB	O
it	PRP	O
,	,	O
becoming	VBG	O
apneic	NN	B-PROBLEM
and	CC	O
obstructing	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
switched	VBN	O
to	TO	O
2	CD	B-TREATMENT
liters	NNS	I-TREATMENT
nasal	JJ	I-TREATMENT
cannula	NN	I-TREATMENT
and	CC	O
oxygen	NN	O
saturating	NN	O
at	IN	O
98	CD	O
to	TO	O
100	CD	O
percent	NN	O
.	.	O

after	IN	O
bipap	NN	B-TREATMENT
was	VBD	O
initiated	VBN	O
,	,	O
the	DT	O
patient	NN	O
became	VBD	O
hypotensive	JJ	B-PROBLEM
down	RB	O
to	TO	O
75/28	CD	O
and	CC	O
bradycardiac	NN	B-PROBLEM
,	,	O
responding	VBG	O
to	TO	O
3	CD	B-TREATMENT
fluid	NN	I-TREATMENT
boluses	NNS	I-TREATMENT
over	IN	O
the	DT	O
course	NN	O
of	IN	O
the	DT	O
night	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
florinef	NN	B-TREATMENT
for	IN	O
concern	NN	O
of	IN	O
adrenal	JJ	B-PROBLEM
insufficiency	NN	I-PROBLEM
;	:	O
however	RB	O
,	,	O
she	PRP	O
was	VBD	O
hemodynamically	RB	O
stable	JJ	O
that	IN	O
morning	NN	O
and	CC	O
was	VBD	O
transferred	VBN	O
back	RB	O
out	IN	O
to	TO	O
the	DT	O
floor	NN	O
.	.	O

it	PRP	O
was	VBD	O
thought	VBN	O
that	IN	O
the	DT	O
patient	NN	O
may	MD	O
have	VB	O
been	VBN	O
mucous	JJ	B-PROBLEM
plugging	VBG	I-PROBLEM
during	IN	O
her	PRP$	O
stay	NN	O
in	IN	O
the	DT	O
icu	NN	O
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
high	JJ	B-PROBLEM
mcv	NN	I-PROBLEM
and	CC	O
megaloblastic	JJ	B-PROBLEM
cells	NNS	I-PROBLEM
on	IN	O
smear	NN	B-TEST
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
anemia	NN	B-PROBLEM
;	:	O
question	NN	O
b12	NN	B-PROBLEM
deficiency	NN	I-PROBLEM
,	,	O
the	DT	O
patient	NN	O
also	RB	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
borderline	NN	B-PROBLEM
low	JJ	I-PROBLEM
b12	NN	I-PROBLEM
levels	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
diagnosed	VBN	O
for	IN	O
b12	NN	B-PROBLEM
deficiency	NN	I-PROBLEM
due	JJ	O
to	TO	O
her	PRP$	O
long	JJ	O
history	NN	O
of	IN	O
poor	JJ	B-PROBLEM
p.o.	NNS	I-PROBLEM
intake	VBP	I-PROBLEM
.	.	O

methylmalonic	JJ	B-TEST
acid	NN	I-TEST
levels	NNS	I-TEST
were	VBD	O
sent	VBN	O
,	,	O
the	DT	O
results	NNS	O
are	VBP	O
pending	VBG	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
.	.	O

asthma	NN	B-PROBLEM
flare	NN	I-PROBLEM
and	CC	O
bronchitis	NN	B-PROBLEM
.	.	O

chronic	JJ	B-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

demyelinating	VBG	B-PROBLEM
polyradiculopathy	NN	I-PROBLEM
.	.	O

anxiety	NN	B-PROBLEM
disorder	NN	I-PROBLEM
.	.	O

chronic	JJ	B-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
stable	JJ	O
without	IN	O
an	DT	B-PROBLEM
oxygen	NN	I-PROBLEM
requirement	NN	I-PROBLEM
.	.	O

1.	CD	O
cholecalciferol	NN	B-TREATMENT
.	.	O

2.	CD	O
vitamin	JJ	B-TREATMENT
d	NN	I-TREATMENT
.	.	O

3.	CD	O
levothyroxine	JJ	B-TREATMENT
50	CD	O
mcg	NN	O
p.o.	NN	O
q.d.	NN	O

4.	CD	O
baclofen	NN	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O

5.	CD	O
clonazepam	NN	B-TREATMENT
1	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O

6.	CD	O
buspirone	NN	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O

7.	CD	O
montelukast	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q.h.s.	NN	O

8.	CD	O
atorvastatin	JJ	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q.h.s.	NN	O

9.	CD	O
protonix	JJ	B-TREATMENT
40	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

10.	CD	O
albuterol	NN	B-TREATMENT
sulfate	JJ	I-TREATMENT
solution	NN	I-TREATMENT
q.05-15	NN	O
h.	NN	O
p.r.n.	NN	O
for	IN	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

11.	CD	O
tizanidine	JJ	B-TREATMENT
8	CD	O
mg	NN	O
p.o.	NN	O
q.6	NN	O
h.	NN	O

12.	CD	O
acetaminophen	JJ	B-TREATMENT
p.r.n.	NN	O

13.	CD	O
prednisone	NN	B-TREATMENT
taper	NN	I-TREATMENT
for	IN	O
3	CD	O
days	NNS	O
.	.	O

14.	CD	O
levofloxacin	JJ	B-TREATMENT
500	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
for	IN	O
10	CD	O
more	JJR	O
days	NNS	O
.	.	O

15.	CD	O
florinef	JJ	B-TREATMENT
acetate	NN	I-TREATMENT
0.1	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

medicine	NN	B-TREATMENT

patient	NN	O
recorded	VBD	O
as	IN	O
having	VBG	O
no	DT	O
known	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM
to	TO	O
drugs	NNS	B-TREATMENT

shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
fever	NN	B-PROBLEM

mr.	NN	O
mcelveen	NN	O
is	VBZ	O
a	DT	O
51	CD	O
year-old	JJ	O
male	NN	O
with	IN	O
metastatic	JJ	B-PROBLEM
rcc	NN	I-PROBLEM
status	NN	O
post	NN	O
left	VBD	B-TREATMENT
radical	JJ	I-TREATMENT
nephrectomy	NN	I-TREATMENT
in	IN	O
2018-03-21	JJ	O
,	,	O
status	NN	O
post	NN	O
avastin	NN	B-TREATMENT
and	CC	O
sorafenib	NN	B-TREATMENT
,	,	O
most	RBS	O
recently	RB	O
on	IN	O
sutent	NN	B-TREATMENT
monotherapy	NN	I-TREATMENT
since	IN	O
2018-12-21	JJ	O
,	,	O
with	IN	O
mild	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
,	,	O
who	WP	O
presented	VBD	O
from	IN	O
home	NN	O
on	IN	O
2019-06-14	JJ	O
with	IN	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
and	CC	O
fever	NN	B-PROBLEM
.	.	O

of	IN	O
note	NN	O
,	,	O
he	PRP	O
was	VBD	O
hospitalized	VBN	O
at	IN	O
dana-farber	JJ	O
cancer	NN	O
institute	NN	O
from	IN	O
9/25-10/6	JJ	O
with	IN	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
at	IN	O
which	WDT	O
time	NN	O
he	PRP	O
reportedly	RB	O
had	VBD	O
cardiac	JJ	B-TEST
enzymes	RB	I-TEST
,	,	O
an	DT	B-TEST
echocardiogram	NN	I-TEST
and	CC	O
a	DT	B-TEST
pharmacological	JJ	I-TEST
stress	NN	I-TEST
test	NN	I-TEST
performed	VBD	O
.	.	O

it	PRP	O
is	VBZ	O
unclear	JJ	O
from	IN	O
history	NN	O
what	WP	O
these	DT	B-TEST
studies	NNS	I-TEST
revealed	VBD	O
.	.	O

he	PRP	O
reports	VBZ	O
that	IN	O
he	PRP	O
felt	VBD	O
fatigued	VBN	B-PROBLEM
during	IN	O
the	DT	O
week	NN	O
prior	RB	O
to	TO	O
the	DT	O
current	JJ	O
admission	NN	O
.	.	O

on	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
,	,	O
he	PRP	O
felt	VBD	O
"	NNP	O
congested	VBD	B-PROBLEM
"	NN	O
in	IN	O
his	PRP$	O
chest	NN	O
,	,	O
and	CC	O
had	VBD	O
a	DT	B-PROBLEM
new	JJ	I-PROBLEM
fever	NN	I-PROBLEM
.	.	O

patrick	NN	O
reports	VBZ	O
a	DT	B-PROBLEM
mild	JJ	I-PROBLEM
cough	NN	I-PROBLEM
for	IN	O
2	CD	O
days	NNS	O
pta	RB	O
,	,	O
non-productive	JJ	B-PROBLEM
.	.	O

he	PRP	O
denies	VBZ	O
a	DT	O
history	NN	O
of	IN	O
aspiration	NN	B-PROBLEM
events	NNS	I-PROBLEM
or	CC	O
choking	VBG	B-PROBLEM
with	IN	O
food	NN	O
intake	NN	O
.	.	O

he	PRP	O
describes	VBZ	O
mild	JJ	B-PROBLEM
reflux	NN	I-PROBLEM
symptoms	NNS	I-PROBLEM
at	IN	O
night	NN	O
.	.	O

further	RB	B-TEST
ros	NN	I-TEST
reveals	NNS	O
mild	VBP	B-PROBLEM
sob	NN	I-PROBLEM
in	IN	O
the	DT	O
days	NNS	O
preceding	VBG	O
admission	NN	O
,	,	O
but	CC	O
he	PRP	O
tells	VBZ	O
me	PRP	O
that	IN	O
he	PRP	O
was	VBD	O
surprised	VBN	O
to	TO	O
find	VB	O
out	RP	O
about	IN	O
his	PRP$	B-PROBLEM
low	JJ	I-PROBLEM
oxygen	NN	I-PROBLEM
saturation	NN	I-PROBLEM
because	IN	O
he	PRP	O
did	VBD	O
not	RB	O
feel	VB	O
that	IN	O
bad	JJ	O
.	.	O

he	PRP	O
denies	VBZ	O
chills	NNS	B-PROBLEM
,	,	O
no	DT	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
no	DT	O
le	NN	B-PROBLEM
swelling	VBG	I-PROBLEM
.	.	O

in	IN	O
the	DT	O
deanna	NN	O
,	,	O
tmax	NN	B-TEST
102.8	CD	O
,	,	O
bp	VBD	B-TEST
100	CD	O
-	:	O
140/60	CD	O
s,	NN	O
hr	NN	B-TEST
80	CD	O
s,	NN	O
rr	NN	B-TEST
20	CD	O
s,	NN	O
sat	VBD	B-TEST
75%	CD	O
on	IN	O
ra	NN	B-TREATMENT
in	IN	O
triage	NN	O
,	,	O
up	RB	O
to	TO	O
100%	CD	O
on	IN	O
nrb	NN	B-TREATMENT
.	.	O

cxr	NN	B-TEST
with	IN	O
bibasilar	JJ	B-PROBLEM
consolidations	NNS	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
given	VBN	O
levo	JJ	B-TREATMENT
750	CD	O
mg	NN	O
po	NN	O
x1	NNP	O
,	,	O
and	CC	O
flagyl	RB	B-TREATMENT
500	CD	O
mg	NNS	O
po	JJ	O
x1	NNP	O
.	.	O

his	PRP$	B-TEST
bp	NN	I-TEST
decreased	VBD	O
to	TO	O
100	CD	O
systolic	JJ	O
despite	IN	O
hydration	NN	B-TREATMENT
with	IN	O
2l	CD	O
of	IN	O
ns	NN	B-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
subsquently	RB	O
admitted	VBN	O
to	TO	O
the	DT	O
icu	NN	O
for	IN	O
further	JJ	B-TREATMENT
care	NN	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
placed	VBN	O
on	IN	O
levo	NN	B-TREATMENT
and	CC	O
ceftriaxone	NN	B-TREATMENT
.	.	O

a	DT	B-TEST
cosyntropin	NN	I-TEST
stimulation	NN	I-TEST
test	NN	I-TEST
revealed	VBD	O
cortisol	NN	B-TEST
32.1	CD	O
-->	NN	O
36.4	CD	O
.	.	O

his	PRP$	B-PROBLEM
oxygen	NN	I-PROBLEM
requirement	NN	I-PROBLEM
decreased	VBN	O
,	,	O
and	CC	O
his	PRP$	O
overall	JJ	O
status	NN	O
improved	VBD	O
quickly	RB	O
.	.	O

he	PRP	O
is	VBZ	O
being	VBG	O
transferred	VBN	O
to	TO	O
the	DT	O
floor	NN	O
for	IN	O
ongoing	VBG	B-TREATMENT
care	NN	I-TREATMENT
.	.	O

1.	CD	O
metastatic	JJ	B-PROBLEM
renal	NN	I-PROBLEM
cell	NN	I-PROBLEM
carcinoma	NN	I-PROBLEM
,	,	O
diagnosed	VBN	O
in	IN	O
2018-03-21	JJ	O
,	,	O
status	NN	O
post	NN	O
left	VBD	B-TREATMENT
radical	JJ	I-TREATMENT
nephrectomy	NN	I-TREATMENT
at	IN	O
st.	JJ	O
margaret's	NN	O
center	NN	O
for	IN	O
women	NNS	O
&	CC	O
infants	NNS	O
in	IN	O
03/2006	CD	O
.	.	O

path	NN	O
consistent	NN	O
with	IN	O
renal	JJ	B-PROBLEM
cell	NN	I-PROBLEM
carcinoma	NN	I-PROBLEM
of	IN	I-PROBLEM
chromophobe	NN	I-PROBLEM
type	NN	I-PROBLEM
with	IN	O
carter	NN	B-PROBLEM
nuclear	JJ	I-PROBLEM
grade	NN	I-PROBLEM
of	IN	O
4/4	CD	O
.	.	O

lymphovascular	JJ	B-PROBLEM
invasion	NN	I-PROBLEM
was	VBD	O
present	JJ	O
.	.	O

he	PRP	O
later	RB	O
presented	VBD	O
with	IN	O
increasing	VBG	B-PROBLEM
back	RB	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
and	CC	O
metastatic	JJ	B-PROBLEM
disease	NN	I-PROBLEM
was	VBD	O
documented	VBN	O
.	.	O

he	PRP	O
is	VBZ	O
status	NN	O
post	NN	O
avastin	NN	B-TREATMENT
plus	CC	O
sorafenib	NN	B-TREATMENT
,	,	O
protocol	JJ	O
#04-393	NN	O
,	,	O
discontinued	VBN	O
in	IN	O
the	DT	O
setting	NN	O
of	IN	O

ongoing	VBG	B-PROBLEM
grade	NN	I-PROBLEM
iii	NN	I-PROBLEM
rash	NN	I-PROBLEM
,	,	O
involving	VBG	O
the	DT	O
hands	NNS	O
and	CC	O
feet	NNS	O
in	IN	O
addition	NN	O
proteinuria	NNS	B-PROBLEM
secondary	JJ	O
to	TO	O
the	DT	O
avastin	NN	B-TREATMENT
.	.	O

he	PRP	O
has	VBZ	O
been	VBN	O
maintained	VBN	O
on	IN	O
single	JJ	B-TREATMENT
timlin	NN	I-TREATMENT
therapy	NN	I-TREATMENT
with	IN	O
sutent	JJ	B-TREATMENT
50	CD	O
mg	JJ	O
daily	RB	O
as	IN	O
of	IN	O
2018-12-21	JJ	O
and	CC	O
has	VBZ	O
completed	VBN	O
nearly	RB	O
6	CD	O
cycles	NNS	O
.	.	O

he	PRP	O
has	VBZ	O
mild	VBN	B-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
sutent	NN	B-TREATMENT
.	.	O

2.	CD	O
seasonal	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM

vitals	NNS	B-TEST
:	:	O
t	NN	B-TEST
96.9	CD	O
,	,	O
bp	NN	B-TEST
110/70	CD	O
,	,	O
hr	NN	B-TEST
84	CD	O
,	,	O
rr	NN	B-TEST
20	CD	O
,	,	O
sat	VBD	B-TEST
97%	CD	O
on	IN	O
4l	CD	O
.	.	O

gen	NN	O
:	:	O
in	IN	O
nad	NN	B-PROBLEM
.	.	O

heent	NN	O
:	:	O
flushed	JJ	B-PROBLEM
cheeks	NN	I-PROBLEM
.	.	O

slightly	RB	B-PROBLEM
dry	JJ	I-PROBLEM
mm	NN	I-PROBLEM
.	.	O

neck	NN	O
:	:	O
jvp	NN	B-TEST
not	RB	O
elevated	VBN	B-PROBLEM
.	.	O

resp	NN	O
:	:	O
decreased	VBN	B-PROBLEM
air	NN	I-PROBLEM
entry	NN	I-PROBLEM
and	CC	O
crackles	NNS	B-PROBLEM
at	IN	I-PROBLEM
both	DT	I-PROBLEM
lung	NN	I-PROBLEM
bases	NNS	I-PROBLEM
.	.	O

+	NN	O
egophony	NN	B-PROBLEM
.	.	O

no	DT	O
s3	NN	B-PROBLEM
,	,	O
s4	NN	B-PROBLEM
.	.	O

no	DT	O
murmur	NN	B-PROBLEM
or	CC	O
rub	NN	B-PROBLEM
.	.	O

abdomen	NNS	O
soft	JJ	O
and	CC	O
non-tender	NN	B-PROBLEM
.	.	O

ext	NN	O
:	:	O
without	IN	O
edema	NN	B-PROBLEM
.	.	O

2019-06-14	JJ	O
10:30	CD	O
am	VBP	O
blood	NN	O
wbc	NN	B-TEST
-	:	O
8.0	CD	O
rbc	NN	B-TEST
-	:	O
4.22	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
12.9	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
41.7	CD	O
mcv	SYM	B-TEST
-	:	O
99	CD	O
*	NN	O
mch	SYM	B-TEST
-	:	O
30.5	CD	O
mchc	SYM	B-TEST
-	:	O
30.8	CD	O
*	NN	O
rdw	NN	B-TEST
-	:	O
16.8	CD	O
*	JJ	O
plt	NN	B-TEST
ct	SYM	I-TEST
-	:	O
797	CD	O
*#	NN	O

2019-06-19	JJ	O
07:20	CD	O
am	VBP	O
blood	NN	O
wbc	NN	B-TEST
-	:	O
11.1	CD	O
*	NN	O
rbc	NN	B-TEST
-	:	O
3.47	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
10.9	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
34.1	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
98	CD	O
mch	SYM	B-TEST
-	:	O
31.3	CD	O
mchc	SYM	B-TEST
-	:	O
31.9	CD	O
rdw	NN	B-TEST
-	:	O
16.7	CD	O
*	JJ	O
plt	NN	B-TEST
ct	SYM	I-TEST
-	:	O
604	CD	O
*	NN	O

2019-06-14	JJ	O
10:30	CD	O
am	VBP	O
blood	NN	O
pt	NN	B-TEST
-	:	O
11.2	CD	O
ptt	NN	B-TEST
-	:	O
23.9	CD	O
inr(pt)	JJ	B-TEST
-	:	O
0.9	CD	O

2019-06-14	JJ	O
10:30	CD	O
am	VBP	O
blood	NN	O
plt	NN	B-TEST
ct	VBD	I-TEST
-	:	O
797	CD	O
*#	NN	O

2019-06-14	JJ	O
10:30	CD	O
am	VBP	O
blood	NN	O
glucose	JJ	B-TEST
-	:	O
134	CD	O
*	JJ	O
urean	JJ	B-TEST
-	:	O
39	CD	O
*	NN	O
creat	NN	B-TEST
-	:	O
2.1	CD	O
*	NN	O
na	SYM	B-TEST
-	:	O
133	CD	O
k	SYM	B-TEST
-	:	O
7.9	CD	O
*	NN	O
cl	NN	B-TEST
-	:	O
94	CD	O
*	NN	O
hco3	NN	B-TEST
-	:	O
28	CD	O
angap	NN	B-TEST
-	:	O
19	CD	O

2019-06-19	JJ	O
07:20	CD	O
am	VBP	O
blood	NN	O
glucose	JJ	B-TEST
-	:	O
73	CD	O
urean	JJ	B-TEST
-	:	O
20	CD	O
creat	NN	B-TEST
-	:	O
1.1	CD	O
na	SYM	B-TEST
-	:	O
136	CD	O
k	SYM	B-TEST
-	:	O
5.0	CD	O
cl	NN	B-TEST
-	:	O
101	CD	O
hco3	NN	B-TEST
-	:	O
27	CD	O
angap	NN	B-TEST
-	:	O
13	CD	O

2019-06-14	JJ	O
10:30	CD	O
am	VBP	O
blood	NN	O
alt	NN	B-TEST
-	:	O
34	CD	O
ast	IN	B-TEST
-	:	O
167	CD	O
*	NN	O
ck(cpk)	NN	B-TEST
-	:	O
313	CD	O
*	NN	O
alkphos	SYM	B-TEST
-	:	O
383	CD	O
*	JJ	O
amylase	NN	B-TEST
-	:	O
44	CD	O
totbili	SYM	B-TEST
-	:	O
0.7	CD	O

2019-06-14	JJ	O
06:03	CD	O
pm	NN	O
blood	NN	O
ck(cpk)	NN	B-TEST
-	:	O
194	CD	O
*	NN	O

2019-06-14	JJ	O
10:30	CD	O
am	VBP	O
blood	NN	O
ck-mb	JJ	B-TEST
-	:	O
3	CD	O
ctropnt	NN	B-TEST
-	:	O
0.05	CD	O
*	NN	O

2019-06-14	JJ	O
06:03	CD	O
pm	JJ	O
blood	NN	O
ck-mb	JJ	B-TEST
-4	NNP	O
ctropnt	NN	B-TEST
-	:	O
0.03	CD	O
*	NN	O

2019-06-17	JJ	O
05:30	CD	O
am	VBP	O
blood	NN	O
probnp	NN	B-TEST
-	:	O
258	CD	O
*	NN	O

2019-06-14	JJ	O
06:03	CD	O
pm	NN	O
blood	NN	O
calcium	NN	B-TEST
-	:	O
8.3	CD	O
*	NN	O
phos	NN	B-TEST
-	:	O
4.3	CD	O
mg	SYM	B-TEST
-	:	O
1.9	CD	O

2019-06-18	JJ	O
07:55	CD	O
am	VBP	O
blood	NN	O
caltibc	NN	B-TEST
-	:	O
229	CD	O
ferritn	SYM	B-TEST
-	:	O
greater	JJR	O
th	NN	O
trf	SYM	O
-	:	O
176	CD	O
*	NN	O

2019-06-16	JJ	O
07:35	CD	O
am	VBP	O
blood	NN	O
tsh	NN	B-TEST
-	:	O
43	CD	O
*	NN	O

2019-06-16	JJ	O
07:35	CD	O
am	VBP	O
blood	NN	O
free	JJ	B-TEST
t4	NN	I-TEST
-	:	O
0.36	CD	O
*	NN	O

2019-06-19	JJ	O
07:20	CD	O
am	VBP	O
blood	NN	O
wbc	NN	B-TEST
-	:	O
11.1	CD	O
*	NN	O
rbc	NN	B-TEST
-	:	O
3.47	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
10.9	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
34.1	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
98	CD	O
mch	SYM	B-TEST
-	:	O
31.3	CD	O
mchc	SYM	B-TEST
-	:	O
31.9	CD	O
rdw	NN	B-TEST
-	:	O
16.7	CD	O
*	JJ	O
plt	NN	B-TEST
ct	SYM	I-TEST
-	:	O
604	CD	O
*	NN	O

2019-06-19	JJ	O
07:20	CD	O
am	VBP	O
blood	NN	O
neuts	NNS	B-TEST
-	:	O
77.0	CD	O
*	NN	O
bands	NNS	B-TEST
-	:	O
5.0	CD	O
lymphs	SYM	B-TEST
-	:	O
11.0	CD	O
*	JJ	O
monos	NNS	B-TEST
-	:	O
3.0	CD	O
eos	SYM	B-TEST
-	:	O
0	CD	O
baso	SYM	B-TEST
-	:	O
0	CD	O
atyps	SYM	B-TEST
-	:	O
1.0	CD	O
*	NN	O
metas	NNS	B-TEST
-	:	O
2.0	CD	O
*	NN	O
myelos	SYM	B-TEST
-	:	O
1.0	CD	O
*	NN	O

2019-06-18	JJ	O
07:55	CD	O
am	VBP	O
blood	NN	O
pt	NN	B-TEST
-	:	O
11.5	CD	O
inr(pt)	JJ	B-TEST
-	:	O
1.0	CD	O

2019-06-19	JJ	O
07:20	CD	O
am	VBP	O
blood	NN	O
glucose	JJ	B-TEST
-	:	O
73	CD	O
urean	JJ	B-TEST
-	:	O
20	CD	O
creat	NN	B-TEST
-	:	O
1.1	CD	O
na	SYM	B-TEST
-	:	O
136	CD	O
k	SYM	B-TEST
-	:	O
5.0	CD	O
cl	NN	B-TEST
-	:	O
101	CD	O
hco3	NN	B-TEST
-	:	O
27	CD	O
angap	NN	B-TEST
-	:	O
13	CD	O

2019-06-19	JJ	O
07:20	CD	O
am	VBP	O
blood	NN	O
calcium	NN	B-TEST
-	:	O
8.0	CD	O
*	NN	O
phos	NN	B-TEST
-	:	O
3.3	CD	O
mg	SYM	B-TEST
-	:	O
2.0	CD	O

1)	CD	O
bilateral	JJ	B-TEST
le	NN	I-TEST
doppler	NN	I-TEST
(	(	O
06-14	JJ	O
):	NN	O
no	DT	O
evidence	NN	O
of	IN	O
deep	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
thrombosis	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
lower	JJR	I-PROBLEM
extremities	NNS	I-PROBLEM
bilaterally	RB	I-PROBLEM
.	.	O

2)	CD	O
cxray	NN	B-TEST
(	(	O
06-14	JJ	O
):	NNP	O
new	JJ	B-PROBLEM
bibasilar	JJ	I-PROBLEM
consolidations	NNS	I-PROBLEM
are	VBP	O
demonstrated	VBN	O
accompanied	VBN	O
by	IN	O
bilateral	JJ	B-PROBLEM
small	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

the	DT	O
lung	NN	O
volumes	NNS	O
are	VBP	O
slightly	RB	B-PROBLEM
increased	VBN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
pneumothorax	NN	B-PROBLEM
identified	VBN	O
.	.	O

3)	CD	O
ct	NN	B-TEST
torso	NN	I-TEST
(	(	O
06-17	JJ	O
):	NN	O

1.	CD	O
marked	VBD	B-PROBLEM
interval	JJ	I-PROBLEM
enlargement	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
cardiac	JJ	I-PROBLEM
silhouette	NN	I-PROBLEM
.	.	O

together	RB	O
with	IN	O
the	DT	O
interval	NN	O
development	NN	O
of	IN	O
bilateral	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
,	,	O
this	DT	O
indicates	VBZ	O
cardiac	JJ	B-PROBLEM
insufficiency	NN	I-PROBLEM
(	(	O
or	CC	O
alternatively	RB	O
volume	NN	B-PROBLEM
overload	NN	I-PROBLEM
)	)	O
and	CC	O
an	DT	B-TEST
echocardiogram	NN	I-TEST
may	MD	O
be	VB	O
indicated	VBN	O
for	IN	O
further	JJ	B-TEST
evaluation	NN	I-TEST
.	.	O

2.	CD	O
bilateral	JJ	B-PROBLEM
basilar	JJ	I-PROBLEM
compressive	JJ	I-PROBLEM
atelectasis	NN	I-PROBLEM
.	.	O

superimposed	VBN	B-PROBLEM
infectious	JJ	I-PROBLEM
consolidation	NN	I-PROBLEM
is	VBZ	O
likely	JJ	O
.	.	O

3.	CD	O
interval	JJ	O
development	NN	O
of	IN	O
tree-in-eric	JJ	B-PROBLEM
nodular	JJ	I-PROBLEM
opacities	NNS	I-PROBLEM
and	CC	O
scattered	VBN	B-PROBLEM
ground	NN	I-PROBLEM
glass	NN	I-PROBLEM
opacities	NNS	I-PROBLEM
involving	VBG	I-PROBLEM
the	DT	I-PROBLEM
right	NN	I-PROBLEM
lung	NN	I-PROBLEM
,	,	O
concerning	VBG	O
for	IN	O
an	DT	B-PROBLEM
infectious	JJ	I-PROBLEM
process	NN	I-PROBLEM
.	.	O

the	DT	O
differential	JJ	O
diagnosis	NN	O
of	IN	O
this	DT	O
is	VBZ	O
wide	JJ	O
including	VBG	O
viral	JJ	B-PROBLEM
,	,	I-PROBLEM
fungal	JJ	I-PROBLEM
and	CC	I-PROBLEM
atypical	JJ	I-PROBLEM
mycobacterial	JJ	I-PROBLEM
infections	NNS	I-PROBLEM
.	.	O

drug	NN	B-PROBLEM
toxicity	NN	I-PROBLEM
would	MD	O
be	VB	O
a	DT	O
consideration	NN	O
,	,	O
although	IN	O
somewhat	RB	O
less	RBR	O
likely	JJ	O
given	VBN	O
the	DT	O
unilaterality	NN	O
of	IN	O
the	DT	O
findings	NNS	O
.	.	O

4.	CD	O
new	JJ	B-PROBLEM
jejunal	JJ	I-PROBLEM
wall	NN	I-PROBLEM
thickening	VBG	I-PROBLEM
with	IN	O
persistent	JJ	B-PROBLEM
distal	JJ	I-PROBLEM
ileal	NN	I-PROBLEM
wall	NN	I-PROBLEM
thickening	NN	I-PROBLEM
and	CC	O
diffuse	NN	B-PROBLEM
mesenteric	NN	I-PROBLEM
stranding	NN	I-PROBLEM
,	,	O
most	RBS	O
likely	JJ	O
reflecting	VBG	O
an	DT	B-PROBLEM
infectious	JJ	I-PROBLEM
etiology	NN	I-PROBLEM
.	.	O

5.	CD	O
overall	JJ	O
stability	NN	O
in	IN	O
metastatic	JJ	B-PROBLEM
burden	NN	I-PROBLEM
.	.	O

4)	CD	O
echo	JJ	B-TEST
(	(	O
06-18	JJ	O
):	NNP	O
mild	NN	B-PROBLEM
symmetric	NN	I-PROBLEM
left	VBD	I-PROBLEM
ventricular	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
with	IN	O
preserved	JJ	O
biventricular	JJ	O
systolic	JJ	O
function	NN	O
.	.	O

mild	JJ	B-PROBLEM
posterior	JJ	I-PROBLEM
mitral	JJ	I-PROBLEM
valve	NN	I-PROBLEM
prolapse	NN	I-PROBLEM
with	IN	O
mild	JJ	B-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

small	JJ	B-PROBLEM
(	(	I-PROBLEM
0.6	CD	I-PROBLEM
cm	NN	I-PROBLEM
)	)	I-PROBLEM
circumferential	JJ	I-PROBLEM
pericardial	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
,	,	O
largest	JJS	O
around	IN	O
the	DT	O
left	JJ	O
atrium	NN	O
.	.	O

5)	CD	O
l	NN	B-TEST
femur	NN	I-TEST
xray	NN	I-TEST
(	(	O
06-18	JJ	O
):	NNP	O
predominantly	RB	B-PROBLEM
sclerotic	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
with	IN	O
interval	JJ	B-PROBLEM
periosteal	JJ	I-PROBLEM
new	JJ	I-PROBLEM
bone	NN	I-PROBLEM
formation	NN	I-PROBLEM
involving	VBG	O
the	DT	O
intertrochanteric	NN	O
and	CC	O
subtrochanteric	JJ	O
regions	NNS	O
.	.	O

no	DT	O
displaced	JJ	B-PROBLEM
fracture	NN	I-PROBLEM
is	VBZ	O
demonstrated	VBN	O
.	.	O

mr.	NN	O
mcelveen	JJ	O
51	CD	O
year-old	JJ	O
male	NN	O
with	IN	O
metastatic	JJ	B-PROBLEM
rcc	NN	I-PROBLEM
on	IN	O
sutent	NN	B-TREATMENT
since	IN	O
2018-12-21	CD	O
,	,	O
admitted	VBN	O
with	IN	O
fever	NN	B-PROBLEM
,	,	O
hypoxemia	NN	B-PROBLEM
,	,	O
and	CC	O
bibasilar	JJ	B-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

1)	CD	O
bibasilar	JJ	B-PROBLEM
pneumonia	NN	I-PROBLEM
:	:	O
patient	NN	O
was	VBD	O
treated	VBN	O
for	IN	O
community-acquired	JJ	B-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
initially	RB	O
placed	VBN	O
on	IN	O
ceftriaxone	NN	B-TREATMENT
,	,	O
levaquin	NN	B-TREATMENT
,	,	O
and	CC	O
flagyl	NN	B-TREATMENT
in	IN	O
the	DT	O
icu	NN	O
but	CC	O
then	RB	O
changed	VBD	O
to	TO	O

azithromycin	NN	B-TREATMENT
&	CC	O
ctx	NN	B-TREATMENT
at	IN	O
time	NN	O
of	IN	O
transfer	NN	O
to	TO	O
the	DT	O
oncology	NN	O
service	NN	O
.	.	O

he	PRP	O
continued	VBD	O
to	TO	O
have	VB	O
an	DT	B-PROBLEM
oxygen	NN	I-PROBLEM
requirement	NN	I-PROBLEM
and	CC	O
ct	NN	B-TEST
scan	JJ	I-TEST
suggested	VBN	O
ground	NN	B-PROBLEM
glass	NN	I-PROBLEM
opacities	NNS	I-PROBLEM
,	,	O
suggestive	NN	O
of	IN	O
an	DT	B-PROBLEM
underlying	VBG	I-PROBLEM
infectious	JJ	I-PROBLEM
process	NN	I-PROBLEM
.	.	O

echo	NN	B-TEST
was	VBD	O
done	VBN	O
and	CC	O
confirmed	VBN	O
normal	JJ	O
ejection	NN	O
fraction	NN	O
.	.	O

his	PRP$	O
respiratory	NN	O
status	NN	O
improved	VBD	O
slowly	RB	O
,	,	O
oxygen	NN	B-TREATMENT
was	VBD	O
weaned	VBN	O
off	RP	O
,	,	O
and	CC	O
he	PRP	O
was	VBD	O
discharged	VBN	O
on	IN	O
course	NN	O
of	IN	O
levaquin	NN	B-TREATMENT
.	.	O

2)	CD	O
metastatic	JJ	B-PROBLEM
rcc	NN	I-PROBLEM
:	:	O
sutent	NN	B-TREATMENT
was	VBD	O
held	VBN	O
on	IN	O
admission	NN	O
in	IN	O
light	NN	O
of	IN	O
acute	JJ	B-PROBLEM
infection	NN	I-PROBLEM
.	.	O

he	PRP	O
underwent	VBD	O
a	DT	B-TEST
staging	NN	I-TEST
ct	NN	I-TEST
scan	JJ	I-TEST
torso	NN	I-TEST
which	WDT	O
suggested	VBD	O
no	DT	O
significant	JJ	B-PROBLEM
increase	NN	I-PROBLEM
in	IN	I-PROBLEM
tumor	NN	I-PROBLEM
burden	NN	I-PROBLEM
.	.	O

patient	NN	O
was	VBD	O
also	RB	O
found	VBN	O
to	TO	O
have	VB	O
abnormal	JJ	B-PROBLEM
tfts	NNS	I-PROBLEM
on	IN	O
sutent	NN	B-TREATMENT
and	CC	O
was	VBD	O
started	VBN	O
on	IN	O
replacement	NN	B-TREATMENT

therapy	NN	B-TREATMENT
.	.	O

he	PRP	O
will	MD	O
need	VB	O
follow-up	JJ	B-TEST
bloodwork	NN	I-TEST
as	IN	O
an	DT	O
outpatient	NN	O
.	.	O

recent	JJ	B-TEST
ct	NN	I-TEST
scan	JJ	I-TEST
showed	VBD	O
destruction	NN	B-PROBLEM
of	IN	I-PROBLEM
l	JJ	I-PROBLEM
femoral	JJ	I-PROBLEM
neck	NN	I-PROBLEM
.	.	O

he	PRP	O
underwent	VBD	O
an	DT	B-TEST
xray	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
l	NN	I-TEST
femur	NN	I-TEST
which	WDT	O
did	VBD	O
not	RB	O
suggest	VB	O
an	DT	B-PROBLEM
acute	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
.	.	O

patient	NN	O
was	VBD	O
instructed	VBN	O
to	TO	O
restart	VB	O
sutent	NN	B-TREATMENT
next	IN	O
monday	NN	O
.	.	O

3)	CD	O
renal	JJ	B-PROBLEM
insufficiency	NN	I-PROBLEM
:	:	O
creatinine	NN	B-TEST
improved	VBN	O
from	IN	O
2.1	CD	O
to	TO	O
1.3	CD	O
at	IN	O
time	NN	O
of	IN	O
discharge	NN	O
.	.	O

likely	RB	O
related	VBN	O
to	TO	O
underlying	VBG	B-PROBLEM
malignancy	NN	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
prerenal	JJ	B-PROBLEM
component	NN	I-PROBLEM
given	VBN	O
improvement	NN	O
with	IN	O
gentle	JJ	B-TREATMENT
hydration	NN	I-TREATMENT
.	.	O

medications	NNS	O
on	IN	O
admission	NN	O
:	:	O
he	PRP	O
takes	VBZ	O
imodium	NN	B-TREATMENT
and	CC	O
lomotil	NN	B-TREATMENT
while	IN	O
on	IN	O
sutent	NN	B-TREATMENT
for	IN	O
diarrhea	NN	B-PROBLEM
.	.	O

he	PRP	O
is	VBZ	O
also	RB	O
on	IN	O
ms	NN	B-TREATMENT
contin	NN	I-TREATMENT
45	CD	O
mg	NN	O
po	NN	O
q12	NN	O
hours	NNS	O
(	(	O
confirmed	VBN	O
with	IN	O
wife	NN	O
)	)	O
and	CC	O
msir	$	B-TREATMENT
15	CD	O
mg	NN	O
every	DT	O
4	CD	O
hours	NNS	O
as	IN	O
needed	VBN	O
.	.	O

heparin	NN	B-TREATMENT
5000	CD	O
unit	NN	O
sc	VBD	O
tid	NN	O

albuterol	NN	B-TREATMENT
0.083%	CD	O
neb	NN	O
soln	NN	O
1	CD	O
neb	JJ	O
ih	NN	O
q6h	NN	O

ipratropium	NN	B-TREATMENT
bromide	NN	I-TREATMENT
neb	RB	I-TREATMENT
1	CD	O
neb	JJ	O
ih	NN	O
q6h	NN	O

ceftriaxone	NN	B-TREATMENT
1	CD	O
gm	NN	O
iv	NN	O
q24h	NN	O

levofloxacin	RB	B-TREATMENT
500	CD	O
mg	NNS	O
po	JJ	O
q24h	NN	O

morphine	JJ	B-TREATMENT
sulfate	NN	I-TREATMENT
2-4	JJ	O
mg	NN	O
iv	NN	O
q4h	NN	O
:	:	O
prn	NN	O

docusate	NN	B-TREATMENT
sodium	NN	I-TREATMENT
100	CD	O
mg	NN	O
po	NN	O
bid	NN	O

pantoprazole	JJ	B-TREATMENT
40	CD	O
mg	NN	O
po	NN	O
q24h	NN	O

fluticasone	NN	B-TREATMENT
propionate	NN	I-TREATMENT
110mcg	CD	O
2	CD	O
puff	NN	O
ih	NN	O
bid	NN	O

1.	CD	O
levothyroxine	JJ	B-TREATMENT
50	CD	O
mcg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

2.	CD	O
levofloxacin	JJ	B-TREATMENT
500	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
q24h	NN	O
(	(	O
every	DT	O
24	CD	O
hours	NNS	O
)	)	O
for	IN	O
4	CD	O
days	NNS	O
:	:	O
last	JJ	O
dose	NN	O
will	MD	O
be	VB	O
nolen	VBN	O
,	,	O
06-23	JJ	O
.	.	O

3.	CD	O
docusate	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
100	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
):	NNP	O
take	NN	O
as	IN	O
necessary	JJ	O
for	IN	O
constipation	NN	B-PROBLEM
.	.	O

4.	CD	O
sutent	JJ	B-TREATMENT
50	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
every	DT	O
other	JJ	O
day	NN	O
:	:	O
please	VB	O
restart	VB	O
on	IN	O
wallace	NN	O
,	,	O
06-24	NN	O
.	.	O

5.	CD	O
morphine	NN	B-TREATMENT
15	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
q4-6h	NN	O
(	(	O
every	DT	O
4	CD	O
to	TO	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
pain	NN	B-PROBLEM
.	.	O

6.	CD	O
morphine	NN	B-TREATMENT
15	CD	O
mg	NN	O
tablet	NN	O
sustained	VBD	O
release	NN	O
sig	NN	O
:	:	O
three	CD	O
(	(	O
3	CD	O
)	)	O
tablet	NN	O
sustained	VBN	O
release	NN	O
po	NN	O
q12h	NN	O
(	(	O
every	DT	O
12	CD	O
hours	NNS	O
).	VBP	O

1)	CD	O
pneumonia	NN	B-PROBLEM

2)	CD	O
acute	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
failure	NN	I-PROBLEM

3)	CD	O
metastatic	JJ	B-PROBLEM
renal	NN	I-PROBLEM
cell	NN	I-PROBLEM
carcinoma	NN	I-PROBLEM

4)	CD	O
hypoxemia	NN	B-PROBLEM

1)	CD	O
please	JJ	O
take	VB	O
all	DT	B-TREATMENT
medications	NNS	I-TREATMENT
as	IN	O
listed	VBN	O
in	IN	O
the	DT	O
discharge	NN	O
instructions	NNS	O
.	.	O

2)	CD	O
you	PRP	O
were	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
hospital	NN	O
and	CC	O
started	VBD	O
on	IN	O
an	DT	B-TREATMENT
antibiotic	JJ	I-TREATMENT
called	VBD	O
levaquin	NN	B-TREATMENT
for	IN	O
a	DT	B-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

you	PRP	O
should	MD	O
continue	VB	O
taking	VBG	O
this	DT	B-TREATMENT
medication	NN	I-TREATMENT
and	CC	O
your	PRP$	O
last	JJ	O
day	NN	O
will	MD	O
be	VB	O
nolen	VBN	O
,	,	O
06-23	JJ	O
.	.	O

3)	CD	O
when	WRB	O
you	PRP	O
were	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
hospital	NN	O
your	PRP$	B-TREATMENT
sutent	NN	I-TREATMENT
was	VBD	O
stopped	VBN	O
.	.	O

you	PRP	O
should	MD	O
resume	VB	O
this	DT	B-TREATMENT
medication	NN	I-TREATMENT
starting	VBG	O
wallace	NN	O
,	,	O
06-24	NN	O
.	.	O

you	PRP	O
should	MD	O
take	VB	O
this	DT	B-TREATMENT
medication	NN	I-TREATMENT
every	DT	O
other	JJ	O
day	NN	O
.	.	O

4)	CD	O
during	IN	O
your	PRP$	O
hospital	NN	O
stay	NN	O
you	PRP	O
were	VBD	O
also	RB	O
found	VBN	O
to	TO	O
have	VB	O
low	JJ	B-PROBLEM
thyroid	NNS	I-PROBLEM
hormone	NN	I-PROBLEM
levels	NNS	I-PROBLEM
.	.	O

as	IN	O
a	DT	O
result	NN	O
,	,	O
you	PRP	O
were	VBD	O
started	VBN	O
on	IN	O
thyroid	NN	B-TREATMENT
supplements	NNS	I-TREATMENT
.	.	O

you	PRP	O
should	MD	O
have	VB	O
follow-up	JJ	B-TEST
blood	NN	I-TEST
tests	NNS	I-TEST
by	IN	O
your	PRP$	O
primary	JJ	O
care	NN	O
physician	NN	O
b	NN	O
3	CD	O
months	NNS	O
.	.	O

6)	CD	O
if	IN	O
you	PRP	O
experience	VBP	O
any	DT	O
fevers	NNS	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
,	,	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
dizziness	NN	B-PROBLEM
or	CC	O
any	DT	B-PROBLEM
other	JJ	I-PROBLEM
concerning	NN	I-PROBLEM
symptoms	NNS	I-PROBLEM
please	VB	O
return	NN	O
to	TO	O
the	DT	O
emergency	NN	O
department	NN	O
.	.	O

patient	NN	O
was	VBD	O
discharged	VBN	O
to	TO	O
rehabilitation	VB	B-TREATMENT
on	IN	O
2013-06-25	JJ	O
.	.	O

discharge	NN	O
was	VBD	O
delayed	VBN	O
by	IN	O
one	CD	O
day	NN	O
to	TO	O
ensure	VB	O
patient	NN	O
could	MD	O
tolerate	VB	O
p.o.	NNS	O
which	WDT	O
patient	VBP	O
did	VBD	O
without	IN	O
difficulty	NN	B-PROBLEM
.	.	O

please	VB	O
see	VB	O
original	JJ	O
discharge	NN	O
summary	NN	O
for	IN	O
discharge	NN	B-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

by	IN	O
report	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
awake	JJ	O
,	,	O
but	CC	O
confused	VBD	B-PROBLEM
at	IN	O
the	DT	O
scene	NN	O
of	IN	O
the	DT	O
accident	NN	O
with	IN	O
no	DT	O
memory	NN	O
of	IN	O
the	DT	O
incident	NN	O
.	.	O

she	PRP	O
was	VBD	O
immobilized	VBN	O
in	IN	O
the	DT	B-TREATMENT
c-spine	JJ	I-TREATMENT
collar	NN	I-TREATMENT
at	IN	O
the	DT	O
scene	NN	O
of	IN	O
the	DT	O
accident	NN	O
and	CC	O
subsequently	RB	O
transported	VBN	O
by	IN	O
ems	NNS	O
to	TO	O
the	DT	O
new	JJ	O
england	NN	O
sinai	NN	O
hospital	NN	O
&	CC	O
rehab	NN	O
center	NN	O
emergency	NN	O
department	NN	O
for	IN	O
further	JJ	B-TREATMENT
management	NN	I-TREATMENT
.	.	O

examination	NN	B-TEST
on	IN	O
presentation	NN	O
to	TO	O
the	DT	O
emergency	NN	O
room	NN	O
revealed	VBD	O
the	DT	O
following	NN	O
:	:	O

temperature	NN	B-TEST
35.4	CD	O
celsius	NN	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
116/63	CD	O
,	,	O
pulse	RB	B-TEST
105	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
18	CD	O
,	,	O
oxygen	NN	B-TEST
saturation	NN	I-TEST
98%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
alert	JJ	O
and	CC	O
oriented	VBD	O
times	NNS	O
three	CD	O
in	IN	O
no	DT	O
apparent	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

boston	NN	B-TEST
coma	NN	I-TEST
scale	NN	I-TEST
of	IN	O
15	CD	O
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
lung	NN	I-TEST
examination	NN	I-TEST
revealed	VBD	O
the	DT	O
lungs	NNS	O
to	TO	O
be	VB	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
,	,	O
no	DT	O
crepitus	NN	B-PROBLEM
,	,	O
and	CC	O
a	DT	B-PROBLEM
left	JJ	I-PROBLEM
clavicular	JJ	I-PROBLEM
deformity	NN	I-PROBLEM
was	VBD	O
grossly	RB	O
apparent	JJ	O
on	IN	O
examination	NN	B-TEST
.	.	O

cardiac	JJ	B-TEST
examination	NN	I-TEST
demonstrated	VBD	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
,	,	O
no	DT	O
murmurs	NN	B-PROBLEM
,	,	O
rubs	NN	B-PROBLEM
,	,	O
or	CC	O
gallops	NNS	B-PROBLEM
.	.	O

soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBN	B-PROBLEM
.	.	O

examination	NN	B-TEST
was	VBD	O
guaiac	JJ	B-TEST
negative	JJ	O
with	IN	O
good	JJ	O
rectal	NN	O
tone	NN	O
.	.	O

the	DT	O
patient	NN	O
's	POS	O
pelvis	NN	O
was	VBD	O
stable	JJ	O
to	TO	O
ap	VB	B-TEST
and	CC	I-TEST
lateral	JJ	I-TEST
compression	NN	I-TEST
.	.	O

a	DT	B-PROBLEM
5	CD	I-PROBLEM
cm	NN	I-PROBLEM
laceration	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
over	IN	O
the	DT	O
patient	NN	O
's	POS	O
occiput	NN	O
on	IN	O
further	JJ	B-TEST
inspection	NN	I-TEST
with	IN	O
no	DT	O
exposed	JJ	B-PROBLEM
underlying	VBG	I-PROBLEM
bone	NN	I-PROBLEM
.	.	O

right	JJ	B-TEST
upper	JJ	I-TEST
extremity	NN	I-TEST
examination	NN	I-TEST
demonstrated	VBD	O
intact	JJ	O
motor	NN	O
,	,	O
sensory	NN	O
,	,	O
and	CC	O
vascular	JJ	O
function	NN	O
.	.	O

left	VBN	B-TEST
upper	JJ	I-TEST
extremity	NN	I-TEST
examination	NN	I-TEST
demonstrated	VBD	O
no	DT	O
gross	JJ	B-PROBLEM
deformities	NNS	I-PROBLEM
,	,	O
tenderness	NN	B-PROBLEM
to	TO	O
palpation	NN	B-TEST
in	IN	I-TEST
the	DT	I-TEST
mid	NN	I-TEST
forearm	NN	I-TEST
,	,	O
intact	JJ	O
motor	NN	O
function	NN	O
in	IN	O
the	DT	O
median	NN	O
,	,	O
radial	JJ	O
,	,	O
and	CC	O
ulnar	JJ	O
nerve	NN	O
distributions	NNS	O
,	,	O
intact	JJ	O
sensation	NN	O
to	TO	O
light	JJ	B-TEST
touch	NN	I-TEST
in	IN	O
the	DT	O
median	JJ	O
and	CC	O
radial	JJ	O
nerve	NN	O
distributions	NNS	O
,	,	O
decreased	VBN	B-PROBLEM
sensation	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
ulnar-nerve	JJ	I-PROBLEM
distribution	NN	I-PROBLEM
,	,	O
warm	NN	O
and	CC	O
well	RB	O
perfused	JJ	O
limb	NN	O
with	IN	O
2+	CD	O
radial	JJ	B-TEST
pulses	NNS	I-TEST
.	.	O

right	RB	B-TEST
lower	JJR	I-TEST
extremity	NN	I-TEST
examination	NN	I-TEST
demonstrated	VBD	O
mild	JJ	B-PROBLEM
swelling	NN	I-PROBLEM
and	CC	O
ecchymosis	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
posterior	NN	I-PROBLEM
thigh	NN	I-PROBLEM
and	CC	O
approximately	RB	O
a	DT	B-PROBLEM
3	CD	I-PROBLEM
cm	NN	I-PROBLEM
laceration	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
lower	JJR	I-PROBLEM
leg	NN	I-PROBLEM
,	,	O
expressive	NN	O
of	IN	O
moderate	JJ	O
amounts	NNS	O
of	IN	O
standard	NN	O
sterile	NN	O

no	DT	O
gross	JJ	B-PROBLEM
deformities	NNS	I-PROBLEM
.	.	O

motor	NN	B-TEST
,	,	I-TEST
sensory	NN	I-TEST
,	,	I-TEST
and	CC	I-TEST
vascular	JJ	I-TEST
examinations	NNS	I-TEST
were	VBD	O
intact	JJ	O
in	IN	O
all	DT	O
distributions	NNS	O
.	.	O

left	VBD	B-TEST
lower	JJR	I-TEST
extremity	NN	I-TEST
examination	NN	I-TEST
demonstrated	VBD	O
no	DT	O
gross	JJ	B-PROBLEM
deformities	NNS	I-PROBLEM
and	CC	O
intact	JJ	O
motor	NN	O
,	,	O
sensory	NN	O
,	,	O
and	CC	O
vascular	JJ	O
examinations	NNS	O
in	IN	O
all	DT	O
distributions	NNS	O
.	.	O

radiographic	JJ	B-TEST
studies	NNS	I-TEST
demonstrated	VBD	O
an	DT	B-PROBLEM
inferior	NN	I-PROBLEM
displaced	VBD	I-PROBLEM
left	VBD	I-PROBLEM
midclavicular	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
,	,	O
no	DT	O
evidence	NN	O
of	IN	O

pneumothorax	NN	B-PROBLEM
.	.	O

trauma	JJ	B-TEST
series	NN	I-TEST
demonstrated	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
a	DT	B-PROBLEM
pelvic	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
.	.	O

head	NN	B-TEST
ct	NN	I-TEST
demonstrated	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
intracranial	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
.	.	O

trauma	NN	B-TEST
ct	NN	I-TEST
demonstrated	VBD	O
mild	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
contusions	NNS	I-PROBLEM
,	,	O
but	CC	O
no	DT	O
pelvic	JJ	B-PROBLEM
fracture	NN	I-PROBLEM
.	.	O

cervical	JJ	B-TEST
spine	NN	I-TEST
imaging	VBG	I-TEST
demonstrated	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
cervical	JJ	B-PROBLEM
spine	JJ	I-PROBLEM
injury	NN	I-PROBLEM
.	.	O

right	JJ	B-TEST
tibial-fibular	JJ	I-TEST
film	NN	I-TEST
series	NN	I-TEST
demonstrated	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
fracture	NN	B-PROBLEM
displacement	NN	I-PROBLEM
.	.	O

left	VBN	B-TEST
humerus	NN	I-TEST
film	NN	I-TEST
series	NN	I-TEST
demonstrated	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
fracture	NN	B-PROBLEM
or	CC	O
displacement	NN	B-PROBLEM
.	.	O

right	JJ	B-TEST
foot	NN	I-TEST
and	CC	I-TEST
femur	JJ	I-TEST
series	NN	I-TEST
demonstrated	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
fracture	NN	B-PROBLEM
displacement	NN	I-PROBLEM
.	.	O

left	VBN	B-TEST
forearm	NN	I-TEST
and	CC	I-TEST
wrist	JJ	I-TEST
series	NN	I-TEST
demonstrated	VBD	O
transverse	JJ	B-PROBLEM
mid	NN	I-PROBLEM
shaft	NN	I-PROBLEM
radial	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
with	IN	O
ulnar	JJ	B-PROBLEM
displacement	NN	I-PROBLEM
.	.	O

diagnosis	NN	B-TEST
peritoneum	NN	I-TEST
lavage	NN	I-TEST
times	NNS	O
two	CD	O
was	VBD	O
negative	JJ	O
for	IN	O
any	DT	O
signs	NNS	O
of	IN	O
intra-abdominal	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
.	.	O

studies	NNS	B-TEST
on	IN	O
admission	NN	O
revealed	VBD	O
the	DT	O
following	NN	O
:	:	O

white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
12.9	CD	O
,	,	O
hemoglobin	NN	B-TEST
11.5	CD	O
,	,	O
hematocrit	NN	B-TEST
32.8	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
197,000	CD	O
,	,	O
sodium	NN	B-TEST
141	CD	O
,	,	O
potassium	NN	B-TEST
3.6	CD	O
,	,	O
chloride	RB	B-TEST
110	CD	O
,	,	O
bicarbonate	NN	B-TEST
21	CD	O
,	,	O
bun	NN	B-TEST
20	CD	O
,	,	O
creatinine	NN	B-TEST
0.7	CD	O
,	,	O
glucose	RB	B-TEST
189	CD	O
,	,	O
pt	NN	B-TEST
13.3	CD	O
,	,	O
inr	NN	B-TEST
1.2	CD	O
,	,	O
ptt	NN	B-TEST
30.0	CD	O
,	,	O
amylase	NN	B-TEST
57	CD	O
,	,	O
arterial	JJ	B-TEST
blood	NN	I-TEST
gas	NN	I-TEST
7.32	CD	O
,	,	O
35	CD	O
,	,	O
159	CD	O
,	,	O
19	CD	O
,	,	O
-7	NN	O
.	.	O

urinalysis	NN	B-TEST
was	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
with	IN	O
6	CD	O
to	TO	O
10	CD	O
red	JJ	B-TEST
blood	NN	I-TEST
cells	NNS	I-TEST
.	.	O

toxicology	NN	B-TEST
screen	NN	I-TEST
was	VBD	O
negative	JJ	O
.	.	O

crystalloid	NN	B-TREATMENT
and	CC	O
four	CD	O
units	NNS	O
packed	VBD	B-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
with	IN	O
good	JJ	O
response	NN	O
.	.	O

in	IN	O
addition	NN	O
,	,	O
the	DT	O
patient	NN	O
received	VBD	O
the	DT	O
above-described	JJ	O
diagnostic	JJ	B-TEST
procedures	NNS	I-TEST
,	,	O
which	WDT	O
demonstrated	VBD	O
injuries	NNS	B-PROBLEM
limited	VBN	O
to	TO	O
a	DT	B-PROBLEM
posterior	JJ	I-PROBLEM
scalp	NN	I-PROBLEM
laceration	NN	I-PROBLEM
,	,	O
left	VBD	B-PROBLEM
fractured	JJ	I-PROBLEM
clavicle	NN	I-PROBLEM
,	,	O
left	VBD	B-PROBLEM
fractured	JJ	I-PROBLEM
radius	NN	I-PROBLEM
,	,	O
right	JJ	B-PROBLEM
thigh	NN	I-PROBLEM
hematoma	NN	I-PROBLEM
,	,	O
and	CC	O
right	JJ	B-PROBLEM
leg	NN	I-PROBLEM
laceration	NN	I-PROBLEM
.	.	O

given	VBN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
right	JJ	I-PROBLEM
thigh	NN	I-PROBLEM
hematoma	NN	I-PROBLEM
,	,	O
a	DT	B-TEST
duplex	JJ	I-TEST
evaluation	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
right	JJ	I-TEST
lower	JJR	I-TEST
extremity	NN	I-TEST
was	VBD	O
performed	VBN	O
on	IN	O
2010-06-28	JJ	O
and	CC	O
demonstrated	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
major	JJ	B-PROBLEM
arterial	JJ	I-PROBLEM
or	CC	I-PROBLEM
venous	JJ	I-PROBLEM
injury	NN	I-PROBLEM
in	IN	O
the	DT	O
level	NN	O
of	IN	O

on	IN	O
06-28	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
also	RB	O
cleared	VBN	O
for	IN	O
removal	NN	O
of	IN	O
her	PRP$	B-TREATMENT
c-spine	JJ	I-TREATMENT
collar	NN	I-TREATMENT
and	CC	O
deemed	VBD	O
stable	JJ	O
for	IN	O
transfer	NN	O
to	TO	O
the	DT	O
orthopedic	JJ	O
service	NN	O
under	IN	O
the	DT	O
direction	NN	O
of	IN	O
dr.	NN	O
ronda	NN	O
lopez	NN	O
.	.	O

the	DT	O
patient	NN	O
remained	VBD	O
stable	JJ	O
through	IN	O
2010-06-29	JJ	O
at	IN	O
which	WDT	O
point	NN	O
she	PRP	O
was	VBD	O
sent	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
to	TO	O
undergo	VB	O
a	DT	B-TREATMENT
left	JJ	I-TREATMENT
radial	JJ	I-TREATMENT
fracture	NN	I-TREATMENT
open	JJ	I-TREATMENT
reduction	NN	I-TREATMENT
and	CC	O
internal	JJ	B-TREATMENT
fixation	NN	I-TREATMENT
procedure	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
and	CC	O
demonstrated	VBD	O
a	DT	B-TEST
postoperative	JJ	I-TEST
hematocrit	NN	I-TEST
of	IN	O
40.9	CD	O
.	.	O

of	IN	O
note	NN	O
,	,	O
the	DT	B-PROBLEM
scalp	NN	I-PROBLEM
and	CC	I-PROBLEM
right	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
leg	NN	I-PROBLEM
lacerations	NNS	I-PROBLEM
were	VBD	O
closed	VBN	O
primarily	RB	O
by	IN	O
the	DT	O
trauma	NN	O
team	NN	O
on	IN	O
admission	NN	O
and	CC	O
on	IN	O
hospital	JJ	O
day	NN	O
#1	NNP	O
were	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
clean	JJ	O
,	,	O
dry	JJ	O
,	,	O
and	CC	O
intact	JJ	O
.	.	O

nonoperative	JJ	B-TREATMENT
treatment	NN	I-TREATMENT
was	VBD	O
elected	VBN	O
for	IN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
left	JJ	I-PROBLEM
clavicular	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
#1	NNP	O
,	,	O
2010-06-30	JJ	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
clinically	RB	O
stable	JJ	O
,	,	O
tolerating	VBG	O
oral	JJ	O
intake	NN	O
,	,	O
and	CC	O
expressive	NN	O
of	IN	O
adequate	JJ	O
amounts	NNS	O
of	IN	O
urine	JJ	O
independent	JJ	O
of	IN	O
a	DT	B-TREATMENT
foley	JJ	I-TREATMENT
catheter	NN	I-TREATMENT
.	.	O

the	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
head	NN	I-PROBLEM
wound	IN	I-PROBLEM
laceration	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
clean	JJ	O
and	CC	O
dry	JJ	O
with	IN	O
intact	JJ	B-TREATMENT
staples	NNS	I-TREATMENT
.	.	O

there	EX	O
was	VBD	O
no	DT	O
erythema	NN	B-PROBLEM
or	CC	O
purulence	NN	B-PROBLEM
.	.	O

the	DT	O
left	JJ	O
clavicle	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
continued	VBN	B-PROBLEM
ecchymosis	NN	I-PROBLEM
decreased	VBN	O
from	IN	O
prior	JJ	B-TEST
examination	NN	I-TEST
with	IN	O
a	DT	B-PROBLEM
minor	JJ	I-PROBLEM
stepoff	NN	I-PROBLEM
and	CC	O
mild	JJ	B-PROBLEM
tenderness	NN	I-PROBLEM
to	TO	O
palpation	NN	B-TEST
decreased	VBN	O
from	IN	O
prior	JJ	B-TEST
examinations	NNS	I-TEST
.	.	O

the	DT	B-TREATMENT
left	JJ	I-TREATMENT
forearm	NN	I-TREATMENT
dressing	NN	I-TREATMENT
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
in	IN	O
place	NN	O
,	,	O
clean	JJ	O
,	,	O
dry	JJ	O
,	,	O
and	CC	O
intact	JJ	O
with	IN	O
no	DT	O
saturation	NN	B-PROBLEM
.	.	O

mild	JJ	B-PROBLEM
swelling	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
in	IN	O
the	DT	O
left	JJ	O
hand	NN	O
.	.	O

fingers	NNS	O
were	VBD	O
warm	JJ	O
and	CC	O
well	RB	O
perfused	VBN	O
with	IN	O
capillary	JJ	B-TEST
refill	NN	I-TEST
less	JJR	O
than	IN	O
3	CD	O
seconds	NNS	O
.	.	O

the	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
right	JJ	I-PROBLEM
anterior	JJ	I-PROBLEM
tibial	NN	I-PROBLEM
wound	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
clean	JJ	O
,	,	O
dry	JJ	O
,	,	O
and	CC	O
intact	JJ	O
with	IN	O
sutures	NNS	B-TREATMENT
intact	JJ	O
and	CC	O
no	DT	O
erythema	NN	B-PROBLEM
or	CC	O
purulence	NN	B-PROBLEM
noted	VBN	O
.	.	O

on	IN	O
06-30	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
evaluated	VBN	O
by	IN	O
occupational	JJ	O
therapy	NN	O
and	CC	O
fitted	VBN	O
for	IN	O
a	DT	B-TREATMENT
left	JJ	I-TREATMENT
upper	JJ	I-TREATMENT
extremity	NN	I-TREATMENT
splint	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
also	RB	O
administered	VBN	O
adaptive	JJ	B-TREATMENT
training	NN	I-TREATMENT
for	IN	O
activities	NNS	B-TREATMENT
of	IN	I-TREATMENT
daily	JJ	I-TREATMENT
life	NN	I-TREATMENT
and	CC	O
advised	VBD	O
regarding	VBG	O
wound	NN	B-TREATMENT
care	NN	I-TREATMENT
.	.	O

in	IN	O
addition	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
also	RB	O
fitted	VBN	O
with	IN	O
a	DT	B-TREATMENT
figure-of-eight	JJ	I-TREATMENT
clavicular	JJ	I-TREATMENT
splint	NN	I-TREATMENT
and	CC	O
instructed	VBN	O
in	IN	O
its	PRP$	O

1.	CD	O
left	VBD	B-PROBLEM
transverse	NN	I-PROBLEM
mid	NN	I-PROBLEM
shaft	NN	I-PROBLEM
radial	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
with	IN	O
ulnar	JJ	B-PROBLEM
displacement	NN	I-PROBLEM
status	NN	O
post	NN	O
left	VBD	B-TREATMENT
radial	JJ	I-TREATMENT
open	JJ	I-TREATMENT
reduction	NN	I-TREATMENT
and	CC	O
internal	JJ	B-TREATMENT
fixation	NN	I-TREATMENT
.	.	O

2.	CD	O
left	VBD	B-PROBLEM
midclavicular	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
managed	VBD	O
nonoperatively	RB	O
.	.	O

3.	CD	O
occipital	JJ	B-PROBLEM
scalp	NN	I-PROBLEM
laceration	NN	I-PROBLEM
.	.	O

4.	CD	O
right	JJ	B-PROBLEM
anterior	RB	I-PROBLEM
tibial	JJ	I-PROBLEM
laceration	NN	I-PROBLEM
.	.	O

percocet	RB	B-TREATMENT
one	CD	O
to	TO	O
two	CD	O
tablets	NNS	O
po	VBP	O
q.4h.	NN	O
to	TO	O
6h.p.r.n.	CD	O
pain	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
to	TO	O
maintain	VB	O
her	PRP$	B-TREATMENT
figure-of-eight	JJ	I-TREATMENT
clavicular	JJ	I-TREATMENT
splint	NN	I-TREATMENT
and	CC	O
left	VBD	B-TREATMENT
posterior	JJ	I-TREATMENT
forearm	JJ	I-TREATMENT
splint	NN	I-TREATMENT
in	IN	O
place	NN	O
for	IN	O
fourteen	JJ	O
days	NNS	O
following	VBG	O
discharge	NN	O
.	.	O

the	DT	B-PROBLEM
left	JJ	I-PROBLEM
forearm	NN	I-PROBLEM
and	CC	I-PROBLEM
right	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
leg	NN	I-PROBLEM
wound	NN	I-PROBLEM
should	MD	O
be	VB	O
kept	VBN	O
clean	JJ	O
and	CC	O
dry	JJ	O
with	IN	O
regular	JJ	B-TREATMENT
dressing	VBG	I-TREATMENT
changes	NNS	I-TREATMENT
with	IN	O
dry	JJ	B-TREATMENT
gauze	NN	I-TREATMENT
once	RB	O
per	IN	O
day	NN	O
.	.	O

scalp	JJ	B-PROBLEM
laceration	NN	I-PROBLEM
should	MD	O
be	VB	O
kept	VBN	O
clean	JJ	O
and	CC	O
dry	JJ	O
for	IN	O
five	CD	O
days	NNS	O
following	VBG	O
discharge	NN	O
after	IN	O
which	WDT	O
point	VBP	O
the	DT	O
patient	NN	O
may	MD	O
once	RB	O
wash	VB	O
her	PRP$	O
hair	NN	O
.	.	O

percocet	NN	B-TREATMENT
for	IN	O
pain	NN	B-PROBLEM
as	IN	O
needed	VBN	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
to	TO	O
followup	VB	O
with	IN	O
an	DT	O
orthopedist	NN	O
in	IN	O
the	DT	O
united	JJ	O
kingdom	NN	O
fourteen	JJ	O
days	NNS	O
following	VBG	O
discharge	NN	O
at	IN	O
which	WDT	O
point	NN	O
repeat	NN	B-TEST
x-rays	NNS	I-TEST
of	IN	I-TEST
her	PRP$	I-TEST
left	JJ	I-TEST
forearm	NN	I-TEST
should	MD	O
be	VB	O
obtained	VBN	O
and	CC	O
her	PRP$	B-TREATMENT
left	JJ	I-TREATMENT
forearm	NN	I-TREATMENT
scalp	NN	I-TREATMENT
and	CC	I-TREATMENT
right	JJ	I-TREATMENT
lower	JJR	I-TREATMENT
leg	NN	I-TREATMENT
sutures	NNS	I-TREATMENT
and	CC	O
staples	NNS	B-TREATMENT
may	MD	O
be	VB	O
removed	VBN	O
.	.	O

patient	NN	O
recorded	VBD	O
as	IN	O
having	VBG	O
no	DT	O
known	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM
to	TO	I-PROBLEM
drugs	NNS	I-PROBLEM

explained	VBN	O
to	TO	O
pt	VB	O
which	WDT	O
of	IN	O
the	DT	B-TREATMENT
meds	NNS	I-TREATMENT
he	PRP	O
should	MD	O
no	RB	O
longer	RBR	O
take	VB	O
that	IN	O
he	PRP	O
was	VBD	O
taking	VBG	O
pre-admission	NN	O
.	.	O

also	RB	O
,	,	O
explained	VBD	O
which	WDT	O
meds	NNS	B-TREATMENT
are	VBP	O
new	JJ	O
.	.	O

1.	CD	O
diltiazem	JJ	B-TREATMENT
hcl	NN	O
240	CD	O
mg	NN	O
capsule	NN	O
,	,	O
sustained	VBD	O
release	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
,	,	O
sustained	VBD	O
release	NN	O
po	NN	O
daily	RB	O
(	(	O
daily	JJ	O
).	NN	O

2.	CD	O
simvastatin	JJ	B-TREATMENT
40	CD	O
mg	JJ	O
tablet	NN	O
sig:	VB	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

3.	CD	O
albuterol-ipratropium	JJ	B-TREATMENT
103-18	JJ	O
mcg	NN	O
/	NNP	O
actuation	NN	O
aerosol	NN	O
sig	NN	O
:	:	O
02-26	JJ	O
puffs	NNS	O
inhalation	NN	O
q6h	NN	O
(	(	O
every	DT	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

4.	CD	O
fluticasone-salmeterol	JJ	B-TREATMENT
250-50	JJ	O
mcg	NN	O
/	NNP	O
dose	JJ	O
disk	NN	O
with	IN	O
device	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
disk	NN	O
with	IN	O
device	JJ	O
inhalation	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

5.	CD	O
terazosin	NN	B-TREATMENT
1	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
capsule	NN	O
po	NN	O
hs	NN	O
(	(	O
at	IN	O
bedtime	NN	O
).	NN	O

6.	CD	O
acetaminophen	JJ	B-TREATMENT
325	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
1-2	JJ	O
tablets	NNS	O
po	JJ	O
q4-6h	JJ	O
(	(	O
every	DT	O
4	CD	O
to	TO	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

7.	CD	O
nimodipine	JJ	B-TREATMENT
30	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
capsule	NN	O
po	NN	O
q4h	NN	O
(	(	O
every	DT	O
4	CD	O
hours	NNS	O
)	)	O
for	IN	O
2	CD	O
weeks	NNS	O
.	.	O

8.	CD	O
ferrous	JJ	B-TREATMENT
sulfate	NN	I-TREATMENT
325	CD	O
(	(	O
65	CD	O
)	)	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

9.	CD	O
aspirin	JJ	B-TREATMENT
81	CD	O
mg	JJ	O
tablet	NN	O
,	,	O
chewable	JJ	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
chewable	JJ	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

10.	CD	O
ipratropium	NN	B-TREATMENT
bromide	RB	I-TREATMENT
0.02	CD	O
%	NN	O
solution	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
inhalation	NN	O
q6h	NN	O
(	(	O
every	DT	O
6	CD	O
hours	NNS	O
).	VBP	O

11.	CD	O
simvastatin	JJ	B-TREATMENT
40	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

12.	CD	O
hydralazine	NN	B-TREATMENT
25	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
1.5	CD	O
tablets	NNS	O
po	JJ	O
tid	NN	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

13.	CD	O
metoprolol	JJ	B-TREATMENT
tartrate	NN	I-TREATMENT
25	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
1.5	CD	O
tablets	NNS	O
po	JJ	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

14.	CD	O
isosorbide	JJ	B-TREATMENT
dinitrate	NN	I-TREATMENT
20	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
tid	NN	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

15.	CD	O
clopidogrel	NN	B-TREATMENT
75	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

16.	CD	O
glipizide	JJ	B-TREATMENT
5	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
once	RB	O
a	DT	O
day	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
initially	RB	O
on	IN	O
several	JJ	B-TREATMENT
antibiotics	NNS	I-TREATMENT
included	VBD	O
cefepime	NN	B-TREATMENT
,	,	O
vancomycin	NN	B-TREATMENT
,	,	O
ciprofloxacin	NN	B-TREATMENT
,	,	O
ambazone	NN	B-TREATMENT
and	CC	O
flagyl	NN	B-TREATMENT
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
hsv	NN	I-TEST
antibody	NN	I-TEST
titer	NN	I-TEST
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
negative	JJ	O
and	CC	O
the	DT	O
patient	NN	O
's	POS	O
acyclovir	NN	B-TREATMENT
was	VBD	O
not	RB	O
restarted	VBN	O
.	.	O

infectious	JJ	O
disease	NN	O
continued	VBD	O
to	TO	O
follow	VB	O
and	CC	O
on	IN	O
2012-02-29	JJ	O
,	,	O
the	DT	O
patient	NN	O
spiked	VBD	O
again	RB	O
which	WDT	O
at	IN	O
that	DT	O
time	NN	O
was	VBD	O
felt	VBN	O
to	TO	O
be	VB	O
due	JJ	O
to	TO	O
his	PRP$	B-TREATMENT
central	JJ	I-TREATMENT
line	NN	I-TREATMENT
and	CC	O
the	DT	B-TREATMENT
central	JJ	I-TREATMENT
line	NN	I-TREATMENT
was	VBD	O
resited	VBN	O
on	IN	O
the	DT	O
left	JJ	O
side	NN	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
intravenous	JJ	B-TREATMENT
vancomycin	NN	I-TREATMENT
.	.	O

over	IN	O
the	DT	O
following	JJ	O
days	NNS	O
until	IN	O
discharge	NN	O
,	,	O
the	DT	O
patient	NN	O
remained	VBD	O
afebrile	JJ	B-PROBLEM
and	CC	O
on	IN	O
2012-03-09	JJ	O
,	,	O
in	IN	O
fact	NN	O
all	PDT	O
the	DT	B-TREATMENT
patient	NN	I-TREATMENT
's	POS	I-TREATMENT
antibiotics	NNS	I-TREATMENT
were	VBD	O
discontinued	VBN	O
.	.	O

as	IN	O
for	IN	O
the	DT	O
patient	NN	O
's	POS	O
all	DT	B-PROBLEM
and	CC	O
aml	NNS	B-PROBLEM
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
a	DT	B-TREATMENT
new	JJ	I-TREATMENT
chemotherapy	NN	I-TREATMENT
protocol	NN	I-TREATMENT
called	VBN	O
hyper-cvad	NN	B-TREATMENT
on	IN	O
2012-03-06	JJ	O
.	.	O

after	IN	O
the	DT	O
patient	NN	O
began	VBD	O
on	IN	O
this	DT	B-TREATMENT
protocol	NN	I-TREATMENT
,	,	O
his	PRP$	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	VBP	I-TEST
steadily	RB	O
began	VBD	O
to	TO	O
climb	VB	O
.	.	O

the	DT	O
patient	NN	O
became	VBD	O
no	RB	O
longer	JJR	O
neutropenic	JJ	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
's	POS	O
also	RB	O
began	VBD	O
to	TO	O
climb	VB	O
and	CC	O
the	DT	B-TEST
percent	NN	I-TEST
blasts	NNS	I-TEST
in	IN	O
his	PRP$	B-TEST
differential	NN	I-TEST
decreased	VBD	O
significantly	RB	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
no	DT	O
further	JJ	B-PROBLEM
complaints	NNS	I-PROBLEM
and	CC	O
on	IN	O
2012-03-10	JJ	O
,	,	O
his	PRP$	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
was	VBD	O
2.3	CD	O
,	,	O
neutrophils	RB	B-TEST
50%	CD	O
,	,	O
bands	VBZ	B-TEST
2%	CD	O
,	,	O
lymphocytes	VBZ	B-TEST
5%	CD	O
,	,	O
monocytes	VBZ	B-TEST
40%	CD	O
,	,	O
and	CC	O
blasts	VBZ	B-TEST
1%	CD	O
.	.	O

platelet	NN	B-TEST
count	NN	I-TEST
was	VBD	O
759,000	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
discharged	VBN	O
to	TO	O
home	NN	O
with	IN	O
instructions	NNS	O
to	TO	O
return	VB	O
to	TO	O
the	DT	O
hospital	NN	O
on	IN	O
monday	NN	O
,	,	O
2012-03-12	JJ	O
,	,	O
for	IN	O
follow-up	JJ	O
and	CC	O
laboratory	JJ	B-TEST
checks	NNS	I-TEST
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
also	RB	O
told	VBN	O
to	TO	O
continue	VB	O
on	IN	O
a	DT	B-TREATMENT
neutropenic	JJ	I-TREATMENT
diet	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
also	RB	O
told	VBD	O
that	IN	O
he	PRP	O
would	MD	O
have	VB	O
to	TO	O
be	VB	O
admitted	VBN	O
for	IN	O
several	JJ	O
days	NNS	O
during	IN	O
his	PRP$	B-TREATMENT
next	JJ	I-TREATMENT
cycle	NN	I-TREATMENT
of	IN	I-TREATMENT
cvad	NN	I-TREATMENT
.	.	O

1.	CD	O
bactrim	JJ	B-TREATMENT
double	JJ	I-TREATMENT
strength	NN	I-TREATMENT
one	CD	O
tablet	NN	O
q.	NN	O
monday	NN	O
,	,	O
wednesday	JJ	O
and	CC	O
friday	JJ	O
.	.	O

2.	CD	O
compazine	NN	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q	VBD	O
6hours	CD	O
p.r.n.	NN	O
nausea	NN	B-PROBLEM
.	.	O

3.	CD	O
anzemet	VBD	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
once	RB	O
daily	JJ	O
p.r.n.	NN	O
nausea	NN	B-PROBLEM
.	.	O

mr.	NN	O
robert	NN	O
mackey	NNP	O
is	VBZ	O
a	DT	O
49	CD	O
year	NN	O
old	JJ	O
gentleman	NN	O
with	IN	O
a	DT	O
22	CD	O
year	NN	O
history	NN	O
of	IN	O
diabetes	NNS	B-PROBLEM
mellitus	NNS	I-PROBLEM
.	.	O

he	PRP	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
peripheral	JJ	B-PROBLEM
neuropathy	NN	I-PROBLEM
,	,	O
kidney	NN	B-TREATMENT
transplantation	NN	I-TREATMENT
in	IN	O
2003	CD	O
secondary	JJ	O
to	TO	O
diabetic	JJ	B-PROBLEM
nephropathy	NN	I-PROBLEM
,	,	O
as	RB	O
well	RB	O
as	IN	O
throat	NN	B-PROBLEM
cancer	NN	I-PROBLEM
in	IN	O
2004	CD	O
treated	VBD	O
with	IN	O
local	JJ	B-TREATMENT
resection	NN	I-TREATMENT
and	CC	O
radical	JJ	B-TREATMENT
neck	NN	I-TREATMENT
dissection	NN	I-TREATMENT
on	IN	I-TREATMENT
the	DT	I-TREATMENT
left	NN	I-TREATMENT
as	RB	O
well	RB	O
as	IN	O
postoperative	JJ	B-TREATMENT
radiation	NN	I-TREATMENT
.	.	O

mr.	NN	O
mackey	NNP	O
also	RB	O
had	VBD	O
signs	NNS	B-PROBLEM
and	CC	I-PROBLEM
symptoms	NNS	I-PROBLEM
consistent	JJ	O
with	IN	O
cervical	JJ	B-PROBLEM
myelopathy	NN	I-PROBLEM
;	:	O
a	DT	B-TEST
cervical	JJ	I-TEST
mri	NN	I-TEST
scan	JJ	I-TEST
showed	VBD	O
very	RB	O
impressive	JJ	B-PROBLEM
disc	NN	I-PROBLEM
herniations	NNS	I-PROBLEM
at	IN	I-PROBLEM
c5-c6	NN	I-PROBLEM
,	,	O
less	RBR	O
so	RB	O
at	IN	O
c4-c5	NN	O
,	,	O
with	IN	O
clear	JJ	B-PROBLEM
cut	NN	I-PROBLEM
cord	NN	I-PROBLEM
compression	NN	I-PROBLEM
,	,	O
particularly	RB	O
on	IN	O
the	DT	O
right	JJ	O
side	NN	O
c5-c6	NN	O
.	.	O

therefore	RB	O
,	,	O
he	PRP	O
was	VBD	O
admitted	VBN	O
for	IN	O
c4-c5	JJ	B-TREATMENT
and	CC	I-TREATMENT
c5-c6	JJ	I-TREATMENT
anterior	JJ	I-TREATMENT
diskectomy	NN	I-TREATMENT
with	IN	O
autologous	JJ	B-TREATMENT
bone	NN	I-TREATMENT
graft	NN	I-TREATMENT
and	CC	O
instrumented	JJ	B-TREATMENT
fusion	NN	I-TREATMENT
.	.	O

postoperative	JJ	B-TEST
physical	JJ	I-TEST
examination	NN	I-TEST
demonstrated	VBD	O
that	IN	O
he	PRP	O
was	VBD	O
afebrile	RB	B-PROBLEM
at	IN	O
97	CD	O
degrees	NNS	O
;	:	O
blood	NN	B-TEST
pressure	NN	I-TEST
145/80	CD	O
;	:	O
pulse	JJ	B-TEST
60	CD	O
;	:	O
respiratory	NN	B-TEST
rate	NN	I-TEST
10	CD	O
;	:	O
100%	CD	O
on	IN	O
a	DT	B-TREATMENT
non-rebreather	NN	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
awake	RB	O
,	,	O
alert	NN	O
,	,	O
uncomfortable	JJ	B-PROBLEM
secondary	JJ	O
to	TO	O
incisional	JJ	B-PROBLEM
tenderness	NN	I-PROBLEM
at	IN	O
neck	NN	B-PROBLEM
site	NN	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
right	JJ	B-PROBLEM
iliac	NN	I-PROBLEM
graft	NN	I-PROBLEM
site	NN	I-PROBLEM
.	.	O

the	DT	B-PROBLEM
wounds	NNS	I-PROBLEM
were	VBD	O
clean	JJ	O
,	,	O
dry	JJ	O
and	CC	O
intact	JJ	O
,	,	O
and	CC	O
flat	JJ	O
.	.	O

while	IN	O
in	IN	O
the	DT	O
pacu	NN	O
,	,	O
anesthesia	NN	O
was	VBD	O
called	VBN	O
because	IN	O
the	DT	O
patient	NN	O
became	VBD	O
dyspneic	JJ	B-PROBLEM
and	CC	O
tachypneic	NN	B-PROBLEM
and	CC	O
his	PRP$	B-TEST
sao2	NN	I-TEST
dropped	VBD	O
to	TO	O
89%	CD	O
.	.	O

his	PRP$	B-TEST
respiratory	NN	I-TEST
rate	NN	I-TEST
was	VBD	O
30	CD	O
on	IN	O
face	NN	B-TREATMENT
mask	NN	I-TREATMENT
.	.	O

interoperatively	RB	O
,	,	O
he	PRP	O
was	VBD	O
positive	JJ	O
two	CD	O
liters	NNS	O
with	IN	O
a	DT	O
stable	JJ	O
blood	NN	O
pressure	NN	O
and	CC	O
heart	NN	B-TEST
rate	NN	I-TEST
,	,	O
although	IN	O
requiring	VBG	O
some	DT	B-TREATMENT
neo-synephrine	JJ	I-TREATMENT
interoperatively	RB	O
.	.	O

he	PRP	O
responded	VBD	O
to	TO	O
intravenous	JJ	B-TREATMENT
lasix	NN	I-TREATMENT
with	IN	O
3.2	CD	O
liters	NNS	O
of	IN	O
urine	JJ	B-TEST
output	NN	I-TEST
as	RB	O
well	RB	O
as	IN	O
marked	JJ	O
clinical	JJ	O
improvement	NN	O
.	.	O

the	DT	O
etiology	NN	O
for	IN	O
his	PRP$	B-PROBLEM
congestive	JJ	I-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
was	VBD	O
determined	VBN	O
likely	RB	O
to	TO	O
be	VB	O
diastolic	JJ	B-PROBLEM
dysfunction	NN	I-PROBLEM
from	IN	O
increased	VBN	B-PROBLEM
heart	NN	I-PROBLEM
rate	NN	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
excess	JJ	B-PROBLEM
volume	NN	I-PROBLEM
.	.	O

no	DT	O
definite	JJ	O
evidence	NN	O
for	IN	O
significant	JJ	B-PROBLEM
myocardial	JJ	I-PROBLEM
ischemia	NN	I-PROBLEM
,	,	O
although	IN	O
cardiac	JJ	B-TEST
enzymes	NNS	I-TEST
were	VBD	O
sent	VBN	O
and	CC	O
he	PRP	O
ruled	VBD	O
out	RP	O
for	IN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
given	VBN	O
lasix	NN	B-TREATMENT
to	TO	O
continue	VB	O
to	TO	O
diurese	VB	O
the	DT	B-PROBLEM
excess	JJ	I-PROBLEM
volume	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
also	RB	O
put	VBN	O
on	IN	O
lopressor	NN	B-TREATMENT
150	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

also	RB	O
in	IN	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
,	,	O
o2	JJ	B-TEST
saturation	NN	I-TEST
was	VBD	O
closely	RB	O
monitored	VBN	O
.	.	O

the	DT	O
patient	NN	O
became	VBD	O
agitated	VBN	B-PROBLEM
with	IN	O
both	DT	O
tent	JJ	B-TREATMENT
and	CC	O
bi-pap	JJ	B-TREATMENT
machine	NN	I-TREATMENT
,	,	O
although	IN	O
continued	VBN	O
to	TO	O
saturate	VB	O
well	RB	O
.	.	O

he	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
medicine	VB	O
the	DT	O
morning	NN	O
of	IN	O
2010-08-30	JJ	O
,	,	O
for	IN	O
continued	VBN	B-TREATMENT
medical	JJ	I-TREATMENT
management	NN	I-TREATMENT
post	NN	O
surgery	NN	O
.	.	O

on	IN	O
the	DT	O
day	NN	O
of	IN	O
transfer	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
confused	VBN	B-PROBLEM
with	IN	O
waxing	NN	B-PROBLEM
and	CC	I-PROBLEM
waning	VBG	I-PROBLEM
sensorium	NN	I-PROBLEM
;	:	O
thus	RB	O
,	,	O
a	DT	B-TEST
delirium	NN	I-TEST
work-up	NN	I-TEST
was	VBD	O
initiated	VBN	O
looking	VBG	O
for	IN	O
precipitants	NNS	O
.	.	O

1.	CD	O
when	WRB	O
his	PRP$	B-TEST
o2	NN	I-TEST
saturation	NN	I-TEST
was	VBD	O
monitored	VBN	O
,	,	O
his	PRP$	B-TEST
pulse	JJ	I-TEST
oximetry	NN	I-TEST
remained	VBD	O
in	IN	O
the	DT	O
90s	CD	O
during	IN	O
his	PRP$	O
stay	NN	O
.	.	O

2.	CD	O
his	PRP$	B-TREATMENT
non-essential	JJ	I-TREATMENT
medications	NNS	I-TREATMENT
that	WDT	O
may	MD	O
have	VB	O
been	VBN	O
contributing	VBG	O
to	TO	O
his	PRP$	B-PROBLEM
change	NN	I-PROBLEM
in	IN	I-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
were	VBD	O
discontinued	VBN	O
;	:	O
those	DT	O
included	JJ	O
temocillin	NN	B-TREATMENT
,	,	O
nortriptyline	NN	B-TREATMENT
,	,	O
haldol	NN	B-TREATMENT
,	,	O
lorazepam	NN	B-TREATMENT
,	,	O
venlafaxine	NN	B-TREATMENT
,	,	O
bupropion	NN	B-TREATMENT
,	,	O
and	CC	O
gabapentin	NN	B-TREATMENT
.	.	O

in	IN	O
addition	NN	O
,	,	O
his	PRP$	B-TEST
cyclosporin	NN	I-TEST
levels	NNS	I-TEST
were	VBD	O
checked	VBN	O
.	.	O

3.	CD	O
hypo	NN	B-PROBLEM
or	CC	I-PROBLEM
hyperglycemia	NN	I-PROBLEM
:	:	O

mahoney	NN	O
had	VBD	O
been	VBN	O
following	VBG	O
with	IN	O
their	PRP$	O
appreciated	JJ	O
recommendations	NNS	O
on	IN	O
glucose	JJ	B-TREATMENT
control	NN	I-TREATMENT
.	.	O

finger	NN	B-TEST
sticks	NNS	I-TEST
were	VBD	O
in	IN	O
the	DT	O
150	CD	O
s	NN	O
when	WRB	O
acutely	RB	B-PROBLEM
agitated	VBN	I-PROBLEM
,	,	O
therefore	RB	O
,	,	O
it	PRP	O
was	VBD	O
not	RB	O
determined	VBN	O
that	IN	O
glucose	JJ	B-TEST
levels	NNS	I-TEST
were	VBD	O
contributory	NN	O
.	.	O

4.	CD	O
infectious	JJ	B-PROBLEM
causes	NNS	I-PROBLEM
were	VBD	O
evaluated	VBN	O
.	.	O

he	PRP	O
was	VBD	O
febrile	RB	B-PROBLEM
in	IN	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
to	TO	O
101.0	CD	O
f.	NN	O
;	:	O
yet	RB	O
,	,	O
chest	JJS	B-TEST
x-ray	JJ	I-TEST
,	,	O
blood	NN	B-TEST
cultures	NNS	I-TEST
,	,	O
urinalysis	NN	B-TEST
and	CC	O
urine	JJ	B-TEST
cultures	NNS	I-TEST
were	VBD	O
all	DT	O
negative	JJ	O
for	IN	O
sources	NNS	O
.	.	O

a	DT	B-TEST
lumbar	NN	I-TEST
puncture	NN	I-TEST
was	VBD	O
considered	VBN	O
,	,	O
although	IN	O
not	RB	O
performed	VBN	O
due	JJ	O
to	TO	O
the	DT	O
fact	NN	O
that	IN	O
the	DT	O
cerebrospinal	JJ	O
fluid	NN	O
was	VBD	O
not	RB	O
breached	VBN	O
during	IN	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
.	.	O

5.	CD	O
mass	NN	B-PROBLEM
effect	NN	I-PROBLEM
was	VBD	O
considered	VBN	O
,	,	O
although	IN	O
no	DT	O
focal	JJ	B-PROBLEM
deficits	NNS	I-PROBLEM
were	VBD	O
ever	RB	O
noted	VBN	O
on	IN	O
examination	NN	B-TEST
and	CC	O
due	JJ	O
to	TO	O
the	DT	B-PROBLEM
fluctuating	NN	I-PROBLEM
sensorium	NN	I-PROBLEM
,	,	O
it	PRP	O
was	VBD	O
determined	VBN	O
that	IN	O
there	EX	O
was	VBD	O
no	DT	O
severe	JJ	B-PROBLEM
underlying	VBG	I-PROBLEM
structural	JJ	I-PROBLEM
abnormality	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
head	NN	I-TEST
and	CC	I-TEST
neck	NN	I-TEST
ct	NN	I-TEST
scan	JJ	I-TEST
,	,	I-TEST
non-contrast	JJ	I-TEST
,	,	O
were	VBD	O
ordered	VBN	O
though	IN	O
to	TO	O
evaluate	VB	O
for	IN	O
such	JJ	B-PROBLEM
processes	NNS	I-PROBLEM
.	.	O

no	DT	O
acute	JJ	B-PROBLEM
intracranial	JJ	I-PROBLEM
hemorrhages	NNS	I-PROBLEM
or	CC	O
midline	JJ	B-PROBLEM
shifts	NNS	I-PROBLEM
were	VBD	O
noted	VBN	O
,	,	O
although	IN	O
a	DT	B-PROBLEM
soft	JJ	I-PROBLEM
tissue	NN	I-PROBLEM
mass	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
at	IN	O
the	DT	O
level	NN	O
of	IN	O
c2	NN	O
.	.	O

6.	CD	O
trauma	NN	B-PROBLEM
was	VBD	O
also	RB	O
considered	VBN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
found	VBN	O
out	IN	O
of	IN	O
bed	NN	O
but	CC	O
no	DT	O
signs	NNS	O
of	IN	O
head	NN	B-PROBLEM
trauma	NN	I-PROBLEM
,	,	O
no	DT	O
loss	NN	B-PROBLEM
of	IN	I-PROBLEM
consciousness	NN	I-PROBLEM
.	.	O

throughout	IN	O
his	PRP$	O
stay	NN	O
,	,	O
chem-10	NN	B-TEST
was	VBD	O
monitored	VBN	O
.	.	O

there	EX	O
were	VBD	O
no	DT	O
electrolytes	NNS	B-PROBLEM
or	CC	I-PROBLEM
mineral	JJ	I-PROBLEM
abnormalities	NNS	I-PROBLEM
that	WDT	O
could	MD	O
explain	VB	O
his	PRP$	B-PROBLEM
delirium	NN	I-PROBLEM
.	.	O

liver	JJ	B-TEST
function	NN	I-TEST
tests	NNS	I-TEST
were	VBD	O
checked	VBN	O
,	,	O
only	RB	O
total	JJ	B-TEST
bilirubin	NN	I-TEST
was	VBD	O
slightly	RB	B-PROBLEM
elevated	VBN	I-PROBLEM
at	IN	O
1.6	CD	O
.	.	O

tsh	NN	B-TEST
was	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
as	IN	O
was	VBD	O
b12	NN	B-TEST
and	CC	O
folate	NN	B-TEST
.	.	O

rpr	NN	B-TEST
evaluating	VBG	I-TEST
for	IN	O
possible	JJ	O
neurologic	JJ	B-PROBLEM
syphilis	NN	I-PROBLEM
was	VBD	O
also	RB	O
checked	VBN	O
.	.	O

the	DT	B-TEST
assay	NN	I-TEST
was	VBD	O
nonreactive	JJ	O
.	.	O

an	DT	B-TEST
eeg	NN	I-TEST
was	VBD	O
also	RB	O
considered	VBN	O
to	TO	O
rule	VB	O
out	IN	O
non-convulsive	JJ	B-PROBLEM
status	NN	I-PROBLEM
epilepticus	NN	I-PROBLEM
,	,	O
although	IN	O
again	RB	O
this	DT	O
did	VBD	O
not	RB	O
seem	VB	O
to	TO	O
be	VB	O
a	DT	O
likely	JJ	O
cause	NN	O
.	.	O

on	IN	O
the	DT	O
evening	NN	O
of	IN	O
the	DT	O
22nd	CD	O
,	,	O
the	DT	O
patient	NN	O
became	VBD	O
acutely	RB	B-PROBLEM
agitated	VBN	I-PROBLEM
,	,	O
threatening	VBG	O
to	TO	O
leave	VB	O
,	,	O
and	CC	O
also	RB	O
threatening	VBG	O
to	TO	O
harm	VB	O
those	DT	O
nurses	NNS	O
and	CC	O
physicians	NNS	O
that	WDT	O
were	VBD	O
attempting	VBG	O
to	TO	O
prevent	VB	O
him	PRP	O
from	IN	O
leaving	VBG	O
.	.	O

restraints	NNS	B-TREATMENT
,	,	O
for	IN	O
the	DT	O
safety	NN	O
of	IN	O
both	CC	O
the	DT	O
patient	NN	O
and	CC	O
the	DT	O
staff	NN	O
of	IN	O
the	DT	O
hospital	NN	O
.	.	O

the	DT	B-TREATMENT
restraints	NNS	I-TREATMENT
were	VBD	O
weaned	VBN	O
off	RB	O
overnight	JJ	O
although	IN	O
he	PRP	O
became	VBD	O
acutely	RB	B-PROBLEM
agitated	VBN	I-PROBLEM
and	CC	O
they	PRP	O
were	VBD	O
replaced	VBN	O
early	RB	O
on	IN	O
08-31	NN	O
.	.	O

later	RB	O
in	IN	O
the	DT	O
morning	NN	O
on	IN	O
08-31	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
more	RBR	O
oriented	JJ	O
and	CC	O
alert	JJ	O
,	,	O
and	CC	O
asked	VBD	O
to	TO	O
have	VB	O
the	DT	B-TREATMENT
restraints	NNS	I-TREATMENT
removed	VBD	O
.	.	O

the	DT	O
patient	NN	O
continued	VBD	O
to	TO	O
do	VB	O
well	RB	O
and	CC	O
did	VBD	O
not	RB	O
require	VB	O
restraints	NNS	B-TREATMENT
after	IN	O
that	DT	B-PROBLEM
event	NN	I-PROBLEM
.	.	O

intramuscular	NN	B-TREATMENT
as	RB	O
well	RB	O
as	IN	O
intravenous	JJ	B-TREATMENT
haldol	NNS	I-TREATMENT
were	VBD	O
ordered	VBN	O
p.r.n.	NN	O
for	IN	O
emergency	NN	O
use	NN	O
should	MD	O
he	PRP	O
become	VB	O
acutely	RB	B-PROBLEM
agitated	JJ	I-PROBLEM
.	.	O

haldol	NN	B-TREATMENT
as	RB	O
well	RB	O
as	IN	O
the	DT	B-TREATMENT
restraints	NNS	I-TREATMENT
were	VBD	O
not	RB	O
required	VBN	O
after	IN	O
the	DT	O
morning	NN	O
of	IN	O
the	DT	O
23rd	CD	O
.	.	O

each	DT	O
progressive	JJ	O
day,	NN	O
mr.	NN	O
donald	NNP	O
delirium	VBZ	B-PROBLEM
abated	VBN	O
with	IN	O
return	NN	O
to	TO	O
baseline	VB	O
mental	JJ	O
status	NN	O
early	RB	O
on	IN	O
09-01	NN	O
.	.	O

the	DT	O
likely	JJ	O
cause	NN	O
of	IN	O
the	DT	B-PROBLEM
delirium	NN	I-PROBLEM
was	VBD	O
a	DT	O
combination	NN	O
of	IN	O
surgery	NN	B-TREATMENT
and	CC	O
intensive	JJ	O
care	NN	O
unit	NN	O
stay	NN	O
in	IN	O
addition	NN	O
to	TO	O
poly-pharmacy	NN	B-TREATMENT
.	.	O

other	JJ	O
concerns	NNS	O
during	IN	O
his	PRP$	O
stay	NN	O
was	VBD	O
his	PRP$	B-TEST
kidney	NN	I-TEST
function	NN	I-TEST
,	,	O
due	JJ	O
to	TO	O
his	PRP$	B-TREATMENT
renal	JJ	I-TREATMENT
transplant	NN	I-TREATMENT
in	IN	O
2003	CD	O
.	.	O

his	PRP$	B-TREATMENT
immunosuppressive	JJ	I-TREATMENT
therapy	NN	I-TREATMENT
was	VBD	O
continued	VBN	O
throughout	IN	O
his	PRP$	O
stay	NN	O
;	:	O
his	PRP$	B-TEST
creatinine	NN	I-TEST
remained	VBD	O
approximately	RB	O
2.3	CD	O
to	TO	O
2.4	CD	O
;	:	O
he	PRP	O
has	VBZ	O
a	DT	B-PROBLEM
baseline	JJ	I-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
.	.	O

with	IN	O
this	DT	O
in	IN	O
mind	NN	O
,	,	O
when	WRB	O
obtaining	VBG	O
a	DT	B-TEST
ct	NN	I-TEST
scan	JJ	I-TEST
it	PRP	O
was	VBD	O
determined	VBN	O
that	IN	O
contrast	NN	B-TREATMENT
would	MD	O
not	RB	O
be	VB	O
the	DT	O
best	JJS	O
option	NN	O
.	.	O

while	IN	O
the	DT	O
patient	NN	O
was	VBD	O
in	IN	O
restraints	NNS	B-TREATMENT
,	,	O
gentle	JJ	B-TREATMENT
hydration	NN	I-TREATMENT
was	VBD	O
initiated	VBN	O
since	IN	O
p.o.	NN	B-TEST
intake	NN	I-TEST
was	VBD	O
not	RB	B-PROBLEM
adequate	JJ	I-PROBLEM
.	.	O

as	IN	O
for	IN	O
his	PRP$	B-PROBLEM
diabetes	NNS	I-PROBLEM
mellitus	VBP	I-PROBLEM
,	,	O
the	DT	O
mahoney	NN	O
team	NN	O
provided	VBD	O
updated	JJ	O
recommendations	NNS	O
each	DT	O
day	NN	O
,	,	O
adjusting	VBG	O
for	IN	O
the	DT	O
changing	VBG	O
p.o.	JJ	O
intake	NN	O
.	.	O

the	DT	O
only	JJ	O
other	JJ	B-PROBLEM
complaints	NNS	I-PROBLEM
from	IN	O
mr.	JJ	O
mackey	NN	O
during	IN	O
his	PRP$	O
stay	NN	O
were	VBD	O
:	:	O

soreness	NN	B-PROBLEM
at	IN	O
his	PRP$	B-PROBLEM
operative	JJ	I-PROBLEM
sites	NNS	I-PROBLEM
,	,	O
for	IN	O
which	WDT	O
he	PRP	O
was	VBD	O
given	VBN	O
p.r.n.	JJ	B-TREATMENT
tylenol	NN	I-TREATMENT
once	IN	O
his	PRP$	B-PROBLEM
delirium	NN	I-PROBLEM
had	VBD	O
resolved	VBN	O
.	.	O

in	IN	O
addition	NN	O
,	,	O
he	PRP	O
also	RB	O
complained	VBD	O
of	IN	O
difficulty	NN	B-PROBLEM
with	IN	I-PROBLEM
swallowing	NN	I-PROBLEM
,	,	O
necessitating	VBG	O
only	RB	O
soft	JJ	B-TREATMENT
and	CC	I-TREATMENT
liquid	JJ	I-TREATMENT
diet	NN	I-TREATMENT
.	.	O

this	DT	O
was	VBD	O
attributed	VBN	O
to	TO	O
postoperative	VB	B-PROBLEM
swelling	NN	I-PROBLEM
and	CC	O
changes	NNS	O
from	IN	O
his	PRP$	B-TREATMENT
diskectomy	NN	I-TREATMENT
performed	VBD	O
2010-08-27	JJ	O
.	.	O

3.	CD	O
he	PRP	O
was	VBD	O
also	RB	O
discharged	VBN	O
home	NN	O
with	IN	O
visiting	VBG	O
nurse	JJ	O
association	NN	O
for	IN	O
physical	JJ	B-TEST
therapy	NN	I-TEST
evaluation	NN	I-TEST
of	IN	O
home	NN	O
safety	NN	O
.	.	O

1.	CD	O
venlafaxine	NN	B-TREATMENT
xr	NN	I-TREATMENT
75	CD	O
mg	NN	O
q.	CD	O
a.m.	NN	O

2.	CD	O
furosemide	JJ	B-TREATMENT
20	CD	O
mg	NN	O
q.o.d.	NN	O

3.	CD	O
metoprolol	JJ	B-TREATMENT
100	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

4.	CD	O
nitroglycerin	JJ	B-TREATMENT
sublingual	JJ	I-TREATMENT
0.3	CD	O
mg	NN	O
p.r.n.	NN	O

5.	CD	O
cyclosporin	JJ	B-TREATMENT
microemulsion	NN	I-TREATMENT
.	.	O

6.	CD	O
neoral	JJ	B-TREATMENT
100	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

7.	CD	O
zithropren	NNS	B-TREATMENT
50	CD	O
mg	NNS	O
q.	JJ	O
day	NN	O
.	.	O

8.	CD	O
prednisone	NN	B-TREATMENT
10	CD	O
mg	NN	O
q.	JJ	O
day	NN	O
.	.	O

9.	CD	O
minoxidil	JJ	B-TREATMENT
10	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

10.	CD	O
prilosec	JJ	B-TREATMENT
20	CD	O
mg	JJ	O
q.	JJ	O
day	NN	O
.	.	O

11.	CD	O
nph	JJ	B-TREATMENT
30	CD	O
units	NNS	O
q.	RB	O
a.m.	RB	O
,	,	O
5	CD	O
to	TO	O
6	CD	O
units	NNS	O
q.	CD	O
p.m.	NN	O

12.	CD	O
regular	JJ	B-TREATMENT
insulin	NN	I-TREATMENT
5	CD	O
units	NNS	O
q.	JJ	O
a.m.	RB	O
and	CC	O
3	CD	O
to	TO	O
5	CD	O
units	NNS	O
q.	CD	O
p.m.	NN	O

13.	CD	O
wellbutrin	JJ	B-TREATMENT
100	CD	O
mg	JJ	O
q.	JJ	O
day	NN	O
.	.	O

14.	CD	O
zocor	NN	B-TREATMENT
60	CD	O
mg	NN	O
q.	JJ	O
day	NN	O
.	.	O

15.	CD	O
nitroglycerin	JJ	B-TREATMENT
sr	NN	I-TREATMENT
2.5	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

he	PRP	O
was	VBD	O
instructed	VBN	O
to	TO	O
hold	VB	O
the	DT	O
following	JJ	O
three	CD	O
medications	NNS	B-TREATMENT
that	IN	O
he	PRP	O
took	VBD	O
prior	RB	O
to	TO	O
admission	NN	O
:	:	O

nortriptyline	JJ	B-TREATMENT
10	CD	O
mg	NN	O
q.	JJ	O
h.s.	NN	O
;	:	O
flomax	CC	B-TREATMENT
0.4	CD	O
mg	NN	O
q.	JJ	O
h.s.	NN	O
;	:	O
neurontin	CC	B-TREATMENT
600	CD	O
mg	NN	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
.	.	O

1.	CD	O
c4-c5	JJ	B-TREATMENT
,	,	I-TREATMENT
c5-c6	JJ	I-TREATMENT
,	,	I-TREATMENT
anterior	JJ	I-TREATMENT
microdiscectomy	NN	I-TREATMENT
and	CC	I-TREATMENT
fusion	NN	I-TREATMENT
with	IN	O
right	JJ	B-TREATMENT
iliac	NN	I-TREATMENT
bone	NN	I-TREATMENT
graft	NN	I-TREATMENT
.	.	O

1.	CD	O
end-stage	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
disease	NN	I-PROBLEM
secondary	JJ	O
to	TO	O
type	VB	B-PROBLEM
1	CD	I-PROBLEM
diabetes	NNS	I-PROBLEM
mellitus	VBP	I-PROBLEM
;	:	O
status	NN	O
post	NN	O
renal	JJ	B-TREATMENT
transplant	NN	I-TREATMENT
in	IN	O
2003	CD	O
.	.	O

2.	CD	O
history	NN	O
of	IN	O
multiple	JJ	B-PROBLEM
urinary	JJ	I-PROBLEM
tract	NN	I-PROBLEM
infections	NNS	I-PROBLEM
.	.	O

3.	CD	O
pyelonephritis	NN	B-PROBLEM
.	.	O

4.	CD	O
creatinine	NN	B-TEST
2.2	CD	O
to	TO	O
2.5	CD	O
.	.	O

5.	CD	O
right	JJ	B-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
stent	NN	I-TREATMENT
in	IN	O
2008	CD	O
;	:	O
ejection	NN	B-TEST
fraction	NN	I-TEST
60	CD	O
to	TO	O
65%	CD	O
.	.	O

6.	CD	O
type	NN	B-PROBLEM
1	CD	I-PROBLEM
diabetes	NNS	I-PROBLEM
mellitus	VBP	I-PROBLEM
with	IN	O
triopathy	NN	B-PROBLEM
,	,	O
retinopathy	NN	B-PROBLEM
,	,	O
neuropathy	JJ	B-PROBLEM
,	,	O
nephropathy	JJ	B-PROBLEM
.	.	O

7.	CD	O
benign	JJ	B-PROBLEM
prostatic	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
status	NN	O
post	NN	O
transurethral	JJ	B-TREATMENT
resection	NN	I-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
prostate	NN	I-TREATMENT
;	:	O
self	CC	B-TREATMENT
catheterization	NN	I-TREATMENT
.	.	O

8.	CD	O
hypertension	NN	B-PROBLEM
.	.	O

9.	CD	O
hypercholesterolemia	NN	B-PROBLEM
.	.	O

10.	CD	O
hepatitis	NN	B-PROBLEM
b	NN	I-PROBLEM
.	.	O

11.	CD	O
throat	NN	B-PROBLEM
cancer	NN	I-PROBLEM
status	NN	O
post	NN	O
right	RB	B-TREATMENT
neck	NN	I-TREATMENT
dissection	NN	I-TREATMENT
and	CC	O
xrt	NN	B-TREATMENT
in	IN	O
2004	CD	O
.	.	O

12.	CD	O
cerebral	JJ	B-PROBLEM
aneurysm	NN	I-PROBLEM
.	.	O

13.	CD	O
left	VBD	B-TREATMENT
prosthetic	JJ	I-TREATMENT
cmed	JJ	O
ccu	NN	O
.	.	O

gentamicin	NN	B-TREATMENT
,	,	O
and	CC	O
ibuprofen	NN	B-TREATMENT
.	.	O

mr.	NN	O
cordano	NN	O
is	VBZ	O
a	DT	O
58-year-old	JJ	O
gentlemen	NNS	O
with	IN	O
a	DT	O
past	JJ	O
medical	JJ	O
history	NN	O
significant	JJ	O
for	IN	O
primary	JJ	B-PROBLEM
sclerosing	VBG	I-PROBLEM
cholangitis	NN	I-PROBLEM
who	WP	O
presented	VBD	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
endoscopic	NN	B-TEST
retrograde	NN	I-TEST
cholangiopancreatography	NN	I-TEST
endoscopic	NN	B-TEST
retrograde	NN	I-TEST
cholangiopancreatography	NN	I-TEST
and	CC	O
percutaneous	JJ	B-TEST
transhepatic	JJ	I-TEST
cholangiogram	NN	I-TEST
.	.	O

the	DT	B-TREATMENT
most	RBS	I-TREATMENT
recent	JJ	I-TREATMENT
percutaneous	JJ	I-TREATMENT
transluminal	JJ	I-TREATMENT
coronary	NN	I-TREATMENT
angioplasty	NN	I-TREATMENT
was	VBD	O
done	VBN	O
in	IN	O
2009-07-25	JJ	O
.	.	O

at	IN	O
the	DT	O
time	NN	O
an	DT	B-TREATMENT
8	CD	I-TREATMENT
caucasian	JJ	I-TREATMENT
catheter	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
in	IN	O
the	DT	O
common	JJ	O
hepatic/bioduct	NN	O
for	IN	O
external	JJ	B-TREATMENT
drainage	NN	I-TREATMENT
.	.	O

the	DT	B-TEST
endoscopic	NN	I-TEST
retrograde	NN	I-TEST
cholangiopancreatography	NN	I-TEST
also	RB	O
showed	VBD	O
the	DT	O
presence	NN	O
proximal	JJ	O
common	JJ	O
bile	NN	O
duct	NN	O
.	.	O

nodularities	NNS	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
common	JJ	I-PROBLEM
bile	NN	I-PROBLEM
duct	NN	I-PROBLEM
visualized	VBN	O
by	IN	O
endoscopic	NN	B-TEST
retrograde	NN	I-TEST
cholangiopancreatography	NN	I-TEST
was	VBD	O
also	RB	O
worrisome	JJ	O
for	IN	O
cholangiocarcinoma	NN	B-PROBLEM
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
blue	JJ	O
general	JJ	O
surgery	NN	O
service	NN	O
for	IN	O
possible	JJ	O
surgical	JJ	B-TREATMENT
interventions	NNS	I-TREATMENT
.	.	O

ulcerative	JJ	B-PROBLEM
colitis	NN	I-PROBLEM
,	,	O
primary	JJ	B-PROBLEM
sclerosing	VBG	I-PROBLEM
cholangitis	NN	I-PROBLEM
.	.	O

status	NN	O
post	NN	O
placement	NN	B-TREATMENT
of	IN	I-TREATMENT
percutaneous	JJ	I-TREATMENT
transhepatic	JJ	I-TREATMENT
biliary	JJ	I-TREATMENT
drainage	NN	I-TREATMENT
with	IN	O
placement	NN	B-TREATMENT
of	IN	I-TREATMENT
8	CD	I-TREATMENT
caucasian	JJ	I-TREATMENT
nephrostomy	NN	I-TREATMENT
catheter	NN	I-TREATMENT
in	IN	O
the	DT	O
common	JJ	O
bile	NN	O
duct	NN	O
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

1.	CD	O
ursodiol	JJ	B-TREATMENT
600	CD	O
mg	NN	O
t.i.d.	NN	O

2.	CD	O
ambien	JJ	B-TREATMENT
5	CD	O
mg	NNS	O
q.h.s.	NN	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
jaundiced	JJ	O
looking	VBG	O
gentlemen	NNS	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

the	DT	O
head	NN	O
is	VBZ	O
normocephalic	JJ	O
,	,	O
atraumatic	JJ	B-PROBLEM
and	CC	O
eyes	NNS	O
are	VBP	O
icteric	JJ	B-PROBLEM
.	.	O

the	DT	O
neck	NN	O
is	VBZ	O
supple	JJ	O
with	IN	O
no	DT	O
lymphadenopathy	NN	B-PROBLEM
.	.	O

the	DT	O
chest	NN	O
is	VBZ	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
murmurs	NN	B-PROBLEM
.	.	O

the	DT	O
abdomen	NNS	O
was	VBD	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
no	DT	O
masses	NNS	B-PROBLEM
and	CC	O
nondistended	VBD	B-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
hepatosplenomegaly	NN	B-PROBLEM
.	.	O

rectal	JJ	B-TEST
exam	NN	I-TEST
showed	VBD	O
no	DT	O
masses	NNS	B-PROBLEM
and	CC	O
is	VBZ	O
guaiac	JJ	B-TEST
negative	JJ	O
.	.	O

neurological	JJ	B-TEST
exam	NN	I-TEST
was	VBD	O
grossly	RB	O
intact	JJ	O
.	.	O

a	DT	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
of	IN	O
14.2	CD	O
,	,	O
hematocrit	NN	B-TEST
of	IN	O
35.3	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
of	IN	O
449,000	CD	O
.	.	O

sodium	NN	B-TEST
of	IN	O
130	CD	O
,	,	O
potassium	NN	B-TEST
3.5	CD	O
,	,	O
chloride	RB	B-TEST
93	CD	O
,	,	O
bicarbonate	NN	B-TEST
28	CD	O
,	,	O
bun	NN	B-TEST
15	CD	O
,	,	O
creatinine	NN	B-TEST
1.1,	CD	O
prothrombin	NN	B-TEST
time	NN	I-TEST
14.1	CD	O
,	,	O
partial	JJ	B-TEST
thrombin	NN	I-TEST
time	NN	I-TEST
29.7	CD	O
.	.	O

inr	RB	B-TEST
1.4	CD	O
.	.	O

alt	RB	B-TEST
106	CD	O
,	,	O
ast	RB	B-TEST
149	CD	O
,	,	O
alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
242	CD	O
.	.	O

total	JJ	B-TEST
bilirubin	NN	I-TEST
10.1	CD	O
,	,	O
amylase	NN	B-TEST
90	CD	O
and	CC	O
lipase	VBD	B-TEST
112	CD	O
.	.	O

chest	JJS	B-TEST
x-ray	NN	I-TEST
revealed	VBD	O
minimal	JJ	B-PROBLEM
left	JJ	I-PROBLEM
base	NN	I-PROBLEM
atelectasis	NN	I-PROBLEM
and	CC	O
elevation	NN	B-PROBLEM
of	IN	I-PROBLEM
left	JJ	I-PROBLEM
hemidiaphragm	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
ct	JJ	I-TEST
scan	JJ	I-TEST
with	IN	I-TEST
po	NN	I-TEST
contrast	NN	I-TEST
showed	VBD	O
dilation	NN	B-PROBLEM
of	IN	I-PROBLEM
intrahepatic	JJ	I-PROBLEM
common	JJ	I-PROBLEM
bile	NN	I-PROBLEM
duct	NN	I-PROBLEM
which	WDT	O
is	VBZ	O
improved	VBN	O
from	IN	O
previous	JJ	B-TEST
studies	NNS	I-TEST
.	.	O

it	PRP	O
is	VBZ	O
also	RB	O
noted	VBN	O
that	IN	O
there	EX	O
was	VBD	O
splenomegaly	NN	B-PROBLEM
.	.	O

mr.	NN	O
cordano	NN	O
was	VBD	O
admitted	VBN	O
on	IN	O
2009-08-17	JJ	O
for	IN	O
a	DT	B-TREATMENT
replacement	NN	I-TREATMENT
of	IN	I-TREATMENT
transhepatic	JJ	I-TREATMENT
biliary	JJ	I-TREATMENT
drainage	NN	I-TREATMENT
catheter	NN	I-TREATMENT
.	.	O

at	IN	O
that	DT	O
time	NN	O
,	,	O
cholangiogram	NN	B-TEST
confirmed	VBD	O
that	IN	O
there	EX	O
was	VBD	O
a	DT	B-PROBLEM
distal	JJ	I-PROBLEM
stricture	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
common	JJ	I-PROBLEM
bile	NN	I-PROBLEM
duct	NN	I-PROBLEM
.	.	O

an	DT	B-TEST
endoscopic	NN	I-TEST
retrograde	NN	I-TEST
cholangiopancreatography	NN	I-TEST
also	RB	O
demonstrated	VBD	O
similar	JJ	O
findings	NNS	O

and	CC	O
it	PRP	O
is	VBZ	O
noted	VBN	O
there	EX	O
was	VBD	O
nodularity	NN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
common	JJ	I-PROBLEM
bile	NN	I-PROBLEM
duct	NN	I-PROBLEM
which	WDT	O
is	VBZ	O
worrisome	JJ	O
for	IN	O
cholangiocarcinoma	NN	B-PROBLEM
.	.	O

therefore	RB	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
on	IN	O
2009-08-24	JJ	O
for	IN	O
a	DT	B-TREATMENT
whipple	JJ	I-TREATMENT
procedure	NN	I-TREATMENT
versus	NN	O
hepaticojejunostomy	NN	B-TREATMENT
.	.	O

on	IN	O
exploration	NN	B-TEST
of	IN	I-TEST
the	DT	I-TEST
abdomen	NNS	I-TEST
revealed	VBD	O
significant	JJ	B-PROBLEM
nodularity	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
liver	NN	I-PROBLEM
indicating	NN	O
of	IN	O
advanced	JJ	B-PROBLEM
cirrhosis	NN	I-PROBLEM
.	.	O

region	NN	B-PROBLEM
nodularity	NN	I-PROBLEM
,	,	O
which	WDT	O
is	VBZ	O
identified	VBN	O
previously	RB	O
by	IN	O
endoscopic	NN	B-TEST
retrograde	NN	I-TEST
cholangiopancreatography	NN	I-TEST
,	,	O
and	CC	O
regional	JJ	O
lymph	NN	O
nodes	NNS	O
were	VBD	O
all	DT	O
sent	VBN	O
to	TO	O
pathology	NN	B-TEST
.	.	O

they	PRP	O
were	VBD	O
all	DT	O
negative	JJ	O
for	IN	O
malignancy	NN	B-PROBLEM
and	CC	O
therefore	VB	O
a	DT	B-TREATMENT
hepaticojejunostomy	NN	I-TREATMENT

cholangiogram	NN	B-TEST
on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
two	CD	O
showed	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
leakage	NN	B-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
anastomosis	NN	I-PROBLEM
site	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
and	CC	O
he	PRP	O
was	VBD	O
sent	VBN	O
to	TO	O
the	DT	O
floor	NN	O
in	IN	O
stable	JJ	O
condition	NN	O
.	.	O

the	DT	O
patient	NN	O
's	POS	O
postoperative	JJ	O
course	NN	O
was	VBD	O
notable	JJ	O
for	IN	O
an	DT	B-PROBLEM
elevation	NN	I-PROBLEM
in	IN	O
white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	O
peaking	VBG	O
at	IN	O
30.0	CD	O
on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
two	CD	O
.	.	O

he	PRP	O
was	VBD	O
given	VBN	O
unasyn	JJ	B-TREATMENT
for	IN	O
empiric	JJ	B-TREATMENT
antibiotic	JJ	I-TREATMENT
treatment	NN	I-TREATMENT
.	.	O

at	IN	O
the	DT	O
time	NN	O
,	,	O
blood	NN	O
,	,	O
urine	JJ	O
and	CC	O
bile	NN	O
was	VBD	O
sent	VBN	O
for	IN	O
culture	NN	B-TEST
,	,	O
which	WDT	O
were	VBD	O
all	DT	O
negative	JJ	O
.	.	O

a	DT	B-TEST
chest	JJ	I-TEST
x-ray	NN	I-TEST
was	VBD	O
also	RB	O
negative	JJ	O
for	IN	O
any	DT	B-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

postoperatively	RB	O
,	,	O
mr.	JJ	O
cordano	NN	O
also	RB	O
suffered	VBD	O
from	IN	O
low	JJ	B-PROBLEM
urine	JJ	I-PROBLEM
output	NN	I-PROBLEM
ranges	VBZ	O
between	IN	O
25	CD	O
to	TO	O
30	CD	O
cc	NNS	O
per	IN	O
hour	NN	O
.	.	O

fractional	JJ	B-TEST
excretion	NN	I-TEST
of	IN	I-TEST
sodium	NN	I-TEST
was	VBD	O
less	JJR	O
than	IN	O
1%	CD	O
suggesting	VBG	O
a	DT	B-PROBLEM
prerenal	JJ	I-PROBLEM
etiology	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
sodium	NN	I-TEST
creatinine	NN	I-TEST
peaked	VBD	O
at	IN	O
2.0	CD	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
treated	VBN	O
with	IN	O
boluses	NNS	B-TREATMENT
of	IN	I-TREATMENT
intravenous	JJ	I-TREATMENT
fluid	NN	I-TREATMENT
and	CC	O
intravenous	JJ	B-TREATMENT
albumin	NN	I-TREATMENT
infusion	NN	I-TREATMENT
was	VBD	O
also	RB	O
administered	VBN	O
.	.	O

he	PRP	O
responded	VBD	O
well	RB	O
to	TO	O
this	DT	B-TREATMENT
regimen	NNS	I-TREATMENT
and	CC	O
made	VBD	O
adequate	JJ	O
urine	JJ	O
output	NN	O
.	.	O

at	IN	O
the	DT	O
same	JJ	O
time	NN	O
,	,	O
the	DT	O
patient	NN	O
also	RB	O
developed	VBD	O
distentions	NNS	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
abdomen	NNS	I-PROBLEM
consistent	JJ	O
with	IN	O
accumulation	NN	B-PROBLEM
of	IN	I-PROBLEM
ascitic	JJ	I-PROBLEM
fluid	NN	I-PROBLEM
.	.	O

he	PRP	O
also	RB	O
had	VBD	O
significant	JJ	B-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
and	CC	I-PROBLEM
scrotum	NN	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
eight	CD	O
,	,	O
the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
oxygen	NN	I-TEST
saturation	NN	I-TEST
dropped	VBD	O
to	TO	O
85%	CD	O
on	IN	O
room	NN	O
air	NN	O
and	CC	O
he	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
surgical	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
for	IN	O
fluid	JJ	B-TREATMENT
management	NN	I-TREATMENT
.	.	O

chest	RBS	B-TEST
x-ray	NN	I-TEST
and	CC	O
sputum	JJ	B-TEST
culture	NN	I-TEST
obtained	VBN	O
at	IN	O
the	DT	O
time	NN	O
were	VBD	O
negative	JJ	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
treated	VBN	O
with	IN	O
100%	CD	B-TREATMENT
nonrebreather	NN	I-TREATMENT
which	WDT	O
improved	VBD	O
his	PRP$	B-TEST
oxygenation	NN	I-TEST
.	.	O

while	IN	O
he	PRP	O
is	VBZ	O
in	IN	O
the	DT	O
surgical	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
,	,	O
paracentesis	NN	B-TEST
was	VBD	O
performed	VBN	O
and	CC	O
it	PRP	O

revealed	VBD	O
greater	JJR	O
than	IN	O
24,000	CD	O
white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
in	IN	O
the	DT	B-PROBLEM
ascites	NNS	I-PROBLEM
which	WDT	O
is	VBZ	O
consistent	JJ	O
with	IN	O
svt	NN	B-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
given	VBN	O
zosyn	NN	B-TREATMENT
for	IN	O
empiric	JJ	B-TREATMENT
treatment	NN	I-TREATMENT
.	.	O

gram	NN	B-TEST
stain	NN	I-TEST
and	CC	O
culture	NN	B-TEST
of	IN	O
the	DT	B-PROBLEM
ascites	NNS	I-PROBLEM
failed	VBD	O
to	TO	O
identify	VB	O
any	DT	B-PROBLEM
organism	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
weaned	VBN	O
from	IN	O
oxygen	NN	B-PROBLEM
requirement	NN	I-PROBLEM
and	CC	O
was	VBD	O
continued	VBN	O
on	IN	O
normal	JJ	B-TREATMENT
saline	NN	I-TREATMENT
boluses	NNS	I-TREATMENT
and	CC	O

intravenous	JJ	B-TREATMENT
albumin	NN	I-TREATMENT
for	IN	O
treatment	NN	O
of	IN	O
prerenal	JJ	B-PROBLEM
azotemia	NN	I-PROBLEM
.	.	O

somatostatin	NN	B-TREATMENT
and	CC	O
midodrine	NN	B-TREATMENT
were	VBD	O
also	RB	O
given	VBN	O
for	IN	O
this	DT	B-PROBLEM
condition	NN	I-PROBLEM
and	CC	O
he	PRP	O
also	RB	O
received	VBD	O
packed	JJ	B-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
ten	NN	O
,	,	O
the	DT	O
patient	NN	O
returned	VBD	O
to	TO	O
the	DT	O
floor	NN	O
with	IN	O
improved	JJ	O
renal	JJ	O
function	NN	O
and	CC	O
without	IN	O
oxygen	NN	B-PROBLEM
requirement	NN	I-PROBLEM
.	.	O

the	DT	B-TREATMENT
somatostatin	NN	I-TREATMENT
and	CC	O
the	DT	B-TREATMENT
midodrine	NN	I-TREATMENT
were	VBD	O
discontinued	VBN	O
and	CC	O
the	DT	O
regimen	NNS	O
of	IN	O
lasix	NN	B-TREATMENT
and	CC	O
spironolactone	NN	B-TREATMENT
was	VBD	O
started	VBN	O
for	IN	O
diuresis	NN	B-TREATMENT
.	.	O

his	PRP$	B-TEST
creatinine	NN	I-TEST
levels	NNS	I-TEST
trended	VBN	O
toward	IN	O
normal	JJ	O
and	CC	O
the	DT	B-TEST
fractional	JJ	I-TEST
excretion	NN	I-TEST
of	IN	I-TEST
sodium	NN	I-TEST
also	RB	O
increased	VBD	O
indicating	VBG	O
a	DT	O
resolution	NN	O
of	IN	O
the	DT	B-PROBLEM
prerenal	JJ	I-PROBLEM
kidney	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

he	PRP	O
has	VBZ	O
a	DT	B-TREATMENT
picc	JJ	I-TREATMENT
line	NN	I-TREATMENT
in	IN	O
place	NN	O
for	IN	O
continued	JJ	O
treatment	NN	O
with	IN	O
rocephin	NN	B-TREATMENT
and	CC	O
he	PRP	O
will	MD	O
have	VB	O
a	DT	O
visiting	NN	O
nurse	NN	O
to	TO	O
help	VB	O
him	PRP	O
to	TO	O
administer	VB	O
these	DT	B-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

while	IN	O
in	IN	O
the	DT	O
hospital	NN	O
,	,	O
the	DT	O
patient	NN	O
received	VBD	O
initial	JJ	B-TEST
work-up	JJ	I-TEST
including	VBG	O
echocardiogram	NN	B-TEST
,	,	O
electrocardiogram	NN	B-TEST
and	CC	O
serology	NN	B-TEST
studies	NNS	I-TEST
to	TO	O
be	VB	O
listed	VBN	O
for	IN	O
liver	NN	B-TREATMENT
transplant	NN	I-TREATMENT
.	.	O

1.	CD	O
rocephin	JJ	B-TREATMENT
1	CD	O
gram	NN	O
q.d.	NN	O

2.	CD	O
furosemide	JJ	B-TREATMENT
10	CD	O
mg	NN	O
q.d.	NN	O

3.	CD	O
spironolactone	NN	B-TREATMENT
100	CD	O
mg	NN	O
q.d.	NN	O

4.	CD	O
ursodiol	JJ	B-TREATMENT
600	CD	O
mg	NN	O
po	NN	O
t.i.d.	NN	O

psc	NN	B-PROBLEM
,	,	O
status	NN	O
post	NN	O
hepaticojejunostomy	NN	B-TREATMENT
.	.	O

this	DT	O
is	VBZ	O
a	DT	O
56	CD	O
year	NN	O
old	JJ	O
man	NN	O
with	IN	O
history	NN	O
of	IN	O
hypercholesterolemia	NN	B-PROBLEM
and	CC	O
type	NN	B-PROBLEM
ii	NN	I-PROBLEM
diabetes	VBZ	I-PROBLEM
mellitus	NNS	I-PROBLEM
.	.	O

he	PRP	O
has	VBZ	O
a	DT	O
recent	JJ	O
history	NN	O
of	IN	O
dyspnea	NN	B-PROBLEM
on	IN	O
exertion	NN	O
on	IN	O
exertional	JJ	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
which	WDT	O
has	VBZ	O
increased	VBN	O
over	IN	O
the	DT	O
last	JJ	O
several	JJ	O
weeks	NNS	O
and	CC	O
is	VBZ	O
relieved	VBN	O
by	IN	O
sublingual	JJ	B-TREATMENT
nitroglycerin	NN	I-TREATMENT
.	.	O

on	IN	O
2016-06-26	JJ	O
,	,	O
he	PRP	O
had	VBD	O
a	DT	B-PROBLEM
positive	JJ	I-PROBLEM
exercise	NN	I-PROBLEM
tolerance	NN	I-PROBLEM
test	NN	I-PROBLEM
.	.	O

cardiac	JJ	B-TEST
catheterization	NN	I-TEST
at	IN	O
the	DT	O
end	NN	O
of	IN	O
october	NNP	O
revealed	VBD	O
a	DT	B-PROBLEM
dilated	JJ	I-PROBLEM
aortic	JJ	I-PROBLEM
root	NN	I-PROBLEM
to	TO	O
4.4	CD	O
cm	NNS	O
and	CC	O
80%	CD	B-PROBLEM
stenosis	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
mid	NN	I-PROBLEM
left	VBD	I-PROBLEM
anterior	JJ	I-PROBLEM
descending	NN	I-PROBLEM
at	IN	O
the	DT	O
bifurcation	NN	O
involving	VBG	O
the	DT	O
diagonal	JJ	O
branch	NN	O
,	,	O
70%	CD	B-PROBLEM
stenoses	NNS	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
circumflex	NN	I-PROBLEM
and	CC	I-PROBLEM
oblique	JJ	I-PROBLEM
marginal	JJ	I-PROBLEM
artery	NN	I-PROBLEM
and	CC	O
90%	CD	B-PROBLEM
stenosis	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
posterior	JJ	I-PROBLEM
descending	NN	I-PROBLEM
artery	NN	I-PROBLEM
.	.	O

his	PRP$	B-TEST
atrioventricular	JJ	I-TEST
valve	NN	I-TEST
gradient	NN	I-TEST
was	VBD	O
27	CD	O
with	IN	O
an	DT	B-TEST
av	JJ	I-TEST
surface	NN	I-TEST
area	NN	I-TEST
of	IN	O
.91	NNP	O
.	.	O

review	NN	B-TEST
of	IN	I-TEST
systems	NNS	I-TEST
shows	VBZ	O
that	IN	O
the	DT	O
patient	JJ	O
denies	VBZ	O
any	DT	B-PROBLEM
orthopnea	NN	I-PROBLEM
,	,	O
paroxysmal	JJ	B-PROBLEM
nocturnal	JJ	I-PROBLEM
dyspnea	NN	I-PROBLEM
.	.	O

he	PRP	O
has	VBZ	O
no	DT	O
bleeding	NN	B-PROBLEM
or	CC	O
clotting	VBG	B-PROBLEM
problems	NNS	I-PROBLEM
.	.	O

juanita	NN	O
does	VBZ	O
not	RB	O
feel	VB	O
any	DT	B-PROBLEM
palpitations	NNS	I-PROBLEM
.	.	O

he	PRP	O
does	VBZ	O
not	RB	O
have	VB	O
wheezing	NN	B-PROBLEM
,	,	O
claudication	NN	B-PROBLEM
or	CC	O
gastrointestinal	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
.	.	O

nor	CC	O
does	VBZ	O
he	PRP	O
have	VB	O
any	DT	O
history	NN	O
of	IN	O
stroke	NN	B-PROBLEM
like	IN	I-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O

hypercholesterolemia	NN	B-PROBLEM
.	.	O

type	NN	B-PROBLEM
ii	NN	I-PROBLEM
diabetes	NNS	I-PROBLEM
.	.	O

recent	JJ	B-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

recent	JJ	B-PROBLEM
weight	NN	I-PROBLEM
loss	NN	I-PROBLEM
associated	VBN	O
with	IN	O
the	DT	B-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

gastroesophageal	NN	B-PROBLEM
reflux	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

one	CD	O
aspirin	VBZ	B-TREATMENT
a	DT	O
day	NN	O
.	.	O

nexium	NN	B-TREATMENT
40	CD	O
mg	NN	O
a	DT	O
day	NN	O
.	.	O

carvedilol	NN	B-TREATMENT
6.125	CD	O
mg	NN	O
a	DT	O
day	NN	O
.	.	O

glucophage	NN	B-TREATMENT
25	CD	O
mg	NN	O
once	RB	O
a	DT	O
day	NN	O
.	.	O

lipitor	NN	B-TREATMENT
10	CD	O
mg	NN	O
once	RB	O
a	DT	O
day	NN	O
.	.	O

on	IN	O
physical	JJ	B-TEST
examination	NN	I-TEST
,	,	O
the	DT	O
patient	NN	O
is	VBZ	O
afebrile	JJ	B-PROBLEM
.	.	O

weight	NN	B-TEST
is	VBZ	O
82	CD	O
kilograms	NNS	O
.	.	O

blood	NN	B-TEST
pressure	NN	I-TEST
126/66	CD	O
.	.	O

head	NN	B-TEST
and	CC	I-TEST
neck	NN	I-TEST
examination	NN	I-TEST
:	:	O

no	DT	O
bruits	NNS	B-PROBLEM
appreciated	VBN	O
.	.	O

lungs	NNS	O
are	VBP	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
.	.	O

3/6	CD	B-PROBLEM
systolic	JJ	I-PROBLEM
ejection	NN	I-PROBLEM
murmur	NN	I-PROBLEM
throughout	IN	O
his	PRP$	O
precordium	NN	O
.	.	O

his	PRP$	O
abdomen	NNS	O
is	VBZ	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBN	B-PROBLEM
.	.	O

no	DT	O
hepatosplenomegaly	NN	B-PROBLEM
and	CC	O
no	DT	O
cva	NN	B-PROBLEM
tenderness	NN	I-PROBLEM
.	.	O

extremities	NNS	O
are	VBP	O
warm	JJ	O
,	,	O
well	RB	O
perfused	VBN	O
,	,	O
no	DT	O
cyanosis	NN	B-PROBLEM
,	,	O
clubbing	NN	B-PROBLEM
or	CC	O

edema	NN	B-PROBLEM
.	.	O

no	DT	O
varicosities	NNS	B-PROBLEM
noted	VBD	O
.	.	O

he	PRP	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
cardiac	JJ	O
surgery	NN	O
service	NN	O
for	IN	O
an	DT	B-TREATMENT
elected	JJ	I-TREATMENT
bental	JJ	I-TREATMENT
procedure	NN	I-TREATMENT
with	IN	O
homograft	NN	B-TREATMENT
and	CC	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
.	.	O

once	RB	O
consent	NN	O
and	CC	O
preoperative	JJ	B-TEST
evaluation	NN	I-TEST
was	VBD	O
complete	JJ	O
,	,	O
he	PRP	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
.	.	O

briefly	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
to	TO	O
repair	VB	B-TREATMENT
his	PRP$	B-PROBLEM
critical	JJ	I-PROBLEM
aortic	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
,	,	O
his	PRP$	B-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
and	CC	O
his	PRP$	B-PROBLEM
significantly	RB	I-PROBLEM
dilated	VBN	I-PROBLEM
ascending	VBG	I-PROBLEM
aortic	JJ	I-PROBLEM
aneurysm	NN	I-PROBLEM
.	.	O

the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
was	VBD	O
an	DT	B-TREATMENT
aortic	JJ	I-TREATMENT
valve	NN	I-TREATMENT
replacement	NN	I-TREATMENT
with	IN	O
a	DT	B-TREATMENT
tissue	NN	I-TREATMENT
valve	NN	I-TREATMENT
,	,	O
a	DT	B-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
procedure	NN	I-TREATMENT
where	WRB	O
five	CD	B-TREATMENT
grafts	NNS	I-TREATMENT
were	VBD	O
performed	VBN	O
.	.	O

the	DT	O
left	JJ	O
internal	JJ	O
mammary	JJ	O
artery	NN	O
was	VBD	O
connected	VBN	O
to	TO	O
the	DT	O
proximal	JJ	O
left	VBD	O
anterior	JJ	O
descending	NN	O
and	CC	O
saphenous	JJ	B-TREATMENT
vein	NNS	I-TREATMENT
grafts	NNS	I-TREATMENT
were	VBD	O
connected	VBN	O
to	TO	O
the	DT	O
posterior	JJ	O
descending	NN	O
artery	NN	O
,	,	O
diagonal	JJ	O
branch	NN	O
,	,	O
obtuse	IN	O
marginal	JJ	O
and	CC	O
distal	JJ	O
left	VBD	O
anterior	JJ	O
descending	NN	O
.	.	O

finally	RB	O
,	,	O
a	DT	B-TREATMENT
super	JJ	I-TREATMENT
coronary	JJ	I-TREATMENT
arch	NN	I-TREATMENT
graft	NN	I-TREATMENT
was	VBD	O
implanted	VBN	O
.	.	O

this	DT	O
was	VBD	O
a	DT	B-TREATMENT
....................	JJ	I-TREATMENT
graft	NN	I-TREATMENT
.	.	O

cardiopulmonary	JJ	B-TREATMENT
bypass	NN	I-TREATMENT
time	NN	O
was	VBD	O
234	CD	O
minutes	NNS	O
.	.	O

his	PRP$	O
aorta	NN	O
was	VBD	O
cross	NN	B-TREATMENT
clamped	VBD	I-TREATMENT
for	IN	O
168	CD	O
minutes	NNS	O
.	.	O

he	PRP	O
had	VBD	O
pharmacologic	JJ	B-TREATMENT
circulatory	NN	I-TREATMENT
arrest	NN	I-TREATMENT
for	IN	O
18	CD	O
minutes	NNS	O
.	.	O

the	DT	O
patient	NN	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
and	CC	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
unit	NN	O
,	,	O
intubated	VBN	B-TREATMENT
on	IN	O
milrinone	NN	B-TREATMENT
,	,	O
levophed	VBN	B-TREATMENT
and	CC	O
propofol	JJ	B-TREATMENT
drips	NNS	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
remained	VBD	O
intubated	JJ	B-TREATMENT
until	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
five	CD	O
.	.	O

after	IN	O
that	DT	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
no	DT	O
major	JJ	B-PROBLEM
problems	NNS	I-PROBLEM
with	IN	I-PROBLEM
his	PRP$	I-PROBLEM
lungs	NNS	I-PROBLEM
.	.	O

his	PRP$	B-TEST
oxygen	NN	I-TEST
saturations	NNS	I-TEST
remained	VBD	O
good	JJ	O
and	CC	O
he	PRP	O
did	VBD	O
not	RB	O
require	VB	O
supplemental	JJ	B-TREATMENT
oxygen	NN	I-TREATMENT
more	JJR	O
than	IN	O
a	DT	O
couple	NN	O
of	IN	O
days	NNS	O
after	IN	O
his	PRP$	O
extubation	NN	O
.	.	O

after	IN	O
an	DT	O
extended	JJ	O
stay	NN	O
for	IN	O
hemodynamic	JJ	B-TEST
monitoring	NN	I-TEST
and	CC	O
pressor	NN	B-TREATMENT
support	NN	I-TREATMENT
to	TO	O
maintain	VB	O
his	PRP$	O
perfusion	NN	O
.	.	O

the	DT	B-PROBLEM
major	JJ	I-PROBLEM
neurologic	JJ	I-PROBLEM
event	NN	I-PROBLEM
of	IN	O
this	DT	O
hospital	NN	O
course	NN	O
was	VBD	O
that	IN	O
the	DT	O
patient	NN	O
was	VBD	O
slow	JJ	B-PROBLEM
to	TO	I-PROBLEM
awake	VB	I-PROBLEM
after	IN	O
his	PRP$	B-TREATMENT
propofol	NN	I-TREATMENT
drip	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
.	.	O

because	IN	O
of	IN	O
his	PRP$	B-PROBLEM
confusion	NN	I-PROBLEM
,	,	O
a	DT	O
neurology	NN	O
consult	NN	O
was	VBD	O
obtained	VBN	O
and	CC	O
subsequent	JJ	B-TEST
radiographic	NN	I-TEST
imaging	VBG	I-TEST
revealed	VBD	O
chronic	JJ	B-PROBLEM
appearing	VBG	I-PROBLEM
infarcts	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
occipital	JJ	I-PROBLEM
lobe	NN	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
both	DT	O
cerebellar	JJ	O
hemispheres	NNS	O
,	,	O
suggestive	NN	O
of	IN	O
more	JJR	B-PROBLEM
chronic	JJ	I-PROBLEM
infarcts	NNS	I-PROBLEM
,	,	O
as	RB	O
well	RB	O
as	IN	O
an	DT	O
area	NN	O
in	IN	O
the	DT	O
left	NN	O
corona	NN	O
radiata	NN	O
,	,	O
adjacent	JJ	O
to	TO	O
the	DT	O
left	JJ	O
lateral	JJ	O
ventricle	NN	O
which	WDT	O
may	MD	O
or	CC	O
may	MD	O
not	RB	O
be	VB	O
an	DT	B-PROBLEM
acute	JJ	I-PROBLEM
infarct	NN	I-PROBLEM
.	.	O

this	DT	O
was	VBD	O
seen	VBN	O
on	IN	O
the	DT	B-TEST
cat	NN	I-TEST
scan	NN	I-TEST
on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
one	CD	O
,	,	O
12-31	CD	O
.	.	O

as	IN	O
the	DT	O
patient	NN	O
became	VBD	O
more	RBR	O
awake	NN	O
,	,	O
he	PRP	O
still	RB	O
remained	VBD	O
somewhat	RB	B-PROBLEM
confused	JJ	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
little	JJ	I-PROBLEM
bit	NN	I-PROBLEM
out	IN	I-PROBLEM
of	IN	I-PROBLEM
it	PRP	I-PROBLEM
.	.	O

in	IN	O
addition	NN	O
,	,	O
he	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
right	NN	I-PROBLEM
sided	VBN	I-PROBLEM
hemiplegia	NN	I-PROBLEM
.	.	O

over	IN	O
his	PRP$	O
postoperative	JJ	O
course	NN	O
,	,	O
mr.	JJ	O
douglass	NN	O
has	VBZ	O
gradually	RB	O
been	VBN	O
able	JJ	O
to	TO	O
utilize	VB	O
more	JJR	O
and	CC	O
more	JJR	O
of	IN	O
his	PRP$	O
right	JJ	O
side	NN	O
and	CC	O
with	IN	O
the	DT	O
assistance	NN	O
of	IN	O
physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
and	CC	O
occupational	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
,	,	O
he	PRP	O
has	VBZ	O
4	CD	O
to	TO	O
5	CD	O
+	JJ	O
strength	NN	O
in	IN	O
his	PRP$	O
right	JJ	O
hand	NN	O
and	CC	O
arm	NN	O
and	CC	O
about	IN	O
4	CD	O
+	JJ	O
strength	NN	O
in	IN	O
his	PRP$	O
right	JJ	O
leg	NN	O
.	.	O

in	IN	O
addition	NN	O
,	,	O
mr.	JJ	O
douglass	NN	O
is	VBZ	O
given	VBN	O
trazodone	NN	B-TREATMENT
to	TO	O
help	VB	O
him	PRP	O
sleep	VB	O
at	IN	O
night	NN	O
.	.	O

a	DT	O
psychiatric	JJ	O
consult	NN	O
was	VBD	O
also	RB	O
obtained	VBN	O
due	JJ	O
to	TO	O
his	PRP$	O
mental	JJ	O
status	NN	O
and	CC	O
confusion	NN	B-PROBLEM
postoperatively	RB	O
but	CC	O
his	PRP$	B-PROBLEM
psychiatric	JJ	I-PROBLEM
issues	NNS	I-PROBLEM
are	VBP	O
mostly	RB	O
related	VBN	O
to	TO	O
his	PRP$	B-PROBLEM
neurologic	JJ	I-PROBLEM
insults	NNS	I-PROBLEM
and	CC	O
he	PRP	O
has	VBZ	O
no	DT	O
distinctive	JJ	B-PROBLEM
psychiatric	JJ	I-PROBLEM
disorder	NN	I-PROBLEM
,	,	O
except	IN	O
for	IN	O
perhaps	RB	O
postoperative	JJ	B-PROBLEM
delirium	NN	I-PROBLEM
.	.	O

cardiovascularly	RB	O
,	,	O
the	DT	O
patient	NN	O
did	VBD	O
extremely	RB	O
well	RB	O
following	VBG	O
the	DT	B-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

the	DT	B-TREATMENT
levophed	JJ	I-TREATMENT
drip	NN	I-TREATMENT
was	VBD	O
continued	VBN	O
until	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
one	CD	O
.	.	O

milrinone	NN	B-TREATMENT
was	VBD	O
continued	VBN	O
until	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
three	CD	O
,	,	O
at	IN	O
which	WDT	O
point	NN	O
he	PRP	O
was	VBD	O
having	VBG	O
good	JJ	O
enough	RB	O
cardiac	JJ	O
output	NN	O
that	IN	O
he	PRP	O
did	VBD	O
not	RB	O
need	VB	O
these	DT	B-TREATMENT
drips	NNS	I-TREATMENT
to	TO	O
help	VB	O
maintain	VB	O
his	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
anymore	RB	O
.	.	O

he	PRP	O
has	VBZ	O
remained	VBN	O
without	IN	O
any	DT	B-PROBLEM
chest	JJS	I-PROBLEM
pain	NN	I-PROBLEM
following	VBG	O
this	DT	B-TREATMENT
procedure	NN	I-TREATMENT
and	CC	O
his	PRP$	B-PROBLEM
sternal	JJ	I-PROBLEM
wound	NN	I-PROBLEM
is	VBZ	O
clean	JJ	O
,	,	O
dry	JJ	O
and	CC	O
intact	JJ	O
at	IN	O
the	DT	O
end	NN	O
of	IN	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
.	.	O

in	IN	O
addition	NN	O
,	,	O
he	PRP	O
has	VBZ	O
hypertension	NN	B-PROBLEM
,	,	O
for	IN	O
which	WDT	O
he	PRP	O
receives	VBZ	O
metoprolol	NN	B-TREATMENT
and	CC	O
he	PRP	O
has	VBZ	O
hypercholesterolemia	NN	B-PROBLEM
,	,	O
for	IN	O
which	WDT	O
he	PRP	O
receives	VBZ	O
nothing	NN	O
at	IN	O
this	DT	O
time	NN	O
.	.	O

the	DT	O
patient	NN	O
remained	VBD	O
intubated	JJ	B-TREATMENT
until	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
five	CD	O
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
gastroesophageal	VBN	B-PROBLEM
reflux	JJ	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
for	IN	O
which	WDT	O
he	PRP	O
has	VBZ	O
been	VBN	O
receiving	VBG	O
zantac	NN	B-TREATMENT
as	IN	O
an	DT	O
inpatient	NN	O
.	.	O

we	PRP	O
will	MD	O
put	VB	O
him	PRP	O
back	RB	O
on	IN	O
his	PRP$	B-TREATMENT
nexium	NN	I-TREATMENT
.	.	O

in	IN	O
addition	NN	O
,	,	O
over	IN	O
the	DT	O
last	JJ	O
couple	NN	O
of	IN	O
days	NNS	O
prior	RB	O
to	TO	O
discharge	VB	O
,	,	O
the	DT	O
patient	NN	O
did	VBD	O
appear	VB	O
a	DT	B-PROBLEM
little	JJ	I-PROBLEM
bit	NN	I-PROBLEM
icteric	JJ	I-PROBLEM
.	.	O

liver	JJ	B-TEST
function	NN	I-TEST
tests	NNS	I-TEST
were	VBD	O
obtained	VBN	O
and	CC	O
they	PRP	O
were	VBD	O
slightly	RB	B-PROBLEM
elevated	VBN	I-PROBLEM
liver	NN	I-PROBLEM
function	NN	I-PROBLEM
tests	NNS	I-PROBLEM
and	CC	O
alt	NN	B-TEST
was	VBD	O
44	CD	O
,	,	O
ast	NN	B-TEST
was	VBD	O
34	CD	O
;	:	O
alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
was	VBD	O
199	CD	O
,	,	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

total	JJ	B-TEST
bilirubin	NN	I-TEST
was	VBD	O
2.8	CD	O
.	.	O

amylase	NN	B-TEST
was	VBD	O
108	CD	O
and	CC	O
lipase	NN	B-TEST
was	VBD	O
213	CD	O
.	.	O

a	DT	B-TEST
right	JJ	I-TEST
upper	NN	I-TEST
quadrant	NN	I-TEST
ultrasound	NN	I-TEST
did	VBD	O
not	RB	O
reveal	VB	O
any	DT	B-PROBLEM
gallstones	NNS	I-PROBLEM
or	CC	O
common	JJ	B-PROBLEM
bile	JJ	I-PROBLEM
duct	NN	I-PROBLEM
dilatation	NN	I-PROBLEM
indicative	NN	O
of	IN	O
cholecystitis	NN	B-PROBLEM
or	CC	O
cholelithiasis	NN	B-PROBLEM
.	.	O

in	IN	O
addition	NN	O
,	,	O
the	DT	O
patient	NN	O
did	VBD	O
have	VB	O
slightly	RB	B-PROBLEM
elevated	VBN	I-PROBLEM
blood	NN	I-PROBLEM
sugars	NNS	I-PROBLEM
over	IN	O
the	DT	O
last	JJ	O
couple	NN	O
of	IN	O
days	NNS	O
and	CC	O
has	VBZ	O
required	VBN	O
an	DT	B-TREATMENT
insulin	NN	I-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT
and	CC	O
basal	NN	B-TREATMENT
insulin	NN	I-TREATMENT
to	TO	O
maintain	VB	O
his	PRP$	B-TEST
blood	NN	I-TEST
sugars	NNS	I-TEST
at	IN	O
a	DT	O
more	RBR	O
appropriate	JJ	O
level	NN	O
.	.	O

please	VB	O
stay	VB	O
on	IN	O
top	NN	O
of	IN	O
the	DT	B-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT
so	IN	O
that	IN	O
the	DT	O
patient	NN	O
can	MD	O
keep	VB	O
a	DT	O
euglycemic	JJ	O
level	NN	O
.	.	O

the	DT	O
patient	NN	O
,	,	O
during	IN	O
this	DT	O
admission	NN	O
,	,	O
required	VBN	O
transfusion	NN	O
of	IN	O
three	CD	O
units	NNS	O
of	IN	O
packed	JJ	B-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
to	TO	O
maintain	VB	O
adequate	JJ	O
hematocrit	NN	O
.	.	O

at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
,	,	O
mr.	NN	O
norman	NNP	O
hematocrit	VBZ	B-TEST
is	VBZ	O
at	IN	O
40.7	CD	O
.	.	O

the	DT	O
patient	NN	O
did	VBD	O
receive	VB	O
a	DT	O
significant	JJ	O
amount	NN	O
of	IN	O
diuresis	NN	B-TREATMENT
postoperatively	RB	O
and	CC	O
is	VBZ	O
well	RB	O
below	IN	O
his	PRP$	O
baseline	NN	O
with	IN	O
weight	NN	B-TEST
,	,	O
most	RBS	O
likely	JJ	O
because	IN	O
of	IN	O
his	PRP$	B-PROBLEM
inability	NN	I-PROBLEM
to	TO	I-PROBLEM
eat	VB	I-PROBLEM
because	IN	O
of	IN	O
his	PRP$	B-PROBLEM
stroke	NN	I-PROBLEM
.	.	O

declared	VBD	O
him	PRP	O
at	IN	O
first	RB	O
an	DT	B-PROBLEM
aspiration	NN	I-PROBLEM
risk	NN	I-PROBLEM
.	.	O

as	IN	O
mr.	NN	O
douglass	NN	O
has	VBZ	O
improved	VBN	O
from	IN	O
his	PRP$	B-PROBLEM
initial	JJ	I-PROBLEM
stroke	NN	I-PROBLEM
,	,	O
he	PRP	O
has	VBZ	O
become	VBN	O
more	RBR	O
lucid	JJ	O

and	CC	O
is	VBZ	O
less	JJR	O
of	IN	O
an	DT	B-PROBLEM
aspiration	NN	I-PROBLEM
risk	NN	I-PROBLEM
.	.	O

he	PRP	O
is	VBZ	O
going	VBG	O
out	RP	O
on	IN	O
a	DT	B-TREATMENT
cardiac	JJ	I-TREATMENT
healthy	JJ	I-TREATMENT
,	,	I-TREATMENT
diabetic	JJ	I-TREATMENT
diet	NN	I-TREATMENT
,	,	O
as	IN	O
tolerated	VBN	O
with	IN	O
boost	NN	B-TREATMENT
supplements	NNS	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
positive	JJ	B-PROBLEM
blood	NN	I-PROBLEM
and	CC	I-PROBLEM
urine	JJ	I-PROBLEM
cultures	NNS	I-PROBLEM
on	IN	O
01-05	JJ	O
for	IN	O
history	NN	O
of	IN	O
methicillin	NN	B-PROBLEM
resistant	JJ	I-PROBLEM
staphylococcus	NN	I-PROBLEM
aureus	NN	I-PROBLEM
,	,	O
which	WDT	O
was	VBD	O
pan	RB	B-TEST
sensitive	JJ	I-TEST
.	.	O

he	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
oct.	NN	O
25	CD	O
for	IN	O
this	DT	B-PROBLEM
bug	NN	I-PROBLEM
.	.	O

on	IN	O
01-08	NN	O
,	,	O
the	DT	B-TREATMENT
patient	NN	I-TREATMENT
's	POS	I-TREATMENT
central	JJ	I-TREATMENT
venous	JJ	I-TREATMENT
line	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
.	.	O

the	DT	B-TEST
catheterization	NN	I-TEST
tip	NN	I-TEST
also	RB	O
grew	VBD	O
out	RP	O
serratia	NN	B-PROBLEM
.	.	O

on	IN	O
the	DT	O
16th	CD	O
,	,	O
a	DT	B-TEST
urine	JJ	I-TEST
culture	NN	I-TEST
was	VBD	O
obtained	VBN	O
and	CC	O
did	VBD	O
grow	VB	O
out	RP	O
greater	JJR	O
than	IN	O
100,000	CD	O
colonies	NNS	O
of	IN	O
e.	NN	B-PROBLEM
coli	NNS	I-PROBLEM
which	WDT	O
was	VBD	O
intermittently	RB	B-PROBLEM
resistant	JJ	I-PROBLEM
to	TO	O
ciprofloxacin	VB	B-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
bactrim	NN	B-TREATMENT
for	IN	O
that	DT	O
.	.	O

please	NN	O
continue	VB	O
mr.	NN	O
david	NN	O
montero	NN	O
for	IN	O
one	CD	O
month	NN	O
to	TO	O
fight	VB	O
his	PRP$	B-PROBLEM
blood	NN	I-PROBLEM
borne	NN	I-PROBLEM
infection	NN	I-PROBLEM
,	,	O
to	TO	O
prevent	VB	O
seeding	NN	O
of	IN	O
his	PRP$	B-TREATMENT
aortic	JJ	I-TREATMENT
graft	NN	I-TREATMENT
and	CC	O
continue	VB	O
bactrim	NN	B-TREATMENT
for	IN	O
ten	JJ	O
days	NNS	O
after	IN	O
discharge	NN	O
to	TO	O
treat	VB	O
the	DT	B-PROBLEM
e.	NN	I-PROBLEM
coli	NN	I-PROBLEM
in	IN	I-PROBLEM
his	PRP$	I-PROBLEM
urine	NN	I-PROBLEM
.	.	O

coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
.	.	O

critical	JJ	B-PROBLEM
aortic	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
aortic	JJ	B-TREATMENT
valve	NN	I-TREATMENT
replacement	NN	I-TREATMENT
.	.	O

aortic	JJ	B-PROBLEM
arch	NN	I-PROBLEM
aneurysm	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
aortic	JJ	B-TREATMENT
arch	NN	I-TREATMENT
graft	NN	I-TREATMENT
.	.	O

acute	JJ	B-PROBLEM
postoperative	JJ	I-PROBLEM
delirium	NN	I-PROBLEM
.	.	O

perioperative	JJ	B-PROBLEM
stroke	NN	I-PROBLEM
.	.	O

chronic	JJ	B-PROBLEM
blood	NN	I-PROBLEM
loss	NN	I-PROBLEM
anemia	NN	I-PROBLEM
and	CC	O
chronic	JJ	B-TREATMENT
rbc	NN	I-TREATMENT
transfusion	NN	I-TREATMENT
.	.	O

urinary	JJ	B-PROBLEM
tract	NN	I-PROBLEM
infection	NN	I-PROBLEM
.	.	O

hypercholesterolemia	NN	B-PROBLEM
.	.	O

type	NN	B-PROBLEM
ii	NN	I-PROBLEM
diabetes	NNS	I-PROBLEM
.	.	O

gastroesophageal	NN	B-PROBLEM
reflux	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

metoprolol	NN	B-TREATMENT
75	CD	O
mg	NN	O
p.o.	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

captopril	NN	B-TREATMENT
12.5	CD	O
mg	NN	O
p.o.	NN	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
.	.	O

aspirin	RB	B-TREATMENT
81	CD	O
mg	NNS	O
p.o.	JJ	O
q.	JJ	O
day	NN	O
.	.	O

plavix	NN	B-TREATMENT
75	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

heparin	NN	B-TREATMENT
5000	CD	O
units	NNS	O
subcutaneous	JJ	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

metformin	NN	B-TREATMENT
1000	CD	O
mg	NN	O
extended	VBD	O
release	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

humalog	NN	B-TREATMENT
max	NN	I-TREATMENT
75/25	CD	O
,	,	O
20	CD	O
units	NNS	O
subcutaneous	JJ	O
once	RB	O
a	DT	O
day	NN	O
in	IN	O
the	DT	O
morning	NN	O
.	.	O

levofloxacin	RB	B-TREATMENT
500	CD	O
mg	NNS	O
p.o.	JJ	O
q.	JJ	O
day	NN	O
.	.	O

bactrim	JJ	B-TREATMENT
ds	NN	I-TREATMENT
tabs	NN	I-TREATMENT
,	,	O
one	CD	O
tablet	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
for	IN	O
ten	JJ	O
days	NNS	O
.	.	O

colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

hold	NN	O
for	IN	O
loose	JJ	B-PROBLEM
stools	NNS	I-PROBLEM
.	.	O

nexium	NN	B-TREATMENT
40	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

trazodone	NN	B-TREATMENT
25	CD	O
mg	NN	O
p.o.	NN	O
q	JJ	O
h.s.	NN	O
as	IN	O
needed	VBN	O
for	IN	O
sleep	NN	O
.	.	O

lasix	RB	B-TREATMENT
20	CD	O
mg	NNS	O
p.o.	JJ	O
q.	JJ	O
day	NN	O
for	IN	O
one	CD	O
week	NN	O
.	.	O

kcl	VB	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
for	IN	O
one	CD	O
week	NN	O
.	.	O

sulfa	NN	B-TREATMENT
(	(	I-TREATMENT
sulfonamides	NNS	I-TREATMENT
)	)	I-TREATMENT

nausea	NN	B-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
,	,	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
distention	NN	B-PROBLEM
.	.	O

1.	CD	O
subtotal	JJ	B-TREATMENT
colectomy	NN	I-TREATMENT
,	,	O
end	NN	B-TREATMENT
ileostomy	NN	I-TREATMENT
,	,	O
hartmann's	NN	B-TREATMENT
pouch	JJ	I-TREATMENT
,	,	O
g-tube	JJ	B-TREATMENT

2.	CD	O
completion	NN	B-TREATMENT
sigmoid	NN	I-TREATMENT
colectomy	NN	I-TREATMENT
,	,	O
repair	NN	B-TREATMENT
of	IN	O
colovesicular	JJ	B-PROBLEM
fistula	NN	I-PROBLEM
,	,	O
small	JJ	B-TREATMENT
bowel	NN	I-TREATMENT
repair	NN	I-TREATMENT

ms	NN	O
crossman	NN	O
is	VBZ	O
an	DT	O
84	CD	O
year	NN	O
old	JJ	O
female	NN	O
with	IN	O
complaints	NNS	O
of	IN	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
diarrhea	NN	B-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
and	CC	O
vomiting	VBG	B-PROBLEM
x	RB	O
1	CD	O
week	NN	O
,	,	O
who	WP	O
presented	VBD	O
to	TO	O
an	DT	O
outside	JJ	O
hospital	NN	O
.	.	O

she	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
arbour	VB	O
hospital	NN	O
on	IN	O
2015-02-21	JJ	O
for	IN	O
bowel	NN	B-PROBLEM
obstruction	NN	I-PROBLEM
,	,	O
ischemia	NN	B-PROBLEM
and	CC	O
worsening	VBG	B-PROBLEM
abdominal	JJ	I-PROBLEM
distention	NN	I-PROBLEM
and	CC	O
pain	NN	B-PROBLEM
.	.	O

cad	NN	B-PROBLEM
s/p	NN	O
mi	NN	B-PROBLEM
,	,	O
htn	NN	B-PROBLEM
,	,	O
dmii	NN	B-PROBLEM

the	DT	O
other	JJ	O
daughter	NN	O
was	VBD	O
recently	RB	O
in	IN	O
a	DT	O
car	NN	O
accident	NN	O
and	CC	O
underwent	JJ	O
surgery	NN	B-TREATMENT
at	IN	O
saint	NN	O
vincent	NN	O
hospital	NN	O
.	.	O

afebrile	NN	B-PROBLEM
,	,	O
vss	NN	O

a&o	NN	O
x	VBZ	O
3	CD	O
,	,	O
nad	NN	B-PROBLEM

ctab	NN	O
,	,	O
mildly	RB	B-PROBLEM
decreased	VBD	I-PROBLEM
breath	NN	I-PROBLEM
sounds	NNS	I-PROBLEM
b/l	VBP	I-PROBLEM

abd	NN	O
soft	JJ	O
,	,	O
nt/nd	JJ	B-PROBLEM
,	,	O
+	JJ	O
bs	NN	O
,	,	O
no	DT	O
masses	NNS	B-PROBLEM
,	,	O
ostomy	NN	B-TREATMENT
in	IN	I-TREATMENT
rlq	NN	I-TREATMENT
pink	NN	O
,	,	O
with	IN	O
stool	NN	O

g-tube	NN	B-TREATMENT
in	IN	O
place	NN	O

le	JJ	B-PROBLEM
trace	NN	I-PROBLEM
edema	NN	I-PROBLEM

2014-02-21	JJ	O
12:20	CD	O
pm	NN	O
blood	NN	B-TEST
wbc	SYM	B-TEST
-	:	O
10.2	CD	O
rbc	NN	B-TEST
-	:	O
5.32	CD	O
hgb	NN	B-TEST
-	:	O
14.9	CD	O
hct	NN	B-TEST
-	:	O
43.4	CD	O
mcv	SYM	B-TEST
-	:	O
82	CD	O
mch	SYM	B-TEST
-	:	O
28.0	CD	O
mchc	SYM	B-TEST
-	:	O
34.4	CD	O
rdw	NN	B-TEST
-	:	O
16.0	CD	O
*	JJ	O
plt	NN	B-TEST
ct	SYM	I-TEST
-	:	O
204	CD	O

2014-02-21	JJ	O
12:20	CD	O
pm	NN	O
blood	NN	B-TEST
pt	NN	B-TEST
-	:	O
12.9	CD	O
ptt	NN	B-TEST
-	:	O
32.5	CD	O
inr(pt)	JJ	B-TEST
-	:	O
1.1	CD	O

2014-02-21	JJ	O
12:20	CD	O
pm	NN	O
blood	NN	B-TEST
glucose	VB	B-TEST
-	:	O
345	CD	O
*	JJ	O
urean	JJ	B-TEST
-	:	O
34	CD	O
*	NN	O
creat	NN	B-TEST
-	:	O
1.0	CD	O
na	SYM	B-TEST
-	:	O
137	CD	O
k	SYM	B-TEST
-	:	O
4.3	CD	O
cl	NN	B-TEST
-	:	O
99	CD	O
hco3	NN	B-TEST
-	:	O
24	CD	O
angap	NN	B-TEST
-	:	O
18	CD	O

2014-02-21	JJ	O
12:20	CD	O
pm	NN	O
blood	NN	B-TEST
alt	SYM	B-TEST
-	:	O
17	CD	O
ast	IN	B-TEST
-	:	O
27	CD	O
alkphos	SYM	B-TEST
-	:	O
119	CD	O
*	JJ	O
amylase	NN	B-TEST
-	:	O
27	CD	O
totbili	SYM	B-TEST
-	:	O
0.9	CD	O

2014-02-21	JJ	O
12:20	CD	O
pm	NN	O
blood	NN	B-TEST
lipase	NN	B-TEST
-	:	O
11	CD	O

2014-02-21	JJ	O
12:20	CD	O
pm	JJ	O
blood	NN	B-TEST
ck-mb	JJ	B-TEST
-	:	O
7	CD	O
ctropnt	NN	B-TEST
-<	CD	O
0.01	CD	O

2014-03-09	JJ	O
02:59	CD	O
am	VBP	O
blood	NN	B-TEST
ctropnt	NN	B-TEST
-	:	O
0.21	CD	O
*	NN	O

2014-03-09	JJ	O
11:29	CD	O
am	VBP	O
blood	NN	B-TEST
ck-mb	JJ	B-TEST
-	:	O
35	CD	O
*	JJ	O
mb	NN	B-TEST
indx	SYM	I-TEST
-	:	O
25.5	CD	O
*	NN	O
ctropnt	NN	B-TEST
-	:	O
0.45	CD	O
*	NN	O

2014-03-09	JJ	O
07:52	CD	O
pm	JJ	O
blood	NN	B-TEST
ck-mb	JJ	B-TEST
-	:	O
notdone	NN	O
ctropnt	NN	B-TEST
-	:	O
0.55	CD	O
*	NN	O

2014-03-10	JJ	O
05:25	CD	O
pm	NN	O
blood	NN	B-TEST
ctropnt	NN	B-TEST
-	:	O
0.42	CD	O
*	NN	O

2014-03-11	JJ	O
02:00	CD	O
am	VBP	O
blood	NN	B-TEST
ctropnt	NN	B-TEST
-	:	O
0.45	CD	O
*	NN	O

2014-03-19	JJ	O
07:13	CD	O
am	VBP	O
blood	NN	B-TEST
ck-mb	JJ	B-TEST
-	:	O
3	CD	O
ctropnt	NN	B-TEST
-	:	O
0.19	CD	O
*	NN	O

2014-03-19	JJ	O
01:33	CD	O
pm	JJ	O
blood	NN	B-TEST
ck-mb	JJ	B-TEST
-	:	O
notdone	NN	O
ctropnt	NN	B-TEST
-	:	O
0.17	CD	O
*	NN	O

2014-03-21	JJ	O
09:58	CD	O
am	VBP	O
blood	NN	B-TEST
ck-mb	JJ	B-TEST
-	:	O
notdone	NN	O
ctropnt	NN	B-TEST
-	:	O
0.06	CD	O
*	NN	O

03-07	JJ	O
wound	NN	B-TEST
swab	NN	I-TEST
:	:	O
vre	NN	B-PROBLEM

ct	NN	B-TEST
abd	VBZ	I-TEST
02-21	NN	O
:	:	O

1.	CD	O
markedly	RB	B-PROBLEM
dilated	VBN	I-PROBLEM
colon	NN	I-PROBLEM
throughout	IN	O
ascending	VBG	O
,	,	O
transverse	NN	O
,	,	O
and	CC	O
descending	VBG	O
colon	NN	O
with	IN	O
air-fluid	JJ	B-PROBLEM
levels	NNS	I-PROBLEM
,	,	O
overall	RB	O
unchanged	JJ	O
since	IN	O
prior	JJ	B-TEST
study	NN	I-TEST
performed	VBD	O
on	IN	O
the	DT	O
same	JJ	O
day	NN	O
with	IN	O
pneumatosis	NN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
ascending	NN	I-PROBLEM
colon	NN	I-PROBLEM
.	.	O

sigmoid	JJ	B-PROBLEM
diverticulosis	NN	I-PROBLEM
with	IN	O
focal	JJ	B-PROBLEM
narrowing	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
sigmoid	JJ	I-PROBLEM
colon	NN	I-PROBLEM
just	RB	O
distal	JJ	O
to	TO	O
the	DT	B-PROBLEM
dilatation	NN	I-PROBLEM
with	IN	O
wall	NN	B-PROBLEM
thickening	NN	I-PROBLEM
,	,	O
due	JJ	O
to	TO	O
diverticulitis	VB	B-PROBLEM
.	.	O

this	DT	O
area	NN	O
can	MD	O
be	VB	O
a	DT	O
leading	JJ	O
point	NN	O
of	IN	O
obstruction	NN	B-PROBLEM
.	.	O

an	DT	B-PROBLEM
underlying	JJ	I-PROBLEM
mass	NN	I-PROBLEM
lesion	NN	I-PROBLEM
or	CC	O
cancer	NN	B-PROBLEM
cannot	NN	O
be	VB	O
excluded	VBN	O
in	IN	O
this	DT	O
area	NN	O
,	,	O
and	CC	O
further	RB	B-TEST
clinical	JJ	I-TEST
investigation	NN	I-TEST
is	VBZ	O
recommended	VBN	O
.	.	O

2.	CD	O
limited	JJ	B-TEST
evaluation	NN	I-TEST
for	IN	O
known	VBN	B-PROBLEM
sigmoid-vesicle	NN	I-PROBLEM
fistula	NN	I-PROBLEM
.	.	O

3.	CD	O
small	JJ	B-PROBLEM
amount	NN	I-PROBLEM
of	IN	I-PROBLEM
ascites	NNS	I-PROBLEM
,	,	O
somewhat	RB	O
increased	VBD	O
anterior	JJ	O
to	TO	O
the	DT	O
liver	NN	O
.	.	O

4.	CD	O
bilateral	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
cysts	NNS	I-PROBLEM
.	.	O

5.	CD	O
heavy	JJ	B-PROBLEM
calcification	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
aorta	NN	I-PROBLEM
and	CC	I-PROBLEM
sma	NN	I-PROBLEM
and	CC	I-PROBLEM
its	PRP$	I-PROBLEM
branches	NNS	I-PROBLEM
.	.	O

due	JJ	O
to	TO	O
atherosclerosis	VB	B-PROBLEM
,	,	O
assessment	NN	B-TEST
of	IN	I-TEST
the	DT	I-TEST
intraluminal	JJ	I-TEST
process	NN	I-TEST
of	IN	O
these	DT	O
branches	NNS	O
is	VBZ	O
limited	JJ	O
.	.	O

cta/ct	NN	B-TEST
abd	VBZ	I-TEST
03-07	NN	O
:	:	O

1.	CD	O
no	DT	O
evidence	NN	O
of	IN	O
pulmonary	JJ	B-PROBLEM
embolism	NN	I-PROBLEM
.	.	O

small	JJ	B-PROBLEM
bilateral	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
with	IN	O
compressive	JJ	B-PROBLEM
atelectasis	NN	I-PROBLEM
.	.	O

2.	CD	O
left	VBD	B-PROBLEM
lower	JJR	I-PROBLEM
quadrant	JJ	I-PROBLEM
thick-walled	JJ	I-PROBLEM
peripherally	RB	I-PROBLEM
enhancing	VBG	I-PROBLEM
fluid	NN	I-PROBLEM
collection	NN	I-PROBLEM
,	,	O
which	WDT	O
appears	VBZ	O
to	TO	O
communicate	VB	O
with	IN	O
the	DT	O
sutured	JJ	O
end	NN	O
of	IN	O
the	DT	O
proximal	JJ	O
sigmoid	NN	O
colon	NN	O
via	IN	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
collection	NN	I-PROBLEM
of	IN	I-PROBLEM
extraluminal	JJ	I-PROBLEM
gas	NN	I-PROBLEM
.	.	O

in	IN	O
the	DT	O
correct	JJ	O
clincial	JJ	O
setting	NN	O
,	,	O
this	DT	O
could	MD	O
be	VB	O
consistent	JJ	O
with	IN	O
an	DT	B-PROBLEM
abscess	NN	I-PROBLEM
.	.	O

3.	CD	O
moderate	JJ	B-PROBLEM
intraabdominal	JJ	I-PROBLEM
ascites	NNS	I-PROBLEM
.	.	O

4.	CD	O
status	NN	O
post	NN	O
ileostomy	NN	B-TREATMENT
without	IN	O
evidence	NN	O
of	IN	O
small-bowel	JJ	B-PROBLEM
obstruction	NN	I-PROBLEM
.	.	O

5.	CD	O
distended	JJ	B-PROBLEM
gallbladder	NN	I-PROBLEM
.	.	O

6.	CD	O
diverticulosis	NN	B-PROBLEM
within	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
remnant	NN	I-PROBLEM
sigmoid	NN	I-PROBLEM
colon	NN	I-PROBLEM
.	.	O

03-21	JJ	O
vcug	NN	B-TEST
-	:	O
no	DT	O
leak	NN	B-PROBLEM

neuro	NN	O
:	:	O
developed	JJ	O
confusion	NN	B-PROBLEM
during	IN	O
her	PRP$	O
first	JJ	O
5	CD	O
days	NNS	O
in	IN	O
the	DT	O
icu	NN	O
.	.	O

intermitent	NN	B-PROBLEM
delirium	NN	I-PROBLEM
throughout	IN	O
admission	NN	O
.	.	O

required	VBN	O
restraints	NNS	B-TREATMENT
to	TO	O
prevent	VB	O
dc	NN	O
of	IN	O
pertinent	JJ	B-TREATMENT
therapies	NNS	I-TREATMENT
while	IN	O
in	IN	O
the	DT	O
icu	NN	O
.	.	O

cardiovascular	NN	O
:	:	O
complained	VBN	O
of	IN	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
during	IN	O
first	JJ	O
few	JJ	O
days	NNS	O
of	IN	O
admission	NN	O
,	,	O
a	DT	O
cardiology	NN	O
consult	NN	O
was	VBD	O
obtained	VBN	O
.	.	O

she	PRP	O
recieved	VBD	O
serial	JJ	B-TEST
enzymes	NNS	I-TEST
and	CC	O
ekgs	NN	B-TEST
.	.	O

troponins	NNS	B-TEST
remained	VBD	O
mildly	RB	B-PROBLEM
elevated	VBN	I-PROBLEM
as	RB	O
high	JJ	O
as	IN	O
0.6	CD	O
throughout	IN	O
her	PRP$	O
admission	NN	O
,	,	O
and	CC	O
most	JJS	O
recent	JJ	O
result	NN	O
now	RB	O
0.1	CD	O
.	.	O

she	PRP	O
was	VBD	O
treated	VBN	O
in	IN	O
iuc	NN	O
for	IN	O
unstable	JJ	B-PROBLEM
angina	NN	I-PROBLEM
with	IN	O
nitroglycerin	NN	B-TREATMENT
.	.	O

it	PRP	O
was	VBD	O
recommended	VBN	O
to	TO	O
maximize	VB	O
her	PRP$	B-TREATMENT
medical	JJ	I-TREATMENT
treatment	NN	I-TREATMENT
with	IN	O
beta	NN	B-TREATMENT
blockers	NNS	I-TREATMENT
,	,	O
aspirin	NN	B-TREATMENT
,	,	O
a	DT	B-TREATMENT
statin	NN	I-TREATMENT
and	CC	O
an	DT	B-TREATMENT
ace	NN	I-TREATMENT
inhibitor	NN	I-TREATMENT
.	.	O

required	VBN	O
diuresis	NN	B-TREATMENT
of	IN	O
>	$	O
9	CD	O
l	NN	O
while	IN	O
in	IN	O
the	DT	O
icu	NN	O
,	,	O
after	IN	O
2nd	CD	B-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

continues	VBZ	O
to	TO	O
have	VB	O
trace	NN	B-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
edema	NN	I-PROBLEM
,	,	O
and	CC	O
recieves	VBZ	O
lasix	JJ	B-TREATMENT
po	NN	I-TREATMENT
.	.	O

respiratory	NN	O
:	:	O
she	PRP	O
was	VBD	O
intubated	VBN	B-TREATMENT
briefly	IN	O
post-op	JJ	O
subtotal	JJ	B-TREATMENT
colectomy	NN	I-TREATMENT
and	CC	O
again	RB	O
for	IN	O
several	JJ	O
days	NNS	O
after	IN	O
second	JJ	B-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

recieved	VBN	O
nebulizer	JJ	B-TREATMENT
treatments	NNS	I-TREATMENT
post-op	NN	O
in	IN	O
the	DT	O
icu	NN	O
,	,	O
after	IN	O
successfully	RB	O
extubated	VBN	O
.	.	O

gastrointestinal	NN	O
:	:	O
her	PRP$	B-TEST
initial	JJ	I-TEST
ct	NN	I-TEST
scan	JJ	I-TEST
showed	VBD	O
dilated	JJ	B-PROBLEM
turner	NN	I-PROBLEM
colon	NN	I-PROBLEM
,	,	O
wall	NN	B-PROBLEM
thickening	NN	I-PROBLEM
and	CC	O
pneumatosis	NN	B-PROBLEM
see	VBP	O
pertinent	JJ	O
results	NNS	O
.	.	O

she	PRP	O
was	VBD	O
initially	RB	O
treated	VBN	O
nonoperatively	RB	O
with	IN	O
iv	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
,	,	O
antibiotics	NNS	B-TREATMENT
,	,	O
serial	JJ	B-TEST
exams	NN	I-TEST
and	CC	O
ngt	JJ	B-TREATMENT
decompression	NN	I-TREATMENT
.	.	O

on	IN	O
hd#5	NN	O
flexible	JJ	B-TEST
sigmoidoscopy	NN	I-TEST
was	VBD	O
performed	VBN	O
for	IN	O
colonic	JJ	B-TREATMENT
decompression	NN	I-TREATMENT
.	.	O

on	IN	O
hd#6	NN	O
,	,	O
colonscopy	NN	B-TEST
was	VBD	O
performed	VBN	O
for	IN	O
decompression	NN	B-TREATMENT
,	,	O
and	CC	O
revealed	VBD	O
pseudomembrane	NN	B-PROBLEM
and	CC	O
friable	JJ	B-PROBLEM
colonic	JJ	I-PROBLEM
tissue	NN	I-PROBLEM
.	.	O

her	PRP$	O
abdomen	NNS	O
remained	VBD	O
tender	NN	B-PROBLEM
and	CC	O
distended	VBD	B-PROBLEM
despite	IN	O
attempted	JJ	O
decompression	NN	B-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
or	CC	O
for	IN	O
subtotal	JJ	B-TREATMENT
colectomy	NN	I-TREATMENT
,	,	O
g	NN	B-TREATMENT
tube	NN	I-TREATMENT
and	CC	O
ileostomy	NN	B-TREATMENT
due	JJ	O
to	TO	O
unresponsiveness	JJ	B-PROBLEM
to	TO	O
non-operative	JJ	B-TREATMENT
treatment	NN	I-TREATMENT
.	.	O

ileostomy	NN	B-TREATMENT
remains	VBZ	O
pink	JJ	O
and	CC	O
intact	JJ	O
,	,	O
draining	VBG	O
green-brown	JJ	O
soft	JJ	O
stool	NN	O
.	.	O

she	PRP	O
developed	VBD	O
additional	JJ	B-PROBLEM
abdominal	JJ	I-PROBLEM
tenderness	NN	I-PROBLEM
and	CC	O
distention	NN	B-PROBLEM
.	.	O

her	PRP$	B-TEST
hct	NN	I-TEST
dropped	VBD	O
and	CC	O
she	PRP	O
recieved	VBD	O
1	CD	B-TREATMENT
unit	NN	I-TREATMENT
prbcs	NN	I-TREATMENT
.	.	O

on	IN	O
pod#8	PDT	O
a	DT	B-TEST
ct	JJ	I-TEST
scan	NN	I-TEST
was	VBD	O
obtained	VBN	O
which	WDT	O
revealed	VBD	O
an	DT	B-PROBLEM
abcess	NN	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
colovesicular	JJ	I-PROBLEM
fistula	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
or	CC	O
for	IN	O
exploration	NN	B-TEST
and	CC	O
drainage	NN	B-TREATMENT
.	.	O

she	PRP	O
recieved	VBD	O
further	JJ	B-TREATMENT
resection	NN	I-TREATMENT
of	IN	I-TREATMENT
remaining	VBG	I-TREATMENT
colon	NN	I-TREATMENT
,	,	O
repair	NN	B-TREATMENT
of	IN	O
a	DT	B-PROBLEM
leak	NN	I-PROBLEM
from	IN	I-PROBLEM
relaford	NN	I-PROBLEM
pouch	NN	I-PROBLEM
and	CC	O
repair	NN	B-TREATMENT
of	IN	O
colovesicular	JJ	B-PROBLEM
fistula	NN	I-PROBLEM
.	.	O

after	IN	O
her	PRP$	B-TREATMENT
2nd	CD	I-TREATMENT
surgery	NN	I-TREATMENT
she	PRP	O
returned	VBD	O
to	TO	O
the	DT	O
icu	NN	O
and	CC	O
improved	VBN	O
steadily	RB	O
.	.	O

abdomen	NNS	O
remained	VBD	O
soft	JJ	O
and	CC	O
nontender	NN	B-PROBLEM
.	.	O

she	PRP	O
remained	VBD	O
on	IN	O
iv	NN	B-TREATMENT
antibiotics	NNS	I-TREATMENT
x	VBP	O
14	CD	O
days	NNS	O
and	CC	O
required	JJ	O
pressors	NNS	B-TREATMENT
for	IN	O
the	DT	O
first	JJ	O
few	JJ	O
days	NNS	O
post-op	RB	O
.	.	O

her	PRP$	B-PROBLEM
incision	NN	I-PROBLEM
has	VBZ	O
remained	VBN	O
clean	JJ	O
,	,	O
dry	JJ	O
,	,	O
intact	JJ	O
,	,	O
with	IN	O
staples	NNS	B-TREATMENT
removed	VBN	O
on	IN	O
pod#	NN	O
27/18	CD	O
.	.	O

genitourinary	NN	O
:	:	O
she	PRP	O
had	VBD	O
a	DT	B-TREATMENT
foley	JJ	I-TREATMENT
catheter	NN	I-TREATMENT
from	IN	O
the	DT	O
time	NN	O
of	IN	O
admission	NN	O
.	.	O

pod#	NN	O
23/14	CD	O
she	PRP	O
recieved	VBD	O
a	DT	B-TEST
cystoscopy	NN	I-TEST
which	WDT	O
revealed	VBD	O
no	DT	O
leak	NN	B-PROBLEM
.	.	O

her	PRP$	B-TREATMENT
foley	NN	I-TREATMENT
was	VBD	O
subsequently	RB	O
dc	JJ	O
'd	MD	O
.	.	O

musculoskeletal	NN	O
:	:	O
has	VBZ	O
suffered	VBN	O
significant	JJ	B-PROBLEM
deconditioning	NN	I-PROBLEM
since	IN	O
admission	NN	O
,	,	O
but	CC	O
has	VBZ	O
consisitently	RB	O
recieved	VBN	O
pt	NN	B-TREATMENT
.	.	O

see	VB	O
pt	JJ	O
note	NN	O
for	IN	O
further	JJ	B-TEST
assessment	NN	I-TEST
and	CC	O
discussion	NN	O
.	.	O

nutrition	NN	O
:	:	O
she	PRP	O
was	VBD	O
held	VBN	O
npo	RB	B-TREATMENT
at	IN	O
admission	NN	O
,	,	O
and	CC	O
initiated	VBN	O
on	IN	O
tpn	NN	B-TREATMENT
by	IN	O
hd#3	NN	O
.	.	O

post-operatively	RB	O
she	PRP	O
began	VBD	O
on	IN	O
tf	NN	B-TREATMENT
s,	NN	I-TREATMENT
and	CC	O
the	DT	B-TREATMENT
tpn	NN	I-TREATMENT
was	VBD	O
weaned	VBN	O
down	RP	O
.	.	O

by	IN	O
pod#	JJ	O
05-29	JJ	O
she	PRP	O
was	VBD	O
having	VBG	O
high	JJ	B-PROBLEM
residuals	NNS	I-PROBLEM
on	IN	O
tf	NN	B-TREATMENT
s,	NN	I-TREATMENT
so	RB	O
tpn	JJ	B-TREATMENT
was	VBD	O
reinitiated	VBN	O
.	.	O

tf	NN	B-TREATMENT
's	POS	I-TREATMENT
were	VBD	O
dc	JJ	O
'ed	JJ	O
prior	RB	O
to	TO	O
second	JJ	B-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

pod#	NN	O
15/6	CD	O
,	,	O
she	PRP	O
resumed	VBD	O
tf	NN	B-TREATMENT
's	POS	I-TREATMENT
and	CC	O
tpn	NN	B-TREATMENT
was	VBD	O
tapered	VBN	O
again	RB	O
.	.	O

tf	NN	O
goals	NNS	O
were	VBD	O
achieved	VBN	O
and	CC	O
tpn	JJ	B-TREATMENT
dc	NN	O
'ed.	NN	O

at	IN	O
time	NN	O
of	IN	O
discharge	NN	O
she	PRP	O
is	VBZ	O
tolerating	VBG	O
a	DT	O
regular	JJ	O
diet	NN	O
with	IN	O
tf	NN	B-TREATMENT
's	POS	I-TREATMENT
at	IN	O
goal	NN	O
.	.	O

patient	NN	O
is	VBZ	O
an	DT	B-PROBLEM
insulin	JJ	I-PROBLEM
dependent	JJ	I-PROBLEM
diabetic	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
followed	VBN	O
by	IN	O
cape	NN	O
cod	NN	O
hospital	NN	O
clinic	NN	O
for	IN	O
treatment	NN	B-TREATMENT
of	IN	O
persistent	JJ	B-PROBLEM
hyperglycemia	NN	I-PROBLEM
.	.	O

pain	NN	B-PROBLEM
:	:	O
her	PRP$	B-PROBLEM
pain	NN	I-PROBLEM
was	VBD	O
controlled	VBN	O
with	IN	O
iv	NN	B-TREATMENT
pain	NN	I-TREATMENT
medicines	NNS	I-TREATMENT
while	IN	O
in	IN	O
icu	NN	O
.	.	O

she	PRP	O
has	VBZ	O
been	VBN	O
adequately	RB	O
controlled	VBN	O
with	IN	O
tylenol	NN	B-TREATMENT
,	,	O
motrin	NN	B-TREATMENT
&	CC	O
oxycodone	NN	B-TREATMENT
by	IN	O
mouth	NN	O
,	,	O
per	IN	O
recommendations	NNS	O
by	IN	O
geriatrics	NNS	O
.	.	O

pod#	NN	O
22/15	CD	O
ms	NN	O
crossman	NN	O
was	VBD	O
transferred	VBN	O
to	TO	O
3	CD	O
north	NN	O
where	WRB	O
she	PRP	O
continued	VBD	O
to	TO	O
progress	VB	O
well	RB	O
with	IN	O
pt	NN	B-TREATMENT
,	,	O
increasing	VBG	O
po	JJ	O
intake	NN	O
,	,	O
tolerating	VBG	O
tf	NN	B-TREATMENT
s,	NN	I-TREATMENT
and	CC	O
weaning	VBG	O
from	IN	O
nasal	JJ	B-TREATMENT
cannula	NN	I-TREATMENT
oxygen	NN	I-TREATMENT
.	.	O

she	PRP	O
has	VBZ	O
remained	VBN	O
stable	JJ	O
with	IN	O
no	DT	O
acute	JJ	B-PROBLEM
events	NNS	I-PROBLEM
.	.	O

norvasc	NN	B-TREATMENT

atenolol	NN	B-TREATMENT

isosorbide	NN	B-TREATMENT

lasix	NN	B-TREATMENT

insulin	NN	B-TREATMENT

1.	CD	O
heparin	NN	B-TREATMENT
(	(	I-TREATMENT
porcine	NN	I-TREATMENT
)	)	I-TREATMENT
5,000	CD	O
unit	NN	O
/	NNP	O
ml	NN	O
solution	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
ml	NN	O
injection	NN	O
tid	NN	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

2.	CD	O
acetaminophen	JJ	B-TREATMENT
325	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
1-2	JJ	O
tablets	NNS	O
po	JJ	O
q4-6h	JJ	O
(	(	O
every	DT	O
4	CD	O
to	TO	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

3.	CD	O
polyvinyl	NN	B-TREATMENT
alcohol	NN	I-TREATMENT
-	:	O
povidone	NN	B-TREATMENT
1.4-0.6	CD	O
%	NN	O
dropperette	NN	O
sig	NN	O
:	:	O
02-25	JJ	O
drops	NNS	O
ophthalmic	JJ	O
prn	NN	O
(	(	O
as	IN	O
needed	VBN	O
).	NN	O

4.	CD	O
metoprolol	JJ	B-TREATMENT
tartrate	NN	I-TREATMENT
25	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
tid	NN	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

5.	CD	O
aspirin	JJ	B-TREATMENT
81	CD	O
mg	JJ	O
tablet	NN	O
,	,	O
chewable	JJ	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
chewable	JJ	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

6.	CD	O
atorvastatin	JJ	B-TREATMENT
10	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

7.	CD	O
lisinopril	JJ	B-TREATMENT
5	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
0.5	CD	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

8.	CD	O
furosemide	JJ	B-TREATMENT
40	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
1.5	CD	O
tablets	NNS	O
po	JJ	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

9.	CD	O
ipratropium	NN	B-TREATMENT
bromide	NN	I-TREATMENT
17	CD	O
mcg	NN	O
/	NNP	O
actuation	NN	O
aerosol	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
puff	NN	O
inhalation	NN	O
q4-6h	NN	O
(	(	O
every	DT	O
4	CD	O
to	TO	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

10.	CD	O
albuterol	NN	B-TREATMENT
90	CD	O
mcg	NN	O
/	NNP	O
actuation	NN	O
aerosol	NN	O
sig	NN	O
:	:	O
1-2	JJ	O
puffs	NNS	O
inhalation	NN	O
q6h	NN	O
(	(	O
every	DT	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

11.	CD	O
oxycodone	NN	B-TREATMENT
5	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
q4-6h	NN	O
(	(	O
every	DT	O
4	CD	O
to	TO	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
pain	NN	B-PROBLEM
.	.	O

12.	CD	O
docusate	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
100	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

13.	CD	O
potassium	NN	B-TREATMENT
chloride	NN	I-TREATMENT
20	CD	O
meq	NN	O
tab	NN	O
sust	NN	O
.	.	O
rel	NN	O
.	.	O
particle	NN	O
/	JJ	O
crystal	JJ	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tab	NN	O
sust	NN	O
.	.	O
rel	NN	O
.	.	O
particle	NN	O
/	JJ	O
crystal	JJ	O
po	NN	O
once	RB	O
a	DT	O
day	NN	O
.	.	O

14.	CD	O
glargine	JJ	B-TREATMENT
sig	NN	O
:	:	O
twenty	NN	O
two	CD	O
(	(	O
22	CD	O
)	)	O
units	NNS	O
at	IN	O
bedtime	NN	O
.	.	O

15.	CD	O
miconazole	JJ	B-TREATMENT
nitrate	RB	I-TREATMENT
2	CD	O
%	NN	O
powder	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
appl	RB	O
topical	JJ	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

16.	CD	O
miconazole	JJ	B-TREATMENT
nitrate	RB	I-TREATMENT
2	CD	O
%	NN	O
cream	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
appl	RB	O
topical	JJ	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

17.	CD	O
ibuprofen	JJ	B-TREATMENT
100	CD	O
mg/5	NN	O
ml	NN	O
suspension	NN	O
sig	NN	O
:	:	O
twenty	NN	O
(	(	O
20	CD	O
)	)	O
ml	NN	O
po	NN	O
q8h	NN	O
(	(	O
every	DT	O
8	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

18.	CD	O
debrox	JJ	B-TREATMENT
6.5	CD	O
%	NN	O
drops	JJ	O
sig	NN	O
:	:	O
five	CD	O
(	(	O
5	CD	O
)	)	O
drop	NN	O
otic	JJ	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
for	IN	O
5	CD	O
days	NNS	O
:	:	O
both	DT	O
ears	NNS	O
.	.	O

19.	CD	O
trazodone	NN	B-TREATMENT
50	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
1	CD	O
/	IN	O
2-1	JJ	O
tablet	NN	O
po	NN	O
hs	NN	O
(	(	O
at	IN	O
bedtime	NN	O
).	NN	O

hurtado	NN	B-PROBLEM
colon	NN	I-PROBLEM

diverticulitis	NN	B-PROBLEM

s/p	JJ	O
subtotal	JJ	B-TREATMENT
colectomy	NN	I-TREATMENT
,	,	O
ileostomy	NN	B-TREATMENT
,	,	O
gastrostomy	NN	B-TREATMENT
tube	NN	I-TREATMENT

s/p	JJ	O
exploratory	NN	B-TEST
laparotomy	NN	I-TEST
,	,	O
resection	NN	B-TREATMENT
of	IN	I-TREATMENT
small	JJ	I-TREATMENT
intestine	NN	I-TREATMENT
with	IN	O
primary	JJ	B-TREATMENT
anastomosis	NN	I-TREATMENT
,	,	O
sigmoid	JJ	B-TREATMENT
colectomy	NN	I-TREATMENT
,	,	O
repair	NN	B-TREATMENT
of	IN	O
colovesicular	JJ	B-PROBLEM
fistula	NN	I-PROBLEM

unstable	JJ	B-PROBLEM
angina	NN	I-PROBLEM

please	VB	O
call	VB	O
the	DT	O
surgeon	NN	O
or	CC	O
return	NN	O
to	TO	O
the	DT	O
emergency	NN	O
department	NN	O
if	IN	O
you	PRP	O
develop	VBP	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
fever	RB	B-PROBLEM
greater	JJR	I-PROBLEM
than	IN	I-PROBLEM
101.5	CD	I-PROBLEM
,	,	O
foul	JJ	B-PROBLEM
smelling	NN	I-PROBLEM
or	CC	I-PROBLEM
colorful	JJ	I-PROBLEM
drainage	NN	I-PROBLEM
from	IN	O
your	PRP$	B-PROBLEM
incisions	NNS	I-PROBLEM
,	,	O
redness	NN	B-PROBLEM
or	CC	O
swelling	NN	B-PROBLEM
,	,	O
severe	JJ	B-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
or	CC	O
distention	NN	B-PROBLEM
,	,	O
persistent	JJ	B-PROBLEM
nausea	NN	I-PROBLEM
or	CC	O
vomiting	NN	B-PROBLEM
,	,	O
inability	NN	B-PROBLEM
to	TO	I-PROBLEM
eat	VB	I-PROBLEM
or	CC	I-PROBLEM
drink	VB	I-PROBLEM
,	,	O
or	CC	O
any	DT	O

other	JJ	B-PROBLEM
symptoms	NNS	I-PROBLEM
which	WDT	O
are	VBP	O
concerning	VBG	O
to	TO	O
you	PRP	O
.	.	O

if	IN	O
there	EX	O
is	VBZ	O
clear	JJ	B-PROBLEM
drainage	NN	I-PROBLEM
from	IN	O
your	PRP$	B-PROBLEM
incisions	NNS	I-PROBLEM
,	,	O
cover	NN	O
with	IN	O
a	DT	B-TREATMENT
dry	JJ	I-TREATMENT
dressing	NN	I-TREATMENT
.	.	O

leave	VB	O
white	JJ	B-TREATMENT
strips	NNS	I-TREATMENT
above	IN	O
your	PRP$	B-PROBLEM
incisions	NNS	I-PROBLEM
in	IN	O
place	NN	O
,	,	O
allow	VB	O
them	PRP	O
to	TO	O
fall	VB	O
off	RP	O
on	IN	O
their	PRP$	O
own	JJ	O
.	.	O

medications	NNS	O
:	:	O
resume	VB	O
your	PRP$	O
home	NN	B-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

you	PRP	O
should	MD	O
take	VB	O
a	DT	B-TREATMENT
stool	NN	I-TREATMENT
softener	NN	I-TREATMENT
,	,	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
twice	RB	O
daily	RB	O
as	IN	O
needed	VBN	O
for	IN	O
constipation	NN	B-PROBLEM
.	.	O

you	PRP	O
will	MD	O
be	VB	O
given	VBN	O
pain	JJ	B-TREATMENT
medication	NN	I-TREATMENT
which	WDT	O
may	MD	O
make	VB	O
you	PRP	O
drowsy	VB	B-PROBLEM
.	.	O

patient	NN	O
recorded	VBD	O
as	IN	O
having	VBG	O
no	DT	O
known	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM
to	TO	I-PROBLEM
drugs	NNS	I-PROBLEM

overdose	NN	B-PROBLEM

ng	NNS	B-TREATMENT
tube	NN	I-TREATMENT

mr.	NN	O
vazquez	NN	O
is	VBZ	O
a	DT	O
48	CD	O
year	NN	O
old	JJ	O
man	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
hepatitis	NN	B-PROBLEM
c	NN	I-PROBLEM
,	,	O
bipolar	JJ	B-PROBLEM
disorder	NN	I-PROBLEM
with	IN	O
suicide	JJ	O
attempts	NNS	O
in	IN	O
the	DT	O
past	NN	O
,	,	O
recent	JJ	O
cmed	VBD	O
admit	NN	O
earlier	RBR	O
in	IN	O
4/05	CD	O
who	WP	O
was	VBD	O
found	VBN	O
alert	RB	O
approximately	RB	O
one	CD	O
hour	NN	O
after	IN	O
taking	VBG	O
an	DT	O
unspecified	JJ	O
number	NN	O
of	IN	O
pills	NNS	B-TREATMENT
.	.	O

per	IN	O
report	NN	O
,	,	O
there	EX	O
were	VBD	O
empty	JJ	O
bottles	NNS	O
of	IN	O
inderal	JJ	B-TREATMENT
and	CC	O
klonopin	VB	B-TREATMENT
found	VBN	O
at	IN	O
bedside	RB	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
02-26	JJ	O
full	JJ	O
bottles	NNS	O
of	IN	O
geodon	NN	B-TREATMENT
,	,	O
gabapentin	NN	B-TREATMENT
,	,	O
lescol	NN	B-TREATMENT
and	CC	O
paroxitine	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
reportedly	RB	O
alert	JJ	O
at	IN	O
scene	NN	O
,	,	O
and	CC	O
then	RB	O
became	VBD	O
unresponsive	JJ	B-PROBLEM
in	IN	O
route	NN	O
to	TO	O
the	DT	O
hospital	NN	O
.	.	O

in	IN	O
the	DT	O
rita	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
intubated	VBN	O
and	CC	O
given	VBN	O
activated	JJ	B-TREATMENT
charcoal	NN	I-TREATMENT
.	.	O

his	PRP$	B-TEST
initial	JJ	I-TEST
bp	NN	I-TEST
was	VBD	O
60/p	CD	O
with	IN	O
a	DT	B-TEST
pulse	NN	I-TEST
in	IN	O
the	DT	O
60	CD	O
s.	NN	O

he	PRP	O
was	VBD	O
given	VBN	O
4	CD	O
amps	NNS	O
of	IN	O
calcium	NN	B-TREATMENT
gluconate	NN	I-TREATMENT
,	,	O
and	CC	O
started	VBD	O
on	IN	O
a	DT	B-TREATMENT
calcium	NN	I-TREATMENT
gtt	NN	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
also	RB	O
given	VBN	O
5mg	CD	O
of	IN	O
glucagon	NN	B-TREATMENT
and	CC	O
started	VBD	O
on	IN	O
a	DT	B-TREATMENT
glucagon	NN	I-TREATMENT
drip	NN	I-TREATMENT
with	IN	O
good	JJ	O
response	NN	O
.	.	O

his	PRP$	B-TEST
urine	NN	I-TEST
and	CC	O
serum	NN	B-TEST
tox	NN	I-TEST
screens	NNS	I-TEST
were	VBD	O
notable	JJ	O
only	RB	O
for	IN	O
benzos	NN	B-TREATMENT
,	,	O
otherwise	RB	O
negative	JJ	O
.	.	O

he	PRP	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
cmed	VBN	O
,	,	O
intubated	VBN	O
for	IN	O
airway	NN	B-TREATMENT
protection	NN	I-TREATMENT
and	CC	O
started	VBN	O
on	IN	O
both	DT	O
a	DT	B-TREATMENT
calcium	NN	I-TREATMENT
and	CC	I-TREATMENT
glucagon	NN	I-TREATMENT
drip	NN	I-TREATMENT
.	.	O

there	EX	O
was	VBD	O
evidence	NN	O
of	IN	O
possible	JJ	O
aspiration	NN	B-PROBLEM
pneumonia	NN	I-PROBLEM
on	IN	O
cxr	NN	B-TEST
,	,	O
though	IN	O
he	PRP	O
was	VBD	O
extubated	VBN	O
without	IN	O
incident	NN	O
on	IN	O
the	DT	O
am	VBP	O
of	IN	O
transfer	NN	O
to	TO	O
the	DT	O
medicine	NN	O
floor	NN	O
.	.	O

hep	NN	B-PROBLEM
c	NN	I-PROBLEM

bipolar	JJ	B-PROBLEM
d/o	NN	I-PROBLEM
with	IN	O
one	CD	O
suicide	NN	O
attempt	NN	O
by	IN	O
overdose	JJ	B-PROBLEM
several	JJ	O
years	NNS	O
ago	RB	O

agoraphobia	NN	B-PROBLEM

panic	JJ	B-PROBLEM
disorder	NN	I-PROBLEM

narcissism	NN	B-PROBLEM

no	DT	O
history	NN	O
of	IN	O
head	NN	B-PROBLEM
trauma	NN	I-PROBLEM
or	CC	O
seizure	NN	B-PROBLEM
disorder	NN	I-PROBLEM

reports	NNS	O
that	IN	O
he	PRP	O
has	VBZ	O
suffered	VBN	O
from	IN	O
anxiety	NN	B-PROBLEM
since	IN	O
childhood	NN	O
and	CC	O
needed	VBN	O
to	TO	O
drop	VB	O
out	IN	O
of	IN	O
college	NN	O
.	.	O

vitals	NNS	B-TEST
:	:	O
99.3	CD	O
67	CD	O
(	(	O
60-70	JJ	O
)	)	O
99/53	CD	O
(	(	O
90-100	CD	O
s)	NN	O
96%	CD	O
on	IN	O
ra	NN	O
3.7l	CD	O
+	NN	O
los	NN	O

gen	NN	O
:	:	O
caucasian	JJ	O
man	NN	O
lying	VBG	O
in	IN	O
bed	NN	O
,	,	O
nad	NN	B-PROBLEM

heent	NN	O
:	:	O
ncat	NN	O
,	,	O
perrl	NN	O
,	,	O
eomi	NN	O
,	,	O
no	DT	O
icterus	NN	B-PROBLEM
,	,	O
op	JJ	O
clear	JJ	O
,	,	O
mmm	NN	O
,	,	O
no	DT	O
tongue	NN	B-PROBLEM
fasciculations	NNS	I-PROBLEM

neck	NN	O
:	:	O
supple	NN	O
,	,	O
no	DT	O
lad	NN	B-PROBLEM
,	,	O
no	DT	O
jvd	NN	B-PROBLEM

cv	NN	O
:	:	O
rrr	NN	O
,	,	O
nl	JJ	O
s1	NN	O
s2	NN	O
,	,	O
no	DT	O
m/g/r	NN	B-PROBLEM

lungs	NNS	O
:	:	O
?	.	O
decreased	VBD	B-PROBLEM
bs	NN	I-PROBLEM
over	IN	I-PROBLEM
left	JJ	I-PROBLEM
middle	JJ	I-PROBLEM
lung	NN	I-PROBLEM
,	,	O
otherwise	RB	O
cta	NN	O

abd	NN	O
:	:	O
normal	JJ	O
size	NN	O
,	,	O
nd	RB	B-PROBLEM
,	,	O
no	DT	O
scars	NNS	B-PROBLEM
,	,	O
nl	JJ	O
bs	NN	O
,	,	O
soft	JJ	O
,	,	O
nt	JJ	B-PROBLEM
,	,	O
palp	JJ	O
liver	NN	O

ext	NN	O
:	:	O
no	DT	O
c/c/e	NN	B-PROBLEM
,	,	O
no	DT	O
edema	NN	B-PROBLEM

neuro	NN	O
:	:	O
no	DT	O
asterixis	NN	B-PROBLEM
,	,	O
cn	JJ	O
ii-xii	JJ	O
intact	NN	O
,	,	O
5/5	CD	O
strength	NN	O
throughout	IN	O
,	,	O
sensation	NN	O
to	TO	O
lt	VB	B-TEST
intact	JJ	O
throughout	IN	O
,	,	O
gait	NN	O
deferred	VBD	O

cmed	VBN	O
:	:	O
a+ox3	NN	O
,	,	O
mood	NN	O
"	NNP	O
great	JJ	O
,"	NNP	O
affect	NN	O
approp	NN	O
,	,	O
speech	NN	B-PROBLEM
stuttering	NN	I-PROBLEM
,	,	O
linear	JJ	O
tp	NN	O
,	,	O
no	DT	O
si	NN	B-PROBLEM
or	CC	O
hi	NN	B-PROBLEM

2012-06-07	JJ	O
09:55	CD	O
pm	NN	O
blood	NN	B-TEST
wbc	SYM	B-TEST
-	:	O
8.9	CD	O
rbc	NN	B-TEST
-	:	O
4.94	CD	O
hgb	NN	B-TEST
-	:	O
15.8	CD	O
hct	NN	B-TEST
-	:	O
45.3	CD	O
mcv	SYM	B-TEST
-	:	O
92	CD	O
mch	SYM	B-TEST
-	:	O
31.9	CD	O
mchc	SYM	B-TEST
-	:	O
34.8	CD	O
rdw	NN	B-TEST
-	:	O
12.4	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
175	CD	O

2012-06-07	JJ	O
09:55	CD	O
pm	NN	O
blood	NN	B-TEST
neuts	NNS	B-TEST
-	:	O
49.9	CD	O
*	NN	O
lymphs	SYM	B-TEST
-	:	O
42.4	CD	O
*	JJ	O
monos	NNS	B-TEST
-	:	O
5.5	CD	O
eos	SYM	B-TEST
-	:	O
1.6	CD	O
baso	SYM	B-TEST
-	:	O
0.6	CD	O

2012-06-07	JJ	O
09:55	CD	O
pm	NN	O
blood	NN	B-TEST
plt	NN	B-TEST
ct	VBD	I-TEST
-	:	O
175	CD	O

2012-06-07	JJ	O
09:55	CD	O
pm	NN	O
blood	NN	B-TEST
pt	NN	B-TEST
-	:	O
12.8	CD	O
ptt	NN	B-TEST
-	:	O
25.7	CD	O
inr(pt)	JJ	B-TEST
-	:	O
1.0	CD	O

2012-06-07	JJ	O
09:55	CD	O
pm	NN	O
blood	NN	B-TEST
glucose	VB	B-TEST
-	:	O
108	CD	O
*	JJ	O
urean	JJ	B-TEST
-	:	O
13	CD	O
creat	NN	B-TEST
-	:	O
0.7	CD	O
na	SYM	B-TEST
-	:	O
146	CD	O
*	NN	O
k	SYM	B-TEST
-	:	O
3.7	CD	O
cl	NN	B-TEST
-	:	O
109	CD	O
*	NN	O
hco3	NN	B-TEST
-	:	O
30	CD	O
*	NN	O
angap	NN	B-TEST
-	:	O
11	CD	O

2012-06-07	JJ	O
09:55	CD	O
pm	NN	O
blood	NN	B-TEST
albumin	SYM	B-TEST
-	:	O
3.9	CD	O
calcium	NN	B-TEST
-	:	O
8.5	CD	O
phos	NN	B-TEST
-	:	O
4.2	CD	O
mg	SYM	B-TEST
-	:	O
2.0	CD	O

2012-06-07	JJ	O
09:55	CD	O
pm	NN	O
blood	NN	B-TEST
alt	SYM	B-TEST
-	:	O
44	CD	O
*	NN	O
ast	VBD	B-TEST
-	:	O
31	CD	O
alkphos	SYM	B-TEST
-	:	O
36	CD	O
*	NN	O
totbili	SYM	B-TEST
-	:	O
0.2	CD	O

2012-06-07	JJ	O
09:55	CD	O
pm	NN	O
blood	NN	B-TEST
asa	SYM	B-TEST
-	:	O
neg	NN	O
ethanol	SYM	B-TEST
-	:	O
neg	NN	O
acetmnp	SYM	B-TEST
-	:	O
neg	NN	O
bnzodzp	SYM	B-TEST
-	:	O
neg	NN	O
barbitr	SYM	B-TEST
-	:	O
neg	NN	O
tricycl	SYM	B-TEST
-	:	O
neg	NN	O

2012-06-08	JJ	O
09:30	CD	O
am	VBP	O
blood	NN	B-TEST
wbc	NN	B-TEST
-	:	O
10.1	CD	O
rbc	NN	B-TEST
-	:	O
4.35	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
14.2	CD	O
hct	NN	B-TEST
-	:	O
39.9	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
92	CD	O
mch	SYM	B-TEST
-	:	O
32.6	CD	O
*	NN	O
mchc	SYM	B-TEST
-	:	O
35.6	CD	O
*	NN	O
rdw	NN	B-TEST
-	:	O
12.4	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
151	CD	O

2012-06-08	JJ	O
09:30	CD	O
am	VBP	O
blood	NN	B-TEST
glucose	JJ	B-TEST
-	:	O
115	CD	O
*	JJ	O
urean	JJ	B-TEST
-	:	O
14	CD	O
creat	NN	B-TEST
-	:	O
0.8	CD	O
na	SYM	B-TEST
-	:	O
142	CD	O
k	SYM	B-TEST
-	:	O
4.1	CD	O
cl	NN	B-TEST
-	:	O
112	CD	O
*	NN	O
hco3	NN	B-TEST
-	:	O
26	CD	O
angap	NN	B-TEST
-	:	O
8	CD	O

2012-06-08	JJ	O
09:30	CD	O
am	VBP	O
blood	NN	B-TEST
calcium	NN	B-TEST
-	:	O
10.4	CD	O
*	NN	O
phos	NN	B-TEST
-	:	O
2.8	CD	O
mg	SYM	B-TEST
-	:	O
1.8	CD	O

cxr	NN	B-TEST
:	:	O

an	DT	B-TREATMENT
endotracheal	JJ	I-TREATMENT
tube	NN	I-TREATMENT
terminates	VBZ	O
just	RB	O
above	IN	O
the	DT	O
thoracic	JJ	O
inlet	NN	O
approximately	RB	O
6.5	CD	O
cm	NNS	O
above	IN	O
the	DT	O
carina	NN	O
.	.	O

the	DT	B-TREATMENT
nasogastric	JJ	I-TREATMENT
tube	NN	I-TREATMENT
terminates	NNS	O
within	IN	O
the	DT	O
stomach	NN	O
.	.	O

there	EX	O
is	VBZ	O
a	DT	B-PROBLEM
patchy	JJ	I-PROBLEM
area	NN	I-PROBLEM
of	IN	I-PROBLEM
increased	JJ	I-PROBLEM
opacity	NN	I-PROBLEM
in	IN	O
the	DT	O
left	JJ	O
retrocardiac	JJ	O
region	NN	O
,	,	O
which	WDT	O
was	VBD	O
not	RB	O
seen	VBN	O
on	IN	O
the	DT	B-TEST
earlier	JJR	I-TEST
study	NN	I-TEST
.	.	O

left	VBN	O
costophrenic	JJ	O
angle	NN	O
has	VBZ	O
been	VBN	O
excluded	VBN	O
from	IN	O
the	DT	B-TEST
study	NN	I-TEST
and	CC	O
cannot	NN	O
be	VB	O
assessed	VBN	O
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
evidence	NN	O
of	IN	O
right	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
or	CC	O
right	JJ	B-PROBLEM
pneumothorax	NN	I-PROBLEM
.	.	O

1)	CD	O
endotracheal	JJ	B-TREATMENT
tube	NN	I-TREATMENT
is	VBZ	O
slightly	RB	O
proximal	JJ	O
in	IN	O
location	NN	O
,	,	O
and	CC	O
could	MD	O
be	VB	O
advanced	VBN	O
approximately	RB	O
1.5	CD	O
cm	NN	O
for	IN	O
more	JJR	O
optimal	JJ	O
placement	NN	O
.	.	O

2)	CD	O
patchy	NN	B-PROBLEM
left	VBD	I-PROBLEM
retrocardiac	JJ	I-PROBLEM
opacity	NN	I-PROBLEM
which	WDT	O
may	MD	O
be	VB	O
due	JJ	O
to	TO	O
patchy	VB	B-PROBLEM
atelectasis	NN	I-PROBLEM
,	,	O
aspiration	NN	B-PROBLEM
,	,	O
or	CC	O
early	RB	B-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

followup	NN	B-TEST
radiograph	NN	I-TEST
suggested	VBD	O

a/p	NN	O
:	:	O
48yo	CD	O
man	NN	O
with	IN	O
h/o	JJ	O
hcv	NN	B-PROBLEM
,	,	O
bipolar	JJ	B-PROBLEM
do	VBP	I-PROBLEM
,	,	O
h/o	VB	O
suicide	NN	O
attempts	NNS	O
,	,	O
a/w	VBP	O
overdose	NN	B-PROBLEM
of	IN	O
inderal	JJ	B-TREATMENT
,	,	O
klonopin	NN	B-TREATMENT
,	,	O
geodon	NN	B-TREATMENT
,	,	O
s/t	NN	O
jackson	NN	O
stay	NN	O
with	IN	O
intubation	NN	B-TREATMENT
for	IN	O
airway	NN	B-TREATMENT
protection	NN	I-TREATMENT
,	,	O
with	IN	O
question	NN	O
of	IN	O
l	NN	B-PROBLEM
retrocardiac	NN	I-PROBLEM
infiltrate	NN	I-PROBLEM
,	,	O
now	RB	O
doing	VBG	O
well	RB	O
.	.	O

-	:	O
monitor	NN	O
on	IN	O
tele	NN	B-TEST
overnight	NN	O

-	:	O
if	IN	O
hr	JJ	B-TEST
drops	NNS	O
,	,	O
restart	NN	O
glucagon	NN	B-TREATMENT
gtt	NN	I-TREATMENT

-	:	O
watch	NN	O
for	IN	O
bzd	NN	B-PROBLEM
withdrawal	NN	I-PROBLEM
,	,	O
agitation	NN	B-PROBLEM

bipolar	JJ	B-PROBLEM
disorder	NN	I-PROBLEM
:	:	O

-	:	O
suicide	NN	B-TREATMENT
precautions	NNS	I-TREATMENT

ppx	NN	O
:	:	O
sc	NN	B-TREATMENT
heparin	NN	I-TREATMENT
,	,	O
bowel	NN	B-TREATMENT
regimen	NNS	I-TREATMENT
,	,	O
nicotine	JJ	B-TREATMENT
patch	NN	I-TREATMENT

neurontin	RB	B-TREATMENT
800	CD	O
mg	NNS	O
tid	NN	O

ziprasidone	CD	B-TREATMENT
bid	NN	O

propanolol	NN	B-TREATMENT
20	CD	O
mg	NN	O
tid	NN	O

klonopin	NN	B-TREATMENT
2	CD	O
mg	NN	O
tid	NN	O

paxil	NN	B-TREATMENT
30	CD	O
mg	NN	O
qd	NN	O

protonix	NN	B-TREATMENT
40	CD	O
mg	NN	O
qd	NN	O

folate	NN	B-TREATMENT
1	CD	O
mg	NN	O
qd	NN	O

lescol	RB	B-TREATMENT
40	CD	O
qd	NN	O

depression	NN	B-PROBLEM

depressed	JJ	B-PROBLEM

the	DT	O
patient	NN	O
was	VBD	O
referred	VBN	O
from	IN	O
an	DT	O
outside	JJ	O
hospital	NN	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
increasing	VBG	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
and	CC	O
tires	NNS	B-PROBLEM
easily	RB	I-PROBLEM
with	IN	O
exertion	NN	O
.	.	O

admitted	VBN	O
to	TO	O
bay	VB	O
state	NN	O
medical	JJ	O
center	NN	O
hospital	NN	O
in	IN	O
2012-10-22	JJ	O
in	IN	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
at	IN	O
that	DT	O
time	NN	O
.	.	O

via	IN	O
echocardiogram	NN	B-TEST
,	,	O
found	VBN	O
to	TO	O
have	VB	O
aortic	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

referred	VBN	O
to	TO	O
memorial	JJ	O
hospital	NN	O
(	(	O
worcester	NN	O
)	)	O
for	IN	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
to	TO	O
further	JJ	O
evaluate	VB	O
her	PRP$	B-PROBLEM
aortic	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

cardiac	JJ	B-TEST
catheterization	NN	I-TEST
done	VBN	O
on	IN	O
01-07	NN	O
showed	VBD	O
an	DT	B-TEST
aortic	JJ	I-TEST
valve	NN	I-TEST
area	NN	I-TEST
of	IN	O
.38	NNP	O
cm.sq.	NN	O
,	,	O
with	IN	O
a	DT	B-TEST
mean	JJ	I-TEST
gradient	NN	I-TEST
of	IN	O
62	CD	O
,	,	O
and	CC	O
a	DT	B-TEST
peak	JJ	I-TEST
gradient	NN	I-TEST
of	IN	O
85	CD	O
.	.	O

moderate	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
hypertension	NN	I-PROBLEM
,	,	O
pa	JJ	B-TEST
pressure	NN	I-TEST
48/24	CD	O
,	,	O
1+	CD	B-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
,	,	O
severe	JJ	B-PROBLEM
aortic	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
with	IN	O
an	DT	B-TEST
lvedp	NN	I-TEST
of	IN	O
19	CD	O
and	CC	O
an	DT	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
of	IN	O
43%	CD	O
.	.	O

she	PRP	O
was	VBD	O
then	RB	O
referred	VBN	O
to	TO	O
cardiothoracic	VB	O
surgery	NN	O
for	IN	O
aortic	JJ	B-TREATMENT
valve	NN	I-TREATMENT
replacement	NN	I-TREATMENT
.	.	O

1.	CD	O
aortic	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM

2.	CD	O
diabetes	NNS	B-PROBLEM
mellitus	VBP	I-PROBLEM
type	NN	I-PROBLEM
2	CD	I-PROBLEM

3.	CD	O
right	JJ	B-TREATMENT
hip	NN	I-TREATMENT
replacement	NN	I-TREATMENT

4.	CD	O
noninsulin	JJ	B-PROBLEM
dependent	NN	I-PROBLEM
diabetes	VBZ	I-PROBLEM
mellitus	NNS	I-PROBLEM

include	NN	O
glucovance	NN	B-TREATMENT
5/500	CD	O
one	CD	O
tablet	NN	O
twice	RB	O
a	DT	O
day	NN	O
,	,	O
univasc	JJ	B-TREATMENT
7.5	CD	O
mg	NN	O
once	RB	O
daily	JJ	O
,	,	O
lasix	JJ	B-TREATMENT
20	CD	O
mg	NN	O
every	DT	O
other	JJ	O
day	NN	O
,	,	O
and	CC	O
aspirin	RB	B-TREATMENT
325	CD	O
mg	NNS	O
once	RB	O
daily	RB	O
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

significant	JJ	O
for	IN	O
her	PRP$	O
father	NN	O
,	,	O
who	WP	O
died	VBD	O
at	IN	O
50	CD	O
years	NNS	O
from	IN	O
myocarditis	NN	B-PROBLEM
.	.	O

heart	NN	B-TEST
rate	NN	I-TEST
108	CD	O
and	CC	O
regular	JJ	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
145/76	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
20	CD	O
,	,	O
height	VBD	B-TEST
5'2"	CD	O
,	,	O
weight	VBD	B-TEST
141	CD	O
pounds	NNS	O
.	.	O

healthy-appearing	JJ	O
woman	NN	O
,	,	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

no	DT	O
lesions	NNS	B-PROBLEM
or	CC	O
rashes	NNS	B-PROBLEM
.	.	O

pupils	NNS	O
equal	JJ	O
,	,	O
round	NN	O
and	CC	O
reactive	JJ	O
to	TO	O
light	JJ	O
,	,	O
extraocular	JJ	O
movements	NNS	O
intact	JJ	O
,	,	O
anicteric	JJ	B-PROBLEM
,	,	O
not	RB	O
injected	VBN	B-PROBLEM
.	.	O

supple	NN	O
,	,	O
no	DT	O
lymphadenopathy	NN	B-PROBLEM
,	,	O
no	DT	O
jugular	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
distention	NN	I-PROBLEM
,	,	O
no	DT	O
thyromegaly	NN	B-PROBLEM
.	.	O

clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
.	.	O

regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
,	,	O
s1	NN	O
,	,	O
s2	NN	O
,	,	O
with	IN	O
iii/vi	JJ	B-PROBLEM
blowing	VBG	I-PROBLEM
murmur	NN	I-PROBLEM
.	.	O

soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBD	B-PROBLEM
,	,	O
normal	JJ	O
active	JJ	O
bowel	NN	O
sounds	NNS	O
,	,	O
no	DT	O
hepatosplenomegaly	NN	B-PROBLEM
.	.	O

warm	NN	O
and	CC	O
well	RB	O
perfused	VBN	O
,	,	O
with	IN	O
no	DT	O
cyanosis	NN	B-PROBLEM
,	,	O
clubbing	VBG	B-PROBLEM
or	CC	O
edema	NN	B-PROBLEM
,	,	O
no	DT	O
varicosities	NNS	B-PROBLEM
.	.	O

strength	NN	B-TEST
5/5	CD	O
in	IN	O
upper	JJ	O
and	CC	O
lower	JJR	O
extremities	NNS	O
.	.	O

pulses	NNS	B-TEST
:	:	O

femoral	JJ	B-TEST
2	CD	O
+	NNP	O
bilaterally	RB	O
,	,	O
dorsalis	NNS	B-TEST
pedis	VBP	I-TEST
1	CD	O
+	NNP	O
bilaterally	RB	O
,	,	O
posterior	JJ	B-TEST
tibial	JJ	I-TEST
1	CD	O
+	NNP	O
bilaterally	RB	O
,	,	O
and	CC	O
radial	JJ	B-TEST
2	CD	O
+	NNP	O
bilaterally	RB	O
.	.	O

no	DT	O
carotid	NN	B-PROBLEM
bruits	NNS	I-PROBLEM
were	VBD	O
noted	VBN	O
.	.	O

white	JJ	B-TEST
count	NN	I-TEST
5.3	CD	O
,	,	O
hematocrit	NN	B-TEST
43	CD	O
,	,	O
platelets	NNS	B-TEST
200	CD	O
.	.	O

sodium	NN	B-TEST
138	CD	O
,	,	O
potassium	NN	B-TEST
4.9	CD	O
,	,	O
chloride	RB	B-TEST
102	CD	O
,	,	O
co2	NN	B-TEST
25	CD	O
,	,	O
bun	NN	B-TEST
24	CD	O
,	,	O
creatinine	NN	B-TEST
0.9	CD	O
,	,	O
glucose	VBD	B-TEST
309	CD	O
.	.	O

electrocardiogram	NN	B-TEST
:	:	O

rate	NN	B-TEST
of	IN	O
91	CD	O
,	,	O
first	RB	B-PROBLEM
degree	JJ	I-PROBLEM
av	NN	I-PROBLEM
block	NN	I-PROBLEM
,	,	O
intervals	NNS	B-TEST
.22	VBP	O
,	,	O
.92	NNP	O
,	,	O
.36	NNP	O
,	,	O
with	IN	O
left	JJ	B-PROBLEM
ventricular	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
.	.	O

chest	JJ	B-TEST
x-ray	NN	I-TEST
is	VBZ	O
pending	VBG	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
physical	JJ	B-TEST
.	.	O

aortic	JJ	B-TREATMENT
valve	NN	I-TREATMENT
replacement	NN	I-TREATMENT
.	.	O

in	IN	O
summary	JJ	O
,	,	O
she	PRP	O
had	VBD	O
an	DT	B-TREATMENT
aortic	JJ	I-TREATMENT
valve	NN	I-TREATMENT
replacement	NN	I-TREATMENT
with	IN	O
a	DT	B-TREATMENT
#21	JJ	I-TREATMENT
mosaic	NN	I-TREATMENT
porcine	NN	I-TREATMENT
valve	NN	I-TREATMENT
.	.	O

she	PRP	O
tolerated	VBD	O
the	DT	B-TREATMENT
operation	NN	I-TREATMENT
well	RB	O
,	,	O
and	CC	O
was	VBD	O
transferred	VBN	O
from	IN	O
the	DT	O
operating	NN	O
room	NN	O
to	TO	O
the	DT	O
cardiothoracic	NN	O
intensive	JJ	O
care	NN	O
unit	NN	O
.	.	O

the	DT	O
patient	NN	O
did	VBD	O
well	RB	O
in	IN	O
the	DT	O
immediate	JJ	O
postoperative	JJ	O
period	NN	O
,	,	O
however	RB	O
,	,	O
her	PRP	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
remained	VBD	O
somewhat	RB	B-PROBLEM
labile	JJ	I-PROBLEM
.	.	O

therefore	RB	O
,	,	O
she	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
a	DT	B-TREATMENT
neo-synephrine	JJ	I-TREATMENT
drip	NN	I-TREATMENT
to	TO	O
maintain	VB	O
a	DT	B-TEST
systolic	JJ	I-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
greater	JJR	O
than	IN	O
110	CD	O
.	.	O

in	IN	O
addition	NN	O
,	,	O
she	PRP	O
was	VBD	O
slow	JJ	O
to	TO	O
awaken	VB	O
after	IN	O
her	PRP$	B-TREATMENT
anesthesia	NN	I-TREATMENT
was	VBD	O
reversed	VBN	O
,	,	O
and	CC	O
in	IN	O
several	JJ	O
attempts	NNS	O
to	TO	O
wean	VB	O
from	IN	O
the	DT	B-TREATMENT
ventilator	NN	I-TREATMENT
,	,	O
she	PRP	O
developed	VBD	O
a	DT	B-PROBLEM
respiratory	JJ	I-PROBLEM
acidosis	NN	I-PROBLEM
.	.	O

she	PRP	O
therefore	RB	O
remained	VBD	O
on	IN	O
the	DT	B-TREATMENT
ventilator	NN	I-TREATMENT
throughout	IN	O
the	DT	O
day	NN	O
of	IN	O
postoperative	JJ	O
day	NN	O
one	CD	O
.	.	O

her	PRP$	B-TREATMENT
neo-synephrine	JJ	I-TREATMENT
drip	NN	I-TREATMENT
was	VBD	O
weaned	VBN	O
to	TO	O
off	RP	O
.	.	O

she	PRP	O
was	VBD	O
again	RB	O
weaned	VBN	O
from	IN	O
the	DT	B-TREATMENT
ventilator	NN	I-TREATMENT
,	,	O
and	CC	O
successfully	RB	O
extubated	VBN	O
.	.	O

her	PRP$	B-TREATMENT
chest	JJS	I-TREATMENT
tubes	NN	I-TREATMENT
were	VBD	O
discontinued	VBN	O
and	CC	O
,	,	O
at	IN	O
the	DT	O
end	NN	O
of	IN	O
the	DT	O
day	NN	O
,	,	O
she	PRP	O
was	VBD	O
transferred	VBN	O
from	IN	O
the	DT	O
cardiothoracic	NN	O
intensive	JJ	O
care	NN	O
unit	NN	O
to	TO	O
the	DT	O
floor	NN	O
for	IN	O
continuing	VBG	B-TREATMENT
postoperative	JJ	I-TREATMENT
care	NN	I-TREATMENT
and	CC	O
cardiac	JJ	B-TREATMENT
rehabilitation	NN	I-TREATMENT
.	.	O

her	PRP$	O
respiratory	JJ	O
condition	NN	O
remained	VBD	O
stable	JJ	O
and	CC	O
,	,	O
on	IN	O
postoperative	JJ	O
day	NN	O
four	CD	O
,	,	O
she	PRP	O
was	VBD	O
deemed	VBN	O
stable	JJ	O
and	CC	O
ready	JJ	O
to	TO	O
be	VB	O
transferred	VBN	O
to	TO	O
rehabilitation	VB	O
for	IN	O
continuing	VBG	B-TREATMENT
postoperative	JJ	I-TREATMENT
care	NN	I-TREATMENT
and	CC	O
physical	JJ	O

therapy	NN	B-TREATMENT
.	.	O

at	IN	O
the	DT	O
time	NN	O
of	IN	O
transfer	NN	O
,	,	O
the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
physical	JJ	I-TEST
examination	NN	I-TEST
is	VBZ	O
as	IN	O
follows	VBZ	O
:	:	O

temperature	NN	B-TEST
98.4	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
78	CD	O
and	CC	O
sinus	JJ	B-TEST
rhythm	NN	I-TEST
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
106/50	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
18	CD	O
,	,	O
oxygen	NN	B-TEST
saturation	NN	I-TEST
97%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

weight	NN	B-TEST
preoperatively	RB	O
was	VBD	O
67	CD	O
kg	NN	O
,	,	O
at	IN	O
discharge	NN	O
is	VBZ	O
70.9	CD	O
kg	NN	O
.	.	O

laboratory	NN	B-TEST
data	NNS	I-TEST
on	IN	O
02-15	NN	O
:	:	O

white	JJ	B-TEST
count	NN	I-TEST
4.1	CD	O
,	,	O
hematocrit	NN	B-TEST
23	CD	O
,	,	O
platelets	NNS	B-TEST
144	CD	O
.	.	O

sodium	NN	B-TEST
141	CD	O
,	,	O
potassium	NN	B-TEST
4.3	CD	O
,	,	O
chloride	RB	B-TEST
108	CD	O
,	,	O
co2	NN	B-TEST
25	CD	O
,	,	O
bun	NN	B-TEST
24	CD	O
,	,	O
creatinine	NN	B-TEST
0.8	CD	O
,	,	O
glucose	VBD	B-TEST
140	CD	O
.	.	O

scattered	VBN	B-PROBLEM
rhonchi	NNS	I-PROBLEM
with	IN	O
diminished	JJ	B-PROBLEM
breath	NN	I-PROBLEM
sounds	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
bases	NNS	I-PROBLEM
.	.	O

regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
,	,	O
s1	NN	O
,	,	O
s2	NN	O
,	,	O
with	IN	O
soft	JJ	B-PROBLEM
systolic	JJ	I-PROBLEM
ejection	NN	I-PROBLEM
murmur	NN	I-PROBLEM
.	.	O

incision	NN	B-PROBLEM
with	IN	O
staples	NNS	B-TREATMENT
,	,	O
open	JJ	O
to	TO	O
air	NN	O
,	,	O
clean	JJ	O
and	CC	O
dry	JJ	O
.	.	O

soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBD	B-PROBLEM
,	,	O
normal	JJ	O
active	JJ	O
bowel	NN	O
sounds	NNS	O
.	.	O

warm	NN	O
and	CC	O
well	RB	O
perfused	VBN	O
,	,	O
with	IN	O
no	DT	O
cyanosis	NN	B-PROBLEM
,	,	O
clubbing	VBG	B-PROBLEM
or	CC	O
edema	NN	B-PROBLEM
.	.	O

ranitidine	NN	B-TREATMENT
150	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
,	,	O
enteric-coated	JJ	B-TREATMENT
aspirin	NN	I-TREATMENT
325	CD	O
mg	NN	O
once	RB	O
daily	JJ	O
,	,	O
glucovance	NN	B-TREATMENT
5/500	CD	O
one	CD	O
tablet	NN	O
twice	RB	O
a	DT	O
day	NN	O
,	,	O
metoprolol	RB	B-TREATMENT
25	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
,	,	O
furosemide	RB	B-TREATMENT
20	CD	O
mg	NNS	O
once	RB	O
daily	RB	O
for	IN	O
14	CD	O
days	NNS	O
,	,	O
potassium	NN	B-TREATMENT
chloride	NN	I-TREATMENT
20	CD	O
meq	NN	O
once	RB	O
daily	JJ	O
for	IN	O
14	CD	O
days	NNS	O
,	,	O
colace	VBP	B-TREATMENT
100	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
,	,	O
niferex	RB	B-TREATMENT
150	CD	O
mg	NNS	O
once	RB	O
daily	RB	O
,	,	O
percocet	VBD	B-TREATMENT
5/325	CD	O
one	CD	O
to	TO	O
two	CD	O
tablets	NNS	O
every	DT	O
four	CD	O
hours	NNS	O
as	IN	O
needed	VBN	O
,	,	O
ibuprofen	JJ	B-TREATMENT
400	CD	O
mg	NN	O
every	DT	O
six	CD	O
hours	NNS	O
as	IN	O
needed	VBN	O
.	.	O

1.	CD	O
aortic	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
status	NN	O
post	NN	O
aortic	JJ	B-TREATMENT
valve	NN	I-TREATMENT
replacement	NN	I-TREATMENT
with	IN	O
a	DT	B-TREATMENT
#21	JJ	I-TREATMENT
mosaic	NN	I-TREATMENT
porcine	NN	I-TREATMENT
valve	NN	I-TREATMENT

2.	CD	O
diabetes	NNS	B-PROBLEM
mellitus	VBP	I-PROBLEM
type	NN	I-PROBLEM
2	CD	I-PROBLEM

3.	CD	O
right	JJ	B-TREATMENT
hip	NN	I-TREATMENT
replacement	NN	I-TREATMENT

mitral	JJ	B-TREATMENT
valve	NN	I-TREATMENT
repair	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
52	CD	O
year	NN	O
old	JJ	O
czech	NN	O
speaking	VBG	O
gentleman	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
severe	JJ	B-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

for	IN	O
the	DT	O
past	JJ	O
several	JJ	O
years	NNS	O
,	,	O
the	DT	O
patient	NN	O
has	VBZ	O
continued	VBN	O
to	TO	O
have	VB	O
significant	JJ	B-PROBLEM
exercise	NN	I-PROBLEM
intolerance	NN	I-PROBLEM
which	WDT	O
has	VBZ	O
limited	VBN	O
his	PRP$	O
ability	NN	O
to	TO	O
work	VB	O
.	.	O

he	PRP	O
reports	VBZ	O
severe	JJ	B-PROBLEM
dyspnea	NN	I-PROBLEM
on	IN	O
exertion	NN	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
a	DT	O
recent	JJ	O
admission	NN	O
earlier	RBR	O
in	IN	O
the	DT	O
month	NN	O
and	CC	O
he	PRP	O
was	VBD	O
discharged	VBN	O
on	IN	O
2015-09-10	JJ	O
,	,	O
after	IN	O
undergoing	VBG	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
.	.	O

this	DT	O
was	VBD	O
significant	JJ	O
for	IN	O
demonstrating	VBG	O
no	DT	O
flow-limited	JJ	B-PROBLEM
disease	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
coronaries	NNS	I-PROBLEM
but	CC	O
several	JJ	B-PROBLEM
fistulae	NNS	I-PROBLEM

several	JJ	O
of	IN	O
these	DT	O
were	VBD	O
coil	NNS	B-TREATMENT
embolized	VBN	I-TREATMENT
during	IN	O
this	DT	O
admission	NN	O
.	.	O

he	PRP	O
tolerated	VBD	O
this	DT	O
well	NN	O
,	,	O
was	VBD	O
sent	VBN	O
home	NN	O
,	,	O
and	CC	O
now	RB	O
returns	VBZ	O
for	IN	O
his	PRP$	B-TREATMENT
mitral	JJ	I-TREATMENT
valve	NN	I-TREATMENT
repair	NN	I-TREATMENT
.	.	O

1.	CD	O
mitral	JJ	B-PROBLEM
valve	NN	I-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

1.	CD	O
atenolol	JJ	B-TREATMENT
25	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

2.	CD	O
enteric-coated	JJ	B-TREATMENT
aspirin	NN	I-TREATMENT
325	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

3.	CD	O
nitroglycerin	JJ	B-TREATMENT
sublingual	JJ	I-TREATMENT
p.r.n.	NN	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

temperature	NN	B-TEST
is	VBZ	O
98.3	CD	O
f.	NN	O
;	:	O
pulse	CC	B-TEST
is	VBZ	O
76	CD	O
;	:	O
blood	NN	B-TEST
pressure	NN	I-TEST
113/52	CD	O
;	:	O
breathing	VBG	B-TEST
18	CD	O
;	:	O
98%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
missing	VBG	B-PROBLEM
many	JJ	I-PROBLEM
teeth	NNS	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
cervical	JJ	B-PROBLEM
lymphadenopathy	NN	I-PROBLEM
.	.	O

heart	NN	O
is	VBZ	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
with	IN	O
a	DT	B-PROBLEM
iii/vi	JJ	I-PROBLEM
systolic	JJ	I-PROBLEM
ejection	NN	I-PROBLEM
murmur	NN	I-PROBLEM
.	.	O

his	PRP$	O
lungs	NNS	O
are	VBP	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
.	.	O

abdomen	NNS	O
is	VBZ	O
soft	JJ	O
and	CC	O
nontender	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
no	DT	O
cyanosis	NN	B-PROBLEM
,	,	O
clubbing	VBG	B-PROBLEM
or	CC	O
edema	NN	B-PROBLEM
in	IN	I-PROBLEM
extremities	NNS	I-PROBLEM
.	.	O

on	IN	O
admission	NN	O
include	VBP	O
a	DT	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
of	IN	O
5.6	CD	O
,	,	O
hematocrit	NN	B-TEST
of	IN	O
32.5	CD	O
,	,	O
platelets	NNS	B-TEST
of	IN	O
202	CD	O
.	.	O

sodium	NN	B-TEST
of	IN	O
140	CD	O
,	,	O
potassium	NN	B-TEST
of	IN	O
3.5	CD	O
,	,	O
bun	NN	B-TEST
of	IN	O
4	CD	O
,	,	O
creatinine	NN	B-TEST
of	IN	O
0.6	CD	O
,	,	O
glucose	NN	B-TEST
of	IN	O
137	CD	O
.	.	O

chest	JJS	B-TEST
x-ray	NN	I-TEST
shows	VBZ	O
no	DT	O
infiltrate	NN	B-PROBLEM
or	CC	O
pneumothorax	NN	B-PROBLEM
.	.	O

cardiac	JJ	B-TEST
catheterization	NN	I-TEST
demonstrates	VBZ	O
no	DT	O
significant	JJ	B-PROBLEM
disease	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
coronary	JJ	I-PROBLEM
arteries	NNS	I-PROBLEM
.	.	O

two	CD	O
branches	NNS	O
of	IN	O
an	DT	B-PROBLEM
left	JJ	I-PROBLEM
anterior	JJ	I-PROBLEM
descending	VBG	I-PROBLEM
to	TO	I-PROBLEM
pa	VB	I-PROBLEM
fistula	NN	I-PROBLEM
which	WDT	O
was	VBD	O
successfully	RB	O
coiled	VBN	O
.	.	O

there	EX	O
is	VBZ	O
a	DT	B-PROBLEM
persistent	JJ	I-PROBLEM
flow	NN	I-PROBLEM
through	IN	O
an	DT	O
inferior	JJ	O
branch	NN	O
of	IN	O
the	DT	O
left	JJ	O
anterior	JJ	O
descending	VBG	O
to	TO	O
pa	VB	B-PROBLEM
fistula	NN	I-PROBLEM
and	CC	O
a	DT	O
persistent	JJ	O
branch	NN	O
of	IN	O
the	DT	B-PROBLEM
circumflex	NN	I-PROBLEM
to	TO	I-PROBLEM
pa	VB	I-PROBLEM
branch	NN	I-PROBLEM
fistula	NN	I-PROBLEM
which	WDT	O
anatomically	RB	O
were	VBD	O
not	RB	O
suitable	JJ	O
for	IN	O
coil	NN	B-TREATMENT
embolization	NN	I-TREATMENT
.	.	O

ejection	NN	B-TEST
fraction	NN	I-TEST
was	VBD	O
60%	CD	O
.	.	O

mitral	JJ	B-TREATMENT
valve	NN	I-TREATMENT
repair	NN	I-TREATMENT
.	.	O

he	PRP	O
tolerated	VBD	O
this	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
brought	VBN	O
to	TO	O
the	DT	O
cardiothoracic	NN	O
intensive	JJ	O
care	NN	O
unit	NN	O
in	IN	O
stable	JJ	O
condition	NN	O
on	IN	O
minimal	JJ	B-TREATMENT
pressor	NN	I-TREATMENT
support	NN	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
successfully	RB	O
weaned	VBN	O
off	RP	O
this	DT	B-TREATMENT
support	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
fully	RB	O
weaned	VBN	O
from	IN	O
ventilatory	JJ	B-TREATMENT
support	NN	I-TREATMENT
secondary	JJ	O
to	TO	O
a	DT	B-PROBLEM
persistent	JJ	I-PROBLEM
acidemia	NN	I-PROBLEM
.	.	O

this	DT	O
was	VBD	O
treated	VBN	O
with	IN	O
sodium	NN	B-TREATMENT
bicarbonate	NN	I-TREATMENT
and	CC	O
a	DT	B-TREATMENT
swan-ganz	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
to	TO	O
provide	VB	O
close	JJ	B-TEST
hemodynamic	JJ	I-TEST
monitoring	NN	I-TEST
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
stable	JJ	O
hemodynamics	NNS	O
with	IN	O
appropriate	JJ	O
mixed	JJ	O
venous	JJ	B-TEST
saturations	NNS	I-TEST
in	IN	O
the	DT	O
70%	CD	O
range	NN	O
.	.	O

he	PRP	O
was	VBD	O
then	RB	O
weaned	VBN	O
off	IN	O
of	IN	O
ventilatory	JJ	B-TREATMENT
support	NN	I-TREATMENT
and	CC	O
was	VBD	O
successfully	RB	O
extubated	VBN	O
.	.	O

the	DT	O
patient	NN	O
did	VBD	O
have	VB	O
a	DT	B-PROBLEM
slight	JJ	I-PROBLEM
bit	NN	I-PROBLEM
of	IN	I-PROBLEM
confusion	NN	I-PROBLEM
early	JJ	O
in	IN	O
post-extubation	NN	O
course	NN	O
which	WDT	O
cleared	VBD	O
.	.	O

in	IN	O
addition	NN	O
,	,	O
the	DT	O
patient	NN	O
's	POS	O
early	JJ	O
postoperative	JJ	O
course	NN	O
had	VBD	O
a	DT	O
tremendous	JJ	O
urine	NN	B-TEST
output	NN	I-TEST
.	.	O

it	PRP	O
was	VBD	O
equally	RB	O
up	RB	O
to	TO	O
700	CD	O
cc.	NNS	O
an	DT	O
hour	NN	O
and	CC	O
a	DT	B-TEST
renal	JJ	I-TEST
consultation	NN	I-TEST
was	VBD	O
obtained	VBN	O
.	.	O

he	PRP	O
underwent	VBD	O
a	DT	B-TEST
head	NN	I-TEST
ct	NN	I-TEST
scan	JJ	I-TEST
to	TO	O
rule	VB	O
out	RP	O
intracranial	JJ	B-PROBLEM
pathology	NN	I-PROBLEM
leading	VBG	O
to	TO	O
diabetes	NNS	B-PROBLEM
insipidus	NNS	I-PROBLEM
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
serum	NN	I-TEST
and	CC	O
urine	JJ	B-TEST
electrolytes	NNS	I-TEST
indicated	VBD	O
that	IN	O
this	DT	B-TREATMENT
diuresis	NN	I-TREATMENT
was	VBD	O
appropriate	JJ	O
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
urine	JJ	I-TEST
output	NN	I-TEST
has	VBZ	O
decreased	VBN	O
and	CC	O
his	PRP$	B-TEST
bun	NN	I-TEST
and	CC	O
creatinine	NN	B-TEST
remained	VBD	O
normal	JJ	O
.	.	O

the	DT	B-TREATMENT
patient	NN	I-TREATMENT
's	POS	I-TREATMENT
foley	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
.	.	O

he	PRP	O
had	VBD	O
developed	VBN	O
some	DT	B-PROBLEM
hematuria	NN	I-PROBLEM
which	WDT	O
has	VBZ	O
resolved	VBN	O
.	.	O

1.	CD	O
mitral	JJ	B-PROBLEM
regurgitation	NN	I-PROBLEM
status	NN	O
post	NN	O
minimally	RB	B-TREATMENT
invasive	JJ	I-TREATMENT
mitral	JJ	I-TREATMENT
valve	NN	I-TREATMENT
repair	NN	I-TREATMENT
.	.	O

1.	CD	O
lopressor	NN	B-TREATMENT
75	CD	O
mg	NN	O
p.o.	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

2.	CD	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

3.	CD	O
percocet	JJ	B-TREATMENT
one	CD	O
to	TO	O
two	CD	O
p.o.	NNS	O
q.	RB	O
four	CD	O
hours	NNS	O
p.r.n.	VBP	O

4.	CD	O
aspirin	JJ	B-TREATMENT
325	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

3.	CD	O
the	DT	O
patient	NN	O
will	MD	O
call	VB	O
for	IN	O
any	DT	B-PROBLEM
fevers	NNS	I-PROBLEM
or	CC	O
difficulties	NNS	B-PROBLEM
with	IN	I-PROBLEM
the	DT	I-PROBLEM
wound	NN	I-PROBLEM
care	NN	I-PROBLEM
,	,	O
and	CC	O
will	MD	O
be	VB	O
instructed	VBN	O
with	IN	O
an	DT	O
interpreter	NN	O
present	NN	O
.	.	O

patient	NN	O
recorded	VBD	O
as	IN	O
having	VBG	O
no	DT	O
known	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM
to	TO	I-PROBLEM
drugs	NNS	I-PROBLEM

coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
requiring	VBG	O
surgical	JJ	B-TREATMENT
intervention	NN	I-TREATMENT

cabg	NN	B-TREATMENT
x	VBZ	O
5	CD	O

mr.	NN	O
andersen	NN	O
is	VBZ	O
a	DT	O
71-year-old	JJ	O
male	NN	O
with	IN	O
worsening	VBG	B-PROBLEM
anginal	JJ	I-PROBLEM
symptoms	NNS	I-PROBLEM
who	WP	O
underwent	VBP	O
catheterization	NN	B-TEST
that	WDT	O
showed	VBD	O
severe	JJ	B-PROBLEM
three-vessel	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

he	PRP	O
is	VBZ	O
presenting	VBG	O
for	IN	O
revascularization	NN	B-TREATMENT
.	.	O

dm2	SYM	B-PROBLEM
-	:	O
dx	NN	O
'd	MD	O
at	IN	O
the	DT	O
age	NN	O
of	IN	O
48	CD	O

arthritis	NN	B-PROBLEM

htn	NN	B-PROBLEM

tonsillectomy	NN	B-TREATMENT
around	IN	O
the	DT	O
age	NN	O
of	IN	O
10	CD	O

father	RB	O
died	VBN	O
of	IN	O
colon	NN	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

mother	NN	O
with	IN	O
pacemaker	NN	B-TREATMENT
,	,	O
alive	JJ	O
at	IN	O
91	CD	O
years	NNS	O
old	JJ	O
.	.	O

awake	NN	O
and	CC	O
alert	NN	O
,	,	O
nad	NN	B-PROBLEM

heent	NN	O
:	:	O
perrla	NN	O
,	,	O
no	DT	O
carotid	NN	B-PROBLEM
bruits	NNS	I-PROBLEM

cv	NN	O
:	:	O
rrr	NN	O
,	,	O
no	DT	O
m/r/g	NN	B-PROBLEM

abd	NN	O
:	:	O
soft	JJ	O
,	,	O
nt/nd	JJ	B-PROBLEM
,	,	O
nabs	JJ	O

ext	NN	O
:	:	O
cool	NN	O
,	,	O
no	DT	O
varicosities	NNS	B-PROBLEM
,	,	O
1+	CD	O
pedal	NN	B-TEST
pulses	NNS	I-TEST

2013-10-29	JJ	O
11:37	CD	O
am	VBP	O
blood	NN	B-TEST
wbc	NN	B-TEST
-	:	O
11.4	CD	O
*#	NN	O
rbc	NN	B-TEST
-	:	O
3.09	CD	O
*#	NN	O
hgb	NN	B-TEST
-	:	O
9.1	CD	O
*#	NN	O
hct	NN	B-TEST
-	:	O
27.5	CD	O
*#	NN	O
mcv	SYM	B-TEST
-	:	O
89	CD	O
mch	SYM	B-TEST
-	:	O
29.5	CD	O
mchc	SYM	B-TEST
-	:	O
33.3	CD	O
rdw	NN	B-TEST
-	:	O
14.6	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
180	CD	O

2013-10-29	JJ	O
11:37	CD	O
am	VBP	O
blood	NN	B-TEST
pt	NN	B-TEST
-	:	O
16.2	CD	O
*	NN	O
ptt	NN	B-TEST
-	:	O
29.0	CD	O
inr(pt)	JJ	B-TEST
-	:	O
1.7	CD	O

2013-10-29	JJ	O
11:37	CD	O
am	VBP	O
blood	NN	B-TEST
plt	NN	B-TEST
ct	VBD	I-TEST
-	:	O
180	CD	O

2013-10-29	JJ	O
01:09	CD	O
pm	NN	O
blood	NN	B-TEST
glucose	VB	B-TEST
-	:	O
172	CD	O
*	JJ	O
urean	JJ	B-TEST
-	:	O
11	CD	O
creat	NN	B-TEST
-	:	O
0.9	CD	O
na	SYM	B-TEST
-	:	O
142	CD	O
cl	NN	B-TEST
-	:	O
111	CD	O
*	NN	O
hco3	NN	B-TEST
-	:	O
22	CD	O

2013-10-29	JJ	O
01:09	CD	O
pm	NN	O
blood	NN	B-TEST
mg	SYM	B-TEST
-	:	O
2.6	CD	O

the	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
on	IN	O
2013-10-29	JJ	O
for	IN	O
a	DT	B-TREATMENT
cabg	NN	I-TREATMENT
x5	NN	O
.	.	O

the	DT	O
patient	NN	O
tolerated	VBD	O
this	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
.	.	O

his	PRP$	B-TREATMENT
central	JJ	I-TREATMENT
line	NN	I-TREATMENT
and	CC	O
chest	NN	B-TREATMENT
tubes	NNS	I-TREATMENT
were	VBD	O
removed	VBN	O
on	IN	O
post-op	JJ	O
day	NN	O
#2	NNP	O
and	CC	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
floor	NN	O
in	IN	O
stable	JJ	O
condition	NN	O
.	.	O

on	IN	O
post-op	JJ	O
day	NN	O
#3	NNP	O
,	,	O
the	DT	B-TREATMENT
patient	NN	I-TREATMENT
's	POS	I-TREATMENT
pacing	NN	I-TREATMENT
wires	NNS	I-TREATMENT
were	VBD	O
removed	VBN	O
,	,	O
and	CC	O
his	PRP$	B-TREATMENT
lopressor	NN	I-TREATMENT
was	VBD	O
started	VBN	O
.	.	O

on	IN	O
post-op	JJ	O
day	NN	O
#4	NNP	O
,	,	O
the	DT	O
patient	NN	O
failed	VBD	O
the	DT	O
first	JJ	O
of	IN	O
his	PRP$	B-TEST
void	NN	I-TEST
trials	NNS	I-TEST
.	.	O

he	PRP	O
was	VBD	O
discharged	VBN	O
home	NN	O
on	IN	O
post-op	JJ	O
day	NN	O
#6	NNP	O
in	IN	O
stable	JJ	O
condition	NN	O
with	IN	O
a	DT	B-TREATMENT
foley	NN	I-TREATMENT
catheter	NN	I-TREATMENT
and	CC	O
leg	NN	B-TREATMENT
bag	NN	I-TREATMENT
.	.	O

avandia	RB	B-TREATMENT
8	CD	O
mg	NNS	O
daily	RB	O

glipizide	RB	B-TREATMENT
10	CD	O
mg	NNS	O
bid	NN	O

diovan	NN	B-TREATMENT
160	CD	O
mg	JJ	O
daily	JJ	O

metformin	NN	B-TREATMENT
500	CD	O
mg	NN	O
two	CD	O
tabs	NNS	O
bid	VBD	O

omeprazole	JJ	B-TREATMENT
20	CD	O
mg	NN	O
q	NN	O
pm	NN	O

1.	CD	O
docusate	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
100	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
constipation	NN	B-PROBLEM
.	.	O

2.	CD	O
aspirin	JJ	B-TREATMENT
81	CD	O
mg	JJ	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

3.	CD	O
oxycodone	CD	B-TREATMENT
-	:	O
acetaminophen	NN	B-TREATMENT
5-325	JJ	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
1-2	JJ	O
tablets	NNS	O
po	VBP	O
q4h	NN	O
(	(	O
every	DT	O
4	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
pain	NN	B-PROBLEM
for	IN	O
30	CD	O
doses	NNS	O
.	.	O

4.	CD	O
atorvastatin	JJ	B-TREATMENT
calcium	NN	I-TREATMENT
10	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

5.	CD	O
rosiglitazone	NN	B-TREATMENT
maleate	NN	I-TREATMENT
8	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

6.	CD	O
glipizide	JJ	B-TREATMENT
10	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

7.	CD	O
tamsulosin	NN	B-TREATMENT
0.4	CD	O
mg	NN	O
capsule	NN	O
,	,	O
sust.	JJ	O
release	NN	O
24	CD	O
hr	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
,	,	O
sust	NN	O
.	.	O
release	VB	O
24	CD	O
hr	NN	O
po	NN	O
hs	NN	O
(	(	O
at	IN	O
bedtime	NN	O
).	NN	O

8.	CD	O
metoprolol	JJ	B-TREATMENT
tartrate	NN	I-TREATMENT
25	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
0.5	CD	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

9.	CD	O
furosemide	JJ	B-TREATMENT
20	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
every	DT	O
twelve	NN	O
(	(	O
12	CD	O
)	)	O
hours	NNS	O
.	.	O

10.	CD	O
pantoprazole	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
40	CD	O
mg	NN	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
q24h	NN	O
(	(	O
every	DT	O
24	CD	O
hours	NNS	O
).	VBP	O

11.	CD	O
potassium	NN	B-TREATMENT
chloride	NN	I-TREATMENT
10	CD	O
meq	NN	O
capsule	NN	O
,	,	O
sustained	VBD	O
release	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
capsule	NN	O
,	,	O
sustained	VBD	O
release	NN	O
po	NN	O
q12h	NN	O
(	(	O
every	DT	O
12	CD	O
hours	NNS	O
).	VBP	O

coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM

please	VB	O
return	NN	O
to	TO	O
the	DT	O
hospital	NN	O
or	CC	O
call	VB	O
dr.	JJ	O
alvarado	NN	O
's	POS	O
office	NN	O
if	IN	O
you	PRP	O
experience	VBP	O
chills	NNS	B-PROBLEM
or	CC	O
fever	RB	B-PROBLEM
greater	JJR	I-PROBLEM
than	IN	I-PROBLEM
101	CD	I-PROBLEM
degrees	NNS	I-PROBLEM
f.	VBP	I-PROBLEM

please	VB	O
call	VB	O
if	IN	O
you	PRP	O
notice	VBP	O
redness	RB	B-PROBLEM
,	,	O
swelling	VBG	B-PROBLEM
,	,	O
or	CC	O
tenderness	NN	B-PROBLEM
of	IN	O
your	PRP$	B-PROBLEM
chest	NN	I-PROBLEM
wound	NN	I-PROBLEM
,	,	O
or	CC	O
if	IN	O
it	PRP	O
begins	VBZ	O
to	TO	O
drain	VB	O
pus	NN	B-PROBLEM
.	.	O

wash	JJ	O
incision	NN	B-PROBLEM
with	IN	O
mild	JJ	O
soap	NN	O
and	CC	O
water	NN	O
,	,	O
then	RB	O
pat	VBZ	O
dry	NN	O
.	.	O

you	PRP	O
will	MD	O
need	VB	O
to	TO	O
follow	VB	O
up	RP	O
with	IN	O
your	PRP$	O
primary	JJ	O
care	NN	O
physician	JJ	O
/	NNP	O
urologist	NN	O
prior	RB	O
to	TO	O
removal	VB	O
of	IN	O
your	PRP$	B-TREATMENT
urinary	JJ	I-TREATMENT
catheter	NN	I-TREATMENT
.	.	O

penicillins	NNS	B-TREATMENT

transfer	NN	O
from	IN	O
newton-wellesley	JJ	O
hospital	NN	O
hospital	NN	O
for	IN	O
epidural	JJ	B-PROBLEM
abscess	NN	I-PROBLEM

1.	CD	O
partial	JJ	B-TREATMENT
vertebrectomy	NN	I-TREATMENT
of	IN	I-TREATMENT
l3	NN	I-TREATMENT
and	CC	I-TREATMENT
l4	NN	I-TREATMENT
.	.	O

2.	CD	O
fusion	NN	B-TREATMENT
at	IN	I-TREATMENT
l3-l4	NN	I-TREATMENT
.	.	O

3.	CD	O
vertebral	JJ	B-TREATMENT
spacer	NN	I-TREATMENT
at	IN	I-TREATMENT
l3-l4	NN	I-TREATMENT
.	.	O

4.	CD	O
anterior	JJ	B-TREATMENT
instrumentation	NN	I-TREATMENT
l3-l4	NN	I-TREATMENT
.	.	O

5.	CD	O
autograft	NN	B-TREATMENT
,	,	O
bone	NN	B-TREATMENT
morphogenic	JJ	I-TREATMENT
protein	NN	I-TREATMENT
,	,	O
and	CC	O
allograft	NN	B-TREATMENT
.	.	O

6.	CD	O
debridement	NN	B-TREATMENT

7.	CD	O
incision	NN	B-TREATMENT
and	CC	O
drainage	NN	B-TREATMENT

8.	CD	O
echocardiogram	NN	B-TEST

73	CD	O
yo	JJ	O
m	NN	O
transferred	VBN	O
from	IN	O
newton-wellesley	JJ	O
hospital	NN	O
hospital	NN	O
for	IN	O
epidural	JJ	B-PROBLEM
abscess	NN	I-PROBLEM
.	.	O

pt	NN	O
has	VBZ	O
h/o	VBN	O
colon	NN	B-PROBLEM
can	MD	I-PROBLEM
to	TO	I-PROBLEM
liver	VB	I-PROBLEM
,	,	O
s/p	VB	O
resxn	NN	B-TREATMENT
with	IN	O
serosal	JJ	B-PROBLEM
implants	NNS	I-PROBLEM
in	IN	O
9/03	CD	O
.	.	O

pt	NN	O
states	NNS	O
he	PRP	O
has	VBZ	O
been	VBN	O
receiving	VBG	O
chemotherapy	NN	B-TREATMENT
up	RB	O
until	IN	O
1	CD	O
week	NN	O
ago	RB	O
.	.	O

states	NNS	O
he	PRP	O
first	RB	O
developed	VBD	O
back	RB	B-PROBLEM
pain	RB	I-PROBLEM
5	CD	O
weeks	NNS	O
ago	RB	O
but	CC	O
was	VBD	O
still	RB	O
able	JJ	O
to	TO	O
ambulate	VB	O
with	IN	O
his	PRP$	B-TREATMENT
cane	NN	I-TREATMENT
.	.	O

an	DT	B-TEST
mri	NN	I-TEST
was	VBD	O
done	VBN	O
and	CC	O
this	DT	O
showed	VBD	O
a	DT	B-PROBLEM
signal	JJ	I-PROBLEM
abno	NN	I-PROBLEM
in	IN	I-PROBLEM
l3	NN	I-PROBLEM
l4	NN	I-PROBLEM
?	.	O
disciitis	NN	B-PROBLEM
vs	NN	O
osteo	NN	B-PROBLEM
without	IN	O
a	DT	B-PROBLEM
definitive	JJ	I-PROBLEM
epidural	JJ	I-PROBLEM
abscess	NN	I-PROBLEM
.	.	O

initially	RB	O
on	IN	O
vanc	NN	B-TREATMENT
and	CC	O
cipro	NN	B-TREATMENT
on	IN	O
friday	NN	O
but	CC	O
then	RB	O
seen	VBN	O
by	IN	O
id	NN	O
who	WP	O
reccommended	VBD	O
no	DT	O
abx	NN	B-TREATMENT
but	CC	O
a	DT	B-TEST
bone	NN	I-TEST
biopsy	NN	I-TEST
,	,	O
blood	NN	B-TEST
cx	NN	I-TEST
.	.	O

he	PRP	O
was	VBD	O
also	RB	O
seen	VBN	O
by	IN	O
spine	NN	O
who	WP	O
repeated	VBD	O
the	DT	B-TEST
mri	NN	I-TEST
and	CC	O
this	DT	O
showed	VBD	O
l3-4	JJ	B-PROBLEM
osteomyelitis	NN	I-PROBLEM
and	CC	O
discitis	NN	B-PROBLEM
and	CC	O
an	DT	B-PROBLEM
epidural	JJ	I-PROBLEM
abscess	NN	I-PROBLEM
,	,	O
5cm	CD	O
.	.	O

he	PRP	O
was	VBD	O
subsequently	RB	O
restared	VBN	O
on	IN	O
vancomycin	NN	B-TREATMENT
for	IN	O
corynebacterium	NN	B-PROBLEM
in	IN	O
blood	NN	B-TEST
cx	NN	I-TEST
from	IN	O
fri	NN	O
;	:	O
followup	NN	B-TEST
cx	NN	I-TEST
has	VBZ	O
been	VBN	O
ngtd	RB	O
.	.	O

cxr	NN	B-TEST
also	RB	O
showed	VBD	O
small	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
and	CC	O
attempt	NN	O
was	VBD	O
made	VBN	O
to	TO	O
tap	VB	B-TREATMENT
it	PRP	O
,	,	O
but	CC	O
pt	RB	O
did	VBD	O
not	RB	O
tolerate	VB	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
and	CC	O
asked	VBD	O
that	IN	O
it	PRP	O
be	VB	O
deferred	VBN	O
.	.	O

he	PRP	O
did	VBD	O
undergo	VB	O
a	DT	B-TEST
ct-guided	JJ	I-TEST
aspiration	NN	I-TEST
/	NNP	I-TEST
biopsy	NN	I-TEST
at	IN	I-TEST
the	DT	I-TEST
l3-4	JJ	I-TEST
disc	NN	I-TEST
space	NN	I-TEST
on	IN	O
2020-03-11	JJ	O
and	CC	O
the	DT	O
pt	NN	O
was	VBD	O
transferred	VBN	O
to	TO	O
mediplex	VB	O
rehab	JJ	O
hospital	NN	O
immediately	RB	O
following	VBG	O
this	DT	O
.	.	O

currently	RB	O
pt	JJ	O
denies	NNS	O
sensory	JJ	B-PROBLEM
deficits	NNS	I-PROBLEM
or	CC	O
weakness	NN	B-PROBLEM
.	.	O

states	NNS	O
he	PRP	O
is	VBZ	O
not	RB	O
able	JJ	O
to	TO	O
walk	VB	O
because	IN	O
of	IN	O
severe	JJ	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

states	NNS	O
pain	VBP	B-PROBLEM
is	VBZ	O
worst	RB	O
when	WRB	O
he	PRP	O
sits	VBZ	O
up	RP	O
or	CC	O
twists	VBZ	O
his	PRP$	O
back	NN	O
.	.	O

no	DT	O
bowel	NN	B-PROBLEM
or	CC	I-PROBLEM
bladder	NN	I-PROBLEM
incontinence	NN	I-PROBLEM
.	.	O

-	:	O
epidural	NN	B-PROBLEM
abscess	NN	I-PROBLEM

-	:	O
colon	NN	B-PROBLEM
cancer	NN	I-PROBLEM
with	IN	O
mets	NNS	B-PROBLEM
to	TO	I-PROBLEM
liver	VB	I-PROBLEM
s/p	JJ	O
resection	NN	B-TREATMENT
09-07	NN	O
.	.	O

-	:	O
cad	NN	B-PROBLEM
s/p	NN	O
cabg	NN	B-TREATMENT
x4	NN	O
in	IN	O
'	POS	O
03	CD	O
.	.	O

-	:	O
hypercholesterolemia	NN	B-PROBLEM

-	:	O
dm	NN	B-PROBLEM
with	IN	O
neuropathy	JJ	B-PROBLEM
.	.	O

-	:	O
persistent	NN	B-PROBLEM
r	JJ	I-PROBLEM
foot	NN	I-PROBLEM
ulcer	NN	I-PROBLEM

he	PRP	O
states	VBZ	O
he	PRP	O
gives	VBZ	O
her	PRP$	O
one	CD	O
of	IN	O
his	PRP$	O
pensions	NNS	O
and	CC	O
she	PRP	O
helps	VBZ	O
him	PRP	O
with	IN	O
medicines	NNS	B-TREATMENT
etc	NNS	O
.	.	O

gen	NN	O
:	:	O
in	IN	O
nad	NN	B-PROBLEM
,	,	O
but	CC	O
winces	NNS	O
in	IN	O
pain	NN	B-PROBLEM
with	IN	O
movements	NNS	O
of	IN	O
his	PRP$	O
back	NN	O
.	.	O

heent	NN	O
:	:	O
clear	JJ	O
op	NN	O
,	,	O
mm	JJ	B-PROBLEM
very	RB	I-PROBLEM
dry	JJ	I-PROBLEM
.	.	O

neck	NN	O
:	:	O
supple	NN	O
,	,	O
no	DT	O
lad	NN	B-PROBLEM
,	,	O
no	DT	O
jvd	NN	B-PROBLEM

chest	NN	O
:	:	O
port	NN	B-TREATMENT
a	DT	I-TREATMENT
cath	NN	I-TREATMENT
in	IN	I-TREATMENT
r	NN	I-TREATMENT
chest	NN	I-TREATMENT
,	,	O
no	DT	O
erythema	NN	B-PROBLEM
or	CC	O
tenderness	NN	B-PROBLEM
.	.	O

ii/vi	NN	B-PROBLEM
sem	NN	I-PROBLEM
at	IN	I-PROBLEM
lsb	NN	I-PROBLEM
with	IN	O
radiation	NN	B-PROBLEM
to	TO	I-PROBLEM
apex	VB	I-PROBLEM
.	.	O

lungs	NNS	O
:	:	O
+	NN	O
crackles	NNS	B-PROBLEM
at	IN	I-PROBLEM
l	JJ	I-PROBLEM
base	NN	I-PROBLEM
>	NNP	O
r	NN	O
base	NN	O
.	.	O

abd	NN	O
:	:	O
pt	JJ	O
very	RB	B-PROBLEM
tense	JJ	I-PROBLEM
in	IN	I-PROBLEM
abdomen	NNS	I-PROBLEM
(	(	O
states	NNS	O
belly	RB	O
is	VBZ	O
fine	JJ	O
,	,	O
but	CC	O
he	PRP	O
is	VBZ	O
weary	JJ	O
of	IN	O
his	PRP$	O
back	NN	O
).	NN	O

well	RB	B-PROBLEM
healed	VBN	I-PROBLEM
midline	NN	I-PROBLEM
scar	NN	I-PROBLEM
from	IN	O
chest	VBG	O
down	RP	O
to	TO	O
pubis	VB	O
.	.	O

no	DT	O
hsm	NN	B-PROBLEM
.	.	O

ext	NN	O
:	:	O
no	DT	O
edema	NN	B-PROBLEM
.	.	O

dressing	VBG	B-TREATMENT
c/d/i	NN	O
over	IN	O
r	NN	B-PROBLEM
le	JJ	I-PROBLEM
ulcer	NN	I-PROBLEM
.	.	O

1	CD	O
+	JJ	O
dp	NN	B-TEST
pulses	NNS	I-TEST
bl	VBP	O

back	RB	O
:	:	O
+	NN	O
ttp	NN	B-PROBLEM
of	IN	I-PROBLEM
lumbar	NN	I-PROBLEM
spine	NN	I-PROBLEM
and	CC	I-PROBLEM
paraspinal	JJ	I-PROBLEM
muscles	NNS	I-PROBLEM
,	,	O
r	NN	O
>	NNP	O
l	NN	O
.	.	O

no	DT	O
erythema	NN	B-PROBLEM
or	CC	O
swelling	VBG	B-PROBLEM
noted	VBN	O
.	.	O

na	NNS	B-TEST
:	:	O
135	CD	O
,	,	O
k	VBD	B-TEST
4.5	CD	O
,	,	O
cl	NN	B-TEST
96	CD	O
,	,	O
co2	NN	B-TEST
27	CD	O
,	,	O
bun	NN	B-TEST
12	CD	O
,	,	O
cr	NN	B-TEST
0.7	CD	O
,	,	O
glu	NN	B-TEST
167	CD	O
,	,	O
ca	MD	B-TEST
8.4	CD	O
,	,	O
vanco	VBD	B-TEST
trough	IN	I-TEST
13	CD	O
,	,	O
wbc	VBD	B-TEST
5.3	CD	O
,	,	O
hct	NN	B-TEST
32.0	CD	O
,	,	O
plt	NN	B-TEST
330	CD	O
,	,	O
inr	RB	B-TEST
1.0	CD	O
.	.	O

no	DT	O
culture	NN	B-TEST
data	NNS	I-TEST
was	VBD	O
sent	VBN	O
.	.	O

mri	NN	B-TEST
lumbar	NN	I-TEST
spine	NN	I-TEST
(	(	O
youville	JJ	O
hospital	NN	O
2020-03-10	JJ	O
):	JJ	O
l3-4	JJ	B-PROBLEM
osteomyelitis	NN	I-PROBLEM
,	,	O
discitis	NN	B-PROBLEM
,	,	O
and	CC	O
epidural	JJ	B-PROBLEM
abscess	NN	I-PROBLEM
.	.	O

degenerative	JJ	B-PROBLEM
changes	NNS	I-PROBLEM
including	VBG	O
multilevel	JJ	B-PROBLEM
central	JJ	I-PROBLEM
spinal	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

impression	NN	B-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
anterior	JJ	I-PROBLEM
aspect	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
lower	JJR	I-PROBLEM
spinal	JJ	I-PROBLEM
cord	NN	I-PROBLEM
at	IN	I-PROBLEM
t11-12	NN	I-PROBLEM
by	IN	O
disc	NN	B-PROBLEM
bulge	NN	I-PROBLEM
.	.	O

addendum	NN	O
:	:	O
findings	NNS	O
are	VBP	O
c/w	JJ	O
paraspinous	JJ	B-PROBLEM
extension	NN	I-PROBLEM
of	IN	I-PROBLEM
infection	NN	I-PROBLEM
anteriorly	RB	O
and	CC	O
laterally	RB	O
into	IN	O
the	DT	O
medial	JJ	O
aspects	NNS	O
of	IN	O
the	DT	O
psoas	NN	O
muscles	VBZ	O
bilaterally	RB	O
at	IN	O
the	DT	O
l3	NN	O
and	CC	O
l4	NN	O
levels	NNS	O
.	.	O

cxr	NN	B-TEST
(	(	O
youville	JJ	O
hospital	NN	O
2020-03-09	JJ	O
):	NNP	O
persistent	NN	B-PROBLEM
unchanged	JJ	I-PROBLEM
l	NN	I-PROBLEM
mid	NN	I-PROBLEM
and	CC	I-PROBLEM
lower	JJR	I-PROBLEM
lung	NN	I-PROBLEM
field	NN	I-PROBLEM
airspace	NN	I-PROBLEM
disease	NN	I-PROBLEM
with	IN	O
moderate	JJ	B-PROBLEM
l	NN	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

73	CD	O
yo	JJ	O
m	NN	O
transferred	VBN	O
from	IN	O
youville	JJ	O
hospital	NN	O
with	IN	O
h/o	JJ	O
colon	NN	B-PROBLEM
cancer	NN	I-PROBLEM
with	IN	O
known	VBN	B-PROBLEM
liver	JJ	I-PROBLEM
mets	NNS	I-PROBLEM
now	RB	O
with	IN	O
epidural	JJ	B-PROBLEM
abscess	NN	I-PROBLEM
and	CC	O
corynebacterium	NN	B-PROBLEM
bacteremia	NN	I-PROBLEM
:	:	O

#	#	O
epidural	JJ	B-PROBLEM
abscess	NN	I-PROBLEM
:	:	O
the	DT	O
patient	NN	O
was	VBD	O
evaluated	VBN	O
by	IN	O
orthopedic	JJ	O
spine	NN	O
consult	NN	O
service	NN	O
and	CC	O
id	NN	O
.	.	O

he	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
iv	NN	B-TREATMENT
vancomycin	NN	I-TREATMENT
throughout	IN	O
his	PRP$	O
course	NN	O
and	CC	O
had	VBD	O
therapeutic	JJ	O
troughs	NNS	B-TEST
.	.	O

please	VB	O
see	VB	O
the	DT	O
operation	NN	O
notes	NNS	O
for	IN	O
details	NNS	O
about	IN	O
the	DT	B-TREATMENT
surgeries	NNS	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
briefly	RB	O
admitted	VBN	O
to	TO	O
the	DT	O
icu	NN	O
for	IN	O
low	JJ	B-PROBLEM
hematocrit	NN	I-PROBLEM
and	CC	O
hyponatremia	NN	B-PROBLEM
immediately	RB	O
following	VBG	O
the	DT	B-TREATMENT
surgery	NN	I-TREATMENT
but	CC	O
was	VBD	O
then	RB	O
transferred	VBN	O
back	RB	O
to	TO	O
the	DT	O
floor	NN	O
in	IN	O
stable	JJ	O
condition	NN	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TREATMENT
picc	JJ	I-TREATMENT
line	NN	I-TREATMENT
placed	VBN	O
and	CC	O
will	MD	O
continue	VB	O
a	DT	B-TREATMENT
8	CD	I-TREATMENT
week	NN	I-TREATMENT
course	NN	I-TREATMENT
of	IN	I-TREATMENT
antibiotics	NNS	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
will	MD	O
also	RB	O
wear	VB	O
a	DT	B-TREATMENT
back	JJ	I-TREATMENT
brace	NN	I-TREATMENT
at	IN	O
all	DT	O
times	NNS	O
while	IN	O
out	IN	O
of	IN	O
bed	NN	O
.	.	O

#	#	O
candidemia	NN	B-PROBLEM
:	:	O
the	DT	O
patient	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
a	DT	O
positive	JJ	O
blood	NN	B-TEST
culture	NN	I-TEST
from	IN	O
03-12	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
diflucan	NN	B-TREATMENT
.	.	O

ophthalmology	NN	O
was	VBD	O
consulted	VBN	O
and	CC	O
ruled	VBN	O
out	RP	O
ocular	JJ	B-PROBLEM
spread	NN	I-PROBLEM
.	.	O

the	DT	B-TREATMENT
patient	NN	I-TREATMENT
's	POS	I-TREATMENT
portocath	NN	I-TREATMENT
was	VBD	O
removed	VBN	O
.	.	O

the	DT	O
tip	NN	O
was	VBD	O
culture	NN	B-TEST
negative	JJ	O
.	.	O

the	DT	O
patient	NN	O
will	MD	O
get	VB	O
a	DT	O
total	NN	O
of	IN	O
a	DT	B-TREATMENT
two	CD	I-TREATMENT
week	NN	I-TREATMENT
course	NN	I-TREATMENT
of	IN	I-TREATMENT
diflucan	JJ	I-TREATMENT
.	.	O

#	#	O
corynebacterium	NN	B-PROBLEM
bacteremia	NN	I-PROBLEM
:	:	O
presumably	RB	O
corynebacterium	NN	B-PROBLEM
in	IN	O
epidural	JJ	B-PROBLEM
abscess	NN	I-PROBLEM
as	RB	O
well	RB	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
no	DT	O
blood	NN	B-TEST
cultures	NNS	I-TEST
to	TO	O
grow	VB	O
corynebacterium	NN	B-PROBLEM
while	IN	O
hospitalized	VBN	O
.	.	O

#	#	O
pleural	JJ	B-PROBLEM
effusion	NN	I-PROBLEM
:	:	O
the	DT	O
patient	NN	O
was	VBD	O
noted	VBN	O
have	VBP	O
an	DT	B-PROBLEM
effusion	NN	I-PROBLEM
on	IN	O
cxr	NN	B-TEST
.	.	O

ip	NN	O
was	VBD	O
consulted	VBN	O
and	CC	O
did	VBD	O
a	DT	B-TEST
thoracentesis	NN	I-TEST
.	.	O

the	DT	B-TEST
tap	NN	I-TEST
was	VBD	O
negative	JJ	O
for	IN	O
malignant	JJ	B-PROBLEM
cells	NNS	I-PROBLEM
.	.	O

a	DT	B-TEST
repeat	NN	I-TEST
ct	NN	I-TEST
was	VBD	O
done	VBN	O
showing	VBG	O
nodular	JJ	B-PROBLEM
thickening	NN	I-PROBLEM
along	IN	O
the	DT	O
right	JJ	O
major	JJ	O
and	CC	O
minor	JJ	O
fissure	NN	O
,	,	O
concerning	VBG	O
for	IN	O
intrapleural	JJ	B-PROBLEM
tumor	NN	I-PROBLEM
implants	NNS	I-PROBLEM
.	.	O

ip	NN	O
reviewed	VBD	O
the	DT	B-TEST
films	NNS	I-TEST
and	CC	O
recommended	VBD	O
continue	NN	O
oncologic	NN	B-TREATMENT
care	NN	I-TREATMENT
according	VBG	O
to	TO	O

outpatient	JJ	O
course	NN	O
and	CC	O
pleurodesis	NN	B-TREATMENT
if	IN	O
the	DT	O
pt	NN	O
becomes	VBZ	O
symptomatic	JJ	B-PROBLEM
02-07	JJ	O
fluid	NN	B-PROBLEM
accumulation	NN	I-PROBLEM
.	.	O

#	#	O
foot	JJ	B-PROBLEM
ulcer	NN	I-PROBLEM
:	:	O
diabetic	JJ	B-PROBLEM
ulcer	NN	I-PROBLEM
s/p	NN	O
surgery	NN	B-TREATMENT
but	CC	O
never	RB	O
healed	VBD	O
.	.	O

wound	NN	O
care	NN	O
was	VBD	O
consulted	VBN	O
and	CC	O
made	VBN	O
recommendations	NNS	O
for	IN	O
ulcer	JJ	B-TREATMENT
care	NN	I-TREATMENT
.	.	O

his	PRP$	B-TREATMENT
dressings	NNS	I-TREATMENT
were	VBD	O
changed	VBN	O
by	IN	O
the	DT	O
nursing	NN	O
staff	NN	O
accordingly	RB	O
.	.	O

#	#	O
anemia	NN	B-PROBLEM
:	:	O
his	PRP$	B-TEST
hct	NN	I-TEST
remained	VBD	O
stable	JJ	O
post-surgery	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
his	PRP$	B-TREATMENT
iron	NN	I-TREATMENT
supplements	NNS	I-TREATMENT
.	.	O

-	:	O
iron	NN	B-TREATMENT
sulfate	NN	I-TREATMENT
300	CD	O
mg	NN	O
po	NN	O
tid	NN	O

-	:	O
procrit	NN	B-TREATMENT
40,000	CD	O
units	NNS	O
sc	JJ	O
q	NNS	O
friday	NN	O

-	:	O
lovenox	NN	B-TREATMENT
40	CD	O
mg	NN	O
sc	NN	O
q24	NN	O
for	IN	O
dvt	NN	O
ppx	NN	O

-	:	O
albuterol	NN	B-TREATMENT
/	JJ	O
atrovent	NN	B-TREATMENT
nebs	NN	O
q4	NN	O

-	:	O
morphine	NN	B-TREATMENT
2-4	JJ	O
mg	NN	O
iv	JJ	O
q3-4	JJ	O
prn	NN	O

-	:	O
mylanta	NN	B-TREATMENT
30	CD	O
cc	NN	O
po	NN	O
q6	NN	O
prn	NN	O

-	:	O
pepcid	NN	B-TREATMENT
20	CD	O
mg	NN	O
po	NNS	O
daily	RB	O

-	:	O
insulin	NN	B-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT

-	:	O
glipizide	NN	B-TREATMENT
5	CD	O
mg	NN	O
po	NN	O
bid	NN	O

-	:	O
metformin	NN	B-TREATMENT
500	CD	O
mg	NN	O
po	NN	O
bid	NN	O

-	:	O
metoprolol	NN	B-TREATMENT
50	CD	O
mg	NN	O
po	NNS	O
daily	RB	O

-	:	O
vancomycin	NN	B-TREATMENT
1.5	CD	O
gm	NN	O
q	VBD	O
12	CD	O
hours	NNS	O

1.	CD	O
albuterol	NN	B-TREATMENT
sulfate	VB	I-TREATMENT
0.083	CD	O
%	NN	O
solution	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
inhalation	NN	O
q4h	NN	O
(	(	O
every	DT	O
4	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

2.	CD	O
ipratropium	NN	B-TREATMENT
bromide	RB	I-TREATMENT
0.02	CD	O
%	NN	O
solution	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
inhalation	NN	O
q6h	NN	O
(	(	O
every	DT	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

3.	CD	O
aluminum-magnesium	JJ	B-TREATMENT
hydroxide	JJ	I-TREATMENT
225-200	JJ	O
mg	NN	O
/	$	O
5	CD	O
ml	JJ	O
suspension	NN	O
sig	NN	O
:	:	O
15-30	JJ	O
mls	NN	O
po	NN	O
qid	NN	O
(	(	O
4	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

4.	CD	O
glipizide	JJ	B-TREATMENT
5	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

5.	CD	O
miconazole	JJ	B-TREATMENT
nitrate	RB	I-TREATMENT
2	CD	O
%	NN	O
powder	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
appl	RB	O
topical	JJ	O
tid	NN	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

6.	CD	O
acetaminophen	JJ	B-TREATMENT
325	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
po	NN	O
q6h	NN	O
(	(	O
every	DT	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
fever	NN	B-PROBLEM
or	CC	O
pain	NN	B-PROBLEM
.	.	O

7.	CD	O
metoprolol	JJ	B-TREATMENT
tartrate	NN	I-TREATMENT
25	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
1.5	CD	O
tablets	NNS	O
po	JJ	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

8.	CD	O
cepacol	NN	B-TREATMENT
2	CD	O
mg	NN	O
lozenge	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
lozenge	NN	O
mucous	JJ	O
membrane	NN	O
prn	NN	O
(	(	O
as	IN	O
needed	VBN	O
).	NN	O

9.	CD	O
docusate	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
100	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

10.	CD	O
senna	JJ	B-TREATMENT
8.6	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

11.	CD	O
oxycodone	NN	B-TREATMENT
5	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
1-2	JJ	O
tablets	NNS	O
po	JJ	O
every	DT	O
4-6	JJ	O
hours	NNS	O
as	IN	O
needed	VBN	O
for	IN	O
pain	NN	B-PROBLEM
for	IN	O
14	CD	O
days	NNS	O
.	.	O

12.	CD	O
fluconazole	JJ	B-TREATMENT
200	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
po	NN	O
q24h	NN	O
(	(	O
every	DT	O
24	CD	O
hours	NNS	O
)	)	O
for	IN	O
7	CD	O
days	NNS	O
.	.	O

13.	CD	O
oxycodone	NN	B-TREATMENT
10	CD	O
mg	NN	O
tablet	NN	O
sustained	VBD	O
release	NN	O
12	CD	O
hr	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
sustained	VBD	O
release	NN	O
12hr	CD	O
po	NN	O
q12h	NN	O
(	(	O
every	DT	O
12	CD	O
hours	NNS	O
).	VBP	O

14.	CD	O
bisacodyl	NN	B-TREATMENT
5	CD	O
mg	NN	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

15.	CD	O
aspirin	JJ	B-TREATMENT
81	CD	O
mg	JJ	O
tablet	NN	O
,	,	O
chewable	JJ	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
chewable	JJ	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

16.	CD	O
vancomycin	NN	B-TREATMENT
in	IN	I-TREATMENT
dextrose	JJ	I-TREATMENT
1	CD	O
g	NN	O
/	VBD	O
200	CD	O
ml	NN	O
piggyback	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
intravenous	JJ	O
q	$	O
12h	CD	O
(	(	O
every	DT	O
12	CD	O
hours	NNS	O
):	VBP	O
to	TO	O
finish	VB	O
on	IN	O
2020-05-12	JJ	O
.	.	O

17.	CD	O
pepcid	JJ	B-TREATMENT
20	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
once	RB	O
a	DT	O
day	NN	O
.	.	O

18.	CD	O
heparin	NN	B-TREATMENT
lock	NN	I-TREATMENT
flush	NN	I-TREATMENT
(	(	I-TREATMENT
porcine	NN	I-TREATMENT
)	)	I-TREATMENT
100	CD	O
unit	NN	O
/	NNP	O
ml	NN	O
syringe	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
ml	FW	O
intravenous	JJ	O
daily	JJ	O
(	(	O
daily	RB	O
)	)	O
as	IN	O
needed	VBN	O
:	:	O
10	CD	O
ml	NN	O
ns	NN	B-TREATMENT
followed	VBN	O
by	IN	O
2	CD	O
ml	NNS	O
of	IN	O
100	CD	O
units	NNS	O
/	VBP	O
ml	JJ	O
heparin	NN	B-TREATMENT
(	(	O
200	CD	O
units	NNS	O
heparin	RB	B-TREATMENT
)	)	O
each	DT	O
lumen	JJ	O
daily	JJ	O
and	CC	O
prn	NN	O
.	.	O

19.	CD	O
insulin	NN	B-TREATMENT
glargine	NN	I-TREATMENT
100	CD	O
unit	NN	O
/	NNP	O
ml	NN	O
solution	NN	O
sig	NN	O
:	:	O
four	CD	O
(	(	O
4	CD	O
)	)	O
units	NNS	O
subcutaneous	JJ	O
at	IN	O
dinner	NN	O
time	NN	O
.	.	O

20.	CD	O
insulin	JJ	B-TREATMENT
lispro	NN	I-TREATMENT
(	(	I-TREATMENT
human	JJ	I-TREATMENT
)	)	I-TREATMENT
100	CD	O
unit	NN	O
/	NNP	O
ml	NN	O
cartridge	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
subcutaneous	JJ	O
four	CD	O
times	NNS	O
a	DT	O
day	NN	O
:	:	O
as	IN	O
directed	VBN	O
by	IN	O
sliding	VBG	B-TREATMENT
scale-please	JJ	I-TREATMENT
see	NN	O
attached	VBN	O
scale	NN	O
.	.	O

primary	JJ	O
diagnosis	NN	O
:	:	O
epidural	JJ	B-PROBLEM
abscess	NN	I-PROBLEM

-	:	O
colon	NN	B-PROBLEM
cancer	NN	I-PROBLEM
with	IN	O
mets	NNS	B-PROBLEM
to	TO	I-PROBLEM
liver	VB	I-PROBLEM
s/p	JJ	O
resection	NN	B-TREATMENT
09-07	NN	O
.	.	O

-	:	O
cad	NN	B-PROBLEM
s/p	NN	O
cabg	NN	B-TREATMENT
x4	NN	O
in	IN	O
'	POS	O
03	CD	O
.	.	O

-	:	O
hypercholesterolemia	NN	B-PROBLEM

-	:	O
dm	NN	B-PROBLEM
with	IN	O
neuropathy	JJ	B-PROBLEM
.	.	O

-	:	O
persistent	NN	B-PROBLEM
r	JJ	I-PROBLEM
foot	NN	I-PROBLEM
ulcer	NN	I-PROBLEM

stable	JJ	O
,	,	O
afebrile	JJ	B-PROBLEM

you	PRP	O
were	VBD	O
diagnosed	VBN	O
with	IN	O
an	DT	B-PROBLEM
epidural	JJ	I-PROBLEM
abscess	NN	I-PROBLEM
.	.	O

continue	NN	O
to	TO	O
take	VB	O
the	DT	B-TREATMENT
antibiotics	NNS	I-TREATMENT
as	IN	O
directed	VBN	O
.	.	O

take	VB	O
the	DT	B-TREATMENT
pain	NN	I-TREATMENT
medication	NN	I-TREATMENT
as	IN	O
directed	VBN	O
and	CC	O
do	VBP	O
not	RB	O
drive	VB	O
while	IN	O
taking	VBG	O
this	DT	B-TREATMENT
medication	NN	I-TREATMENT
.	.	O

-	:	O
fever	NN	B-PROBLEM
>	VBZ	O
102	CD	O

-	:	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
or	CC	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM

-	:	O
worsening	NN	B-PROBLEM
pain	NN	I-PROBLEM
or	CC	O
weakness	NN	B-PROBLEM
in	IN	I-PROBLEM
your	PRP$	I-PROBLEM
legs	NNS	I-PROBLEM
,	,	O
loss	NN	B-PROBLEM
of	IN	I-PROBLEM
bowel	NN	I-PROBLEM
or	CC	I-PROBLEM
bladder	NN	I-PROBLEM
function	NN	I-PROBLEM
or	CC	O
any	DT	B-PROBLEM
other	JJ	I-PROBLEM
concerning	NN	I-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O

morphine	NN	B-TREATMENT
/	NNP	O
histamine	NN	B-TREATMENT
h2	NN	I-TREATMENT
inhibitors	NNS	I-TREATMENT
/	VBP	O
heparin	NN	B-TREATMENT
agents	NNS	I-TREATMENT

increasing	VBG	B-PROBLEM
abdominal	JJ	I-PROBLEM
girth	NN	I-PROBLEM

4u	CD	B-TREATMENT
ffp	NN	I-TREATMENT

paracentesis	NN	B-TREATMENT

47	CD	O
female	JJ	O
with	IN	O
h/o	JJ	O
hcv	NN	B-PROBLEM
cirrhosis	NN	I-PROBLEM
compocated	VBN	O
by	IN	O
encephalopathy	NN	B-PROBLEM
,	,	O
ascites	NNS	B-PROBLEM
,	,	O
and	CC	O
h/o	JJ	O
portal	JJ	B-PROBLEM
vein	NN	I-PROBLEM
thrombosis	NN	I-PROBLEM
(	(	O
right	JJ	O
anterior	NN	O
portal	JJ	O
vein	NN	O
)	)	O
and	CC	O
portalcaval	JJ	B-TREATMENT
shunt	NN	I-TREATMENT
(	(	O
reversed	VBN	O
flow	NN	O
in	IN	O
main	JJ	O
portal	JJ	O
vein	NN	O
)	)	O
presents	NNS	O
from	IN	O
liver	JJ	O
clinic	NN	O
with	IN	O
increasing	VBG	B-PROBLEM
abdominal	JJ	I-PROBLEM
girth	NN	I-PROBLEM
.	.	O

she	PRP	O
also	RB	O
described	VBD	O
sob	JJ	B-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
,	,	O
worsening	VBG	B-PROBLEM
lower	JJR	I-PROBLEM
ext	JJ	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

she	PRP	O
denied	VBD	O
abd	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
fevers	NNS	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
admitted	VBN	O
for	IN	O
a	DT	B-TREATMENT
large	JJ	I-TREATMENT
volume	NN	I-TREATMENT
paracentesis	NN	I-TREATMENT
but	CC	O
her	PRP$	B-TEST
inr	NN	I-TEST
on	IN	O
admission	NN	O
was	VBD	O
3.8	CD	O
.	.	O

she	PRP	O
received	VBD	O
4units	CD	O
of	IN	O
ffp	NN	B-TREATMENT
which	WDT	O
decreased	VBD	O
her	PRP	B-TEST
inr	NN	I-TEST
to	TO	O
2.2	CD	O
and	CC	O
then	RB	O
2	CD	O
more	JJR	O
units	NNS	O
during	IN	O
the	DT	B-TREATMENT
tap	NN	I-TREATMENT
.	.	O

she	PRP	O
then	RB	O
had	VBD	O
6l	CD	O
of	IN	O
non-bloody	JJ	B-PROBLEM
ascitic	JJ	I-PROBLEM
fluid	NN	I-PROBLEM
removed	VBD	O
without	IN	O
complication	NN	B-PROBLEM
.	.	O

she	PRP	O
received	VBD	O
36gm	CD	O
of	IN	O
albumin	NN	B-TREATMENT
following	VBG	O
the	DT	B-TREATMENT
tap	NN	I-TREATMENT
.	.	O

her	PRP$	B-TEST
bp	NN	I-TEST
on	IN	O
admission	NN	O
was	VBD	O
120/70	CD	O
and	CC	O
remained	VBD	O
stable	JJ	O
following	VBG	O
the	DT	B-TREATMENT
tap	NN	I-TREATMENT
.	.	O

over	IN	O
the	DT	O
next	JJ	O
several	JJ	O
hours	NNS	O
,	,	O
pt	NN	O
complained	VBD	O
of	IN	O
abd	JJ	B-PROBLEM
pain	NN	I-PROBLEM
but	CC	O
this	DT	O
resolved	VBD	O
on	IN	O
its	PRP$	O
own	JJ	O
without	IN	O
medication	NN	B-TREATMENT
.	.	O

in	IN	O
the	DT	O
am	VBP	O
,	,	O
she	PRP	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	B-TEST
hct	NN	I-TEST
of	IN	O
24	CD	O
,	,	O
down	RB	O
from	IN	O
32	CD	O
and	CC	O
plts	NNS	B-TEST
35	CD	O
,	,	O
down	RB	O
from	IN	O
72	CD	O
.	.	O

she	PRP	O
received	VBD	O
2	CD	O
units	NNS	O
of	IN	O
plts	NNS	B-TREATMENT
and	CC	O
1	CD	O
unit	NN	O
of	IN	O
prbc	NN	B-TREATMENT
s.	NN	I-TREATMENT

her	PRP$	B-TEST
bp	NN	I-TEST
was	VBD	O
then	RB	O
noted	VBN	O
to	TO	O
be	VB	O
decreased	VBN	B-PROBLEM
at	IN	O
80/40	CD	O
which	WDT	O
improved	VBD	O
mildly	RB	O
to	TO	O
90/30	CD	O
with	IN	O
1.5l	CD	O
of	IN	O
ns	NN	B-TREATMENT
.	.	O

temp	RB	B-TEST
noted	VBN	O
to	TO	O
be	VB	O
low	JJ	B-PROBLEM
at	IN	O
94	CD	O
and	CC	O
she	PRP	O
was	VBD	O
placed	VBN	O
on	IN	O
bear	NN	B-TREATMENT
hugger	NN	I-TREATMENT
which	WDT	O
improved	VBD	O
temp	NNS	B-TEST
to	TO	O
96.7	CD	O
.	.	O

her	PRP$	O
mental	JJ	O
status	NN	O
also	RB	O
had	VBD	O
decreased	VBN	B-PROBLEM
from	IN	O
admission	NN	O
and	CC	O
her	PRP$	B-TEST
urine	JJ	I-TEST
output	NN	I-TEST
was	VBD	O
minimal	JJ	B-PROBLEM
,	,	O
225cc	CD	O
over	IN	O
the	DT	O
past	JJ	O
12	CD	O
hours	NNS	O
.	.	O

creatinine	NN	B-TEST
this	DT	O
am	VBP	O
was	VBD	O
1.9	CD	O
from	IN	O
0.9	CD	O
yesterday	NN	O
.	.	O

she	PRP	O
was	VBD	O
recently	RB	O
hospitalised	VBN	O
from	IN	O
02-23	JJ	O
/	JJ	O
03-04	NN	O
for	IN	O
abdominal	JJ	B-PROBLEM
discomfort	NN	I-PROBLEM
at	IN	O
which	WDT	O
time	NN	O
she	PRP	O
underwent	JJ	O
paracentesis	NN	B-TREATMENT
that	WDT	O
ruled	VBD	O
out	RP	O
sbp	NN	B-PROBLEM
and	CC	O
relieved	VBD	O
her	PRP$	B-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

she	PRP	O
also	RB	O
underwent	VBD	O
us	PRP	B-TEST
that	IN	O
revealed	VBD	O
patent	NN	O
portal	NN	O
and	CC	O
hepatic	JJ	O
vessels	NNS	O
.	.	O

while	IN	O
her	PRP$	O
discharge	NN	O
summary	JJ	O
maintains	NNS	O
that	IN	O
she	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
furosemide	NN	B-TREATMENT
/	NNP	O
spirinolactone	NN	B-TREATMENT
/	NNP	O
propranolol	NN	B-TREATMENT
,	,	O
the	DT	O
patient	NN	O
did	VBD	O
not	RB	O
receive	VB	O
any	DT	O
scripts	NNS	O
on	IN	O
discharge	NN	O
and	CC	O
as	IN	O
a	DT	O
result	NN	O
did	VBD	O
not	RB	O
take	VB	O
these	DT	B-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

also	RB	O
,	,	O
due	JJ	O
to	TO	O
worsening	VBG	B-PROBLEM
renal	JJ	I-PROBLEM
function	NN	I-PROBLEM
,	,	O
she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
octreotide	NN	B-TREATMENT
/	NNP	O
midodrine	NN	B-TREATMENT
/	NNP	O
albumin	NN	B-TREATMENT
for	IN	O
hepatorenal	JJ	O

syndrome	NN	B-PROBLEM
(	(	O
cr	JJ	B-TEST
3.3	CD	O
at	IN	O
its	PRP$	O
worst	JJS	O
)	)	O
which	WDT	O
resolved	VBD	O
prior	RB	O
to	TO	O
her	PRP$	O
discharge	NN	O
.	.	O

the	DT	O
hospitalisation	NN	O
was	VBD	O
also	RB	O
significant	JJ	O
for	IN	O
mild	JJ	B-PROBLEM
dic	NN	I-PROBLEM
for	IN	O
which	WDT	O
she	PRP	O
received	VBD	O
cryoglobulins	NNS	B-TREATMENT
and	CC	O
uti	JJ	B-PROBLEM
(+	NNP	O
enterococcus	NN	B-PROBLEM
and	CC	O
+	NNP	O
klebsiella	NN	B-PROBLEM
).	NN	O

she	PRP	O
received	VBD	O
a	DT	O
7	CD	O
day	NN	O
course	NN	O
of	IN	O
amoxicillin	NN	B-TREATMENT
for	IN	O
which	WDT	O
enterococcus	NN	B-PROBLEM
was	VBD	O
sensitive	JJ	O
but	CC	O
klebsiella	JJ	B-PROBLEM
unknown	JJ	O
.	.	O

hcv	JJ	B-PROBLEM
cirrhosis	NN	I-PROBLEM
c/b	NN	O
esophageal	NN	B-PROBLEM
varices	NNS	I-PROBLEM
,	,	O
ascites	NNS	B-PROBLEM
,	,	O
partial	JJ	B-PROBLEM
portal	NN	I-PROBLEM
vein	NN	I-PROBLEM
thrombosis	NN	I-PROBLEM

h/o	NN	O
gastritis	NN	B-PROBLEM

morbid	NN	B-PROBLEM
obesity	NN	I-PROBLEM

recent	JJ	O
cholecystitis	NN	B-PROBLEM
08-10	NN	O

sickle	NN	B-PROBLEM
cell	NN	I-PROBLEM
trait	NN	I-PROBLEM

physical	JJ	O
exam	NN	O
:	:	O
t	NN	B-TEST
95	CD	O
,	,	O
bp	NN	B-TEST
120/70	CD	O
,	,	O
hr	NN	B-TEST
82	CD	O
,	,	O
rr	NN	B-TEST
20	CD	O
,	,	O
96%	CD	O
ra	NN	O
wt	VBD	B-TEST
301.6	CD	O
lb	NN	O

heent	NN	O
:	:	O
+	JJ	O
scleral	JJ	B-PROBLEM
icterus	NN	I-PROBLEM
.	.	O

no	DT	O
thrush	NN	B-PROBLEM
.	.	O

cardiac	NN	O
:	:	O
rrr	NN	O
,	,	O
no	DT	O
murmurs	NN	B-PROBLEM

abdomen	NNS	O
:	:	O
obese	JJ	B-PROBLEM
,	,	O
soft	JJ	O
,	,	O
mildly	RB	B-PROBLEM
distended	VBD	I-PROBLEM
dull	NN	B-PROBLEM
to	TO	O
percussion	NN	B-TEST
throughout	IN	O
,	,	O
no	DT	O
tenderness	NN	B-PROBLEM
,	,	O
liver	RB	B-PROBLEM
non-palpable	JJ	I-PROBLEM
due	JJ	O
to	TO	O
large	JJ	B-PROBLEM
volume	NN	I-PROBLEM
of	IN	I-PROBLEM
ascited	JJ	I-PROBLEM

extremities	NNS	O
:	:	O
05-09	JJ	O
+	NNP	O
pretibial	NN	B-PROBLEM
edema	NN	I-PROBLEM
extending	VBG	O
above	IN	O
knee	NN	O
r	NN	O
>	NNP	O
l	NN	O
,	,	O
no	DT	O
asterixis	NN	B-PROBLEM
.	.	O

no	DT	O
palmar	NN	B-PROBLEM
erythema	NN	I-PROBLEM

2015-03-26	JJ	O
10:10	CD	O
am	VBP	O
blood	NN	B-TEST
wbc	NN	B-TEST
-	:	O
8.1	CD	O
rbc	NN	B-TEST
-	:	O
3.69	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
11.0	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
32.4	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
88	CD	O
mch	SYM	B-TEST
-	:	O
29.8	CD	O
mchc	SYM	B-TEST
-	:	O
33.9	CD	O
rdw	NN	B-TEST
-	:	O
26.0	CD	O
*	JJ	O
plt	NN	B-TEST
ct	SYM	I-TEST
-	:	O
72	CD	O
*#	NN	O

2015-03-26	JJ	O
10:10	CD	O
am	VBP	O
blood	NN	B-TEST
neuts	NNS	B-TEST
-	:	O
68.3	CD	O
bands	NNS	B-TEST
-	:	O
0	CD	O
lymphs	SYM	B-TEST
-	:	O
19.8	CD	O
monos	NNS	B-TEST
-	:	O
10.6	CD	O
eos	SYM	B-TEST
-	:	O
1.1	CD	O
baso	SYM	B-TEST
-	:	O
0.2	CD	O

2015-03-26	JJ	O
10:10	CD	O
am	VBP	O
blood	NN	B-TEST
hypochr	NN	B-TEST
-	:	O
1	CD	O
+	NN	O
anisocy	SYM	B-TEST
-	:	O
2	CD	O
+	NN	O
poiklo	NN	B-TEST
-	:	O
2	CD	O
+	NN	O
macrocy	SYM	B-TEST
-	:	O
2	CD	O
+	NN	O
microcy	SYM	B-TEST
-	:	O
normal	JJ	O
polychr	JJ	B-TEST
-	:	O
normal	JJ	O
ovalocy	JJ	B-TEST
-	:	O
occasional	JJ	O
target	NN	B-TEST
-	:	O
occasional	JJ	O
schisto	NN	B-TEST
-	:	O
occasional	JJ	O
tear	JJ	O
dr	NN	O
clark	NN	O

2015-03-26	JJ	O
10:10	CD	O
am	VBP	O
blood	NN	B-TEST
pt	NN	B-TEST
-	:	O
23.0	CD	O
*	NN	O
ptt	NN	B-TEST
-	:	O
63.2	CD	O
*	NN	O
inr(pt)	NN	B-TEST
-	:	O
3.8	CD	O

2015-03-26	JJ	O
10:10	CD	O
am	VBP	O
blood	NN	B-TEST
glucose	JJ	B-TEST
-	:	O
76	CD	O
urean	JJ	B-TEST
-	:	O
17	CD	O
creat	NN	B-TEST
-	:	O
0.8	CD	O
na	SYM	B-TEST
-	:	O
129	CD	O
*	NN	O
k	SYM	B-TEST
-	:	O
3.9	CD	O
cl	NN	B-TEST
-	:	O
101	CD	O
hco3	NN	B-TEST
-	:	O
19	CD	O
*	NN	O
angap	NN	B-TEST
-	:	O
13	CD	O

2015-03-26	JJ	O
10:10	CD	O
am	VBP	O
blood	NN	B-TEST
alt	NN	B-TEST
-	:	O
33	CD	O
ast	IN	B-TEST
-	:	O
65	CD	O
*	NN	O
alkphos	SYM	B-TEST
-	:	O
70	CD	O
totbili	SYM	B-TEST
-	:	O
30.3	CD	O
*	NN	O
dirbili	NN	B-TEST
-	:	O
20.8	CD	O
*	NN	O
indbili	NN	B-TEST
-	:	O
9.5	CD	O

2015-03-26	JJ	O
10:10	CD	O
am	VBP	O
blood	NN	B-TEST
albumin	NN	B-TEST
-	:	O
3.1	CD	O
*	NN	O

2015-03-26	JJ	O
10:10	CD	O
am	VBP	O
blood	NN	B-TEST
ammonia	NN	B-TEST
-	:	O
39	CD	O

1.	CD	O
small	JJ	B-PROBLEM
cirrhotic	JJ	I-PROBLEM
liver	NN	I-PROBLEM
with	IN	O
what	WP	O
appears	VBZ	O
to	TO	O
be	VB	O
a	DT	B-TREATMENT
portocaval	JJ	I-TREATMENT
shunt	NN	I-TREATMENT
.	.	O

2.	CD	O
moderate	JJ	B-PROBLEM
ascites	NNS	I-PROBLEM
.	.	O

3.	CD	O
cholelithiasis	NN	B-PROBLEM
without	IN	O
evidence	NN	O
of	IN	O
acute	JJ	B-PROBLEM
cholecystitis	NN	I-PROBLEM
.	.	O

4.	CD	O
no	DT	O
hydronephrosis	NN	B-PROBLEM
.	.	O

5.	CD	O
borderline	NN	B-PROBLEM
splenomegaly	NN	I-PROBLEM
.	.	O

a/p	NN	O
:	:	O
48	CD	O
yo	NNS	O
morbidly	RB	O
obese	JJ	O
woman	NN	O
with	IN	O
hcv	JJ	B-PROBLEM
cirrhosis	NN	I-PROBLEM
c/b	NN	O
encephalopathy	NN	B-PROBLEM
,	,	O
esophageal	JJ	B-PROBLEM
varices	NNS	I-PROBLEM
and	CC	O
partial	JJ	B-PROBLEM
vein	NN	I-PROBLEM
thrombosis	NN	I-PROBLEM
(	(	O
but	CC	O
no	DT	O
hx	NN	O
of	IN	O
sbp	NN	B-PROBLEM
)	)	O
presents	VBZ	O
with	IN	O
increasing	VBG	B-PROBLEM
abdominal	JJ	I-PROBLEM
girth	NN	I-PROBLEM
likely	RB	O
secondary	JJ	O
to	TO	O
ascites	NNS	B-PROBLEM
.	.	O

admitted	VBN	O
for	IN	O
diagnostic	JJ	B-TREATMENT
/	NNP	I-TREATMENT
therapeutic	JJ	I-TREATMENT
paracentesis	NN	I-TREATMENT
and	CC	O
then	RB	O
transferred	VBD	O
to	TO	O
the	DT	O
icu	NN	O
for	IN	O
hypotension	NN	B-PROBLEM
,	,	O
confusion	NN	B-PROBLEM
and	CC	O
anemia	NN	B-PROBLEM
.	.	O

#	#	O
liver	JJ	B-PROBLEM
cirrhosis	NN	I-PROBLEM
:	:	O
meld	NN	B-TEST
score	NN	I-TEST
of	IN	O
34	CD	O
on	IN	O
admission	NN	O
.	.	O

pt	NN	O
became	VBD	O
more	RBR	B-PROBLEM
encephalopathic	JJ	I-PROBLEM
during	IN	O
her	PRP$	O
hospital	JJ	O
course	NN	O
.	.	O

she	PRP	O
was	VBD	O
not	RB	O
a	DT	O
transplant	JJ	O
candidate	NN	O
due	JJ	O
to	TO	O
her	PRP$	B-PROBLEM
obesity	NN	I-PROBLEM
.	.	O

after	IN	O
it	PRP	O
was	VBD	O
explained	VBN	O
that	IN	O
the	DT	B-PROBLEM
pt	NN	I-PROBLEM
's	POS	I-PROBLEM
prognosis	NN	I-PROBLEM
was	VBD	O
very	RB	O
poor	JJ	O
given	VBN	O
that	IN	O
she	PRP	O
was	VBD	O
not	RB	O
a	DT	B-TREATMENT
transplant	JJ	I-TREATMENT
candidate	NN	O
,	,	O
the	DT	O

decision	NN	O
was	VBD	O
made	VBN	O
by	IN	O
the	DT	O
family	NN	O
and	CC	O
the	DT	O
medical	JJ	O
team	NN	O
to	TO	O
withdraw	VB	O
care	NN	B-TREATMENT
.	.	O

#	#	O
recurrent	NN	B-PROBLEM
ascites	NNS	I-PROBLEM
:	:	O
on	IN	O
the	DT	O
medical	JJ	O
floor	NN	O
,	,	O
pt	NN	O
had	VBD	O
a	DT	B-TREATMENT
large	JJ	I-TREATMENT
volume	NN	I-TREATMENT
paracentesis	NN	I-TREATMENT
(	(	O
6	CD	O
liters	NNS	O
)	)	O
followed	VBN	O
by	IN	O
replacement	NN	B-TREATMENT
with	IN	I-TREATMENT
albumin	NN	I-TREATMENT
.	.	O

she	PRP	O
had	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
sbp	NN	B-PROBLEM
.	.	O

#	#	O
hypotension	NN	B-PROBLEM
:	:	O
pt	NN	O
became	VBD	O
hypotensive	JJ	B-PROBLEM
following	VBG	O
the	DT	B-TREATMENT
large	JJ	I-TREATMENT
volume	NN	I-TREATMENT
paracentesis	NN	I-TREATMENT
despite	IN	O
replacement	NN	B-TREATMENT
with	IN	I-TREATMENT
albumin	NN	I-TREATMENT
.	.	O

this	DT	O
was	VBD	O
thought	VBN	O
to	TO	O
be	VB	O
04-09	JJ	O
the	DT	B-TREATMENT
large	JJ	I-TREATMENT
volume	NN	I-TREATMENT
tap	NN	I-TREATMENT
verses	VBZ	O
sepsis	NN	B-PROBLEM
though	IN	O
she	PRP	O
had	VBD	O
no	DT	O
other	JJ	O
evidence	NN	O
of	IN	O
sepsis	NN	B-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
placed	VBN	O
on	IN	O
pressors	NNS	B-TREATMENT
to	TO	O
maintain	VB	O
a	DT	B-TEST
map	NN	I-TEST
>	NN	O
55	CD	O
.	.	O

once	RB	O
the	DT	O
decision	NN	O
was	VBD	O
made	VBN	O
to	TO	O
withdraw	VB	O
care	NN	O
,	,	O
the	DT	B-TREATMENT
pressors	NNS	I-TREATMENT
were	VBD	O
discontinued	VBN	O
.	.	O

#	#	O
anemia	NN	B-PROBLEM
:	:	O
hct	NN	B-PROBLEM
dropped	VBD	I-PROBLEM
following	VBG	O
the	DT	B-TREATMENT
tap	NN	I-TREATMENT
and	CC	O
there	EX	O
was	VBD	O
concern	NN	O
for	IN	O
bleed	NN	B-PROBLEM
into	IN	I-PROBLEM
her	PRP$	I-PROBLEM
abdomen	NNS	I-PROBLEM
.	.	O

she	PRP	O
received	VBD	O
one	CD	O
unit	NN	O
of	IN	O
prbc	NN	B-TREATMENT
s.	NN	I-TREATMENT

ct	NN	B-TEST
of	IN	I-TEST
the	DT	I-TEST
abdomen	NNS	I-TEST
and	CC	I-TEST
pelvis	NN	I-TEST
showed	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
bleed	NN	B-PROBLEM
.	.	O

her	PRP$	B-TEST
hematocrit	NN	I-TEST
remained	VBD	O
stable	JJ	O
at	IN	O
24-26	JJ	O
following	VBG	O
the	DT	B-PROBLEM
acute	JJ	I-PROBLEM
drop.	NN	I-PROBLEM

#	#	O
arf	NN	B-PROBLEM
:	:	O
creatinine	NN	B-TEST
has	VBZ	O
increased	VBN	O
from	IN	O
0.9	CD	O
on	IN	O
admission	NN	O
to	TO	O
1.9	CD	O
on	IN	O
admission	NN	O
to	TO	O
icu	VB	O
.	.	O

urine	JJ	B-TEST
lytes	VBZ	I-TEST
with	IN	O
na	NN	B-TEST
of	IN	O
10	CD	O
indicating	VBG	O
either	CC	O
pre-renal	JJ	B-PROBLEM
or	CC	O
hepatorenal	JJ	B-PROBLEM
.	.	O

fluid	NN	B-TEST
challenge	NN	I-TEST
with	IN	O
36gm	CD	O
of	IN	O
albumin	NN	B-TREATMENT
,	,	O
one	CD	O
unit	NN	O
of	IN	O
prbcs	NN	B-TREATMENT
and	CC	O
2l	CD	O
of	IN	O
ns	NN	B-TREATMENT
.	.	O

will	MD	O
check	VB	O
creatinine	VB	B-TEST
this	DT	O
afternoon	NN	O
.	.	O

pt	NN	O
previously	RB	O
diagnosed	VBN	O
with	IN	O
hepatorenal	JJ	B-PROBLEM
and	CC	O
was	VBD	O
started	VBN	O
on	IN	O
midodrine	NN	B-TREATMENT
,	,	O
octreotide	RB	B-TREATMENT
and	CC	O
albumin	RB	B-TREATMENT
;	:	O
these	DT	O
were	VBD	O

her	PRP$	B-TEST
creatinine	NN	I-TEST
continued	VBD	O
to	TO	O
increase	VB	O
,	,	O
likely	RB	O
due	JJ	O
to	TO	O
her	PRP$	B-PROBLEM
worsening	VBG	I-PROBLEM
liver	JJ	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

rifaximine	NN	B-TREATMENT
200	CD	O
mg	NN	O
tid	NN	O

lactulose	RB	B-TREATMENT
30	CD	O
cc	NN	O
qid	NN	O
titrated	VBD	O
to	TO	O
3-4	JJ	O
bm	JJ	O
/	NNS	O
day	NN	O

protonix	NN	B-TREATMENT
40	CD	O
mg	NN	O
po	NN	O
qd	NN	O

expired	VBD	B-PROBLEM

maternal	JJ	B-TEST
blood	NN	I-TEST
type	NN	I-TEST
0-positive	JJ	O
,	,	O
dat	JJ	B-TEST
negative	JJ	O
,	,	O
negative	JJ	O
,	,	O
rpr	JJ	B-TEST
nonreactive	NN	O
.	.	O

1.	CD	O
tuberculosis	NN	B-PROBLEM
,	,	O
mother	NN	O
was	VBD	O
treated	VBN	O
in	IN	O
2001	CD	O
according	VBG	O
to	TO	O
chart	NN	O
with	IN	O
subsequent	JJ	O
negative	JJ	O
chest	NN	B-TEST
x-ray	NN	I-TEST
,	,	O
and	CC	O

2.	CD	O
infertility	NN	B-PROBLEM
.	.	O

the	DT	O
pregnancy	NN	O
was	VBD	O
complicated	VBN	O
by	IN	O
twin	JJ	B-PROBLEM
gestation	NN	I-PROBLEM
and	CC	O
by	IN	O
polyhydramnios	NNS	B-PROBLEM
with	IN	O
apparent	JJ	O
duodenal	JJ	B-PROBLEM
atresia	NN	I-PROBLEM
and	CC	O
nuchal	NN	O

thickening	VBG	B-PROBLEM
consistent	JJ	O
with	IN	O
trisomy	JJ	B-PROBLEM
21	CD	I-PROBLEM
in	IN	O
the	DT	O
b	NN	O
co-twin	NN	O
.	.	O

amniocentesis	NN	B-TEST
was	VBD	O
not	RB	O
performed	VBN	O
.	.	O

maternal	JJ	B-PROBLEM
hypertension	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
in	IN	O
the	DT	O
doctor	NN	O
's	POS	O
office	NN	O
and	CC	O
mom	NN	O
was	VBD	O
referred	VBN	O
to	TO	O
nonreassuring	VBG	B-TEST
fetal	JJ	I-TEST
tracing	NN	I-TEST
,	,	O
necessitating	VBG	O
an	DT	B-TREATMENT
urgent	JJ	I-TREATMENT
cesarean	JJ	I-TREATMENT
section	NN	I-TREATMENT
.	.	O

twin	NN	O
#1	NNP	O
cried	VBD	O
spontaneously	RB	O
at	IN	O
birth	NN	O
,	,	O
was	VBD	O
bulb	VBN	B-TREATMENT
suctioned	JJ	I-TREATMENT
and	CC	O
received	VBD	O
blow-by	JJ	B-TREATMENT
oxygen	NN	I-TREATMENT
.	.	O

apgars	NNS	B-TEST
were	VBD	O
8	CD	O
at	IN	O
one	CD	O
minute	NN	O
and	CC	O
8	CD	O
at	IN	O
five	CD	O
minutes	NNS	O
.	.	O

twin	NN	O
#1	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
in	IN	O
a	DT	B-PROBLEM
breech	JJ	I-PROBLEM
presentation	NN	I-PROBLEM
.	.	O

sepsis	NN	B-PROBLEM
risk	NN	I-PROBLEM
factors	NNS	I-PROBLEM
:	:	O

no	DT	O
fever	NN	B-PROBLEM
,	,	O
no	DT	O
fetal	JJ	B-PROBLEM
tachycardia	NN	I-PROBLEM
,	,	O
rupture	NN	B-PROBLEM
of	IN	I-PROBLEM
membranes	NNS	I-PROBLEM
at	IN	O
delivery	NN	O
.	.	O

group	NN	B-TEST
b	VBD	I-TEST
streptococcus	NN	I-TEST
status	NN	I-TEST
unknown	JJ	O
.	.	O

well-appearing	JJ	O
female	NN	O
without	IN	O
distress	NN	B-PROBLEM
on	IN	O
admission	NN	O
to	TO	O
the	DT	O
newborn	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TEST
weight	NN	I-TEST
of	IN	O
1400	CD	O
gm	NN	O
,	,	O
length	NN	B-TEST
41.5	CD	O
cm	NN	O
and	CC	O
head	NN	B-TEST
circumference	NN	I-TEST
of	IN	O
29.25	CD	O
cm	NN	O
.	.	O

anterior	JJ	O
fontanelle	NN	O
,	,	O
soft	JJ	O
and	CC	O
flat	JJ	O
,	,	O
palate	JJ	O
intact	NN	O
,	,	O
nondysmorphic	JJ	B-PROBLEM
features	NNS	I-PROBLEM
.	.	O

lungs	NNS	O
:	:	O
breath	NN	B-TEST
sounds	VBZ	I-TEST
clear	JJ	O
and	CC	O
equal	JJ	O
bilaterally	RB	O
,	,	O
no	DT	O
retractions	NNS	B-PROBLEM
.	.	O

heart	NN	O
:	:	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
,	,	O
no	DT	O
murmur	NN	B-PROBLEM
,	,	O
normal	JJ	O
s1	NN	O
and	CC	O
s2	NN	O
,	,	O
pulses	VBZ	B-TEST
2	CD	O
+.	NN	O

abdomen	NNS	O
:	:	O
soft	JJ	O
,	,	O
nondistended	JJ	B-PROBLEM
.	.	O

without	IN	O
hepatosplenomegaly	NN	B-PROBLEM
,	,	O
without	IN	O
masses	NNS	B-PROBLEM
.	.	O

positive	JJ	O
suck	NN	B-TEST
,	,	O
positive	JJ	O
grasp	NN	B-TEST
.	.	O

1.	CD	O
respiratory	JJ	O
-	:	O
gerardo	NN	O
was	VBD	O
initially	RB	O
placed	VBN	O
in	IN	O
nasal	JJ	B-TREATMENT
cannula	NN	I-TREATMENT
oxygen	NN	I-TREATMENT
to	TO	O
maintain	VB	O
oxygen	NN	B-TEST
saturation	NN	I-TEST
greater	JJR	O
than	IN	O
94	CD	O
.	.	O

on	IN	O
day	NN	O
of	IN	O
life	NN	O
#1	NNP	O
,	,	O
caffeine	NN	B-TREATMENT
was	VBD	O
started	VBN	O
.	.	O

caffeine	NN	B-TREATMENT
was	VBD	O
discontinued	VBN	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
#19	NN	O
.	.	O

breath	NN	B-TEST
sounds	NNS	I-TEST
,	,	O
clear	JJ	O
and	CC	O
equal	JJ	O
,	,	O
without	IN	O
retractions	NNS	B-PROBLEM
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
30	CD	O
s	NN	O
to	TO	O
60	CD	O
s.	NN	O

2.	CD	O
cardiovascular	JJ	O
-	:	O
the	DT	O
patient	NN	O
has	VBZ	O
been	VBN	O
cardiovascularly	RB	O
stable	JJ	O
without	IN	O
murmur	NN	B-PROBLEM
.	.	O

3.	CD	O
fluids	NNS	O
,	,	O
electrolytes	NNS	O
and	CC	O
nutrition	NN	O
-	:	O
birthweight	NN	B-TEST
was	VBD	O
1400	CD	O
gm	NN	O
,	,	O
25th	CD	O
percentile	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
initially	RB	O
started	VBN	O
on	IN	O
d10	NN	B-TREATMENT
/	NN	I-TREATMENT
w	NN	I-TREATMENT
at	IN	O
80	CD	O
cc	NN	O
/	NNP	O
kg	NN	O
/	NNP	O
day	NN	O
.	.	O

she	PRP	O
began	VBD	O
enteral	JJ	B-TREATMENT
feeds	NNS	I-TREATMENT
on	IN	O
day	NN	O
of	IN	O
life	NN	O
#2	NNP	O
advancing	VBG	O
to	TO	O
mother	VB	O
's	POS	O
breastmilk	NN	O
30	CD	O
with	IN	O
promod	NN	B-TREATMENT
at	IN	O
150	CD	O
cc	NN	O
/	NNP	O
kg	NN	O
/	NNP	O
day	NN	O
.	.	O

baby	NN	O
received	VBD	O
parenteral	JJ	B-TREATMENT
nutrition	NN	I-TREATMENT
and	CC	O
lipids	NNS	B-TREATMENT
for	IN	O
four	CD	O
days	NNS	O
.	.	O

no	DT	O
hypoglycemia	NN	B-PROBLEM
issues	NNS	I-PROBLEM
noted	VBD	O
.	.	O

baby	NN	O
is	VBZ	O
presently	RB	O
tolerating	VBG	O
mother	NN	O
's	POS	O
breastmilk	NN	O
with	IN	O
enfamil	JJ	B-TREATMENT
powder	NN	I-TREATMENT
to	TO	O
make	VB	O
24	CD	O
cal	JJ	O
/	NN	O
oz	NN	O
at	IN	O
130	CD	O
cc	NN	O
/	NNP	O
kg	NN	O
/	NNP	O
day	NN	O
.	.	O

4.	CD	O
gastrointestinal	JJ	O
,	,	O
genitourinary	JJ	O
-	:	O
peak	NN	B-TEST
bilirubin	NN	I-TEST
8.5	CD	O
,	,	O
phototherapy	NN	B-TREATMENT
times	NNS	O
24	CD	O
hours	NNS	O
.	.	O

rebound	NN	B-TEST
bilirubin	VBD	I-TEST
6.4	CD	O
.	.	O

5.	CD	O
hematology	NN	O
-	:	O
most	RBS	O
recent	JJ	O
hematocrit	NN	B-TEST
was	VBD	O
42.8	CD	O
on	IN	O
50-05-25	NNS	O
.	.	O

the	DT	O
baby	NN	O
received	VBD	O
no	DT	O
blood	NN	B-TREATMENT
products	NNS	I-TREATMENT
.	.	O

6.	CD	O
infectious	JJ	O
disease	NN	O
-	:	O
no	DT	O
sepsis	NN	B-PROBLEM
risk	NN	I-PROBLEM
factors	NNS	I-PROBLEM
.	.	O

initial	JJ	B-TEST
complete	JJ	I-TEST
blood	NN	I-TEST
count	NN	I-TEST
with	IN	O
white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
14	CD	O
,	,	O
hemoglobin	NN	B-TEST
21.6	CD	O
,	,	O
hematocrit	NN	B-TEST
62.9	CD	O
,	,	O
65	CD	O
neutrophils	NNS	B-TEST
,	,	O
no	DT	O
bands	NNS	B-TEST
,	,	O
28	CD	O
lymphocytes	NNS	B-TEST
.	.	O

blood	NN	B-TEST
cultures	NNS	I-TEST
negative	JJ	O
.	.	O

8.	CD	O
sensory	JJ	O
-	:	O
audiology	NN	O
,	,	O
hearing	VBG	B-TEST
screening	NN	I-TEST
was	VBD	O
performed	VBN	O
with	IN	O
automated	JJ	O
auditory	NN	O
brain	NN	O
stem	NN	O
responses	NNS	O
.	.	O

baby	NN	O
passed	VBD	O
hearing	VBG	B-TEST
test	NN	I-TEST
on	IN	O
2009-01-21	JJ	O
.	.	O

a	DT	B-TEST
follow	JJ	I-TEST
up	RP	I-TEST
examination	NN	I-TEST
is	VBZ	O
recommended	VBN	O
in	IN	O
six	CD	O
to	TO	O
eight	CD	O
months	NNS	O
.	.	O

1.	CD	O
feeds	NNS	O
-	:	O
breastfeeding	VBG	O
ad	NN	O
lib	NN	O
,	,	O
supplementing	VBG	O
with	IN	O
enfamil	JJ	B-TREATMENT
24	CD	O
or	CC	O
breastmilk	VB	O
24	CD	O
cal	JJ	O
/	NN	O
oz	NN	O
made	VBD	O
with	IN	O
1	CD	O
tsp	NN	O
of	IN	O
enfamil	JJ	B-TREATMENT
powder	NN	I-TREATMENT
per	IN	O
100	CD	O
cc	NN	O
of	IN	O
breastmilk	NN	O
.	.	O

2.	CD	O
medications	NNS	B-TREATMENT
-	:	O
poly-vi-james	RB	B-TREATMENT
1	CD	O
cc	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
;	:	O
iron	NN	B-TREATMENT
or	CC	O
fer-in-james	NNS	B-TREATMENT
0.2	CD	O
cc	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
to	TO	O
give	VB	O
2	CD	O
mg	NN	O
/	NNP	O
kg	NN	O
/	NNP	O
day	NN	O

3.	CD	O
car	NN	B-TEST
seat	NN	I-TEST
screening	VBG	I-TEST
-	:	O
passed	VBN	O
.	.	O

4.	CD	O
state	NN	B-TEST
newborn	JJ	I-TEST
screening	VBG	I-TEST
-	:	O
last	JJ	O
on	IN	O
2009-01-07	JJ	O
,	,	O
all	DT	O
within	IN	O
normal	JJ	O
range	NN	O
.	.	O

5.	CD	O
immunizations	NNS	B-TREATMENT
received	VBD	O
-	:	O
hepatitis	NN	B-TREATMENT
b	NN	I-TREATMENT
vaccine	NN	I-TREATMENT
given	VBN	O
2009-01-22	CD	O
.	.	O

6.	CD	O
immunizations	NNS	B-TREATMENT
recommended	VBD	O
-	:	O

synagis	JJ	B-TREATMENT
respiratory	NN	I-TREATMENT
syncytial	JJ	I-TREATMENT
virus	NN	I-TREATMENT
prophylaxis	NN	I-TREATMENT
should	MD	O
be	VB	O
considered	VBN	O
from	IN	O
october	VBN	O
through	IN	O
april	NN	O
for	IN	O
infants	NNS	O
who	WP	O
meet	VBP	O

3.	CD	O
with	IN	O
chronic	JJ	B-PROBLEM
lung	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

after	IN	O
some	DT	O
debate	NN	O
,	,	O
we	PRP	O
concluded	VBD	O
that	IN	O
vetrano	NN	O
was	VBD	O
not	RB	O
at	IN	O
unusually	RB	O
high	JJ	O
risk	NN	O
from	IN	O
rsv	NN	B-PROBLEM
,	,	O
but	CC	O
that	IN	O
her	PRP$	O
sister	NN	O
might	MD	O
be	VB	O
.	.	O

vetrano	NN	O
probably	RB	O
does	VBZ	O
not	RB	O
need	VB	O
synagis	NNS	B-TREATMENT
at	IN	O
least	JJS	O
until	IN	O
her	PRP$	O
sibling	NN	O
is	VBZ	O
discharged	VBN	O
from	IN	O
the	DT	O
hospital	NN	O
.	.	O

influenza	JJ	B-TREATMENT
immunization	NN	I-TREATMENT
should	MD	O
be	VB	O
considered	VBN	O
annually	RB	O
in	IN	O
the	DT	O
fall	NN	O
for	IN	O
preterm	JJ	O
infants	NNS	O
with	IN	O
chronic	JJ	B-PROBLEM
lung	NN	I-PROBLEM
disease	NN	I-PROBLEM
once	IN	O
they	PRP	O

reach	NN	O
six	CD	O
months	NNS	O
of	IN	O
age	NN	O
,	,	O
before	IN	O
this	DT	O
age	NN	O
the	DT	O
family	NN	O
and	CC	O
other	JJ	O
caregivers	NNS	O
should	MD	O
be	VB	O
considered	VBN	O
for	IN	O
immunization	NN	B-TREATMENT
against	IN	O

influenza	NN	B-PROBLEM
to	TO	O
protect	VB	O
the	DT	O
infant	NN	O
.	.	O

1.	CD	O
prematurity	NN	B-PROBLEM
,	,	O
former	JJ	O
32	CD	O
4/7	CD	O
weeks	NNS	O
,	,	O
twin	NNS	O
#1	VBP	O

2.	CD	O
rule	NN	O
out	IN	O
sepsis	NN	B-PROBLEM

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
49-year-old	JJ	O
gravida	NN	O
iii	NN	O
,	,	O
para	NN	O
ii	NN	O
,	,	O
who	WP	O
was	VBD	O
sent	VBN	O
from	IN	O
her	PRP$	O
primary	JJ	O
care	NN	O
physician	NN	O
's	POS	O
office	NN	O
secondary	NN	O
to	TO	O
lower	VB	B-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
status	NN	O
post	NN	O
uterine	JJ	B-TREATMENT
artery	NN	I-TREATMENT
embolization	NN	I-TREATMENT
on	IN	O
2009-01-07	JJ	O
secondary	JJ	O
to	TO	O
fibroids	NNS	B-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
had	VBD	O
continuing	VBG	B-PROBLEM
vaginal	JJ	I-PROBLEM
discharge	NN	I-PROBLEM
,	,	O
and	CC	O
was	VBD	O
diagnosed	VBN	O
with	IN	O
bacterial	JJ	B-PROBLEM
vaginosis	NN	I-PROBLEM
one	CD	O
day	NN	O
prior	RB	O
to	TO	O
admission	NN	O
,	,	O
and	CC	O
was	VBD	O
given	VBN	O
a	DT	O
prescription	NN	O
for	IN	O
flagyl	NN	B-TREATMENT
.	.	O

she	PRP	O
noted	VBD	O
increasing	VBG	B-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
two	CD	O
days	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
,	,	O
which	WDT	O
became	VBD	O
more	RBR	O
severe	JJ	O
on	IN	O
the	DT	O
day	NN	O
prior	RB	O
to	TO	O
admission	NN	O
.	.	O

she	PRP	O
went	VBD	O
to	TO	O
her	PRP$	O
primary	JJ	O
care	NN	O
physician	NN	O
's	POS	O
office	NN	O
on	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
complaining	NN	O
of	IN	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
which	WDT	O
she	PRP	O
stated	VBD	O
was	VBD	O
constant	JJ	O
but	CC	O
intermittently	RB	O
sharper	JJR	O
at	IN	O
times	NNS	O
.	.	O

she	PRP	O
also	RB	O
complained	VBD	O
of	IN	O
some	DT	B-PROBLEM
loose	JJ	I-PROBLEM
stools	NNS	I-PROBLEM
on	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
,	,	O
no	DT	O
nausea	NN	B-PROBLEM
or	CC	O
vomiting	NN	B-PROBLEM
.	.	O

her	PRP$	B-TEST
temperature	NN	I-TEST
was	VBD	O
100.4	CD	O
in	IN	O
the	DT	O
office	NN	O
,	,	O
and	CC	O
she	PRP	O
had	VBD	O
no	DT	O
chills	NNS	B-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
sent	VBN	O
for	IN	O
a	DT	B-TEST
ct	JJ	I-TEST
scan	NN	I-TEST
of	IN	I-TEST
her	PRP$	I-TEST
abdomen	NNS	I-TEST
,	,	O
which	WDT	O
revealed	VBD	O
fluid	NN	B-PROBLEM
and	CC	O
question	NN	O
of	IN	O
gas	NN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
endometrial	JJ	I-PROBLEM
cavity	NN	I-PROBLEM
,	,	O
and	CC	O
she	PRP	O
was	VBD	O
sent	VBN	O
to	TO	O
pinewood	VB	O
,	,	O
norfolk	FW	O
for	IN	O
treatment	NN	B-TREATMENT
and	CC	O
admission	NN	B-TREATMENT
.	.	O

cesarean	JJ	B-TREATMENT
section	NN	I-TREATMENT
x	VBD	O
2	CD	O
,	,	O
spontaneous	JJ	B-PROBLEM
abortion	NN	I-PROBLEM
x	VBD	O
1	CD	O
.	.	O

some	DT	B-PROBLEM
spotting	NN	I-PROBLEM
on	IN	O
the	DT	O
day	NN	O
prior	RB	O
to	TO	O
admission	NN	O
,	,	O
but	CC	O
not	RB	O
a	DT	O
normal	JJ	O
period	NN	O
.	.	O

lupron	NN	B-TREATMENT
x	NNP	O
three	CD	O
months	NNS	O
prior	RB	O
to	TO	O
embolization	NN	B-TREATMENT
.	.	O

fibroid	JJ	B-PROBLEM
uterus	NN	I-PROBLEM
status	NN	O
post	NN	O
embolization	NN	B-TREATMENT
on	IN	O
2009-01-07	JJ	O
.	.	O

dilatation	NN	B-TREATMENT
and	CC	I-TREATMENT
curettage	NN	I-TREATMENT
x	VBP	O
1	CD	O
for	IN	O
sab	NN	B-PROBLEM
.	.	O

history	NN	O
of	IN	O
herpes	NNS	B-PROBLEM
simplex	JJ	I-PROBLEM
virus	NN	I-PROBLEM
,	,	O
last	JJ	O
outbreak	NN	O
in	IN	O
2000	CD	O
.	.	O

no	DT	O
history	NN	O
of	IN	O
abnormal	JJ	B-PROBLEM
pap	NN	I-PROBLEM
smears	NNS	I-PROBLEM
.	.	O

cesarean	JJ	B-TREATMENT
section	NN	I-TREATMENT
x	VBD	O
2	CD	O
,	,	O
dilatation	NN	B-TREATMENT
and	CC	I-TREATMENT
curettage	NN	I-TREATMENT
x	NN	O
1	CD	O
,	,	O
neck	NN	B-TREATMENT
fusion	NN	I-TREATMENT
after	IN	O
motor	NN	O
vehicle	NN	O
accident	NN	O
,	,	O
shoulder	NN	B-TREATMENT
surgery	NN	I-TREATMENT
after	IN	O
motor	NN	O
vehicle	NN	O
accident	NN	O
.	.	O

flagyl	NN	B-TREATMENT
.	.	O

temperature	NN	B-TEST
100.4	CD	O
,	,	O
pulse	RB	B-TEST
108	CD	O
,	,	O
respirations	NNS	B-TEST
20	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
110/70	CD	O
,	,	O
oxygen	NN	B-TEST
saturation	NN	I-TEST
100%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

in	IN	O
general	JJ	O
,	,	O
she	PRP	O
was	VBD	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

her	PRP$	O
abdomen	NNS	O
was	VBD	O
notable	JJ	O
for	IN	O
voluntary	JJ	B-PROBLEM
guarding	NN	I-PROBLEM
but	CC	O
no	DT	O
involuntary	JJ	B-PROBLEM
guarding	NN	I-PROBLEM
or	CC	O
rebound	NN	B-PROBLEM
,	,	O
mild	VB	B-PROBLEM
right	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
quadrant	NN	I-PROBLEM
tenderness	NN	I-PROBLEM
greater	JJR	O
than	IN	O
left	VBD	O
lower	JJR	O
quadrant	NN	O
,	,	O
nondistended	VBN	B-PROBLEM
.	.	O

her	PRP$	B-TEST
pelvic	JJ	I-TEST
examination	NN	I-TEST
was	VBD	O
notable	JJ	O
for	IN	O
some	DT	B-PROBLEM
brownish	JJ	I-PROBLEM
discharge	NN	I-PROBLEM
.	.	O

her	PRP$	O
uterus	NN	O
and	CC	O
adnexa	NN	O
were	VBD	O
difficult	JJ	O
to	TO	O
assess	VB	O
secondary	JJ	O
to	TO	O
voluntary	JJ	B-PROBLEM
tensing	NN	I-PROBLEM
of	IN	I-PROBLEM
her	PRP$	I-PROBLEM
abdomen	NNS	I-PROBLEM
.	.	O

this	DT	O
is	VBZ	O
a	DT	O
49-year-old	JJ	O
gravida	NN	O
iii	NN	O
,	,	O
para	NN	O
ii	NN	O
,	,	O
status	NN	B-TREATMENT
post	NN	I-TREATMENT
uterine	JJ	I-TREATMENT
artery	NN	I-TREATMENT
embolization	NN	I-TREATMENT
on	IN	O
2009-01-07	JJ	O
due	JJ	O
to	TO	O
uterine	JJ	B-PROBLEM
fibroids	NNS	I-PROBLEM
,	,	O
with	IN	O
continued	JJ	B-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
ct	NN	B-TEST
scan	JJ	I-TEST
revealing	NN	O
fluid	NN	B-PROBLEM
and	CC	I-PROBLEM
gas	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
endometrial	JJ	I-PROBLEM
cavity	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
and	CC	O
was	VBD	O
initially	RB	O
started	VBN	O
on	IN	O
intravenous	JJ	B-TREATMENT
ampicillin	NN	I-TREATMENT
,	,	O
gentamicin	NN	B-TREATMENT
and	CC	O
clindamycin	NN	B-TREATMENT
.	.	O

her	PRP$	B-TEST
initial	JJ	I-TEST
white	JJ	I-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
was	VBD	O
11.3	CD	O
,	,	O
with	IN	O
a	DT	O
normal	JJ	O
differential	NN	O
.	.	O

her	PRP$	B-TEST
sedimentation	NN	I-TEST
rate	NN	I-TEST
was	VBD	O
elevated	VBN	B-PROBLEM
at	IN	O
110	CD	O
.	.	O

her	PRP$	B-TEST
electrolytes	NNS	I-TEST
were	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

she	PRP	O
was	VBD	O
maintained	VBN	O
on	IN	O
intravenous	JJ	B-TREATMENT
antibiotics	NNS	I-TREATMENT
.	.	O

on	IN	O
hospital	JJ	O
day	NN	O
number	NN	O
three	CD	O
,	,	O
her	PRP$	B-TEST
blood	NN	I-TEST
cultures	NNS	I-TEST
came	VBD	O
back	RB	O
positive	JJ	B-PROBLEM
in	IN	O
the	DT	B-TEST
anaerobic	JJ	I-TEST
culture	NN	I-TEST
for	IN	O
gram-positive	JJ	B-PROBLEM
cocci	NN	I-PROBLEM
in	IN	I-PROBLEM
pairs	NNS	I-PROBLEM
and	CC	I-PROBLEM
clusters	NNS	I-PROBLEM
.	.	O

further	JJ	B-TEST
identification	NN	I-TEST
revealed	VBD	O
staphylococcus	JJ	B-PROBLEM
coag-negative	JJ	I-PROBLEM
,	,	O
which	WDT	O
was	VBD	O
sensitive	JJ	O
to	TO	O
gentamicin	VB	B-TREATMENT
and	CC	O
clindamycin	VB	B-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
her	PRP	B-TREATMENT
antibiotics	NNS	I-TREATMENT
,	,	O
and	CC	O
was	VBD	O
afebrile	RB	B-PROBLEM
until	IN	O
hospital	JJ	O
day	NN	O
number	NN	O
five	CD	O
,	,	O
when	WRB	O
she	PRP	O
had	VBD	O
a	DT	B-PROBLEM
temperature	NN	I-PROBLEM
spike	NN	I-PROBLEM
to	TO	O
102.3	CD	O
.	.	O

repeat	NN	B-TEST
blood	NN	I-TEST
cultures	NNS	I-TEST
were	VBD	O
sent	VBN	O
.	.	O

her	PRP$	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
was	VBD	O
12.8	CD	O
,	,	O
with	IN	O
a	DT	O
normal	JJ	O
differential	NN	O
.	.	O

at	IN	O
this	DT	O
time	NN	O
,	,	O
an	DT	O
infectious	JJ	O
disease	NN	O
consult	NN	O
was	VBD	O
obtained	VBN	O
,	,	O
and	CC	O
the	DT	O
recommendation	NN	O
was	VBD	O
to	TO	O
discontinue	VB	O
the	DT	B-TREATMENT
ampicillin	NN	I-TREATMENT
,	,	O
gentamicin	NN	B-TREATMENT
and	CC	O
clindamycin	NN	B-TREATMENT
,	,	O
and	CC	O
start	VB	O
her	PRP$	O
on	IN	O
intravenous	JJ	B-TREATMENT
unasyn	NN	I-TREATMENT
.	.	O

she	PRP	O
underwent	VBD	O
a	DT	B-TEST
pelvic	JJ	I-TEST
ultrasound	NN	I-TEST
and	CC	O
an	DT	B-TEST
abdomen	NNS	I-TEST
and	CC	I-TEST
pelvis	NN	I-TEST
ct	NN	I-TEST
,	,	O
which	WDT	O
revealed	VBD	O
continued	VBD	B-PROBLEM
air	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
endometrial	JJ	I-PROBLEM
cavity	NN	I-PROBLEM
vs.	NN	O
in	IN	O
the	DT	B-PROBLEM
fundal	JJ	I-PROBLEM
fibroid	NN	I-PROBLEM
.	.	O

discussion	NN	O
was	VBD	O
had	VBN	O
at	IN	O
this	DT	O
time	NN	O
with	IN	O
the	DT	O
patient	NN	O
regarding	VBG	O
whether	IN	O
or	CC	O
not	RB	O
this	DT	O
represented	VBD	O
an	DT	B-PROBLEM
infected	JJ	I-PROBLEM
abscess	NN	I-PROBLEM
vs.	IN	O
post-surgical	JJ	B-PROBLEM
change	NN	I-PROBLEM
.	.	O

possible	JJ	O
drainage	NN	B-TREATMENT
of	IN	O
the	DT	B-PROBLEM
abscess	NN	I-PROBLEM
vs.	FW	O
hysterectomy	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
requested	VBD	O
an	DT	O
outside	JJ	O
second	JJ	O
opinion	NN	O
,	,	O
as	IN	O
she	PRP	O
was	VBD	O
reluctant	JJ	O
to	TO	O
undergo	VB	O
hysterectomy	NN	B-TREATMENT
at	IN	O
this	DT	O
time	NN	O
.	.	O

she	PRP	O
was	VBD	O
discharged	VBN	O
to	TO	O
home	NN	O
on	IN	O
hospital	JJ	O
day	NN	O
number	NN	O
eight	CD	O
,	,	O
on	IN	O
oral	JJ	B-TREATMENT
antibiotics	NNS	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
to	TO	O
have	VB	O
a	DT	B-TEST
repeat	NN	I-TEST
ct	JJ	I-TEST
scan	JJ	I-TEST
in	IN	O
one	CD	O
week	NN	O
.	.	O

she	PRP	O
was	VBD	O
also	RB	O
to	TO	O
obtain	VB	O
a	DT	O
second	JJ	O
opinion	NN	O
regarding	VBG	O
the	DT	O
question	NN	O
of	IN	O
possible	JJ	O
surgical	JJ	B-TREATMENT
management	NN	I-TREATMENT
.	.	O

trazodone	NN	B-TREATMENT
/	NNP	O
ambien	NN	B-TREATMENT
/	NNP	O
sinequan	NN	B-TREATMENT

acquired	VBN	B-PROBLEM
defect	NN	I-PROBLEM
from	IN	O
basal	NN	B-TREATMENT
cell	NN	I-TREATMENT
carcinoma	NN	I-TREATMENT
resection	NN	I-TREATMENT

right	RB	B-TREATMENT
nose	JJ	I-TREATMENT
/	NNP	I-TREATMENT
ala	NN	I-TREATMENT
reconstruction	NN	I-TREATMENT
using	VBG	O
right	JJ	B-TREATMENT
cheek	NN	I-TREATMENT
advancement	NN	I-TREATMENT
and	CC	O
forehead	JJ	B-TREATMENT
local	JJ	I-TREATMENT
flap	NN	I-TREATMENT

ms.	NN	O
marshall	NN	O
is	VBZ	O
a	DT	O
64-year	JJ	O
old	JJ	O
,	,	O
mentally	RB	B-PROBLEM
retarded	JJ	I-PROBLEM
,	,	O
female	JJ	O
who	WP	O
presented	VBD	O
with	IN	O
an	DT	B-PROBLEM
aquired	JJ	I-PROBLEM
defect	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
nasal	NN	I-PROBLEM
ala	NN	I-PROBLEM
and	CC	I-PROBLEM
medial	JJ	I-PROBLEM
cheek	NN	I-PROBLEM
region	NN	I-PROBLEM
after	IN	O
basal	NN	B-PROBLEM
cell	NN	I-PROBLEM
carcinoma	NN	I-PROBLEM
was	VBD	O
resected	VBN	O
by	IN	O
dermatology	NN	O
.	.	O

mental	JJ	B-PROBLEM
retardation	NN	I-PROBLEM

diabetes	NNS	B-PROBLEM

bipolar	JJ	B-PROBLEM
disorder	NN	I-PROBLEM

on	IN	O
presentation	NN	O
,	,	O
pt	NN	O
was	VBD	O
afebrile	JJ	B-PROBLEM
with	IN	O
normal	JJ	O
vital	JJ	O
signs	NNS	O

gen	NN	O
:	:	O
no	DT	O
acute	NN	B-PROBLEM
distress	NN	I-PROBLEM
,	,	O
able	JJ	O
to	TO	O
communicate	VB	O
and	CC	O
follow	VB	O
orders	NNS	O

head	NN	O
and	CC	O
neck	NN	O
:	:	O
5	CD	B-PROBLEM
cm	NN	I-PROBLEM
circular	JJ	I-PROBLEM
full	JJ	I-PROBLEM
thickness	NN	I-PROBLEM
defect	NN	I-PROBLEM
at	IN	O
the	DT	O
junction	NN	O
of	IN	O
the	DT	O
right	JJ	O
ala	NN	O
and	CC	O
cheek	NN	O

lungs	NNS	O
:	:	O
clear	JJ	O
to	TO	O
asculation	VB	B-TEST

abdomen	NNS	O
:	:	O
soft	JJ	O
,	,	O
non-tender	JJ	B-PROBLEM
,	,	O
non-distended	JJ	B-PROBLEM

extremities	NNS	O
:	:	O
no	DT	O
edema	NN	B-PROBLEM
,	,	O
cyanosis	NN	B-PROBLEM
,	,	O
full	JJ	O
range	NN	O
of	IN	O
motion	NN	O

upon	IN	O
admission	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
pre-op	JJ	O
'd	NN	O
and	CC	O
made	VBD	O
npo	NNS	B-TREATMENT
/	JJ	O
ivf	NN	B-TREATMENT
.	.	O

she	PRP	O
went	VBD	O
to	TO	O
surgery	VB	B-TREATMENT
the	DT	O
next	JJ	O
morning	NN	O
and	CC	O
tolerated	VBD	O
the	DT	B-TREATMENT
surgery	NN	I-TREATMENT
well	RB	O
.	.	O

however	RB	O
,	,	O
she	PRP	O
was	VBD	O
slow	JJ	O
to	TO	O
awake	VB	O
from	IN	O
anesthesia	NN	B-TREATMENT
,	,	O
and	CC	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
cmed	VBN	O
ccu	NN	O
observation	NN	B-TEST
.	.	O

she	PRP	O
was	VBD	O
transfered	VBN	O
to	TO	O
the	DT	O
floor	NN	O
post-op	JJ	O
day	NN	O
2	CD	O
where	WRB	O
she	PRP	O
had	VBD	O
been	VBN	O
afebrile	RB	B-PROBLEM
with	IN	O
normal	JJ	O
vitals	NNS	O
,	,	O
making	VBG	O
good	JJ	O
urine	NN	O
,	,	O
and	CC	O
tolerating	VBG	O
a	DT	O
regular	JJ	O
diet	NN	O
.	.	O

her	PRP$	B-PROBLEM
wound	NN	I-PROBLEM
has	VBZ	O
remaind	VBN	O
dry	JJ	O
and	CC	O
closed	VBD	O
,	,	O
without	IN	O
evidence	NN	O
of	IN	O
infection	NN	B-PROBLEM
or	CC	O
breakdown	NN	B-PROBLEM
.	.	O

she	PRP	O
will	MD	O
be	VB	O
discharged	VBN	O
today	NN	O
back	RB	O
to	TO	O
her	PRP$	O
nursing	NN	O
home	NN	O
in	IN	O
good	JJ	O
condition	NN	O
,	,	O
on	IN	O
pain	NN	B-TREATMENT
meds	NNS	I-TREATMENT
,	,	O
antibiotics	NNS	B-TREATMENT
,	,	O
and	CC	O
with	IN	O
anticipated	JJ	O
1:1	CD	O
watch	NN	O
.	.	O

stage	NN	O
two	CD	O
of	IN	O
her	PRP$	B-TREATMENT
surgery	NN	I-TREATMENT
will	MD	O
be	VB	O
done	VBN	O
in	IN	O
3	CD	O
weeks	NNS	O
.	.	O

1.	CD	O
paroxetine	NN	B-TREATMENT
hcl	NN	I-TREATMENT
10	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
am	VBP	O
().	NN	O

2.	CD	O
multivitamin	NN	B-TREATMENT
capsule	NN	I-TREATMENT
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
cap	NN	O
po	NN	O
qam	NN	O
(	(	O
once	RB	O
a	DT	O
day	NN	O
(	(	O
in	IN	O
the	DT	O
morning	NN	O
)).	NN	O

3.	CD	O
divalproex	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
500	CD	O
mg	NN	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
qam	NN	O
(	(	O
once	RB	O
a	DT	O
day	NN	O
(	(	O
in	IN	O
the	DT	O
morning	NN	O
)).	NN	O

4.	CD	O
docusate	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
100	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
as	IN	O
needed	VBN	O
:	:	O
constipation	NN	B-PROBLEM
.	.	O

5.	CD	O
triamcinolone	NN	B-TREATMENT
acetonide	RB	I-TREATMENT
0.1	CD	O
%	NN	O
cream	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
appl	RB	O
topical	JJ	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

6.	CD	O
divalproex	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
oral	JJ	O

7.	CD	O
atorvastatin	JJ	B-TREATMENT
10	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
hs	NN	O
(	(	O
at	IN	O
bedtime	NN	O
).	NN	O

8.	CD	O
oxybutynin	JJ	B-TREATMENT
chloride	NN	I-TREATMENT
5	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
qpm	NN	O
(	(	O
once	RB	O
a	DT	O
day	NN	O
(	(	O
in	IN	O
the	DT	O
evening	NN	O
)).	NN	O

9.	CD	O
hydrocodone-acetaminophen	JJ	B-TREATMENT
5-500	JJ	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
1-2	JJ	O
tablets	NNS	O
po	VBP	O
q4h	NN	O
(	(	O
every	DT	O
4	CD	O
hours	NNS	O
).	VBP	O

10.	CD	O
bacitracin-polymyxin-neosp	JJ	B-TREATMENT
hc	NN	I-TREATMENT
ointment	NN	I-TREATMENT
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
topical	JJ	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
.	.	O

aquired	JJ	B-PROBLEM
deformity	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
ala	NN	I-PROBLEM
/	NNP	I-PROBLEM
nose	NN	I-PROBLEM
and	CC	I-PROBLEM
medial	JJ	I-PROBLEM
cheek	NN	I-PROBLEM
from	IN	O
basal	NN	B-TREATMENT
cell	NN	I-TREATMENT
carcinoma	NN	I-TREATMENT
resection	NN	I-TREATMENT

please	VB	O
give	JJ	O
patient	NN	O
medications	NNS	B-TREATMENT
as	IN	O
prescribed	JJ	O
and	CC	O
read	JJ	O
warning	NN	O
labels	NNS	O
carefully	RB	O
.	.	O

if	IN	O
signs	NNS	B-PROBLEM
and	CC	I-PROBLEM
symptoms	NNS	I-PROBLEM
of	IN	O
infection	NN	B-PROBLEM
,	,	O
such	JJ	O
as	IN	O
fevers	NNS	B-PROBLEM
/	VBP	O
chills	NNS	B-PROBLEM
,	,	O
purulent	JJ	B-PROBLEM
discharge	NN	I-PROBLEM
from	IN	I-PROBLEM
wound	NN	I-PROBLEM
/	NNP	I-PROBLEM
incision	NN	I-PROBLEM
site	NN	I-PROBLEM
,	,	O
increased	VBD	B-PROBLEM
redness	NN	I-PROBLEM
,	,	O
increased	VBD	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
please	VB	O
call	NN	O
or	CC	O
go	VB	O
to	TO	O
the	DT	O
emergency	NN	O
room	NN	O
.	.	O

stage	NN	O
2	CD	O
of	IN	O
the	DT	B-TREATMENT
surgery	NN	I-TREATMENT
will	MD	O
be	VB	O
done	VBN	O
in	IN	O
3	CD	O
weeks	NNS	O
.	.	O

please	VB	O
clean	JJ	O
incision	NN	B-PROBLEM
site	NN	I-PROBLEM
with	IN	O
normal	JJ	B-TREATMENT
saline	NN	I-TREATMENT
or	CC	O
clean	JJ	O
water	NN	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
and	CC	O
place	NN	O
antibiotic	JJ	B-TREATMENT
ointment	NN	I-TREATMENT
(	(	O
given	VBN	O
)	)	O
on	IN	O
top	NN	O
of	IN	O
wound	NN	B-PROBLEM
.	.	O

most	JJS	O
importantly	RB	O
,	,	O
the	DT	O
patient	NN	O
must	MD	O
be	VB	O
watch	JJ	O
one-on-one	NN	O
so	IN	O
that	IN	O
she	PRP	O
does	VBZ	O
not	RB	O
pick	VB	O
at	IN	O
her	PRP$	B-PROBLEM
wound	NN	I-PROBLEM
.	.	O

patient	NN	O
recorded	VBD	O
as	IN	O
having	VBG	O
no	DT	O
known	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM
to	TO	I-PROBLEM
drugs	NNS	I-PROBLEM

hip	NN	B-PROBLEM
fracture	NN	I-PROBLEM

1.	CD	O
closed	JJ	B-TREATMENT
reduction	NN	I-TREATMENT
of	IN	I-TREATMENT
right	JJ	I-TREATMENT
hip	NN	I-TREATMENT
with	IN	O
open	JJ	B-TREATMENT
placement	NN	I-TREATMENT
of	IN	I-TREATMENT
dynamic	JJ	I-TREATMENT
hip	NN	I-TREATMENT
screw	NN	I-TREATMENT
,	,	I-TREATMENT
right	JJ	I-TREATMENT
hip	NN	I-TREATMENT
.	.	O

2.	CD	O
examination	NN	B-TEST
under	IN	I-TEST
anesthesia	NN	I-TEST
with	IN	O
placement	NN	B-TREATMENT
of	IN	I-TREATMENT
splint	NN	I-TREATMENT
,	,	I-TREATMENT
right	JJ	I-TREATMENT
elbow	NN	I-TREATMENT
.	.	O

1.	CD	O
exploratory	JJ	B-TEST
laparotomy	NN	I-TEST
with	IN	O
drainage	NN	B-TREATMENT
of	IN	O
intra-abdominal	JJ	B-PROBLEM
abscess	NN	I-PROBLEM
and	CC	O
peritonitis	NN	B-PROBLEM
with	IN	O
gross	JJ	B-PROBLEM
soilage	NN	I-PROBLEM
with	IN	I-PROBLEM
bile	NN	I-PROBLEM
and	CC	I-PROBLEM
gastric	JJ	I-PROBLEM
contents	NNS	I-PROBLEM
.	.	O

2.	CD	O
exposure	NN	B-TREATMENT
and	CC	O
wide	JJ	B-TREATMENT
drainage	NN	I-TREATMENT
of	IN	O
perforated	JJ	B-PROBLEM
posterior	JJ	I-PROBLEM
duodenal	JJ	I-PROBLEM
ulcer	NN	I-PROBLEM
with	IN	O
internal	JJ	B-TREATMENT
and	CC	I-TREATMENT
external	JJ	I-TREATMENT
drainage	NN	I-TREATMENT
.	.	O

3.	CD	O
feeding	VBG	B-TREATMENT
jejunostomy	NN	I-TREATMENT
.	.	O

4.	CD	O
tube	JJ	B-TREATMENT
gastrostomy	NN	I-TREATMENT
.	.	O

5.	CD	O
placement	NN	O
of	IN	O
a	DT	B-TREATMENT
right	JJ	I-TREATMENT
femoral	JJ	I-TREATMENT
arterial	JJ	I-TREATMENT
line	NN	I-TREATMENT
.	.	O

90	CD	O
yo	NNS	O
f	JJ	O
with	IN	O
mmp	NN	B-PROBLEM
(	(	O
see	VB	O
below	IN	O
)	)	O
who	WP	O
sustained	VBD	O
a	DT	B-PROBLEM
mechanical	JJ	I-PROBLEM
fall	NN	I-PROBLEM
down	RP	O
stairs	NNS	O
resulting	VBG	O
in	IN	O
a	DT	B-PROBLEM
hip	NN	I-PROBLEM
and	CC	I-PROBLEM
arm	NN	I-PROBLEM
fracture	NN	I-PROBLEM
.	.	O

fall	NN	B-PROBLEM
was	VBD	O
witnessed	VBN	O
by	IN	O
daughter	NN	O
.	.	O

nicholas	NNS	B-PROBLEM
seizures	NNS	I-PROBLEM
,	,	O
no	DT	O
loc	NN	B-PROBLEM
,	,	O
no	DT	O
head	NN	B-PROBLEM
or	CC	I-PROBLEM
neck	NN	I-PROBLEM
trauma	NN	I-PROBLEM
.	.	O

patient	JJ	O
denies	NNS	O
cp	VBP	B-PROBLEM
,	,	O
sob	JJ	B-PROBLEM
,	,	O
light	JJ	B-PROBLEM
headedness	NN	I-PROBLEM
,	,	O
or	CC	O
dizziness	RB	B-PROBLEM
prior	JJ	O
to	TO	O
of	IN	O
after	IN	O
the	DT	B-PROBLEM
fall	NN	I-PROBLEM
.	.	O

she	PRP	O
fell	VBD	O
on	IN	O
her	PRP$	O
r	JJ	O
side	NN	O
and	CC	O
had	VBD	O
a	DT	O
great	JJ	O
deal	NN	O
of	IN	O
pain	NN	B-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
r	NN	I-PROBLEM
arm	NN	I-PROBLEM
and	CC	I-PROBLEM
hip	NN	I-PROBLEM
.	.	O

presented	VBN	O
to	TO	O
taunton	VB	O
and	CC	O
found	VBN	O
to	TO	O
have	VB	O
r	VBN	B-PROBLEM
humerus	NN	I-PROBLEM
and	CC	I-PROBLEM
r	NN	I-PROBLEM
hip	NN	I-PROBLEM
fx	NN	I-PROBLEM
.	.	O

ct	NN	B-TEST
of	IN	I-TEST
head	NN	I-TEST
and	CC	I-TEST
neck	NN	I-TEST
neg	NN	O
for	IN	O
fx	NN	B-PROBLEM
,	,	O
bleed	NN	B-PROBLEM
,	,	O
and	CC	O
dislocation	NN	B-PROBLEM
.	.	O

1.	CD	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
status	NN	O
post	NN	O
non-st-elevation	JJ	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
in	IN	O
2009-05-05	JJ	O
,	,	O
status	NN	O
post	NN	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
with	IN	O
left	JJ	B-TREATMENT
anterior	JJ	I-TREATMENT
descending	VBG	I-TREATMENT
artery	JJ	I-TREATMENT
stent	JJ	I-TREATMENT
placement	NN	I-TREATMENT
in	IN	O
05/2001	CD	O
.	.	O

2.	CD	O
chf	NN	B-PROBLEM
with	IN	O
an	DT	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
of	IN	O
40-45%	JJ	O
02-09	JJ	O

3.	CD	O
diabetes	NNS	B-PROBLEM
type	JJ	I-PROBLEM
2	CD	I-PROBLEM
.	.	O

4.	CD	O
anemia	NN	B-PROBLEM
,	,	O
transfusion	NN	B-PROBLEM
dependent	NN	I-PROBLEM
every	DT	O
three	CD	O
months	NNS	O
.	.	O

hct	NN	B-TEST
28	CD	O
b/l	NN	O

5.	CD	O
polymyalgia	NN	B-PROBLEM
rheumatica	NN	I-PROBLEM
.	.	O

6.	CD	O
hypertension	NN	B-PROBLEM
.	.	O

7.	CD	O
hypothyroidism	NN	B-PROBLEM
.	.	O

8.	CD	O
chronic	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
with	IN	O
a	DT	B-TEST
b/l	JJ	I-TEST
creatinine	NN	I-TEST
of	IN	O
1.4	CD	O
.	.	O

9.	CD	O
history	NN	O
of	IN	O
syncope	NN	B-PROBLEM
and	CC	O
first	JJ	B-PROBLEM
degree	JJ	I-PROBLEM
a-v	JJ	I-PROBLEM
heart	NN	I-PROBLEM
block	NN	I-PROBLEM
with	IN	O
beta	NN	B-TREATMENT
blocker	NN	I-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

10.	CD	O
history	NN	O
of	IN	O
lower	JJR	B-PROBLEM
gastrointestinal	JJ	I-PROBLEM
bleed	NN	I-PROBLEM
in	IN	O
2009-06-05	JJ	O
.	.	O

11.	CD	O
spinal	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM

12.	CD	O
pacemaker	NN	B-TREATMENT
-	:	O
ddd	NN	B-TREATMENT
dual	JJ	I-TREATMENT
chamber	NN	I-TREATMENT
rate	NN	I-TREATMENT
response	NN	I-TREATMENT
pacemaker	NN	I-TREATMENT
2011-08-22	JJ	O
for	IN	O
symptomatic	JJ	B-PROBLEM
bradycardia	NN	I-PROBLEM

t	RB	B-TEST
96.0	CD	O
bp	NN	B-TEST
177/61	CD	O
p	NN	B-TEST
70	CD	O
r	NN	B-TEST
18	CD	O
o2	NN	B-TEST
97	CD	O
on	IN	O
ra	NN	O

gen	NN	O
-	:	O
somnolent	NN	B-PROBLEM
,	,	O
confused	VBD	B-PROBLEM

cor	SYM	O
-	:	O
rrr	NN	O
,	,	O
no	DT	O
m/r/g	NN	B-PROBLEM

abd	SYM	O
-	:	O
s/nt/nd	NN	B-PROBLEM
+bs	NN	O

ext	JJ	O
-	:	O
2	CD	O
+	JJ	O
edema	NN	B-PROBLEM
to	TO	I-PROBLEM
knees	NNS	I-PROBLEM
,	,	O
warm	JJ	O
2	CD	O
+	JJ	O
pulses	NNS	B-TEST
,	,	O
pain	NN	B-PROBLEM
in	IN	I-PROBLEM
r	NN	I-PROBLEM
arm	NN	I-PROBLEM
and	CC	I-PROBLEM
r	NN	I-PROBLEM
hip	NN	I-PROBLEM

2013-05-18	JJ	O
06:00	CD	O
pm	NN	O
glucose	VBD	B-TEST
-	:	O
188	CD	O
*	JJ	O
urea	JJ	B-TEST
n	SYM	I-TEST
-	:	O
48	CD	O
*	NN	O
creat	NN	B-TEST
-	:	O
1.3	CD	O
*	JJ	O
sodium	NN	B-TEST
-	:	O
138	CD	O
potassium	NN	B-TEST
-	:	O
4.0	CD	O
chloride	NN	B-TEST
-	:	O
106	CD	O
total	JJ	B-TEST
co2	NN	I-TEST
-	:	O
21	CD	O
*	JJ	O
anion	NN	B-TEST
gap	NN	I-TEST
-	:	O
15	CD	O

2013-05-18	JJ	O
06:00	CD	O
pm	NN	O
ck(cpk)	NN	B-TEST
-	:	O
32	CD	O

2013-05-18	JJ	O
06:00	CD	O
pm	JJ	O
ck-mb	JJ	B-TEST
-	:	O
notdone	NN	O

2013-05-18	JJ	O
06:00	CD	O
pm	NN	O
wbc	SYM	B-TEST
-	:	O
14.9	CD	O
*#	NN	O
rbc	NN	B-TEST
-	:	O
2.91	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
8.5	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
24.7	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
85	CD	O
mch	SYM	B-TEST
-	:	O
29.3	CD	O
mchc	SYM	B-TEST
-	:	O
34.5	CD	O
rdw	NN	B-TEST
-	:	O
14.6	CD	O

2013-05-18	JJ	O
06:00	CD	O
pm	NN	O
neuts	NNS	B-TEST
-	:	O
87.9	CD	O
*	NN	O
bands	NNS	B-TEST
-	:	O
0	CD	O
lymphs	SYM	B-TEST
-	:	O
6.3	CD	O
*	JJ	O
monos	NNS	B-TEST
-	:	O
5.7	CD	O
eos	SYM	B-TEST
-	:	O
0.1	CD	O
basos	SYM	B-TEST
-	:	O
0	CD	O

2013-05-18	JJ	O
06:00	CD	O
pm	NN	O
hypochrom	NN	B-TEST
-	:	O
1	CD	O
+	NN	O
anisocyt	SYM	B-TEST
-	:	O
normal	JJ	O
poikilocy	JJ	B-TEST
-	:	O
normal	JJ	O
macrocyt	JJ	B-TEST
-	:	O
normal	JJ	O
microcyt	JJ	B-TEST
-	:	O
normal	JJ	O
polychrom	JJ	B-TEST
-	:	O
normal	JJ	O

2013-05-18	JJ	O
06:00	CD	O
pm	NN	O
plt	NN	B-TEST
smr	SYM	I-TEST
-	:	O
normal	JJ	O
plt	NN	B-TEST
count	NN	I-TEST
-	:	O
216	CD	O

2013-05-18	JJ	O
06:00	CD	O
pm	NN	O
pt	NN	B-TEST
-	:	O
13.3	CD	O
ptt	NN	B-TEST
-	:	O
26.4	CD	O
inr(pt)	JJ	B-TEST
-	:	O
1.2	CD	O
ekg	SYM	B-TEST
-	:	O
nsr	NN	O
64	CD	O
,	,	O
1st	CD	B-PROBLEM
deg	NN	I-PROBLEM
block	NN	I-PROBLEM
,	,	O
lad	NN	B-PROBLEM
,	,	O
new	JJ	B-PROBLEM
twi	NN	I-PROBLEM
inf/lat	JJ	I-PROBLEM
leads	NNS	I-PROBLEM
,	,	O
new	JJ	B-PROBLEM
st	JJ	I-PROBLEM
depressions	NNS	I-PROBLEM
v4-6	NNS	I-PROBLEM

echo	JJ	B-TEST
02-09	NN	O

1.	CD	O
the	DT	O
left	NN	O
atrium	NN	O
is	VBZ	O
moderately	RB	B-PROBLEM
dilated	VBN	I-PROBLEM
.	.	O

the	DT	O
left	JJ	O
atrium	NN	O
is	VBZ	O
elongated	VBN	B-PROBLEM
.	.	O

2.	CD	O
the	DT	B-TEST
left	NN	I-TEST
ventricular	NN	I-TEST
wall	NN	I-TEST
thicknesses	NNS	I-TEST
are	VBP	O
normal	JJ	O
.	.	O

the	DT	B-TEST
left	NN	I-TEST
ventricular	JJ	I-TEST
cavity	NN	I-TEST
size	NN	I-TEST
is	VBZ	O
normal	JJ	O
.	.	O

there	EX	O
is	VBZ	O
mild	JJ	B-PROBLEM
regional	JJ	I-PROBLEM
left	VBD	I-PROBLEM
ventricular	JJ	I-PROBLEM
systolic	JJ	I-PROBLEM
dysfunction	NN	I-PROBLEM
.	.	O

overall	JJ	O
left	VBD	B-TEST
ventricular	JJ	I-TEST
systolic	JJ	I-TEST
function	NN	I-TEST
is	VBZ	O
mildly	RB	B-PROBLEM
depressed	JJ	I-PROBLEM
.	.	O

resting	VBG	B-PROBLEM
regional	JJ	I-PROBLEM
wall	NN	I-PROBLEM
motion	NN	I-PROBLEM
abnormalities	NNS	I-PROBLEM
include	VBP	O
inferolateral	JJ	B-PROBLEM
,	,	I-PROBLEM
inferior	JJ	I-PROBLEM
and	CC	I-PROBLEM
mid	JJ	I-PROBLEM
septal	JJ	I-PROBLEM
hypokinesis	NN	I-PROBLEM
.	.	O

3.	CD	O
right	JJ	B-TEST
ventricular	JJ	I-TEST
chamber	NN	I-TEST
size	NN	I-TEST
is	VBZ	O
normal	JJ	O
.	.	O

right	RB	B-TEST
ventricular	JJ	I-TEST
systolic	JJ	I-TEST
function	NN	I-TEST
is	VBZ	O
normal	JJ	O
.	.	O

4.	CD	O
the	DT	O
aortic	JJ	O
valve	NN	O
leaflets	NNS	O
(	(	O
3	CD	O
)	)	O
are	VBP	O
mildly	RB	B-PROBLEM
thickened	VBN	I-PROBLEM
.	.	O

no	DT	O
aortic	JJ	B-PROBLEM
regurgitation	NN	I-PROBLEM
present	NN	O
.	.	O

5.	CD	O
the	DT	O
mitral	JJ	O
valve	NN	O
leaflets	NNS	O
are	VBP	O
mildly	RB	B-PROBLEM
thickened	VBN	I-PROBLEM
.	.	O

moderate	NN	B-PROBLEM
(	(	I-PROBLEM
2	CD	I-PROBLEM
+)	RB	I-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
.	.	O

6.	CD	O
there	EX	O
is	VBZ	O
moderate	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
systolic	JJ	I-PROBLEM
hypertension	NN	I-PROBLEM
.	.	O

7.	CD	O
there	EX	O
is	VBZ	O
no	DT	O
pericardial	JJ	B-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

compared	VBN	O
with	IN	O
the	DT	O
findings	NNS	O
of	IN	O
the	DT	B-TEST
prior	JJ	I-TEST
study	NN	I-TEST
(	(	O
tape	NN	O
reviewed	VBN	O
)	)	O
of	IN	O
2009-06-05	JJ	O
,	,	O
the	DT	B-TEST
lv	NN	I-TEST
function	NN	I-TEST
has	VBZ	O
improved	VBN	O
with	IN	O
an	DT	O
improvementt	NN	O
in	IN	O
function	NN	O
of	IN	O
the	DT	O
apex	NN	O
,	,	O
septal	JJ	O
and	CC	O
anterior	JJ	O
walls	NNS	O
.	.	O

new	JJ	B-PROBLEM
inferior	NN	I-PROBLEM
and	CC	I-PROBLEM
inferolateral	JJ	I-PROBLEM
wall	NN	I-PROBLEM
motion	NN	I-PROBLEM
abnormalities	NNS	I-PROBLEM
with	IN	O
more	RBR	B-PROBLEM
severe	JJ	I-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
present	NN	O
.	.	O

cath	NN	B-TEST
2001	CD	O

1.	CD	O
coronary	JJ	B-TEST
angiography	NN	I-TEST
demonstrated	VBD	O
single	JJ	B-PROBLEM
vessel	NN	I-PROBLEM
disease	NN	I-PROBLEM
in	IN	I-PROBLEM
a	DT	I-PROBLEM
right	JJ	I-PROBLEM
dominant	NN	I-PROBLEM
system	NN	I-PROBLEM
.	.	O

the	DT	O
lad	NN	O
had	VBD	O
serial	JJ	B-PROBLEM
90%	CD	I-PROBLEM
lesions	NNS	I-PROBLEM
proximally	RB	I-PROBLEM
,	,	O
involving	VBG	O
the	DT	O
origin	NN	O
of	IN	O
the	DT	O
first	JJ	O
diagonal	NN	O
,	,	O
which	WDT	O
was	VBD	O
occluded	VBN	B-PROBLEM
and	CC	O
filled	VBN	O
via	IN	O
left	NN	O
to	TO	O
left	JJ	O
collaterals	NNS	O
.	.	O

the	DT	O
mid-distal	JJ	O
lad	NN	O
was	VBD	O
underfilled	VBN	B-PROBLEM
initially	RB	O
but	CC	O
was	VBD	O
without	IN	O
obstructive	JJ	B-PROBLEM
disease	NN	I-PROBLEM
.	.	O

the	DT	O
non-dominant	JJ	O
circumflex	NN	O
system	NN	O
had	VBD	O
no	DT	O
hemodynamically	RB	B-PROBLEM
significant	JJ	I-PROBLEM
stenoses	NNS	I-PROBLEM
.	.	O

the	DT	O
dominant	JJ	O
rca	NN	O
was	VBD	O
a	DT	O
large	JJ	O
vessel	NN	O
with	IN	O
no	DT	O
significant	JJ	B-PROBLEM
disease	NN	I-PROBLEM
.	.	O

2.	CD	O
resting	VBG	B-TEST
hemodynamics	NNS	I-TEST
revealed	VBD	O
elevated	VBN	B-PROBLEM
right	RB	I-PROBLEM
and	CC	I-PROBLEM
left	VBD	I-PROBLEM
sided	VBN	I-PROBLEM
filling	NN	I-PROBLEM
pressures	NNS	I-PROBLEM
with	IN	O
a	DT	B-TEST
mean	JJ	I-TEST
ra	NN	I-TEST
pressure	NN	I-TEST
of	IN	O
12	CD	O
mm	NNS	O
hg	NN	O
and	CC	O
a	DT	B-TEST
mean	JJ	I-TEST
wedge	NN	I-TEST
pressure	NN	I-TEST
24	CD	O
mm	NN	O
hg	NN	O
.	.	O

moderate	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
hypertension	NN	I-PROBLEM
was	VBD	O
present	JJ	O
with	IN	O
a	DT	B-TEST
pa	NN	I-TEST
of	IN	O
52/28	CD	O
.	.	O

the	DT	B-TEST
cardiac	JJ	I-TEST
index	NN	I-TEST
was	VBD	O
preserved	VBN	O
at	IN	O
3.0	CD	O
l	NN	O
/	NNP	O
min	NN	O
/	NNP	O
m2	NN	O
.	.	O

3.	CD	O
left	VBD	B-TEST
ventriculography	NN	I-TEST
was	VBD	O
not	RB	O
performed	VBN	O
due	JJ	O
to	TO	O
the	DT	O
presence	NN	O
of	IN	O
moderate	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
(	(	O
creatinine	JJ	B-TEST
1.6	CD	O
).	NN	O

4.	CD	O
successful	JJ	B-TREATMENT
ptca	NN	I-TREATMENT
and	CC	O
stenting	NN	B-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
proximal	JJ	I-TREATMENT
lad	NN	I-TREATMENT
with	IN	O
overlapping	VBG	B-TREATMENT
2.25	CD	I-TREATMENT
x	JJ	I-TREATMENT
13	CD	I-TREATMENT
mm	NN	I-TREATMENT
and	CC	I-TREATMENT
2.25	CD	I-TREATMENT
x	NNS	I-TREATMENT
18	CD	I-TREATMENT
mm	NNS	I-TREATMENT
hepacoat	NN	I-TREATMENT
stents	NNS	I-TREATMENT
with	IN	O
no	DT	O
residual	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
or	CC	O
dissection	NN	B-PROBLEM
and	CC	O
normal	JJ	O
flow	NN	O
(	(	O
see	VB	O
ptca	JJ	B-TREATMENT
comments	NNS	O
).	VB	O

1.	CD	O
one	CD	B-PROBLEM
vessel	NN	I-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

2.	CD	O
moderately	RB	B-PROBLEM
elevated	VBN	I-PROBLEM
right	NN	I-PROBLEM
and	CC	I-PROBLEM
left	VBD	I-PROBLEM
sided	VBN	I-PROBLEM
filling	NN	I-PROBLEM
pressures	NNS	I-PROBLEM
.	.	O

3.	CD	O
successful	JJ	B-TREATMENT
stenting	NN	I-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
proximal	JJ	I-TREATMENT
lad	NN	I-TREATMENT
.	.	O

complete	JJ	B-TEST
blood	NN	I-TEST
count	NN	I-TEST
wbc	VBD	B-TEST
rbc	JJ	B-TEST
hgb	NN	B-TEST
hct	NN	B-TEST
mcv	NN	B-TEST
mch	NN	B-TEST
mchc	NN	B-TEST
rdw	NN	B-TEST
plt	NN	B-TEST
ct	NN	I-TEST

differential	JJ	B-TEST
neuts	NNS	B-TEST
bands	VBZ	B-TEST
lymphs	JJ	B-TEST
monos	NNS	B-TEST
eos	VBP	B-TEST
baso	JJ	B-TEST
atyps	NNS	B-TEST
metas	NNS	B-TEST

red	JJ	B-TEST
cell	NN	I-TEST
morphology	NN	I-TEST
hypochr	NN	B-TEST
anisocy	NN	B-TEST
poiklo	NN	B-TEST
macrocy	NN	B-TEST
microcy	NN	B-TEST
polychr	NN	B-TEST

basic	JJ	B-TEST
coagulation	NN	I-TEST
(	(	O
pt	NN	B-TEST
,	,	O
ptt	NN	B-TEST
,	,	O
plt	NN	B-TEST
,	,	O
inr	NN	B-TEST
)	)	O
pt	NN	B-TEST
ptt	NN	B-TEST
plt	NN	B-TEST
smr	NN	I-TEST
plt	NN	B-TEST
ct	NN	I-TEST
inr(pt)	NN	B-TEST
lplt	NN	B-TEST

chemistry	NN	B-TEST

renal	JJ	O
&	CC	O
glucose	JJ	O
glucose	JJ	B-TEST
urean	JJ	B-TEST
creat	NN	B-TEST
na	TO	B-TEST
k	VB	B-TEST
cl	JJ	B-TEST
hco3	NN	B-TEST
angap	NN	B-TEST

enzymes	NNS	B-TEST
&	CC	O
bilirubin	NN	B-TEST
alt	NN	B-TEST
ast	IN	B-TEST
ld(ldh)	JJ	B-TEST
ck(cpk)	NN	B-TEST
alkphos	NN	B-TEST
amylase	NN	B-TEST
totbili	NN	B-TEST
dirbili	NN	B-TEST

other	JJ	B-TEST
enzymes	NNS	I-TEST
&	CC	O
bilirubins	NNS	B-TEST
lipase	NN	B-TEST

cpk	NN	B-TEST
isoenzymes	VBZ	B-TEST
ck-mb	JJ	B-TEST
mb	NN	B-TEST
indx	NN	I-TEST
ctropnt	NN	B-TEST

1	CD	O
ctropnt	NN	B-TEST
>	VBD	O
0.10	CD	O
ng/ml	JJ	O
suggests	NNS	O
acute	VBP	B-PROBLEM
mi	NN	I-PROBLEM

chemistry	NN	B-TEST
totprot	NN	B-TEST
albumin	NN	B-TEST
globuln	NN	B-TEST
calcium	NN	B-TEST
phos	NN	B-TEST
mg	NN	B-TEST
uricacd	JJ	B-TEST
iron	NN	B-TEST
cholest	NN	B-TEST

lipid	JJ	B-TEST
/	NNP	O
cholesterol	NN	B-TEST
triglyc	NN	B-TEST
hdl	NN	B-TEST
chol/hd	NN	B-TEST
ldlcalc	NN	B-TEST

2013-05-19	JJ	O
09:20	CD	O
am	VBP	O
1603	CD	O
-	:	O
5419	CD	O
ldl(calc)	NN	B-TEST
invalid	JJ	O
if	IN	O
trig	JJ	B-TEST
>	VBP	O
400	CD	O
or	CC	O
non-fasting	JJ	O
sample	NN	O
lab	NN	O
use	NN	O
only	RB	O
greenhd	NN	O

blood	NN	B-TEST
gas	NN	I-TEST

blood	NN	B-TEST
gases	NNS	I-TEST
type	VBP	B-TEST
temp	JJ	B-TEST
rates	NNS	B-TEST
tidal	VBP	B-TEST
v	JJ	I-TEST
peep	JJ	B-TEST
fio2	NN	B-TEST
o2	NN	B-TEST
flow	NN	B-TEST
po2	NN	B-TEST
pco2	NN	B-TEST
ph	NN	B-TEST
calhco3	NN	B-TEST
base	NN	B-TEST
xs	NNP	I-TEST
aado2	NN	B-TEST
req	NN	B-TREATMENT
o2	NN	I-TREATMENT
intubat	NN	B-TREATMENT
vent	NN	B-TREATMENT

2013-05-24	JJ	O
07:58	CD	O
am	VBP	O
art	RB	B-TEST
102	CD	O
36	CD	O
7.26	CD	O
*	JJ	O
17	CD	O
*	NN	O
-9	NN	O

2013-05-24	JJ	O
04:31	CD	O
am	VBP	O
art	RB	B-TEST
36.4	CD	O
16	CD	O
/	JJ	O
662-15484	JJ	O
*	NN	O
7.26	CD	O
*	NN	O
16	CD	O
*	NN	O
-10	NN	O

assist	NN	O
/	NNP	O
con1	NN	O
intubated	VBD	B-TREATMENT

whole	JJ	O
blood	NN	O
,	,	O
miscellaneous	JJ	B-TEST
chemistry	NN	I-TEST
glucose	JJ	B-TEST
lactate	NN	B-TEST
na	NNS	B-TEST
k	VBP	B-TEST
cl	JJ	B-TEST
calhco3	NN	B-TEST

hemogloblin	NN	B-TEST
fractions	NNS	I-TEST
(	(	O
cooximetry	NN	B-TEST
)	)	O
hgb	NN	B-TEST
calchct	NN	B-TEST
o2	NN	B-TEST
sat	VBD	I-TEST
cohgb	NNS	B-TEST
methgb	NN	B-TEST

calcium	NN	B-TEST
freeca	NN	B-TEST

ct	JJ	B-TEST
abdomen	NNS	I-TEST
w/o	VBD	I-TEST
contrast	JJ	I-TEST
2013-05-23	JJ	O
5:46	CD	O
pm	NN	O

ct	JJ	B-TEST
abdomen	NNS	I-TEST
w/o	VBP	I-TEST
contrast	NN	I-TEST
;	:	O
ct	CC	B-TEST
pelvis	VB	I-TEST
w/o	NN	I-TEST
contrast	NN	I-TEST

reason	NN	O
:	:	O
please	NN	O
eval	NN	O
for	IN	O
perf	NN	B-PROBLEM
/	NNP	I-PROBLEM
ischemic	JJ	I-PROBLEM
bowel	NN	I-PROBLEM

92	CD	O
year	NN	O
old	JJ	O
woman	NN	O
with	IN	O
ms	NN	B-PROBLEM
changes	NNS	I-PROBLEM
,	,	O
abd	NN	B-PROBLEM
pain	NN	I-PROBLEM
hypotension	NN	B-PROBLEM
and	CC	O
bloody	JJ	B-PROBLEM
lavage	NN	I-PROBLEM
on	IN	O
lovenox+asa	NN	B-TREATMENT

please	NN	O
eval	NN	O
for	IN	O
perf	NN	B-PROBLEM
/	NNP	I-PROBLEM
ischemic	JJ	I-PROBLEM
bowel	NN	I-PROBLEM

contraindications	NNS	O
for	IN	O
iv	JJ	B-TEST
contrast	NN	I-TEST
:	:	O
renal	JJ	B-PROBLEM
failure	NN	I-PROBLEM

indication	NN	O
:	:	O
94-year-old	JJ	O
woman	NN	O
with	IN	O
mental	JJ	B-PROBLEM
status	NN	I-PROBLEM
changes	NNS	I-PROBLEM
,	,	O
now	RB	O
with	IN	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
hypertension	NN	B-PROBLEM
.	.	O

technique	NN	O
:	:	O
a	DT	O
multidetector	NN	O
scanner	NN	O
was	VBD	O
used	VBN	O
to	TO	O
obtain	VB	O
contiguous	JJ	B-TEST
axial	JJ	I-TEST
images	NNS	I-TEST
from	IN	O
the	DT	O
lung	NN	O
bases	VBZ	O
to	TO	O
the	DT	O
pubic	JJ	O
symphysis	NN	O
.	.	O

neither	DT	O
iv	JJ	B-TEST
nor	CC	I-TEST
oral	JJ	I-TEST
contrast	NN	I-TEST
were	VBD	O
used	VBN	O
.	.	O

ct	NN	B-TEST
of	IN	I-TEST
the	DT	I-TEST
abdomen	NNS	I-TEST
without	IN	I-TEST
iv	JJ	I-TEST
contrast	NN	I-TEST
:	:	O
there	EX	O
are	VBP	O
bilateral	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
,	,	O
right	RB	O
greater	JJR	O
the	DT	O
left	NN	O
;	:	O
there	EX	O
is	VBZ	O
compressive	JJ	B-PROBLEM
atelectasis	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
lung	NN	I-PROBLEM
base	NN	I-PROBLEM
.	.	O

there	EX	O
are	VBP	O
coronary	JJ	B-PROBLEM
vascular	JJ	I-PROBLEM
calcifications	NNS	I-PROBLEM
.	.	O

a	DT	B-TREATMENT
nasogastric	JJ	I-TREATMENT
tube	NN	I-TREATMENT
is	VBZ	O
seen	VBN	O
coiling	VBG	O
in	IN	O
the	DT	O
stomach	NN	O
.	.	O

a	DT	B-TREATMENT
dual	JJ	I-TREATMENT
chamber	NN	I-TREATMENT
pacemaker	NN	I-TREATMENT
is	VBZ	O
seen	VBN	O
with	IN	O
leads	NNS	O
terminating	VBG	O
in	IN	O
the	DT	O
right	JJ	O
atrium	NN	O
and	CC	O
right	JJ	O
ventricle	NN	O
.	.	O

nasogastric	JJ	B-TREATMENT
tube	NN	I-TREATMENT
is	VBZ	O
seen	VBN	O
coiling	VBG	O
in	IN	O
the	DT	O
stomach	NN	O
,	,	O
with	IN	O
its	PRP$	O
tip	NN	O
at	IN	O
the	DT	O
pylorus	NN	O
.	.	O

allowing	VBG	O
for	IN	O
the	DT	O
limitations	NNS	O
of	IN	O
this	DT	B-TEST
noncontrast	NN	I-TEST
study	NN	I-TEST
,	,	O
the	DT	O
liver	NN	O
,	,	O
pancreas	NNS	O
,	,	O
adrenals	NNS	O
,	,	O
stomach	NN	O
are	VBP	O
unremarkable	JJ	O
.	.	O

a	DT	B-PROBLEM
1.8	CD	I-PROBLEM
cm	NN	I-PROBLEM
exophytic	JJ	I-PROBLEM
renal	JJ	I-PROBLEM
cyst	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
on	IN	O
the	DT	O
left	NN	O
.	.	O

a	DT	B-PROBLEM
similar	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
on	IN	O
the	DT	O
right	NN	O
,	,	O
measuring	VBG	O
2.2	CD	O
cm	NN	O
.	.	O

the	DT	O
aorta	NN	O
is	VBZ	O
normal	JJ	O
in	IN	O
caliber	NN	O
,	,	O
with	IN	O
vascular	JJ	B-PROBLEM
calcifications	NNS	I-PROBLEM
.	.	O

a	DT	B-PROBLEM
small	JJ	I-PROBLEM
amount	NN	I-PROBLEM
of	IN	I-PROBLEM
free	JJ	I-PROBLEM
fluid	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
tracking	VBG	O
around	IN	O
the	DT	O
liver	NN	O
,	,	O
right	JJ	O
pericolic	NN	O
gutter	NN	O
,	,	O
along	IN	O
the	DT	O
mesentery	NN	O
and	CC	O
surrounding	VBG	O
the	DT	O
right	NN	O
colon	NN	O
,	,	O
which	WDT	O
is	VBZ	O
collapsed	VBN	O
.	.	O

a	DT	B-PROBLEM
small	JJ	I-PROBLEM
amount	NN	I-PROBLEM
of	IN	I-PROBLEM
nondependent	JJ	I-PROBLEM
free	JJ	I-PROBLEM
air	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
in	IN	O
the	DT	O
anterior	JJ	O
aspect	NN	O
of	IN	O
the	DT	O
abdomen	NNS	O
.	.	O

the	DT	O
remainder	NN	O
of	IN	O
the	DT	O
bowel	NN	O
loops	NNS	O
are	VBP	O
fluid	JJ	O
filled	VBN	O
,	,	O
and	CC	O
nondilated	VBD	B-PROBLEM
.	.	O

ct	NN	B-TEST
of	IN	I-TEST
the	DT	I-TEST
pelvis	NN	I-TEST
without	IN	I-TEST
iv	JJ	I-TEST
contrast	NN	I-TEST
:	:	O
as	IN	O
previously	RB	O
noted	VBN	O
,	,	O
there	EX	O
is	VBZ	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
amount	NN	I-PROBLEM
of	IN	I-PROBLEM
free	JJ	I-PROBLEM
fluid	NN	I-PROBLEM
surrounding	VBG	O
the	DT	O
right	NN	O
colon	NN	O
,	,	O
tracking	VBG	O
along	IN	O
the	DT	O
mesentery	NN	O
and	CC	O
into	IN	O
the	DT	O
pelvis	NN	O
.	.	O

a	DT	B-PROBLEM
small	JJ	I-PROBLEM
amount	NN	I-PROBLEM
of	IN	I-PROBLEM
free	JJ	I-PROBLEM
air	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
in	IN	O
the	DT	O
nondependent	JJ	O
portion	NN	O
of	IN	O
the	DT	O
pelvis	NN	O
.	.	O

vascular	JJ	B-PROBLEM
calcifications	NNS	I-PROBLEM
are	VBP	O
seen	VBN	O
in	IN	O
the	DT	O
abdominal	JJ	O
aorta	NN	O
and	CC	O
iliac	JJ	O
arteries	NNS	O
.	.	O

subcutaneous	JJ	B-PROBLEM
edema	NN	I-PROBLEM
is	VBZ	O
noted	VBN	O
in	IN	O
the	DT	O
lower	JJR	O
abdomen	NNS	O
and	CC	O
pelvis	NN	O
.	.	O

a	DT	B-TREATMENT
catheter	NN	I-TREATMENT
is	VBZ	O
seen	VBN	O
entering	VBG	O
the	DT	O
left	JJ	O
inguinal	JJ	O
region	NN	O
and	CC	O
coursing	NN	O
along	IN	O
the	DT	O
iliac	NN	O
vessels	NNS	O
,	,	O
terminating	VBG	O
in	IN	O
the	DT	O
left	NN	O
pelvis	NN	O
.	.	O

osseous	JJ	O
structures	NNS	O
are	VBP	O
remarkable	JJ	O
for	IN	O
degenerative	JJ	B-PROBLEM
changes	NNS	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
spine	NN	I-PROBLEM
,	,	O
and	CC	O
a	DT	B-PROBLEM
fracture	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
proximal	JJ	I-PROBLEM
right	NN	I-PROBLEM
humerus	NN	I-PROBLEM
,	,	O
with	IN	O
orthopedic	JJ	B-TREATMENT
hardware	NN	I-TREATMENT
causing	VBG	O
beam	NN	B-PROBLEM
hardening	VBG	I-PROBLEM
artifact	NN	I-PROBLEM
.	.	O

1.	CD	O
a	DT	O
small	JJ	O
amount	NN	O
of	IN	O
free	JJ	B-PROBLEM
air	NN	I-PROBLEM
and	CC	I-PROBLEM
free	JJ	I-PROBLEM
fluid	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
pelvis	NN	I-PROBLEM
and	CC	I-PROBLEM
abdomen	NNS	I-PROBLEM
,	,	O
mostly	RB	O
along	IN	O
the	DT	O
right	JJ	O
pericolic	NN	O
gutter	NN	O
and	CC	O
surrounding	VBG	O
the	DT	O
ascending	VBG	O
colon	NN	O
,	,	O
concerning	VBG	O
for	IN	O
perforation	NN	B-PROBLEM
.	.	O

other	JJ	O
bowel	NN	O
loops	NNS	O
are	VBP	O
unremarkable	JJ	O
on	IN	O
this	DT	B-TEST
limited	JJ	I-TEST
study	NN	I-TEST
.	.	O

2.	CD	O
bilateral	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
,	,	O
right	RB	O
greater	JJR	O
than	IN	O
left	VBD	O
,	,	O
with	IN	O
left-sided	JJ	B-PROBLEM
compressive	JJ	I-PROBLEM
atelectasis	NN	I-PROBLEM
.	.	O

3.	CD	O
right	JJ	B-PROBLEM
proximal	JJ	I-PROBLEM
humeral	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
status	NN	O
post	NN	O
fixation	NN	B-TREATMENT
.	.	O

the	DT	B-TEST
study	NN	I-TEST
and	CC	O
the	DT	O
report	NN	O
were	VBD	O
reviewed	VBN	O
by	IN	O
the	DT	O
staff	NN	O
radiologist	NN	O
.	.	O

95	CD	O
yo	NNS	O
f	JJ	O
with	IN	O
mmp	NN	B-PROBLEM
who	WP	O
sustained	VBD	O
a	DT	B-PROBLEM
mechanical	JJ	I-PROBLEM
fall	NN	I-PROBLEM
down	RP	O
stairs	NNS	O
resulting	VBG	O
in	IN	O
a	DT	B-PROBLEM
hip	NN	I-PROBLEM
and	CC	I-PROBLEM
arm	NN	I-PROBLEM
fracture	NN	I-PROBLEM
.	.	O

1)	CD	O
s/p	JJ	O
fall	NN	B-PROBLEM
-	:	O
unlikely	JJ	O
to	TO	O
be	VB	O
mechanical	JJ	O
in	IN	O
nature	NN	O
.	.	O

patient	NN	O
has	VBZ	O
injuries	NNS	B-PROBLEM
to	TO	I-PROBLEM
her	PRP$	I-PROBLEM
shoulder	NN	I-PROBLEM
and	CC	I-PROBLEM
hip	NN	I-PROBLEM
.	.	O

2)	CD	O
cv	JJ	O
-	:	O
patient	NN	O
has	VBZ	O
cad	VBN	B-PROBLEM
and	CC	O
chf	VBN	B-PROBLEM
with	IN	O
a	DT	B-PROBLEM
low	JJ	I-PROBLEM
hct	NN	I-PROBLEM
and	CC	O
major	JJ	B-PROBLEM
trauma	NN	I-PROBLEM
.	.	O

she	PRP	O
also	RB	O
has	VBZ	O
new	JJ	B-PROBLEM
changes	NNS	I-PROBLEM
on	IN	I-PROBLEM
ekg	NN	I-PROBLEM
.	.	O

on	IN	O
pressor	NN	B-TREATMENT
to	TO	O
hold	VB	O
mean	JJ	O
60	CD	O
.	.	O

3)	CD	O
anemia	JJ	B-PROBLEM
-	:	O
patient	JJ	O
transfusion	NN	B-PROBLEM
dependant	NN	I-PROBLEM
with	IN	O
a	DT	O
baseline	NN	O
of	IN	O
28	CD	O
.	.	O

-	:	O
transfuse	NN	O
2	CD	O
units	NNS	O
today	NN	O
,	,	O
with	IN	O
lasix	NN	B-TREATMENT

4)	CD	O
gerd	JJ	B-PROBLEM
-	:	O
ppi	NN	B-TREATMENT

5)	CD	O
dm	JJ	B-PROBLEM
-	:	O
glipizide	NN	B-TREATMENT
,	,	O
iss	VB	B-TREATMENT

6)	CD	O
pmr	JJ	B-PROBLEM
-	:	O
cont	NN	O
prednisone	NN	B-TREATMENT

7)	CD	O
gi	NN	O
:	:	O
ms.	NN	O
pimental	NN	O
is	VBZ	O
an	DT	O
unfortunate	JJ	O
95	CD	O
year	NN	O
old	JJ	O
woman	NN	O
,	,	O
status	NN	O
post	NN	O
a	DT	B-PROBLEM
recent	JJ	I-PROBLEM
fall	NN	I-PROBLEM
necessitating	VBG	O
right	JJ	B-TREATMENT
orif	NN	I-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
hip	NN	I-TREATMENT
and	CC	O
right	JJ	B-PROBLEM
wrist	NN	I-PROBLEM
fracture	NN	I-PROBLEM
orif	NN	B-TREATMENT
,	,	O
who	WP	O
was	VBD	O
in	IN	O
the	DT	O
hospital	NN	O
for	IN	O
this	DT	O
event	NN	O
,	,	O
when	WRB	O
it	PRP	O
was	VBD	O
noted	VBN	O
that	IN	O
she	PRP	O
had	VBD	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
distention	NN	B-PROBLEM
and	CC	O
coffee	NN	B-PROBLEM
ground	NN	I-PROBLEM
emesis	NN	I-PROBLEM
with	IN	O
worsening	VBG	B-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
and	CC	O
renal	JJ	B-PROBLEM
failure	NN	I-PROBLEM
.	.	O

ct	JJ	B-TEST
scan	NN	I-TEST
was	VBD	O
obtained	VBN	O
and	CC	O
this	DT	O
revealed	VBD	O
free	JJ	B-PROBLEM
air	NN	I-PROBLEM
and	CC	O
massive	JJ	B-PROBLEM
ascites	NNS	I-PROBLEM
.	.	O

pt	NN	O
underwent	JJ	O
surgery	NN	B-TREATMENT
on	IN	O
05-23	NN	O

1.	CD	O
exploratory	JJ	B-TEST
laparotomy	NN	I-TEST
with	IN	O
drainage	NN	B-TREATMENT
of	IN	O
intra-abdominal	JJ	B-PROBLEM
abscess	NN	I-PROBLEM
and	CC	O
peritonitis	NN	B-PROBLEM
with	IN	O
gross	JJ	B-PROBLEM
soilage	NN	I-PROBLEM
with	IN	I-PROBLEM
bile	NN	I-PROBLEM
and	CC	I-PROBLEM
gastric	JJ	I-PROBLEM
contents	NNS	I-PROBLEM
.	.	O

2.	CD	O
exposure	NN	B-TREATMENT
and	CC	O
wide	JJ	B-TREATMENT
drainage	NN	I-TREATMENT
of	IN	O
perforated	JJ	B-PROBLEM
posterior	JJ	I-PROBLEM
duodenal	JJ	I-PROBLEM
ulcer	NN	I-PROBLEM
with	IN	O
internal	JJ	B-TREATMENT
and	CC	I-TREATMENT
external	JJ	I-TREATMENT
drainage	NN	I-TREATMENT
.	.	O

3.	CD	O
feeding	VBG	B-TREATMENT
jejunostomy	NN	I-TREATMENT
.	.	O

4.	CD	O
tube	JJ	B-TREATMENT
gastrostomy	NN	I-TREATMENT
.	.	O

continue	NN	O
to	TO	O
deteriorate	VB	O
spiking	VBG	B-PROBLEM
fevers	NNS	I-PROBLEM
with	IN	O
ventilatory	JJ	B-TREATMENT
support	NN	I-TREATMENT
on	IN	O
pressors	NNS	B-TREATMENT
to	TO	O
hold	VB	O
the	DT	B-TEST
bp.	NN	I-TEST
with	IN	O
no	DT	O
improvement	NN	O
in	IN	O
mental	JJ	O
staus	NN	O
was	VBD	O
made	VBN	O
cmo	NN	O
5/20/5	CD	O
.	.	O

lasix	NN	B-TREATMENT
alt	VBD	O
40	CD	O
mg	NN	O
and	CC	O
20	CD	O
mg	NNS	O
qday	JJ	O

levothyrox	RB	B-TREATMENT
50	CD	O
mcg	NNS	O
qday	JJ	O

lisinopril	RB	B-TREATMENT
5	CD	O
mg	NNS	O
qday	JJ	O

famotidine	NN	B-TREATMENT
20	CD	O
mg	NN	O
qday	NN	O

fe	NN	B-TREATMENT
so4	VBZ	I-TREATMENT
325	CD	O
mg	NN	O
qday	NN	O

asa	RB	B-TREATMENT
325	CD	O
mg	NNS	O
qday	JJ	O

toprol	NN	B-TREATMENT
xl	VBZ	I-TREATMENT
25	CD	O
mg	NN	O
qday	NN	O

glipizide	RB	B-TREATMENT
5	CD	O
mg	NNS	O
qday	JJ	O

imdur	NN	B-TREATMENT
60	CD	O
mg	NN	O
qdau	NN	O

prednisone	NN	B-TREATMENT
5	CD	O
mg	NN	O
qday	NN	O

tylenol	NN	B-TREATMENT

expired	VBD	B-PROBLEM

multiorgan	JJ	B-PROBLEM
failure	NN	I-PROBLEM

duodenal	JJ	B-PROBLEM
perforation	NN	I-PROBLEM

multiple	JJ	B-PROBLEM
trauma	NN	I-PROBLEM

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
originally	RB	O
for	IN	O
airway	RB	B-TEST
monitoring	NN	I-TEST
status	NN	O
post	NN	O
endoscopic	NN	O
retrograde	NN	O

cholangiopancreatography	NN	B-TEST
with	IN	O
adverse	JJ	B-PROBLEM
reaction	NN	I-PROBLEM
to	TO	O
fentanyl	VB	B-TREATMENT
and	CC	O
tongue	VB	B-PROBLEM
injury	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
59	JJ	O
year-old	JJ	O
female	NN	O
status	NN	O
post	NN	O
endoscopic	NN	B-TEST
retrograde	NN	I-TEST
cholangiopancreatography	NN	I-TEST
on	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
,	,	O
which	WDT	O
had	VBD	O
been	VBN	O
done	VBN	O
to	TO	O
evaluate	VB	O
for	IN	O
possible	JJ	O
bile	NN	B-PROBLEM
leak	NN	I-PROBLEM
after	IN	O
cholecystectomy	NN	B-TREATMENT
was	VBD	O
performed	VBN	O
four	CD	O
days	NNS	O
ago	RB	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
in	IN	O
her	PRP$	O
usual	JJ	O
state	NN	O
of	IN	O
health	NN	O
until	IN	O
four	CD	O
days	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
when	WRB	O
she	PRP	O
had	VBD	O
a	DT	B-TREATMENT
cholecystectomy	NN	I-TREATMENT
.	.	O

her	PRP$	O
postop	JJ	O
course	NN	O
was	VBD	O
uneventful	JJ	O
until	IN	O
one	CD	O
day	NN	O
prior	RB	O
to	TO	O
admission	NN	O
when	WRB	O
she	PRP	O
developed	VBD	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

on	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
she	PRP	O
returned	VBD	O
to	TO	O
the	DT	O
outside	JJ	O
hospital	NN	O
emergency	NN	O
room	NN	O
where	WRB	O
an	DT	B-TEST
abdominal	JJ	I-TEST
ct	NN	I-TEST
was	VBD	O
performed	VBN	O
,	,	O
which	WDT	O
showed	VBD	O
"	NNP	O
thickened	VBD	B-PROBLEM
stomach	NN	I-PROBLEM
and	CC	O
free	JJ	B-PROBLEM
air	NN	I-PROBLEM
."	NNS	O

she	PRP	O
was	VBD	O
sent	VBN	O
to	TO	O
new	JJ	O
england	NN	O
sinai	NN	O
hospital	NN	O
&	CC	O
rehab	NN	O
center	NN	O
for	IN	O
an	DT	B-TEST
endoscopic	NN	I-TEST
retrograde	NN	I-TEST
cholangiopancreatography	NN	I-TEST
and	CC	O
possible	JJ	O
stent	NN	B-TREATMENT
placement	NN	I-TREATMENT
.	.	O

she	PRP	O
had	VBD	O
a	DT	B-TEST
successful	JJ	I-TEST
endoscopic	NN	I-TEST
retrograde	NN	I-TEST
cholangiopancreatography	NN	I-TEST
,	,	O
which	WDT	O
showed	VBD	O
a	DT	B-PROBLEM
bile	JJ	I-PROBLEM
leak	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
duct	NN	I-PROBLEM
of	IN	I-PROBLEM
luschka	NN	I-PROBLEM
.	.	O

a	DT	B-TREATMENT
stent	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
successfully	RB	O
.	.	O

after	IN	O
her	PRP$	B-TEST
endoscopic	NN	I-TEST
retrograde	NN	I-TEST
cholangiopancreatography	VBD	I-TEST
the	DT	O
patient	NN	O
developed	VBD	O
"	NNP	O
jaw	NN	B-PROBLEM
clenching	NN	I-PROBLEM
,	,	O
biting	VBG	B-PROBLEM
tongue	NN	I-PROBLEM
,	,	O
rigidity	NN	B-PROBLEM
and	CC	O
cold	JJ	B-PROBLEM
/	NN	I-PROBLEM
chills	NNS	I-PROBLEM
."	VBP	O

the	DT	O
patient	NN	O
received	VBD	O
ampicillin	RB	B-TREATMENT
,	,	O
gentamycin	NN	B-TREATMENT
and	CC	O
flagyl	VB	B-TREATMENT
empirically	RB	O
as	RB	O
well	RB	O
as	IN	O
narcan	JJ	B-TREATMENT
to	TO	O
reverse	VB	O
fentanyl	NN	B-TREATMENT
.	.	O

because	IN	O
of	IN	O
the	DT	B-PROBLEM
tongue	JJ	I-PROBLEM
injury	NN	I-PROBLEM
and	CC	O
tachycardia	NN	B-PROBLEM
as	RB	O
well	RB	O
as	IN	O
possible	JJ	O
infection	NN	B-PROBLEM
given	VBN	O
her	PRP$	B-PROBLEM
fevers	NNS	I-PROBLEM
or	CC	O
chills	VBZ	B-PROBLEM
the	DT	O
gi	NN	O
service	NN	O
transferred	VBD	O
the	DT	O
patient	NN	O
to	TO	O
the	DT	O
cmed	VBN	O
ccu	NN	O
for	IN	O
close	JJ	O
observation	NN	O
.	.	O

1.	CD	O
hiatal	JJ	B-PROBLEM
hernia	NN	I-PROBLEM
.	.	O

2.	CD	O
status	NN	O
post	NN	O
cholecystectomy	VB	B-TREATMENT
four	CD	O
days	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
.	.	O

3.	CD	O
urinary	JJ	B-PROBLEM
frequency	NN	I-PROBLEM
secondary	JJ	O
to	TO	O
interstitial	JJ	B-PROBLEM
cystitis	NN	I-PROBLEM
.	.	O

4.	CD	O
mitral	JJ	B-PROBLEM
valve	NN	I-PROBLEM
prolapse	NN	I-PROBLEM
.	.	O

5.	CD	O
tubal	JJ	B-TREATMENT
ligation	NN	I-TREATMENT
many	JJ	O
years	NNS	O
ago	RB	O
.	.	O

1.	CD	O
prempro	NN	B-TREATMENT
.	.	O

2.	CD	O
cmed	VBD	B-TREATMENT
ccu	JJ	I-TREATMENT
drops	NNS	I-TREATMENT
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
at	IN	O
the	DT	O
time	NN	O
of	IN	O
admission	NN	O
,	,	O
however	RB	O
,	,	O
it	PRP	O
is	VBZ	O
assumed	VBN	O
that	IN	O
her	PRP$	B-PROBLEM
rigidity	NN	I-PROBLEM
and	CC	O
jaw	NN	B-PROBLEM
clenching	NN	I-PROBLEM
was	VBD	O
secondary	JJ	O
to	TO	O
fentanyl	VB	B-TREATMENT
.	.	O

vital	JJ	B-TEST
signs	NNS	I-TEST
temperature	NN	B-TEST
100.6	CD	O
.	.	O

heart	NN	B-TEST
rate	NN	I-TEST
105	CD	O
.	.	O

blood	NN	B-TEST
pressure	NN	I-TEST
162/76	CD	O
.	.	O

respiratory	NN	B-TEST
rate	NN	I-TEST
18	CD	O
.	.	O

sating	VBG	B-TEST
98%	CD	O
on	IN	O
3	CD	O
liters	NNS	O
.	.	O

in	IN	O
general	JJ	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
groggy	JJ	B-PROBLEM
status	NN	O
post	NN	O
anesthesia	NN	B-TREATMENT
,	,	O
shivering	NN	B-PROBLEM
,	,	O
but	CC	O
awake	VBP	O
.	.	O

heent	NN	O
showed	VBD	O
tongue	NN	O
with	IN	O
laceration	NN	B-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
right	NN	I-PROBLEM
edge	NN	I-PROBLEM
.	.	O

lungs	NNS	O
were	VBD	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
.	.	O

no	DT	O
murmurs	NN	B-PROBLEM
,	,	O
rubs	NN	B-PROBLEM
or	CC	O
gallops	NNS	B-PROBLEM
.	.	O

abdomen	NNS	O
was	VBD	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBN	B-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
rebound	NN	B-PROBLEM
or	CC	O
guarding	NN	B-PROBLEM
.	.	O

there	EX	O
were	VBD	O
post	NN	B-PROBLEM
laparoscopic	NN	I-PROBLEM
incisions	NNS	I-PROBLEM
without	IN	O
erythema	NN	B-PROBLEM
with	IN	O
steri-strips	NNS	B-TREATMENT
in	IN	O
place	NN	O
.	.	O

the	DT	O
extremities	NNS	O
were	VBD	O
without	IN	O
edema	NN	B-PROBLEM
.	.	O

dorsalis	NN	B-TEST
pedis	NN	I-TEST
pulses	NNS	I-TEST
were	VBD	O
intact	JJ	O
bilaterally	RB	O
.	.	O

there	EX	O
were	VBD	O
no	DT	O
rashes	NNS	B-PROBLEM
.	.	O

white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
9.0	CD	O
,	,	O
hematocrit	NN	B-TEST
39.3	CD	O
,	,	O
platelets	NNS	B-TEST
296	CD	O
,	,	O
neutrophil	RB	B-TEST
count	NN	I-TEST
82	CD	O
,	,	O
lymphocytes	VBZ	B-TEST
14	CD	O
,	,	O
4	CD	O
monocytes	NNS	B-TEST
,	,	O
troponin	NN	B-TEST
was	VBD	O
less	JJR	O
then	RB	O
0.3	CD	O
.	.	O

sodium	NN	B-TEST
139	CD	O
,	,	O
potassium	NN	B-TEST
3.8	CD	O
,	,	O
chloride	RB	B-TEST
101	CD	O
,	,	O
bicarb	NN	B-TEST
26	CD	O
,	,	O
bun	NN	B-TEST
9	CD	O
,	,	O
creatinine	NN	B-TEST
0.7	CD	O
,	,	O
glucose	RB	B-TEST
141	CD	O
,	,	O
albumin	RB	B-TEST
4.1	CD	O
,	,	O
calcium	NN	B-TEST
8.9	CD	O
,	,	O
ldh	VBD	B-TEST
665	CD	O
,	,	O
ast	RB	B-TEST
44	CD	O
,	,	O
alt	NN	B-TEST
of	IN	O
57	CD	O
,	,	O
amylase	NN	B-TEST
41	CD	O
,	,	O
ck	NN	B-TEST
32	CD	O
.	.	O

electrocardiogram	RB	B-TEST
showed	VBN	O
normal	JJ	O
sinus	NN	O
rhythm	NN	O
at	IN	O
73	CD	O
beats	NNS	O
per	IN	O
minute	NN	O
.	.	O

there	EX	O
were	VBD	O
no	DT	O
st	NN	B-PROBLEM
or	CC	I-PROBLEM
t	NN	I-PROBLEM
wave	NN	I-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

abdominal	JJ	B-TEST
ct	NN	I-TEST
showed	VBD	O
inflammation	NN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
upper	NN	I-PROBLEM
quadrant	NN	I-PROBLEM
,	,	O
small	JJ	B-PROBLEM
fluid	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
circumferential	JJ	I-PROBLEM
thickening	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
distal	JJ	I-PROBLEM
stomach	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
a	DT	O
question	NN	O
of	IN	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
ulcer	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
a	DT	O
tiny	JJ	O
amount	NN	O
of	IN	O
free	JJ	B-PROBLEM
air	NN	I-PROBLEM
.	.	O

in	IN	O
summary	JJ	O
the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
59	JJ	O
year-old	JJ	O
female	NN	O
who	WP	O
was	VBD	O
admitted	VBN	O
to	TO	O
quincy	VB	O
medical	JJ	O
center	NN	O
for	IN	O
an	DT	B-TEST
endoscopic	NN	I-TEST
retrograde	NN	I-TEST
cholangiopancreatography	NN	I-TEST
for	IN	O
possible	JJ	O
stent	JJ	B-TREATMENT
placement	NN	I-TREATMENT
for	IN	O
a	DT	B-PROBLEM
bile	JJ	I-PROBLEM
leak	NN	I-PROBLEM
secondary	JJ	O
to	TO	O
cholecystectomy	VB	B-TREATMENT
performed	JJ	O
four	CD	O
days	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
.	.	O

she	PRP	O
then	RB	O
suffered	VBD	O
rigidity	NN	B-PROBLEM
with	IN	O
jaw	NN	B-PROBLEM
clenching	NN	I-PROBLEM
and	CC	O
tongue	NN	B-PROBLEM
biting	NN	I-PROBLEM
secondary	JJ	O
to	TO	O
fentanyl	VB	B-TREATMENT
administration	NN	O
and	CC	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
cmed	VBN	O
ccu	NN	O
for	IN	O
close	JJ	O
observation	NN	O
.	.	O

she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
ampicillin	NN	B-TREATMENT
,	,	O
gentamycin	NN	B-TREATMENT
and	CC	O
flagyl	NN	B-TREATMENT
.	.	O

her	PRP$	B-TEST
liver	JJ	I-TEST
function	NN	I-TEST
tests	NNS	I-TEST
and	CC	O
amylase	NN	B-TEST
and	CC	O
lipase	NN	B-TEST
were	VBD	O
followed	VBN	O
closely	RB	O
.	.	O

as	IN	O
stated	VBN	O
the	DT	O
patient	NN	O
was	VBD	O
status	NN	O
post	NN	O
endoscopic	NN	B-TEST
retrograde	VBD	I-TEST
cholangiopancreatography	NN	I-TEST
with	IN	O
stent	NN	O

placement	NN	B-TREATMENT
for	IN	O
a	DT	B-PROBLEM
bile	JJ	I-PROBLEM
leak	NN	I-PROBLEM
from	IN	I-PROBLEM
the	DT	I-PROBLEM
duct	NN	I-PROBLEM
of	IN	I-PROBLEM
luschka	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
ampicillin	NN	B-TREATMENT
,	,	O
gentamycin	NN	B-TREATMENT
and	CC	O
flagyl	NN	B-TREATMENT
,	,	O
which	WDT	O
had	VBD	O
been	VBN	O
started	VBN	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
transfer	NN	O
to	TO	O
the	DT	O
cmed	VBN	O
ccu	NN	O
.	.	O

she	PRP	O
had	VBD	O
waxing	VBG	B-PROBLEM
and	CC	I-PROBLEM
waning	VBG	I-PROBLEM
fevers	NNS	I-PROBLEM
.	.	O

however	RB	O
,	,	O
her	PRP	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
was	VBD	O
never	RB	O
really	RB	B-PROBLEM
elevated	VBN	I-PROBLEM
and	CC	O
she	PRP	O
did	VBD	O
not	RB	O
have	VB	O
a	DT	B-PROBLEM
bandemia	NN	I-PROBLEM
.	.	O

on	IN	O
the	DT	O
day	NN	O
of	IN	O
transfer	NN	O
to	TO	O
the	DT	O
general	JJ	O
medical	JJ	O
floor	NN	O
the	DT	O
patient	NN	O
had	VBD	O
received	VBN	O
clear	JJ	B-TREATMENT
liquids	NNS	I-TREATMENT
.	.	O

her	PRP$	B-TEST
amylase	NN	I-TEST
and	CC	O
lipase	NN	B-TEST
on	IN	O
the	DT	O
day	NN	O
following	VBG	O
the	DT	B-TEST
endoscopic	NN	I-TEST
retrograde	NN	I-TEST
cholangiopancreatography	NN	I-TEST

were	VBD	O
elevated	VBN	B-PROBLEM
.	.	O

amylase	NN	B-TEST
was	VBD	O
2304	CD	O
with	IN	O
lipase	NN	B-TEST
being	VBG	O
7116	CD	O
.	.	O

therefore	RB	O
she	PRP	O
was	VBD	O
made	VBN	O
npo	NN	B-TREATMENT
and	CC	O
given	VBN	O
aggressive	JJ	B-TREATMENT
intravenous	JJ	I-TREATMENT
hydration	NN	I-TREATMENT
.	.	O

on	IN	O
the	DT	O
second	JJ	O
hospital	NN	O
day	NN	O
on	IN	O
the	DT	O
general	JJ	O
medical	JJ	O
floor	NN	O
the	DT	O
patient	NN	O
had	VBD	O
marked	VBN	B-PROBLEM
rebound	NN	I-PROBLEM
to	TO	O
palpation	NN	B-TEST
of	IN	I-TEST
her	PRP$	I-TEST
abdomen	NNS	I-TEST
.	.	O

she	PRP	O
was	VBD	O
followed	VBN	O
closely	RB	O
with	IN	O
serial	JJ	B-TEST
abdominal	JJ	I-TEST
examinations	NNS	I-TEST
.	.	O

her	PRP$	B-TEST
amylase	NN	I-TEST
and	CC	O
lipase	NN	B-TEST
were	VBD	O
trending	VBG	O
down	RP	O
,	,	O
however	RB	O
.	.	O

an	DT	B-TEST
abdominal	JJ	I-TEST
ct	NN	I-TEST
was	VBD	O
obtained	VBN	O
,	,	O
which	WDT	O
showed	VBD	O
only	RB	O
mild	JJ	B-PROBLEM
pancreatitis	NN	I-PROBLEM
.	.	O

there	EX	O
were	VBD	O
no	DT	O
intra-abdominal	JJ	B-PROBLEM
fluid	NN	I-PROBLEM
collections	NNS	I-PROBLEM
,	,	O
which	WDT	O
required	VBD	O
any	DT	B-TREATMENT
drainage	NN	I-TREATMENT
.	.	O

on	IN	O
the	DT	O
third	JJ	O
hospital	NN	O
day	NN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
pain	NN	I-PROBLEM
was	VBD	O
improving	VBG	O
and	CC	O
the	DT	B-PROBLEM
rebound	NN	I-PROBLEM
was	VBD	O
decreasing	VBG	O
.	.	O

her	PRP$	B-TEST
enzymes	NNS	I-TEST
continued	VBN	O
to	TO	O
trend	NN	O
down	RP	O
.	.	O

she	PRP	O
received	VBD	O
clear	JJ	B-TREATMENT
liquids	NNS	I-TREATMENT
in	IN	O
the	DT	O
evening	NN	O
and	CC	O
tolerated	VBN	O
these	DT	O
well	RB	O
.	.	O

on	IN	O
the	DT	O
day	NN	O
of	IN	O
discharge	NN	O
the	DT	O
patient	NN	O
was	VBD	O
tolerating	VBG	O
a	DT	B-TREATMENT
brat	NN	I-TREATMENT
diet	NN	I-TREATMENT
without	IN	O
significant	JJ	O
abdominal	JJ	O

pain	NN	B-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
no	DT	O
further	JJ	B-PROBLEM
rebound	NN	I-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
no	DT	O
temperature	NN	B-PROBLEM
spikes	VBZ	I-PROBLEM
in	IN	O
greater	JJR	O
then	RB	O
24	CD	O
hours	NNS	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
hematocrit	NN	I-TEST
was	VBD	O
34.8	CD	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
admission	NN	O
.	.	O

it	PRP	O
decreased	VBD	O
to	TO	O
30	CD	O
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
aggressive	JJ	B-TREATMENT
hydration	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
aggressively	RB	B-TREATMENT
hydrated	VBN	I-TREATMENT
given	VBN	O
that	IN	O
she	PRP	O
was	VBD	O
npo	RB	B-TREATMENT
.	.	O

she	PRP	O
required	VBD	O
periodic	JJ	B-TREATMENT
repletion	NN	I-TREATMENT
of	IN	I-TREATMENT
her	PRP$	I-TREATMENT
potassium	NN	I-TREATMENT
.	.	O

her	PRP$	B-TEST
bicarb	NN	I-TEST
began	VBD	O
to	TO	O
drop	VB	O
and	CC	O
she	PRP	O
developed	VBD	O
an	DT	B-PROBLEM
anion	NN	I-PROBLEM
gap	NN	I-PROBLEM
acidosis	NN	I-PROBLEM
.	.	O

this	DT	O
was	VBD	O
most	RBS	O
likely	JJ	O
secondary	JJ	O
to	TO	O
ketoacidosis	VB	B-PROBLEM
as	IN	O
she	PRP	O
had	VBD	O
no	DT	O
dextrose	NN	B-TREATMENT
in	IN	O
her	PRP$	B-TREATMENT
intravenous	JJ	I-TREATMENT
fluids	NNS	I-TREATMENT
.	.	O

this	DT	O
was	VBD	O
added	VBN	O
on	IN	O
the	DT	O
evening	NN	O
prior	RB	O
to	TO	O
discharge	VB	O
and	CC	O
on	IN	O
the	DT	O
day	NN	O
of	IN	O
discharge	NN	O
her	PRP$	B-PROBLEM
anion	NN	I-PROBLEM
gap	NN	I-PROBLEM
acidosis	NN	I-PROBLEM
had	VBD	O
resolved	VBN	O
.	.	O

1.	CD	O
levaquin	JJ	B-TREATMENT
500	CD	O
mg	NN	O
one	CD	O
po	NN	O
q	NN	O
day	NN	O
times	NNS	O
seven	CD	O
days	NNS	O
.	.	O

2.	CD	O
protonix	JJ	B-TREATMENT
40	CD	O
mg	NN	O
po	NN	O
q	JJ	O
day	NN	O
.	.	O

3.	CD	O
percocet	JJ	B-TREATMENT
one	CD	O
to	TO	O
two	CD	O
tablets	NNS	O
po	VBP	O
q	RB	O
4	CD	O
to	TO	O
6	CD	O
hours	NNS	O
prn	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
a	DT	B-TREATMENT
prescription	NN	I-TREATMENT
for	IN	I-TREATMENT
ten	JJ	I-TREATMENT
pills	NNS	I-TREATMENT
.	.	O

4.	CD	O
prempro	NN	B-TREATMENT
as	IN	O
the	DT	O
patient	NN	O
was	VBD	O
formerly	RB	O
taking	VBG	O
.	.	O

5.	CD	O
trazodone	NN	B-TREATMENT
at	IN	O
bedtime	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
to	TO	O
make	VB	O
an	DT	O
appointment	NN	O
with	IN	O
dr.	JJ	O
nicholson	NN	O
within	IN	O
one	CD	O
to	TO	O
two	CD	O
months	NNS	O
after	IN	O
discharge	NN	O
for	IN	O
removal	NN	B-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
stent	NN	I-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
to	TO	O
continue	VB	O
on	IN	O
a	DT	B-TREATMENT
brat	NN	I-TREATMENT
diet	NN	I-TREATMENT
over	IN	O
the	DT	O
weekend	NN	O
and	CC	O
two	CD	O
days	NNS	O
after	IN	O
discharge	NN	O
she	PRP	O
could	MD	O
advance	VB	O
to	TO	O
a	DT	B-TREATMENT
low	JJ	I-TREATMENT
fat	NN	I-TREATMENT
no	DT	I-TREATMENT
dairy	NN	I-TREATMENT
diet	NN	I-TREATMENT
.	.	O

1.	CD	O
post	NN	B-PROBLEM
endoscopic	NN	I-PROBLEM
retrograde	NN	I-PROBLEM
cholangiopancreatography	NN	I-PROBLEM
pancreatitis	NN	I-PROBLEM
.	.	O

2.	CD	O
anemia	NN	B-PROBLEM
.	.	O

3.	CD	O
hypokalemia	NN	B-PROBLEM
.	.	O

4.	CD	O
anion	NN	B-PROBLEM
gap	NN	I-PROBLEM
acidosis	NN	I-PROBLEM
.	.	O

5.	CD	O
bile	JJ	B-PROBLEM
leak	NN	I-PROBLEM
.	.	O

again	RB	O
,	,	O
this	DT	O
was	VBD	O
a	DT	O
47-year-old	JJ	O
female	NN	O
admitted	VBN	O
with	IN	O
berkitt's	JJ	B-PROBLEM
lymphoma	NN	I-PROBLEM
.	.	O

1.	CD	O
liver	JJ	B-PROBLEM
lesions	NNS	I-PROBLEM
:	:	O

the	DT	O
patient	NN	O
went	VBD	O
for	IN	O
a	DT	B-TEST
repeat	NN	I-TEST
mri	NN	I-TEST
which	WDT	O
showed	VBD	O
no	DT	O
change	NN	O
in	IN	O
the	DT	B-PROBLEM
previously	RB	I-PROBLEM
noted	VBN	I-PROBLEM
enumerable	JJ	I-PROBLEM
hepatic	JJ	I-PROBLEM
cyst	NN	I-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
liver	NN	I-PROBLEM
.	.	O

a	DT	O
hepatology	NN	O
consult	NN	O
was	VBD	O
obtained	VBN	O
who	WP	O
felt	VBD	O
that	IN	O
the	DT	O
most	RBS	O
likely	JJ	O
etiology	NN	O
of	IN	O
these	DT	B-PROBLEM
cysts	NNS	I-PROBLEM
were	VBD	O
from	IN	O
hepatic	JJ	B-PROBLEM
candidiasis	NN	I-PROBLEM
,	,	O
although	IN	O
one	CD	O
could	MD	O
not	RB	O
rule	VB	O
out	RP	O
lymphoma	NN	B-PROBLEM
involving	VBG	O
from	IN	O
burkitt's	NN	B-PROBLEM
.	.	O

she	PRP	O
will	MD	O
be	VB	O
discharged	VBN	O
on	IN	O
ambisome	JJ	B-TREATMENT
300	CD	O
mg	NN	O
iv	NN	O
q.d.	NN	O
for	IN	O
treatment	NN	O
of	IN	O
her	PRP$	B-PROBLEM
hepatic	JJ	I-PROBLEM
candidiasis	NN	I-PROBLEM
.	.	O

this	DT	O
regimen	NN	O
,	,	O
that	IN	O
being	VBG	O
ambisome	JJ	B-TREATMENT
,	,	O
was	VBD	O
recommended	VBN	O
by	IN	O
the	DT	O
infectious	JJ	O
disease	NN	O
physicians	NNS	O
,	,	O
who	WP	O
felt	VBD	O
that	IN	O
ambisome	NN	B-TREATMENT
was	VBD	O
a	DT	O
better	JJR	O
drug	NN	O
of	IN	O
choice	NN	O
as	IN	O
compared	VBN	O
to	TO	O
fluconazole	VB	B-TREATMENT
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
platelets	NNS	I-TEST
,	,	O
white	JJ	B-TEST
count	NN	I-TEST
,	,	O
and	CC	O
hematocrit	NNS	B-TEST
have	VBP	O
all	DT	O
been	VBN	O
stable	JJ	O
.	.	O

her	PRP$	B-TEST
white	JJ	I-TEST
count	NN	I-TEST
remained	VBD	O
elevated	JJ	B-PROBLEM
despite	IN	O
discontinuing	VBG	O
her	PRP$	B-TREATMENT
g-csf	NN	I-TREATMENT
.	.	O

however	RB	O
,	,	O
the	DT	O
patient	NN	O
is	VBZ	O
not	RB	O
febrile	JJ	B-PROBLEM
and	CC	O
her	PRP$	B-TEST
white	JJ	I-TEST
count	NN	I-TEST
should	MD	O
be	VB	O
continued	VBN	O
to	TO	O
be	VB	O
watched	VBN	O
.	.	O

3.	CD	O
on	IN	O
the	DT	O
morning	NN	O
of	IN	O
12-01	JJ	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
some	DT	O
transient	JJ	O
episodes	NNS	O
of	IN	O
hypotension	NN	B-PROBLEM
with	IN	O
sbp	JJ	B-TEST
s	NN	I-TEST
in	IN	O
the	DT	O
70	CD	O
s.	NN	O

her	PRP$	B-TREATMENT
captopril	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
,	,	O
and	CC	O
she	PRP	O
was	VBD	O
given	VBN	O
two	CD	B-TREATMENT
iv	JJ	I-TREATMENT
fluid	NN	I-TREATMENT
boluses	NNS	I-TREATMENT
with	IN	O
appropriate	JJ	O
response	NN	O
.	.	O

her	PRP$	B-TEST
blood	NN	I-TEST
pressures	NNS	I-TEST
and	CC	O
all	DT	O
of	IN	O
her	PRP$	B-TEST
vital	JJ	I-TEST
signs	NNS	I-TEST
are	VBP	O
stable	JJ	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
tpn	NN	B-TREATMENT
over	IN	O
the	DT	O
past	JJ	O
couple	NN	O
days	NNS	O
.	.	O

she	PRP	O
is	VBZ	O
also	RB	O
started	VBN	O
on	IN	O
marinol	NN	B-TREATMENT
2.5	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O
and	CC	O
encouraged	VBD	O
p.o.	NNS	O
intake	NN	O
.	.	O

guarded	VBN	B-PROBLEM
,	,	O
but	CC	O
stable	JJ	O
.	.	O

1.	CD	O
burkitt's	JJ	B-PROBLEM
lymphoma	NN	I-PROBLEM
.	.	O

2.	CD	O
hepatic	JJ	B-PROBLEM
candidiasis	NN	I-PROBLEM
.	.	O

1.	CD	O
ambisome	JJ	B-TREATMENT
300	CD	O
mg	NN	O
iv	NN	O
q.d.	NN	O

2.	CD	O
marinol	JJ	B-TREATMENT
2.5	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O
before	IN	O
breakfast	NN	O
and	CC	O
dinner	NN	O
.	.	O

3.	CD	O
atarax	NN	B-TREATMENT
25	CD	O
mg	NN	O
iv	NN	O
/	NNP	O
p.o.	NN	O
q.	VBD	O
4-6	JJ	O
h.	NN	O
prn	NN	O
for	IN	O
itching	VBG	B-PROBLEM
.	.	O

4.	CD	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

5.	CD	O
protonix	JJ	B-TREATMENT
40	CD	O
mg	NN	O
p.o.	NN	O
/	NNP	O
iv	NN	O
q.d.	NN	O

6.	CD	O
nystatin	JJ	B-TREATMENT
06-18	JJ	O
ml	NN	O
swish	NN	O
and	CC	O
swallow	JJ	O
q.6.	NN	O
prn	NN	O
.	.	O

7.	CD	O
peridex	NN	B-TREATMENT
15	CD	O
ml	NN	O
swish	NN	O
and	CC	O
swallow	JJ	O
prn	NN	O
.	.	O

transfer	NN	O
from	IN	O
rehab	JJ	O
hospital	NN	O
of	IN	O
the	DT	O
cape	NN	O
&	CC	O
islands	NNS	O
hospital	NN	O
for	IN	O
an	DT	B-TEST
endoscopic	NN	I-TEST
retrogram	NN	I-TEST
cholangiopancreatography	NN	I-TEST
.	.	O

mr.	NN	O
eugene	NN	O
is	VBZ	O
a	DT	O
67	CD	O
year	NN	O
old	JJ	O
male	NN	O
with	IN	O
a	DT	O
remote	JJ	O
history	NN	O
of	IN	O
chronic	JJ	B-PROBLEM
pancreatitis	NN	I-PROBLEM
due	JJ	O
to	TO	O
alcohol	VB	O
abuse	IN	O
30	CD	O
years	NNS	O
ago	RB	O
,	,	O
who	WP	O
is	VBZ	O
transferred	VBN	O
now	RB	O
from	IN	O
rehab	JJ	O
hospital	NN	O
of	IN	O
the	DT	O
cape	NN	O
&	CC	O
islands	NNS	O
hospital	NN	O
for	IN	O
an	DT	B-TEST
ercp	NN	I-TEST
and	CC	O
work-up	NN	B-TEST
for	IN	O
a	DT	B-PROBLEM
cystic	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
at	IN	O
the	DT	O
head	NN	O
of	IN	O
his	PRP$	O
pancreas	NNS	O
on	IN	O
ct	NNS	B-TEST
scan	JJ	I-TEST
shown	VBN	O
at	IN	O
the	DT	O
outside	JJ	O
hospital	NN	O
.	.	O

the	DT	O
patient	NN	O
presented	VBD	O
initially	RB	O
to	TO	O
rehab	VB	O
hospital	NN	O
of	IN	O
the	DT	O
cape	NN	O
&	CC	O
islands	NNS	O
hospital	NN	O
at	IN	O
the	DT	O
end	NN	O
of	IN	O
december	NN	O
for	IN	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
and	CC	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
pancreatitis	NN	B-PROBLEM
.	.	O

during	IN	O
this	DT	O
admission	NN	O
,	,	O
two	CD	B-TEST
ct	NN	I-TEST
scans	NNS	I-TEST
had	VBD	O
shown	VBN	O
a	DT	O
question	NN	O
of	IN	O
an	DT	B-PROBLEM
enlargement	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
head	NN	I-PROBLEM
of	IN	I-PROBLEM
his	PRP$	I-PROBLEM
pancreas	NNS	I-PROBLEM

versus	NN	O
early	JJ	B-PROBLEM
pseudocyst	NN	I-PROBLEM
.	.	O

on	IN	O
an	DT	O
office	NN	O
visit	NN	O
on	IN	O
01-14	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
significantly	RB	B-PROBLEM
elevated	VBN	I-PROBLEM
alkaline	JJ	I-PROBLEM
phosphatase	NN	I-PROBLEM
.	.	O

that	IN	O
evening	NN	O
,	,	O
the	DT	O
patient	NN	O
again	RB	O
developed	VBD	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
"	NNS	O
like	IN	O
his	PRP$	B-PROBLEM
pancreatitis	NN	I-PROBLEM
"	NN	O
with	IN	O
nausea	NN	B-PROBLEM
and	CC	O
vomiting	NN	B-PROBLEM
,	,	O
for	IN	O
which	WDT	O
he	PRP	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
rehab	JJ	O
hospital	NN	O
of	IN	O
the	DT	O
cape	NN	O
&	CC	O
islands	NNS	O
hospital	NN	O
.	.	O

his	PRP$	B-TEST
complete	JJ	I-TEST
blood	NN	I-TEST
count	NN	I-TEST
showed	VBD	O
11%	CD	B-PROBLEM
bandemia	NN	I-PROBLEM
with	IN	O
a	DT	B-TEST
total	JJ	I-TEST
white	JJ	I-TEST
count	NN	I-TEST
of	IN	O
10	CD	O
.	.	O

a	DT	B-TEST
hida	NN	I-TEST
scan	JJ	I-TEST
showed	VBD	O
no	DT	B-PROBLEM
flow	NN	I-PROBLEM
,	,	O
question	NN	O
of	IN	O
pancreatitis	NN	B-PROBLEM
versus	NN	O
common	JJ	B-PROBLEM
bile	NN	I-PROBLEM
duct	NN	I-PROBLEM
obstruction	NN	I-PROBLEM
.	.	O

his	PRP$	B-TEST
electrocardiogram	NN	I-TEST
showed	VBD	O
a	DT	O
normal	JJ	O
sinus	NN	O
rhythm	NN	O
.	.	O

a	DT	B-TEST
chest	JJ	I-TEST
x-ray	NN	I-TEST
was	VBD	O
unremarkable	JJ	O
.	.	O

during	IN	O
his	PRP$	O
admission	NN	O
to	TO	O
rehab	VB	O
hospital	NN	O
of	IN	O
the	DT	O
cape	NN	O
&	CC	O
islands	NNS	O
hospital	NN	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
dropped	VBN	O
his	PRP$	B-TEST
hematocrit	NN	I-TEST
to	TO	O
the	DT	O
30	CD	O
s	NN	O
with	IN	O
recorded	JJ	B-PROBLEM
melena	NN	I-PROBLEM
.	.	O

he	PRP	O
received	VBD	O
an	DT	B-TEST
mrcp	NN	I-TEST
which	WDT	O
was	VBD	O
negative	JJ	O
for	IN	O
evidence	NN	O
of	IN	O
stones	NNS	B-PROBLEM
.	.	O

an	DT	B-TEST
ultrasound	JJ	I-TEST
showed	VBD	O
normal	JJ	O
gallbladder	NN	O
with	IN	O
no	DT	O
wall	NN	B-PROBLEM
thickening	VBG	I-PROBLEM
but	CC	O
a	DT	B-PROBLEM
dilated	JJ	I-PROBLEM
common	JJ	I-PROBLEM
bile	IN	I-PROBLEM
duct	NN	I-PROBLEM
of	IN	O
8	CD	O
mm	NNS	O
measured	VBN	O
on	IN	O
ct	JJ	B-TEST
scan	JJ	I-TEST
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
an	DT	B-TEST
attempted	JJ	I-TEST
ercp	NN	I-TEST
on	IN	O
01-18	NN	O
,	,	O
which	WDT	O
was	VBD	O
unsuccessful	JJ	O
due	JJ	O
to	TO	O
a	DT	B-PROBLEM
long	JJ	I-PROBLEM
nipple	NN	I-PROBLEM
like	IN	I-PROBLEM
papilla	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
therefore	RB	O
transferred	VBN	O
to	TO	O
saints	NNS	O
medical	JJ	O
center	NN	O
for	IN	O
endoscopic	JJ	B-TEST
retrogram	NN	I-TEST
cholangiopancreatography	NN	I-TEST
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
blood	NN	I-TEST
cultures	NNS	I-TEST
at	IN	O
outside	JJ	O
hospital	NN	O
grew	VBD	O
out	RP	O
streptococcus	JJ	B-PROBLEM
sanguis-gordonii	JJ	I-PROBLEM
on	IN	O
01-18	NN	O
.	.	O

this	DT	O
was	VBD	O
sensitive	JJ	O
to	TO	O
clindamycin	VB	B-TREATMENT
,	,	O
erythromycin	FW	B-TREATMENT
,	,	O
penicillin	FW	B-TREATMENT
s	NN	I-TREATMENT
and	CC	O
vancomycin	NN	B-TREATMENT
.	.	O

prior	RB	O
to	TO	O
this	DT	O
result	NN	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
already	RB	O
been	VBN	O
on	IN	O
ampicillin	NN	B-TREATMENT
,	,	O
sulbactam	NN	B-TREATMENT
and	CC	O
gentamycin	NN	B-TREATMENT
.	.	O

it	PRP	O
appears	VBZ	O
from	IN	O
the	DT	O
discharge	NN	O
summary	NN	O
that	IN	O
the	DT	O
patient	NN	O
was	VBD	O
placed	VBN	O
on	IN	O
unasyn	JJ	B-TREATMENT
3	CD	O
grams	NNS	O
intravenously	RB	O
every	DT	O
six	CD	O
hours	NNS	O
after	IN	O
his	PRP$	B-TEST
ercp	NN	I-TEST
.	.	O

1.	CD	O
type	NN	B-PROBLEM
2	CD	I-PROBLEM
diabetes	NNS	I-PROBLEM
mellitus	NN	I-PROBLEM
.	.	O

2.	CD	O
right	JJ	B-PROBLEM
rotator	NN	I-PROBLEM
cuff	JJ	I-PROBLEM
injury	NN	I-PROBLEM
.	.	O

3.	CD	O
gastroesophageal	JJ	B-PROBLEM
reflux	JJ	I-PROBLEM
disease	NN	I-PROBLEM
with	IN	O
esophageal	JJ	B-TREATMENT
dilatation	NN	I-TREATMENT
for	IN	O
stricture	NN	B-PROBLEM
.	.	O

4.	CD	O
recent	JJ	B-PROBLEM
pancreatitis	NN	I-PROBLEM
;	:	O
prior	JJ	O
history	NN	O
for	IN	O
recurrent	NN	B-PROBLEM
pancreatitis	NN	I-PROBLEM
30	CD	O
years	NNS	O
ago	RB	O
from	IN	O
alcohol	NN	O
.	.	O

5.	CD	O
history	NN	O
of	IN	O
streptococcemia	NN	B-PROBLEM
in	IN	O
the	DT	O
year	NN	O
2008	CD	O
;	:	O
source	NN	O
was	VBD	O
unclear	JJ	O
but	CC	O
presumed	VBN	O
to	TO	O
be	VB	O
urinary	JJ	O
.	.	O

6.	CD	O
status	NN	O
post	NN	O
tonsillectomy	NN	B-TREATMENT
as	IN	O
a	DT	O
child	NN	O
.	.	O

1.	CD	O
prilosec	JJ	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

2.	CD	O
flomax	JJ	B-TREATMENT
4	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

3.	CD	O
humalog	NN	B-TREATMENT
75/25	CD	O
,	,	O
subcutaneously	RB	O
.	.	O

4.	CD	O
regular	JJ	B-TREATMENT
insulin	NN	I-TREATMENT
15	CD	O
units	NNS	O
q.	JJ	O
a.m.	RB	O
and	CC	O
14	CD	O
units	NNS	O
q.	CD	O
p.m.	NN	O

1.	CD	O
unasyn	JJ	B-TREATMENT
3	CD	O
grams	NNS	O
intravenous	JJ	O
every	DT	O
six	CD	O
hours	NNS	O
.	.	O

2.	CD	O
nph	JJ	B-TREATMENT
10	CD	O
units	NNS	O
subcutaneously	RB	O
every	DT	O
morning	NN	O
and	CC	O
8	CD	O
units	NNS	O
subcutaneously	RB	O
every	DT	O
evening	NN	O
.	.	O

3.	CD	O
flomax	JJ	B-TREATMENT
0.4	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

4.	CD	O
prilosec	JJ	B-TREATMENT
30	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

5.	CD	O
regular	JJ	B-TREATMENT
insulin	NN	I-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT
.	.	O

6.	CD	O
tylenol	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
allergic	JJ	B-PROBLEM
to	TO	O
ciprofloxacin	VB	B-TREATMENT
,	,	O
morphine	VB	B-TREATMENT
sulfate	NN	I-TREATMENT
and	CC	O
droperidol	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
lives	VBZ	O
with	IN	O
his	PRP$	O
disabled	JJ	O
wife	NN	O
who	WP	O
has	VBZ	O
a	DT	B-PROBLEM
psychiatric	JJ	I-PROBLEM
condition	NN	I-PROBLEM
.	.	O

on	IN	O
admission	NN	O
showed	VBD	O
a	DT	B-TEST
temperature	NN	I-TEST
of	IN	O
97.1	CD	O
f.	NN	O
;	:	O
heart	NN	B-TEST
rate	NN	I-TEST
of	IN	O
65	CD	O
;	:	O
blood	NN	B-TEST
pressure	NN	I-TEST
of	IN	O
146/74	CD	O
;	:	O
respiratory	JJ	B-TEST
rate	NN	I-TEST
of	IN	O
20	CD	O
;	:	O
oxygen	NN	B-TEST
saturation	NN	I-TEST
98%	CD	O
on	IN	O
three	CD	O
liters	NNS	O
and	CC	O
95%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
alert	JJ	O
,	,	O
awake	JJ	O
and	CC	O
oriented	VBN	O
,	,	O
pleasant	JJ	O
,	,	O
and	CC	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

head	NN	B-TEST
,	,	I-TEST
eyes	NNS	I-TEST
,	,	I-TEST
ears	NNS	I-TEST
,	,	I-TEST
nose	RB	I-TEST
and	CC	I-TEST
throat	VB	I-TEST
examination	NN	I-TEST
revealed	VBD	O
mucous	JJ	O
membranes	NNS	O
that	WDT	O
were	VBD	O
moist	RBS	O
.	.	O

he	PRP	O
had	VBD	O
no	DT	O
icterus	NN	B-PROBLEM
.	.	O

cardiovascular	JJ	O
system	NN	O
revealed	VBD	O
normal	JJ	O
s1	NN	O
and	CC	O
s2	NN	O
,	,	O
no	DT	O
murmurs	NN	B-PROBLEM
or	CC	O
gallops	NNS	B-PROBLEM
and	CC	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
.	.	O

pulmonary	JJ	B-TEST
examination	NN	I-TEST
revealed	VBD	O
lungs	NNS	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
.	.	O

abdominal	JJ	B-TEST
examination	NN	I-TEST
revealed	VBD	O
an	DT	O
abdomen	NNS	O
that	WDT	O
is	VBZ	O
nondistended	VBN	B-PROBLEM
,	,	O
nontender	NN	B-PROBLEM
.	.	O

his	PRP$	B-TEST
liver	NN	I-TEST
span	NN	I-TEST
was	VBD	O
8	CD	O
cm	NN	O
.	.	O

there	EX	O
was	VBD	O
no	DT	O
rebound	NN	B-PROBLEM
;	:	O
no	DT	O
munos	JJ	B-PROBLEM
sign	NN	I-PROBLEM
.	.	O

extremities	NNS	O
reveal	VBP	O
no	DT	O
edema	NN	B-PROBLEM
,	,	O
no	DT	O
swelling	VBG	B-PROBLEM
.	.	O

neurologic	JJ	B-TEST
examination	NN	I-TEST
revealed	VBD	O
an	DT	O
alert	NN	O
and	CC	O
oriented	VBN	O
individual	NN	O
.	.	O

there	EX	O
was	VBD	O
no	DT	O
formal	JJ	B-TEST
strength	NN	I-TEST
test	NN	I-TEST
done	VBN	O
.	.	O

studies	NNS	O
revealed	VBD	O
a	DT	B-TEST
hematocrit	NN	I-TEST
of	IN	O
32.6	CD	O
,	,	O
white	JJ	B-TEST
count	NN	I-TEST
of	IN	O
6.0	CD	O
.	.	O

his	PRP$	B-TEST
platelet	NN	I-TEST
count	NN	I-TEST
was	VBD	O
267	CD	O
.	.	O

his	PRP$	B-TEST
mcv	NN	I-TEST
was	VBD	O
88	CD	O
,	,	O
red	JJ	B-TEST
cell	NN	I-TEST
distribution	NN	I-TEST
was	VBD	O
13.4	CD	O
.	.	O

chemistry	NN	O
on	IN	O
admission	NN	O
showed	VBD	O
a	DT	B-TEST
sodium	NN	I-TEST
of	IN	O
141	CD	O
,	,	O
potassium	NN	B-TEST
of	IN	O
4.3	CD	O
,	,	O
chloride	NN	B-TEST
of	IN	O
107	CD	O
,	,	O
bicarbonate	NN	B-TEST
of	IN	O
25	CD	O
,	,	O
bun	NN	B-TEST
of	IN	O
4	CD	O
,	,	O
creatinine	NN	B-TEST
of	IN	O
0.6	CD	O
and	CC	O
a	DT	B-TEST
sugar	NN	I-TEST
of	IN	O
177	CD	O
.	.	O

liver	JJ	B-TEST
function	NN	I-TEST
tests	NNS	I-TEST
revealed	VBD	O
an	DT	B-TEST
alt	NN	I-TEST
of	IN	O
31	CD	O
,	,	O
ast	NN	B-TEST
of	IN	O
36	CD	O
,	,	O
alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
of	IN	O
509	CD	O
.	.	O

total	JJ	B-TEST
bilirubin	NN	I-TEST
was	VBD	O
0.8	CD	O
.	.	O

albumin	NN	B-TEST
was	VBD	O
2.6	CD	O
.	.	O

his	PRP$	B-TEST
blood	NN	I-TEST
cultures	NNS	I-TEST
were	VBD	O
drawn	VBN	O
and	CC	O
pending	VBG	O
.	.	O

urinalysis	NN	B-TEST
revealed	VBD	O
trace	NN	B-PROBLEM
glucose	NN	I-PROBLEM
,	,	O
no	DT	O
ketones	NNS	B-PROBLEM
,	,	O
no	DT	O
red	JJ	B-PROBLEM
cells	NNS	I-PROBLEM
,	,	O
no	DT	O
white	JJ	B-PROBLEM
cells	NNS	I-PROBLEM
and	CC	O
less	JJR	O
than	IN	O
one	CD	O
epithelial	JJ	O
cells	NNS	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
down	RB	O
to	TO	O
the	DT	B-TEST
endoscopic	NN	I-TEST
retrogram	NN	I-TEST
cholangiopancreatogram	NN	I-TEST
upon	IN	O
admission	NN	O
.	.	O

on	IN	O
this	DT	B-TEST
examination	NN	I-TEST
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
mild	JJ	B-PROBLEM
biliary	JJ	I-PROBLEM
stricture	NN	I-PROBLEM
most	RBS	O
likely	JJ	O
secondary	JJ	O
to	TO	O
chronic	JJ	B-PROBLEM
pancreatitis	NN	I-PROBLEM
.	.	O

cytology	NN	B-TEST
was	VBD	O
obtained	VBN	O
.	.	O

he	PRP	O
was	VBD	O
also	RB	O
found	VBN	O
to	TO	O
have	VB	O
dilated	VBN	B-PROBLEM
pancreatic	JJ	I-PROBLEM
ducts	NNS	I-PROBLEM
with	IN	O
calcifications	NNS	B-PROBLEM
consistent	JJ	O
with	IN	O
chronic	JJ	B-PROBLEM
pancreatitis	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
underwent	NN	O
a	DT	B-TREATMENT
percutaneous	JJ	I-TREATMENT
sphincterotomy	NN	I-TREATMENT
extended	VBD	O
to	TO	O
a	DT	B-TREATMENT
full	JJ	I-TREATMENT
sphincterectomy	NN	I-TREATMENT
.	.	O

he	PRP	O
also	RB	O
had	VBD	O
successful	JJ	B-TREATMENT
extraction	NN	I-TREATMENT
of	IN	O
stone	NN	B-PROBLEM
fragments	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
tolerated	VBD	O
this	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
and	CC	O
had	VBD	O
no	DT	O
complications	NNS	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
subsequently	RB	O
underwent	VBD	O
a	DT	B-TEST
ct	JJ	I-TEST
scan	JJ	I-TEST
angiogram	NN	I-TEST
with	IN	O
pancreas	NNS	B-TEST
protocol	VBP	I-TEST
to	TO	O
assess	VB	O
the	DT	O
pseudocyst	NN	B-PROBLEM
versus	NN	O
enlarged	VBD	B-PROBLEM
pancreas	JJ	I-PROBLEM
head	NN	I-PROBLEM
.	.	O

the	DT	O
results	NNS	O
of	IN	O
this	DT	B-TEST
study	NN	I-TEST
indicated	VBD	O
that	IN	O
this	DT	O
structure	NN	O
at	IN	O
the	DT	O
head	NN	O
of	IN	O
his	PRP$	O
pancreas	NN	O
is	VBZ	O
most	RBS	O
likely	JJ	O
a	DT	B-PROBLEM
forming	JJ	I-PROBLEM
pseudocyst	NN	I-PROBLEM
;	:	O
however	RB	O
,	,	O
the	DT	O
suspicion	NN	O
of	IN	O
malignancy	NN	B-PROBLEM
is	VBZ	O
still	RB	O
possible	JJ	O
and	CC	O
the	DT	O
patient	NN	O
underwent	VBD	O
an	DT	B-TEST
ultrasound	NN	I-TEST
guided	VBD	I-TEST
biopsy	NN	I-TEST
of	IN	O
this	DT	B-PROBLEM
mass	NN	I-PROBLEM
on	IN	O
2011-01-20	JJ	O
.	.	O

the	DT	O
cytology	NN	O
for	IN	O
this	DT	B-TEST
biopsy	NN	I-TEST
is	VBZ	O
still	RB	O
pending	VBG	O
.	.	O

the	DT	O
patient	NN	O
recovered	VBD	O
well	RB	O
status	NN	O
post	NN	O
these	DT	B-TEST
two	CD	I-TEST
procedures	NNS	I-TEST
.	.	O

he	PRP	O
had	VBD	O
no	DT	O
complications	NNS	B-PROBLEM
and	CC	O
no	DT	O
subsequently	RB	B-PROBLEM
pancreatitis	NN	I-PROBLEM
.	.	O

his	PRP$	B-TEST
alkaline	NN	I-TEST
phosphatase	NN	I-TEST
and	CC	O
all	PDT	B-PROBLEM
the	DT	I-PROBLEM
other	JJ	I-PROBLEM
abnormal	JJ	I-PROBLEM
liver	NN	I-PROBLEM
function	NN	I-PROBLEM
tests	NNS	I-PROBLEM
were	VBD	O
resolving	VBG	O
.	.	O

he	PRP	O
had	VBD	O
no	DT	O
pain	NN	B-PROBLEM
and	CC	O
did	VBD	O
not	RB	O
require	VB	O
any	DT	B-TREATMENT
pain	NN	I-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
tolerating	VBG	O
food	NN	O
very	RB	O
well	RB	O
and	CC	O
was	VBD	O
afebrile	VBN	B-PROBLEM
throughout	IN	O
admission	NN	O
.	.	O

with	IN	O
regards	NNS	O
to	TO	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
documented	JJ	I-PROBLEM
strep	NN	I-PROBLEM
septicemia	NN	I-PROBLEM
in	IN	O
the	DT	O
outside	JJ	O
hospital	NN	O
,	,	O
the	DT	O
infectious	JJ	O
disease	NN	O
team	NN	O
was	VBD	O
formally	RB	O
consulted	VBN	O
.	.	O

upon	IN	O
obtaining	VBG	O
more	JJR	O
information	NN	O
from	IN	O
rehab	JJ	O
hospital	NN	O
of	IN	O
the	DT	O
cape	NN	O
&	CC	O
islands	NNS	O
hospital	NN	O
,	,	O
it	PRP	O
appears	VBZ	O
that	IN	O
the	DT	O
patient	NN	O
had	VBD	O
two	CD	O
out	IN	O
of	IN	O
four	CD	O
bottles	NNS	O
growing	VBG	O
out	RP	O
streptococcus	NN	B-PROBLEM
sanguis	NN	I-PROBLEM
in	IN	O
the	DT	O
outside	JJ	O
hospital	NN	O
.	.	O

the	DT	O
patient	NN	O
appeared	VBD	O
to	TO	O
have	VB	O
been	VBN	O
covered	VBN	O
by	IN	O
ampicillin	NN	B-TREATMENT
,	,	O
gentamycin	NN	B-TREATMENT
and	CC	O
then	RB	O
unasyn	VB	B-TREATMENT
in	IN	O
the	DT	O
outside	JJ	O
hospital	NN	O
.	.	O

the	DT	O
patient	NN	O
,	,	O
on	IN	O
admission	NN	O
,	,	O
was	VBD	O
placed	VBN	O
on	IN	O
ampicillin	NN	B-TREATMENT
,	,	O
gentamycin	NN	B-TREATMENT
and	CC	O
flagyl	NN	B-TREATMENT
.	.	O

with	IN	O
repeated	VBN	B-TEST
blood	NN	I-TEST
cultures	NNS	I-TEST
that	WDT	O
were	VBD	O
negative	JJ	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
reduced	VBN	O
to	TO	O
single	JJ	O
mckenzie	NN	O
of	IN	O
intravenous	JJ	B-TREATMENT
ampicillin	NN	I-TREATMENT
.	.	O

for	IN	O
this	DT	B-PROBLEM
documented	JJ	I-PROBLEM
septicemia	NN	I-PROBLEM
,	,	O
this	DT	O
patient	NN	O
went	VBD	O
for	IN	O
a	DT	B-TEST
endocarditis	NN	I-TEST
work-up	NN	I-TEST
.	.	O

he	PRP	O
had	VBD	O
a	DT	B-TEST
transthoracic	NN	I-TEST
echocardiogram	NN	I-TEST
which	WDT	O
revealed	VBD	O
no	DT	O
vegetations	NNS	B-PROBLEM
.	.	O

on	IN	O
this	DT	B-TEST
echocardiogram	NN	I-TEST
,	,	O
he	PRP	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
mildly	RB	B-PROBLEM
dilated	VBN	I-PROBLEM
left	JJ	I-PROBLEM
atrium	NN	I-PROBLEM
,	,	O
mild	JJ	B-PROBLEM
symmetric	JJ	I-PROBLEM
left	VBD	I-PROBLEM
ventricular	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
,	,	O
and	CC	O
a	DT	O
normal	JJ	O
ejection	NN	O
fraction	NN	O
of	IN	O
greater	JJR	O
than	IN	O
55%	CD	O
.	.	O

there	EX	O
were	VBD	O
no	DT	O
other	JJ	B-PROBLEM
abnormalities	NNS	I-PROBLEM
noted	VBN	O
on	IN	O
this	DT	B-TEST
study	NN	I-TEST
.	.	O

the	DT	O
patient	NN	O
then	RB	O
underwent	VBD	O
a	DT	B-TEST
transesophageal	JJ	I-TEST
echocardiogram	NN	I-TEST
on	IN	O
01-24	NN	O
.	.	O

on	IN	O
this	DT	B-TEST
echocardiogram	NN	I-TEST
,	,	O
he	PRP	O
was	VBD	O
again	RB	O
noted	VBN	O
to	TO	O
not	RB	O
have	VB	O
any	DT	O
evidence	NN	O
for	IN	O
valvular	JJ	B-PROBLEM
vegetations	NNS	I-PROBLEM
.	.	O

a	DT	B-PROBLEM
complex	JJ	I-PROBLEM
plaque	NN	I-PROBLEM
was	VBD	O
found	VBN	O
in	IN	O
the	DT	O
aortic	JJ	O
arch	NN	O
in	IN	O
the	DT	O
descending	NN	O
thoracic	NN	O
aorta	RB	O
,	,	O
although	IN	O
this	DT	B-PROBLEM
plaque	NN	I-PROBLEM
is	VBZ	O
non-mobile	JJ	O
.	.	O

there	EX	O
was	VBD	O
focal	JJ	B-PROBLEM
mitral	JJ	I-PROBLEM
valve	NN	I-PROBLEM
prolapse	NN	I-PROBLEM
noted	VBD	O
without	IN	O
pathologic	JJ	B-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
trace	NN	B-PROBLEM
aortic	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
panorex	JJ	I-TEST
x-ray	NN	I-TEST
of	IN	O
his	PRP$	O
two	CD	O
teeth	NNS	O
were	VBD	O
obtained	VBN	O
and	CC	O
a	DT	B-TEST
dental	JJ	I-TEST
consultation	NN	I-TEST
was	VBD	O
done	VBN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
thought	VBN	O
to	TO	O
have	VB	O
normal	JJ	O
dental	JJ	O
hygiene	NN	O
and	CC	O
low	JJ	O
suspicion	NN	O
for	IN	O
a	DT	O
source	NN	O
of	IN	O
his	PRP$	B-PROBLEM
alpha	NN	I-PROBLEM
septicemia	NN	I-PROBLEM
from	IN	I-PROBLEM
his	PRP$	I-PROBLEM
mouth	NN	I-PROBLEM
.	.	O

infectious	JJ	O
disease	NN	O
department	NN	O
as	RB	O
well	RB	O
as	IN	O
cardiology	NN	O
had	VBD	O
recommended	VBN	O
a	DT	O
formal	JJ	O
14	CD	O
-	:	O
day	NN	O
course	NN	O
of	IN	O
intravenous	JJ	B-TREATMENT
antibiotics	NNS	I-TREATMENT
to	TO	O
treat	VB	O
a	DT	B-PROBLEM
documented	JJ	I-PROBLEM
alpha	JJ	I-PROBLEM
streptococcal	JJ	I-PROBLEM
septicemia	NN	I-PROBLEM
from	IN	O
outside	JJ	O
hospital	NN	O
blood	NN	B-TEST
cultures	NNS	I-TEST
.	.	O

the	DT	O
patient	NN	O
's	POS	O
insurance	NN	O
company	NN	O
,	,	O
however	RB	O
,	,	O
would	MD	O
not	RB	O
pay	VB	O
for	IN	O
home	NN	B-TREATMENT
antibiotics	NNS	I-TREATMENT
.	.	O

after	IN	O
much	JJ	O
discussion	NN	O
with	IN	O
the	DT	O
patient	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
informed	VBN	O
of	IN	O
the	DT	O
risks	NNS	O
of	IN	O
not	RB	O
finishing	VBG	O
a	DT	O
14	CD	O
day	NN	O
course	NN	O
of	IN	O
intravenous	JJ	B-TREATMENT
antibiotics	NNS	I-TREATMENT
and	CC	O
chose	VB	O
to	TO	O
go	VB	O
home	NN	O
.	.	O

he	PRP	O
had	VBD	O
three	CD	O
days	NNS	O
of	IN	O
antibiotics	NNS	B-TREATMENT
remaining	VBG	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
.	.	O

it	PRP	O
was	VBD	O
discussed	VBN	O
with	IN	O
the	DT	O
patient	NN	O
to	TO	O
send	VB	O
him	PRP	O
out	RP	O
on	IN	O
augmentin	NN	B-TREATMENT
500	CD	O
mg	NN	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
for	IN	O
ten	RB	O
more	JJR	O
days	NNS	O
.	.	O

he	PRP	O
was	VBD	O
to	TO	O
follow-up	JJ	O
with	IN	O
his	PRP$	O
primary	JJ	O
care	NN	O
physician	NN	O
within	IN	O
two	CD	O
to	TO	O
three	CD	O
days	NNS	O
for	IN	O
repeat	NN	B-TEST
laboratory	NN	I-TEST
studies	NNS	I-TEST
and	CC	O
blood	NN	B-TEST
cultures	NNS	I-TEST
.	.	O

he	PRP	O
was	VBD	O
to	TO	O
return	VB	O
to	TO	O
the	DT	O
hospital	NN	O
with	IN	O
any	DT	O
signs	NNS	O
of	IN	O
shaking	VBG	B-PROBLEM
chills	NNS	B-PROBLEM
or	CC	O
fever	NN	B-PROBLEM
.	.	O

1.	CD	O
pancreatitis	NN	B-PROBLEM
status	NN	O
post	NN	O
endoscopic	NN	B-TEST
retrogram	NN	I-TEST
cholangiopancreatography	NN	I-TEST
and	CC	O
sphincterotomy	NN	B-TREATMENT
.	.	O

2.	CD	O
alpha	JJ	B-PROBLEM
streptococcus	NN	I-PROBLEM
septicemia	NN	I-PROBLEM
.	.	O

1.	CD	O
augmentin	JJ	B-TREATMENT
500	CD	O
mg	NN	O
p.o.	NN	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
times	NNS	O
ten	JJ	O
days	NNS	O
.	.	O

2.	CD	O
flomax	JJ	B-TREATMENT
0.4	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

3.	CD	O
prilosec	JJ	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

4.	CD	O
humalog	NN	B-TREATMENT
and	CC	O
regular	JJ	B-TREATMENT
insulin	NN	I-TREATMENT
subcutaneously	RB	O
.	.	O

respiratory	NN	B-PROBLEM
distress	NN	I-PROBLEM
-	:	O
on	IN	O
10-12	NNS	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
transferred	VBN	O
to	TO	O
medicine	VB	O
intensive	JJ	O
care	NN	O
unit	NN	O
secondary	JJ	O
to	TO	O
respiratory	VB	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

in	IN	O
the	DT	O
medicine	NN	O
intensive	JJ	O
care	NN	O
unit	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
initially	RB	O
placed	VBN	O
on	IN	O
high-flow	JJ	B-TREATMENT
60%	CD	I-TREATMENT
oxygen	NN	I-TREATMENT
face	NN	I-TREATMENT
mask	NN	I-TREATMENT
and	CC	O
they	PRP	O
diuresed	VBD	O
approximately	RB	O
5	CD	O
liters	NNS	O
off	RB	O
into	IN	O
the	DT	B-TREATMENT
intravenous	JJ	I-TREATMENT
lasix	NN	I-TREATMENT
.	.	O

since	IN	O
then	RB	O
the	DT	O
patient	NN	O
's	POS	O
oxygenation	NN	O
has	VBZ	O
been	VBN	O
improving	VBG	O
and	CC	O
today	NN	O
,	,	O
10-17	JJ	O
,	,	O
she	PRP	O
is	VBZ	O
requiring	VBG	O
.5	JJ	O
liters	NNS	O
of	IN	O
keep	VB	O
her	PRP$	B-TEST
saturations	NNS	I-TEST
above	IN	O
94	CD	O
.	.	O

the	DT	O
patient	NN	O
continues	VBZ	O
to	TO	O
be	VB	O
diuresed	VBN	O
with	IN	O
approximately	RB	O
20	CD	O
mg	NNS	O
of	IN	O
lasix	NN	B-TREATMENT
a	DT	O
day	NN	O
and	CC	O
she	PRP	O
has	VBZ	O
had	VBD	O
good	JJ	O
urine	JJ	O
output	NN	O
.	.	O

anemia	SYM	B-PROBLEM
-	:	O
the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
hematocrit	NN	I-TEST
dropped	VBD	O
in	IN	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
to	TO	O
the	DT	O
mid	NN	O
20s	CD	O
and	CC	O
she	PRP	O
received	VBD	O
one	CD	O
unit	NN	O
of	IN	O
packed	JJ	O

red	JJ	B-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
with	IN	O
a	DT	O
good	JJ	O
response	NN	O
up	RB	O
to	TO	O
30	CD	O
.	.	O

hypotension	NN	B-PROBLEM
-	:	O
on	IN	O
the	DT	O
night	NN	O
of	IN	O
10-16	JJ	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
diuresed	VBN	O
with	IN	O
20	CD	O
mg	NNS	O
of	IN	O
intravenous	JJ	B-TREATMENT
lasix	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
became	VBD	O
hypotensive	JJ	B-PROBLEM
into	IN	O
the	DT	O
70	CD	O
s	NN	O
without	IN	O
any	DT	B-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O

her	PRP$	B-TEST
oxygen	NN	I-TEST
saturations	NNS	I-TEST
were	VBD	O
greater	JJR	O
than	IN	O
94%	CD	O
at	IN	O
the	DT	O
time	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
250	CD	O
cc	NN	O
of	IN	O
normal	JJ	B-TREATMENT
saline	NN	I-TREATMENT
and	CC	O
her	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
responded	VBD	O
coming	VBG	O
back	RB	O
up	RB	O
to	TO	O
the	DT	O
high	JJ	O
90	CD	O
s.	NN	O

no	DT	O
further	JJ	O
episodes	NNS	O
of	IN	O
hypotension	NN	B-PROBLEM
were	VBD	O
noted	VBN	O
.	.	O

recent	JJ	B-TEST
chest	JJS	I-TEST
x-ray	JJ	I-TEST
shows	NNS	O
resolving	VBG	B-PROBLEM
right	RB	I-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

she	PRP	O
continues	VBZ	O
on	IN	O
her	PRP$	B-TREATMENT
prednisone	NN	I-TREATMENT
taper	NN	I-TREATMENT
for	IN	O
her	PRP$	B-PROBLEM
asthma	NN	I-PROBLEM
and	CC	O
this	DT	O
is	VBZ	O
day	NN	O
#	#	O
14	CD	O
of	IN	O
antibiotics	NNS	B-TREATMENT
.	.	O

patient	NN	O
recorded	VBD	O
as	IN	O
having	VBG	O
no	DT	O
known	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM
to	TO	O
drugs	NNS	B-TREATMENT

nausea	NN	B-PROBLEM
and	CC	O
vomiting	NN	B-PROBLEM

01-23	JJ	O
port	NN	B-TREATMENT
line	NN	I-TREATMENT
removal	NN	I-TREATMENT
.	.	O

01-23	JJ	O
picc	NN	B-TREATMENT
placement	NN	I-TREATMENT
.	.	O

01-24	JJ	O
picc	NN	B-TREATMENT
removal	NN	I-TREATMENT
.	.	O

this	DT	O
is	VBZ	O
a	DT	O
37	CD	O
y/o	JJ	O
male	JJ	O
patient	NN	O
with	IN	O
pmh	JJ	O
type	NN	B-PROBLEM
i	NN	I-PROBLEM
dm	NN	I-PROBLEM
,	,	O
htn	NN	B-PROBLEM
,	,	O
gastroparesis	NN	B-PROBLEM
,	,	O
esrd	NN	B-PROBLEM
on	IN	O
hd	NN	B-TREATMENT
(	(	O
last	JJ	O
in	IN	O
12/26	CD	O
per	IN	O
patient	NN	O
)	)	O
who	WP	O
presents	VBZ	O
to	TO	O
cmed	VB	O
ccu	NN	O
with	IN	O
hypertensive	JJ	B-PROBLEM
urgency	NN	I-PROBLEM
unable	JJ	O
from	IN	O
the	DT	O
larry	NN	O
.	.	O

the	DT	O
patient	NN	O
early	RB	O
this	DT	O
morning	NN	O
to	TO	O
the	DT	O
ruthie	NN	O
with	IN	O
his	PRP$	B-PROBLEM
usual	JJ	I-PROBLEM
nausea	NN	I-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
,	,	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
hypertensive	JJ	B-PROBLEM
to	TO	O
256/110	CD	O
,	,	O
hr	NN	B-TEST
102	CD	O
,	,	O
t	NN	B-TEST
99.2	CD	O
,	,	O
rr	NN	B-TEST
22	CD	O
,	,	O
92%	CD	O
ra	NN	O
.	.	O

history	NN	O
is	VBZ	O
difficult	JJ	O
to	TO	O
obtain	VB	O
from	IN	O
patient	JJ	O
d/t	NN	O
somnolence	NN	B-PROBLEM
and	CC	O
lack	NN	B-PROBLEM
of	IN	I-PROBLEM
desire	NN	I-PROBLEM
to	TO	O
participate	VB	O
in	IN	O
interview	NN	O
,	,	O
but	CC	O
per	IN	O
frank	JJ	O
note	NN	O
he	PRP	O
was	VBD	O
diaphoretic	JJ	B-PROBLEM
and	CC	O
'	POS	O
writing	NN	O
in	IN	O
pain	NN	B-PROBLEM
',	CD	O
vomiting	VBG	O
clear	JJ	O
substance	NN	O
.	.	O

he	PRP	O
was	VBD	O
given	VBN	O
ativan	RP	B-TREATMENT
a	DT	O
total	NN	O
of	IN	O
4	CD	O
mg	NN	O
of	IN	O
ativan	NN	B-TREATMENT
,	,	O
6	CD	O
mg	NN	O
of	IN	O
dilaudid	NN	B-TREATMENT
,	,	O
labetolol	VBZ	B-TREATMENT
20	CD	O
mg	NN	O
iv	NN	O
x	$	O
1	CD	O
and	CC	O
hydralazine	VB	B-TREATMENT
10	CD	O
mg	NN	O
iv	NN	O
x	$	O
1	CD	O
without	IN	O
good	JJ	O
response	NN	O
(	(	O
200/99	CD	O
).	NN	O

he	PRP	O
recieved	VBD	O
2l	CD	B-TREATMENT
ns	NN	I-TREATMENT
and	CC	O
was	VBD	O
started	VBN	O
on	IN	O
labetolol	NN	B-TREATMENT
gtt	NN	I-TREATMENT
and	CC	O
bp	NN	B-TEST
decreased	VBD	O
to	TO	O
161/79	CD	O
.	.	O

tranferred	VBN	O
to	TO	O
cmed	VB	O
ccu	NN	O
for	IN	O
further	JJ	O
management	NN	O
while	IN	O
on	IN	O
labetolol	JJ	B-TREATMENT
gtt	NN	I-TREATMENT
.	.	O

at	IN	O
that	DT	O
time	NN	O
bp	NN	B-TEST
was	VBD	O
attributed	VBN	O
to	TO	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
inability	NN	O
to	TO	O
take	VB	O
po	NN	O
meds	NNS	O
d/t	VBP	O
nausea	NN	B-PROBLEM
/	NN	O
vomiting	NN	B-PROBLEM
.	.	O

also	RB	O
had	VBD	O
labile	JJ	B-PROBLEM
blood	NN	I-PROBLEM
sugars	NNS	I-PROBLEM
with	IN	O
repeated	JJ	O
episodes	NNS	O
of	IN	O
hypoglycemia	NN	B-PROBLEM
,	,	O
and	CC	O
strickland	NN	O
recommended	VBD	O
sugars	NNS	B-TEST
in	IN	O
the	DT	O
range	NN	O
of	IN	O
150-200	JJ	O
.	.	O

he	PRP	O
eloped	VBD	O
prior	RB	O
to	TO	O
formal	VB	O
discharge	NN	O
when	WRB	O
his	PRP$	B-TEST
fs	NN	I-TEST
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
critically	RB	B-PROBLEM
high	JJ	I-PROBLEM
-	:	O
recommended	VBD	O
to	TO	O
patient	VB	O
that	IN	O
he	PRP	O
stay	VB	O
for	IN	O
repeat	NN	O
,	,	O
but	CC	O
left	VBD	O
ama	NN	O
without	IN	O
signing	VBG	O
any	DT	O
forms	NNS	O
.	.	O

upon	NN	O
transfer	NN	O
to	TO	O
the	DT	O
cmed	VBN	O
ccu	VBP	O
the	DT	O
patient	NN	O
appears	VBZ	O
somewhat	RB	B-PROBLEM
uncomfortable	JJ	I-PROBLEM
,	,	O
reporting	VBG	O
nausea	NN	B-PROBLEM
and	CC	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
but	CC	O
when	WRB	O
questioned	VBD	O
he	PRP	O
was	VBD	O
unable	JJ	O
/	JJ	O
unwilling	NN	O
to	TO	O
participate	VB	O
in	IN	O
hpi	NN	O
or	CC	O
exam	VB	B-TEST
d/t	JJ	O
sleepiness	NN	B-PROBLEM
.	.	O

he	PRP	O
denied	VBD	O
cp	NN	B-PROBLEM
,	,	O
sob	NN	B-PROBLEM
,	,	O
ha	NN	B-PROBLEM
,	,	O
vision	NN	B-PROBLEM
changes	NNS	I-PROBLEM
,	,	O
neck	NN	B-PROBLEM
stiffness	NN	I-PROBLEM
,	,	O
dysuria	NN	B-PROBLEM
,	,	O
or	CC	O
other	JJ	B-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O

in	IN	O
the	DT	O
cmed	JJ	O
ccu	NN	O
he	PRP	O
became	VBD	O
hypotensive	JJ	B-PROBLEM
to	TO	O
sbp	VB	B-TEST
80	CD	O
s.	NN	O

labetalol	NN	B-TREATMENT
was	VBD	O
stopped	VBN	O
and	CC	O
he	PRP	O
received	VBD	O
a	DT	B-TREATMENT
500	CD	I-TREATMENT
cc	NN	I-TREATMENT
fluid	NN	I-TREATMENT
bolus	NN	I-TREATMENT
and	CC	O
his	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
rose	VBD	O
to	TO	O
sbp	VB	B-TEST
90	CD	O
s.	NN	O

cardiac	NN	O
and	CC	O
infectious	JJ	O
sources	NNS	O
of	IN	O
hypotension	NN	B-PROBLEM
were	VBD	O
considered	VBN	O
,	,	O
but	CC	O
cardiac	JJ	B-TEST
enzymes	NNS	I-TEST
were	VBD	O
not	RB	O
changed	VBN	O
from	IN	O
prior	JJ	O
studies	NNS	O
and	CC	O
he	PRP	O
had	VBD	O
no	DT	O
localizing	JJ	B-PROBLEM
signs	NNS	I-PROBLEM
of	IN	I-PROBLEM
infection	NN	I-PROBLEM
;	:	O
blood	NN	B-TEST
cultures	NNS	I-TEST
were	VBD	O
sent	VBN	O
and	CC	O
a	DT	B-TEST
ultrasound	NN	I-TEST
of	IN	O
the	DT	B-TREATMENT
l	NN	I-TREATMENT
arm	NN	I-TREATMENT
avf	NN	I-TREATMENT
ordered	VBD	O
to	TO	O
rule	VB	O
out	RP	O
abscess	NN	B-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
site	NN	I-PROBLEM
.	.	O

he	PRP	O
received	VBD	O
a	DT	B-TREATMENT
partial	JJ	I-TREATMENT
hd	NN	I-TREATMENT
session	NN	I-TREATMENT
,	,	O
limited	VBN	O
by	IN	O
hypotension	NN	B-PROBLEM
.	.	O

over	IN	O
night	NN	O
,	,	O
his	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
trended	VBD	O
up	RB	O
to	TO	O
130	CD	O
s	NNS	O
systolic	JJ	O
.	.	O

he	PRP	O
was	VBD	O
restarted	VBN	O
on	IN	O
his	PRP$	B-TREATMENT
home	NN	I-TREATMENT
blood	NN	I-TREATMENT
pressure	NN	I-TREATMENT
regimen	NNS	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
to	TO	O
be	VB	O
called	VBN	O
out	RP	O
to	TO	O
the	DT	O
medical	JJ	O
floor	NN	O
on	IN	O
2019-01-20	JJ	O
but	CC	O
became	VBD	O
somnolent	JJ	B-PROBLEM
after	IN	O
receiving	VBG	O
pain	NN	B-TREATMENT
and	CC	I-TREATMENT
anti-nausea	NN	I-TREATMENT
meds	NNS	I-TREATMENT
,	,	O
so	IN	O
he	PRP	O
stayed	VBD	O
in	IN	O
the	DT	O
icu	NN	O
for	IN	O
closer	JJR	O
monitoring	NN	O
of	IN	O
respiratory	NN	O
status	NN	O
,	,	O
which	WDT	O
spontaneously	RB	O
improved	VBN	O
.	.	O

his	PRP$	B-TEST
blood	NN	I-TEST
sugar	NN	I-TEST
at	IN	O
10	CD	O
pm	NN	O
was	VBD	O
low	JJ	O
at	IN	O
22	CD	O
and	CC	O
he	PRP	O
was	VBD	O
disoriented	VBN	B-PROBLEM
,	,	O
which	WDT	O
resolved	VBD	O
with	IN	O
two	CD	O
glasses	NNS	O
of	IN	O
juice	NN	O
;	:	O
he	PRP	O
did	VBD	O
not	RB	O
receive	VB	O
his	PRP$	O
standing	VBG	O
dose	NN	O
of	IN	O
nph	NN	B-TREATMENT
that	IN	O
evening	VBG	O
.	.	O

blood	NN	B-TEST
cultures	NNS	I-TEST
returned	VBD	O
positive	JJ	O
with	IN	O
gpc	NN	B-PROBLEM
in	IN	I-PROBLEM
pairs	NNS	I-PROBLEM
and	CC	I-PROBLEM
clusters	NNS	I-PROBLEM
,	,	O
so	IN	O
a	DT	B-TEST
tte	NN	I-TEST
and	CC	O
surveillance	NN	B-TEST
cultures	NNS	I-TEST
were	VBD	O
ordered	VBN	O
and	CC	O
vancomycin	NN	B-TREATMENT
was	VBD	O
started	VBN	O
.	.	O

1.	CD	O
dm	JJ	B-PROBLEM
type	NN	I-PROBLEM
i	NN	O

2.	CD	O
esrd	NN	B-PROBLEM
on	IN	O
hemodialysis	NN	B-TREATMENT
started	VBN	O
2017-01-07	CD	O
on	IN	O
tu	NN	O
,	,	O
th	NN	O
,	,	O
sat	VBD	O

3.	CD	O
severe	JJ	B-PROBLEM
autonomic	JJ	I-PROBLEM
dysfunction	NN	I-PROBLEM
with	IN	O
multiple	JJ	O
hospitalizations	NNS	O
for	IN	O
hypertensive	JJ	B-PROBLEM
emergency	NN	I-PROBLEM
,	,	O
gastroparesis	NN	B-PROBLEM
,	,	O
and	CC	O
orthostatic	JJ	B-PROBLEM
hypotension	NN	I-PROBLEM
.	.	O

4.	CD	O
history	NN	O
of	IN	O
esophageal	JJ	B-PROBLEM
erosion	NN	I-PROBLEM
,	,	O
mw	CD	B-PROBLEM
tear	NN	I-PROBLEM

5.	CD	O
cad	NN	B-PROBLEM
with	IN	O
1-vessel	JJ	B-PROBLEM
disease	NN	I-PROBLEM
(	(	O
50%	CD	B-PROBLEM
stenosis	NN	I-PROBLEM
d1	NN	I-PROBLEM
in	IN	O
2014-06-07	JJ	O
),	NNP	O
normal	JJ	O
stress	NN	O

6.	CD	O
hx	NN	O
of	IN	O
foot	NN	B-PROBLEM
ulcer	NN	I-PROBLEM

7.	CD	O
h/o	NN	O
clot	NN	B-PROBLEM
in	IN	O
av	NN	B-TREATMENT
graft	NN	I-TREATMENT
x2	NN	O
(	(	O
march	NN	O
and	CC	O
2018-07-07	JJ	O
)	)	O

his	PRP$	O
father	NN	O
recently	RB	O
died	VBD	O
of	IN	O
esrd	NN	B-PROBLEM
and	CC	O
diabetes	NNS	B-PROBLEM
.	.	O

his	PRP$	O
mother	NN	O
is	VBZ	O
in	IN	O
her	PRP$	O
50	CD	O
s	NN	O
and	CC	O
has	VBZ	O
hypertension	NN	B-PROBLEM
.	.	O

he	PRP	O
has	VBZ	O
two	CD	O
sisters	NNS	O
,	,	O
one	CD	O
with	IN	O
diabetes	NNS	B-PROBLEM
,	,	O
and	CC	O
six	CD	O
brothers	NNS	O
,	,	O
one	CD	O
with	IN	O
diabetes	NNS	B-PROBLEM
.	.	O

vitals	NNS	B-TEST
:	:	O
97.4	CD	O
,	,	O
164/90	CD	O
,	,	O
102	CD	O
,	,	O
10	CD	O
,	,	O
97%	CD	O
4l	CD	O

general	JJ	O
:	:	O
sleepy	NN	B-PROBLEM
,	,	O
arouses	VBZ	O
to	TO	O
voice	VB	O
but	CC	O
limited	JJ	O
participation	NN	O
with	IN	O
physical	JJ	B-TEST
exam	NN	I-TEST

heent	NN	O
:	:	O
perrl	NN	O
,	,	O
left	VBD	B-PROBLEM
pupil	RP	I-PROBLEM
smaller	JJR	I-PROBLEM
than	IN	I-PROBLEM
right	NN	I-PROBLEM
,	,	O
pt	NN	O
will	MD	O
not	RB	O
participate	VB	O
in	IN	O
eomi	NN	O
,	,	O
sclera	NN	O
anicteric	NN	B-PROBLEM
,	,	O
mm	NN	B-PROBLEM
dry	NN	I-PROBLEM
,	,	O
no	DT	O
op	NN	B-PROBLEM
lesions	NNS	I-PROBLEM

neck	NN	O
:	:	O
supple	NN	O
,	,	O
no	DT	O
jvd	NN	B-PROBLEM

cv	NN	O
:	:	O
rrr	NN	O
,	,	O
nl	JJ	O
s1	NN	O
,	,	O
s2	NN	O
,	,	O
2/6	CD	B-PROBLEM
systolic	JJ	I-PROBLEM
murmur	NN	I-PROBLEM
at	IN	I-PROBLEM
lusb	NN	I-PROBLEM

chest	NN	O
:	:	O
hd	NN	B-TREATMENT
line	NN	I-TREATMENT
in	IN	O
place	NN	O
without	IN	O
erythema	NN	B-PROBLEM

abd	NN	O
:	:	O
soft	JJ	O
,	,	O
nd	JJ	B-PROBLEM
,	,	O
nontender	NN	B-PROBLEM
,	,	O
+	NNP	O
bs	NN	O
,	,	O
no	DT	O
guarding	NN	B-PROBLEM
,	,	O
no	DT	O
rebound	NN	B-PROBLEM
,	,	O
multiple	RB	B-PROBLEM
well	RB	I-PROBLEM
healed	VBN	I-PROBLEM
scars	NNS	I-PROBLEM

ext	NN	O
:	:	O
no	DT	O
c/c/e	NN	B-PROBLEM
,	,	O
left	VBD	B-PROBLEM
arm	NN	I-PROBLEM
with	IN	I-PROBLEM
fistula	NN	I-PROBLEM
with	IN	O
good	JJ	O
thrill	NN	O

skin	NN	O
:	:	O
no	DT	O
rashes	NNS	B-PROBLEM

pt	RB	O
admitted	VBN	O
to	TO	O
medical	JJ	O
floor	NN	O
in	IN	O
hemodynamically	RB	O
stable	JJ	O
condition	NN	O
without	IN	O
specific	JJ	B-PROBLEM
complaints	NNS	I-PROBLEM
.	.	O

#	#	O
hypertensive	JJ	B-PROBLEM
urgency	NN	I-PROBLEM
:	:	O

upon	IN	O
presentation	NN	O
it	PRP	O
was	VBD	O
unclear	JJ	O
when	WRB	O
last	JJ	O
time	NN	O
was	VBD	O
that	IN	O
patient	JJ	O
took	VBD	O
meds	NNS	B-TREATMENT
,	,	O
but	CC	O
hypertension	NN	B-PROBLEM
likely	RB	O
d/t	JJ	O
inability	NN	B-PROBLEM
to	TO	I-PROBLEM
take	VB	I-PROBLEM
meds	NNS	I-PROBLEM
in	IN	O
setting	NN	O
of	IN	O
n/v	NN	B-PROBLEM
.	.	O

also	RB	O
contribution	NN	O
of	IN	O
autonomic	JJ	B-PROBLEM
dysfunction	NN	I-PROBLEM
.	.	O

no	DT	O
evidence	NN	O
of	IN	O
active	JJ	B-PROBLEM
end	NN	I-PROBLEM
organ	JJ	I-PROBLEM
damage	NN	I-PROBLEM
.	.	O

pt	NN	O
was	VBD	O
treated	VBN	O
with	IN	O
labetalol	JJ	B-TREATMENT
gtt	NN	I-TREATMENT
in	IN	O
cmed	VBN	O
ccu	NN	O
which	WDT	O
was	VBD	O
weaned	VBN	O
off	RP	O
on	IN	O
01-20	NN	O
.	.	O

carduac	NN	B-PROBLEM
enzymes	NNS	I-PROBLEM
mildly	RB	I-PROBLEM
elevated	VBD	I-PROBLEM
,	,	O
felt	VBD	O
02-08	JJ	O
demand	NN	B-PROBLEM
ischemia	NN	I-PROBLEM
in	IN	O
setting	VBG	O
of	IN	O
hypertensive	JJ	B-PROBLEM
urgency	NN	I-PROBLEM
,	,	O
ck	NN	B-TEST
and	CC	O
mb	NN	B-TEST
trended	VBD	O
mcewen	NN	O
at	IN	O
time	NN	O
of	IN	O
admission	NN	O
to	TO	O
medical	JJ	O
floor	NN	O
.	.	O

pt	NN	B-PROBLEM
's	POS	I-PROBLEM
hypertensive	JJ	I-PROBLEM
urgency	NN	I-PROBLEM
was	VBD	O
resolved	VBN	O
upon	IN	O
admission	NN	O
to	TO	O
the	DT	O
medical	JJ	O
floor	NN	O
.	.	O

his	PRP$	B-TEST
sbp	NN	I-TEST
s	VBD	I-TEST
ranged	VBD	O
140	CD	O
s-	JJ	O
170	CD	O
s	NN	O
.	.	O

he	PRP	O
was	VBD	O
restarted	VBN	O
on	IN	O
his	PRP$	O
home	NN	O
regimen	NNS	O
of	IN	O
antihypertensives	NNS	B-TREATMENT
without	IN	O
difficulty	NN	O
(	(	O
metoprolol	JJ	B-TREATMENT
75	CD	O
tid	NN	O
,	,	O
clonidine	JJ	B-TREATMENT
patch	NN	I-TREATMENT
and	CC	I-TREATMENT
oral	JJ	I-TREATMENT
,	,	O
nifedipine	JJ	B-TREATMENT
30	CD	O
sr	JJ	O
q	JJ	O
daily	JJ	O
).	NN	O

#	#	O
bacteremia	NN	B-PROBLEM
:	:	O

pt	NN	O
with	IN	O
2/4	CD	O
bottles	NNS	O
coag	VBP	B-PROBLEM
neg	JJ	I-PROBLEM
staph	NN	I-PROBLEM
on	IN	O
01-19	NN	O
and	CC	O
again	RB	O
on	IN	O
01-20	NN	O
.	.	O

port	NN	B-TREATMENT
was	VBD	O
felt	VBN	O
most	JJS	O
likely	JJ	O
source	NN	O
,	,	O
and	CC	O
pt	NN	O
has	VBZ	O
had	VBN	O
at	IN	O
least	JJS	O
2	CD	O
sets	NNS	O
of	IN	O
+	NNP	B-PROBLEM
blood	NN	I-PROBLEM
cultures	NNS	I-PROBLEM
since	IN	O
it	PRP	O
was	VBD	O
placed	VBN	O
.	.	O

tte	NN	B-TEST
was	VBD	O
obtained	VBN	O
which	WDT	O
was	VBD	O
not	RB	O
concerning	VBG	O
for	IN	O
endocarditis	NN	B-PROBLEM
.	.	O

pt	NN	O
without	IN	O
stigmata	NN	B-PROBLEM
of	IN	I-PROBLEM
sbe	NN	I-PROBLEM
.	.	O

id	NN	O
consult	NN	O
obtained	VBD	O
which	WDT	O
recommended	VBD	O
removal	NN	B-TREATMENT
of	IN	I-TREATMENT
port	NN	I-TREATMENT
,	,	O
which	WDT	O
was	VBD	O
taken	VBN	O
out	RP	O
on	IN	O
01-23	NN	O
.	.	O

pt	NN	O
will	MD	O
compelete	VB	O
a	DT	O
2	CD	O
week	NN	O
course	NN	O
of	IN	O
vancomycin	NN	B-TREATMENT
at	IN	O
hemodialysis	NN	B-TREATMENT
,	,	O
which	WDT	O
has	VBZ	O
been	VBN	O
arranged	VBN	O
by	IN	O
renal	JJ	O
service	NN	O
.	.	O

a	DT	B-TREATMENT
picc	NN	I-TREATMENT
was	VBD	O
breifly	NN	O
placed	VBN	O
,	,	O
however	RB	O
removed	VBN	O
as	IN	O
it	PRP	O
is	VBZ	O
unclear	JJ	O
if	IN	O
pt	NNS	O
can	MD	O
reliably	RB	O
flush	VB	O
this	DT	O
.	.	O

port	NN	B-TREATMENT
will	MD	O
be	VB	O
replaced	VBN	O
on	IN	O
2019-02-11	JJ	O
per	IN	O
ir	NN	O
(	(	O
dr.	JJ	O
welsh	NN	O
placed	VBD	O
last	JJ	O
port	NN	B-TREATMENT
,	,	O
then	RB	O
removed	VBD	O
it	PRP	O
on	IN	O
01-23	JJ	O
),	NN	O
ordered	VBD	O
placed	VBN	O
in	IN	O
omr	NN	O
.	.	O

diabetic	JJ	B-PROBLEM
gastropathy	NN	I-PROBLEM
causing	VBG	O
inability	NN	B-PROBLEM
to	TO	I-PROBLEM
toleral	JJ	I-PROBLEM
oral	JJ	I-PROBLEM
antihypertensive	JJ	I-PROBLEM
medication	NN	I-PROBLEM
prompting	VBG	O
repeated	VBN	O
donald	JJ	O
presentation	NN	O
for	IN	O
hypertensive	JJ	B-PROBLEM
urgency	NN	I-PROBLEM
.	.	O

pt	NN	O
with	IN	O
surveillance	NN	B-TEST
cultures	NNS	I-TEST
and	CC	O
port	VB	B-TEST
tip	NN	I-TEST
cultures	NNS	I-TEST
showing	VBG	O
ngtd	JJ	O
on	IN	O
01-24	NN	O
,	,	O
he	PRP	O
will	MD	O
have	VB	O
futher	JJR	B-TEST
surveillance	NN	I-TEST
cultures	NNS	I-TEST
drawn	VBN	O
at	IN	O
hemodialysis	NN	B-TREATMENT
and	CC	O
followed	VBN	O
by	IN	O
his	PRP$	O
nephrologist	NN	O
.	.	O

#	#	O
n/v/	JJ	B-PROBLEM
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
:	:	O
pt	NN	O
with	IN	O
multiple	JJ	O
admissions	NNS	O
with	IN	O
similar	JJ	B-PROBLEM
complaints	NNS	I-PROBLEM
,	,	O
etiology	NN	O
02-08	JJ	O
gastroparesis	NN	B-PROBLEM
,	,	O
improves	VBZ	O
considerably	RB	O
with	IN	O
ativan	NN	B-TREATMENT
,	,	O
dilaudid	NN	B-TREATMENT
,	,	O
reglan	NN	B-TREATMENT
,	,	O
pt	NN	O
was	VBD	O
tolerating	VBG	O
po	NN	B-TREATMENT
meds	NNS	I-TREATMENT
/	VBP	O
diet	JJ	O
at	IN	O
time	NN	O
of	IN	O
admission	NN	O
to	TO	O
medical	JJ	O
service	NN	O
and	CC	O
was	VBD	O
restarted	VBN	O
on	IN	O
oral	JJ	B-TREATMENT
reglan	NN	I-TREATMENT
.	.	O

#	#	O
dmi	NN	B-PROBLEM
:	:	O
pt	NN	O
on	IN	O
sliding	VBG	B-TREATMENT
scale	NN	I-TREATMENT
as	IN	O
inpatient	NN	O
and	CC	O
taking	VBG	O
nph	JJ	B-TREATMENT
2	CD	O
units	NNS	O
bid	NN	O
at	IN	O
home	NN	O
.	.	O

pt	NN	O
with	IN	O
two	CD	O
episodes	NNS	O
of	IN	O
hypoglycemia	NN	B-PROBLEM
(	(	O
fsbs	JJ	B-TEST
22	CD	O
and	CC	O
27	CD	O
),	NNP	O
etiology	NN	O
unclear	JJ	O
,	,	O
pt	NN	O
followed	VBN	O
by	IN	O
strickland	NN	O
,	,	O
who	WP	O
recommend	VBP	O
no	DT	O
changes	NNS	O
to	TO	O
current	JJ	B-TREATMENT
insulin	NN	I-TREATMENT
regimen	NNS	I-TREATMENT
.	.	O

will	MD	O
discharge	VB	O
pt	NN	O
with	IN	O
instructions	NNS	O
to	TO	O
continue	VB	O
nph	RB	B-TREATMENT
2	CD	O
units	NNS	O
bid	VBD	O
as	IN	O
frederick	JJ	O
tracey	NN	O
recs	NN	O
.	.	O

#	#	O
cad	SYM	B-PROBLEM
-	:	O
pt	NN	O
denied	VBD	O
cp	JJ	B-PROBLEM
/	NN	O
sob	NN	B-PROBLEM
throughout	IN	O
hospitalization	NN	O
.	.	O

troponins	NNS	B-TEST
rose	VBD	O
at	IN	O
admission	NN	O
,	,	O
however	RB	O
ck	NN	B-TEST
and	CC	O
mb	NN	B-TEST
trending	VBG	O
mcewen	JJ	O
wat	JJ	O
time	NN	O
of	IN	O
admission	NN	O
to	TO	O
medical	JJ	O
service	NN	O
.	.	O

etiology	NN	O
felt	VBD	O
most	RBS	O
likely	JJ	O
demand	NN	B-PROBLEM
ischemia	NN	I-PROBLEM
in	IN	O
setting	VBG	O
of	IN	O
original	JJ	B-PROBLEM
hypertensive	JJ	I-PROBLEM
urgency	NN	I-PROBLEM
with	IN	O
persistent	JJ	B-PROBLEM
elevation	NN	I-PROBLEM
of	IN	I-PROBLEM
trop	JJ	I-PROBLEM
02-08	JJ	O
esrd	NN	B-PROBLEM
.	.	O

pt	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
aspirin	NN	B-TREATMENT
,	,	O
metoprolol	NN	B-TREATMENT
,	,	O
nifedipine	NN	B-TREATMENT
.	.	O

#	#	O
esrd	NN	B-PROBLEM
:	:	O
etiology	NN	O
likely	JJ	O
02-08	JJ	O
dm	NN	B-PROBLEM
and	CC	O
htn	NN	B-PROBLEM
,	,	O
pt	NN	O
tolerating	VBG	O
hd	NN	B-TREATMENT
well	RB	O
,	,	O
and	CC	O
underwent	JJ	O
dialysis	NN	B-TREATMENT
without	IN	O
difficulty	NN	B-PROBLEM
on	IN	O
01-24	NN	O
.	.	O

pt	NN	O
will	MD	O
be	VB	O
discharged	VBN	O
home	NN	O
with	IN	O
plan	NN	O
to	TO	O
continue	VB	O
current	JJ	B-TREATMENT
dialysis	NN	I-TREATMENT
schedule	NN	I-TREATMENT
(	(	O
tue	JJ	O
/	NNP	O
th	NN	O
/	NNP	O
sat	VBD	O
).	NNS	O

in	IN	O
addition	NN	O
pt	NN	O
will	MD	O
be	VB	O
given	VBN	O
vancomycin	NNS	B-TREATMENT
at	IN	O
dialysis	NN	O
x	$	O
2	CD	O
week	NN	O
course	NN	O
(	(	O
last	JJ	O
day	NN	O
2019-02-05	JJ	O
)	)	O
given	VBN	O
his	PRP$	B-PROBLEM
port	NN	I-PROBLEM
line	NN	I-PROBLEM
infection	NN	I-PROBLEM
.	.	O

he	PRP	O
will	MD	O
have	VB	O
levels	NNS	B-TEST
drawn	VBN	O
at	IN	O
dialysis	NN	B-TREATMENT
and	CC	O
be	VB	O
dosed	VBN	O
with	IN	O
vancomycin	NN	B-TREATMENT
as	IN	O
appropriate	NN	O
.	.	O

plan	NN	O
is	VBZ	O
for	IN	O
surveillance	NN	B-TEST
cultures	NNS	I-TEST
to	TO	O
be	VB	O
drawn	VBN	O
at	IN	O
dialysis	NN	B-TREATMENT
.	.	O

if	IN	O
negative	JJ	O
,	,	O
pt	NN	O
is	VBZ	O
scheduled	VBN	O
for	IN	O
presumptively	RB	B-TREATMENT
replacement	NN	I-TREATMENT
of	IN	I-TREATMENT
port	NN	I-TREATMENT
on	IN	O
2019-02-11	JJ	O
with	IN	O
interventional	JJ	B-TREATMENT
radiology	NN	I-TREATMENT
(	(	O
dr.	JJ	O
arevalo	NN	O
).	NN	O

pt	NN	O
continued	VBD	O
on	IN	O
home	NN	O
regimen	NNS	O
of	IN	O
calcium	NN	B-TREATMENT
acetate	NN	I-TREATMENT
667	CD	O
mg	NN	O
,	,	O
3	CD	O
capsules	NNS	O
tid	RB	O
.	.	O

#	#	O
av	JJ	B-TREATMENT
fistula	NN	I-TREATMENT
:	:	O
pt	NN	O
with	IN	O
h/o	JJ	O
numerous	JJ	B-PROBLEM
clots	NNS	I-PROBLEM
in	IN	O
av	JJ	B-TREATMENT
fistula	NN	I-TREATMENT
.	.	O

no	DT	O
signs	NNS	O
of	IN	O
infection	NN	B-PROBLEM
presently	RB	O
,	,	O
and	CC	O
tolerating	VBG	O
dialysis	NN	B-TREATMENT
without	IN	O
difficulty	NN	B-PROBLEM
.	.	O

pt	NN	O
was	VBD	O
subtherapeuticon	JJ	B-PROBLEM
inr	NN	I-PROBLEM
on	IN	O
admission	NN	O
,	,	O
thus	RB	O
treated	VBN	O
with	IN	O
heparin	JJ	B-TREATMENT
gtt	NN	I-TREATMENT
.	.	O

coumadin	NNS	B-TREATMENT
held	VBD	O
on	IN	O
01-22	NN	O
for	IN	O
port	NN	B-TREATMENT
removal	NN	I-TREATMENT
,	,	O
and	CC	O
restarted	VBN	O
on	IN	O
01-24	NN	O
.	.	O

pt	NNS	O
discharged	VBD	O
with	IN	O
instructions	NNS	O
to	TO	O
continue	VB	O
coumadin	JJ	B-TREATMENT
1.5	CD	O
mg	NN	O
po	NN	O
q	JJ	O
daily	JJ	O
with	IN	O
goal	NN	B-TEST
inr	JJ	I-TEST
02-09	NN	O
.	.	O

pt	NN	O
discharged	VBD	O
home	NN	O
on	IN	O
01-24	JJ	O
with	IN	O
instructions	NNS	O
to	TO	O
complete	VB	O
2	CD	O
week	NN	O
course	NN	O
of	IN	O
vancomycin	NN	B-TREATMENT
at	IN	O
hemodialysis	NN	B-TREATMENT
for	IN	O
his	PRP$	B-PROBLEM
port	NN	I-PROBLEM
line	NN	I-PROBLEM
infection	NN	I-PROBLEM
.	.	O

an	DT	O
appointment	NN	O
was	VBD	O
made	VBN	O
with	IN	O
interventional	JJ	O
radiology	NN	O
on	IN	O
2019-02-11	JJ	O
to	TO	O
replace	VB	O
his	PRP$	B-TREATMENT
port	NN	I-TREATMENT
,	,	O
under	IN	O
the	DT	O
assumption	NN	O
that	IN	O
his	PRP$	B-TEST
surveillance	NN	I-TEST
cultures	NNS	I-TEST
from	IN	O
dialysis	NN	B-TREATMENT
remain	VBP	O
negative	JJ	O
.	.	O

metoclopramide	RB	B-TREATMENT
10	CD	O
mg	NNS	O
po	JJ	O
q6	NN	O

metoprolol	NN	B-TREATMENT
tartrate	NN	I-TREATMENT
75	CD	O
mg	NN	O
po	NN	O
tid	NN	O

calcium	NN	B-TREATMENT
acetate	NN	I-TREATMENT
1340	CD	O
mg	NN	O
tid	NN	O
with	IN	O
meals	NNS	O

anzemet	RB	B-TREATMENT
12.5	CD	O
iv	NNS	O
prn	NN	O

prochlorperazine	NN	B-TREATMENT
10	CD	O
mg	NN	O
iv	NN	O
q6h	NN	O
prn	NN	O

ativan	RB	B-TREATMENT
1	CD	O
mg	NNS	O
po	JJ	O
q6h	NNS	O
prn	NN	O

dilaudid	RB	B-TREATMENT
4mg	CD	O
po	JJ	O
q3-4h	JJ	O
prn	NN	O

insulin	NN	B-TREATMENT
nph	CC	I-TREATMENT
2	CD	O
units	NNS	O
subcutaneous	JJ	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

clonidine	NN	B-TREATMENT
0.3	CD	O
mg	NN	O
/	VBD	O
24	CD	O
hr	NN	O
patch	NN	O
weekly	JJ	O
transdermal	NN	O
qthur	NN	O

clonidine	NN	B-TREATMENT
0.2	CD	O
mg	NN	O
po	NN	O
tid	NN	O

prochlorperazine	NN	B-TREATMENT
10	CD	O
mg	NN	O
q	NN	O
6	CD	O
h	NN	O

coumadin	NN	B-TREATMENT
1.5	CD	O
mg	NN	O
po	NN	O
qhs	NN	O

nifedipine	JJ	B-TREATMENT
30	CD	O
sr	NN	O
mg	NN	O
po	NN	O
qd	NN	O

bisacodyl	NN	B-TREATMENT
prn	NN	O

protonix	NN	B-TREATMENT
40	CD	O
qd	NN	O

1.	CD	O
metoclopramide	JJ	B-TREATMENT
10	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
q6h	NN	O
(	(	O
every	DT	O
6	CD	O
hours	NNS	O
).	VBP	O

2.	CD	O
metoprolol	JJ	B-TREATMENT
tartrate	NN	I-TREATMENT
25	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
three	CD	O
(	(	O
3	CD	O
)	)	O
tablet	NN	O
po	NN	O
tid	NN	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

3.	CD	O
calcium	NN	B-TREATMENT
acetate	NN	I-TREATMENT
667	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
three	CD	O
(	(	O
3	CD	O
)	)	O
capsule	NN	O
po	NN	O
tid	NN	O
w/	NN	O
meals	NNS	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
with	IN	O
meals	NNS	O
).	VBP	O

4.	CD	O
ativan	JJ	B-TREATMENT
1	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
q6h	NN	O
prn	NN	O
.	.	O

5.	CD	O
dilaudid	JJ	B-TREATMENT
4	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
q3-4hr	JJ	O
prn	NN	O
.	.	O

6.	CD	O
clonidine	NN	B-TREATMENT
0.3	CD	O
mg	NN	O
/	VBD	O
24	CD	O
hr	NN	O
patch	NN	O
weekly	JJ	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
patch	NN	O
weekly	JJ	O
transdermal	NN	O
q	NN	O
wed	VBD	O
(	(	O
every	DT	O
wednesday	NN	O
).	NN	O

7.	CD	O
clonidine	NN	B-TREATMENT
0.2	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
tid	NN	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

8.	CD	O
warfarin	JJ	B-TREATMENT
1	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
1.5	CD	O
tablets	NNS	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

9.	CD	O
nifedipine	JJ	B-TREATMENT
30	CD	O
mg	JJ	O
tablet	NN	O
sustained	VBD	O
release	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
sustained	VBN	O
release	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

10.	CD	O
pantoprazole	JJ	B-TREATMENT
40	CD	O
mg	JJ	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
q24h	NN	O
(	(	O
every	DT	O
24	CD	O
hours	NNS	O
).	VBP	O

11.	CD	O
bisacodyl	NN	B-TREATMENT
5	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
once	RB	O
a	DT	O
day	NN	O
as	IN	O
needed	VBN	O
for	IN	O
constipation	NN	B-PROBLEM
.	.	O

12.	CD	O
vancomycin	NN	B-TREATMENT
in	IN	I-TREATMENT
dextrose	JJ	I-TREATMENT
1	CD	O
g	NN	O
/	VBD	O
200	CD	O
ml	NN	O
piggyback	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
intravenous	JJ	O
qhd	NN	O
(	(	O
each	DT	O
hemodialysis	NN	B-TREATMENT
):	VBD	O
2	CD	O
week	NN	O
course	NN	O
to	TO	O
be	VB	O
given	VBN	O
at	IN	O
dialysis	NN	O
,	,	O
last	JJ	O
day	NN	O
2019-02-05	JJ	O
.	.	O

13.	CD	O
aspirin	JJ	B-TREATMENT
81	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
once	RB	O
a	DT	O
day	NN	O
.	.	O

14.	CD	O
humalog	NN	B-TREATMENT
100	CD	O
unit	NN	O
/	NNP	O
ml	NN	O
solution	NN	O
sig	NN	O
:	:	O
use	NN	O
as	IN	O
directed	VBN	O
subcutaneous	JJ	O
four	CD	O
times	NNS	O
a	DT	O
day	NN	O
:	:	O
please	NN	O
use	NN	O
attached	VBD	O
sliding	VBG	B-TREATMENT
scale	NN	I-TREATMENT
.	.	O

15.	CD	O
insulin	NN	B-TREATMENT
nph	JJ	I-TREATMENT
human	JJ	I-TREATMENT
recomb	NN	I-TREATMENT
100	CD	O
unit	NN	O
/	NNP	O
ml	NN	O
suspension	NN	O
sig	NN	O
:	:	O
2	CD	O
units	NNS	O
subcutaneous	JJ	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

bacteremia	NN	B-PROBLEM
02-08	JJ	O
port	NN	B-PROBLEM
line	NN	I-PROBLEM
infection	NN	I-PROBLEM

hypertensive	JJ	B-PROBLEM
urgency	NN	I-PROBLEM

diabetic	JJ	B-PROBLEM
gastropathy	NN	I-PROBLEM

please	NN	O
continue	VB	O
to	TO	O
take	VB	O
all	DT	O
of	IN	O
your	PRP$	B-TREATMENT
medications	NNS	I-TREATMENT
as	IN	O
prescribed	NN	O
.	.	O

you	PRP	O
were	VBD	O
started	VBN	O
on	IN	O
a	DT	O
2	CD	O
week	NN	O
course	NN	O
of	IN	O
vancomycin	NN	B-TREATMENT
to	TO	O
be	VB	O
given	VBN	O
at	IN	O
hemodialysis	NN	B-TREATMENT
for	IN	O
your	PRP$	B-PROBLEM
line	NN	I-PROBLEM
infection	NN	I-PROBLEM
.	.	O

you	PRP	O
will	MD	O
have	VB	O
your	PRP$	B-TREATMENT
port	NN	I-TREATMENT
replaced	VBD	O
after	IN	O
2	CD	O
weeks	NNS	O
of	IN	O
antibiotics	NNS	B-TREATMENT
if	IN	O
your	PRP$	B-TEST
blood	NN	I-TEST
cultures	NNS	I-TEST
remain	VBP	O
negative	JJ	O
.	.	O

if	IN	O
you	PRP	O
have	VBP	O
recurrent	JJ	B-PROBLEM
fevers	NNS	I-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
,	,	O
naseau	NN	B-PROBLEM
,	,	O
vomitting	VBG	B-PROBLEM
,	,	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
or	CC	O
other	JJ	B-PROBLEM
worrisome	NN	I-PROBLEM
symptoms	NNS	I-PROBLEM
,	,	O
please	VB	O
contact	VB	O
your	PRP$	O
primary	JJ	O
care	NN	O
physician	NN	O
or	CC	O
the	DT	O
emergency	NN	O
department	NN	O
.	.	O

please	VB	O
follow-up	JJ	O
with	IN	O
your	PRP$	O
dialysis	NN	O
physician	NN	O
regarding	VBG	O
replacing	VBG	O
your	PRP$	B-TREATMENT
port	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
stage	NN	B-PROBLEM
1	CD	I-PROBLEM
sacral	JJ	I-PROBLEM
decubitus	NN	I-PROBLEM
on	IN	I-PROBLEM
her	PRP$	I-PROBLEM
buttocks	NNS	I-PROBLEM
.	.	O

this	DT	O
was	VBD	O
treated	VBN	O
with	IN	O
wound	NN	B-TREATMENT
care	NN	I-TREATMENT
using	VBG	O
eucerin	JJ	B-TREATMENT
cream	NN	I-TREATMENT
and	CC	O
also	RB	O
patient	NN	O
was	VBD	O
treated	VBN	O
with	IN	O
lidocaine	NN	B-TREATMENT
jelly	RB	I-TREATMENT
for	IN	O
pain	NN	B-TREATMENT
control	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
seen	VBN	O
by	IN	O
the	DT	O
wound	NN	O
care	NN	O
nurse	NN	O
and	CC	O
the	DT	B-PROBLEM
decubitus	NN	I-PROBLEM
ulcer	NN	I-PROBLEM
was	VBD	O
felt	VBN	O
to	TO	O
be	VB	O
mild	JJ	O
,	,	O
but	CC	O
was	VBD	O
causing	VBG	O
the	DT	O
patient	NN	O
a	DT	O
lot	NN	O
of	IN	O
discomfort	NN	B-PROBLEM
and	CC	O
the	DT	O
wound	NN	O
care	NN	O
nurse	JJ	O
ivy	NN	O
rose	VBD	O
lidocaine	JJ	B-TREATMENT
jelly	RB	I-TREATMENT
.	.	O

with	IN	O
regard	NN	O
to	TO	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
chronic	JJ	I-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
the	DT	O
patient	NN	O
's	POS	O
respiratory	NN	O
status	NN	O
improved	VBN	O
throughout	IN	O
the	DT	O
remainder	NN	O
of	IN	O
her	PRP$	O
hospital	JJ	O
course	NN	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
no	DT	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
or	CC	O
cough	NN	B-PROBLEM
on	IN	O
discharge	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
oxygenating	VBG	O
well	RB	O
on	IN	O
her	PRP$	B-TREATMENT
home	NN	I-TREATMENT
o2	NN	I-TREATMENT
dose	NN	I-TREATMENT
of	IN	O
2	CD	O
liters	NNS	O
per	IN	O
minute	NN	O
.	.	O

the	DT	O
patient	NN	O
overall	JJ	O
continued	VBD	O
to	TO	O
improve	VB	O
,	,	O
but	CC	O
remained	VBD	O
physically	RB	B-PROBLEM
decompensated	VBN	I-PROBLEM
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
transferred	VBN	O
to	TO	O
waltham/weston	VB	O
hospital	NN	O
rehabilitation	NN	O
hospital	NN	O
for	IN	O
intensive	JJ	B-TREATMENT
physical	JJ	I-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

discharge	NN	B-TREATMENT
medications	NNS	I-TREATMENT
are	VBP	O
the	DT	O
same	JJ	O
with	IN	O
the	DT	O
addition	NN	O
of	IN	O
viscous	JJ	B-TREATMENT
lidocaine	NN	I-TREATMENT
jelly	RB	I-TREATMENT
to	TO	O
be	VB	O
applied	VBN	O
to	TO	O
buttock	VB	O
prn	NN	O
and	CC	O
viscous	JJ	B-TREATMENT
lidocaine	NN	I-TREATMENT
swish	NN	I-TREATMENT
and	CC	I-TREATMENT
swallow	JJ	I-TREATMENT
tid	NN	O
prn	NN	O
before	IN	O
meals	NNS	O
.	.	O

this	DT	O
is	VBZ	O
an	DT	O
86-year-old	JJ	O
female	NN	O
with	IN	O
a	DT	O
past	JJ	O
medical	JJ	O
history	NN	O
of	IN	O
diabetes	NNS	B-PROBLEM
and	CC	O
hypertension	NN	B-PROBLEM
who	WP	O
presented	VBD	O
to	TO	O
the	DT	O
emergency	NN	O
department	NN	O
with	IN	O
a	DT	O
two	CD	O
day	NN	O
history	NN	O
of	IN	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
and	CC	O
easy	JJ	B-PROBLEM
fatigability	NN	I-PROBLEM
.	.	O

she	PRP	O
also	RB	O
noted	VBD	O
increased	JJ	B-PROBLEM
dyspnea	NN	I-PROBLEM
on	IN	O
exertion	NN	O
.	.	O

she	PRP	O
denies	VBZ	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
orthopnea	NN	B-PROBLEM
,	,	O
paroxysmal	JJ	B-PROBLEM
nocturnal	JJ	I-PROBLEM
dyspnea	NN	I-PROBLEM
.	.	O

however	RB	O
,	,	O
the	DT	O
patient	NN	O
has	VBZ	O
noted	VBN	O
some	DT	B-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
intermittent	NN	O
times	NNS	O
a	DT	O
couple	NN	O
of	IN	O
days	NNS	O
,	,	O
none	NN	O
on	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
.	.	O

denied	VBN	O
nausea	NN	B-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
,	,	O
diaphoresis	NN	B-PROBLEM
,	,	O
bowel	FW	B-PROBLEM
movement	NN	I-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
noted	VBN	O
increased	VBN	B-PROBLEM
urinary	JJ	I-PROBLEM
frequency	NN	I-PROBLEM
.	.	O

denies	NNS	O
fever	VBP	B-PROBLEM
or	CC	O
chills	NNS	B-PROBLEM
.	.	O

of	IN	O
note	NN	O
,	,	O
she	PRP	O
has	VBZ	O
had	VBN	O
recent	JJ	B-TREATMENT
medication	NN	I-TREATMENT
changes	NNS	I-TREATMENT
which	WDT	O
included	VBD	O
discontinuing	VBG	O
diovan	NN	B-TREATMENT
and	CC	O
starting	VBG	O
terazosin	NN	B-TREATMENT
.	.	O

1.	CD	O
diabetes	NNS	B-PROBLEM
mellitus	NN	I-PROBLEM
.	.	O

2.	CD	O
hypertension	NN	B-PROBLEM
.	.	O

3.	CD	O
osteoarthritis	NN	B-PROBLEM
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

1.	CD	O
aspirin	JJ	B-TREATMENT
325	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

2.	CD	O
norvasc	JJ	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

3.	CD	O
isosorbide	JJ	B-TREATMENT
mononitrate	NN	I-TREATMENT
30	CD	O
q.	JJ	O
day	NN	O
.	.	O

4.	CD	O
terazosin	NN	B-TREATMENT
1	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

positive	JJ	O
for	IN	O
diabetes	NNS	B-PROBLEM
.	.	O

no	DT	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

on	IN	O
admission	NN	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
151/61	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
75	CD	O
,	,	O
sao2	VBD	B-TEST
93%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

in	IN	O
general	JJ	O
,	,	O
patient	NN	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

jugular	JJ	B-TEST
venous	JJ	I-TEST
pressure	NN	I-TEST
notable	JJ	O
at	IN	O
the	DT	O
mid	NN	O
neck	NN	O
upright	VBD	O
about	RB	O
80	CD	O
degree	JJ	O
angles	NNS	O
.	.	O

cardiovascular	JJ	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
with	IN	O
a	DT	B-PROBLEM
1-2/6	JJ	I-PROBLEM
holosystolic	JJ	I-PROBLEM
murmur	NN	I-PROBLEM
.	.	O

crackles	NNS	B-PROBLEM
bilaterally	RB	I-PROBLEM
one-third	JJ	O
to	TO	O
one-half	VB	O
the	DT	O
way	NN	O
up	RP	O
.	.	O

bowel	NN	B-TEST
sounds	VBZ	I-TEST
positive	JJ	O
,	,	O
soft	JJ	O
,	,	O
non-tender	JJ	B-PROBLEM
,	,	O
non-distended	JJ	B-PROBLEM
.	.	O

1+	CD	B-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

included	VBN	O
normal	JJ	O
cbc	NN	O
,	,	O
bun	NN	B-TEST
47	CD	O
,	,	O
creatinine	NN	B-TEST
2.4	CD	O
up	IN	O
from	IN	O
baseline	NN	O
of	IN	O
about	IN	O
1.5	CD	O
.	.	O

troponin	NN	B-TEST
4.7	CD	O
,	,	O
ck	NN	B-TEST
101	CD	O
,	,	O
mb	VBD	B-TEST
3	CD	O
.	.	O

chest	JJS	B-TEST
x-ray	JJ	I-TEST
showed	VBD	O
patient	NN	O
was	VBD	O
in	IN	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

electrocardiogram	NN	B-TEST
:	:	O

showed	VBN	O
normal	JJ	O
sinus	NN	O
rhythm	NN	O
at	IN	O
107	CD	O
beats	NNS	O
per	IN	O
minute	NN	O
with	IN	O
left	JJ	B-PROBLEM
axis	JJ	I-PROBLEM
deviation	NN	I-PROBLEM
and	CC	O
poor	JJ	B-PROBLEM
r-wave	JJ	I-PROBLEM
progression	NN	I-PROBLEM
.	.	O

however	RB	O
,	,	O
no	DT	O
acute	NN	B-PROBLEM
changes	NNS	I-PROBLEM
were	VBD	O
apparent	JJ	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
cardiac	JJ	O
medicine	NN	O
service	NN	O
and	CC	O
treated	VBN	O
for	IN	O
presumed	JJ	O
diastolic	JJ	B-PROBLEM
and	CC	I-PROBLEM
systolic	JJ	I-PROBLEM
dysfunction	NN	I-PROBLEM
.	.	O

echocardiogram	NN	B-TEST
was	VBD	O
obtained	VBN	O
which	WDT	O
showed	VBD	O
moderately	RB	B-PROBLEM
depressed	JJ	I-PROBLEM
left	VBD	I-PROBLEM
ventricular	JJ	I-PROBLEM
systolic	JJ	I-PROBLEM
function	NN	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
hypokinesis	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
lower	JJR	I-PROBLEM
half	NN	I-PROBLEM
of	IN	I-PROBLEM
septum	NN	I-PROBLEM
and	CC	I-PROBLEM
apex	NN	I-PROBLEM
.	.	O

also	RB	O
of	IN	O
note	NN	O
was	VBD	O
the	DT	B-PROBLEM
distal	JJ	I-PROBLEM
lateral	JJ	I-PROBLEM
wall	NN	I-PROBLEM
hypokinesis	NN	I-PROBLEM
.	.	O

the	DT	B-PROBLEM
wall	NN	I-PROBLEM
motion	NN	I-PROBLEM
abnormalities	NNS	I-PROBLEM
were	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
new	JJ	O
.	.	O

it	PRP	O
was	VBD	O
believed	VBN	O
that	IN	O
a	DT	B-TEST
troponin	NN	I-TEST
on	IN	O
admission	NN	O
in	IN	O
addition	NN	O
to	TO	O
the	DT	B-PROBLEM
wall	NN	I-PROBLEM
motion	NN	I-PROBLEM
abnormalities	VBZ	I-PROBLEM
she	PRP	O
underwent	VBD	O
a	DT	B-PROBLEM
non-q	JJ	I-PROBLEM
wave	NN	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
prior	RB	O
to	TO	O
resulted	VB	O
in	IN	O
her	PRP$	B-PROBLEM
current	JJ	I-PROBLEM
cardiac	JJ	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

throughout	IN	O
hospital	JJ	O
course	NN	O
patient	NN	B-TEST
's	POS	I-TEST
troponin	NN	I-TEST
trended	VBD	O
down	RB	O
to	TO	O
less	JJR	O
than	IN	O
0.3	CD	O
.	.	O

she	PRP	O
was	VBD	O
continued	VBN	O
with	IN	O
aggressive	JJ	B-TREATMENT
diuresis	NN	I-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
_________	NN	O
with	IN	O
excellent	JJ	O
diuresis	NN	O
,	,	O
however	RB	O
,	,	O
her	PRP	B-PROBLEM
renal	JJ	I-PROBLEM
functioning	VBG	I-PROBLEM
worsening	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
cardiac	JJ	I-TEST
catheterization	NN	I-TEST
was	VBD	O
deferred	VBN	O
until	IN	O
the	DT	B-PROBLEM
renal	JJ	I-PROBLEM
issue	NN	I-PROBLEM
could	MD	O
be	VB	O
resolved	VBN	O
.	.	O

however	RB	O
,	,	O
her	PRP	B-TEST
creatinine	VBP	I-TEST
continued	VBN	O
to	TO	O
increase	VB	O
.	.	O

diuresis	NN	B-TREATMENT
was	VBD	O
halted	VBN	O
and	CC	O
without	IN	O
improvement	NN	O
in	IN	O
creatinine	NN	B-TEST
.	.	O

a	DT	B-TEST
renal	JJ	I-TEST
ultrasound	NN	I-TEST
was	VBD	O
obtained	VBN	O
.	.	O

it	PRP	O
showed	VBD	O
a	DT	B-TEST
right	JJ	I-TEST
kidney	NN	I-TEST
size	NN	I-TEST
of	IN	O
6.3	CD	O
cm	NN	O
and	CC	O
a	DT	B-TEST
left	JJ	I-TEST
kidney	NN	I-TEST
size	NN	I-TEST
of	IN	O
8.4	CD	O
cm	NN	O
.	.	O

given	VBN	O
her	PRP$	B-PROBLEM
hypertension	NN	I-PROBLEM
which	WDT	O
was	VBD	O
very	RB	O
difficult	JJ	O
to	TO	O
control	VB	O
,	,	O
it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
she	PRP	O
had	VBD	O
renal	JJ	B-PROBLEM
artery	NN	I-PROBLEM
stenosis	NN	I-PROBLEM
and	CC	O
thus	RB	O
she	PRP	O
underwent	JJ	O
mra	NN	B-TEST
of	IN	I-TEST
the	DT	I-TEST
kidney	NN	I-TEST
which	WDT	O
showed	VBD	O
severe	JJ	B-PROBLEM
right	JJ	I-PROBLEM
renal	JJ	I-PROBLEM
artery	NN	I-PROBLEM
stenosis	NN	I-PROBLEM
at	IN	I-PROBLEM
its	PRP$	I-PROBLEM
origin	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
also	RB	O
moderate	JJ	B-PROBLEM
to	TO	I-PROBLEM
severe	VB	I-PROBLEM
focal	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
renal	JJ	I-PROBLEM
artery	NN	I-PROBLEM
approximately	RB	O
1.3	CD	O
cm	NN	O
from	IN	O
its	PRP$	O
origin	NN	O
.	.	O

she	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
unit	NN	O
overnight	VBD	O
to	TO	O
assess	VB	O
volume	NN	B-TEST
which	WDT	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
optimal	JJ	O
.	.	O

on	IN	O
05-25	JJ	O
she	PRP	O
underwent	JJ	O
catheterization	NN	B-TEST
and	CC	O
subsequent	JJ	B-TREATMENT
stenting	NN	I-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
left	JJ	I-TREATMENT
renal	JJ	I-TREATMENT
artery	NN	I-TREATMENT
.	.	O

due	JJ	O
to	TO	O
dye	VB	B-TREATMENT
load	NN	I-TREATMENT
required	VBN	O
to	TO	O
assess	VB	O
the	DT	B-PROBLEM
coronary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
were	VBD	O
not	RB	O
visualized	VBN	O
.	.	O

after	IN	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
the	DT	O
patient	NN	O
did	VBD	O
well	RB	O
.	.	O

however	RB	O
,	,	O
her	PRP	B-TEST
creatinine	NN	I-TEST
has	VBZ	O
worsened	VBN	B-PROBLEM
up	RP	O
to	TO	O
4.2	CD	O
.	.	O

however	RB	O
,	,	O
her	PRP	B-TEST
urine	JJ	I-TEST
output	NN	I-TEST
has	VBZ	O
improved	VBN	O
.	.	O

she	PRP	O
has	VBZ	O
not	RB	O
required	VBN	O
hemodialysis	NN	B-TREATMENT
at	IN	O
this	DT	O
time	NN	O
.	.	O

1.	CD	O
non-q	JJ	B-PROBLEM
wave	NN	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

2.	CD	O
systolic	JJ	B-PROBLEM
and	CC	I-PROBLEM
diastolic	JJ	I-PROBLEM
congestive	JJ	I-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

3.	CD	O
bilateral	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
artery	NN	I-PROBLEM
stenosis	NN	I-PROBLEM
status	NN	O
post	NN	O
stent	NN	B-TREATMENT
left	VBD	I-TREATMENT
renal	JJ	I-TREATMENT
artery	NN	I-TREATMENT
.	.	O

4.	CD	O
acute	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

5.	CD	O
hypertension	NN	B-PROBLEM
.	.	O

1.	CD	O
aspirin	JJ	B-TREATMENT
325	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

2.	CD	O
norvasc	JJ	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

3.	CD	O
atorvastatin	JJ	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

4.	CD	O
protonix	JJ	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

5.	CD	O
multivitamin	NN	B-TREATMENT
one	CD	O
p.o.	NN	O
q.	NN	O
day	NN	O
.	.	O

6.	CD	O
carvedilol	NN	B-TREATMENT
3.125	CD	O
p.o.	NN	O
b.i.d.	NN	O

7.	CD	O
___________	JJ	O
dinitrate	NN	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O

8.	CD	O
erythropoietin	JJ	B-TREATMENT
10,000	CD	O
units	NNS	O
two	CD	O
times	NNS	O
a	DT	O
week	NN	O
tuesday	NN	O
and	CC	O
saturday	NN	O
.	.	O

9.	CD	O
calcium	NN	B-TREATMENT
acetate	NN	I-TREATMENT
tums	NNS	I-TREATMENT
one	CD	O
p.o.	NN	O
t.i.d.	NN	O
with	IN	O
meals	NNS	O
.	.	O

10.	CD	O
tylenol	JJ	B-TREATMENT
325	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
4-6	JJ	O
h.	NN	O
p.r.n.	NN	O

11.	CD	O
iron	NN	B-TREATMENT
sulfate	NN	I-TREATMENT
325	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

12.	CD	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

13.	CD	O
hydralazine	NN	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q.	VBD	O
6h.	CD	O

14.	CD	O
plavix	JJ	B-TREATMENT
75	CD	O
mg	NN	O
p.o.	NN	O
q.	NN	O
day	NN	O
times	VBZ	O
30	CD	O
days	NNS	O
.	.	O

22	CD	O
year	NN	O
old	JJ	O
female	NN	O
transfer	NN	O
from	IN	O
outside	JJ	O
hospital	NN	O
after	IN	O
a	DT	O
motor	NN	O
vehicle	NN	O
accident	NN	O
with	IN	O
diagnosed	JJ	B-PROBLEM
liver	NN	I-PROBLEM
laceration	NN	I-PROBLEM
by	IN	O
ct	JJ	B-TEST
scan	JJ	I-TEST
.	.	O

neck	NN	O
with	IN	O
cervical	JJ	B-TREATMENT
collar	NN	I-TREATMENT
.	.	O

left	VBN	B-PROBLEM
forarm	NN	I-PROBLEM
and	CC	I-PROBLEM
right	JJ	I-PROBLEM
knee	NN	I-PROBLEM
abrasions	NNS	I-PROBLEM
.	.	O

chest	NN	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilateral	JJ	O
,	,	O
s1	JJ	O
s2	NN	O
normal	JJ	O
and	CC	O
with	IN	O
no	DT	O
murmors	NNS	B-PROBLEM
.	.	O

abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
predominally	RB	O
on	IN	O
the	DT	O
right	JJ	O
upper	NN	O
quadrant	NN	O
,	,	O
no	DT	O
signs	NNS	O
of	IN	O
peritoneal	JJ	B-PROBLEM
irritation	NN	I-PROBLEM
.	.	O

glucose	JJ	B-TEST
-	:	O
74	CD	O
urea	JJ	B-TEST
n	SYM	I-TEST
-	:	O
9	CD	O
creat	NN	B-TEST
-	:	O
0.7	CD	O
sodium	NN	B-TEST
-	:	O
139	CD	O
potassium	NN	B-TEST
-	:	O
3.5	CD	O
chloride	NN	B-TEST
-	:	O
106	CD	O
total	JJ	B-TEST
co2	NN	I-TEST
-	:	O
23	CD	O
anion	NN	B-TEST
gap	NN	I-TEST
-	:	O
14	CD	O

alt(sgpt)	SYM	B-TEST
-	:	O
241	CD	O
*	NN	O
ast(sgot)	SYM	B-TEST
-	:	O
207	CD	O
*	JJ	O
alk	NN	B-TEST
phos	SYM	I-TEST
-	:	O
51	CD	O
tot	NN	B-TEST
bili	SYM	I-TEST
-	:	O
0.8	CD	O

calcium	NN	B-TEST
-	:	O
8.2	CD	O
*	NN	O
phosphate	NN	B-TEST
-	:	O
3.1	CD	O
magnesium	NN	B-TEST
-	:	O
2.2	CD	O

glucose	JJ	B-TEST
-	:	O
75	CD	O
urea	JJ	B-TEST
n	SYM	I-TEST
-	:	O
10	CD	O
creat	NN	B-TEST
-	:	O
0.6	CD	O
sodium	NN	B-TEST
-	:	O
137	CD	O
potassium	NN	B-TEST
-	:	O
3.7	CD	O
chloride	NN	B-TEST
-	:	O
103	CD	O
total	JJ	B-TEST
co2	NN	I-TEST
-	:	O
23	CD	O
anion	NN	B-TEST
gap	NN	I-TEST
-	:	O
15	CD	O

alt(sgpt)	SYM	B-TEST
-	:	O
318	CD	O
*	NN	O
ast(sgot)	SYM	B-TEST
-	:	O
307	CD	O
*	JJ	O
alk	NN	B-TEST
phos	SYM	I-TEST
-	:	O
61	CD	O
tot	NN	B-TEST
bili	SYM	I-TEST
-	:	O
0.9	CD	O

wbc	SYM	B-TEST
-	:	O
8.3	CD	O
rbc	NN	B-TEST
-	:	O
3.64	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
12.6	CD	O
hct	NN	B-TEST
-	:	O
36.1	CD	O
mcv	SYM	B-TEST
-	:	O
99	CD	O
*	NN	O
mch	SYM	B-TEST
-	:	O
34.7	CD	O
*	NN	O
mchc	SYM	B-TEST
-	:	O
35.0	CD	O
rdw	NN	B-TEST
-	:	O
12.4	CD	O

pt	SYM	B-TEST
-	:	O
11.6	CD	O
ptt	NN	B-TEST
-	:	O
26.0	CD	O
inr(pt)	JJ	B-TEST
-	:	O
0.9	CD	O

patient	NN	O
was	VBD	O
admited	VBN	O
,	,	O
pain	NN	B-PROBLEM
was	VBD	O
managed	VBN	O
with	IN	O
a	DT	B-TREATMENT
pca	NN	I-TREATMENT
and	CC	O
later	RB	O
with	IN	O
po	JJ	B-TREATMENT
medication	NN	I-TREATMENT
.	.	O

the	DT	B-PROBLEM
liver	NN	I-PROBLEM
laceration	NN	I-PROBLEM
was	VBD	O
stable	JJ	O
,	,	O
no	DT	O
sign	NN	O
of	IN	O
rupture	NN	B-PROBLEM
or	CC	O
further	JJ	B-PROBLEM
complication	NN	I-PROBLEM
,	,	O
did	VBD	O
not	RB	O
required	VBN	O
surgical	JJ	B-TREATMENT
managment	NN	I-TREATMENT
.	.	O

the	DT	B-TEST
liver	NN	I-TEST
enzimes	VBZ	I-TEST
come	VBP	O
down	RP	O
,	,	O
no	DT	O
signs	NNS	O
of	IN	O
biliary	JJ	B-PROBLEM
stasis	NN	I-PROBLEM
.	.	O

1.	CD	O
docusate	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
100	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
for	IN	O
4	CD	O
days	NNS	O
.	.	O

2.	CD	O
hydromorphone	NN	B-TREATMENT
2	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
q2h	NN	O
(	(	O
every	DT	O
2	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
pain	NN	B-PROBLEM
for	IN	O
4	CD	O
days	NNS	O
.	.	O

-	:	O
follow	VB	O
up	RP	O
with	IN	O
trauma	NN	O
surgery	NN	O
clinic	NN	O
with	IN	O
the	DT	O
result	NN	O
from	IN	O
the	DT	B-TEST
ct	NN	I-TEST
scan	JJ	I-TEST
abdomen	NNS	I-TEST

-	:	O
call	NN	O
for	IN	O
appointment	NN	O
to	TO	O
(	(	O
289	CD	O
)	)	O
411-5387	NN	O
for	IN	O
the	DT	O
trauma	NN	O
clinic	NN	O
and	CC	O
abdominal	JJ	B-TEST
ct	NN	I-TEST
scan	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
abdomen	NNS	I-TEST
in	IN	O
4	CD	O
weeks	NNS	O

-	:	O
if	IN	O
any	DT	B-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
fever	NN	B-PROBLEM
or	CC	O
dizziness	NN	B-PROBLEM
,	,	O
go	VB	O
to	TO	O
the	DT	O
emergency	NN	O
room	NN	O

-	:	O
analgesic	NN	B-TREATMENT
(	(	I-TREATMENT
percocet	NN	I-TREATMENT
)	)	I-TREATMENT
as	IN	O
needed	VBN	O

-	:	O
trauma	NN	O
surgery	NN	O
clinic	NN	O
in	IN	O
four	CD	O
weeks	NNS	O
with	IN	O
ct	JJ	B-TEST
abdomen	NNS	I-TEST
results	NNS	O
.	.	O

call	NN	O
trauma	NN	O
clinic	NN	O
to	TO	O
coordinate	VB	O
the	DT	B-TEST
study	NN	I-TEST
,	,	O
result	NN	O
and	CC	O
appointment	NN	O
dates	NNS	O
((	VBP	O
289	CD	O
)	)	O
411-5387	CD	O
).	NN	O

he	PRP	O
is	VBZ	O
a	DT	O
39	CD	O
year-old	JJ	O
gentleman	NN	O
with	IN	O
hyperlipidemia	NN	B-PROBLEM
and	CC	O
smoking	NN	O
who	WP	O
presented	VBD	O
with	IN	O
acute	JJ	O
onset	NN	O
of	IN	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
since	IN	O
five	CD	O
in	IN	O
the	DT	O
morning	NN	O
with	IN	O
radiation	NN	O
to	TO	O
the	DT	O
left	JJ	O
arm	NN	O
and	CC	O
nausea	NN	B-PROBLEM
.	.	O

symptoms	NNS	B-PROBLEM
resolved	VBD	O
spontaneously	RB	O
.	.	O

cath	NN	O
lab	NN	O
at	IN	O
the	DT	O
pinewood	NN	O
,	,	O
norfolk	NN	O
that	IN	O
evening	VBG	O
where	WRB	O
a	DT	B-TREATMENT
stent	JJ	I-TREATMENT
procedure	NN	I-TREATMENT
to	TO	I-TREATMENT
the	DT	I-TREATMENT
rca	NN	I-TREATMENT
was	VBD	O
complicated	VBN	O
by	IN	O
guidewire	NN	O
entrapment	NN	O
inside	IN	O
of	IN	O
a	DT	B-TREATMENT
stent	NN	I-TREATMENT
requiring	VBG	O
ct	NN	B-TREATMENT
surgery	NN	I-TREATMENT
to	TO	O
do	VB	O
a	DT	B-TREATMENT
thoracotomy	NN	I-TREATMENT
with	IN	O
bypass	NN	B-TREATMENT
and	CC	O
excision	NN	B-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
wire	NN	I-TREATMENT
.	.	O

the	DT	O
case	NN	O
was	VBD	O
complicated	VBN	O
by	IN	O
an	DT	O
episode	NN	O
of	IN	O
coffee	NN	B-PROBLEM
ground	NN	I-PROBLEM
emesis	NN	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
bleed	NN	I-PROBLEM
from	IN	I-PROBLEM
femoral	JJ	I-PROBLEM
access	NN	I-PROBLEM
site	NN	I-PROBLEM
prior	RB	O
to	TO	O
ct	VB	B-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

gastroenterology	NN	O
was	VBD	O
consulted	VBN	O
and	CC	O
they	PRP	O
recommended	VBD	O
protonix	NN	B-TREATMENT
and	CC	O
felt	VBD	O
it	PRP	O
was	VBD	O
due	JJ	O
to	TO	O
peptic	JJ	B-PROBLEM
ulcer	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

1.	CD	O
hepatitis	NN	B-PROBLEM
b	NN	I-PROBLEM
.	.	O

2.	CD	O
hypercholesterolemia	NN	B-PROBLEM
.	.	O

3.	CD	O
fatty	JJ	B-PROBLEM
liver	RB	I-PROBLEM
resolved	VBN	O
.	.	O

relatively	RB	O
unknown	JJ	O
other	JJ	O
than	IN	O
lipitor	NN	B-TREATMENT
.	.	O

allergies	NNS	O
:	:	O
he	PRP	O
had	VBD	O
no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

family	NN	O
history	NN	O
:	:	O
not	RB	O
significant	JJ	O
for	IN	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
diagnosed	VBN	O
as	IN	O
having	VBG	O
an	DT	B-PROBLEM
acute	JJ	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
emergently	RB	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
on	IN	O
2009-05-02	JJ	O
for	IN	O
his	PRP$	B-TREATMENT
cabg	NN	I-TREATMENT
,	,	O
right	JJ	B-TREATMENT
coronary	JJ	I-TREATMENT
endarterectomy	NN	I-TREATMENT
,	,	O
removal	NN	B-TREATMENT
of	IN	I-TREATMENT
rca	NN	I-TREATMENT
stents	NNS	I-TREATMENT
and	CC	O
retrieval	NN	B-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
aortic	JJ	I-TREATMENT
guidewire	NN	I-TREATMENT
.	.	O

postoperatively	RB	O
he	PRP	O
did	VBD	O
well	RB	O
and	CC	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
cardiac	NN	O
surgery	NN	O
intensive	JJ	O
care	NN	O
unit	NN	O
where	WRB	O
he	PRP	O
was	VBD	O
on	IN	O
pressor	JJ	B-TREATMENT
support	NN	I-TREATMENT
of	IN	O
neo-synephrine	JJ	B-TREATMENT
and	CC	O
he	PRP	O
was	VBD	O
extubated	VBN	O
.	.	O

the	DT	O
patient	NN	O
slowly	RB	O
weaned	VBD	O
off	RP	O
neo-synephrine	JJ	B-TREATMENT
as	IN	O
tolerated	VBN	O
.	.	O

his	PRP$	B-TREATMENT
chest	JJS	I-TREATMENT
tube	NN	I-TREATMENT
had	VBD	O
been	VBN	O
discontinued	VBN	O
.	.	O

upon	IN	O
arrival	NN	O
to	TO	O
the	DT	O
floor	NN	O
the	DT	B-TREATMENT
patient	NN	I-TREATMENT
's	POS	I-TREATMENT
wires	NNS	I-TREATMENT
were	VBD	O
discontinued	VBN	O
on	IN	O
2009-05-05	JJ	O
and	CC	O
his	PRP$	B-TREATMENT
foley	NN	I-TREATMENT
catheter	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
.	.	O

his	PRP$	B-TEST
electrolytes	NNS	I-TEST
were	VBD	O
repleted	VBN	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
discharged	VBN	O
home	NN	O
on	IN	O
2009-05-06	JJ	O
after	IN	O
tolerating	VBG	O
a	DT	O
level	NN	O
v	NN	O
.	.	O

medications	NNS	O
:	:	O
his	PRP$	B-TREATMENT
prescriptions	NNS	I-TREATMENT
shall	MD	O
include	VB	O

1.	CD	O
lopressor	NN	B-TREATMENT
25	CD	O
milligrams	NNS	O
po	JJ	O
bid	NN	O
.	.	O

2.	CD	O
lipitor	NN	B-TREATMENT
20	CD	O
milligrams	NNS	O
po	VBP	O
q	JJ	O
hs	NN	O
.	.	O

3.	CD	O
niferex	JJ	B-TREATMENT
150	CD	O
milligrams	NNS	O
caplet	VBP	O
one	CD	O
cap	NN	O
per	IN	O
day	NN	O
.	.	O

4.	CD	O
protonix	JJ	B-TREATMENT
40	CD	O
milligrams	NNS	O
po	JJ	O
q	JJ	O
day	NN	O
.	.	O

5.	CD	O
colace	NN	B-TREATMENT
100	CD	O
milligrams	NNS	O
po	JJ	O
bid	NN	O
.	.	O

6.	CD	O
percocet	JJ	B-TREATMENT
one	CD	O
to	TO	O
two	CD	O
tablets	NNS	O
q	VBP	O
four	CD	O
h	NN	O
prn	NN	O
for	IN	O
pain	NN	B-PROBLEM
.	.	O

7.	CD	O
plavix	JJ	B-TREATMENT
75	CD	O
milligrams	NNS	O
po	JJ	O
q	JJ	O
day	NN	O
times	NNS	O
three	CD	O
months	NNS	O
.	.	O

8.	CD	O
aspirin	JJ	B-TREATMENT
325	CD	O
milligrams	NNS	O
po	JJ	O
q	JJ	O
day	NN	O
.	.	O

9.	CD	O
lasix	JJ	B-TREATMENT
20	CD	O
milligrams	NNS	O
po	VBP	O
times	NNS	O
30	CD	O
days	NNS	O
.	.	O

10.	CD	O
kcl	$	B-TREATMENT
20	CD	O
milliequivalents	NNS	O
po	JJ	O
q	NN	O
d	NN	O
times	NNS	O
three	CD	O
days	NNS	O
.	.	O

prostate	NN	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

status	NN	O
post	NN	O
radical	JJ	B-TREATMENT
retropubic	NN	I-TREATMENT
prostatectomy	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
64	CD	O
year	NN	O
old	JJ	O
gentleman	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
elevated	JJ	B-PROBLEM
psa	NN	I-PROBLEM
,	,	O
prostate	NN	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
diagnosed	VBN	O
with	IN	O
needle	JJ	B-TEST
biopsy	NN	I-TEST
on	IN	O
either	DT	O
side	NN	O
of	IN	O
the	DT	O
prostate	NN	O
with	IN	O
3+3	CD	O
equals	NNS	O
6	CD	O
on	IN	O
the	DT	O
right	JJ	O
side	NN	O
and	CC	O
3+4	CD	O
equals	NNS	O
7	CD	O
on	IN	O
the	DT	O
left	JJ	O
side	NN	O
.	.	O

the	DT	O
patient	JJ	O
underwent	JJ	O
radical	JJ	B-TREATMENT
retropubic	NN	I-TREATMENT
prostatectomy	NN	I-TREATMENT
on	IN	O
2012-01-20	JJ	O
.	.	O

dr.	NN	O
marie	NN	O
anderson	NN	O
performed	VBD	O
the	DT	B-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
one	CD	O
,	,	O
he	PRP	O
was	VBD	O
administered	VBN	O
1	CD	B-TREATMENT
mg	JJ	I-TREATMENT
coumadin	NN	I-TREATMENT
per	FW	O
protocol	NN	O
as	RB	O
well	RB	O
as	IN	O
on	IN	O
the	DT	O
operative	JJ	O
day	NN	O
1	CD	O
mg	NN	O
of	IN	O
coumadin	NN	B-TREATMENT
.	.	O

his	PRP$	B-TEST
laboratories	NNS	I-TEST
were	VBD	O
checked	VBN	O
and	CC	O
his	PRP$	B-TEST
hematocrit	NN	I-TEST
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
stable	JJ	O
.	.	O

his	PRP$	B-PROBLEM
pain	NN	I-PROBLEM
was	VBD	O
well	RB	O
controlled	VBN	O
with	IN	O
oral	JJ	B-TREATMENT
medication	NN	I-TREATMENT
at	IN	O
this	DT	O
time	NN	O
.	.	O

his	PRP$	B-TREATMENT
intravenous	JJ	I-TREATMENT
fluids	NNS	I-TREATMENT
were	VBD	O
discontinued	VBN	O
at	IN	O
this	DT	O
time	NN	O
.	.	O

his	PRP$	B-TREATMENT
penrose	NN	I-TREATMENT
drain	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
at	IN	O
this	DT	O
time	NN	O
.	.	O

he	PRP	O
was	VBD	O
discharged	VBN	O
home	NN	O
with	IN	O
a	DT	B-TREATMENT
foley	NN	I-TREATMENT
catheter	NN	I-TREATMENT
and	CC	O
he	PRP	O
will	MD	O
follow-up	VB	O
with	IN	O
dr.	JJ	O
ross	NN	O
in	IN	O
one	CD	O
to	TO	O
two	CD	O
weeks	NNS	O
.	.	O

iodine	NN	B-TREATMENT
;	:	O
iodine	NN	B-TREATMENT
containing	NN	I-TREATMENT

tracheostomy	JJ	B-TREATMENT
2014-11-11	JJ	O

bronchoscopy	NN	B-TEST
2014-11-05	JJ	O

atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
(	(	O
on	IN	O
coumadin	NN	B-TREATMENT
)	)	O

coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM

ulcerative	JJ	B-PROBLEM
colitis	NN	I-PROBLEM
w/	NN	O
colostomy	NN	B-TREATMENT

hypertension	NN	B-PROBLEM

pacemaker	NN	B-TREATMENT

cva	NN	B-PROBLEM
2012	CD	O
w/	NN	O
right	RB	B-PROBLEM
sided	VBD	I-PROBLEM
weakness	NN	I-PROBLEM

cataracts	NNS	B-PROBLEM
,	,	O
s/p	JJ	O
cataract	NN	B-TREATMENT
surgery	NN	I-TREATMENT

s/p	NN	O
turp	NN	B-TREATMENT

glucose	JJ	B-TEST
-	:	O
126	CD	O
*	JJ	O
urea	JJ	B-TEST
n	SYM	I-TEST
-	:	O
9	CD	O
creat	NN	B-TEST
-	:	O
0.8	CD	O
sodium	NN	B-TEST
-	:	O
135	CD	O
potassium	NN	B-TEST
-	:	O
3.4	CD	O
chloride	NN	B-TEST
-	:	O
99	CD	O
total	JJ	B-TEST
co2	NN	I-TEST
-	:	O
25	CD	O
anion	NN	B-TEST
gap	NN	I-TEST
-	:	O
14	CD	O

calcium	NN	B-TEST
-	:	O
8.2	CD	O
*	NN	O
phosphate	NN	B-TEST
-	:	O
2.1	CD	O
*	JJ	O
magnesium	NN	B-TEST
-	:	O
1.9	CD	O

wbc	SYM	B-TEST
-	:	O
6.5	CD	O
rbc	NN	B-TEST
-	:	O
3.68	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
11.6	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
32.5	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
88	CD	O
mch	SYM	B-TEST
-	:	O
31.5	CD	O
mchc	SYM	B-TEST
-	:	O
35.6	CD	O
*	NN	O
rdw	NN	B-TEST
-	:	O
13.6	CD	O

plt	NN	B-TEST
count	NN	I-TEST
-	:	O
207	CD	O

pt	SYM	B-TEST
-	:	O
15.0	CD	O
*	NN	O
ptt	NN	B-TEST
-	:	O
31.3	CD	O
inr(pt)	JJ	B-TEST
-	:	O
1.5	CD	O

type	NN	O
-	:	O
art	NN	O
temp	SYM	B-TEST
-	:	O
36.6	CD	O
rates	NNS	B-TEST
-	:	O
14	CD	O
/	JJ	O
tidal	JJ	B-TEST
vol	NN	I-TEST
-	:	O
550	CD	O
peep	JJ	B-TREATMENT
-	:	O
5	CD	O
o2	SYM	B-TREATMENT
-	:	O
100	CD	O
po2	NN	B-TEST
-	:	O
416	CD	O
*	NN	O
pco2	NN	B-TEST
-	:	O
39	CD	O
ph	NN	B-TEST
-	:	O
7.41	CD	O
total	JJ	B-TEST
co2	NN	I-TEST
-	:	O
26	CD	O
base	NN	B-TEST
xs	NNP	I-TEST
-	:	O
0	CD	O
aado2	SYM	B-TEST
-	:	O
279	CD	O
req	NN	B-TEST
o2	SYM	I-TEST
-	:	O
52	CD	O
-	:	O
assist	NN	O
/	JJ	O
con	NN	O
intubated	VBD	O
-	:	O
intubated	VBN	O

asa	SYM	B-TEST
-	:	O
neg	NN	O
ethanol	SYM	B-TEST
-	:	O
neg	NN	O
acetmnphn	SYM	B-TEST
-	:	O
neg	NN	O
bnzodzpn	SYM	B-TEST
-	:	O
neg	NN	O
barbitrt	SYM	B-TEST
-	:	O
neg	JJ	O
tricyclic	JJ	B-TEST
-	:	O
neg	NN	O

2014-10-21	JJ	O
09:35	CD	O
am	VBP	O
urine	JJ	B-TEST

bnzodzpn	SYM	B-TEST
-	:	O
neg	NN	O
barbitrt	SYM	B-TEST
-	:	O
neg	NN	O
opiates	VBZ	B-TEST
-	:	O
neg	NN	O
cocaine	NN	B-TEST
-	:	O
neg	NN	O
amphetmn	SYM	B-TEST
-	:	O
neg	NN	O
mthdone	NN	B-TEST
-	:	O
neg	NN	O

ct	NN	B-TEST
c	SYM	I-TEST
-	:	I-TEST
spine	NN	I-TEST
w/o	NN	I-TEST
contrast	NN	I-TEST

ct	NN	B-TEST
c	SYM	I-TEST
-	:	I-TEST
spine	NN	I-TEST
w/o	IN	I-TEST
contrast	NN	I-TEST
;	:	O
ct	CC	O
reconstruction	NN	O

technique	NN	O
:	:	O
noncontrast	JJ	B-TEST
cervical	JJ	I-TEST
spine	NN	I-TEST
ct	NN	I-TEST
.	.	O

note	NN	O
:	:	O
this	DT	B-TEST
study	NN	I-TEST
was	VBD	O
initially	RB	O
performed	VBN	O
on	IN	O
2014-10-21	JJ	O
.	.	O

findings	NNS	O
were	VBD	O
discussed	VBN	O
with	IN	O
dr.	JJ	O
leanne	NN	O
vazquez	NN	O
at	IN	O
the	DT	O
time	NN	O
this	DT	B-TEST
study	NN	I-TEST
was	VBD	O
performed	VBN	O
,	,	O
but	CC	O
the	DT	B-TEST
study	NN	I-TEST
was	VBD	O
not	RB	O
dictated	VBN	O
until	IN	O
the	DT	O
morning	NN	O
of	IN	O
2014-10-22	JJ	O
,	,	O
due	JJ	O
to	TO	O
pacs	VB	O
malfunction	NN	O
.	.	O

noncontrast	RB	B-TEST
cervical	JJ	I-TEST
spine	NN	I-TEST
ct	NN	I-TEST
:	:	O
there	EX	O
are	VBP	O
minimally	RB	B-PROBLEM
displaced	VBN	I-PROBLEM
and	CC	I-PROBLEM
comminuted	VBN	I-PROBLEM
fractures	NNS	I-PROBLEM
through	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
c7	NN	I-PROBLEM
and	CC	I-PROBLEM
t1	JJ	I-PROBLEM
transverse	NN	I-PROBLEM
processes	NNS	I-PROBLEM
.	.	O

positioning	VBG	O
limits	NNS	O
assessment	NN	B-TEST
of	IN	I-TEST
alignment	NN	I-TEST
due	JJ	O
to	TO	O
extreme	JJ	B-PROBLEM
head	NN	I-PROBLEM
tilting	VBG	I-PROBLEM
to	TO	I-PROBLEM
the	DT	I-PROBLEM
right	NN	I-PROBLEM
,	,	O
but	CC	O
this	DT	O
is	VBZ	O
likely	JJ	O
the	DT	O
best	JJS	O
obtainable	JJ	O
secondary	JJ	O
to	TO	O
intubation	NN	B-TREATMENT
and	CC	O
nasogastric	JJ	B-TREATMENT
tube	NN	I-TREATMENT
placement	NN	I-TREATMENT
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
atlantoaxial	JJ	B-PROBLEM
subluxation	NN	I-PROBLEM
.	.	O

prevertebral	JJ	B-PROBLEM
soft	JJ	I-PROBLEM
tissue	NN	I-PROBLEM
swelling	VBG	I-PROBLEM
cannot	NN	O
be	VB	O
excluded	VBN	O
secondary	JJ	O
to	TO	O
intubation	NN	B-TREATMENT
.	.	O

extensive	JJ	B-PROBLEM
carotid	NN	I-PROBLEM
arterial	JJ	I-PROBLEM
calcifications	NNS	I-PROBLEM
are	VBP	O
present	JJ	O
in	IN	O
the	DT	O
bulb	NN	O
regions	NNS	O
bilaterally	RB	O
.	.	O

biapical	JJ	B-PROBLEM
lung	NN	I-PROBLEM
scarring	NN	I-PROBLEM
and	CC	O
mild	JJ	B-PROBLEM
bronchiectasis	NN	I-PROBLEM
are	VBP	O
present	JJ	O
.	.	O

also	RB	O
noted	VBN	O
is	VBZ	O
sclerosis	JJ	B-PROBLEM
and	CC	O
opacification	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
visualized	JJ	I-PROBLEM
left	NN	I-PROBLEM
mastoid	NN	I-PROBLEM
air	NN	I-PROBLEM
cells	NNS	I-PROBLEM
and	CC	I-PROBLEM
mastoid	JJ	I-PROBLEM
tip	NN	I-PROBLEM
,	,	O
likely	JJ	O
chronic	JJ	O
inflammatory	NN	O

disease	NN	B-PROBLEM
.	.	O

impression	NN	O
:	:	O
minimally	RB	B-PROBLEM
displaced	VBD	I-PROBLEM
,	,	I-PROBLEM
comminuted	VBD	I-PROBLEM
fractures	NNS	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
c7	NN	I-PROBLEM
and	CC	I-PROBLEM
t1	JJ	I-PROBLEM
transverse	NN	I-PROBLEM
processes	NNS	I-PROBLEM
.	.	O

no	DT	O
evidence	NN	O
of	IN	O
extension	NN	B-PROBLEM
into	IN	I-PROBLEM
the	DT	I-PROBLEM
foramina	JJ	I-PROBLEM
transversaria	NN	I-PROBLEM
.	.	O

ct	JJ	B-TEST
head	NN	I-TEST
w/o	NN	I-TEST
contrast	NN	I-TEST

ct	JJ	B-TEST
head	NN	I-TEST
w/o	NN	I-TEST
contrast	NN	I-TEST

reason	NN	O
:	:	O
bleed	NN	B-PROBLEM
?	.	O

72	CD	O
year	NN	O
old	JJ	O
man	NN	O
with	IN	O
intraparenchymal	JJ	B-PROBLEM
bleed	NN	I-PROBLEM
s/p	NN	O
fall	NN	O

bleed	NN	B-PROBLEM
?	.	O

indication	NN	O
:	:	O
intraparenchymal	JJ	B-PROBLEM
hemorrhage	NN	I-PROBLEM
after	IN	O
fall	NN	O
.	.	O

assess	NN	O
for	IN	O
hemorrhage	NN	B-PROBLEM
.	.	O

technique	NN	O
:	:	O
non-contrast	JJ	B-TEST
head	NN	I-TEST
ct	NN	I-TEST
.	.	O

comparison	NN	O
:	:	O
no	DT	O
prior	JJ	B-TEST
studies	NNS	I-TEST
are	VBP	O
available	JJ	O
.	.	O

by	IN	O
report	NN	O
,	,	O
the	DT	O
patient	NN	O
has	VBZ	O
an	DT	B-TEST
outside	JJ	I-TEST
study	NN	I-TEST
.	.	O

should	MD	O
this	DT	O
become	NN	O
available	JJ	O
,	,	O
an	DT	O
addendum	NN	O
will	MD	O
be	VB	O
issued	VBN	O
to	TO	O
this	DT	O
report	NN	O
following	VBG	O
the	DT	O
comparison	NN	O
with	IN	O
the	DT	B-TEST
outside	JJ	I-TEST
examination	NN	I-TEST
.	.	O

note	NN	O
:	:	O
this	DT	B-TEST
study	NN	I-TEST
was	VBD	O
initially	RB	O
performed	VBN	O
on	IN	O
the	DT	O
morning	NN	O
of	IN	O
10-21	JJ	O
,	,	O
and	CC	O
is	VBZ	O
being	VBG	O
dictated	VBN	O
on	IN	O
the	DT	O
morning	NN	O
of	IN	O
10-22	NNS	O
due	JJ	O
to	TO	O
pacs	VB	O
malfunction	NN	O
.	.	O

non-contrast	JJ	B-TEST
head	NN	I-TEST
ct	NN	I-TEST
:	:	O
there	EX	O
is	VBZ	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
amount	NN	I-PROBLEM
of	IN	I-PROBLEM
hemorrhage	NN	I-PROBLEM
within	IN	O
the	DT	O
occipital	JJ	O
horns	NNS	O
of	IN	O
both	DT	O
lateral	JJ	O
ventricles	NNS	O
,	,	O
right	RB	O
greater	JJR	O
than	IN	O
left	NN	O
.	.	O

located	VBN	O
within	IN	O
the	DT	O
atrium	NN	O
of	IN	O
the	DT	O
right	JJ	O
lateral	JJ	O
ventricle	NN	O
is	VBZ	O
an	DT	B-PROBLEM
18	CD	I-PROBLEM
x	NN	I-PROBLEM
10	CD	I-PROBLEM
mm	NN	I-PROBLEM
nodular	JJ	I-PROBLEM
area	NN	I-PROBLEM
of	IN	I-PROBLEM
increased	VBN	I-PROBLEM
density	NN	I-PROBLEM
which	WDT	O
is	VBZ	O
separate	JJ	O
from	IN	O
the	DT	O
choroid	NN	O
plexus	NN	O
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
evidence	NN	O
of	IN	O
surrounding	VBG	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
diffuse	NN	B-PROBLEM
brain	NN	I-PROBLEM
atrophy	NN	I-PROBLEM
and	CC	O
chronic	JJ	B-PROBLEM
microvascular	NN	I-PROBLEM
infarction	NN	I-PROBLEM
throughout	IN	I-PROBLEM
the	DT	I-PROBLEM
white	JJ	I-PROBLEM
matter	NN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
a	DT	B-PROBLEM
remote	JJ	I-PROBLEM
right	JJ	I-PROBLEM
frontal	NN	I-PROBLEM
infarct	NN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
evidence	NN	O
of	IN	O
subarachnoid	JJ	B-PROBLEM
hemorrhage	NN	I-PROBLEM
or	CC	O
acute	JJ	B-PROBLEM
major	JJ	I-PROBLEM
vascular	JJ	I-PROBLEM
territorial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

the	DT	O
ventricles	NNS	O
do	VBP	O
not	RB	O
appear	VB	O
dilated	JJ	O
relative	NN	O
to	TO	O
the	DT	O
sulci	NN	O
,	,	O
and	CC	O
there	EX	O
is	VBZ	O
no	DT	O
shift	NN	B-PROBLEM
of	IN	I-PROBLEM
normally	RB	I-PROBLEM
midline	JJ	I-PROBLEM
structures	NNS	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
skull	JJ	B-PROBLEM
fracture	NN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
opacification	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
posterior	JJ	I-PROBLEM
nasal	JJ	I-PROBLEM
cavity	NN	I-PROBLEM
and	CC	I-PROBLEM
nasopharynx	NN	I-PROBLEM
but	CC	O
an	DT	B-TREATMENT
ng	JJ	I-TREATMENT
tube	NN	I-TREATMENT
is	VBZ	O
present	JJ	O
,	,	O
and	CC	O
the	DT	O
patient	NN	O
is	VBZ	O
intubated	VBN	O
.	.	O

opacified	VBN	B-PROBLEM
and	CC	I-PROBLEM
sclerotic	JJ	I-PROBLEM
left	NN	I-PROBLEM
mastoid	NN	I-PROBLEM
air	NN	I-PROBLEM
cells	NNS	I-PROBLEM
are	VBP	O
noted	VBN	O
.	.	O

1.	CD	O
small	JJ	O
amount	NN	O
of	IN	O
intraventricular	JJ	B-PROBLEM
hemorrhage	NN	I-PROBLEM
.	.	O

2.	CD	O
ovoid	JJ	B-PROBLEM
18	CD	I-PROBLEM
-	:	I-PROBLEM
mm	NN	I-PROBLEM
density	NN	I-PROBLEM
within	IN	I-PROBLEM
the	DT	I-PROBLEM
atrium	NN	I-PROBLEM
of	IN	O
the	DT	O
right	JJ	O
lateral	JJ	O
ventricle	NN	O
.	.	O

this	DT	O
could	MD	O
represent	VB	O
either	CC	O
an	DT	B-PROBLEM
atypically	RB	I-PROBLEM
located	VBN	I-PROBLEM
blood	NN	I-PROBLEM
clot	NN	I-PROBLEM
or	CC	O
an	DT	B-PROBLEM
intraventricular	JJ	I-PROBLEM
mass	NN	I-PROBLEM
,	,	O
and	CC	O
further	JJ	O
evaluation	NN	O
with	IN	O
contrast	NN	B-TEST
-	:	I-TEST
enhanced	JJ	I-TEST
mri	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
brain	NN	I-TEST
,	,	O
when	WRB	O
clinically	RB	O
feasible	JJ	O
,	,	O
is	VBZ	O
recommended	VBN	O
.	.	O

ct	JJ	B-TEST
head	NN	I-TEST
w/o	NN	I-TEST
contrast	NN	I-TEST

ct	JJ	B-TEST
head	NN	I-TEST
w/o	NN	I-TEST
contrast	NN	I-TEST

reason	NN	O
:	:	O
altered	VBN	B-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM

altered	VBN	B-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM

indication	NN	O
:	:	O
72-year-old	JJ	O
male	NN	O
with	IN	O
altered	JJ	B-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
.	.	O

technique	NN	O
:	:	O
axial	JJ	B-TEST
noncontrast	NN	I-TEST
ct	NN	I-TEST
scans	NNS	I-TEST
of	IN	I-TEST
the	DT	I-TEST
brain	NN	I-TEST
were	VBD	O
obtained	VBN	O
.	.	O

comparison	NN	O
is	VBZ	O
made	VBN	O
to	TO	O
a	DT	B-TEST
previous	JJ	I-TEST
study	NN	I-TEST
from	IN	O
2014-10-27	JJ	O
.	.	O

there	EX	O
are	VBP	O
numerous	JJ	O
areas	NNS	O
of	IN	O
decreased	JJ	B-PROBLEM
attenuation	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
periventricular	NN	I-PROBLEM
and	CC	I-PROBLEM
subcortical	JJ	I-PROBLEM
white	JJ	I-PROBLEM
matter	NN	I-PROBLEM
of	IN	O
both	DT	O
cerebral	JJ	O
hemispheres	NNS	O
,	,	O
indicating	VBG	O
chronic	JJ	B-PROBLEM
microvascular	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
also	RB	O
an	DT	B-PROBLEM
old	JJ	I-PROBLEM
right	JJ	I-PROBLEM
frontal	NN	I-PROBLEM
lobe	NN	I-PROBLEM
cortical	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

a	DT	B-PROBLEM
small	JJ	I-PROBLEM
right	JJ	I-PROBLEM
occipital	JJ	I-PROBLEM
lobe	NN	I-PROBLEM
chronic	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
is	VBZ	O
also	RB	O
evident	JJ	O
.	.	O

there	EX	O
is	VBZ	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
amount	NN	I-PROBLEM
of	IN	I-PROBLEM
blood	NN	I-PROBLEM
layering	NN	I-PROBLEM
in	IN	I-PROBLEM
both	DT	I-PROBLEM
lateral	JJ	I-PROBLEM
ventricles	NNS	I-PROBLEM
,	,	O
and	CC	O
this	DT	O
has	VBZ	O
decreased	VBN	O
since	IN	O
the	DT	B-TEST
previous	JJ	I-TEST
study	NN	I-TEST
.	.	O

no	DT	O
new	JJ	B-PROBLEM
hemorrhage	NN	I-PROBLEM
is	VBZ	O
observed	VBN	O
.	.	O

there	EX	O
is	VBZ	O
opacification	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
mastoid	JJ	I-PROBLEM
air	NN	I-PROBLEM
cells	NNS	I-PROBLEM
,	,	O
greater	JJR	O
on	IN	O
the	DT	O
left	NN	O
than	IN	O
the	DT	O
right	NN	O
.	.	O

there	EX	O
is	VBZ	O
some	DT	B-PROBLEM
fluid	NN	I-PROBLEM
or	CC	O
mucosal	NN	B-PROBLEM
thickening	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
ethmoid	NN	I-PROBLEM
and	CC	I-PROBLEM
sphenoid	JJ	I-PROBLEM
sinuses	NNS	I-PROBLEM
.	.	O

impression	NN	O
:	:	O
no	DT	O
new	JJ	B-PROBLEM
cortical	JJ	I-PROBLEM
territorial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
or	CC	O
hemorrhage	NN	B-PROBLEM
is	VBZ	O
identified	VBN	O
.	.	O

there	EX	O
is	VBZ	O
decreased	JJ	B-PROBLEM
intraventricular	JJ	I-PROBLEM
blood	NN	I-PROBLEM
,	,	O
compared	VBN	O
to	TO	O
the	DT	B-TEST
previous	JJ	I-TEST
study	NN	I-TEST
,	,	O
and	CC	O
there	EX	O
are	VBP	O
no	DT	O
signs	NNS	O
of	IN	O
hydrocephalus	NN	B-PROBLEM
.	.	O

chest	NN	B-TEST
(	(	I-TEST
portable	JJ	I-TEST
ap	NN	I-TEST
)	)	I-TEST

chest	NN	B-TEST
(	(	I-TEST
portable	JJ	I-TEST
ap	NN	I-TEST
)	)	I-TEST

reason	NN	O
:	:	O
fever	NN	B-PROBLEM
,	,	O
f/u	NN	O
infiltrte	NN	B-PROBLEM

72	CD	O
yo	NNS	O
m	NN	O
with	IN	O
rib	NN	B-PROBLEM
fx	NN	I-PROBLEM
s/p	NN	O
trauma	NN	B-PROBLEM
,	,	O
failure	NN	O
on	IN	O
previous	JJ	B-TEST
cxr	NNS	I-TEST
,	,	O
now	RB	O
with	IN	O
fever	NN	B-PROBLEM
.	.	O

fever	NN	B-PROBLEM
,	,	O
f/u	NN	O
infiltrte	NN	B-PROBLEM

history	NN	O
:	:	O
trauma	NN	B-PROBLEM
,	,	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
,	,	O
fever	NN	B-PROBLEM
,	,	O
pneumonia	NN	B-PROBLEM
.	.	O

portable	JJ	B-TEST
supine	NN	I-TEST
chest	NN	I-TEST
radiograph	NN	I-TEST
shows	VBZ	O
improvement	NN	O
in	IN	O
edema	NN	B-PROBLEM
compared	VBN	O
to	TO	O
studies	NNS	B-TEST
from	IN	O
four	CD	O
and	CC	O
five	CD	O
days	NNS	O
earlier	RBR	O
with	IN	O
no	DT	O
significant	JJ	B-PROBLEM
radiographic	JJ	I-PROBLEM
change	NN	I-PROBLEM
in	IN	O
right	JJ	B-PROBLEM
upper	JJ	I-PROBLEM
lobe	NN	I-PROBLEM
consolidation	NN	I-PROBLEM
consistent	NN	O
with	IN	O
pneumonia	NN	B-PROBLEM
.	.	O

some	DT	B-PROBLEM
interstitial	JJ	I-PROBLEM
edema	NN	I-PROBLEM
still	RB	O
persists	VBZ	O
,	,	O
but	CC	O
there	EX	O
is	VBZ	O
no	DT	O
central	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
vascular	JJ	I-PROBLEM
congestion	NN	I-PROBLEM
.	.	O

cardiac	JJ	B-TEST
size	NN	I-TEST
is	VBZ	O
unchanged	JJ	O
.	.	O

the	DT	O
amount	NN	O
of	IN	O
fluid	NN	B-PROBLEM
layering	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
apices	NNS	I-PROBLEM
and	CC	I-PROBLEM
the	DT	I-PROBLEM
pleural	JJ	I-PROBLEM
spaces	NNS	I-PROBLEM
appear	VBP	O
slightly	RB	O
decreased	VBN	O
.	.	O

multiple	JJ	B-PROBLEM
left-sided	JJ	I-PROBLEM
rib	NN	I-PROBLEM
fractures	NNS	I-PROBLEM
are	VBP	O
seen	VBN	O
.	.	O

supporting	VBG	B-TREATMENT
tubes	NNS	I-TREATMENT
and	CC	I-TREATMENT
lines	NNS	I-TREATMENT
are	VBP	O
in	IN	O
unchanged	JJ	O
position	NN	O
and	CC	O
the	DT	O
patient	NN	O
has	VBZ	O
a	DT	B-TREATMENT
single	JJ	I-TREATMENT
lead	NN	I-TREATMENT
pacemaker	NN	I-TREATMENT
projected	VBN	O
on	IN	O
the	DT	O
left	NN	O
.	.	O

calcification	NN	B-PROBLEM
is	VBZ	O
seen	VBN	O
at	IN	O
both	DT	O
carotid	JJ	O
bifurcations	NNS	O
.	.	O

conclusion	NN	O
:	:	O
improvement	NN	O
in	IN	O
congestion	NN	B-PROBLEM
from	IN	O
edema	NN	B-PROBLEM
with	IN	O
no	DT	O
worsening	NN	O
,	,	O
but	CC	O
no	DT	O
significant	JJ	O
improvement	NN	O
,	,	O
in	IN	O
the	DT	B-PROBLEM
right	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
lobe	NN	I-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

supporting	VBG	B-TREATMENT
lines	NNS	I-TREATMENT
and	CC	I-TREATMENT
tubes	NNS	I-TREATMENT
in	IN	O
unchanged	JJ	O
position	NN	O
.	.	O

admitted	VBN	O
to	TO	O
tsicu	VB	O
for	IN	O
subarachnoid	JJ	B-PROBLEM
hemorrhage	NN	I-PROBLEM
and	CC	O
multiple	JJ	B-PROBLEM
spinal	JJ	I-PROBLEM
fractures	NNS	I-PROBLEM
.	.	O

intubated	VBN	B-TREATMENT
and	CC	O
sedated	VBN	B-TREATMENT
for	IN	O
desats	NNS	B-PROBLEM
on	IN	O
2014-10-27	JJ	O
.	.	O

ct	JJ	B-TEST
head	NN	I-TEST
remained	VBD	O
stable	JJ	O
for	IN	O
sah	NN	B-PROBLEM
.	.	O

evaluated	VBN	O
by	IN	O
orthopedic	JJ	O
spine	JJ	O
surgeons	NNS	O
with	IN	O
recommendations	NNS	O
for	IN	O
soft	JJ	B-TREATMENT
c-collar	JJ	I-TREATMENT
for	IN	O
comfort	NN	O
.	.	O

in	IN	O
tsicu	NN	O
,	,	O
developed	VBD	O
mrsa	VB	B-PROBLEM
pneumonia	NN	I-PROBLEM
with	IN	O
question	NN	O
of	IN	O
aspiration	NN	B-PROBLEM
,	,	O
treated	VBD	O
zosyn	NN	B-TREATMENT
-->	NNP	O
vanc	NN	B-TREATMENT
/	NNP	O
levo	VBZ	B-TREATMENT
-->	NNP	O
then	RB	O
2	CD	O
week	NN	O
course	NN	O
of	IN	O
linazolid	JJ	B-TREATMENT
with	IN	O
resolution	NN	O
of	IN	O
fevers	NNS	B-PROBLEM
and	CC	O
decreased	VBD	B-PROBLEM
pulmonary	JJ	I-PROBLEM
secretions	NNS	I-PROBLEM
.	.	O

2014-11-11	JJ	O
:	:	O
tracheostomy	NN	B-TREATMENT
performed	VBD	O
without	IN	O
complication	NN	B-PROBLEM
.	.	O

patient	NN	O
tolerated	VBD	O
decreasing	VBG	B-TREATMENT
ventillary	JJ	I-TREATMENT
support.	NN	I-TREATMENT

mental	JJ	O
status	NN	O
improved	VBN	O
with	IN	O
the	DT	O
discontinuation	NN	O
of	IN	O
his	PRP$	B-TREATMENT
bensodiazapines	NNS	I-TREATMENT
.	.	O

failed	VBD	B-PROBLEM
swallow	NN	I-PROBLEM
study	NN	I-PROBLEM
x	VBD	O
2	CD	O
in	IN	O
early	JJ	O
november	NN	O
.	.	O

decision	NN	O
to	TO	O
continue	VB	O
dobhoff	NN	B-TREATMENT
at	IN	O
rehab	NN	O
given	VBN	O
continued	JJ	O
clinical	JJ	O
improvement	NN	O
and	CC	O
his	PRP$	O
poor	JJ	O
candidacy	NN	O
for	IN	O
g/j	NN	B-TREATMENT
tube	NN	I-TREATMENT
.	.	O

communicating	NN	O
by	IN	O
speech	NN	O
s/p	NN	O
pmv	NN	B-TREATMENT
placement	NN	I-TREATMENT
.	.	O

occasionally	RB	O
required	VBN	O
haldol	NN	B-TREATMENT
/	NN	O
ativan	NN	B-TREATMENT
at	IN	O
night	NN	O
for	IN	O
agitation	NN	B-PROBLEM
.	.	O

progressed	VBN	O
adequately	RB	O
with	IN	O
physical	JJ	B-TREATMENT
/	NNP	I-TREATMENT
occupational	JJ	I-TREATMENT
therapy	NN	I-TREATMENT
,	,	O
however	RB	O
was	VBD	O
noted	VBN	O
to	TO	O
develop	VB	O
an	DT	B-PROBLEM
early	JJ	I-PROBLEM
bilateral	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
extermity	NN	I-PROBLEM
contracture	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
elbows	NNS	I-PROBLEM
and	CC	I-PROBLEM
wrists	NNS	I-PROBLEM
.	.	O

serial	JJ	B-TEST
ct	NN	I-TEST
head	NN	I-TEST
revealed	VBD	O
decreased	JJ	B-PROBLEM
blood	NN	I-PROBLEM
through	IN	O
2014-11-14	JJ	O
.	.	O

1.	CD	O
heparin	NN	B-TREATMENT
(	(	I-TREATMENT
porcine	NN	I-TREATMENT
)	)	I-TREATMENT
5,000	CD	O
unit/ml	JJ	O
solution	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
injection	NN	O
tid	NN	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

2.	CD	O
lisinopril	JJ	B-TREATMENT
15	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

3.	CD	O
lansoprazole	JJ	B-TREATMENT
30	CD	O
mg	NN	O
susp	NN	O
,	,	O
delayed	JJ	O
release	NN	O
for	IN	O
recon	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
po	NN	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

4.	CD	O
linezolid	JJ	B-TREATMENT
600	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
q12h	NN	O
(	(	O
every	DT	O
12	CD	O
hours	NNS	O
):	VBN	O
last	JJ	O
dose	JJ	O
2014-11-20	JJ	O
.	.	O

5.	CD	O
metoprolol	JJ	B-TREATMENT
tartrate	NN	I-TREATMENT
25	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
tid	NN	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

6.	CD	O
digoxin	NN	B-TREATMENT
125	CD	O
mcg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

7.	CD	O
docusate	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
150	CD	O
mg	NN	O
/	VBD	O
15	CD	O
ml	NN	O
liquid	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

8.	CD	O
bisacodyl	NN	B-TREATMENT
5	CD	O
mg	NN	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
daily	JJ	O
(	(	O
daily	RB	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
constipation	NN	B-PROBLEM
.	.	O

9.	CD	O
magnesium	NN	B-TREATMENT
hydroxide	NN	I-TREATMENT
400	CD	O
mg	NN	O
/	VBD	O
5	CD	O
ml	JJ	O
suspension	NN	O
sig	NN	O
:	:	O
thirty	NN	O
(	(	O
30	CD	O
)	)	O
ml	NN	O
po	NN	O
q6h	NN	O
(	(	O
every	DT	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
consitpation	NN	B-PROBLEM
.	.	O

subarachnoid	JJ	B-PROBLEM
hemorrhage	NN	I-PROBLEM
w/	JJ	O
bilateral	JJ	B-PROBLEM
intraventricular	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM

left	VBN	B-PROBLEM
t1	JJ	I-PROBLEM
transverse	NN	I-PROBLEM
process	NN	I-PROBLEM
fracture	NN	I-PROBLEM

c7	NN	B-PROBLEM
&	CC	I-PROBLEM
t1	NN	I-PROBLEM
mimimally	RB	I-PROBLEM
displaced	VBD	I-PROBLEM
transverse	JJ	I-PROBLEM
process	NN	I-PROBLEM
fracture	NN	I-PROBLEM

left	VBN	B-PROBLEM
rib	JJ	I-PROBLEM
fractures	NNS	I-PROBLEM
05-22	JJ	O

you	PRP	O
must	MD	O
continue	VB	O
to	TO	O
wear	VB	O
your	PRP$	B-TREATMENT
cervical	JJ	I-TREATMENT
collar	NN	I-TREATMENT
for	IN	O
the	DT	O
next	JJ	O
4	CD	O
weeks	NNS	O
(	(	O
through	IN	O
12-11	CD	O
).	NNS	O

surgery	NN	B-TREATMENT

sulfa	NN	B-TREATMENT
(	(	I-TREATMENT
sulfonamides	NNS	I-TREATMENT
)	)	I-TREATMENT
/	VBP	O
penicillins	NNS	B-TREATMENT

2015-10-27	JJ	O
open	JJ	B-TREATMENT
reduction	NN	I-TREATMENT
and	CC	O
internal	JJ	B-TREATMENT
fixation	NN	I-TREATMENT
of	IN	O
right	JJ	B-PROBLEM
tib/fib	NN	I-PROBLEM
fractures	NNS	I-PROBLEM

17	CD	O
yo	JJ	O
male	JJ	O
pedestrian	NN	O
who	WP	O
was	VBD	O
struck	VBN	O
by	IN	O
auto	NN	O
at	IN	O
unknown	JJ	O
speed	NN	O
;	:	O
+loc	NNP	B-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
medflighted	VBN	O
to	TO	O
the	DT	O
hospital	NN	O
for	IN	O
orthopedics	NNS	O
for	IN	O
ongoing	VBG	B-TREATMENT
trauma	NN	I-TREATMENT
care	NN	I-TREATMENT
.	.	O

upon	IN	O
arrival	JJ	O
gcs	NN	B-TEST
15	CD	O
,	,	O
alert	NN	O
and	CC	O
oriented	VBN	O
x3	NN	O
.	.	O

attention	NN	B-PROBLEM
deficit	NN	I-PROBLEM
disorder	NN	I-PROBLEM
(	(	O
diagnosed	VBN	O
@	RB	O
14	CD	O
yrs	NN	O
of	IN	O
age	NN	O
)	)	O

glucose	JJ	B-TEST
-	:	O
101	CD	O
lactate	JJ	B-TEST
-	:	O
2.9	CD	O
*	NN	O
na+	SYM	B-TEST
-	:	O
142	CD	O
k+	SYM	B-TEST
-	:	O
3.6	CD	O
cl-	JJ	B-TEST
-	:	O
102	CD	O
tco2	SYM	B-TEST
-	:	O
26	CD	O

urea	JJ	B-TEST
n	SYM	I-TEST
-	:	O
12	CD	O
creat	NN	B-TEST
-	:	O
1.0	CD	O

amylase	NN	B-TEST
-	:	O
44	CD	O

asa	SYM	B-TEST
-	:	O
neg	NN	O
ethanol	SYM	B-TEST
-	:	O
neg	NN	O
acetmnphn	SYM	B-TEST
-	:	O
neg	NN	O
bnzodzpn	SYM	B-TEST
-	:	O
neg	NN	O
barbitrt	SYM	B-TEST
-	:	O
neg	JJ	O
tricyclic	JJ	B-TEST
-	:	O
neg	NN	O

wbc	SYM	B-TEST
-	:	O
16.0	CD	O
*	NN	O
rbc	NN	B-TEST
-	:	O
4.89	CD	O
hgb	NN	B-TEST
-	:	O
14.5	CD	O
hct	NN	B-TEST
-	:	O
40.4	CD	O
mcv	SYM	B-TEST
-	:	O
83	CD	O
mch	SYM	B-TEST
-	:	O
29.7	CD	O
mchc	SYM	B-TEST
-	:	O
35.9	CD	O
*	NN	O
rdw	NN	B-TEST
-	:	O
13.4	CD	O

plt	NN	B-TEST
count	NN	I-TEST
-	:	O
247	CD	O

pt	SYM	B-TEST
-	:	O
12.7	CD	O
ptt	NN	B-TEST
-	:	O
23.8	CD	O
inr(pt)	JJ	B-TEST
-	:	O
1.1	CD	O

ct	JJ	B-TEST
head	NN	I-TEST
w/o	NN	I-TEST
contrast	NN	I-TEST

eval	NN	B-TEST
for	IN	O
bleed	NN	B-PROBLEM

technique	NN	O
:	:	O
axial	JJ	B-TEST
mdct	NN	I-TEST
images	NNS	I-TEST
of	IN	I-TEST
the	DT	I-TEST
brain	NN	I-TEST
without	IN	O
iv	JJ	O
contrast	NN	O
.	.	O

findings	NNS	O
:	:	O
there	EX	O
is	VBZ	O
a	DT	B-PROBLEM
linear	JJ	I-PROBLEM
nondepressed	JJ	I-PROBLEM
right	JJ	I-PROBLEM
temporal	JJ	I-PROBLEM
calvarial	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
extending	VBG	O
into	IN	O
the	DT	O
mastoid	JJ	O
process	NN	O
.	.	O

there	EX	O
is	VBZ	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
subdural	JJ	I-PROBLEM
hematoma	NN	I-PROBLEM
with	IN	O
components	NNS	O
of	IN	O
pneumocephalus	JJ	B-PROBLEM
tracking	VBG	O
from	IN	O
the	DT	O
mastoid	NN	O
air	NN	O
cells	NNS	O
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
shift	NN	B-PROBLEM
of	IN	I-PROBLEM
normally	RB	I-PROBLEM
midline	JJ	I-PROBLEM
structures	NNS	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
also	RB	O
a	DT	B-PROBLEM
left	JJ	I-PROBLEM
occipital	JJ	I-PROBLEM
scalp	JJ	I-PROBLEM
contusion	NN	I-PROBLEM
but	CC	O
no	DT	O
associated	JJ	B-PROBLEM
skull	NN	I-PROBLEM
fracture	NN	I-PROBLEM
.	.	O

prominent	JJ	B-TREATMENT
sutures	NNS	I-TREATMENT
in	IN	O
this	DT	O
young	JJ	O
patient	NN	O
,	,	O
the	DT	B-TREATMENT
right	JJ	I-TREATMENT
calvarial	JJ	I-TREATMENT
suture	NN	I-TREATMENT
extending	VBG	O
into	IN	O
the	DT	O
right	JJ	O
temporal	JJ	O
bones	NNS	O
appears	VBZ	O
more	JJR	O
prominent	JJ	O
than	IN	O
its	PRP$	O
counterpart	NN	O
on	IN	O
the	DT	O
left	NN	O
,	,	O
however	RB	O
,	,	O
does	VBZ	O
not	RB	O
appear	VB	O
to	TO	O
represent	VB	O
an	DT	B-PROBLEM
acute	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
.	.	O

no	DT	O
other	JJ	B-PROBLEM
acute	NN	I-PROBLEM
fractures	NNS	I-PROBLEM
are	VBP	O
appreciated	VBN	O
.	.	O

there	EX	O
is	VBZ	O
small	JJ	O
amount	NN	O
of	IN	O
mucosal	NN	B-PROBLEM
thickening	VBG	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
sphenoid	NN	I-PROBLEM
sinuses	VBZ	I-PROBLEM
.	.	O

no	DT	O
air-fluid	JJ	B-TEST
levels	NNS	I-TEST
to	TO	O
suggest	VB	O
occult	NN	B-PROBLEM
facial	JJ	I-PROBLEM
fractures	NNS	I-PROBLEM
.	.	O

impression	NN	O
:	:	O
linear	JJ	B-PROBLEM
right	JJ	I-PROBLEM
temporal	JJ	I-PROBLEM
calvarial	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
extending	VBG	O
into	IN	O
the	DT	O
mastoid	JJ	O
process	NN	O
with	IN	O
small	JJ	B-PROBLEM
associated	VBN	I-PROBLEM
right	JJ	I-PROBLEM
posterior	NN	I-PROBLEM
convexity	NN	I-PROBLEM
subdural	JJ	I-PROBLEM
hematoma	NN	I-PROBLEM
and	CC	O
pneumocephalus	NN	B-PROBLEM
.	.	O

discussed	VBN	O
with	IN	O
trauma	JJ	O
team	NN	O
during	IN	O
the	DT	B-TEST
study	NN	I-TEST
.	.	O

ct	JJ	B-TEST
c-spine	JJ	I-TEST
w/o	NN	O
contrast	NN	O

eval	NN	B-TEST
for	IN	O
fx	NN	B-PROBLEM

head	NN	B-PROBLEM
injury	NN	I-PROBLEM
to	TO	I-PROBLEM
the	DT	I-PROBLEM
occiput	NN	I-PROBLEM
.	.	O

technique	NN	O
:	:	O
axial	JJ	B-TEST
mdct	NN	I-TEST
images	NNS	I-TEST
of	IN	I-TEST
the	DT	I-TEST
cervical	JJ	I-TEST
spine	NN	I-TEST
with	IN	O
coronal	JJ	O
and	CC	O
sagittal	JJ	O
reformats	NNS	O
without	IN	O
iv	JJ	O
contrast	NN	O
.	.	O

there	EX	O
is	VBZ	O
normal	JJ	O
alignment	NN	O
of	IN	O
the	DT	O
cervical	JJ	O
vertebral	JJ	O
bodies	NNS	O
without	IN	O
acute	JJ	B-PROBLEM
fracture	NN	I-PROBLEM
or	CC	O
traumatic	JJ	B-PROBLEM
malalignment	NN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
significant	JJ	B-PROBLEM
prevertebral	JJ	I-PROBLEM
soft	JJ	I-PROBLEM
tissue	NN	I-PROBLEM
swelling	VBG	I-PROBLEM
.	.	O

the	DT	O
lung	NN	O
apices	NNS	O
are	VBP	O
clear	JJ	O
without	IN	O
pneumothorax	NN	B-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
a	DT	B-PROBLEM
linear	JJ	I-PROBLEM
right	JJ	I-PROBLEM
temporal	JJ	I-PROBLEM
calvarial	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
extending	VBG	O
into	IN	O
the	DT	O
right	JJ	O
temporal	JJ	O
bones	NNS	O
.	.	O

multiple	JJ	O
posterior	RB	O
right	JJ	O
-	:	O
sided	VBN	O
mastoid	JJ	O
air	NN	O
cells	NNS	O
are	VBP	O
opacified	VBN	B-PROBLEM
with	IN	I-PROBLEM
blood	NN	I-PROBLEM
.	.	O

1)	CD	O
no	DT	O
acute	JJ	B-PROBLEM
cervical	JJ	I-PROBLEM
spine	NN	I-PROBLEM
fracture	NN	I-PROBLEM
.	.	O

2)	CD	O
linear	JJ	B-PROBLEM
right	JJ	I-PROBLEM
temporal	JJ	I-PROBLEM
calvarial	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
extending	VBG	O
into	IN	O
the	DT	O
mastoid	NN	O
with	IN	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
right	JJ	I-PROBLEM
posterior	NN	I-PROBLEM
convexity	NN	I-PROBLEM
subdural	JJ	I-PROBLEM
hematoma	NN	I-PROBLEM
and	CC	O
pneumocephalus	NN	B-PROBLEM
;	:	O
see	VB	O
head	JJ	B-TEST
ct	JJ	I-TEST
report	NN	O
.	.	O

chest	NN	B-TEST
(	(	I-TEST
pa	JJ	I-TEST
&	CC	I-TEST
lat	NN	I-TEST
)	)	I-TEST

reason	NN	O
:	:	O
please	NN	O
r/o	VB	O
acute	JJ	B-PROBLEM
process	NN	I-PROBLEM
.	.	O

17	CD	O
year	NN	O
old	JJ	O
man	NN	O
with	IN	O
post-op	JJ	B-PROBLEM
fever	NN	I-PROBLEM
.	.	O

please	VB	O
r/o	JJ	O
acute	JJ	B-PROBLEM
process	NN	I-PROBLEM
.	.	O

indication	NN	O
:	:	O
postoperative	JJ	B-PROBLEM
fever	NN	I-PROBLEM
.	.	O

technique	NN	O
:	:	O
pa	NN	B-TEST
and	CC	I-TEST
lateral	JJ	I-TEST
views	NNS	I-TEST
of	IN	I-TEST
the	DT	I-TEST
chest	NN	I-TEST
.	.	O

there	EX	O
are	VBP	O
no	DT	O
pleural	JJ	B-PROBLEM
effusions	NNS	I-PROBLEM
or	CC	O
focal	JJ	B-PROBLEM
consolidations	NNS	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
evidence	NN	O
of	IN	O
chf	NN	B-PROBLEM
.	.	O

impression	NN	O
:	:	O
no	DT	O
evidence	NN	O
of	IN	O
significant	JJ	B-PROBLEM
abnormality	NN	I-PROBLEM
.	.	O

tib	NN	B-TEST
/	NN	I-TEST
fib	NN	I-TEST
(	(	I-TEST
ap	JJ	I-TEST
&	CC	I-TEST
lat	JJ	I-TEST
)	)	I-TEST
soft	JJ	O
tissue	NN	O

reason	NN	O
:	:	O
eval	NN	B-TEST
for	IN	I-TEST
alignment	NN	I-TEST
,	,	I-TEST
post	NN	I-TEST
op	NN	I-TEST
changes	NNS	I-TEST

56	CD	O
year	NN	O
old	JJ	O
man	NN	O
with	IN	O
open	JJ	B-PROBLEM
rle	NNS	I-PROBLEM
fx	RB	I-PROBLEM
now	RB	O
s/p	VBZ	B-TREATMENT
fixation	NN	I-TREATMENT

eval	NN	B-TEST
for	IN	I-TEST
alignment	NN	I-TEST
,	,	I-TEST
post	NN	I-TEST
op	NN	I-TEST
changes	NNS	I-TEST

indication	NN	O
:	:	O
fracture	NN	B-PROBLEM
.	.	O
assess	NN	O
for	IN	O
alignment	NN	O
.	.	O

right	RB	B-TEST
tibia	NN	I-TEST
/	NNP	I-TEST
fibula	NN	I-TEST
,	,	I-TEST
ap	NN	I-TEST
and	CC	I-TEST
lateral	JJ	I-TEST
views	NNS	I-TEST
:	:	O
an	DT	B-TREATMENT
intramedullary	JJ	I-TREATMENT
rod	NN	I-TREATMENT
is	VBZ	O
seen	VBN	O
fixating	VBG	O
a	DT	B-PROBLEM
proximal	JJ	I-PROBLEM
diaphyseal	NN	I-PROBLEM
comminuted	VBN	I-PROBLEM
tibial	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
with	IN	O
six	CD	B-TREATMENT
proximal	JJ	I-TREATMENT
and	CC	I-TREATMENT
two	CD	I-TREATMENT
distal	JJ	I-TREATMENT
screws	NNS	I-TREATMENT
.	.	O

additionally	RB	O
,	,	O
a	DT	B-TREATMENT
side	NN	I-TREATMENT
plate	NN	I-TREATMENT
is	VBZ	O
seen	VBN	O
medially	RB	O
fixating	VBG	O
the	DT	B-PROBLEM
fracture	NN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
a	DT	B-PROBLEM
non-displaced	JJ	I-PROBLEM
comminuted	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
proximal	JJ	I-PROBLEM
fibular	JJ	I-PROBLEM
diaphysis	NN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
surrounding	VBG	O
soft	JJ	B-PROBLEM
tissue	NN	I-PROBLEM
swelling	VBG	I-PROBLEM
.	.	O

impression	NN	O
:	:	O
comminuted	VBN	B-PROBLEM
proximal	JJ	I-PROBLEM
tibiofibular	JJ	I-PROBLEM
fractures	NNS	I-PROBLEM
status	NN	B-TREATMENT
post	NN	I-TREATMENT
orif	NN	I-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
tibia	NN	I-TREATMENT
with	IN	O
an	DT	B-TREATMENT
intramedullary	JJ	I-TREATMENT
rod	NN	I-TREATMENT
and	CC	I-TREATMENT
side	NN	I-TREATMENT
plate	NN	I-TREATMENT
.	.	O

no	DT	O
evidence	NN	O
of	IN	O
immediate	JJ	B-PROBLEM
hardware	NN	I-PROBLEM
complication	NN	I-PROBLEM
.	.	O

ct	JJ	B-TEST
head	NN	I-TEST
w/o	NN	O
contrast	NN	O

reason	NN	O
:	:	O
follow	VB	B-TEST
up	RP	I-TEST
ct	NN	I-TEST

17	CD	O
year	NN	O
old	JJ	O
man	NN	O
with	IN	O
pneumocephalus	JJ	B-PROBLEM
s/p	NN	O
cmed	VBD	O
ccu	JJ	O
v.	NN	O
mvc	NN	O

follow	VB	B-TEST
up	RP	I-TEST
ct	NN	I-TEST

clinical	JJ	O
history	NN	O
:	:	O
history	NN	O
of	IN	O
pneumocephalus	NN	B-PROBLEM
status	NN	O
post	NN	O
pedestrian	JJ	O
versus	NN	O
motor	NN	O
vehicle	NN	O
collision	NN	O
.	.	O

follow	VB	B-TEST
up	RP	I-TEST
ct	JJ	I-TEST
scan	NN	I-TEST
.	.	O

comparison	NN	O
:	:	O
non-contrast	JJ	B-TEST
head	NN	I-TEST
ct	NN	I-TEST
from	IN	O
2015-10-27	JJ	O
.	.	O

technique	NN	O
:	:	O
non-contrast	JJ	B-TEST
head	NN	I-TEST
ct	NN	I-TEST
.	.	O

findings	NNS	O
:	:	O
the	DT	O
previously	RB	O
noted	VBN	O
subdural	JJ	B-PROBLEM
hemorrhage	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
posterior	NN	I-PROBLEM
fossa	NN	I-PROBLEM
appears	VBZ	O
less	RBR	O
conspicuous	JJ	O
.	.	O

the	DT	O
pneumocephalus	JJ	B-PROBLEM
adjacent	NN	O
to	TO	O
the	DT	B-PROBLEM
linear	JJ	I-PROBLEM
skull	NN	I-PROBLEM
fracture	NN	I-PROBLEM
appears	VBZ	O
to	TO	O
have	VB	O
decreased	VBN	O
in	IN	O
size	NN	O
.	.	O

there	EX	O
are	VBP	O
persistent	JJ	B-PROBLEM
bifrontal	NN	I-PROBLEM
and	CC	I-PROBLEM
right	JJ	I-PROBLEM
parietal	NN	I-PROBLEM
hemorrhagic	JJ	I-PROBLEM
contusions	NNS	I-PROBLEM
with	IN	O
surrounding	VBG	B-PROBLEM
edema	NN	I-PROBLEM
and	CC	O
possible	JJ	O
small	JJ	B-PROBLEM
left	VBD	I-PROBLEM
frontal	JJ	I-PROBLEM
subarachnoid	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
(	(	O
adjacent	JJ	O
to	TO	O
falx	VB	O
)	)	O
which	WDT	O
are	VBP	O
largely	RB	O
unchanged	JJ	O
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
shift	NN	B-PROBLEM
of	IN	I-PROBLEM
normally	RB	I-PROBLEM
midline	JJ	I-PROBLEM
structures	NNS	I-PROBLEM
or	CC	O
hydrocephalus	NN	B-PROBLEM
.	.	O

the	DT	B-TEST
air-	JJ	I-TEST
fluid	NN	I-TEST
level	NN	I-TEST
in	IN	I-TEST
the	DT	I-TEST
right	JJ	I-TEST
sphenoid	NN	I-TEST
sinus	NN	I-TEST
and	CC	O
bilateral	JJ	B-PROBLEM
opacification	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
mastoid	JJ	I-PROBLEM
air	NN	I-PROBLEM
cells	NNS	I-PROBLEM
are	VBP	O
unchanged	JJ	O
.	.	O

1.	CD	O
decreased	JJ	O
size	NN	O
of	IN	O
right	JJ	B-PROBLEM
posterior	JJ	I-PROBLEM
subdural	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
.	.	O

2.	CD	O
multifocal	JJ	B-PROBLEM
hemorrhagic	NN	I-PROBLEM
contusions	NNS	I-PROBLEM
and	CC	O
surrounding	VBG	B-PROBLEM
edema	NN	I-PROBLEM
are	VBP	O
largely	RB	O
unchanged	JJ	O
.	.	O

he	PRP	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
trauma	NN	O
service	NN	O
.	.	O
orthopedics	NNS	O
and	CC	O
neurosurgery	NN	O
were	VBD	O
consulted	VBN	O
because	IN	O
of	IN	O
his	PRP$	B-PROBLEM
injuries	NNS	I-PROBLEM
.	.	O

his	PRP$	B-PROBLEM
neurosurgical	JJ	I-PROBLEM
issues	NNS	I-PROBLEM
were	VBD	O
nonoperative	JJ	O
;	:	O
he	PRP	O
was	VBD	O
loaded	VBN	O
with	IN	O
dilantin	NN	B-TREATMENT
;	:	O
serial	JJ	B-TEST
head	NN	I-TEST
ct	NN	I-TEST
scans	NNS	I-TEST
were	VBD	O
performed	VBN	O
and	CC	O
were	VBD	O
stable	JJ	O
.	.	O

he	PRP	O
will	MD	O
need	VB	O
to	TO	O
follow	VB	O
up	RP	O
with	IN	O
dr.	JJ	O
mckinney	NN	O
in	IN	O
4	CD	O
weeks	NNS	O
for	IN	O
repeat	NN	B-TEST
head	NN	I-TEST
imaging	NN	I-TEST
and	CC	O
continue	NN	O
with	IN	O
dilantin	NN	B-TREATMENT
for	IN	O
one	CD	O
month	NN	O
.	.	O

his	PRP$	B-PROBLEM
right	JJ	I-PROBLEM
tib	NN	I-PROBLEM
/	NNP	I-PROBLEM
fib	NN	I-PROBLEM
fracture	NN	I-PROBLEM
was	VBD	O
repaired	VBN	O
by	IN	O
orthopedics	NNS	O
on	IN	O
10-27	JJ	O
;	:	O
postoperatively	RB	O
there	EX	O
were	VBD	O
no	DT	O
complications	NNS	B-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
fitted	VBN	O
with	IN	O
a	DT	B-TREATMENT
hinged	JJ	I-TREATMENT
mcdonald	NN	I-TREATMENT
brace	NN	I-TREATMENT
for	IN	O
his	PRP$	B-PROBLEM
lle	NN	I-PROBLEM
.	.	O

he	PRP	O
will	MD	O
need	VB	O
to	TO	O
continue	VB	O
on	IN	O
lovenox	JJ	B-TREATMENT
injections	NNS	I-TREATMENT
for	IN	O
at	IN	O
least	JJS	O
4-6	JJ	O
weeks	NNS	O
.	.	O

he	PRP	O
was	VBD	O
transfused	VBN	O
with	IN	O
3	CD	B-TREATMENT
u	JJ	I-TREATMENT
packed	VBD	I-TREATMENT
cells	NNS	I-TREATMENT
for	IN	O
a	DT	B-TEST
hematocrit	NN	I-TEST
of	IN	O
21	CD	O
,	,	O
post	NN	B-TEST
transfusion	NN	I-TEST
hct	NN	I-TEST
was	VBD	O
26.1	CD	O
;	:	O
there	EX	O
was	VBD	O
a	DT	O
questionable	JJ	O
transfusion	NN	B-PROBLEM
reaction	NN	I-PROBLEM
at	IN	O
the	DT	O
end	NN	O
of	IN	O
his	PRP$	B-TREATMENT
first	JJ	I-TREATMENT
unit	NN	I-TREATMENT
of	IN	I-TREATMENT
packed	JJ	I-TREATMENT
cells	NNS	I-TREATMENT
;	:	O
he	PRP	O
did	VBD	O
subsequently	RB	O
receive	VB	O
the	DT	B-TREATMENT
remaining	VBG	I-TREATMENT
2	CD	I-TREATMENT
units	NNS	I-TREATMENT
without	IN	O
any	DT	B-PROBLEM
further	JJ	I-PROBLEM
reaction	NN	I-PROBLEM
.	.	O

allergic	NN	B-PROBLEM
to	TO	O
pcn	VB	B-TREATMENT
and	CC	O
sulfa	VB	B-TREATMENT

1.	CD	O
phenytoin	NN	B-TREATMENT
50	CD	O
mg	NN	O
tablet	NN	O
,	,	O
chewable	JJ	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
,	,	O
chewable	JJ	O
po	NN	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
for	IN	O
1	CD	O
months	NNS	O
.	.	O

2.	CD	O
oxycodone	NN	B-TREATMENT
5	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
po	NN	O
q4h	NN	O
(	(	O
every	DT	O
4	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
pain	NN	B-PROBLEM
.	.	O

3.	CD	O
docusate	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
100	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

4.	CD	O
magnesium	NN	B-TREATMENT
hydroxide	NN	I-TREATMENT
400	CD	O
mg	NN	O
/	VBD	O
5	CD	O
ml	JJ	O
suspension	NN	O
sig	NN	O
:	:	O
thirty	NN	O
(	(	O
30	CD	O
)	)	O
ml	NN	O
po	NN	O
q6h	NN	O
(	(	O
every	DT	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
constipation	NN	B-PROBLEM
.	.	O

5.	CD	O
lovenox	JJ	B-TREATMENT
40	CD	O
mg	NN	O
/	VBD	O
0.4	CD	O
ml	NN	O
syringe	NN	O
sig	NN	O
:	:	O
0.4	CD	O
ml	NN	O
's	POS	O
subcutaneous	JJ	O
once	RB	O
a	DT	O
day	NN	O
for	IN	O
30	CD	O
days	NNS	O
.	.	O

subdural	JJ	B-PROBLEM
hematoma	NN	I-PROBLEM

skull	JJ	B-PROBLEM
fracture	NN	I-PROBLEM

right	RB	B-PROBLEM
comminuted	VBN	I-PROBLEM
tibia	JJ	I-PROBLEM
/	NNP	I-PROBLEM
fibula	NN	I-PROBLEM
fracture	NN	I-PROBLEM

return	NN	O
to	TO	O
the	DT	O
emergency	NN	O
room	NN	O
if	IN	O
you	PRP	O
develop	VBP	O
fevers	NNS	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
,	,	O
severe	JJ	B-PROBLEM
headaches	NNS	I-PROBLEM
,	,	O
visual	JJ	B-PROBLEM
disturbances	NNS	I-PROBLEM
,	,	O
nause	RB	B-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
and	CC	O
/	CD	O
or	CC	O
any	DT	B-PROBLEM
other	JJ	I-PROBLEM
symptoms	NNS	I-PROBLEM
that	WDT	O
are	VBP	O
concerning	VBG	O
to	TO	O
you	PRP	O
.	.	O

you	PRP	O
will	MD	O
need	VB	O
to	TO	O
conrtinue	VB	O
with	IN	O
your	PRP$	B-TREATMENT
lovenox	JJ	I-TREATMENT
injections	NNS	I-TREATMENT
for	IN	O
at	IN	O
least	JJS	O
4-6	JJ	O
weeks	NNS	O
as	IN	O
instructed	VBN	O
by	IN	O
orthopedics	NNS	O

inform	VB	O
the	DT	O
office	NN	O
that	IN	O
you	PRP	O
will	MD	O
need	VB	O
a	DT	B-TEST
repeat	NN	I-TEST
head	NN	I-TEST
ct	NN	I-TEST
scan	JJ	I-TEST
for	IN	O
this	DT	O
appointment	NN	O
.	.	O

liver	NN	B-TREATMENT
transplant	NN	I-TREATMENT
surgery	NN	I-TREATMENT
service	NN	O

hepatitis	NN	B-PROBLEM
c	NN	I-PROBLEM
cirrhosis	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
49	CD	O
year-old	JJ	O
man	NN	O
with	IN	O
hepatitis	NN	B-PROBLEM
c	NNS	I-PROBLEM
cirrhosis	NN	I-PROBLEM
complicated	VBN	O
by	IN	O
encephalopathy	NN	B-PROBLEM
,	,	O
positive	JJ	B-PROBLEM
esophageal	NN	I-PROBLEM
varices	NNS	I-PROBLEM
,	,	O
now	RB	O
with	IN	O
worsening	VBG	B-PROBLEM
confusion	NN	I-PROBLEM
and	CC	O
lethargy	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
been	VBN	O
admitted	VBN	O
5	CD	O
x	NN	O
in	IN	O
the	DT	O
past	NN	O
to	TO	O
nantucket	NN	O
cottage	NN	O
hospital	NN	O
since	IN	O
11-30	CD	O
for	IN	O
encephalopathy	NN	B-PROBLEM
.	.	O

infectious	JJ	B-TEST
work-up	NN	I-TEST
was	VBD	O
negative	JJ	O
.	.	O

trazodone	NN	B-TREATMENT
stopped	VBD	O
.	.	O

patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
lactulose	NN	B-TREATMENT
and	CC	O
rifaximine	NN	B-TREATMENT
which	WDT	O
improved	VBD	O
his	PRP$	O
mental	JJ	O
status	NN	O
.	.	O

today	NN	O
,	,	O
on	IN	O
2014-03-03	JJ	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
seen	VBN	O
in	IN	O
clinic	JJ	O
with	IN	O
increased	JJ	B-PROBLEM
lethargy	NN	I-PROBLEM
,	,	O
confusion	NN	B-PROBLEM
.	.	O

wife	NN	O
reports	NNS	O
that	IN	O
the	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
lethargy	NN	B-PROBLEM
and	CC	O
confusion	NN	B-PROBLEM
,	,	O
similar	JJ	O
to	TO	O
the	DT	B-PROBLEM
symptoms	NNS	I-PROBLEM
for	IN	O
which	WDT	O
the	DT	O
patient	NN	O
was	VBD	O
recently	RB	O
admitted	VBN	O
.	.	O

the	DT	O
patient	NN	O
also	RB	O
reports	VBZ	O
that	IN	O
he	PRP	O
has	VBZ	O
had	VBN	O
"	VBN	O
yellowish	JJ	B-PROBLEM
eyes	NNS	I-PROBLEM
,	,	O
some	DT	B-PROBLEM
shaking	NN	I-PROBLEM
and	CC	O
his	PRP$	O
breath	NN	O
smelled	VBD	O
more	RBR	O
like	IN	O
ammonia	NN	O
over	IN	O
the	DT	O
past	JJ	O
3	CD	O
days	NNS	O
."	VBP	O

the	DT	O
patient	NN	O
has	VBZ	O
been	VBN	O
compliant	JJ	O
with	IN	O
his	PRP$	B-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

he	PRP	O
has	VBZ	O
had	VBN	O
night	NN	B-PROBLEM
sweats	NNS	I-PROBLEM
for	IN	O
the	DT	O
past	JJ	O
2	CD	O
weeks	NNS	O
.	.	O

he	PRP	O
denies	VBZ	O
any	DT	B-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

he	PRP	O
gets	VBZ	O
cold	JJ	B-PROBLEM
easily	RB	O
but	CC	O
denies	VBZ	O
fevers	NNS	B-PROBLEM
.	.	O

hcv	JJ	B-PROBLEM
cirrhosis	NN	I-PROBLEM
.	.	O

underwent	JJ	O
treatment	NN	B-TREATMENT
with	IN	O
interferon	JJ	B-TREATMENT
10	CD	O
years	NNS	O
ago	RB	O
.	.	O

he	PRP	O
stopped	VBD	O
secondary	JJ	O
to	TO	O
aggressive	JJ	B-PROBLEM
behavior	NN	I-PROBLEM
.	.	O

history	NN	O
of	IN	O
hepatic	JJ	B-PROBLEM
encephalopathy	NN	I-PROBLEM
.	.	O

esophageal	JJ	B-PROBLEM
varices	NNS	I-PROBLEM
.	.	O

egd	NN	B-TEST
on	IN	O
2013-12-08	JJ	O
demonstrated	JJ	O
5	CD	B-PROBLEM
cores	NNS	I-PROBLEM
of	IN	I-PROBLEM
varices	NNS	I-PROBLEM
,	,	O
grade	VBD	O
1	CD	O
to	TO	O
2	CD	O
at	IN	O
the	DT	O
lower	JJR	O
third	NN	O
of	IN	O
the	DT	O
esophagus	NN	O
.	.	O

four	CD	B-TREATMENT
bands	NNS	I-TREATMENT
were	VBD	O
placed	VBN	O
without	IN	O
difficulty	NN	O
.	.	O

also	RB	O
,	,	O
the	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
past	JJ	O
medical	JJ	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
,	,	O
glucose	JJ	B-PROBLEM
intolerance	NN	I-PROBLEM
,	,	O
peripheral	JJ	B-PROBLEM
neuropathy	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
off	RB	O
of	IN	O
neurontin	NN	B-TREATMENT
because	IN	O
it	PRP	O
started	VBD	O
to	TO	O
worsen	VB	O
his	PRP$	O
mental	JJ	O
status	NN	O
.	.	O

nadolol	RB	B-TREATMENT
20	CD	O
mg	NNS	O
q.	JJ	O
day	NN	O
.	.	O

protonix	NN	B-TREATMENT
20	CD	O
mg	NN	O
q.	NN	O
24	CD	O
hours	NNS	O
.	.	O

osamine	JJ	B-TREATMENT
200	CD	O
mg	NN	O
t.i.d.	NN	O

lactulose	RB	B-TREATMENT
30	CD	O
mg	NNS	O
q.i.d.	NN	O

lasix	RB	B-TREATMENT
40	CD	O
mg	NNS	O
q.	JJ	O
day	NN	O
.	.	O

insulin	NN	B-TREATMENT
regular	NN	I-TREATMENT
.	.	O

amlodipine	NN	B-TREATMENT
5	CD	O
mg	NN	O
q.	JJ	O
day	NN	O
.	.	O

retazepine	NN	B-TREATMENT
50	CD	O
mg	NN	O
q	NN	O
h.s.	NN	O

testosterone	NN	B-TREATMENT
4	CD	O
mg	NN	O
q.	NN	O
24	CD	O
hours	NNS	O
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
contracted	VBD	O
hcv	JJ	B-PROBLEM
20	CD	O
years	NNS	O
ago	RB	O
secondary	JJ	O
to	TO	O
iv	VB	O
drug	NN	O
use	NN	O
.	.	O

family	NN	O
history	NN	O
:	:	O
father	NN	O
died	VBD	O
of	IN	O
metastatic	JJ	B-PROBLEM
colon	NN	I-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

mother	NN	O
died	VBD	O
of	IN	O
end	NN	B-PROBLEM
stage	NN	I-PROBLEM
renal	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

vital	JJ	B-TEST
signs	NNS	I-TEST
were	VBD	O
stable	JJ	O
.	.	O

weight	NN	B-TEST
was	VBD	O
122.5	CD	O
.	.	O

general	JJ	O
:	:	O
patient	NN	O
is	VBZ	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

lethargic	NN	B-PROBLEM
,	,	O
occasionally	RB	O
falling	VBG	O
asleep	NN	O
.	.	O

sclera	NN	B-PROBLEM
mildly	RB	I-PROBLEM
icteric	JJ	I-PROBLEM
.	.	O

neck	NN	O
:	:	O
no	DT	O
lad	NN	B-PROBLEM
.	.	O

lungs	NNS	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
.	.	O

normal	JJ	O
s1	NN	O
and	CC	O
s2	NN	O
without	IN	O
murmurs	NNS	B-PROBLEM
or	CC	O
rubs	NNS	B-PROBLEM
.	.	O

positive	JJ	B-PROBLEM
gynecomastia	NN	I-PROBLEM
.	.	O

abdomen	NNS	O
:	:	O
positive	JJ	O
bowel	NN	O
sounds	NNS	O
,	,	O
soft	JJ	O
,	,	O
nondistended	JJ	B-PROBLEM
,	,	O
nontender	NN	B-PROBLEM
.	.	O

obvious	JJ	B-PROBLEM
ascites	NNS	I-PROBLEM
.	.	O

1+	CD	B-PROBLEM
edema	NN	I-PROBLEM
bilaterally	RB	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
mild	JJ	B-PROBLEM
asterixis	NN	I-PROBLEM
.	.	O

patient	JJ	O
continued	VBD	O
on	IN	O
lactulose	NN	B-TREATMENT
.	.	O

continue	NN	O
on	IN	O
rifaximine	NN	B-TREATMENT
.	.	O

continue	NN	O
lasix	NN	B-TREATMENT
.	.	O

on	IN	O
2014-04-02	JJ	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
awake	RB	O
,	,	O
alert	NN	O
and	CC	O
oriented	VBN	O
,	,	O
taking	VBG	O
lactulose	NN	B-TREATMENT
.	.	O

difficulty	NN	B-PROBLEM
with	IN	I-PROBLEM
word	NN	I-PROBLEM
finding	NN	I-PROBLEM
at	IN	O
times	NNS	O
.	.	O

denies	NNS	O
any	DT	B-PROBLEM
pain	NN	I-PROBLEM
or	CC	O
discomfort	NN	B-PROBLEM
.	.	O

abdomen	NNS	O
:	:	O
slightly	RB	B-PROBLEM
distended	VBD	I-PROBLEM
,	,	O
nontender	NN	B-PROBLEM
.	.	O

ultrasound	NN	B-TEST
was	VBD	O
performed	VBN	O
on	IN	O
2014-04-01	JJ	O
demonstrating	NN	O
severe	JJ	B-PROBLEM
portal	JJ	I-PROBLEM
hypertension	NN	I-PROBLEM
with	IN	O
massive	JJ	B-PROBLEM
peri	NN	I-PROBLEM
splenic	JJ	I-PROBLEM
varices	NNS	I-PROBLEM
and	CC	O
splenorenal	JJ	B-TREATMENT
shunt	NN	I-TREATMENT
.	.	O

repeat	NN	B-PROBLEM
hepato	NN	I-PROBLEM
fungal	JJ	I-PROBLEM
flare	NN	I-PROBLEM
.	.	O

on	IN	O
2014-04-04	JJ	O
,	,	O
the	DT	O
transplant	NN	O
service	NN	O
was	VBD	O
consulted	VBN	O
because	IN	O
the	DT	O
patient	NN	O
was	VBD	O
possibly	RB	O
going	VBG	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
for	IN	O
transplant	NN	B-TREATMENT
on	IN	O
2014-04-04	JJ	O
.	.	O

the	DT	O
patient	NN	O
did	VBD	O
go	VB	O
to	TO	O
operating	VBG	O
room	NN	O
on	IN	O
2014-04-04	JJ	O
and	CC	O
the	DT	O
patient	NN	O
had	VBD	O
cadaveric	JJ	B-TREATMENT
liver	NN	I-TREATMENT
transplant	NN	I-TREATMENT
performed	VBN	O
by	IN	O
dr.	NN	O
michael	NN	O
sanders	NNS	O
.	.	O

please	VB	O
see	VB	O
detailed	JJ	O
operative	JJ	O
note	NN	O
for	IN	O
more	JJR	O
information	NN	O
about	IN	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
received	VBD	O
mmf	JJ	B-TREATMENT
1	CD	O
gram	NN	O
b.i.d.	NN	O
,	,	O
flagyl	VBP	B-TREATMENT
500	CD	O
mg	NN	O
iv	NN	O
x1	NN	O
.	.	O

the	DT	O
patient	NN	O
also	RB	O
received	VBD	O
unasyn	JJ	B-TREATMENT
for	IN	O
2	CD	O
days	NNS	O
,	,	O
fluconazole	JJ	B-TREATMENT
,	,	O
heparin	NN	B-TREATMENT
,	,	O
protonix	NN	B-TREATMENT
,	,	O
insulin	NN	B-TREATMENT
,	,	O
morphine	NN	B-TREATMENT
,	,	O
bactrim	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
on	IN	O
propofol	NN	B-TREATMENT
for	IN	O
2	CD	O
days	NNS	O
.	.	O

on	IN	O
2014-04-04	JJ	O
,	,	O
labs	NNS	B-TEST
were	VBD	O
as	IN	O
follows	VBZ	O
:	:	O

wbc	NN	B-TEST
of	IN	O
8.3	CD	O
;	:	O
hematocrit	NN	B-TEST
of	IN	O
30.6	CD	O
;	:	O
platelets	NNS	B-TEST
69	CD	O
;	:	O
sodium	NN	B-TEST
132	CD	O
;	:	O
3.9	CD	O
,	,	O
102	CD	O
,	,	O
22	CD	O
,	,	O
serum	JJR	B-TEST
creatinine	NN	I-TEST
of	IN	O
13	CD	O
and	CC	O
1.1	CD	O
.	.	O

glucose	RB	B-TEST
114	CD	O
.	.	O

ast	RB	B-TEST
87	CD	O
.	.	O

alt	RB	B-TEST
44	CD	O
.	.	O

alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
169	CD	O
.	.	O

pt	NN	B-TEST
of	IN	O
20.6	CD	O
.	.	O

ptt	NN	B-TEST
of	IN	O
38.7	CD	O
.	.	O

inr	NN	B-TEST
of	IN	O
2.0	CD	O
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
1	CD	O
,	,	O
duplex	JJ	B-TEST
ultrasound	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
patient	NN	I-TEST
's	POS	I-TEST
liver	NN	I-TEST
was	VBD	O
performed	VBN	O
demonstrating	VBG	O
normal	JJ	O
appearing	VBG	O
portal	JJ	O
veins	NNS	O
and	CC	O
hepatic	JJ	O
arteries	NNS	O
.	.	O

there	RB	O
appears	VBZ	O
to	TO	O
be	VB	O
a	DT	B-PROBLEM
decreased	JJ	I-PROBLEM
and	CC	I-PROBLEM
sluggish	JJ	I-PROBLEM
flow	NN	I-PROBLEM
within	IN	I-PROBLEM
the	DT	I-PROBLEM
right	NN	I-PROBLEM
and	CC	I-PROBLEM
left	VBD	I-PROBLEM
hepatic	JJ	I-PROBLEM
veins	NNS	I-PROBLEM
with	IN	O
loss	NN	B-PROBLEM
of	IN	I-PROBLEM
normal	JJ	I-PROBLEM
respiratory	JJ	I-PROBLEM
variations	NNS	I-PROBLEM
,	,	I-PROBLEM
wave	VBP	I-PROBLEM
forms	NNS	I-PROBLEM
and	CC	I-PROBLEM
the	DT	I-PROBLEM
intrahepatic	JJ	I-PROBLEM
portion	NN	I-PROBLEM
.	.	O

additionally	RB	O
,	,	O
there	EX	O
is	VBZ	O
diminished	JJ	B-PROBLEM
color	NN	I-PROBLEM
flow	NN	I-PROBLEM
with	IN	O
confluence	NN	O
of	IN	O
the	DT	O
hepatic	JJ	O
veins	NNS	O
.	.	O

these	DT	O
findings	NNS	O
may	MD	O
reflect	VB	O
thrombus	NN	B-PROBLEM
within	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
and	CC	I-PROBLEM
right	JJ	I-PROBLEM
hepatic	NN	I-PROBLEM
veins	NNS	I-PROBLEM
.	.	O

caval	NN	B-PROBLEM
narrowing	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
,	,	O
most	RBS	O
likely	JJ	O
correlation	NN	O
to	TO	O
clinical	JJ	O
history	NN	O
is	VBZ	O
recommended	VBN	O
and	CC	O
further	JJ	O
evaluation	NN	O
of	IN	O
the	DT	B-TEST
ct	NN	I-TEST
or	CC	O
short-term	JJ	B-TEST
ultrasounds	NNS	I-TEST
for	IN	O
follow-up	NN	O
was	VBD	O
recommended	VBN	O
.	.	O

the	DT	B-TREATMENT
feeney	NN	I-TREATMENT
gann-burlington	NN	I-TREATMENT
drain	NN	I-TREATMENT
on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
demonstrated	VBD	O
medial	JJ	B-TEST
output	NN	I-TEST
of	IN	O
780	CD	O
with	IN	O
lateral	JJ	B-TEST
output	NN	I-TEST
of	IN	O
150	CD	O
.	.	O

patient	NN	O
continued	VBD	O
getting	VBG	O
acyclovir	RB	B-TREATMENT
,	,	O
prednisone	NN	B-TREATMENT
,	,	O
mmf	VB	B-TREATMENT
one	CD	O
gram	NN	O
b.i.d	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
on	IN	O
fk	JJ	B-TREATMENT
2	CD	I-TREATMENT
and	CC	O
2	CD	O
that	WDT	O
was	VBD	O
started	VBN	O
on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
2	CD	O
.	.	O

waltham-ludlow	JJ	B-TREATMENT
drains	NNS	I-TREATMENT
put	VBD	O
out	RP	O
on	IN	O
the	DT	O
13th	CD	O
620	CD	O
and	CC	O
380	CD	O
.	.	O

omalley	NN	O
was	VBD	O
consulted	VBN	O
on	IN	O
2014-04-08	JJ	O
for	IN	O
better	JJR	O
glucose	NN	B-TREATMENT
control	NN	I-TREATMENT
since	IN	O
the	DT	O
patient	NN	O
was	VBD	O
on	IN	O
steroids	NNS	B-TREATMENT
.	.	O

patient	NN	O
was	VBD	O
transfused	VBN	O
1	CD	B-TREATMENT
unit	NN	I-TREATMENT
of	IN	I-TREATMENT
platelets	NNS	I-TREATMENT
on	IN	O
2014-04-08	JJ	O
for	IN	O
platelet	NN	B-TEST
count	NN	I-TEST
of	IN	O
66	CD	O
.	.	O

a	DT	B-TEST
heparin	JJ	I-TEST
independent	JJ	I-TEST
antibody	NN	I-TEST
was	VBD	O
sent	VBN	O
off	RP	O
on	IN	O
2014-04-07	JJ	O
which	WDT	O
was	VBD	O
unremarkable	JJ	O
.	.	O

on	IN	O
2014-04-09	JJ	O
,	,	O
patient	JJ	O
continued	VBD	O
to	TO	O
do	VB	O
very	RB	O
well	RB	O
,	,	O
ambulating	VBG	O
,	,	O
tolerating	VBG	O
a	DT	O
diet	JJ	O
,	,	O
urinating	VBG	O
without	IN	O
difficulty	NN	B-PROBLEM
.	.	O

drains	NNS	B-TREATMENT
continued	VBD	O
to	TO	O
put	VB	O
out	RP	O
significant	JJ	O
amount	NN	O
of	IN	O
fluid	NN	O
.	.	O

patient	NN	B-TEST
's	POS	I-TEST
labs	NN	I-TEST
from	IN	O
2014-04-10	JJ	O
were	VBD	O
the	DT	O
following	NN	O
:	:	O

7.1	CD	O
,	,	O
hematocrit	NN	B-TEST
of	IN	O
30.8	CD	O
,	,	O
platelets	NNS	B-TEST
90	CD	O
.	.	O

sodium	NN	B-TEST
of	IN	O
138	CD	O
;	:	O
potassium	NN	B-TEST
3.5	CD	O
;	:	O
106	CD	O
,	,	O
28	CD	O
,	,	O
31	CD	O
,	,	O
1.0	CD	O
,	,	O
glucose	VBD	B-TEST
134	CD	O
.	.	O

ast	RB	B-TEST
82	CD	O
.	.	O

alt	RB	B-TEST
176	CD	O
.	.	O

alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
78	CD	O
which	WDT	O
all	DT	O
have	VBP	O
significantly	RB	O
decreased	VBN	O
since	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
1	CD	O
.	.	O

total	JJ	B-TEST
bilirubin	NN	I-TEST
was	VBD	O
0.9	CD	O
.	.	O

on	IN	O
2014-04-09	JJ	O
,	,	O
fk	JJ	B-TEST
level	NN	I-TEST
was	VBD	O
10.3	CD	O
.	.	O

protonix	NN	B-TREATMENT
40	CD	O
mg	NN	O
q.	NN	O
24	CD	O
.	.	O

moltipine	NN	B-TREATMENT
5	CD	O
mg	NN	O
q.	JJ	O
day	NN	O
.	.	O

fluconazole	JJ	B-TREATMENT
400	CD	O
mg	NN	O
q.	NN	O
24	CD	O
hours	NNS	O
.	.	O

prednisone	NN	B-TREATMENT
20	CD	O
mg	NN	O
q.	JJ	O
day	NN	O
.	.	O

mmf	NN	B-TREATMENT
1000	CD	O
mg	NN	O
b.i.d.	NN	O
.	.	O

lopressor	NN	B-TREATMENT
50	CD	O
m	NN	O
b.i.d.	NN	O

percocet	RB	B-TREATMENT
1	CD	O
to	TO	O
2	CD	O
tabs	NNS	O
q.	RB	O
4	CD	O
to	TO	O
6	CD	O
hours	NNS	O
prn	NN	O
.	.	O

colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
b.i.d.	NN	O

bactrim	JJ	B-TREATMENT
ss	NN	O
1	CD	O
tab	NN	O
q.	JJ	O
day	NN	O
.	.	O

tacrolimus	RB	B-TREATMENT
3	CD	O
mg	NNS	O
b.i.d.	NN	O

lasix	RB	B-TREATMENT
20	CD	O
mg	NNS	O
b.i.d.	NN	O

valcyte	NN	B-TREATMENT
900	CD	O
mg	NN	O
q.	JJ	O
day	NN	O
.	.	O

patient	NN	O
is	VBZ	O
on	IN	O
insulin	NN	B-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT
with	IN	O
fixed	JJ	O
dose	NN	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
to	TO	O
call	VB	O
787-984-9608	JJ	O
if	IN	O
any	DT	O
fevers	NNS	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
and	CC	O
vomiting	NN	B-PROBLEM
,	,	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
inability	NN	B-PROBLEM
to	TO	I-PROBLEM
take	VB	I-PROBLEM
medications	NNS	I-PROBLEM
,	,	O
inability	NN	B-PROBLEM
to	TO	I-PROBLEM
eat	VB	I-PROBLEM
or	CC	I-PROBLEM
drink	VB	I-PROBLEM
.	.	O

patient	NN	O
needs	NNS	O
to	TO	O
have	VB	O
labs	VBN	B-TEST
every	DT	O
monday	NN	O
and	CC	O
thursday	JJ	O
including	VBG	O
a	DT	B-TEST
cbc	NN	I-TEST
,	,	O
chem-10	JJ	B-TEST
,	,	O
ast	JJ	B-TEST
,	,	O
alt	NN	B-TEST
,	,	O
alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
,	,	O
albumin	NN	B-TEST
,	,	O
total	JJ	B-TEST
bilirubin	NN	I-TEST
and	CC	O
prograf	NN	B-TEST
level	NN	I-TEST
need	NN	O
to	TO	O
be	VB	O
obtained	VBN	O
.	.	O

all	DT	B-TEST
cultures	NNS	I-TEST
have	VBP	O
been	VBN	O
unremarkable	JJ	O
.	.	O

cultures	NNS	B-TEST
were	VBD	O
obtained	VBN	O
on	IN	O
2014-03-31	JJ	O
.	.	O

urine	JJ	B-TEST
culture	NN	I-TEST
and	CC	O
blood	NN	B-TEST
culture	NN	I-TEST
have	VBP	O
been	VBN	O
unremarkable	JJ	O
on	IN	O
2014-04-03	JJ	O
.	.	O

hepatitis	NN	B-TEST
viral	JJ	I-TEST
load	NN	I-TEST
was	VBD	O
76,500	CD	O
.	.	O

pathology	NN	O
demonstrates	VBZ	O
that	IN	O
the	DT	B-TEST
pathology	NN	I-TEST
results	NNS	I-TEST
of	IN	I-TEST
the	DT	I-TEST
liver	NN	I-TEST
were	VBD	O
not	RB	O
finalized	VBN	O
.	.	O

fetal	JJ	B-TEST
screens	NNS	I-TEST
,	,	O
o	RB	O
positive	JJ	O
,	,	O
antibody	JJ	B-TEST
negative	JJ	O
,	,	O
rpr	JJ	B-TEST
nonreactive	JJ	O
,	,	O
rubella	NN	B-TEST
immune	NN	O
,	,	O
hepatitis	NN	B-TEST
surface	NN	I-TEST
antigen	NN	I-TEST
negative	JJ	O
,	,	O
gbs	JJ	B-TEST
unknown	NN	O
.	.	O

ivf	JJ	B-PROBLEM
pregnancy	NN	I-PROBLEM
complicated	VBN	O
by	IN	O
iugr	NN	B-PROBLEM
,	,	O
2	CD	B-PROBLEM
vessel	NN	I-PROBLEM
cord	NN	I-PROBLEM
,	,	O
normal	JJ	O
fetal	JJ	O
echo	JJ	O
reverse	NN	O
diastolic	NN	O
flow	NN	O
and	CC	O
demise	NN	B-PROBLEM
of	IN	I-PROBLEM
twin	NN	I-PROBLEM
a	DT	I-PROBLEM
at	IN	O
27	CD	O
weeks	NNS	O
.	.	O

twin	NN	O
b	NN	O
with	IN	O
normal	JJ	O
fetal	JJ	O
survey	NN	O
was	VBD	O
transferred	VBN	O
to	TO	O
boston	VB	O
medical	JJ	O
center	NN	O
at	IN	O
26	CD	O
and	CC	O
2/7	CD	O
weeks	NNS	O
with	IN	O
iugr	NN	B-PROBLEM
of	IN	I-PROBLEM
twin	NN	I-PROBLEM
a	DT	I-PROBLEM
was	VBD	O
first	RB	O
noted	VBN	O
,	,	O
presented	VBN	O
with	IN	O
preterm	JJ	B-PROBLEM
labor	NN	I-PROBLEM
at	IN	O
31	CD	O
weeks	NNS	O
.	.	O

betamethasone	NN	B-TREATMENT
complete	NN	O
at	IN	O
approximately	RB	O
26	CD	O
weeks	NNS	O
and	CC	O
31	CD	O
weeks	NNS	O
.	.	O

mother	NN	O
was	VBD	O
on	IN	O
clindamycin	NN	B-TREATMENT
since	IN	O
11-04	CD	O
.	.	O

pprom	NN	B-PROBLEM
with	IN	O
bleeding	NN	B-PROBLEM
and	CC	O
transverse	NN	B-PROBLEM
lie	NN	I-PROBLEM
prompted	VBD	O
cesarean	JJ	B-TREATMENT
section	NN	I-TREATMENT
.	.	O

abruption	NN	B-PROBLEM
noted	VBD	O
.	.	O

apgars	NNS	B-TEST
were	VBD	O
6	CD	O
and	CC	O
9	CD	O
.	.	O

on	IN	O
admission	NN	O
weight	NN	B-TEST
1670	CD	O
grams	NNS	O
approximately	RB	O
50	CD	O
th	NNS	O
percentile	RB	O
,	,	O
length	VBD	B-TEST
43	CD	O
cm	NN	O
50	CD	O
th	NN	O
percentile	NN	O
,	,	O
head	NN	B-TEST
circumference	NN	I-TEST
not	RB	O
done	VBN	O
.	.	O

anterior	JJ	O
fontanel	NN	O
soft	JJ	O
,	,	O
flat	JJ	O
,	,	O
cap	NN	O
and	CC	O
prong	JJ	B-TREATMENT
cpap	NN	I-TREATMENT
in	IN	O
place	NN	O
.	.	O

nondysmorphic	JJ	B-PROBLEM
intact	JJ	O
veliz	NN	O
.	.	O

no	DT	O
murmur	NN	B-PROBLEM
.	.	O

no	DT	O
hepatosplenomegaly	NN	B-PROBLEM
.	.	O

positive	JJ	O
vaginal	JJ	B-PROBLEM
tag	NN	I-PROBLEM
.	.	O

no	DT	O
hip	NN	B-PROBLEM
click	NN	I-PROBLEM
.	.	O

no	DT	O
sacral	JJ	B-PROBLEM
dimple	NN	I-PROBLEM
.	.	O

decrease	NN	B-PROBLEM
tone	NN	I-PROBLEM
,	,	O
ruddy	NN	O
,	,	O
warm	NN	O
,	,	O
well	RB	O
perfused	VBN	O
with	IN	O
peripheral	JJ	B-TREATMENT
iv	NN	I-TREATMENT
in	IN	I-TREATMENT
left	JJ	I-TREATMENT
hand	NN	I-TREATMENT
.	.	O

mills	NNS	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
newborn	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
with	IN	O
moderate	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
distress	NN	I-PROBLEM
.	.	O

infant	NN	O
placed	VBD	O
on	IN	O
cpap	NN	B-TREATMENT
.	.	O

x-ray	NN	B-TEST
revealed	VBD	O
mild	JJ	B-PROBLEM
respiratory	JJ	I-PROBLEM
distress	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
.	.	O

she	PRP	O
remained	VBD	O
on	IN	O
cpap	NN	B-TREATMENT
for	IN	O
a	DT	O
total	NN	O
of	IN	O
24	CD	O
hours	NNS	O
at	IN	O
which	WDT	O
time	NN	O
she	PRP	O
transitioned	VBD	O
to	TO	O
room	NN	O
air	NN	O
and	CC	O
continues	VBZ	O
to	TO	O
be	VB	O
stable	JJ	O
in	IN	O
room	NN	O
air	NN	O
.	.	O

caffeine	NN	B-TREATMENT
citrate	NN	I-TREATMENT
was	VBD	O
initiated	VBN	O
on	IN	O
11-14	NN	O
for	IN	O
apnea	NN	B-PROBLEM
and	CC	O
bradycardia	NN	B-PROBLEM
of	IN	I-PROBLEM
prematurity	NN	I-PROBLEM
.	.	O

heart	NN	B-TEST
ranges	VBZ	I-TEST
130	CD	O
s	NN	O
to	TO	O
160	CD	O
s.	NN	O

blood	NN	B-TEST
pressure	NN	I-TEST
most	RBS	O
recently	RB	O
60/37	CD	O
with	IN	O
a	DT	O
mean	NN	O
of	IN	O
44	CD	O
.	.	O

birth	NN	B-TEST
weight	NN	I-TEST
was	VBD	O
1670	CD	O
grams	NNS	O
50	CD	O
th	NN	O
percentile	NN	O
,	,	O
length	VBZ	B-TEST
43	CD	O
cm	NN	O
50	CD	O
th	NN	O
percentile	NN	O
.	.	O

head	NN	B-TEST
circumference	NN	I-TEST
not	RB	O
done	VBN	O
.	.	O

infant	NN	O
was	VBD	O
initially	RB	O
started	VBN	O
on	IN	O
80	CD	O
cc	NNS	O
per	IN	O
kilo	FW	O
per	IN	O
day	NN	O
of	IN	O
d10w	NN	B-TREATMENT
.	.	O

enteral	JJ	B-TREATMENT
feedings	NNS	I-TREATMENT
were	VBD	O
initiated	VBN	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
#1	NN	O
.	.	O

infant	NN	O
achieved	VBN	O
full	JJ	B-TREATMENT
enteral	JJ	I-TREATMENT
feedings	NNS	I-TREATMENT
by	IN	O
day	NN	O
of	IN	O
life	NN	O
6	CD	O
.	.	O

she	PRP	O
is	VBZ	O
currently	RB	O
receiving	VBG	O
150	CD	O
cc	JJ	O
per	IN	O
kilo	FW	O
per	IN	O
day	NN	O
of	IN	O
special	JJ	B-TREATMENT
care	NN	I-TREATMENT
20	CD	I-TREATMENT
.	.	O

her	PRP$	B-TEST
discharge	NN	I-TEST
weight	NN	I-TEST
is	VBZ	O
1477	CD	O
gm	NN	O
.	.	O

her	PRP$	O
most	RBS	O
recent	JJ	O
set	NN	O
of	IN	O
electrolytes	NNS	O
were	VBD	O
on	IN	O
2015-11-13	JJ	O
with	IN	O
a	DT	B-TEST
sodium	NN	I-TEST
of	IN	O
143	CD	O
,	,	O
a	DT	B-TEST
potassium	NN	I-TEST
of	IN	O
6.3	CD	O
hemolyzed	NNS	O
,	,	O
a	DT	B-TEST
chloride	NN	I-TEST
of	IN	O
113	CD	O
and	CC	O
a	DT	B-TEST
total	JJ	I-TEST
co2	NN	I-TEST
of	IN	O
17	CD	O
.	.	O

she	PRP	O
will	MD	O
need	VB	O
advance	NN	B-TREATMENT
calorie	NN	I-TREATMENT
density	NN	I-TREATMENT
for	IN	O
better	JJR	O
growth	NN	O
.	.	O

gi	NN	B-TEST
.	.	I-TEST
bilirubin	NN	I-TEST
peaked	VBD	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
#2	NN	O
of	IN	O
9.0	CD	O
/	JJ	O
0.3	CD	O
.	.	O

infant	NN	O
is	VBZ	O
under	IN	O
phototherapy	NN	B-TREATMENT
,	,	O
which	WDT	O
was	VBD	O
discontinued	VBN	O
on	IN	O
11-13	NNS	O
.	.	O

most	RBS	B-TEST
recent	JJ	I-TEST
bilirubin	NN	I-TEST
was	VBD	O
on	IN	O
11-14	NN	O
of	IN	O
4.8	CD	O
/	JJ	O
0.3	CD	O
.	.	O

hematocrit	NN	B-TEST
on	IN	O
admission	NN	O
was	VBD	O
53.7	CD	O
.	.	O

she	PRP	O
has	VBZ	O
not	RB	O
required	VBN	O
any	DT	B-TREATMENT
blood	NN	I-TREATMENT
transfusions	NNS	I-TREATMENT
.	.	O

a	DT	B-TEST
cbc	NN	I-TEST
and	CC	O
blood	NN	B-TEST
culture	NN	I-TEST
obtained	VBN	O
on	IN	O
admission	NN	O
.	.	O

cbc	NN	B-TEST
had	VBD	O
a	DT	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
of	IN	O
9	CD	O
,	,	O
17	CD	O
polys	NN	B-TEST
,	,	O
0	CD	O
bands	NNS	B-TEST
,	,	O
platelets	NNS	B-TEST
of	IN	O
326	CD	O
.	.	O

she	PRP	O
received	VBD	O
48	CD	O
hours	NNS	O
of	IN	O
ampicillin	NN	B-TREATMENT
and	CC	O
gentamycin	NN	B-TREATMENT
with	IN	O
negative	JJ	O
blood	NN	B-TEST
cultures	NNS	I-TEST
and	CC	O
antibiotics	NNS	B-TREATMENT
were	VBD	O
discontinued	VBN	O
.	.	O

head	NN	B-TEST
ultrasound	NN	I-TEST
was	VBD	O
performed	VBN	O
on	IN	O
2015-11-16	JJ	O
and	CC	O
was	VBD	O
normal	JJ	O
.	.	O

sensory	NN	B-TEST
,	,	I-TEST
hearing	VBG	I-TEST
screen	NN	I-TEST
has	VBZ	O
not	RB	O
yet	RB	O
been	VBN	O
performed	VBN	O
,	,	O
but	CC	O
should	MD	O
be	VB	O
done	VBN	O
prior	RB	O
to	TO	O
discharge	VB	O
.	.	O

continue	VB	O
150	CD	O
cc	NN	O
per	IN	O
kilo	FW	O
per	IN	O
day	NN	O
of	IN	O
special	JJ	B-TREATMENT
care	NN	I-TREATMENT
20	CD	I-TREATMENT
calories	NNS	I-TREATMENT
advancing	VBG	O
caloric	JJ	O
intake	NN	O
as	IN	O
required	VBN	O
to	TO	O
maintain	VB	O
weight	JJ	O
gain	NN	O
of	IN	O
3	CD	O
grams	NNS	O
per	IN	O
kilogram	FW	O
per	IN	O
day	NN	O
.	.	O

medications	NNS	B-TREATMENT
,	,	O
continue	VBP	O
caffeine	JJ	B-TREATMENT
citrate	NN	I-TREATMENT
of	IN	O
11	CD	O
mg	NNS	O
po	JJ	O
every	DT	O
day	NN	O
.	.	O

car	NN	B-TEST
seat	NN	I-TEST
position	NN	I-TEST
screening	NN	I-TEST
has	VBZ	O
not	RB	O
yet	RB	O
been	VBN	O
done	VBN	O
.	.	O

state	NN	B-TEST
newborn	JJ	I-TEST
screen	NN	I-TEST
was	VBD	O
sent	VBN	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
#3	NN	O
and	CC	O
at	IN	O
discharge	NN	O
.	.	O

immunizations	NNS	B-TREATMENT
received	VBD	O
,	,	O
infant	NN	O
has	VBZ	O
not	RB	O
received	VBN	O
any	DT	B-TREATMENT
immunizations	NNS	I-TREATMENT
to	TO	O
date	NN	O
.	.	O

state	NN	B-TEST
newborn	JJ	I-TEST
screen	NN	I-TEST
was	VBD	O
sent	VBN	O
on	IN	O
2015-11-12	JJ	O
.	.	O

immunizations	NNS	B-TREATMENT
:	:	O
recommended	VBN	O
synagis	NN	B-TREATMENT
rsv	NN	I-TREATMENT
prophylaxis	NN	I-TREATMENT
should	MD	O
be	VB	O
considered	VBN	O
from	IN	O
november	CC	O
through	IN	O
march	NN	O
for	IN	O
infants	NNS	O
who	WP	O
meet	VBP	O
any	DT	O
of	IN	O
the	DT	O
following	VBG	O
3	CD	O
criteria	NNS	O
,	,	O
born	VBN	O
at	IN	O
less	JJR	O
than	IN	O
32	CD	O
weeks	NNS	O
,	,	O
born	VBN	O
between	IN	O
32	CD	O
and	CC	O
35	CD	O
weeks	NNS	O
with	IN	O
2	CD	O
of	IN	O
the	DT	O
following	JJ	O
,	,	O
daycare	JJ	O
during	IN	O
rsv	NN	O
season	NN	O
,	,	O
a	DT	O
smoker	NN	O
in	IN	O
the	DT	O
household	NN	O
,	,	O
neuromuscular	JJ	B-PROBLEM
disease	NN	I-PROBLEM
and	CC	O
weight	JJ	B-PROBLEM
abnormalities	NNS	I-PROBLEM
or	CC	O
school	NN	O
age	NN	O
siblings	NNS	O
with	IN	O
chronic	JJ	B-PROBLEM
lung	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

influenza	JJ	B-TREATMENT
immunization	NN	I-TREATMENT
is	VBZ	O
recommended	VBN	O
annually	RB	O
in	IN	O
the	DT	O
fall	NN	O
for	IN	O
all	DT	O
infants	NNS	O
once	IN	O
they	PRP	O
reach	VBP	O
6	CD	O
months	NNS	O
of	IN	O
age	NN	O
.	.	O

before	IN	O
this	DT	O
age	NN	O
and	CC	O
for	IN	O
the	DT	O
first	JJ	O
24	CD	O
months	NNS	O
of	IN	O
the	DT	B-TREATMENT
child	NN	I-TREATMENT
's	POS	I-TREATMENT
life	NN	I-TREATMENT
immunizations	NNS	I-TREATMENT
against	IN	O
influenza	NN	B-PROBLEM
is	VBZ	O
recommended	VBN	O
for	IN	O
household	NN	O
contacts	NNS	O
and	CC	O
out	IN	O
of	IN	O
home	NN	O
care	NN	O
givers	NNS	O
.	.	O

premature	NN	B-PROBLEM
infant	NN	I-PROBLEM
born	VBN	O
at	IN	O
31	CD	O
and	CC	O
6/7	CD	O
weeks	NNS	O
gestation	NN	O
,	,	O
resolved	VBD	O
respiratory	JJ	B-PROBLEM
distress	JJ	I-PROBLEM
syndrome	NN	I-PROBLEM
.	.	O

rule	NN	O
out	IN	O
sepsis	NN	B-PROBLEM
with	IN	O
antibiotic	JJ	B-TREATMENT
.	.	O

hyperbilirubinemia	NN	B-PROBLEM
resolving	NN	O
.	.	O

apnea	NN	B-PROBLEM
and	CC	O
bradycardia	NN	B-PROBLEM
of	IN	I-PROBLEM
prematurity	NN	I-PROBLEM
.	.	O

codeine	NN	B-TREATMENT
/	CD	O
iodine	NN	B-TREATMENT

large	JJ	B-PROBLEM
pericardial	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
,	,	O
transfer	NN	O
from	IN	O
osh	NN	O

thoracentesis	NN	B-TREATMENT
2018-05-27	JJ	O

82	CD	O
f	NN	O
with	IN	O
h/o	NN	O
copd	NN	B-PROBLEM
,	,	O
cad	NN	B-PROBLEM
,	,	O
pafib	NN	B-PROBLEM
and	CC	O
sss	NN	B-PROBLEM
s/p	NN	O
pacer	NN	B-TREATMENT
on	IN	O
05-08	NN	O
for	IN	O
symptomatic	JJ	B-PROBLEM
pauses	NNS	I-PROBLEM
is	VBZ	O
transferred	VBN	O
for	IN	O
large	JJ	B-PROBLEM
pericardial	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
?	.	O
needing	JJ	O
drainage	NN	B-TREATMENT
and	CC	O
chf	NN	B-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
admitted	VBN	O
to	TO	O
cambridge	VB	O
hospital	JJ	O
2018-05-24	JJ	O
with	IN	O
arf	NN	B-PROBLEM
(	(	O
cr	NN	B-TEST
3.5	CD	O
up	RB	O
from	IN	O
0.9	CD	O
)	)	O
and	CC	O
sob	NN	B-PROBLEM
.	.	O

according	VBG	O
to	TO	O
her	PRP$	O
guardian	JJ	O
she	PRP	O
was	VBD	O
discharged	VBN	O
to	TO	O
her	PRP$	O
nh	NN	O
for	IN	O
a	DT	O
few	JJ	O
days	NNS	O
after	IN	O
her	PRP$	B-TREATMENT
pacer	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
05-08	NN	O
,	,	O
which	WDT	O
was	VBD	O
complicated	VBN	O
by	IN	O
a	DT	B-PROBLEM
ptx	NN	I-PROBLEM
requiring	VBG	O
ct	NN	B-TREATMENT
placement	NN	I-TREATMENT
which	WDT	O
had	VBD	O
been	VBN	O
d/c	JJ	O
'd	MD	O
in	IN	O
the	DT	O
hospital	NN	O
after	IN	O
resolution	NN	O
of	IN	O
her	PRP$	B-PROBLEM
ptx	NN	I-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
some	DT	O
nausea	NN	B-PROBLEM
/	VBD	O
vomiting	NN	B-PROBLEM
and	CC	O
generally	RB	O
was	VBD	O
taking	VBG	O
poor	JJ	O
pos	NN	O
at	IN	O
her	PRP$	O
nh	NN	O
.	.	O

there	EX	O
had	VBD	O
been	VBN	O
some	DT	O
concern	NN	O
her	PRP$	B-PROBLEM
nausea	NN	I-PROBLEM
was	VBD	O
due	JJ	O
to	TO	O
her	PRP$	B-TREATMENT
amiodarone	NN	I-TREATMENT
which	WDT	O
had	VBD	O
been	VBN	O
discontinued	VBN	O
about	IN	O
1	CD	O
week	NN	O
ago	RB	O
.	.	O

she	PRP	O
was	VBD	O
then	RB	O
sent	VBN	O
to	TO	O
franklin	VB	O
medical	JJ	O
center	NN	O
05-24	NN	O
with	IN	O
lethargy	NN	B-PROBLEM
and	CC	O
n/v	NN	B-PROBLEM
.	.	O

at	IN	O
erich	JJ	O
lindemann	JJ	O
mental	JJ	O
health	NN	O
center	NN	O
she	PRP	O
was	VBD	O
discovered	VBN	O
to	TO	O
have	VB	O
arf	NNS	B-PROBLEM
,	,	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
pericardial	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
,	,	O
and	CC	O
bilateral	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
ivf	NN	B-TREATMENT
for	IN	O
her	PRP$	B-PROBLEM
arf	NN	I-PROBLEM
.	.	O

she	PRP	O
underwent	VBD	O
a	DT	B-TEST
tte	NN	I-TEST
at	IN	O
erich	JJ	O
lindemann	JJ	O
mental	JJ	O
health	NN	O
center	NN	O
today	NN	O
(	(	O
05-26	JJ	O
)	)	O
showing	VBG	O
mod-lg	JJ	B-PROBLEM
circumferential	JJ	I-PROBLEM
pericardial	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
without	IN	O
evidence	NN	O
of	IN	O
rv	JJ	B-PROBLEM
diastolic	JJ	I-PROBLEM
collapse	NN	I-PROBLEM
and	CC	O
no	DT	O
mv	NN	O
inflow	JJ	O
evidence	NN	O
of	IN	O
tamponade	NN	B-PROBLEM
,	,	O
pacer	NN	B-TREATMENT
wire	NN	I-TREATMENT
located	VBN	O
in	IN	O
rv	NN	O
apex	NN	O
.	.	O

there	EX	O
was	VBD	O
still	RB	O
concern	NN	O
for	IN	O
her	PRP$	B-PROBLEM
effusion	NN	I-PROBLEM
contributing	NN	O
to	TO	O
her	PRP$	B-PROBLEM
sob	NN	I-PROBLEM
at	IN	O
the	DT	O
osh	NN	O
so	IN	O
she	PRP	O
was	VBD	O
transferred	VBN	O
for	IN	O
drainage	NN	B-TREATMENT
and	CC	O
treatment	NN	B-TREATMENT
of	IN	O
chf	NN	B-PROBLEM
.	.	O

today	NN	O
she	PRP	O
only	RB	O
complains	VBZ	O
of	IN	O
some	DT	B-PROBLEM
sob	NN	I-PROBLEM
,	,	O
which	WDT	O
she	PRP	O
says	VBZ	O
remains	VBZ	O
largely	RB	O
unchanged	JJ	O
over	IN	O
the	DT	O
past	JJ	O
few	JJ	O
days	NNS	O
.	.	O

she	PRP	O
denies	VBZ	O
any	DT	B-PROBLEM
cp	JJ	I-PROBLEM
/	JJ	O
cough	NN	B-PROBLEM
/	NN	O
fever	NN	B-PROBLEM
/	NNP	O
abd	NN	B-PROBLEM
pain	NN	I-PROBLEM
/	NNP	O
diarrhea	NN	B-PROBLEM
/	NNP	O
black	JJ	B-PROBLEM
or	CC	I-PROBLEM
bloody	JJ	I-PROBLEM
stools	NNS	I-PROBLEM
/	JJ	O
headache	NN	B-PROBLEM
.	.	O

htn	NN	B-PROBLEM

afib	NN	B-PROBLEM
,	,	O
sss	NN	B-PROBLEM

copd	NN	B-PROBLEM

cad	NN	B-PROBLEM

pacer	NN	B-TREATMENT
dddr	NN	I-TREATMENT
(	(	I-TREATMENT
vitatron	FW	I-TREATMENT
cl860	NN	I-TREATMENT
)	)	I-TREATMENT
placed	VBD	O
05-08	NN	O
for	IN	O
sss	NN	B-PROBLEM
with	IN	O
symptomatic	JJ	B-PROBLEM
bradycardia	NN	I-PROBLEM
,	,	O
c/b	NN	O
r	NN	B-PROBLEM
ptx	NN	I-PROBLEM
requiring	VBG	O
chest	JJS	B-TREATMENT
tube	NN	I-TREATMENT

gerd	NN	B-PROBLEM

cva	NN	B-PROBLEM

hypothyroidism	NN	B-PROBLEM

legally	RB	B-PROBLEM
blind	VB	I-PROBLEM

exam	NN	O
:	:	O
t	NN	B-TEST
96.2	CD	O
hr	NN	B-TEST
70	CD	O
bp	NN	B-TEST
118/46	CD	O
r	NN	B-TEST
24	CD	O
sat	VBD	B-TEST
90%	CD	O
on	IN	O
60%fm	CD	B-TREATMENT

pulsus	NN	B-PROBLEM
parodoxus	NN	I-PROBLEM
=	VBD	O
6-8	CD	O
mm	NN	O

gen	NN	O
:	:	O
mild	JJ	B-PROBLEM
resp	NN	I-PROBLEM
distress	NN	I-PROBLEM
speaking	NN	O
in	IN	O
full	JJ	O
sentences	NNS	O
but	CC	O
using	VBG	O
accessory	JJ	O
muscles	NNS	O

heent	NN	O
:	:	O
mmm	NN	O
,	,	O
jvp	NN	B-TEST
at	IN	O
14	CD	O
cm	NN	O
,	,	O
no	DT	O
bruits	NNS	B-PROBLEM
,	,	O
supple	NN	O

pulm	NN	O
:	:	O
no	DT	O
bs	JJ	B-TEST
01-15	JJ	O
way	NN	O
up	IN	O
bilat	NN	O
,	,	O
no	DT	O
consolidation	NN	B-PROBLEM

abd	NN	O
:	:	O
s/nt/slightly	RB	O
distended	VBD	B-PROBLEM
,	,	O
dec	JJ	B-PROBLEM
bs	NN	I-PROBLEM
,	,	O
no	DT	O
cva	NN	B-PROBLEM
tenderness	NN	I-PROBLEM

ext	NN	O
:	:	O
1+	CD	B-PROBLEM
le	NN	I-PROBLEM
edema	NN	I-PROBLEM

ecg	NN	B-TEST
:	:	O
a	DT	O
paced	VBN	O
at	IN	O
70	CD	O
bpm	NN	O
/	NNP	O
nml	NN	O
axis	NN	O
,	,	O
lbbb	NN	B-PROBLEM
,	,	O
no	DT	O
st	NN	B-PROBLEM
or	CC	I-PROBLEM
tw	NN	I-PROBLEM
changes	NNS	I-PROBLEM

cxr	NN	B-TEST
at	IN	O
erich	JJ	O
lindemann	JJ	O
mental	JJ	O
health	NN	O
center	NN	O
05-26	NN	O
:	:	O
bilateral	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
eff	NN	I-PROBLEM
and	CC	O
pericardial	JJ	B-PROBLEM
eff	NN	I-PROBLEM

ct	NN	B-TEST
chest	NN	I-TEST
at	IN	O
erich	JJ	O
lindemann	JJ	O
mental	JJ	O
health	NN	O
center	NN	O
05-25	NN	O
:	:	O
large	JJ	B-PROBLEM
pericardial	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
,	,	O
bilat	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
eff	NN	I-PROBLEM
with	IN	O
underlying	JJ	B-PROBLEM
consolidation	NN	I-PROBLEM
which	WDT	O
could	MD	O
represent	VB	O
pna	JJ	B-PROBLEM
vs.	FW	O
atelectasis	NN	B-PROBLEM

tte	NN	B-TEST
at	IN	O
erich	JJ	O
lindemann	JJ	O
mental	JJ	O
health	NN	O
center	NN	O
05-26	NN	O
:	:	O
mod-lg	JJ	B-PROBLEM
circumferential	JJ	I-PROBLEM
pericardial	NN	I-PROBLEM
eff	NN	I-PROBLEM
,	,	O
no	DT	O
evidence	NN	O
of	IN	O
rv	JJ	B-PROBLEM
diastolic	JJ	I-PROBLEM
collapse	NN	I-PROBLEM
,	,	O
no	DT	O
mv	NN	O
inflow	JJ	O
evidence	NN	O
of	IN	O
tamponade	NN	B-PROBLEM
,	,	O
pacer	JJ	B-TREATMENT
lead	NN	I-TREATMENT
located	VBN	O
in	IN	O
rv	NN	O
apex	NN	O

head	NN	B-TEST
ct	NN	I-TEST
at	IN	O
erich	JJ	O
lindemann	JJ	O
mental	JJ	O
health	NN	O
center	NN	O
05-24	NN	O
:	:	O
atrophy	NN	B-PROBLEM
,	,	O
dense	JJ	B-PROBLEM
calcification	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
tentorium	NN	I-PROBLEM
,	,	O
most	RBS	O
likely	JJ	O
of	IN	O
metabolic	JJ	O
etiology	NN	O

imaging	VBG	B-TEST
at	IN	O
providence	NN	O
behavioral	JJ	O
health	NN	O
hospital	NN	O
:	:	O

echo	JJ	B-TEST
2018-05-28	JJ	O

impression	NN	O
:	:	O
moderate	NN	B-PROBLEM
to	TO	I-PROBLEM
large	JJ	I-PROBLEM
pericardial	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
(	(	O
minimal	JJ	B-PROBLEM
fluid	NN	I-PROBLEM
anteriorly	RB	I-PROBLEM
(	(	O
1cm	CD	O
),	NN	O
?	.	O
bloody	NN	B-PROBLEM
).	NN	O

no	DT	O
definite	NN	B-PROBLEM
tamponade	VBD	I-PROBLEM
physiology	NN	I-PROBLEM
.	.	O

pacer	NN	B-TREATMENT
seen	VBN	O
in	IN	O
rv	NN	O
apex	NN	O
,	,	O
but	CC	O
cannot	JJ	O
exclude	JJ	O
perforation	NN	B-PROBLEM
.	.	O

cxr	NN	B-TEST
2018-05-30	JJ	O

findings	NNS	O
:	:	O
the	DT	B-TEST
lung	NN	I-TEST
volumes	NNS	I-TEST
are	VBP	O
moderate	JJ	O
bilateral	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
are	VBP	O
unchanged	JJ	O
.	.	O

mild	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
edema	NN	I-PROBLEM
is	VBZ	O
unchanged	JJ	O
.	.	O

lung	NN	B-TEST
volumes	NNS	I-TEST
are	VBP	O
low	JJ	B-PROBLEM
.	.	O

bibasilar	JJ	B-PROBLEM
atelectasis	NN	I-PROBLEM
is	VBZ	O
unchanged	JJ	O
.	.	O

impression	NN	O
:	:	O
unchanged	JJ	B-PROBLEM
moderate	JJ	I-PROBLEM
bilateral	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
and	CC	O
mild	JJ	B-PROBLEM
chf	NN	I-PROBLEM
.	.	O

renal	JJ	B-TEST
us	PRP	I-TEST
2018-05-28	JJ	O

findings	NNS	O
:	:	O
the	DT	O
right	JJ	O
kidney	NN	O
measures	NNS	O
11	CD	O
cm	NN	O
in	IN	O
length	NN	B-TEST
,	,	O
the	DT	O
left	JJ	O
kidney	NN	O
measures	NNS	O
9.7	CD	O
cm	NN	O
in	IN	O
length	NN	B-TEST
.	.	O

no	DT	O
hydronephrosis	NN	B-PROBLEM
is	VBZ	O
seen	VBN	O
.	.	O

no	DT	O
urinary	JJ	B-PROBLEM
calculi	NNS	I-PROBLEM
are	VBP	O
seen	VBN	O
.	.	O

the	DT	O
bladder	NN	O
appears	VBZ	O
unremarkable	JJ	O
and	CC	O
contains	VBZ	O
a	DT	B-TREATMENT
foley	NN	I-TREATMENT
catheter	NN	I-TREATMENT
.	.	O

impression	NN	O
:	:	O
no	DT	O
evidence	NN	O
of	IN	O
hydronephrosis	NN	B-PROBLEM
.	.	O

82	CD	O
y/o	JJ	O
f	NN	O
w	NN	O
h/o	NN	O
afib	NN	B-PROBLEM
,	,	O
sss	JJ	B-PROBLEM
s/p	JJ	O
pacer	NN	B-TREATMENT
05-08	JJ	O
c/b	NN	O
ptx	NN	B-PROBLEM
requiring	VBG	O
ct	NN	B-TREATMENT
,	,	O
cad	NN	B-PROBLEM
,	,	O
who	WP	O
was	VBD	O
readmitted	VBN	O
05-24	JJ	O
with	IN	O
arf	NN	B-PROBLEM
and	CC	O
lethargy	NN	B-PROBLEM
,	,	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
pericardial	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
and	CC	O
bilateral	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
,	,	O
with	IN	O
echo	JJ	B-TEST
showing	VBG	O
no	DT	O
evidence	NN	O
of	IN	O
tamponade	NN	B-PROBLEM
,	,	O
who	WP	O
is	VBZ	O
transferred	VBN	O
for	IN	O
possible	JJ	O
pericardial	JJ	B-TREATMENT
effusion	NN	I-TREATMENT
drainage	NN	I-TREATMENT
and	CC	O
treatment	NN	B-TREATMENT
of	IN	O
chf	NN	B-PROBLEM
,	,	O
as	RB	O
well	RB	O
as	IN	O
drainage	NN	B-TREATMENT
of	IN	O
bilateral	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
a	DT	B-TEST
bnp	NN	I-TEST
of	IN	O
>	JJ	O
5000	CD	O
on	IN	O
admission	NN	O
.	.	O

since	IN	O
admission	NN	O
,	,	O
she	PRP	O
ruled	VBD	O
out	RP	O
for	IN	O
mi	NN	B-PROBLEM
by	IN	O
enzymes	NNS	B-TEST
,	,	O
and	CC	O
had	VBD	O
a	DT	B-TEST
right	NN	I-TEST
sided	VBN	I-TEST
thoracentesis	NN	I-TEST
which	WDT	O
yielded	VBD	O
transudative	JJ	B-PROBLEM
fluid	NN	I-PROBLEM
.	.	O

wbc	NN	B-TEST
s	NN	I-TEST
since	IN	O
admission	NN	O
were	VBD	O
as	RB	O
high	JJ	O
as	IN	O
14,000	CD	O
but	CC	O
normalized	JJ	O
.	.	O

she	PRP	O
also	RB	O
had	VBD	O
2	CD	B-TEST
echocardiograms	NNS	I-TEST
which	WDT	O
revealed	VBD	O
persistent	JJ	B-PROBLEM
pericardial	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
been	VBN	O
gently	RB	O
diuresed	VBN	O
but	CC	O
has	VBZ	O
worsening	VBG	B-PROBLEM
arf	RP	I-PROBLEM
.	.	O

her	PRP$	B-PROBLEM
o2	JJ	I-PROBLEM
requirement	NN	I-PROBLEM
has	VBZ	O
increased	VBN	O
despite	IN	O
diuresis	NN	B-TREATMENT
.	.	O

she	PRP	O
denies	VBZ	O
any	DT	O
cp	JJ	B-PROBLEM
/	JJ	O
cough	NN	B-PROBLEM
/	NN	O
fever	NN	B-PROBLEM
,	,	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
/	NNP	O
diarrhea	NN	B-PROBLEM
,	,	O
black	JJ	B-PROBLEM
or	CC	I-PROBLEM
bloody	JJ	I-PROBLEM
stools	NNS	I-PROBLEM
or	CC	O
headache	NN	B-PROBLEM
.	.	O

her	PRP$	B-TEST
urine	JJ	I-TEST
output	NN	I-TEST
decreased	VBD	B-PROBLEM
to	TO	O
nearly	RB	O
zero	NN	O
.	.	O

in	IN	O
the	DT	O
setting	NN	O
of	IN	O
her	PRP$	B-PROBLEM
ongoing	JJ	I-PROBLEM
pericardial	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
,	,	O
she	PRP	O
was	VBD	O
transferred	VBN	O
for	IN	O
closer	JJR	O
observation	NN	O
to	TO	O
the	DT	O
ccu	NN	O
.	.	O

the	DT	O
ccu	NN	O
fellow	NN	O
and	CC	O
team	NN	O
declined	VBD	O
to	TO	O
do	VB	O
pericardial	JJ	B-TREATMENT
drainage	NN	I-TREATMENT
,	,	O
as	IN	O
the	DT	O
pt	NN	O
was	VBD	O
hemodynamically	RB	O
stable	JJ	O
,	,	O
without	IN	O
change	NN	B-PROBLEM
in	IN	I-PROBLEM
appearance	NN	I-PROBLEM
of	IN	I-PROBLEM
effusion	NN	I-PROBLEM
by	IN	O
echo	NN	B-TEST
performed	VBN	O
at	IN	O
bedside	NN	O
by	IN	O
cards	NNS	O
fellow	NN	O
.	.	O

as	IN	O
she	PRP	O
was	VBD	O
felt	VBN	O
by	IN	O
the	DT	O
ccu	NN	O
to	TO	O
be	VB	O
a	DT	O
poor	JJ	O
candidate	NN	O
for	IN	O
right	JJ	B-TEST
heart	NN	I-TEST
cath	NN	I-TEST
,	,	O
was	VBD	O
hemodynamically	RB	O
stable	JJ	O
with	IN	O
blood	NN	B-TEST
pressure	NN	I-TEST
110	CD	O
s-	JJ	O
120	CD	O
s	JJ	O
systolic	NN	B-TEST
and	CC	O
pulse	JJ	B-TEST
70	CD	O
s-	JJ	O
80	CD	O
s	NN	O
,	,	O
she	PRP	O
was	VBD	O
called	VBN	O
out	IN	O
of	IN	O
the	DT	O
ccu	NN	O
and	CC	O
back	RB	O
to	TO	O
the	DT	O
cardiac	JJ	O
floor	NN	O
without	IN	O
intervention	NN	B-TREATMENT
.	.	O

the	DT	O
procedure	NN	O
team	NN	O
was	VBD	O
called	VBN	O
to	TO	O
consider	VB	O
doing	VBG	O
a	DT	B-TREATMENT
left	JJ	I-TREATMENT
thoracentesis	NN	I-TREATMENT
,	,	O
but	CC	O
she	PRP	O
was	VBD	O
declined	VBN	O
because	IN	O
it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
her	PRP$	B-PROBLEM
effusions	NNS	I-PROBLEM
were	VBD	O
transudative	JJ	B-PROBLEM
,	,	O
secondary	JJ	O
to	TO	O
chf	VB	B-PROBLEM
,	,	O
and	CC	O
it	PRP	O
was	VBD	O
recommended	VBN	O
to	TO	O
treat	VB	O
chf	NN	B-PROBLEM
.	.	O

the	DT	O
pt	NN	O
continued	VBD	O
to	TO	O
have	VB	O
low	JJ	B-PROBLEM
urine	JJ	I-PROBLEM
output	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
given	VBN	O
a	DT	B-TREATMENT
lasix	JJ	I-TREATMENT
drip	NN	I-TREATMENT
iv	NN	I-TREATMENT
upon	IN	O
call-out	NN	O
of	IN	O
the	DT	O
icu	NN	O
,	,	O
and	CC	O
additional	JJ	O
boluses	NNS	B-TREATMENT
of	IN	I-TREATMENT
iv	NN	I-TREATMENT
lasix	NN	I-TREATMENT
,	,	O
200	CD	O
mg	NN	O
then	RB	O
300	CD	O
mg	NNS	O
iv	NN	O
were	VBD	O
given	VBN	O
with	IN	O
a	DT	O
good	JJ	O
response	NN	O
,	,	O
however	RB	O
,	,	O
she	PRP	O
remained	VBD	O
net	JJ	B-PROBLEM
positive	JJ	I-PROBLEM
fluid	NN	I-PROBLEM
balance	NN	I-PROBLEM
.	.	O

renal	JJ	O
consultants	NNS	O
did	VBD	O
not	RB	O
feel	VB	O
there	RB	O
was	VBD	O
an	DT	O
emergent	JJ	O
need	NN	O
for	IN	O
dialysis	NN	B-TREATMENT
.	.	O

a	DT	B-TREATMENT
nitro	JJ	I-TREATMENT
drip	NN	I-TREATMENT
was	VBD	O
started	VBN	O
in	IN	O
an	DT	O
effort	NN	O
to	TO	O
decrease	VB	O
her	PRP$	O
preload	NN	B-TEST
and	CC	O
afterload	NN	B-TEST
.	.	O

on	IN	O
call	NN	O
out	IN	O
from	IN	O
the	DT	O
ccu	NN	O
,	,	O
the	DT	O
pt	NN	O
was	VBD	O
satting	VBG	B-TEST
93%	CD	O
on	IN	O
4-5l	JJ	O
nc	NN	B-TREATMENT
,	,	O
and	CC	O
through	IN	O
the	DT	O
following	JJ	O
night	NN	O
,	,	O
her	PRP$	B-PROBLEM
oxygen	JJ	I-PROBLEM
requirement	NN	I-PROBLEM
increased	VBD	O
to	TO	O
nrb	VB	B-TREATMENT
,	,	O
wherein	VB	O
she	PRP	O
was	VBD	O
satting	VBG	B-TEST
upper	JJ	O
80	CD	O
s-	JJ	O
low	JJ	O
90	CD	O
s.	NN	O

abg	NN	B-TEST
that	IN	O
evening	NN	O
was	VBD	O
7.29/51/56	CD	O
on	IN	O
4l	CD	O
nc	NNS	B-TREATMENT
and	CC	O
early	RB	O
the	DT	O
next	JJ	O
morning	NN	O
,	,	O
was	VBD	O
7.25/62/64	CD	O
on	IN	O
nrb	NN	B-TREATMENT
.	.	O

a	DT	B-TEST
cxr	NN	I-TEST
was	VBD	O
performed	VBN	O
the	DT	O
evening	NN	O
of	IN	O
5/16	CD	O
,	,	O
showing	VBG	O
moderate	JJ	B-PROBLEM
sized	VBN	I-PROBLEM
bilateral	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
,	,	O
stable	JJ	B-PROBLEM
cardiomegaly	NN	I-PROBLEM
and	CC	O
a	DT	O
possible	JJ	O
rll	NN	B-PROBLEM
infiltrate	NN	I-PROBLEM
.	.	O

vancomycin	NN	B-TREATMENT
and	CC	O
zosyn	NN	B-TREATMENT
were	VBD	O
started	VBN	O
.	.	O

she	PRP	O
was	VBD	O
afebrile	RB	B-PROBLEM
.	.	O

the	DT	O
morning	NN	O
of	IN	O
5/17	CD	O
,	,	O
her	PRP$	B-TEST
pulsus	NN	I-TEST
parodoxicus	NN	I-TEST
was	VBD	O
12	CD	O
.	.	O

because	IN	O
of	IN	O
her	PRP$	B-TEST
abg	NN	I-TEST
,	,	O
and	CC	O
declining	VBG	O
clinical	JJ	O
status	NN	O
,	,	O
the	DT	O
ccu	NN	O
was	VBD	O
notified	VBN	O
for	IN	O
possible	JJ	O
transfer	NN	O
.	.	O

it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
given	VBN	O
her	PRP$	O
age	NN	O
,	,	O
multiple	JJ	B-PROBLEM
co-morbidities	NNS	I-PROBLEM
,	,	O
that	IN	O
her	PRP$	O
prognosis	NN	O
was	VBD	O
poor	JJ	O
even	RB	O
prior	VBP	O
to	TO	O
ccu	VB	O
admission	NN	O
,	,	O
possible	JJ	O
pericardial	JJ	B-TREATMENT
drainage	NN	I-TREATMENT
or	CC	O
repeat	NN	B-TREATMENT
thoracenteses	NNS	I-TREATMENT
.	.	O

explained	VBN	O
to	TO	O
lewin	VB	O
that	DT	O
pt	NN	O
will	MD	O
likely	RB	O
need	VB	O
to	TO	O
be	VB	O
intubated	VBN	O
,	,	O
as	IN	O
she	PRP	O
cannot	VBZ	O
lie	JJ	O
flat	JJ	O
,	,	O
and	CC	O
most	JJS	O
likely	JJ	O
cannot	NN	O
undergo	JJ	O
pericardial	JJ	B-TREATMENT
drainage	NN	I-TREATMENT
,	,	O
thoracentesis	NN	B-TREATMENT
,	,	O
or	CC	O
right	JJ	B-TREATMENT
heart	NN	I-TREATMENT
cath	NN	I-TREATMENT
with	IN	O
bipap	NN	B-TREATMENT
(	(	O
which	WDT	O
would	MD	O
have	VB	O
been	VBN	O
the	DT	O
next	JJ	O
measure	NN	O
after	IN	O
nrb	NN	B-TREATMENT
,	,	O
and	CC	O
prior	RB	O
to	TO	O
intubation	NN	B-TREATMENT
).	NN	O

explained	VBD	O
that	IN	O
despite	IN	O
these	DT	B-TREATMENT
invasive	JJ	I-TREATMENT
measures	NNS	I-TREATMENT
,	,	O
she	PRP	O
still	RB	O
has	VBZ	O
a	DT	O
very	RB	O
poor	JJ	O
prognosis	NN	O
.	.	O

odell	NN	O
does	VBZ	O
not	RB	O
believe	VB	O
the	DT	O
pt	NN	O
would	MD	O
want	VB	O
to	TO	O
be	VB	O
intubated	VBN	O
,	,	O
with	IN	O
central	JJ	B-TREATMENT
line	NN	I-TREATMENT
,	,	O
right	JJ	B-TREATMENT
heart	NN	I-TREATMENT
cath	NN	I-TREATMENT
,	,	O
in	IN	O
the	DT	O
ccu	NN	O
.	.	O

she	PRP	O
requested	VBD	O
the	DT	O
patient	NN	O
be	VB	O
made	VBN	O
comfort	NN	B-TREATMENT
measures	VBZ	I-TREATMENT
only	RB	O
.	.	O

the	DT	O
pt	NN	O
will	MD	O
be	VB	O
made	VBN	O
comfortable	JJ	O
,	,	O
with	IN	O
goals	NNS	O
of	IN	O
care	NN	O
shifted	VBN	O
towards	NNS	O
suppressing	VBG	O
her	PRP$	B-PROBLEM
air	NN	I-PROBLEM
hunger	NN	I-PROBLEM
and	CC	O
pain	NN	B-PROBLEM
.	.	O

#.	JJ	O
sob	NN	B-PROBLEM
:	:	O
most	RBS	O
consistent	JJ	O
with	IN	O
chf	NN	B-PROBLEM
by	IN	O
exam	NN	B-TEST
,	,	O
although	IN	O
unknown	JJ	O
what	WP	O
the	DT	O
severity	NN	O
of	IN	O
her	PRP$	B-PROBLEM
copd	NN	I-PROBLEM
is	VBZ	O
currently	RB	O
.	.	O

tte	NN	B-TEST
revealed	VBD	O
large	JJ	B-PROBLEM
pericardial	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

pt	NN	O
is	VBZ	O
now	RB	O
s/p	JJ	O
drainage	NN	B-TREATMENT
of	IN	O
right	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
,	,	O
diagnostic	JJ	O
and	CC	O
therapeutic	JJ	O
,	,	O
with	IN	O
studies	NNS	B-TEST
consistent	VBP	O
with	IN	O
transudate	NN	B-PROBLEM
,	,	O
etiology	NN	O
most	RBS	O
likely	JJ	O
02-15	JJ	O
chf	NN	B-PROBLEM
.	.	O

we	PRP	O
continued	VBD	O
her	PRP	B-TREATMENT
albuterol	NN	I-TREATMENT
/	JJ	O
atrovent	NN	B-TREATMENT
nebs	NN	I-TREATMENT
,	,	O
diuresis	NN	B-TREATMENT
with	IN	O
iv	JJ	B-TREATMENT
lasix	NN	I-TREATMENT
drip	NN	I-TREATMENT
and	CC	O
boluses	NNS	B-TREATMENT
.	.	O

her	PRP$	B-TEST
05-27	JJ	I-TEST
cxr	NN	I-TEST
post	NN	O
procedure	NN	O
w/o	NN	O
pnx	NN	B-PROBLEM
,	,	O
effusion	NN	B-PROBLEM
much	RB	O
improved	VBN	O
,	,	O
yet	RB	O
her	PRP$	B-TEST
05-28	JJ	I-TEST
cxr	NN	I-TEST
worse	JJR	O
than	IN	O
05-27	NN	O
with	IN	O
some	DT	O
reaccumulation	NN	O
of	IN	O
right	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

then	RB	O
,	,	O
on	IN	O
05-29	NN	O
,	,	O
she	PRP	O
demonstrated	VBD	O
bilateral	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
(	(	O
reaccumulated	VBN	O
),	RB	O
right	JJ	B-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
infiltrate	NN	I-PROBLEM
(	(	O
started	VBN	O
on	IN	O
vanco	NN	B-TREATMENT
/	JJ	O
zosyn	CD	B-TREATMENT
)->	JJ	O
put	NN	O
on	IN	O
face	NN	B-TREATMENT
mask	NN	I-TREATMENT
,	,	O
given	VBN	O
lasix	VBP	B-TREATMENT
x	JJ	O
1	CD	O
bolus	JJ	O
100	CD	O
mg	NN	O
,	,	O
responded	VBD	O
somewhat	RB	O
and	CC	O
o2	JJ	B-TEST
sat	NN	I-TEST
stable	JJ	O
in	IN	O
low	JJ	O
90	CD	O
s.	NN	O

she	PRP	O
was	VBD	O
given	VBN	O
200	CD	B-TREATMENT
mg	JJ	I-TREATMENT
iv	NN	I-TREATMENT
lasix	NN	I-TREATMENT
x	VBD	O
1	CD	O
with	IN	O
an	DT	O
additional	JJ	O
100	CD	O
cc	NN	O
of	IN	O
urine	JJ	B-TEST
output	NN	I-TEST
the	DT	O
evening	NN	O
of	IN	O
5/16	CD	O
.	.	O

her	PRP$	B-TREATMENT
lasix	NN	I-TREATMENT
gtt	NN	I-TREATMENT
continued	VBD	O
during	IN	O
this	DT	O
time	NN	O
.	.	O

her	PRP$	B-TEST
oxygen	NN	I-TEST
sats	NNS	I-TEST
did	VBD	O
not	RB	O
improve	VB	O
.	.	O

#.	JJ	O
pericardial	JJ	B-PROBLEM
effusion	NN	I-PROBLEM
:	:	O
unclear	JJ	O
etiology	NN	O
,	,	O
osh	NN	O
had	VBD	O
raised	VBN	O
question	NN	O
of	IN	O
rv	JJ	B-PROBLEM
perforation	NN	I-PROBLEM
from	IN	O
pacer	NN	B-TREATMENT
,	,	O
however	RB	O
she	PRP	O
had	VBD	O
a	DT	O
normal	JJ	O
echo	JJ	O
appearance	NN	O
of	IN	O
lead	NN	O
,	,	O
no	DT	O
tamponade	NN	B-PROBLEM
by	IN	O
exam	NN	B-TEST
.	.	O

this	DT	O
has	VBZ	O
still	RB	O
be	VB	O
known	VBN	O
to	TO	O
occur	VB	O
during	IN	O
the	DT	B-TREATMENT
placement	NN	I-TREATMENT
of	IN	I-TREATMENT
pacemaker	NN	I-TREATMENT
.	.	O

it	PRP	O
was	VBD	O
felt	VBN	O
posthumously	RB	O
that	IN	O
her	PRP$	B-PROBLEM
large	JJ	I-PROBLEM
pericardial	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
was	VBD	O
most	RBS	O
likely	JJ	O
secondary	JJ	O
to	TO	O
a	DT	B-PROBLEM
complication	NN	I-PROBLEM
of	IN	O
pacer	NN	B-TREATMENT
placement	NN	I-TREATMENT
,	,	O
although	IN	O
this	DT	O
was	VBD	O
not	RB	O
seen	VBN	O
on	IN	O
imaging	NN	B-TEST
.	.	O

in	IN	O
the	DT	O
last	JJ	O
12	CD	O
hours	NNS	O
of	IN	O
her	PRP$	O
life	NN	O
,	,	O
her	PRP$	B-TEST
pulsus	NN	I-TEST
was	VBD	O
12	CD	O
,	,	O
and	CC	O
she	PRP	O
was	VBD	O
felt	VBN	O
to	TO	O
likely	RB	O
to	TO	O
have	VB	O
aspect	NN	O
of	IN	O
tamponade	NN	B-PROBLEM
physiology	NN	I-PROBLEM
,	,	O
since	IN	O
her	PRP$	B-TEST
preload	NN	I-TEST
was	VBD	O
reduced	VBN	O
.	.	O

#.	JJ	O
chf	NN	B-PROBLEM
:	:	O
normal	JJ	O
ef	NN	O
on	IN	O
tte	NN	B-TEST
so	IN	O
possibly	RB	O
with	IN	O
diastolic	JJ	B-PROBLEM
dysfunction	NN	I-PROBLEM
,	,	O
ruled	VBD	O
out	RP	O
for	IN	O
mi	NN	B-PROBLEM

-	:	O
see	NN	O
course	NN	O
of	IN	O
diuresis	NN	B-TREATMENT
above	IN	O
.	.	O

-	:	O
we	PRP	O
continued	VBD	O
asa	JJ	B-TREATMENT
/	NNP	O
imdur	NN	B-TREATMENT
/	NNP	O
ccb	NN	B-TREATMENT
/	NNP	O
hold	NN	O
diovan	NN	B-TREATMENT
until	IN	O
pt	NN	O
was	VBD	O
made	VBN	O
cmo	NN	O
.	.	O

#.	JJ	O
pleural	JJ	B-PROBLEM
effusions	NNS	I-PROBLEM
:	:	O
likely	RB	O
due	JJ	O
to	TO	O
chf	VB	B-PROBLEM
although	IN	O
had	VBD	O
some	DT	B-PROBLEM
leukocytosis	NN	I-PROBLEM
at	IN	O
admission	NN	O
to	TO	O
osh	VB	O
.	.	O

mary	JJ	B-TEST
studies	NNS	I-TEST
c/w	VBP	O
transudate	NN	B-PROBLEM
.	.	O

-	:	O
after	IN	O
she	PRP	O
was	VBD	O
made	VBN	O
cmo	NN	O
,	,	O
the	DT	O
pt	NN	O
was	VBD	O
started	VBN	O
on	IN	O
morphine	NN	B-TREATMENT
gtt	NN	I-TREATMENT
to	TO	O
maximize	VB	O
comfort	NN	O
and	CC	O
minimize	VB	O
air	NN	B-PROBLEM
hunger	NN	I-PROBLEM
.	.	O

#.	JJ	O
afib/sss	NN	B-PROBLEM
:	:	O
she	PRP	O
was	VBD	O
a-paced	JJ	B-TREATMENT
,	,	O
pacer	NN	B-TREATMENT
placed	VBD	O
05-08	CD	O
in	IN	O
dddr	NN	B-TREATMENT
mode	NN	I-TREATMENT
,	,	O
complicated	VBN	O
by	IN	O
ptx	NN	B-PROBLEM
requiring	VBG	O
chest	JJS	B-TREATMENT
tube	NN	I-TREATMENT
which	WDT	O
resolved	VBD	O
and	CC	O
tube	NN	B-TREATMENT
was	VBD	O
removed	VBN	O
during	IN	O
admit	NN	O
for	IN	O
pacer	NN	B-TREATMENT
,	,	O
no	DT	O
evidence	NN	O
of	IN	O
ptx	NN	B-PROBLEM
on	IN	O
most	JJS	B-TEST
recent	JJ	I-TEST
cxr	NN	I-TEST
.	.	O

her	PRP$	B-TREATMENT
pacer	NN	I-TREATMENT
wires	NNS	I-TREATMENT
in	IN	O
correct	JJ	O
position	NN	O
.	.	O

we	PRP	O
continued	VBD	O
amiodarone	RB	B-TREATMENT
until	IN	O
pt	NN	O
was	VBD	O
made	VBN	O
cmo	NN	O
.	.	O

anticoagulation	NN	B-TREATMENT
has	VBZ	O
not	RB	O
been	VBN	O
given	VBN	O
this	DT	O
admission	NN	O
.	.	O

we	PRP	O
started	VBD	O
her	PRP	O
on	IN	O
dilt	NN	B-TREATMENT
for	IN	O
additional	JJ	B-TREATMENT
a	DT	I-TREATMENT
fib	NN	I-TREATMENT
control	NN	I-TREATMENT
(	(	O
revert	VB	O
back	RB	O
to	TO	O
a	DT	B-PROBLEM
fib	NN	I-PROBLEM
on	IN	O
05-29	NNP	O
),	NNP	O
which	WDT	O
was	VBD	O
stopped	VBN	O
when	WRB	O
the	DT	O
pt	NN	O
was	VBD	O
made	VBN	O
cmo	NN	O
.	.	O

#.	JJ	O
oliguric	JJ	B-PROBLEM
arf	NN	I-PROBLEM
:	:	O
likely	JJ	O
prerenal	JJ	O
due	JJ	O
to	TO	O
n/v	JJ	B-PROBLEM
poor	JJ	B-PROBLEM
po	NNS	I-PROBLEM
intake	VBP	I-PROBLEM
and	CC	O
poor	JJ	B-PROBLEM
forward	RB	I-PROBLEM
flow	NN	I-PROBLEM
,	,	O
however	RB	O
,	,	O
need	VBP	O
to	TO	O
continue	VB	O
diuresis	NN	B-TREATMENT
.	.	O

her	PRP$	B-TEST
urine	JJ	I-TEST
lytes	NNS	I-TEST
consistent	JJ	O
with	IN	O
atn	NN	B-PROBLEM
,	,	O
fena	JJ	B-TEST
4%	CD	O
.	.	O

renal	JJ	B-TEST
u/s	JJ	I-TEST
negative	JJ	O
for	IN	O
hydronephrosis	NN	B-PROBLEM
.	.	O

renal	JJ	O
consultants	NNS	O
did	VBD	O
not	RB	O
feel	VB	O
that	IN	O
there	EX	O
was	VBD	O
an	DT	O
indication	NN	O
for	IN	O
urgent	JJ	B-TREATMENT
hemodialysis	NN	I-TREATMENT
.	.	O

she	PRP	O
continued	VBD	O
to	TO	O
put	VB	O
out	RP	O
low	JJ	B-PROBLEM
amounts	NNS	I-PROBLEM
of	IN	I-PROBLEM
urine	NN	I-PROBLEM
throughout	IN	O
the	DT	O
admission	NN	O
,	,	O
despite	IN	O
aggressive	JJ	B-TREATMENT
diuresis	NN	I-TREATMENT
with	IN	O
iv	JJ	B-TREATMENT
lasix	NN	I-TREATMENT
gtt	NN	I-TREATMENT
and	CC	O
boluses	NNS	B-TREATMENT
.	.	O

#.	JJ	O
id	NN	O
:	:	O
initially	RB	O
had	VBD	O
leukocytosis	NN	B-PROBLEM
at	IN	O
admission	NN	O
,	,	O
with	IN	O
chest	JJ	B-TEST
ct	NN	I-TEST
showing	VBG	O
possible	JJ	O
underlying	JJ	B-PROBLEM
consolidations	NNS	I-PROBLEM
vs.	FW	O
atelectasis	NN	B-PROBLEM
,	,	O
levoflox	NN	B-TREATMENT
started	VBD	O
05-24	CD	O
and	CC	O
subsequently	RB	O
stopped	VBD	O
(	(	O
no	DT	O
consolidations	NNS	B-PROBLEM
on	IN	O
cxr	NN	B-TEST
and	CC	O
afebrile	NN	B-PROBLEM
).	NN	O

u/a	NN	B-TEST
on	IN	O
05-27	JJ	O
c/w	NN	O
uti	NN	B-PROBLEM
.	.	O

pt	NN	O
now	RB	O
on	IN	O
iv	NN	B-TREATMENT
ceftriaxone	NN	I-TREATMENT
(	(	O
was	VBD	O
on	IN	O
levoflox	JJ	B-TREATMENT
since	IN	O
05-24	JJ	O
however	RB	O
ua	RB	B-TEST
now	RB	O
floridly	RB	B-PROBLEM
positive	JJ	I-PROBLEM
(	(	O
more	RBR	O
so	RB	O
than	IN	O
ua	NN	B-TEST
at	IN	O
osh	NN	O
)	)	O
so	RB	O
felt	VBD	O
possibly	RB	O
levo-resistant	JJ	B-PROBLEM
.	.	O

pt	NN	O
started	VBD	O
on	IN	O
ctx	NN	B-TREATMENT
05-27	NN	O
.	.	O

she	PRP	O
was	VBD	O
empirically	RB	O
started	VBN	O
on	IN	O
vanco/zosyn	NN	B-TREATMENT
for	IN	O
empiric	JJ	B-TREATMENT
hosp	NN	I-TREATMENT
acquired	VBD	I-TREATMENT
pna	JJ	I-TREATMENT
coverage	NN	I-TREATMENT

-	:	O
possible	JJ	O
opacity	NN	B-PROBLEM
on	IN	O
cxr	NN	B-TEST
-	:	O
along	IN	O
w/	JJ	O
leukocytosis	NN	B-PROBLEM
.	.	O

#.	JJ	O
anemia	NN	B-PROBLEM
:	:	O
unclear	JJ	O
source	NN	O
.	.	O

she	PRP	O
was	VBD	O
guiaic	JJ	B-TEST
negative	JJ	O
.	.	O

-	:	O
no	DT	O
transfusions	NNS	B-TREATMENT
,	,	O
cmo/dnr/dni	NN	O

#.	JJ	O
fen	NN	O
:	:	O
check	NN	O
lytes	NNS	B-TEST
,	,	O
most	JJS	O
recently	RB	O
normal	JJ	O
.	.	O

cardiac/renal	JJ	B-TREATMENT
diet	NN	I-TREATMENT

#.	JJ	O
access	NN	O
:	:	O
piv	NN	B-TREATMENT

aranesp	RB	B-TREATMENT
100	CD	O
mcg	NN	O
(	(	O
x1	JJ	O
05-26	NN	O
)	)	O

diltiazem	JJ	B-TREATMENT
cd	NN	I-TREATMENT
240	CD	O
mg	NN	O

paxil	NN	B-TREATMENT
20	CD	O
mg	JJ	O
daily	JJ	O

detrol	NN	B-TREATMENT
la	VBZ	I-TREATMENT
4	CD	O
mg	JJ	O
daily	JJ	O

ec	NN	B-TREATMENT
asa	VBD	I-TREATMENT
81	CD	O
mg	NNS	O
daily	RB	O

pepcid	NN	B-TREATMENT
20	CD	O
mg	JJ	O
daily	JJ	O

amiodarone	RB	B-TREATMENT
200	CD	O
mg	NNS	O
daily	RB	O

levofloxacin	RB	B-TREATMENT
250	CD	O
mg	NNS	O
iv	JJ	O
daily	JJ	O
(	(	O
started	JJ	O
05-24	NN	O
)	)	O

levothyroxine	NN	B-TREATMENT
50	CD	O
mcg	JJ	O
daily	JJ	O

diovan	NN	B-TREATMENT
160	CD	O
mg	JJ	O
daily	JJ	O

imdur	NN	B-TREATMENT
60	CD	O
mg	JJ	O
daily	JJ	O

albuterol-ipratroprium	JJ	B-TREATMENT
inh	NN	O
2	CD	O
sprays	NNS	O
tid	VBP	O
prn	NN	O

1.	CD	O
pulmonary	JJ	B-PROBLEM
edema	NN	I-PROBLEM
and	CC	O
hypoxic	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
failure	NN	I-PROBLEM

2.	CD	O
large	JJ	B-PROBLEM
pericardial	JJ	I-PROBLEM
effusion	NN	I-PROBLEM

3.	CD	O
moderate	JJ	B-PROBLEM
bilateral	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM

4.	CD	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM

5.	CD	O
paroxysmal	JJ	B-PROBLEM
atrial	JJ	I-PROBLEM
fibrillation	NN	I-PROBLEM

6.	CD	O
sick	JJ	B-PROBLEM
sinus	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
status	NN	O
post	NN	O
pacer	NN	B-TREATMENT
placement	NN	I-TREATMENT

7.	CD	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM

penicillins	NNS	B-TREATMENT

dyspnea	NN	B-PROBLEM

46	CD	O
-	:	O
yo-man	JJ	O
w/	NN	O
active	JJ	O
cocaine	NN	O
use	NN	O
presents	NNS	O
w/	VBP	O
le	JJ	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

10	CD	O
days	NNS	O
ago	RB	O
,	,	O
he	PRP	O
developed	VBD	O
b/l	VB	B-PROBLEM
le	JJ	I-PROBLEM
edema	NN	I-PROBLEM
that	WDT	O
has	VBZ	O
gotten	VBN	O
progressively	RB	O
worse	RBR	O
until	IN	O
now	RB	O
.	.	O

three	CD	O
days	NNS	O
ago	RB	O
,	,	O
he	PRP	O
developed	VBD	O
dyspnea	NN	B-PROBLEM
on	IN	O
exertion	NN	O
when	WRB	O
climbing	VBG	O
stairs	NNS	O
,	,	O
assoc	JJ	O
w/	JJ	O
2-pillow	JJ	B-PROBLEM
orthopnea	NN	I-PROBLEM
and	CC	O
pnd	NN	B-PROBLEM
.	.	O

he	PRP	O
denies	VBZ	O
any	DT	B-PROBLEM
recent	JJ	I-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
palpitations	NNS	B-PROBLEM
,	,	O
headache	NN	B-PROBLEM
,	,	O
confusion	NN	B-PROBLEM
,	,	O
weakness	NN	B-PROBLEM
,	,	O
numbness	RB	B-PROBLEM
,	,	O
abd	JJ	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
or	CC	O
hematuria	NNS	B-PROBLEM
.	.	O

no	DT	O
recent	JJ	B-PROBLEM
viral	JJ	I-PROBLEM
syndromes	NNS	I-PROBLEM
or	CC	O
uri	JJ	B-PROBLEM
s.	NN	I-PROBLEM

today	NN	O
,	,	O
his	PRP$	O
wife	NN	O
convinced	VBD	O
him	PRP	O
to	TO	O
present	VB	O
to	TO	O
the	DT	O
deanna	NN	O
for	IN	O
evaluation	NN	B-TEST
.	.	O

in	IN	O
the	DT	O
deanna	NN	O
,	,	O
his	PRP$	B-TEST
bp	NN	I-TEST
was	VBD	O
230/170	CD	O
.	.	O

bnp	NN	B-TEST
was	VBD	O
elevated	VBN	O
at	IN	O
7500	CD	O
.	.	O

cxr	NN	B-TEST
revealed	VBD	O
evidence	NN	O
of	IN	O
cardiomegaly	NN	B-PROBLEM
and	CC	O
pulm	NN	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
treated	VBN	O
w/	JJ	O
asa	RB	B-TREATMENT
325	CD	O
mg	NN	O
,	,	O
lasix	VBZ	B-TREATMENT
10	CD	O
mg	NN	O
iv	NN	O
,	,	O
and	CC	O
hydralazine	VB	B-TREATMENT
10	CD	O
mg	NN	O
iv	NN	O
x	VBD	O
2	CD	O
.	.	O

he	PRP	O
responded	VBD	O
well	RB	O
to	TO	O
lasix	VB	B-TREATMENT
w/	RB	O
good	JJ	O
uop	NN	B-TEST
,	,	O
but	CC	O
diastolic	JJ	B-TEST
bp	NN	I-TEST
remained	VBD	O
elevated	VBN	B-PROBLEM
at	IN	O
170	CD	O
,	,	O
prompting	VBG	O
initiation	NN	O
of	IN	O
nitroprusside	JJ	B-TREATMENT
gtt	NN	I-TREATMENT
.	.	O

drinks	NNS	O
3-4	JJ	O
beers	NNS	O
a	DT	O
few	JJ	O
times	NNS	O
weekly	RB	O
,	,	O
no	DT	O
h/o	NN	O
withdrawal	NN	B-PROBLEM
symptoms	NNS	I-PROBLEM
,	,	O
seizures	NNS	B-PROBLEM
or	CC	O
dt	NNS	B-PROBLEM
s.	VBP	I-PROBLEM

there	EX	O
is	VBZ	O
no	DT	O
family	NN	O
history	NN	O
of	IN	O
premature	NN	B-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
or	CC	O
sudden	JJ	B-PROBLEM
death	NN	I-PROBLEM
.	.	O

vs	NN	B-TEST
:	:	O
t,	NN	B-TEST
bp	NN	B-TEST
181/122	CD	O
,	,	O
hr	NN	B-TEST
84	CD	O
,	,	O
rr	NN	B-TEST
12	CD	O
,	,	O
o2	VBD	B-TEST
98%	CD	O
2l/m	CD	O

gen	NN	O
:	:	O
lying	VBG	O
flat	JJ	O
in	IN	O
bed	NN	O
,	,	O
pleasant	NN	O
and	CC	O
conversational	JJ	O
,	,	O
nad	JJ	B-PROBLEM

heent	NN	O
:	:	O
ncat	NN	B-PROBLEM
.	.	O

sclera	NN	B-PROBLEM
anicteric	NN	I-PROBLEM
.	.	O

neck	NN	O
:	:	O
supple	NN	O
with	IN	O
jvp	NN	B-TEST
of	IN	O
8	CD	O
cm	NN	O
.	.	O

cv	NN	O
:	:	O
reg	NN	O
s1	NN	O
,	,	O
loud	JJ	B-PROBLEM
s2	NN	I-PROBLEM
,	,	O
+	VBZ	O
2/6	CD	B-PROBLEM
systolic	JJ	I-PROBLEM
murmur	NN	I-PROBLEM
radiating	VBG	I-PROBLEM
to	TO	I-PROBLEM
axilla	VB	I-PROBLEM
,	,	O
no	DT	O
s3/s4/r	NN	B-PROBLEM

pulm	NN	O
:	:	O
cta	NN	O
b/l	NN	O
w/	VBZ	O
no	DT	O
crackles	NNS	B-PROBLEM
or	CC	O
wheezing	VBG	B-PROBLEM

abd	NN	O
:	:	O
obese	JJ	B-PROBLEM
,	,	O
+bs	NNP	O
,	,	O
soft	JJ	O
,	,	O
ntnd	JJ	B-PROBLEM
.	.	O

ext	NN	O
:	:	O
warm	NN	O
,	,	O
2+	CD	O
dp	NN	B-TEST
b/l	NN	O
,	,	O
2+	CD	B-PROBLEM
pitting	VBG	I-PROBLEM
edema	NN	I-PROBLEM
to	TO	I-PROBLEM
knees	NNS	I-PROBLEM
b/l	VB	I-PROBLEM

wbc	SYM	B-TEST
-	:	O
7.7	CD	O
rbc	NN	B-TEST
-	:	O
5.00	CD	O
hgb	NN	B-TEST
-	:	O
15.0	CD	O
hct	NN	B-TEST
-	:	O
42.8	CD	O
mcv	SYM	B-TEST
-	:	O
86	CD	O
mch	SYM	B-TEST
-	:	O
30.0	CD	O
mchc	SYM	B-TEST
-	:	O
35.0	CD	O
rdw	NN	B-TEST
-	:	O
14.6	CD	O

plt	NN	B-TEST
count	NN	I-TEST
-	:	O
315	CD	O

ck-mb	JJ	B-TEST
-	:	O
4	CD	O
probnp	NN	B-TEST
-	:	O
7489	CD	O
*	NN	O

ctropnt	SYM	B-TEST
-	:	O
0.02	CD	O
*	NN	O

alt(sgpt)	SYM	B-TEST
-	:	O
77	CD	O
*	NN	O
ast(sgot)	SYM	B-TEST
-	:	O
60	CD	O
*	NN	O
ck(cpk)	NN	B-TEST
-	:	O
195	CD	O
*	JJ	O
alk	NN	B-TEST
phos	SYM	I-TEST
-	:	O
104	CD	O
amylase	NN	B-TEST
-	:	O
100	CD	O
tot	NN	B-TEST
bili	SYM	I-TEST
-	:	O
0.4	CD	O

ekg	RB	B-TEST
demonstrated	VBN	O
nsr	NN	O
at	IN	O
87	CD	O
bpm	NN	O
,	,	O
nl	JJ	O
axis	NN	O
,	,	O
nl	JJ	O
int	NN	O
,	,	O
lvh	JJ	B-PROBLEM
w/	NN	O
strain	NN	B-PROBLEM
pattern	NN	I-PROBLEM
,	,	O
no	DT	O
ischemic	JJ	B-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

cxr	NN	B-TEST
:	:	O

moderate	NN	B-PROBLEM
to	TO	I-PROBLEM
severe	VB	I-PROBLEM
enlargement	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
cardiac	JJ	I-PROBLEM
silhouette	NN	I-PROBLEM
,	,	O
and	CC	O
particularly	RB	O
the	DT	O
left	NN	O
atrium	NN	O
accompanied	VBN	O
by	IN	O
pulmonary	JJ	B-PROBLEM
vascular	JJ	I-PROBLEM
congestion	NN	I-PROBLEM
and	CC	O
mild	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
edema	NN	I-PROBLEM
consistent	NN	O
with	IN	O
heart	NN	B-PROBLEM
failure	NN	I-PROBLEM
.	.	O

the	DT	O
left	JJ	O
atrium	NN	O
is	VBZ	O
moderately	RB	B-PROBLEM
dilated	VBN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
moderate	JJ	B-PROBLEM
symmetric	JJ	I-PROBLEM
left	VBD	I-PROBLEM
ventricular	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
with	IN	O
mild	JJ	B-PROBLEM
cavity	NN	I-PROBLEM
dilation	NN	I-PROBLEM
and	CC	O
severe	JJ	B-PROBLEM
global	JJ	I-PROBLEM
hypokinesis	NN	I-PROBLEM
.	.	O

no	DT	O
left	VBD	B-PROBLEM
ventricular	JJ	I-PROBLEM
thrombus	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
.	.	O

tissue	NN	B-TEST
doppler	NN	I-TEST
imaging	VBG	I-TEST
suggests	VBZ	O
an	DT	B-PROBLEM
increased	VBN	I-PROBLEM
left	NN	I-PROBLEM
ventricular	JJ	I-PROBLEM
filling	NN	I-PROBLEM
pressure	NN	I-PROBLEM
(	(	O
pcwp	JJ	B-TEST
>	$	O
18	CD	O
mmhg	NN	O
).	NN	O

the	DT	O
right	JJ	O
ventricular	NN	O
cavity	NN	O
is	VBZ	O
mildly	RB	B-PROBLEM
dilated	VBN	I-PROBLEM
with	IN	O
severe	JJ	B-PROBLEM
free	JJ	I-PROBLEM
wall	NN	I-PROBLEM
hypokinesis	NN	I-PROBLEM
.	.	O

the	DT	O
aortic	JJ	O
valve	NN	O
leaflets	NNS	O
(	(	O
3	CD	O
)	)	O
are	VBP	O
minimally	RB	B-PROBLEM
thickened	VBN	I-PROBLEM
.	.	O

no	DT	O
aortic	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
or	CC	O
aortic	JJ	B-PROBLEM
regurgitation	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
mitral	JJ	B-PROBLEM
valve	NN	I-PROBLEM
prolapse	NN	I-PROBLEM
.	.	O

mild	NN	B-PROBLEM
(	(	I-PROBLEM
1+	CD	I-PROBLEM
)	)	I-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
.	.	O

there	EX	O
is	VBZ	O
moderate	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
systolic	JJ	I-PROBLEM
hypertension	NN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
a	DT	B-PROBLEM
very	RB	I-PROBLEM
small	JJ	I-PROBLEM
circumferential	JJ	I-PROBLEM
pericardial	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

impression	NN	O
:	:	O
moderate	JJ	B-PROBLEM
symmetric	NN	I-PROBLEM
eft	VBD	I-PROBLEM
ventricular	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
with	IN	O
severe	JJ	B-PROBLEM
global	JJ	I-PROBLEM
biventricular	JJ	I-PROBLEM
hypokinesis	NN	I-PROBLEM
c/w	NN	O
diffuse	NN	B-PROBLEM
process	NN	I-PROBLEM
(	(	O
toxin	NN	B-PROBLEM
,	,	O
metabolic	NN	O
,	,	O
cannot	JJ	O
exclude	NN	O
myocarditis	NN	B-PROBLEM
;	:	O
in	IN	O
the	DT	O
absence	NN	O
of	IN	O
lvh	NN	B-PROBLEM
on	IN	O
ecg	NN	B-TEST
,	,	O
an	DT	B-PROBLEM
infiltrative	JJ	I-PROBLEM
process	NN	I-PROBLEM
should	MD	O
also	RB	O
be	VB	O
considered	VBN	O
).	JJ	O

mild	JJ	B-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

moderate	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
arterial	JJ	I-PROBLEM
hypertension	NN	I-PROBLEM
.	.	O

very	RB	B-PROBLEM
small	JJ	I-PROBLEM
circumferential	JJ	I-PROBLEM
pericardial	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

possible	JJ	O
abnormality	NN	B-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
aortic	JJ	I-PROBLEM
valve	NN	I-PROBLEM
as	IN	O
described	VBN	O
above	IN	O
without	IN	O
aortic	JJ	B-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

if	IN	O
clinically	RB	O
indicated	VBD	O
a	DT	B-TEST
tee	NN	I-TEST
would	MD	O
be	VB	O
better	RBR	O
able	JJ	O
to	TO	O
define	VB	O
an	DT	B-PROBLEM
abnormality	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
aortic	JJ	I-PROBLEM
valve	NN	I-PROBLEM
.	.	O

46	CD	O
-	:	O
yo-man	JJ	O
w/	JJ	O
cocaine	NN	O
abuse	NN	O
presents	VBZ	O
w/	JJ	O
le	JJ	B-PROBLEM
edema	NN	I-PROBLEM
and	CC	O
doe	VB	B-PROBLEM
likely	RB	O
from	IN	O
diastolic	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
cocaine	NN	O
use	NN	O
complicated	VBN	O
by	IN	O
hypertensive	JJ	B-PROBLEM
urgency	NN	I-PROBLEM
.	.	O

hypertensive	JJ	B-PROBLEM
urgency	NN	I-PROBLEM
:	:	O

bp	RB	B-TEST
230/170	CD	O
on	IN	O
presentation	NN	O
,	,	O
most	RBS	O
likely	JJ	O
from	IN	O
chronic	JJ	B-PROBLEM
htn	NN	I-PROBLEM
exacerbated	VBN	O
by	IN	O
cocaine	NN	O
use	NN	O
.	.	O

no	DT	O
signs	NNS	O
of	IN	O
end-organ	JJ	B-PROBLEM
damage	NN	I-PROBLEM
at	IN	O
present	JJ	O
except	IN	O
for	IN	O
elevated	JJ	B-PROBLEM
creatinine	NN	I-PROBLEM
,	,	O
which	WDT	O
is	VBZ	O
more	RBR	O
likely	JJ	O
a	DT	B-PROBLEM
chronic	JJ	I-PROBLEM
problem	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
labetalol	NN	B-TREATMENT
and	CC	O
lisinopril	NN	B-TREATMENT
.	.	O

his	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
was	VBD	O
taken	VBN	O
down	RB	O
from	IN	O
230	CD	O
systolic	JJ	B-TEST
to	TO	O
approx	VB	O
160	CD	O
systolic	JJ	B-TEST
/	RB	O
100	CD	O
diastolic	NN	B-TEST
on	IN	O
discharge	NN	O
.	.	O

his	PRP$	B-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
edema	VBZ	I-PROBLEM
improved	VBN	O
with	IN	O
diuresis	NN	B-TREATMENT
.	.	O

an	DT	B-TEST
echo	NN	I-TEST
performed	VBN	O
on	IN	O
admission	NN	O
showed	VBD	O
an	DT	B-TEST
lf	JJ	I-TEST
ef	NN	I-TEST
of	IN	O
25%	CD	O
.	.	O

it	PRP	O
is	VBZ	O
hoped	VBN	O
with	IN	O
good	JJ	B-TREATMENT
blood	NN	I-TREATMENT
pressure	NN	I-TREATMENT
control	NN	I-TREATMENT
and	CC	O
use	NN	O
of	IN	O
an	DT	B-TREATMENT
ace-i	JJ	I-TREATMENT
with	IN	O
follow	JJ	O
up	RP	O
in	IN	O
addition	NN	O
to	TO	O
cocaine	VB	O
abstaining	NN	O
will	MD	O
improved	VB	O
his	PRP$	O
cardiac	JJ	O
function	NN	O
.	.	O

renal	JJ	B-PROBLEM
failure	NN	I-PROBLEM
:	:	O
creatinine	NN	B-TEST
on	IN	O
admission	NN	O
was	VBD	O
1.6	CD	O
likely	JJ	O
acute	JJ	B-PROBLEM
hypertensive	NN	I-PROBLEM
nephropathy	JJ	I-PROBLEM
plus	CC	O
probalbe	JJ	O
long-standing	JJ	B-PROBLEM
hypertensive	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

discharged	VBN	O
on	IN	O
ace-i	NN	B-TREATMENT
.	.	O

1.	CD	O
aspirin	JJ	B-TREATMENT
325	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

2.	CD	O
hydrochlorothiazide	JJ	B-TREATMENT
25	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

3.	CD	O
labetalol	JJ	B-TREATMENT
200	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

4.	CD	O
lisinopril	JJ	B-TREATMENT
20	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

-	:	O
hypertensive	NN	B-PROBLEM
emergency	NN	I-PROBLEM

-	:	O
arf	NN	B-PROBLEM

-	:	O
mild	NN	B-PROBLEM
transaminitis	NN	I-PROBLEM
likely	JJ	O
03-25	JJ	O
etoh	NN	O
and	CC	O
cocaine	NN	O
abuse	NN	O

-	:	O
lower	JJR	B-PROBLEM
extremity	NN	I-PROBLEM
edema	NN	I-PROBLEM
improved	VBD	O

you	PRP	O
came	VBD	O
in	IN	O
with	IN	O
hypertensive	JJ	B-PROBLEM
emergency	NN	I-PROBLEM
.	.	O

you	PRP	O
were	VBD	O
treated	VBN	O
with	IN	O
medications	NNS	B-TREATMENT
to	TO	O
improve	VB	O
your	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
.	.	O

1.	CD	O
lisinopril	JJ	B-TREATMENT
20	CD	O
mg	NNS	O
daily	RB	O

2.	CD	O
hctz	JJ	B-TREATMENT
25	CD	O
mg	NNS	O
daily	RB	O

3.	CD	O
labetalol	JJ	B-TREATMENT
400	CD	O
mg	NNS	O
bid	NN	O

4.	CD	O
asa	JJ	B-TREATMENT
162mg	CD	O
daily	JJ	O

it	PRP	O
is	VBZ	O
extremely	RB	O
important	JJ	O
for	IN	O
you	PRP	O
to	TO	O
take	VB	O
these	DT	B-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

please	VB	O
return	NN	O
to	TO	O
the	DT	O
deanna	NN	O
if	IN	O
you	PRP	O
experience	VBP	O
sob	JJ	B-PROBLEM
,	,	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
fevers	NNS	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
,	,	O
dizziness	NN	B-PROBLEM
,	,	O
decreased	VBN	B-PROBLEM
urine	JJ	I-PROBLEM
output	NN	I-PROBLEM
.	.	O

ken	VBN	O
nansteel-miller	NN	O
is	VBZ	O
the	DT	O
triplet	NN	O
#3	NNP	O
of	IN	O
a	DT	B-PROBLEM
spontaneous	JJ	I-PROBLEM
triamniotic-trichorionic	JJ	I-PROBLEM
triplet	NN	I-PROBLEM
pregnancy	NN	I-PROBLEM
born	VBN	O
to	TO	O
a	DT	O
39-year-old	JJ	O
g4	NN	O
p1	NN	O
spontaneous	JJ	O
abortion	NN	O
2	CD	O
woman	NN	O
.	.	O

blood	NN	B-TEST
type	NN	I-TEST
a	DT	O
positive	JJ	O
,	,	O
antibody	JJ	B-TEST
negative	JJ	O
,	,	O
rubella	NN	B-TEST
immune	NN	O
,	,	O
rpr	NN	B-TEST
nonreactive	JJ	O
,	,	O
hepatitis	NN	B-TEST
b	NN	I-TEST
surface	NN	I-TEST
antigen	NN	I-TEST
negative	JJ	O
,	,	O
group	NN	B-TEST
beta	VBD	I-TEST
strep	JJ	I-TEST
status	NN	I-TEST
unknown	NN	O
.	.	O

the	DT	O
mother	NN	O
was	VBD	O
followed	VBN	O
closely	RB	O
and	CC	O
received	VBD	O
betamethasone	RB	B-TREATMENT
2011-08-22	JJ	O
.	.	O

she	PRP	O
was	VBD	O
admitted	VBN	O
on	IN	O
2011-08-25	JJ	O
for	IN	O
nausea	NN	B-PROBLEM
,	,	O
vomiting	NN	B-PROBLEM
,	,	O
and	CC	O
a	DT	B-PROBLEM
shortened	JJ	I-PROBLEM
cervix	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
bed	NN	B-TREATMENT
rest	NN	I-TREATMENT
and	CC	O
prn	JJ	O
terbutaline	NN	B-TREATMENT
.	.	O

other	JJ	B-TREATMENT
medications	NNS	I-TREATMENT
including	VBG	O
prozac	NN	B-TREATMENT
.	.	O

the	DT	O
babies	NNS	O
were	VBD	O
born	VBN	O
by	IN	O
elective	JJ	B-TREATMENT
cesarean	JJ	I-TREATMENT
section	NN	I-TREATMENT
at	IN	O
34	CD	O
weeks	NNS	O
gestation	NN	O
.	.	O

this	DT	O
triplet	NN	O
#3	VBZ	O
emerged	VBN	O
with	IN	O
spontaneous	JJ	O
respirations	NNS	O
,	,	O
and	CC	O
required	VBD	O
blow-by	JJ	B-TREATMENT
oxygen	NN	I-TREATMENT
in	IN	O
the	DT	O
delivery	NN	O
room	NN	O
.	.	O

apgars	NNS	B-TEST
were	VBD	O
seven	CD	O
at	IN	O
one	CD	O
minute	NN	O
and	CC	O
eight	CD	O
at	IN	O
five	CD	O
minutes	NNS	O
.	.	O

he	PRP	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
neonatal	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
for	IN	O
treatment	NN	B-TREATMENT
of	IN	O
prematurity	NN	B-PROBLEM
.	.	O

weight	NN	B-TEST
1.7	CD	O
kg	NN	O
,	,	O
length	VBZ	B-TEST
41.5	CD	O
cm	NN	O
,	,	O
head	NN	B-TEST
circumference	NN	I-TEST
29	CD	O
cm	NN	O
,	,	O
all	DT	O
10th-25th	JJ	O
percentile	NN	O
for	IN	O
34	CD	O
weeks	NNS	O
.	.	O

general	JJ	O
:	:	O
nondysmorphic	JJ	B-PROBLEM
preterm	NNS	O
male	NN	O
in	IN	O
mild	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
distress	NN	I-PROBLEM
.	.	O

positive	JJ	O
red	JJ	B-TEST
reflex	NN	I-TEST
bilaterally	RB	O
.	.	O

chest	NN	O
:	:	O
mild	JJ	B-PROBLEM
intercostal	JJ	I-PROBLEM
and	CC	I-PROBLEM
sternal	JJ	I-PROBLEM
retractions	NNS	I-PROBLEM
.	.	O

breath	NN	B-TEST
sounds	VBZ	I-TEST
equal	JJ	O
with	IN	O
fair	JJ	O
aeration	NN	O
.	.	O

cardiovascular	NN	O
:	:	O
regular	JJ	O
,	,	O
rate	NN	O
,	,	O
and	CC	O
rhythm	NN	O
,	,	O
no	DT	O
murmur	NN	B-PROBLEM
.	.	O

femoral	JJ	B-TEST
pulses	NNS	I-TEST
+2	VBP	O
.	.	O

abdomen	NNS	O
is	VBZ	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBD	B-PROBLEM
,	,	O
no	DT	O
masses	NNS	B-PROBLEM
,	,	O
positive	JJ	O
bowel	NN	O
sounds	NNS	O
.	.	O

1.	CD	O
respiratory	NN	O
:	:	O
lincoln	NN	O
required	VBN	O
nasal	RB	B-TREATMENT
cannula	JJ	I-TREATMENT
o2	NN	I-TREATMENT
for	IN	O
approximately	RB	O
the	DT	O
first	JJ	O
8-12	JJ	O
hours	NNS	O
of	IN	O
life	NN	O
.	.	O

he	PRP	O
has	VBZ	O
had	VBN	O
no	DT	O
episodes	NNS	O
of	IN	O
spontaneous	JJ	B-PROBLEM
apnea	NN	I-PROBLEM
during	IN	O
admission	NN	O
.	.	O

2.	CD	O
cardiovascular	NN	O
:	:	O
falmouth	NN	O
has	VBZ	O
maintained	VBN	O
normal	JJ	O
heart	NN	O
rates	NNS	O
and	CC	O
blood	NN	B-TEST
pressures	NNS	I-TEST
.	.	O

no	DT	O
murmurs	NNS	B-PROBLEM
have	VBP	O
been	VBN	O
noted	VBN	O
.	.	O

beverly	RB	O
was	VBD	O
initially	RB	O
npo	JJ	B-TREATMENT
and	CC	O
maintained	VBD	O
on	IN	O
intravenous	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
.	.	O

enteral	JJ	B-TREATMENT
feeds	NNS	I-TREATMENT
were	VBD	O
started	VBN	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
#1	NNP	O
,	,	O
and	CC	O
gradually	RB	O
advanced	VBD	O
to	TO	O
full	JJ	O
volume	NN	O
.	.	O

discharge	NN	B-TEST
weight	NN	I-TEST
is	VBZ	O
1.89	CD	O
kg	NN	O
.	.	O

4.	CD	O
gastrointestinal	JJ	O
:	:	O
boston	NN	O
required	VBN	O
treatment	NN	B-TREATMENT
for	IN	O
unconjungated	JJ	B-PROBLEM
hyperbilirubinemia	NN	I-PROBLEM
with	IN	O
phototherapy	NN	B-TREATMENT
.	.	O

his	PRP$	B-TEST
peak	NN	I-TEST
serum	NN	I-TEST
bilirubin	NN	I-TEST
occurred	VBD	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
three	CD	O
with	IN	O
a	DT	O
total	NN	O
of	IN	O
8.3	CD	O
/	JJ	O
0.2	CD	O
direct	JJ	O
,	,	O
8.1	CD	O
indirect	JJ	O
mg/dl	NN	O
.	.	O

he	PRP	O
received	VBD	O
phototherapy	NN	B-TREATMENT
for	IN	O
approximately	RB	O
72	CD	O
hours	NNS	O
.	.	O

rebound	NN	B-TEST
bilirubin	NN	I-TEST
on	IN	O
day	NN	O
of	IN	O
life	NN	O
#7	NNP	O
was	VBD	O
6.6	CD	O
,	,	O
and	CC	O
total	NN	O
was	VBD	O
0.2	CD	O
direct	JJ	O
.	.	O

throughout	IN	O
admission	NN	O
,	,	O
there	EX	O
are	VBP	O
no	DT	O
neurological	JJ	B-PROBLEM
concerns	NNS	I-PROBLEM
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
.	.	O

audiology	NN	O
:	:	O
hearing	NN	B-TEST
screening	NN	I-TEST
was	VBD	O
performed	VBN	O
with	IN	O
automated	JJ	O
auditory	NN	O
brain	NN	O
stem	NN	O
responses	NNS	O
.	.	O

2.	CD	O
medications	NNS	B-TREATMENT
:	:	O
ferrous	JJ	B-TREATMENT
sulfate	NN	I-TREATMENT
0.15	CD	O
cc	NN	O
po	NN	O
q	JJ	O
day	NN	O
25	CD	O
mg	NN	O
/	NNP	O
ml	NN	O
dilution	NN	O
.	.	O

3.	CD	O
car	NN	B-TEST
seat	NN	I-TEST
position	NN	I-TEST
screening	NN	I-TEST
was	VBD	O
performed	VBN	O
.	.	O

waltham	NN	O
was	VBD	O
monitored	VBN	O
for	IN	O
90	CD	O
minutes	NNS	O
without	IN	O
any	DT	O
episodes	NNS	O
of	IN	O
apnea	NN	B-PROBLEM
or	CC	O
oxygen	NN	B-PROBLEM
desaturation	NN	I-PROBLEM
.	.	O

4.	CD	O
state	NN	B-TEST
newborn	JJ	I-TEST
screens	NNS	I-TEST
were	VBD	O
sent	VBN	O
on	IN	O
09-27	JJ	O
and	CC	O
2011-10-05	JJ	O
with	IN	O
no	DT	O
notification	NN	O
of	IN	O
abnormal	JJ	B-PROBLEM
results	NNS	I-PROBLEM
to	TO	O
date	NN	O
.	.	O

5.	CD	O
no	DT	O
immunizations	NNS	B-TREATMENT
administered	VBD	O
.	.	O

plan	NN	O
is	VBZ	O
to	TO	O
receive	VB	O
hepatitis	NN	B-TREATMENT
b	NN	I-TREATMENT
in	IN	O
the	DT	O
pediatrician	NN	O
's	POS	O
office	NN	O
,	,	O
once	RB	O
he	PRP	O
reaches	VBZ	O
a	DT	O
weight	NN	O
of	IN	O
2	CD	O
kg	NNS	O
.	.	O

6.	CD	O
immunizations	NNS	B-TREATMENT
recommended	VBD	O
:	:	O
synagis	NN	B-TREATMENT
rsv	NN	I-TREATMENT
prophylaxis	NN	I-TREATMENT
should	MD	O
be	VB	O
considered	VBN	O
from	IN	O
october	VBN	O
through	IN	O
april	NN	O
for	IN	O
infants	NNS	O
who	WP	O
meet	VBP	O
any	DT	O
of	IN	O
the	DT	O
following	JJ	O
three	CD	O
criteria	NNS	O
:	:	O

3)	CD	O
with	IN	O
chronic	JJ	B-PROBLEM
lung	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

influenza	JJ	B-TREATMENT
immunization	NN	I-TREATMENT
should	MD	O
be	VB	O
considered	VBN	O
annually	RB	O
in	IN	O
the	DT	O
fall	NN	O
for	IN	O
preterm	JJ	O
infants	NNS	O
with	IN	O
chronic	JJ	B-PROBLEM
lung	NN	I-PROBLEM
disease	NN	I-PROBLEM
once	IN	O
they	PRP	O
reach	VBP	O
six	CD	O
months	NNS	O
of	IN	O
age	NN	O
.	.	O

before	IN	O
this	DT	O
age	NN	O
,	,	O
the	DT	O
family	NN	O
and	CC	O
other	JJ	O
caregivers	NNS	O
should	MD	O
be	VB	O
considered	VBN	O
for	IN	O
immunization	NN	B-TREATMENT
against	IN	O
influenza	NN	B-PROBLEM
to	TO	O
protect	VB	O
the	DT	O
infant	NN	O
.	.	O

1.	CD	O
prematurity	NN	B-PROBLEM
at	IN	I-PROBLEM
34	CD	I-PROBLEM
weeks	NNS	I-PROBLEM
gestation	NN	I-PROBLEM
.	.	O

3.	CD	O
unconjugated	JJ	B-PROBLEM
hyperbilirubinemia	NN	I-PROBLEM
.	.	O

patient	NN	O
recorded	VBD	O
as	IN	O
having	VBG	O
no	DT	O
known	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM
to	TO	I-PROBLEM
drugs	NNS	I-PROBLEM

exertional	JJ	B-PROBLEM
angina	NN	I-PROBLEM

10-01	JJ	O
cabg	NN	B-TREATMENT
x	VBZ	O
3	CD	O

60	CD	O
yo	NNS	O
m	NN	O
with	IN	O
exertional	JJ	B-PROBLEM
angina	NNS	I-PROBLEM
->	VBP	O
positive	JJ	B-PROBLEM
ett	NN	I-PROBLEM
->	NNP	O
cath	NN	B-TEST
with	IN	O
severe	JJ	B-PROBLEM
3vd	CD	I-PROBLEM

htn	NN	B-PROBLEM

dm	NN	B-PROBLEM

cataracts	NNS	B-PROBLEM
s/p	VBP	O
removal	NN	B-TREATMENT
of	IN	O
in	IN	O
mayotte	NN	O
c/b	NN	O
enucleated	VBD	O
cmed	JJ	O
csru	NN	O

urinary	JJ	B-PROBLEM
incontinence	NN	I-PROBLEM

father	NN	O
with	IN	O
?	.	O
mi	NN	B-PROBLEM
at	IN	O
unknown	JJ	O
age	NN	O

nad	RB	B-TEST
76	CD	O
184/87	CD	O
18	CD	O

teeth	NNS	B-PROBLEM
in	IN	I-PROBLEM
poor	JJ	I-PROBLEM
repair	NN	I-PROBLEM

distant	JJ	B-PROBLEM
heart	NN	I-PROBLEM
sounds	VBZ	I-PROBLEM
,	,	O
rrr	VB	O

extrem	NN	B-PROBLEM
warm	NN	I-PROBLEM
,	,	O
no	DT	O
edema	NN	B-PROBLEM
,	,	O
no	DT	O
varicosities	NNS	B-PROBLEM
,	,	O
2+	CD	O
pedal	NN	B-TEST
pulses	NNS	I-TEST

2019-10-07	JJ	O
05:30	CD	O
am	VBP	O
blood	NN	B-TEST
wbc	NN	B-TEST
-	:	O
6.5	CD	O
rbc	NN	B-TEST
-	:	O
3.23	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
9.5	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
27.6	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
86	CD	O
mch	SYM	B-TEST
-	:	O
29.4	CD	O
mchc	SYM	B-TEST
-	:	O
34.4	CD	O
rdw	NN	B-TEST
-	:	O
14.0	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
356	CD	O
#	#	O

2019-10-07	JJ	O
05:30	CD	O
am	VBP	O
blood	NN	B-TEST
plt	NN	B-TEST
ct	VBD	I-TEST
-	:	O
356	CD	O
#	#	O

2019-10-04	JJ	O
06:50	CD	O
am	VBP	O
blood	NN	B-TEST
pt	NN	B-TEST
-	:	O
13.2	CD	O
*	NN	O
ptt	NN	B-TEST
-	:	O
32.1	CD	O
inr(pt)	JJ	B-TEST
-	:	O
1.2	CD	O
*	NN	O

2019-10-07	JJ	O
05:30	CD	O
am	VBP	O
blood	NN	B-TEST
glucose	JJ	B-TEST
-	:	O
156	CD	O
*	JJ	O
urean	JJ	B-TEST
-	:	O
20	CD	O
creat	NN	B-TEST
-	:	O
1.0	CD	O
na	SYM	B-TEST
-	:	O
140	CD	O
k	SYM	B-TEST
-	:	O
3.8	CD	O
cl	NN	B-TEST
-	:	O
99	CD	O
hco3	NN	B-TEST
-	:	O
31	CD	O
angap	NN	B-TEST
-	:	O
14	CD	O

he	PRP	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
on	IN	O
2019-10-01	JJ	O
where	WRB	O
he	PRP	O
underwent	VBD	O
a	DT	B-TREATMENT
cabg	NN	I-TREATMENT
x	NN	O
3	CD	O
.	.	O

he	PRP	O
was	VBD	O
weaned	VBN	O
from	IN	O
his	PRP$	B-TREATMENT
vasoactive	JJ	I-TREATMENT
drips	NNS	I-TREATMENT
and	CC	O
transferred	VBN	O
to	TO	O
the	DT	O
floor	NN	O
on	IN	O
pod	NN	O
#2	NN	O
.	.	O

he	PRP	O
was	VBD	O
seen	VBN	O
by	IN	O
speech	NN	O
and	CC	O
swallowing	NN	O
who	WP	O
recommended	VBD	O
npo	RB	B-TREATMENT
,	,	O
he	PRP	O
then	RB	O
underwent	VBD	O
a	DT	B-TEST
video	NN	I-TEST
swallow	NN	I-TEST
after	IN	O
which	WDT	O
he	PRP	O
was	VBD	O
changed	VBN	O
to	TO	O
a	DT	B-TREATMENT
diet	NN	I-TREATMENT
of	IN	I-TREATMENT
thin	JJ	I-TREATMENT
liquids	NNS	I-TREATMENT
and	CC	I-TREATMENT
soft	JJ	I-TREATMENT
solids	NNS	I-TREATMENT
,	,	O
and	CC	O
felt	VBD	O
that	IN	O
his	PRP$	O
eeating	NN	O
may	MD	O
be	VB	O
limited	VBN	O
by	IN	O
his	PRP$	B-PROBLEM
loose	JJ	I-PROBLEM
teeth	NNS	I-PROBLEM
.	.	O

lisinopril	NN	B-TREATMENT
,	,	O
protonix	NN	B-TREATMENT
,	,	O
glipizide	NN	B-TREATMENT
,	,	O
metformin	NN	B-TREATMENT
,	,	O
asa	NN	B-TREATMENT

1.	CD	O
aspirin	JJ	B-TREATMENT
81	CD	O
mg	JJ	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

2.	CD	O
pantoprazole	JJ	B-TREATMENT
40	CD	O
mg	JJ	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
q24h	NN	O
(	(	O
every	DT	O
24	CD	O
hours	NNS	O
).	VBP	O

3.	CD	O
metoprolol	JJ	B-TREATMENT
tartrate	NN	I-TREATMENT
50	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

4.	CD	O
docusate	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
150	CD	O
mg	NN	O
/	VBD	O
15	CD	O
ml	NN	O
liquid	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

5.	CD	O
oxycodone	CD	B-TREATMENT
-	:	O
acetaminophen	NN	B-TREATMENT
5-325	JJ	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
1-2	JJ	O
tablets	NNS	O
po	JJ	O
every	DT	O
4-6	JJ	O
hours	NNS	O
as	IN	O
needed	VBN	O
for	IN	O
pain	NN	B-PROBLEM
.	.	O

6.	CD	O
clopidogrel	NN	B-TREATMENT
75	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

7.	CD	O
atorvastatin	JJ	B-TREATMENT
10	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

8.	CD	O
glipizide	JJ	B-TREATMENT
5	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

9.	CD	O
lisinopril	JJ	B-TREATMENT
10	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

10.	CD	O
hydrochlorothiazide	JJ	B-TREATMENT
25	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
once	RB	O
a	DT	O
day	NN	O
.	.	O

cad	NN	B-PROBLEM

htn	NN	B-PROBLEM

dm	NN	B-PROBLEM

cataracts	NNS	B-PROBLEM
s/p	VBP	O
removal	JJ	B-TREATMENT
c/b	NN	O
enucleated	VBD	O
left	VBD	O
cmed	JJ	O
csru	NN	O

urinary	JJ	B-PROBLEM
incontinence	NN	I-PROBLEM

?	.	O
tia	NN	B-PROBLEM

call	NN	O
with	IN	O
fever	NN	B-PROBLEM
,	,	O
redness	NN	B-PROBLEM
or	CC	O
drainage	NN	B-PROBLEM
from	IN	I-PROBLEM
incision	NN	I-PROBLEM
or	CC	O
weight	JJ	B-PROBLEM
gain	NN	I-PROBLEM
more	JJR	O
than	IN	O
2	CD	O
pounds	NNS	O
in	IN	O
one	CD	O
day	NN	O
or	CC	O
five	CD	O
in	IN	O
one	CD	O
week	NN	O
.	.	O

shower	NN	O
,	,	O
no	DT	O
baths	NNS	O
,	,	O
no	DT	O
lotions	NNS	B-TREATMENT
,	,	O
creams	NNS	B-TREATMENT
or	CC	O
powders	NNS	B-TREATMENT
to	TO	O
incisions	NNS	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
found	VBN	B-PROBLEM
down	RB	I-PROBLEM
.	.	O

following	VBG	O
evaluation	NN	B-TEST
and	CC	O
treatment	NN	B-TREATMENT
,	,	O
the	DT	O
patient	NN	O
's	POS	O
disposition	NN	O
at	IN	O
the	DT	O
end	NN	O
of	IN	O
the	DT	O
visit	NN	O
was	VBD	O
admitted	VBN	O
as	IN	O
an	DT	O
inpatient	NN	O
to	TO	O
bri	VB	O
health	NN	O
.	.	O

your	PRP$	O
patient	NN	O
was	VBD	O
admitted	VBN	O
under	IN	O
the	DT	O
care	NN	O
of	IN	O
reefraup	NN	O
,	,	O
ja	NN	O
y	NN	O
with	IN	O
a	DT	O
preliminary	JJ	O
diagnosis	NN	O
of	IN	O
syncope	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
57	JJ	O
-	:	O
year-old	JJ	O
female	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
and	CC	O
hypercholesterolemia	NN	B-PROBLEM
but	CC	O
no	DT	O
prior	JJ	B-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
history	NN	I-PROBLEM
who	WP	O
presented	VBD	O
with	IN	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
reports	VBZ	O
the	DT	B-PROBLEM
pain	NN	I-PROBLEM
began	VBD	O
at	IN	O
4:00	CD	O
p.m.	NN	O
on	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
.	.	O

she	PRP	O
reports	VBZ	O
that	IN	O
it	PRP	O
had	VBD	O
essentially	RB	O
started	VBN	O
earlier	RBR	O
in	IN	O
the	DT	O
day	NN	O
with	IN	O
some	DT	B-PROBLEM
gerd-like	JJ	I-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
taken	VBN	O
maalox	NN	B-TREATMENT
but	CC	O
had	VBD	O
no	DT	O
relief	NN	O
with	IN	O
this	DT	O
.	.	O

the	DT	B-PROBLEM
pain	NN	I-PROBLEM
was	VBD	O
intermittent	JJ	O
through	IN	O
the	DT	O
day	NN	O
and	CC	O
then	RB	O
at	IN	O
4:00	CD	O
p.m.	NN	O
increased	VBD	O
and	CC	O
was	VBD	O
also	RB	O
associated	VBN	O
with	IN	O
nausea	NN	B-PROBLEM
and	CC	O
diaphoresis	NN	B-PROBLEM
.	.	O

she	PRP	O
reports	VBZ	O
that	IN	O
the	DT	B-PROBLEM
pain	NN	I-PROBLEM
shot	NN	O
through	IN	O
her	PRP$	O
back	NN	O
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
never	RB	O
had	VBN	O
these	DT	B-PROBLEM
symptoms	NNS	I-PROBLEM
in	IN	O
the	DT	O
past	NN	O
.	.	O

at	IN	O
that	DT	O
time	NN	O
,	,	O
the	DT	B-PROBLEM
pain	NN	I-PROBLEM
was	VBD	O
unremitting	VBG	O
.	.	O

in	IN	O
the	DT	O
emergency	NN	O
room	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
lopressor	NN	B-TREATMENT
,	,	O
nitroglycerin	NN	B-TREATMENT
,	,	O
and	CC	O
aspirin	NN	B-TREATMENT
.	.	O

a	DT	B-TREATMENT
tp3a	NN	I-TREATMENT
inhibitor	NN	I-TREATMENT
was	VBD	O
not	RB	O
given	VBN	O
for	IN	O
concern	NN	O
for	IN	O
dissection	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
5057	CD	O
e.	JJ	O
sixth	JJ	O
blvd.	NN	O
elevations	NNS	B-PROBLEM
in	IN	I-PROBLEM
i	NN	I-PROBLEM
,	,	I-PROBLEM
avl	NN	I-PROBLEM
,	,	I-PROBLEM
and	CC	I-PROBLEM
v1	NN	I-PROBLEM
through	IN	I-PROBLEM
v2	NN	I-PROBLEM
and	CC	O
st	JJ	B-PROBLEM
depressions	NNS	I-PROBLEM
in	IN	I-PROBLEM
ii	NN	I-PROBLEM
,	,	I-PROBLEM
iii	NN	I-PROBLEM
,	,	I-PROBLEM
and	CC	I-PROBLEM
avf	NN	I-PROBLEM
.	.	O

1.	CD	O
hypertension	NN	B-PROBLEM
.	.	O

2.	CD	O
hypercholesterolemia	NN	B-PROBLEM
.	.	O

3.	CD	O
chondrocalcinosis	NN	B-PROBLEM
.	.	O

4.	CD	O
carpal	JJ	B-PROBLEM
tunnel	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
.	.	O

5.	CD	O
gerd	NN	B-PROBLEM
.	.	O

1.	CD	O
atenolol	JJ	B-TREATMENT
25	CD	O
.	.	O

2.	CD	O
crestor	NN	B-TREATMENT
10	CD	O
q.d.	NN	O

3.	CD	O
uniretic	JJ	B-TREATMENT
15/25	CD	O
.	.	O

allergies	NNS	O
:	:	O
the	DT	O
patient	NN	O
has	VBZ	O
no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

on	IN	O
admission	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
afebrile	RB	B-PROBLEM
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
146/88	CD	O
,	,	O
pulse	RB	B-TEST
71	CD	O
,	,	O
respirations	NNS	B-TEST
18	CD	O
.	.	O

general	JJ	O
:	:	O
the	DT	O
patient	NN	O
was	VBD	O
a	DT	O
well	RB	O
appearing	VBG	O
female	NN	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

no	DT	O
murmurs	NNS	B-PROBLEM
were	VBD	O
appreciated	VBN	O
.	.	O

lungs	NNS	O
:	:	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
.	.	O

abdomen	NNS	O
:	:	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBN	B-PROBLEM
,	,	O
good	JJ	O
bowel	NN	O
sounds	NNS	O
.	.	O

extremities	NNS	O
:	:	O
there	EX	O
was	VBD	O
no	DT	O
edema	NN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
extremities	NNS	I-PROBLEM
.	.	O

the	DT	B-TEST
dorsalis	NN	I-TEST
pedis	NN	I-TEST
pulses	NNS	I-TEST
were	VBD	O
2+	CD	O
bilaterally	RB	O
.	.	O

laboratory	NN	O
and	CC	O
radiologic	JJ	O
data	NNS	O
:	:	O
on	IN	O
admission	NN	O
,	,	O
white	JJ	B-TEST
count	NN	I-TEST
10.8	CD	O
,	,	O
hematocrit	NN	B-TEST
38.2	CD	O
,	,	O
platelets	NNS	B-TEST
324,000	CD	O
.	.	O

1.	CD	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
:	:	O
the	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
to	TO	O
cardiac	VB	B-TEST
catheterization	NN	I-TEST
where	WRB	O
she	PRP	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
two	CD	B-PROBLEM
vessel	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

the	DT	O
proximal	JJ	O
lad	NN	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
90%	CD	I-PROBLEM
lesion	NN	I-PROBLEM
with	IN	O
a	DT	O
septal	JJ	O
branch	NN	O
with	IN	O
a	DT	B-PROBLEM
95%	CD	I-PROBLEM
stenosis	NN	I-PROBLEM
and	CC	O
a	DT	O
diagonal	JJ	O
branch	NN	O
with	IN	O
99%	CD	B-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
twin	VBN	B-TREATMENT
lad	JJ	I-TREATMENT
stents	NNS	I-TREATMENT
to	TO	O
the	DT	O
lad	JJ	O
diagonal	JJ	O
and	CC	O
lad	JJ	O
septal	JJ	O
branches	NNS	O
with	IN	O
taxus	JJ	B-TREATMENT
stents	NNS	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
also	RB	O
had	VBD	O
proximal	JJ	B-PROBLEM
rca	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
of	IN	I-PROBLEM
80%	CD	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
mid	JJ	I-PROBLEM
rca	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
of	IN	I-PROBLEM
80-90%	CD	I-PROBLEM
which	WDT	O
were	VBD	O
not	RB	O
intervened	VBN	O
upon	IN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
an	DT	B-TREATMENT
aspirin	NN	I-TREATMENT
and	CC	O
plavix	NN	B-TREATMENT
and	CC	O
in	IN	O
addition	NN	O
started	VBN	O
on	IN	O
a	DT	B-TREATMENT
beta	NN	I-TREATMENT
elmore	NN	I-TREATMENT
,	,	O
maxine	JJ	B-TREATMENT
ace	NN	I-TREATMENT
inhibitor	NN	I-TREATMENT
,	,	O
and	CC	O
these	DT	O
were	VBD	O
titrated	VBN	O
up	RP	O
as	IN	O
her	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
tolerated	VBD	O
.	.	O

given	VBN	O
the	DT	O
fact	NN	O
that	IN	O
the	DT	O
patient	NN	O
had	VBD	O
issues	NNS	O
with	IN	O
muscle	NN	B-PROBLEM
cramping	VBG	I-PROBLEM
with	IN	O
atorvastatin	NN	B-TREATMENT
in	IN	O
the	DT	O
past	NN	O
,	,	O
she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
pravastatin	NN	B-TREATMENT
which	WDT	O
should	MD	O
give	VB	O
less	JJR	O
of	IN	O
these	DT	B-PROBLEM
side	NN	I-PROBLEM
effects	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
will	MD	O
follow-up	VB	O
with	IN	O
cardiology	NN	O
in	IN	O
one	CD	O
months	NNS	O
time	NN	O
for	IN	O
further	JJ	B-TREATMENT
management	NN	I-TREATMENT
of	IN	O
her	PRP$	B-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
and	CC	O
further	JJ	B-TEST
evaluation	NN	I-TEST
of	IN	O
her	PRP$	B-PROBLEM
remaining	VBG	I-PROBLEM
rca	JJ	I-PROBLEM
lesions	NNS	I-PROBLEM
.	.	O

2.	CD	O
pump	NN	O
:	:	O
the	DT	O
patient	NN	O
had	VBD	O
an	DT	B-TEST
echocardiogram	NN	I-TEST
to	TO	O
assess	VB	O
her	PRP$	O
lv	JJ	O
function	NN	O
.	.	O

she	PRP	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
an	DT	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
of	IN	O
30-35%	JJ	O
as	RB	O
well	RB	O
as	IN	O
an	DT	B-PROBLEM
akinetic	JJ	I-PROBLEM
apex	NN	I-PROBLEM
and	CC	O
apical	JJ	B-PROBLEM
mid	NN	I-PROBLEM
and	CC	I-PROBLEM
septal	JJ	I-PROBLEM
akinesis	NN	I-PROBLEM
.	.	O

given	VBN	O
the	DT	O
fact	NN	O
that	IN	O
the	DT	O
patient	NN	O
had	VBD	O
significant	JJ	B-PROBLEM
apical	JJ	I-PROBLEM
akinesis	NN	I-PROBLEM
,	,	O
she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
heparin	NN	B-TREATMENT
with	IN	O
a	DT	O
transition	NN	O
to	TO	O
coumadin	VB	B-TREATMENT
for	IN	O
anticoagulation	NN	B-TREATMENT
for	IN	O
stroke	NN	B-TREATMENT
prevention	NN	I-TREATMENT
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
apical	JJ	B-PROBLEM
akinesis	NN	I-PROBLEM
.	.	O

on	IN	O
discharge	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
lovenox	JJ	B-TREATMENT
injections	NNS	I-TREATMENT
which	WDT	O
should	MD	O
be	VB	O
continued	VBN	O
until	IN	O
the	DT	O
patient	NN	O
reaches	VBZ	O
a	DT	O
therapeutic	JJ	O
dose	NN	O
of	IN	O
coumadin	NN	B-TREATMENT
.	.	O

3.	CD	O
rhythm	NN	O
:	:	O
the	DT	O
patient	NN	O
was	VBD	O
monitored	VBN	O
on	IN	O
telemetry	NN	B-TEST
throughout	IN	O
her	PRP$	O
hospitalization	NN	O
with	IN	O
no	DT	O
significant	JJ	B-PROBLEM
events	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
an	DT	B-TEST
ep	JJ	I-TEST
evaluation	NN	I-TEST
and	CC	O
will	MD	O
be	VB	O
followed-up	JJ	O
by	IN	O
dr.	JJ	O
welch	NN	O
.	.	O

14-087	JJ	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TEST
signal-averaged	JJ	I-TEST
ekg	NN	I-TEST
.	.	O

she	PRP	O
will	MD	O
follow-up	VB	O
with	IN	O
dr.	JJ	O
welch	NN	O
with	IN	O
an	DT	B-TEST
echocardiogram	NN	I-TEST
on	IN	O
2015-07-24	JJ	O
in	IN	O
a	DT	O
meeting	NN	O
to	TO	O
discuss	VB	O
risk	NN	O
stratification	NN	O
for	IN	O
sudden	JJ	B-PROBLEM
cardiac	JJ	I-PROBLEM
death	NN	I-PROBLEM
and	CC	O
possible	JJ	O
icd	NN	B-TREATMENT
placement	NN	I-TREATMENT
.	.	O

4.	CD	O
neurology	NN	O
:	:	O
the	DT	O
patient	NN	O
complained	VBD	O
of	IN	O
left	JJ	B-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
weakness	NN	I-PROBLEM
with	IN	O
ambulation	NN	O
two	CD	O
days	NNS	O
after	IN	O
her	PRP$	B-TEST
cardiac	JJ	I-TEST
catheterization	NN	I-TEST
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
no	DT	O
evidence	NN	O
for	IN	O
weakness	NN	B-PROBLEM
on	IN	O
examination	NN	B-TEST
with	IN	O
good	JJ	O
proximal	NN	O
and	CC	O
distal	JJ	O
strength	NN	O
in	IN	O
the	DT	O
lower	JJR	O
extremities	NNS	O
as	RB	O
well	RB	O
as	IN	O
intact	JJ	O
sensation	NN	O
.	.	O

she	PRP	O
was	VBD	O
also	RB	O
able	JJ	O
to	TO	O
ascend	VB	O
stairs	NNS	O
without	IN	O
difficulty	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
already	RB	O
on	IN	O
an	DT	B-TREATMENT
aspirin	NN	I-TREATMENT
and	CC	O
plavix	NN	B-TREATMENT
should	MD	O
this	DT	O
represent	VB	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
stroke	NN	I-PROBLEM
.	.	O

however	RB	O
,	,	O
there	EX	O
was	VBD	O
no	DT	O
evidence	NN	O
for	IN	O
neurologic	JJ	B-PROBLEM
deficit	NN	I-PROBLEM
on	IN	O
examination	NN	B-TEST
and	CC	O
this	DT	O
will	MD	O
be	VB	O
followed-up	JJ	O
by	IN	O
her	PRP$	O
primary	JJ	O
care	NN	O
physician	NN	O
.	.	O

5.	CD	O
hematology	NN	O
:	:	O
the	DT	O
patient	NN	O
was	VBD	O
discharged	VBN	O
on	IN	O
coumadin	NN	B-TREATMENT
for	IN	O
apical	JJ	B-PROBLEM
akinesis	NN	I-PROBLEM
and	CC	O
stroke	NN	B-PROBLEM
risk	NN	I-PROBLEM
.	.	O

this	DT	O
will	MD	O
be	VB	O
further	RB	O
monitored	VBN	O
by	IN	O
her	PRP$	O
primary	JJ	O
care	NN	O
physician	NN	O
,	,	O
dr.	JJ	O
banks	NNS	O
,	,	O
who	WP	O
will	MD	O
adjust	VB	O
her	PRP$	B-TREATMENT
coumadin	NN	I-TREATMENT
dose	NN	I-TREATMENT
.	.	O

discharge	NN	O
diagnosis	NN	O
:	:	O
st	JJ	B-PROBLEM
elevation	NN	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
left	VBD	B-TREATMENT
anterior	JJ	I-TREATMENT
descending	VBG	I-TREATMENT
artery	JJ	I-TREATMENT
stent	NN	I-TREATMENT
.	.	O

1.	CD	O
aspirin	JJ	B-TREATMENT
325	CD	O
q.d.	NN	O

2.	CD	O
lisinopril	JJ	B-TREATMENT
5	CD	O
q.d.	NN	O

3.	CD	O
toprol	NN	B-TREATMENT
xl	VBD	I-TREATMENT
100	CD	O
q.d.	NN	O

4.	CD	O
coumadin	NN	B-TREATMENT
5	CD	O
q.d.	NN	O

5.	CD	O
plavix	JJ	B-TREATMENT
75	CD	O
q.d.	NN	O

6.	CD	O
lovenox	JJ	B-TREATMENT
60	CD	O
mg	NN	O
b.i.d.	NN	O
until	IN	O
therapeutic	JJ	O
on	IN	O
coumadin	NN	B-TREATMENT
.	.	O

7.	CD	O
pravastatin	NN	B-TREATMENT
80	CD	O
q.d.	NN	O

follow-up	JJ	O
plans	NNS	O
:	:	O
the	DT	O
patient	NN	O
will	MD	O
follow-up	VB	O
with	IN	O
her	PRP$	O
primary	JJ	O
care	NN	O
physician	NN	O
in	IN	O
the	DT	O
week	NN	O
following	VBG	O
discharge	NN	O
for	IN	O
further	JJ	O
monitoring	NN	O
of	IN	O
her	PRP$	B-TEST
inr	NN	I-TEST
and	CC	O
adjustment	NN	O
of	IN	O
her	PRP$	B-TREATMENT
coumadin	NN	I-TREATMENT
dose	NN	I-TREATMENT
.	.	O

in	IN	O
addition	NN	O
to	TO	O
this	DT	O
,	,	O
the	DT	O
patient	NN	O
will	MD	O
follow-up	VB	O
with	IN	O
cardiology	NN	O
,	,	O
dr.	NN	O
foster	NN	O
,	,	O
and	CC	O
dr.	NN	O
upshaw	NN	O
,	,	O
on	IN	O
2015-07-06	JJ	O
for	IN	O
further	JJ	B-TEST
monitoring	NN	I-TEST
.	.	O

richard	NN	O
williams	NNS	O
,	,	O
twin	EX	O
number	NN	O
ii	NN	O
,	,	O
was	VBD	O
born	VBN	O
at	IN	O
31-6/7	JJ	O
weeks	NNS	O
gestation	NN	O
by	IN	O
cesarean	JJ	B-TREATMENT
section	NN	I-TREATMENT
for	IN	O
rupture	NN	B-PROBLEM
of	IN	I-PROBLEM
membranes	NNS	I-PROBLEM
of	IN	O
twin	JJ	O
number	NN	O
i	NN	O
and	CC	O
progressive	JJ	B-PROBLEM
preterm	NN	I-PROBLEM
labor	NN	I-PROBLEM
.	.	O

mother	NN	O
is	VBZ	O
a	DT	O
37	CD	O
year	NN	O
old	JJ	O
gravida	NN	O
1	CD	O
,	,	O
para	VBZ	O
0	CD	O
now	RB	O
2	CD	O
woman	NN	O
whose	WP$	O
blood	NN	B-TEST
type	NN	I-TEST
is	VBZ	O
a	DT	O
negative	JJ	O
,	,	O
antibody	JJ	B-TEST
negative	JJ	O
,	,	O
rubella	NN	B-TEST
immune	NN	O
,	,	O
rpr	NN	B-TEST
nonreactive	JJ	O
,	,	O
hepatitis	NN	B-TEST
b	NN	I-TEST
surface	NN	I-TEST
antigen	NN	I-TEST
negative	JJ	O
and	CC	O
group	NN	B-TEST
b	NN	I-TEST
streptococcus	NN	I-TEST
unknown	JJ	O
.	.	O

the	DT	O
mother	NN	O
had	VBD	O
received	VBN	O
a	DT	O
complete	JJ	O
course	NN	O
of	IN	O
betamethasone	NN	B-TREATMENT
prior	RB	O
to	TO	O
delivery	NN	O
.	.	O

this	DT	O
pregnancy	NN	O
was	VBD	O
achieved	VBN	O
with	IN	O
in	IN	O
bartley	NN	B-TREATMENT
fertilization	NN	I-TREATMENT
.	.	O

a	DT	B-TREATMENT
cerclage	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
at	IN	O
18	CD	O
weeks	NNS	O
gestation	NN	O
.	.	O

cesarean	JJ	B-TREATMENT
section	NN	I-TREATMENT
was	VBD	O
performed	VBN	O
under	IN	O
spinal	JJ	B-TREATMENT
anesthesia	NN	I-TREATMENT
.	.	O

this	DT	O
infant	NN	O
emerged	VBD	O
with	IN	O
apgars	NNS	B-TEST
of	IN	O
8	CD	O
at	IN	O
one	CD	O
minute	NN	O
and	CC	O
8	CD	O
at	IN	O
five	CD	O
minutes	NNS	O
.	.	O

on	IN	O
admission	NN	O
,	,	O
revealed	VBD	O
a	DT	O
vigorous	JJ	O
non-dysmorphic	JJ	O
premature	NN	O
infant	NN	O
,	,	O
with	IN	O
moderate	JJ	B-PROBLEM
subcostal	JJ	I-PROBLEM
retractions	NNS	I-PROBLEM
and	CC	O
some	DT	B-PROBLEM
occasional	JJ	I-PROBLEM
grunting	NN	I-PROBLEM
,	,	O
normal	JJ	O
s1	NN	O
,	,	O
s2	JJ	O
heart	NN	O
sounds	VBZ	O
,	,	O
no	DT	O
murmur	NN	B-PROBLEM
.	.	O

the	DT	B-TEST
birth	NN	I-TEST
weight	NN	I-TEST
was	VBD	O
1,980	CD	O
grams	NNS	O
,	,	O
80th	CD	O
percentile	NN	O
.	.	O

the	DT	B-TEST
birth	NN	I-TEST
length	NN	I-TEST
was	VBD	O
44	CD	O
centimeters	NNS	O
,	,	O
the	DT	O
75th	CD	O
percentile	NN	O
and	CC	O
the	DT	B-TEST
birth	NN	I-TEST
head	NN	I-TEST
circumference	NN	I-TEST
was	VBD	O
30.6	CD	O
centimeters	NNS	O
,	,	O
in	IN	O
the	DT	O
65th	CD	O
percentile	NN	O

the	DT	O
infant	NN	O
was	VBD	O
intubated	VBN	O
soon	RB	O
after	IN	O
admission	NN	O
to	TO	O
the	DT	O
cmed	VBN	O
csru	NN	O
and	CC	O
received	VBD	O
two	CD	O
doses	NNS	O
of	IN	O
surfactant	NN	B-TREATMENT
.	.	O

her	PRP$	B-TEST
respirations	NNS	I-TEST
are	VBP	O
comfortable	JJ	O
.	.	O

her	PRP$	B-TEST
lung	NN	I-TEST
sounds	NNS	I-TEST
are	VBP	O
clear	JJ	O
and	CC	O
equal	JJ	O
.	.	O

she	PRP	O
has	VBZ	O
had	VBD	O
no	DT	O
apnea	NN	B-PROBLEM
,	,	O
bradycardia	NN	B-PROBLEM
or	CC	O
desaturation	NN	B-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
a	DT	O
normal	JJ	O
s1	NN	O
,	,	O
s2	JJ	O
heart	NN	O
sound	NN	O
and	CC	O
no	DT	O
murmur	NN	B-PROBLEM
.	.	O

she	PRP	O
started	VBD	O
on	IN	O
enteral	JJ	B-TREATMENT
feeds	NNS	I-TREATMENT
on	IN	O
day	NN	O
of	IN	O
life	NN	O
number	NN	O
two	CD	O
and	CC	O
progressed	VBD	O
without	IN	O
difficulty	NN	O
to	TO	O
full	JJ	B-TREATMENT
volume	NN	I-TREATMENT
feedings	NNS	I-TREATMENT
by	IN	O
day	NN	O
of	IN	O
life	NN	O
five	CD	O
and	CC	O
then	RB	O
was	VBD	O
advanced	VBN	O
to	TO	O
calorie	VB	B-TREATMENT
enhanced	JJ	I-TREATMENT
breast	NN	I-TREATMENT
milk	NN	I-TREATMENT
of	IN	O
24	CD	O
calories	NNS	O
per	IN	O
ounce	NN	O
.	.	O

she	PRP	O
has	VBZ	O
been	VBN	O
taking	VBG	O
from	IN	O
130	CD	O
to	TO	O
160	CD	O
cc.	NNS	O
per	IN	O
kilo	FW	O
per	IN	O
day	NN	O
on	IN	O
an	DT	B-TREATMENT
ad	NN	I-TREATMENT
lib	NN	I-TREATMENT
feeding	NN	I-TREATMENT
plan	NN	I-TREATMENT
.	.	O

at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
,	,	O
her	PRP$	B-TEST
weight	NN	I-TEST
is	VBZ	O
2,200	CD	O
grams	NNS	O
;	:	O
her	PRP$	B-TEST
length	NN	I-TEST
is	VBZ	O
49.5	CD	O
centimeters	NNS	O
(	(	O
19.5	CD	O
inches	NNS	O
)	)	O
and	CC	O
her	PRP$	B-TEST
head	NN	I-TEST
circumference	NN	I-TEST
is	VBZ	O
30.5	CD	O
centimeters	NNS	O
.	.	O

her	PRP$	B-TEST
peak	NN	I-TEST
bilirubin	NN	I-TEST
occurred	VBD	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
five	CD	O
and	CC	O
was	VBD	O
total	JJ	B-TEST
12.1	CD	O
,	,	O
direct	JJ	B-TEST
0.3	CD	O
;	:	O
the	DT	B-TEST
last	JJ	I-TEST
bilirubin	NN	I-TEST
on	IN	O
day	NN	O
of	IN	O
life	NN	O
six	CD	O
was	VBD	O
total	JJ	B-TEST
11.1	CD	O
,	,	O
direct	JJ	B-TEST
0.4	CD	O
.	.	O

she	PRP	O
never	RB	O
required	VBD	O
phototherapy	NN	B-TREATMENT
.	.	O

her	PRP$	B-TEST
hematocrit	NN	I-TEST
at	IN	O
the	DT	O
time	NN	O
of	IN	O
admission	NN	O
was	VBD	O
45.4	CD	O
,	,	O
platelets	NNS	B-TEST
were	VBD	O
360,000	CD	O
.	.	O

she	PRP	O
is	VBZ	O
receiving	VBG	O
supplemental	JJ	B-TREATMENT
iron	NN	I-TREATMENT
to	TO	O
provide	VB	O
2	CD	O
mg	NN	O
per	IN	O
kilo	FW	O
per	FW	O
day	NN	O
as	IN	O
elemental	JJ	B-TREATMENT
iron	NN	I-TREATMENT
.	.	O

she	PRP	O
has	VBZ	O
never	RB	O
received	VBN	O
any	DT	O
blood	NN	B-TREATMENT
products	NNS	I-TREATMENT
during	IN	O
this	DT	O
cmed	VBN	O
csru	NN	O
stay	NN	O
.	.	O

the	DT	O
infant	NN	O
was	VBD	O
started	VBN	O
on	IN	O
ampicillin	NN	B-TREATMENT
and	CC	O
gentamycin	NN	B-TREATMENT
at	IN	O
the	DT	O
time	NN	O
of	IN	O
admission	NN	O
for	IN	O
sepsis	NN	B-PROBLEM
risk	NN	I-PROBLEM
factor	NN	I-PROBLEM
.	.	O

the	DT	B-TREATMENT
antibiotics	NNS	I-TREATMENT
were	VBD	O
discontinued	VBN	O
after	IN	O
48	CD	O
hours	NNS	O
when	WRB	O
the	DT	O
infant	NN	O
was	VBD	O
clinically	RB	O
well	RB	O
and	CC	O
the	DT	B-TEST
blood	NN	I-TEST
cultures	NNS	I-TEST
remained	VBD	O
negative	JJ	O
.	.	O

she	PRP	O
had	VBD	O
a	DT	B-TEST
head	NN	I-TEST
ultrasound	NN	I-TEST
on	IN	O
2013-05-02	JJ	O
,	,	O
that	WDT	O
was	VBD	O
completely	RB	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

the	DT	O
infant	NN	O
is	VBZ	O
on	IN	O
breast	NN	B-TREATMENT
milk	NN	I-TREATMENT
with	IN	I-TREATMENT
enfamil	JJ	I-TREATMENT
powder	NN	I-TREATMENT
to	TO	O
provide	VB	O
24	CD	O
calories	NNS	O
per	IN	O
ounce	NN	O
and	CC	O
on	IN	O
an	DT	B-TREATMENT
ad	NN	I-TREATMENT
lib	NN	I-TREATMENT
feeding	VBG	I-TREATMENT
schedule	NN	I-TREATMENT
.	.	O

ferinsol	RB	B-TREATMENT
0.2	CD	O
cc.	NN	O
to	TO	O
provide	VB	O
5	CD	O
mg	NNS	O
a	DT	O
day	NN	O
.	.	O

3.	CD	O
the	DT	O
infant	NN	O
passed	VBD	O
a	DT	B-TEST
car	NN	I-TEST
seat	NN	I-TEST
positioning	VBG	I-TEST
test	NN	I-TEST
on	IN	O
2013-05-11	JJ	O
.	.	O

4.	CD	O
state	NN	B-TEST
screens	NNS	I-TEST
were	VBD	O
sent	VBN	O
on	IN	O
04-27	JJ	O
and	CC	O
2013-05-08	JJ	O
.	.	O

5.	CD	O
the	DT	O
infant	NN	O
received	VBD	O
the	DT	B-TREATMENT
hepatitis	NN	I-TREATMENT
b	NN	I-TREATMENT
vaccine	NN	I-TREATMENT
on	IN	O
2013-05-09	JJ	O
,	,	O
and	CC	O
synagis	VB	B-TREATMENT
on	IN	O
2013-05-11	JJ	O
.	.	O

1)	CD	O
synagis	JJ	B-TREATMENT
rsv	NN	I-TREATMENT
prophylaxis	NN	I-TREATMENT
should	MD	O
be	VB	O
considered	VBN	O
from	IN	O
october	VBN	O
through	IN	O
april	NN	O
for	IN	O
infants	NNS	O
who	WP	O
meet	VBP	O
any	DT	O
of	IN	O
the	DT	O
following	JJ	O
three	CD	O
criteria	NNS	O
:	:	O

smoker	NN	O
in	IN	O
the	DT	O
household	NN	O
,	,	O
with	IN	O
preschool	JJ	O
siblings	NNS	O
,	,	O
or	CC	O
with	IN	O
chronic	JJ	B-PROBLEM
lung	NN	I-PROBLEM
disease	NN	I-PROBLEM
;	:	O

2)	CD	O
influenza	JJ	B-TREATMENT
immunization	NN	I-TREATMENT
should	MD	O
be	VB	O
considered	VBN	O
annually	RB	O
in	IN	O
the	DT	O
fall	NN	O
for	IN	O
preterm	JJ	O
infants	NNS	O
with	IN	O
chronic	JJ	B-PROBLEM
lung	NN	I-PROBLEM
disease	NN	I-PROBLEM
once	IN	O
they	PRP	O
reach	VBP	O
six	CD	O
months	NNS	O
of	IN	O
age	NN	O
.	.	O

before	IN	O
this	DT	O
age	NN	O
,	,	O
the	DT	O
family	NN	O
and	CC	O
other	JJ	O
care	NN	O
givers	NNS	O
should	MD	O
be	VB	O
considered	VBN	O
for	IN	O
immunization	NN	B-TREATMENT
against	IN	O
influenza	NN	B-PROBLEM
to	TO	O
protect	VB	O
the	DT	O
infant	NN	O
.	.	O

1.	CD	O
prematurity	NN	B-PROBLEM
at	IN	O
31-6/7	JJ	O
weeks	NNS	O
gestation	NN	O
.	.	O

3.	CD	O
sepsis	NN	B-PROBLEM
,	,	O
ruled	VBD	O
out	RP	O
.	.	O

4.	CD	O
status	NN	O
post	NN	O
respiratory	NN	B-PROBLEM
distress	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
.	.	O

patient	NN	O
recorded	VBD	O
as	IN	O
having	VBG	O
no	DT	O
known	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM
to	TO	O
drugs	NNS	B-TREATMENT

bright	JJ	B-PROBLEM
red	JJ	I-PROBLEM
blood	NN	I-PROBLEM
per	IN	I-PROBLEM
rectum	NN	I-PROBLEM

colonoscopy	NN	B-TREATMENT

virtual	JJ	B-TREATMENT
colonoscopy	NN	I-TREATMENT

55	CD	O
yo	JJ	O
m	NN	O
w/	NN	O
h/o	NN	O
recurrent	NN	B-PROBLEM
bladder	NN	I-PROBLEM
ca	MD	I-PROBLEM
s/p	VB	O
cystectomy	JJ	B-TREATMENT
w/	JJ	O
ileal	NN	B-TREATMENT
conduit	NN	I-TREATMENT
p/w	NN	O
brbpr	NN	B-PROBLEM
to	TO	O
osh	VB	O
.	.	O

hct	NN	B-TEST
dropped	VBD	O
34	CD	O
->	JJ	O
22	CD	O
.	.	O

egd	NN	B-TEST
normal	JJ	O
.	.	O

cscope	NN	B-TEST
unable	JJ	O
to	TO	O
complete	VB	O
due	JJ	O
to	TO	O
blood	VB	B-PROBLEM
but	CC	O
tics	NNS	B-PROBLEM
seen	VBN	O
.	.	O

tagged	VBN	O
rbc	JJ	B-TEST
+	NN	O
activity	NN	O
in	IN	O
rlq	NN	O
.	.	O

transferred	VBN	O
to	TO	O
mediplex	VB	O
rehab	JJ	O
hospital	NN	O
icu	NN	O
where	WRB	O
hct	NN	B-TEST
has	VBZ	O
remained	VBN	O
stable	JJ	O
.	.	O

seen	VBN	O
by	IN	O
gi	NNS	O
and	CC	O
plan	NN	O
is	VBZ	O
to	TO	O
continue	VB	O
holding	VBG	O
anticoagulation	NN	B-TREATMENT
and	CC	O
repeat	NN	B-TEST
scope	NN	I-TEST
on	IN	O
monday	NN	O
.	.	O

pt	NN	O
feeling	NN	O
well	RB	O
,	,	O
denies	VBZ	O
abd	RB	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
n/v	NN	B-PROBLEM
,	,	O
lh	NN	B-PROBLEM
,	,	O
sob	NN	B-PROBLEM
,	,	O
cp	NN	B-PROBLEM
.	.	O

metastatic	JJ	B-PROBLEM
bladder	NN	I-PROBLEM
ca	MD	I-PROBLEM
now	RB	O
in	IN	O
remission	NN	O
s/p	NN	O
chemo/xrt	NN	B-TREATMENT
s/p	NN	O
cystectomy	NN	B-TREATMENT
and	CC	O
ileal	JJ	B-TREATMENT
loop	NN	I-TREATMENT
urinary	JJ	I-TREATMENT
diversion	NN	I-TREATMENT
and	CC	O
also	RB	O
radical	JJ	B-TREATMENT
prstatectomy	NN	I-TREATMENT
with	IN	O
bilateral	JJ	B-TREATMENT
pelvic	JJ	I-TREATMENT
lymph	NN	I-TREATMENT
node	DT	I-TREATMENT
dissection	NN	I-TREATMENT
.	.	O

b/l	NN	B-PROBLEM
dvt	NN	I-PROBLEM
s,	NN	O
most	RBS	O
recent	JJ	O
seen	VBN	O
in	IN	O
ivc	NN	O
to	TO	O
right	JJ	O
femoral	JJ	O
vein	NN	O
s/p	NN	O
ivc	JJ	B-TREATMENT
filter	NN	I-TREATMENT
2015-01-15	JJ	O

nephrolithiasis	NN	B-PROBLEM
.	.	O

anemia	SYM	B-PROBLEM
-	:	O
baseline	NN	O
mid	NN	O
30	CD	O
s.	NN	O

denies	NNS	O
fh	NN	O
of	IN	O
bleeding	NN	B-PROBLEM
or	CC	O
clotting	VBG	B-PROBLEM
disorders	NNS	I-PROBLEM
.	.	O

t	RB	B-TEST
97.4	CD	O
bp	NN	B-TEST
100/62	CD	O
p	NN	B-TEST
56	CD	O
rr	NN	B-TEST
16	CD	O

mid	NNS	O
aged	VBN	O
man	NN	O
in	IN	O
nad	NN	B-PROBLEM

sclera	NN	B-PROBLEM
anicteric	NN	I-PROBLEM
,	,	O
mmm	NN	O

supple	NN	O
,	,	O
no	DT	O
lad	NN	B-PROBLEM

rrr	NN	O
s1/s2	VBZ	O
no	DT	O
m	NN	B-PROBLEM

soft	JJ	O
,	,	O
+bs	NNP	O
,	,	O
nt	RB	B-PROBLEM
,	,	O
midline	JJ	B-PROBLEM
surgical	JJ	I-PROBLEM
scar	NN	I-PROBLEM
,	,	O
nephrostomy	JJ	B-TREATMENT
bag	NN	I-TREATMENT
draining	VBG	O

yellowish	JJ	B-PROBLEM
urine	NN	I-PROBLEM
in	IN	I-PROBLEM
rlq	NN	I-PROBLEM

no	DT	O
edema	NN	B-PROBLEM
,	,	O
no	DT	O
clubbing	NN	B-PROBLEM

2015-12-03	JJ	O
10:27	CD	O
pm	NN	O
glucose	VBD	B-TEST
-	:	O
88	CD	O
urea	JJ	B-TEST
n	SYM	I-TEST
-	:	O
12	CD	O
creat	NN	B-TEST
-	:	O
1.0	CD	O
sodium	NN	B-TEST
-	:	O
138	CD	O
potassium	NN	B-TEST
-	:	O
3.3	CD	O
chloride	NN	B-TEST
-	:	O
107	CD	O
total	JJ	B-TEST
co2	NN	I-TEST
-	:	O
25	CD	O
anion	NN	B-TEST
gap	NN	I-TEST
-	:	O
9	CD	O

2015-12-03	JJ	O
10:27	CD	O
pm	NN	O
estgfr	SYM	B-TEST
-	:	O
using	VBG	O
this	DT	O

2015-12-03	JJ	O
10:27	CD	O
pm	NN	O
calcium	NN	B-TEST
-	:	O
8.7	CD	O
phosphate	NN	B-TEST
-	:	O
2.4	CD	O
*	JJ	O
magnesium	NN	B-TEST
-	:	O
1.5	CD	O
*	NN	O

2015-12-03	JJ	O
10:27	CD	O
pm	NN	O
wbc	SYM	B-TEST
-	:	O
8.4	CD	O
rbc	NN	B-TEST
-	:	O
2.98	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
9.3	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
26.3	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
88	CD	O
mch	SYM	B-TEST
-	:	O
31.1	CD	O
mchc	SYM	B-TEST
-	:	O
35.3	CD	O
*	NN	O
rdw	NN	B-TEST
-	:	O
14.4	CD	O

2015-12-03	JJ	O
10:27	CD	O
pm	NN	O
plt	NN	B-TEST
count	NN	I-TEST
-	:	O
164	CD	O

2015-12-03	JJ	O
10:27	CD	O
pm	NN	O
pt	NN	B-TEST
-	:	O
11.4	CD	O
ptt	NN	B-TEST
-	:	O
27.5	CD	O
inr(pt)	JJ	B-TEST
-	:	O
1.0	CD	O

55	CD	O
year	NN	O
old	JJ	O
man	NN	O
with	IN	O
history	NN	O
of	IN	O
metastatic	JJ	B-PROBLEM
bladder	NN	I-PROBLEM
cancer	NN	I-PROBLEM
and	CC	O
recurrent	NN	B-PROBLEM
dvt	NN	I-PROBLEM
s	NN	I-PROBLEM
on	IN	O
lovenox	NN	B-TREATMENT
admitted	VBN	O
with	IN	O
lower	JJR	B-PROBLEM
gi	NN	I-PROBLEM
bleeding	NN	I-PROBLEM
.	.	O

right	RB	B-PROBLEM
lower	JJR	I-PROBLEM
quadrant	JJ	I-PROBLEM
source	NN	I-PROBLEM
of	IN	I-PROBLEM
bleed	NN	I-PROBLEM
on	IN	O
red	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
scan	JJ	I-TEST
.	.	O

attempts	NNS	O
to	TO	O
visualize	VB	O
colon	NN	O
by	IN	O
conventional	JJ	B-TEST
and	CC	I-TEST
ct	JJ	I-TEST
virtual	JJ	I-TEST
colonoscopy	NN	I-TEST
failed	VBD	O
because	IN	O
of	IN	O
sigmoid	JJ	B-PROBLEM
angulation	NN	I-PROBLEM
and	CC	O
inadequate	JJ	O
preparation	NN	O
,	,	O
respectively	RB	O
.	.	O

on	IN	O
ct	JJ	B-TEST
scan	JJ	I-TEST
,	,	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
psoas	NN	I-PROBLEM
mass	NN	I-PROBLEM
,	,	O
most	RBS	O
consistent	JJ	O
with	IN	O
a	DT	B-PROBLEM
hematoma	NN	I-PROBLEM
,	,	O
was	VBD	O
seen	VBN	O
.	.	O

since	IN	O
the	DT	B-TEST
hematocrit	NN	I-TEST
of	IN	O
the	DT	O
patient	NN	O
was	VBD	O
stable	JJ	O
and	CC	O
outside	JJ	O
records	NNS	O
from	IN	O
2015-03-28	JJ	O
mentioned	VBD	O
a	DT	B-PROBLEM
mass	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
pelvis	NN	I-PROBLEM
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
discharged	VBN	O
.	.	O

lovenox	NN	B-TREATMENT
was	VBD	O
held	VBN	O
until	IN	O
follow-up	JJ	O
with	IN	O
primary	JJ	O
care	NN	O
doctor	NN	O
.	.	O

also	RB	O
,	,	O
a	DT	B-TEST
repeat	NN	I-TEST
outpatient	JJ	I-TEST
ct	NN	I-TEST
colonoscopy	NN	I-TEST
with	IN	O
better	JJR	O
preparation	NN	O
should	MD	O
be	VB	O
considered	VBN	O
.	.	O

lovenox	RB	B-TREATMENT
0.6	CD	O
mg	NNS	O
/	JJ	O
kg	JJ	O
sc	NN	O
bid	NN	O

1.	CD	O
pantoprazole	JJ	B-TREATMENT
40	CD	O
mg	JJ	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
once	RB	O
a	DT	O
day	NN	O
.	.	O

cbc	NN	B-TEST
,	,	O
creatinine	NN	B-TEST

gib	NN	B-PROBLEM

metastatic	JJ	B-PROBLEM
,	,	I-PROBLEM
recurrent	JJ	I-PROBLEM
bladder	NN	I-PROBLEM
cancer	NN	I-PROBLEM

h/o	NN	O
dvt	NN	B-PROBLEM
s	NN	I-PROBLEM

we	PRP	O
recommend	VBP	O
that	IN	O
you	PRP	O
do	VBP	O
not	RB	O
resume	VB	O
your	PRP$	B-TREATMENT
lovenox	NN	I-TREATMENT
until	IN	O
talking	VBG	O
to	TO	O
your	PRP$	O
pcp	NN	O
,	,	O
dr.	JJ	O
jessie	NN	O
.	.	O

you	PRP	O
likely	RB	O
have	VBP	O
a	DT	B-PROBLEM
bleeding	NN	I-PROBLEM
source	NN	I-PROBLEM
in	IN	I-PROBLEM
your	PRP$	I-PROBLEM
colon	NN	I-PROBLEM
that	IN	O
we	PRP	O
have	VBP	O
been	VBN	O
unable	JJ	O
to	TO	O
visualize	VB	O
.	.	O

the	DT	B-PROBLEM
bleeding	NN	I-PROBLEM
has	VBZ	O
stopped	VBN	O
and	CC	O
you	PRP	O
have	VBP	O
remained	VBN	O
hemodynamically	RB	O
stable	JJ	O
and	CC	O
your	PRP$	B-TEST
hematocrit	NN	I-TEST
is	VBZ	O
stable	JJ	O
,	,	O
but	CC	O
you	PRP	O
are	VBP	O
at	IN	O
risk	NN	O
of	IN	O
bleeding	VBG	B-PROBLEM
from	IN	O
this	DT	O
source	NN	O
again	RB	O
with	IN	O
anticoagulation	NN	B-TREATMENT
.	.	O

a	DT	B-TEST
ct	JJ	I-TEST
scan	NN	I-TEST
of	IN	I-TEST
your	PRP$	I-TEST
abdomen	NNS	I-TEST
showed	VBD	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
pelvic	NN	I-PROBLEM
mass	NN	I-PROBLEM
,	,	O
most	RBS	O
likely	RB	O
a	DT	B-PROBLEM
hematoma	NN	I-PROBLEM
,	,	O
which	WDT	O
had	VBD	O
been	VBN	O
described	VBN	O
previously	RB	O
in	IN	O
2015-03-28	JJ	O
.	.	O

please	NN	O
continue	VB	O
to	TO	O
take	VB	O
your	PRP$	B-TREATMENT
other	JJ	I-TREATMENT
medications	NNS	I-TREATMENT
as	IN	O
prescribed	NN	O
.	.	O

please	VB	O
see	VB	O
a	DT	O
doctor	NN	O
if	IN	O
you	PRP	O
feel	VBP	O
dizzy	JJ	B-PROBLEM
,	,	O
or	CC	O
have	VBP	O
blood	VBN	B-PROBLEM
in	IN	I-PROBLEM
your	PRP$	I-PROBLEM
stool	NN	I-PROBLEM
again	RB	O
.	.	O

please	NN	O
go	VB	O
to	TO	O
dr.	VB	O
colombo	JJ	O
office	NN	O
later	RB	O
this	DT	O
week	NN	O
to	TO	O
have	VB	O
your	PRP$	B-TEST
labs	NNS	I-TEST
drawn	VBN	O
and	CC	O
sent	VBN	O
to	TO	O
dr.	VB	O
powell	NN	O
.	.	O

cardiothoracic	NN	B-TREATMENT
surgery	NN	I-TREATMENT

this	DT	O
is	VBZ	O
a	DT	O
67	CD	O
-	:	O
year-old	JJ	O
male	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
high	JJ	B-PROBLEM
cholesterol	NN	I-PROBLEM
who	WP	O
was	VBD	O
in	IN	O
his	PRP$	O
usual	JJ	O
state	NN	O
of	IN	O
health	NN	O
until	IN	O
2016-04-03	JJ	O
.	.	O

he	PRP	O
was	VBD	O
raking	VBG	O
leaves	NNS	O
on	IN	O
04-02	NN	O
and	CC	O
then	RB	O
developed	VBD	O
episodes	NNS	O
of	IN	O
mid	JJ	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
burning	NN	B-PROBLEM
which	WDT	O
radiated	VBD	O
to	TO	O
the	DT	O
left	JJ	O
arm	NN	O
.	.	O

that	DT	O
night	NN	O
he	PRP	O
reportedly	RB	O
stopped	VBD	O
breathing	VBG	B-PROBLEM
and	CC	O
was	VBD	O
unresponsive	JJ	B-PROBLEM
.	.	O

his	PRP$	O
wife	NN	O
gave	VBD	O
him	PRP	O
mouth-to-mouth	JJ	B-TREATMENT
resuscitation	NN	I-TREATMENT
and	CC	O
he	PRP	O
regained	VBD	O
consciousness	NN	O
.	.	O

he	PRP	O
presented	VBD	O
to	TO	O
an	DT	O
outside	JJ	O
hospital	NN	O
with	IN	O
an	DT	B-PROBLEM
acute	JJ	I-PROBLEM
inferior	JJ	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
and	CC	O
was	VBD	O
treated	VBN	O
with	IN	O
thrombolytic	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

his	PRP$	B-TEST
troponin	NN	I-TEST
was	VBD	O
20	CD	O
and	CC	O
he	PRP	O
had	VBD	O
ekg	VBN	B-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

he	PRP	O
underwent	JJ	O
catheterization	NN	B-TEST
on	IN	O
2016-04-05	JJ	O
which	WDT	O
revealed	VBD	O
a	DT	B-TEST
left	JJ	I-TEST
ventricular	JJ	I-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
of	IN	O
50%	CD	O
,	,	O
no	DT	O
mitral	JJ	B-PROBLEM
regurgitation	NN	I-PROBLEM
,	,	O
insufficiency	NN	B-PROBLEM
or	CC	O
hypokinesis	NN	B-PROBLEM
.	.	O

left	VBN	O
main	JJ	O
coronary	JJ	O
artery	NN	O
was	VBD	O
narrowed	VBN	B-PROBLEM
50-60%	JJ	O
,	,	O
left	VBD	O
anterior	RP	O
descending	VBG	O
coronary	JJ	O
artery	RB	O
70%	CD	O
proximally	RB	O
,	,	O
right	JJ	B-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
dominant	NN	I-PROBLEM
diseased	VBD	I-PROBLEM
up	RB	O
to	TO	O
90%	CD	O
proximally	RB	O
in	IN	O
the	DT	O
midportion	NN	O
,	,	O
70%	CD	O
distally	RB	O
.	.	O

1.	CD	O
history	NN	O
of	IN	O
high	JJ	B-PROBLEM
cholesterol	NN	I-PROBLEM
.	.	O

2.	CD	O
hemorrhoidectomy	NN	B-TREATMENT
.	.	O

3.	CD	O
carotid	JJ	B-PROBLEM
disease	NN	I-PROBLEM
.	.	O

1.	CD	O
lipitor	NN	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

2.	CD	O
aspirin	JJ	B-TREATMENT
325	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

3.	CD	O
lopressor	NN	B-TREATMENT
25	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

4.	CD	O
plavix	JJ	B-TREATMENT
75	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
which	WDT	O
has	VBZ	O
been	VBN	O
discontinued	VBN	O
prior	RB	O
to	TO	O
surgery	NN	B-TREATMENT
.	.	O

positive	JJ	O
for	IN	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

in	IN	O
general	JJ	O
the	DT	O
patient	NN	O
was	VBD	O
in	IN	O
no	DT	O
acute	NN	B-PROBLEM
distress	NN	I-PROBLEM
,	,	O
afebrile	NN	B-PROBLEM
,	,	O
vital	JJ	B-TEST
signs	NNS	I-TEST
stable	JJ	O
.	.	O

heent	NN	O
:	:	O
normocephalic	JJ	O
,	,	O
atraumatic	JJ	B-PROBLEM
.	.	O

neck	NN	O
:	:	O
supple	NN	O
with	IN	O
full	JJ	O
range	NN	O
of	IN	O
motion	NN	O
,	,	O
no	DT	O
lymphadenopathy	JJ	B-PROBLEM
nor	CC	O
thyromegaly	JJ	B-PROBLEM
.	.	O

carotids	NNS	B-TEST
were	VBD	O
1+	CD	O
bilaterally	RB	O
.	.	O

positive	JJ	O
right	NN	B-PROBLEM
carotid	NN	I-PROBLEM
bruits	NNS	I-PROBLEM
.	.	O

lungs	NNS	O
:	:	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
.	.	O

cardiovascular	NN	O
:	:	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
,	,	O
no	DT	O
murmurs	NN	B-PROBLEM
.	.	O

abdomen	NNS	O
:	:	O
positive	JJ	O
bowel	NN	O
sounds	NNS	O
,	,	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBD	B-PROBLEM
,	,	O
no	DT	O
masses	NNS	B-PROBLEM
,	,	O
no	DT	O
hepatosplenomegaly	NN	B-PROBLEM
.	.	O

extremities	NNS	O
:	:	O
without	IN	O
cyanosis	NN	B-PROBLEM
,	,	O
clubbing	VBG	B-PROBLEM
or	CC	O
edema	NN	B-PROBLEM
.	.	O

pulses	NNS	B-TEST
were	VBD	O
2+	CD	O
bilaterally	RB	O
throughout	IN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
hospital	NN	O
and	CC	O
on	IN	O
2016-04-06	JJ	O
the	DT	O
patient	JJ	O
underwent	JJ	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
grafting	VBG	I-TREATMENT
x	$	O
4	CD	O
with	IN	O
left	JJ	O
internal	JJ	O
mammary	JJ	O
artery	NN	O
to	TO	O
the	DT	O
left	VBN	O
anterior	JJ	O
descending	VBG	O
coronary	JJ	O
artery	NN	O
,	,	O
saphenous	JJ	B-TREATMENT
vein	NN	I-TREATMENT
graft	NN	I-TREATMENT
to	TO	I-TREATMENT
the	DT	I-TREATMENT
diagonal	NN	I-TREATMENT
,	,	O
saphenous	JJ	B-TREATMENT
vein	NN	I-TREATMENT
graft	NN	I-TREATMENT
to	TO	I-TREATMENT
obtuse	VB	I-TREATMENT
marginal	JJ	I-TREATMENT
,	,	O
saphenous	JJ	B-TREATMENT
vein	NN	I-TREATMENT
graft	NN	I-TREATMENT
to	TO	I-TREATMENT
right	JJ	I-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
,	,	O
posterior	JJ	O
descending	VBG	O
coronary	JJ	O
artery	NN	O
.	.	O

the	DT	O
patient	NN	O
appeared	VBD	O
to	TO	O
have	VB	O
tolerated	VBN	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
and	CC	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
cardiac	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
for	IN	O
postoperative	JJ	B-TREATMENT
management	NN	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
beta	NN	B-TREATMENT
blockers	NNS	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
pacing	JJ	B-TREATMENT
wires	NNS	I-TREATMENT
and	CC	O
chest	JJS	B-TREATMENT
tubes	NNS	I-TREATMENT
in	IN	O
place	NN	O
,	,	O
both	DT	O
of	IN	O
which	WDT	O
over	IN	O
the	DT	O
course	NN	O
of	IN	O
his	PRP$	O
stay	NN	O
were	VBD	O
removed	VBN	O
successfully	RB	O
.	.	O

they	PRP	O
requested	VBD	O
that	IN	O
he	PRP	O
follow	VB	O
up	RP	O
in	IN	O
three	CD	O
to	TO	O
five	CD	O
weeks	NNS	O
for	IN	O
endurance	NN	B-TREATMENT
training	NN	I-TREATMENT
,	,	O
however	RB	O
then	RB	O
physical	JJ	O
therapy	NN	O
followed	VBD	O
him	PRP	O
a	DT	O
number	NN	O
of	IN	O
times	NNS	O
afterward	RB	O
and	CC	O
decided	VBD	O
that	IN	O
he	PRP	O
was	VBD	O
in	IN	O
good	JJ	O
condition	NN	O
and	CC	O
did	VBD	O
not	RB	O
need	VB	O
further	RB	O
physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

he	PRP	O
may	MD	O
observe	VB	O
regular	JJ	O
activity	NN	O
although	IN	O
he	PRP	O
should	MD	O
avoid	VB	O
strenuous	JJ	O
activity	NN	O
and	CC	O
should	MD	O
not	RB	O
drive	VB	O
while	IN	O
on	IN	O
pain	NN	B-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

1.	CD	O
lasix	JJ	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q.	VBD	O
12	CD	O
.	.	O

2.	CD	O
potassium	NN	B-TREATMENT
20	CD	O
meq	NN	O
p.o.	NN	O
q.	VBD	O
12	CD	O
.	.	O

3.	CD	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

4.	CD	O
aspirin	JJ	B-TREATMENT
325	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

5.	CD	O
percocet	JJ	B-TREATMENT
1-2	JJ	O
tablets	NNS	O
p.o.	VBP	O
q.	RB	O
4	CD	O
p.r.n.	NN	O
pain	NN	B-PROBLEM
.	.	O

6.	CD	O
lopressor	NN	B-TREATMENT
12.5	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

peggy	NN	O
hammock	NN	O
is	VBZ	O
a	DT	O
full	JJ	O
term	NN	O
baby	NN	O
boy	VBD	O
born	VBN	O
at	IN	O
38	CD	O
1/7	CD	O
weeks	NNS	O
by	IN	O
repeat	NN	B-TREATMENT
cesarean	JJ	I-TREATMENT
section	NN	I-TREATMENT
to	TO	O
a	DT	O
34	CD	O
year	NN	O
old	JJ	O
gravida	NN	O
iii	NN	O
,	,	O
now	RB	O
para	VBZ	O
ii	NN	O
mother	NN	O
.	.	O

serologies	NNS	B-TEST
include	VBP	O
blood	NN	B-TEST
type	NN	I-TEST
o	NN	O
negative	JJ	O
,	,	O
antibody	JJ	B-TEST
negative	JJ	O
,	,	O
rpr	JJ	B-TEST
nonreactive	NN	O
.	.	O

hepatitis	NN	B-TEST
b	NN	I-TEST
surface	NN	I-TEST
antigen	NN	I-TEST
negative	JJ	O
,	,	O
rubella	JJ	B-TEST
immune	NN	O
.	.	O

group	NN	B-TEST
b	VBD	I-TEST
strep	NN	I-TEST
screening	NN	I-TEST
was	VBD	O
negative	JJ	O
.	.	O

pregnancy	NN	O
was	VBD	O
uncomplicated	VBN	B-PROBLEM
until	IN	O
an	DT	O
occurrence	NN	O
of	IN	O
hsv	NN	B-PROBLEM
outbreak	NN	I-PROBLEM
occurred	VBD	O
on	IN	O
2017-09-13	CD	O
approximately	RB	O
one	CD	O
week	NN	O
prior	RB	O
to	TO	O
delivery	NN	B-TREATMENT
.	.	O

pregnancy	NN	O
was	VBD	O
also	RB	O
complicated	VBN	O
by	IN	O
maternal	JJ	O
history	NN	O
of	IN	O
depression	NN	B-PROBLEM
for	IN	O
which	WDT	O
mother	NN	O
received	VBD	O
zoloft	NN	B-TREATMENT
.	.	O

on	IN	O
day	NN	O
of	IN	O
delivery	NN	B-TREATMENT
mother	NN	O
presented	VBN	O
in	IN	O
spontaneous	JJ	B-PROBLEM
labor	NN	I-PROBLEM
.	.	O

there	EX	O
were	VBD	O
no	DT	O
sepsis	NN	B-PROBLEM
risk	NN	I-PROBLEM
factors	NNS	I-PROBLEM
.	.	O

gbs	NN	B-TEST
negative	JJ	O
.	.	O

no	DT	O
maternal	JJ	B-PROBLEM
fever	NN	I-PROBLEM
.	.	O

rupture	NN	B-PROBLEM
of	IN	I-PROBLEM
membranes	NNS	I-PROBLEM
at	IN	O
time	NN	O
of	IN	O
delivery	NN	B-TREATMENT
.	.	O

delivery	NN	B-TREATMENT
was	VBD	O
by	IN	O
repeat	NN	B-TREATMENT
cesarean	JJ	I-TREATMENT
section	NN	I-TREATMENT
and	CC	O
apgars	NNS	B-TEST
of	IN	O
8	CD	O
and	CC	O
9	CD	O
were	VBD	O
given	VBN	O
at	IN	O
one	CD	O
and	CC	O
five	CD	O
minutes	NNS	O
respectively	RB	O
.	.	O

baby	NN	O
appeared	VBD	O
well	RB	O
and	CC	O
went	VBD	O
to	TO	O
the	DT	O
newborn	JJ	O
nursery	NN	O
and	CC	O
was	VBD	O
breast	VBN	O
feeding	NN	O
and	CC	O
undergoing	JJ	O
routine	NN	B-TREATMENT
newborn	VBN	I-TREATMENT
care	NN	I-TREATMENT
.	.	O

on	IN	O
the	DT	O
newborn	JJ	O
nursery	NN	O
the	DT	O
mother	NN	O
called	VBD	O
the	DT	O
nurse	NN	O
for	IN	O
concern	NN	O
of	IN	O
baby	NN	O
turning	VBG	O
dusky	NN	B-PROBLEM
while	IN	O
feeding	VBG	O
.	.	O

this	DT	B-PROBLEM
episode	NN	I-PROBLEM
was	VBD	O
also	RB	O
accompanied	VBN	O
by	IN	O
gagging	VBG	B-PROBLEM
motions	NNS	I-PROBLEM
noted	VBN	O
of	IN	O
the	DT	O
infant	NN	O
.	.	O

a	DT	B-PROBLEM
second	JJ	I-PROBLEM
episode	NN	I-PROBLEM
occurred	VBD	O
where	WRB	O
the	DT	O
baby	NN	O
turned	VBD	O
pale	JJ	B-PROBLEM
.	.	O

the	DT	O
baby	NN	O
did	VBD	O
not	RB	O
turn	VB	O
blue	NN	B-PROBLEM
at	IN	O
that	DT	O
time	NN	O
.	.	O

the	DT	O
neonatal	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
was	VBD	O
notified	VBN	O
and	CC	O
the	DT	O
baby	NN	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
newborn	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
for	IN	O
further	JJ	B-TEST
evaluation	NN	I-TEST
.	.	O

full	JJ	O
term	NN	O
well	RB	O
appearing	VBG	O
infant	NN	O
with	IN	O
some	DT	B-PROBLEM
facial	JJ	I-PROBLEM
jaundice	NN	I-PROBLEM
,	,	O
overall	JJ	O
pink	NN	O
,	,	O
warm	NN	O
and	CC	O
well	RB	O
perfused	VBN	O
,	,	O
alert	JJ	O
and	CC	O
responsive	JJ	O
.	.	O

red	JJ	B-TEST
reflexes	NNS	I-TEST
noted	VBD	O
bilaterally	RB	O
.	.	O

he	PRP	O
had	VBD	O
a	DT	O
left	VBN	O
pupil	NN	O
that	WDT	O
was	VBD	O
in	IN	O
unequal	JJ	B-PROBLEM
in	IN	I-PROBLEM
size	NN	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
keyhole	JJ	I-PROBLEM
appearance	NN	I-PROBLEM
consistent	NN	O
with	IN	O
a	DT	B-PROBLEM
coloboma	NN	I-PROBLEM
.	.	O

his	PRP$	O
neck	NN	O
was	VBD	O
supple	RB	O
without	IN	O
masses	NNS	B-PROBLEM
or	CC	O
bruits	NNS	B-PROBLEM
.	.	O

lungs	NNS	O
were	VBD	O
clear	JJ	O
to	TO	O
auscultation	NN	B-TEST
and	CC	O
equal	JJ	O
.	.	O

regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
,	,	O
no	DT	O
murmur	NN	B-PROBLEM
.	.	O

2	CD	O
plus	CC	O
femoral	JJ	B-TEST
pulses	NNS	I-TEST
were	VBD	O
noted	VBN	O
.	.	O

infant	NN	O
was	VBD	O
circumcised	VBN	B-TREATMENT
in	IN	O
the	DT	O
newborn	JJ	O
nursery	NN	O
which	WDT	O
was	VBD	O
healing	VBG	O
well	RB	O
.	.	O

tone	NN	B-TEST
was	VBD	O
appropriate	JJ	O
for	IN	O
gestational	JJ	O
age	NN	O
with	IN	O
equal	JJ	O
strength	NN	B-TEST
,	,	O
symmetric	JJ	O
reflexes	NNS	B-TEST
.	.	O

the	DT	O
infant	NN	O
was	VBD	O
placed	VBN	O
on	IN	O
a	DT	B-TEST
cardiopulmonary	JJ	I-TEST
monitor	NN	I-TEST
upon	IN	O
admission	NN	O
to	TO	O
the	DT	O
newborn	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
with	IN	O
pulse	JJ	B-TEST
oximetry	NN	I-TEST
.	.	O

he	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
an	DT	O
episode	NN	O
of	IN	O
desaturation	NN	B-PROBLEM
related	VBN	O
to	TO	O
feeding	VBG	O
with	IN	O
desaturations	NNS	B-PROBLEM
in	IN	O
the	DT	O
70	CD	O
percent	NN	O
.	.	O

jule	NN	O
remained	VBD	O
in	IN	O
room	NN	O
air	NN	O
without	IN	O
any	DT	O
evidence	NN	O
of	IN	O
respiratory	NN	B-PROBLEM
distress	NN	I-PROBLEM
and	CC	O
was	VBD	O
without	IN	O
any	DT	B-PROBLEM
further	JJ	I-PROBLEM
dusky	NN	I-PROBLEM
spells	NNS	I-PROBLEM
or	CC	O
pale	JJ	B-PROBLEM
episodes	NNS	I-PROBLEM
in	IN	O
the	DT	O
48	CD	O
hours	NNS	O
prior	RB	O
to	TO	O
discharge	VB	O
.	.	O

renee	NN	O
remained	VBD	O
cardiovascularly	RB	O
stable	JJ	O
with	IN	O
ap	JJ	B-TEST
s	NN	I-TEST
noted	VBD	O
to	TO	O
be	VB	O
120	CD	O
to	TO	O
130	CD	O
s.	NN	O

blood	NN	B-TEST
pressure	NN	I-TEST
84/43	CD	O
with	IN	O
a	DT	B-TEST
mean	NN	I-TEST
of	IN	O
59	CD	O
.	.	O

he	PRP	O
was	VBD	O
fed	VBN	O
with	IN	O
a	DT	O
bottle	NN	O
occasionally	RB	O
by	IN	O
his	PRP$	O
dad	NN	O
and	CC	O
had	VBD	O
a	DT	O
vigorous	JJ	O
suck	NN	O
and	CC	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
some	DT	B-PROBLEM
discoordination	NN	I-PROBLEM
of	IN	I-PROBLEM
his	PRP$	I-PROBLEM
suck	NN	I-PROBLEM
while	IN	O
breathing	VBG	O
at	IN	O
the	DT	O
initial	JJ	O
onset	NN	O
of	IN	O
feeding	JJ	O
time	NN	O
.	.	O

breast	NN	O
feeding	NN	O
was	VBD	O
limited	VBN	O
to	TO	O
four	CD	O
to	TO	O
five	CD	O
minutes	NNS	O
on	IN	O
each	DT	O
side	NN	O
per	IN	O
recommendation	NN	O
of	IN	O
neurology	NN	O
after	IN	O
their	PRP$	B-TEST
evaluation	NN	I-TEST
to	TO	O
try	VB	O
and	CC	O
minimize	VB	O
incidence	NN	O
of	IN	O
gastroesophageal	JJ	B-PROBLEM
reflux	NN	I-PROBLEM
.	.	O

weight	NN	B-TEST
at	IN	O
time	NN	O
of	IN	O
discharge	NN	O
is	VBZ	O
3.13	CD	O
kilograms	NNS	O
.	.	O

birth	NN	B-TEST
weight	NN	I-TEST
was	VBD	O
3.29	CD	O
kilograms	NNS	O
in	IN	O
the	DT	O
75th	CD	O
percentile	NN	O
.	.	O

head	NN	B-TEST
circumference	NN	I-TEST
was	VBD	O
34.5	CD	O
cm	NN	O
,	,	O
75th	CD	O
percentile	NN	O
,	,	O
and	CC	O
length	NN	B-TEST
was	VBD	O
50.7	CD	O
cm	NN	O
,	,	O
also	RB	O
the	DT	O
75th	CD	O
percentile	NN	O
.	.	O

baby	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
frequent	JJ	B-PROBLEM
spitting	VBG	I-PROBLEM
episodes	NNS	I-PROBLEM
.	.	O

this	DT	O
was	VBD	O
minimized	VBN	O
with	IN	O
limitation	NN	B-TREATMENT
of	IN	I-TREATMENT
volume	NN	I-TREATMENT
at	IN	I-TREATMENT
each	DT	I-TREATMENT
feed	NN	I-TREATMENT
with	IN	O
frequent	JJ	B-TREATMENT
feeding	NN	I-TREATMENT
.	.	O

the	DT	O
baby	NN	O
demonstrated	VBD	O
mild	JJ	B-PROBLEM
physiologic	JJ	I-PROBLEM
jaundice	NN	I-PROBLEM
with	IN	O
a	DT	B-TEST
serum	NN	I-TEST
bilirubin	NN	I-TEST
obtained	VBN	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
three	CD	O
which	WDT	O
was	VBD	O
6.7	CD	O
with	IN	O
a	DT	O
direct	NN	O
of	IN	O
0.2	CD	O
.	.	O

mother	NN	B-TEST
's	POS	I-TEST
blood	NN	I-TEST
type	NN	I-TEST
is	VBZ	O
o	JJ	O
negative	JJ	O
.	.	O

infant	NN	B-TEST
's	POS	I-TEST
blood	NN	I-TEST
type	NN	I-TEST
was	VBD	O
o	JJ	O
positive	JJ	O
and	CC	O
coombs	NN	B-TEST
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
negative	JJ	O
.	.	O

in	IN	O
addition	NN	O
a	DT	B-TEST
complete	JJ	I-TEST
blood	NN	I-TEST
count	NN	I-TEST
was	VBD	O
obtained	VBN	O
on	IN	O
admission	NN	O
with	IN	O
a	DT	B-TEST
white	JJ	I-TEST
count	NN	I-TEST
of	IN	O
10.1	CD	O
with	IN	O
43	CD	O
polys	NNS	B-TEST
and	CC	O
0	CD	O
bands	NNS	B-TEST
.	.	I-TEST

hematocrit	NN	B-TEST
was	VBD	O
noted	VBN	O
to	TO	O
47.5	CD	O
with	IN	O
platelets	NNS	B-TEST
of	IN	O
257,000	CD	O
.	.	O

there	EX	O
were	VBD	O
no	DT	O
blood	NN	B-TREATMENT
products	NNS	I-TREATMENT
received	VBD	O
during	IN	O
hospitalization	NN	O
.	.	O

a	DT	B-TEST
blood	NN	I-TEST
culture	NN	I-TEST
was	VBD	O
obtained	VBN	O
upon	IN	O
admission	NN	O
and	CC	O
ampicillin	NN	B-TREATMENT
and	CC	O
gentamicin	NN	B-TREATMENT
were	VBD	O
given	VBN	O
for	IN	O
48	CD	O
hours	NNS	O
with	IN	O
blood	NN	B-TEST
cultures	NNS	I-TEST
remaining	VBG	O
sterile	NN	O
.	.	O

antibiotics	NNS	B-TREATMENT
were	VBD	O
discontinued	VBN	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
three	CD	O
and	CC	O
infant	NN	O
has	VBZ	O
remained	VBN	O
clinically	RB	O
well	RB	O
off	IN	O
antibiotics	NNS	B-TREATMENT
.	.	O

neurology	NN	O
was	VBD	O
consulted	VBN	O
due	JJ	O
to	TO	O
the	DT	O
concern	NN	O
for	IN	O
seizures	NNS	B-PROBLEM
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
dusky	JJ	B-PROBLEM
episodes	NNS	I-PROBLEM
.	.	O

an	DT	B-TEST
eeg	NN	I-TEST
was	VBD	O
performed	VBN	O
.	.	O

the	DT	B-TEST
eeg	NN	I-TEST
showed	VBD	O
transient	JJ	B-PROBLEM
sharp	JJ	I-PROBLEM
waves	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
front	NN	I-PROBLEM
,	,	O
left	VBD	O
occipital	JJ	O
and	CC	O
right	JJ	O
parietal	NN	O
regions	NNS	O
.	.	O

there	EX	O
was	VBD	O
no	DT	O
electrographic	JJ	B-TEST
evidence	NN	I-TEST
of	IN	O
seizure	NN	B-PROBLEM
activity	NN	I-PROBLEM
noted	VBD	O
.	.	O

hearing	VBG	B-TEST
screening	NN	I-TEST
was	VBD	O
performed	VBN	O
with	IN	O
automated	JJ	O
auditory	NN	O
brain	NN	O
stem	NN	O
responses	NNS	O
.	.	O

ophthalmology	NN	O
was	VBD	O
consulted	VBN	O
due	JJ	O
to	TO	O
the	DT	O
presence	NN	O
of	IN	O
a	DT	B-PROBLEM
coloboma	NN	I-PROBLEM
into	IN	O
the	DT	O
left	NN	O
cmed	VBD	O
.	.	O

ophthalmology	NN	O
noted	VBD	O
that	IN	O
this	DT	B-PROBLEM
left	VBD	I-PROBLEM
martha	NN	I-PROBLEM
coloboma	NN	I-PROBLEM
was	VBD	O
likely	RB	O
an	DT	B-PROBLEM
isolated	JJ	I-PROBLEM
anomaly	NN	I-PROBLEM
in	IN	O
the	DT	O
absence	NN	O
of	IN	O
other	JJ	B-PROBLEM
pathology	NN	I-PROBLEM
.	.	O

medications	NNS	B-TREATMENT
are	VBP	O
tri-vi-michael	JJ	B-TREATMENT
1	CD	O
cc	NN	O
by	IN	O
mouth	JJ	O
each	DT	O
day	NN	O
.	.	O

newborn	JJ	B-TEST
state	NN	I-TEST
screen	NN	I-TEST
was	VBD	O
sent	VBN	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
three	CD	O
.	.	O

immunizations	NNS	B-TREATMENT
received	VBN	O
are	VBP	O
hepatitis	JJ	B-TREATMENT
b	JJ	I-TREATMENT
vaccine	NN	I-TREATMENT
given	VBN	O
on	IN	O
09-26	NN	O
.	.	O

full	JJ	O
term	NN	O
male	NN	O
infant	NN	O
with	IN	O
cyanosis	NN	B-PROBLEM
episodes	NNS	I-PROBLEM
.	.	O

rule	NN	O
out	IN	O
sepsis	NN	B-PROBLEM
.	.	O

left	VBN	B-PROBLEM
coloboma	NN	I-PROBLEM
.	.	O

rule	NN	O
out	IN	O
seizures	NNS	B-PROBLEM
.	.	O

mr.	NN	O
pohl	NN	O
is	VBZ	O
a	DT	O
53	JJ	O
-	:	O
year-old	JJ	O
male	NN	O
with	IN	O
history	NN	O
of	IN	O
alcohol	NN	O
use	NN	O
and	CC	O
hypertension	NN	B-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
found	VBN	O
in	IN	O
his	PRP$	O
apartment	NN	O
lobby	NN	O
"	NN	O
shouting	VBG	O
"	NNS	O
and	CC	O
very	RB	B-PROBLEM
agitated	JJ	I-PROBLEM
.	.	O

he	PRP	O
by	IN	O
emergency	NN	O
room	NN	O
report	NN	O
,	,	O
was	VBD	O
found	VBN	O
in	IN	O
his	PRP$	O
apartment	NN	O
lobby	NN	O
agitated	VBD	B-PROBLEM
.	.	O

blood	NN	B-TEST
alcohol	NN	I-TEST
level	NN	I-TEST
was	VBD	O
383	CD	O
.	.	O

agitated	VBN	B-PROBLEM
in	IN	O
emergency	NN	O
room	NN	O
requiring	VBG	O
4	CD	B-TREATMENT
leather	NN	I-TREATMENT
restraints	NNS	I-TREATMENT
,	,	O
received	VBD	O
5	CD	O
mg	NN	O
of	IN	O
haldol	NN	B-TREATMENT
,	,	O
2	CD	O
mg	NN	O
of	IN	O
ativan	NN	B-TREATMENT
.	.	O

he	PRP	O
became	VBD	O
hypotensive	JJ	B-PROBLEM
in	IN	O
the	DT	O
emergency	NN	O
room	NN	O
with	IN	O
a	DT	B-TEST
systolic	JJ	I-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
in	IN	O
the	DT	O
80	CD	O
's	POS	O
and	CC	O
had	VBD	O
decreased	VBN	B-PROBLEM
respiratory	NN	I-PROBLEM
rate	NN	I-PROBLEM
.	.	O

he	PRP	O
received	VBD	O
a	DT	B-TREATMENT
normal	JJ	I-TREATMENT
saline	JJ	I-TREATMENT
bolus	NN	I-TREATMENT
of	IN	O
2	CD	O
liters	NNS	O
of	IN	O
good	JJ	O
blood	NN	O
pressure	NN	O
response	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
then	RB	O
admitted	VBN	O
to	TO	O
the	DT	O
medical	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
for	IN	O
observation	NN	O
of	IN	O
his	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
and	CC	O
then	RB	O
transferred	VBD	O
to	TO	O
our	PRP$	O
service	NN	O
on	IN	O
medicine	NN	O
when	WRB	O
the	DT	B-TEST
blood	NN	I-TEST
pressures	NNS	I-TEST
remained	VBD	O
stable	JJ	O
overnight	NN	O
.	.	O

the	DT	O
patient	JJ	O
denies	VBZ	O
any	DT	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
dysuria	NN	B-PROBLEM
,	,	O
diarrhea	NN	B-PROBLEM
,	,	O
bright	JJ	B-PROBLEM
red	JJ	I-PROBLEM
blood	NN	I-PROBLEM
per	IN	I-PROBLEM
rectum	NN	I-PROBLEM
.	.	O

he	PRP	O
does	VBZ	O
complain	VB	O
of	IN	O
cold	NN	B-PROBLEM
symptoms	NNS	I-PROBLEM
times	NNS	O
one	CD	O
week	NN	O
.	.	O

the	DT	O
patient	NN	O
states	NNS	O
in	IN	O
the	DT	O
past	NN	O
that	IN	O
he	PRP	O
has	VBZ	O
participated	VBN	O
in	IN	O
several	JJ	O
alcohol	NN	B-TREATMENT
treatment	NN	I-TREATMENT
programs	NNS	I-TREATMENT
,	,	O
most	JJS	O
recently	RB	O
star	NN	O
which	WDT	O
is	VBZ	O
similar	JJ	O
alcoholics	NNS	O
anonymous	JJ	O
.	.	O

his	PRP$	O
brother	NN	O
is	VBZ	O
mentally	RB	B-PROBLEM
handicapped	JJ	I-PROBLEM
and	CC	O
might	MD	O
be	VB	O
sent	VBN	O
away	RB	O
from	IN	O
his	PRP$	O
instate	JJ	O
institution	NN	O
.	.	O

in	IN	O
the	DT	O
past	NN	O
,	,	O
he	PRP	O
has	VBZ	O
been	VBN	O
very	RB	B-PROBLEM
depressed	JJ	I-PROBLEM
and	CC	O
has	VBZ	O
seen	VBN	O
a	DT	B-TREATMENT
counselor	NN	I-TREATMENT
at	IN	O
greenfield	NNP	O
community	NN	O
college	NN	O
community	NN	O
health	NN	O
.	.	O

1.	CD	O
hypertension	NN	B-PROBLEM
.	.	O

2.	CD	O
history	NN	O
of	IN	O
colonic	JJ	B-PROBLEM
polyps	NNS	I-PROBLEM
times	NNS	O
3	CD	O
,	,	O
benign	NN	O
in	IN	O
2007	CD	O
,	,	O
repeat	NN	B-TEST
colonoscopy	NN	I-TEST
due	JJ	O
to	TO	O
in	IN	O
2010	CD	O
.	.	O

3.	CD	O
history	NN	O
of	IN	O
right	JJ	B-PROBLEM
inguinal	JJ	I-PROBLEM
hernia	NN	I-PROBLEM
in	IN	O
2002	CD	O
.	.	O

positive	JJ	O
tobacco	NN	O
,	,	O
10	CD	O
pack	NN	O
year	NN	O
history	NN	O
,	,	O
quit	NN	O
for	IN	O
8	CD	O
years	NNS	O
in	IN	O
his	PRP$	O
40	CD	O
's	POS	O
and	CC	O
now	RB	O
no	DT	O
cigarettes	NNS	O
for	IN	O
one	CD	O
week	NN	O
using	VBG	O
no	DT	O
pharmacal	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
only	RB	O
male	JJ	O
sexual	JJ	O
partners	NNS	O
and	CC	O
in	IN	O
the	DT	O
last	JJ	O
six	CD	O
months	NNS	O
has	VBZ	O
two	CD	O
regular	JJ	O
partners	NNS	O
who	WP	O
reportedly	RB	O
are	VBP	O
human	JJ	B-PROBLEM
immunodeficiency	NN	I-PROBLEM
virus	NN	I-PROBLEM
negative	JJ	O
and	CC	O
no	DT	O
iv	JJ	O
drug	NN	O
use	NN	O
.	.	O

he	PRP	O
uses	VBZ	O
condoms	NNS	B-TREATMENT
consistently	RB	O
.	.	O

major	JJ	O
stressors	NNS	O
in	IN	O
his	PRP$	O
life	NN	O
include	VBP	O
unstable	JJ	O
job	NN	O
,	,	O
brother	NN	O
is	VBZ	O
mentally	RB	B-PROBLEM
handicapped	JJ	I-PROBLEM
,	,	O
war	NN	O
.	.	O

allergies	NNS	O
:	:	O
no	DT	O
known	JJ	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

1.	CD	O
lisinopril	JJ	B-TREATMENT
5	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

2.	CD	O
mavik	JJ	B-TREATMENT
question	NN	O
of	IN	O
dosage	NN	O
.	.	O

3.	CD	O
hydrochlorothiazide	JJ	B-TREATMENT
question	NN	O
of	IN	O
dosage	NN	O
.	.	O

1.	CD	O
ranitidine	NN	B-TREATMENT
150	CD	O
mg	NN	O
b.i.d.	NN	O

2.	CD	O
thiamine	JJ	B-TREATMENT
100	CD	O
mg	NN	O
q.d.	NN	O

3.	CD	O
folic	JJ	B-TREATMENT
acid	RB	I-TREATMENT
1	CD	O
mg	NN	O
q.	NN	O
d.	NN	O

4.	CD	O
multivitamin	NN	B-TREATMENT

vitals	NNS	B-TEST
on	IN	I-TEST
admission	NN	I-TEST
:	:	O
please	NN	O
refer	VB	O
to	TO	O
addendum	VB	O
.	.	O

vital	JJ	B-TEST
signs	NNS	I-TEST
were	VBD	O
stable	JJ	O
.	.	O

systolic	JJ	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
in	IN	O
the	DT	O
120	CD	O
's	POS	O
to	TO	O
130	CD	O
's.	NNS	O

pulse	NN	B-TEST
in	IN	O
the	DT	O
60	CD	O
's	POS	O
to	TO	O
70	CD	O
's.	NNS	O

the	DT	O
patient	NN	O
was	VBD	O
a	DT	O
thin	JJ	O
well-appearing	JJ	O
man	NN	O
who	WP	O
was	VBD	O
visibly	RB	B-PROBLEM
restless	JJ	I-PROBLEM
in	IN	O
bed	NN	O
.	.	O

he	PRP	O
was	VBD	O
alert	JJ	O
and	CC	O
oriented	VBD	O
times	NNS	O
3	CD	O
and	CC	O
with	IN	O
slightly	RB	B-PROBLEM
pressured	VBN	I-PROBLEM
speech	NN	I-PROBLEM
.	.	O

he	PRP	O
states	VBZ	O
that	IN	O
mood	NN	O
is	VBZ	O
depressed	VBN	B-PROBLEM
.	.	O

he	PRP	O
denies	VBZ	O
auditory	NN	B-PROBLEM
,	,	I-PROBLEM
visual	JJ	I-PROBLEM
or	CC	I-PROBLEM
tactile	JJ	I-PROBLEM
hallucinations	NNS	I-PROBLEM
.	.	O

cranial	JJ	B-TEST
nerves	NNS	I-TEST
ii-xii	NNS	I-TEST
are	VBP	O
grossly	RB	O
intact	JJ	O
,	,	O
5/5	CD	O
strength	NN	B-TEST
in	IN	I-TEST
all	DT	I-TEST
extremities	NNS	I-TEST
,	,	O
sensation	NN	B-TEST
is	VBZ	O
intact	JJ	O
in	IN	O
all	DT	O
extremities	NNS	O
.	.	O

head	NN	B-TEST
,	,	I-TEST
ears	VBZ	I-TEST
,	,	I-TEST
eyes	NNS	I-TEST
,	,	I-TEST
nose	RB	I-TEST
and	CC	I-TEST
throat	NN	I-TEST
:	:	O
atraumatic	JJ	B-PROBLEM
and	CC	O
normocephalic	JJ	O
.	.	O

sclerae	NN	O
were	VBD	O
anicteric	JJ	B-PROBLEM
.	.	O

oropharynx	NN	O
was	VBD	O
benign	VBN	O
without	IN	O
exudate	NN	B-PROBLEM
.	.	O

no	DT	O
murmurs	NN	B-PROBLEM
,	,	O
rubs	NN	B-PROBLEM
or	CC	O
gallops	NNS	B-PROBLEM
.	.	O

rare	JJ	B-PROBLEM
crackles	NNS	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
base	NN	I-PROBLEM
,	,	O
otherwise	RB	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	I-TEST
.	.	O

positive	JJ	O
bowel	NN	O
sounds	NNS	O
,	,	O
nontender	NN	B-PROBLEM
and	CC	O
nondistended	VBD	B-PROBLEM
.	.	O

no	DT	O
hepatosplenomegaly	NN	B-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
dorsalis	VBN	B-TEST
pedis	NN	I-TEST
in	IN	O
radial	JJ	B-TEST
pulses	NNS	I-TEST
,	,	O
hands	NNS	B-PROBLEM
and	CC	I-PROBLEM
feet	NNS	I-PROBLEM
notably	RB	I-PROBLEM
tremulous	JJ	I-PROBLEM
without	IN	O
asterixis	NN	B-PROBLEM
.	.	O

no	DT	O
stigmata	NN	B-PROBLEM
of	IN	O
iv	JJ	O
drug	NN	O
use	NN	O
.	.	O

cbc	NN	B-TEST
:	:	O
white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
is	VBZ	O
8.8	CD	O
,	,	O
hematocrit	NN	B-TEST
35.5	CD	O
platelets	NNS	B-TEST
266	CD	O
,	,	O
pt	NN	B-TEST
13	CD	O
,	,	O
pt-t	JJ	B-TEST
23.3	CD	O
,	,	O
inr	NN	B-TEST
was	VBD	O
1.1	CD	O
.	.	O

chem-7	NN	B-TEST
:	:	O
sodium	NN	B-TEST
145	CD	O
,	,	O
potassium	NN	B-TEST
3.4	CD	O
,	,	O
chloride	RB	B-TEST
116	CD	O
,	,	O
bicarb	NN	B-TEST
21	CD	O
,	,	O
bun	NN	B-TEST
12	CD	O
,	,	O
creatinine	NN	B-TEST
0.6	CD	O
,	,	O
glucose	RB	B-TEST
96	CD	O
,	,	O
calcium	NN	B-TEST
7.2	CD	O
,	,	O
phos	NN	B-TEST
3.6	CD	O
,	,	O
magnesium	NN	B-TEST
1.7	CD	O
.	.	O

liver	JJ	B-TEST
function	NN	I-TEST
tests	NNS	I-TEST
:	:	O
alt	NN	B-TEST
38	CD	O
,	,	O
ast	RB	B-TEST
34	CD	O
,	,	O
alk	NN	B-TEST
phos	NN	I-TEST
is	VBZ	I-TEST
107	CD	O
,	,	O
albumin	NN	B-TEST
is	VBZ	O
3.2	CD	O
,	,	O
peak	NN	B-TEST
bili	NN	I-TEST
is	VBZ	I-TEST
0.3	CD	O
,	,	O
amylase	NN	B-TEST
31	CD	O
,	,	O
and	CC	O
lipase	NN	B-TEST
is	VBZ	O
32	CD	O
.	.	O

ua	NN	B-TEST
was	VBD	O
negative	JJ	O
.	.	O

urine	JJ	B-TEST
tox	NN	I-TEST
was	VBD	O
negative	JJ	O
.	.	O

serum	NN	B-TEST
tox	NN	I-TEST
was	VBD	O
positive	JJ	O
for	IN	O
etoh	NN	B-TEST
at	IN	O
383	CD	O
,	,	O
otherwise	RB	O
negative	JJ	O
.	.	O

serum	NN	B-TEST
osmolality	NN	I-TEST
was	VBD	O
38397	CD	O
,	,	O
calculated	VBN	B-TEST
osmolality	NN	I-TEST
gap	NN	I-TEST
was	VBD	O
21	CD	O
.	.	O

chest	JJS	B-TEST
x-ray	JJ	I-TEST
from	IN	O
02-07	JJ	O
had	VBD	O
linear	JJ	B-PROBLEM
atelectasis	NN	I-PROBLEM
in	IN	I-PROBLEM
right	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
with	IN	O
no	DT	O
evidence	NN	O
of	IN	O
a	DT	B-PROBLEM
band-like	JJ	I-PROBLEM
opacity	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
which	WDT	O
was	VBD	O
evident	JJ	O
on	IN	O
the	DT	B-TEST
chest	JJS	I-TEST
x-ray	JJ	I-TEST
on	IN	O
02-06	NN	O
.	.	O

ct	NN	B-TEST
of	IN	I-TEST
the	DT	I-TEST
head	NN	I-TEST
on	IN	O
02-06	NN	O
was	VBD	O
negative	JJ	O
for	IN	O
hemorrhage	NN	B-PROBLEM
.	.	O

there	EX	O
was	VBD	O
bran	NN	B-PROBLEM
atrophy	NN	I-PROBLEM
and	CC	O
right	JJ	B-PROBLEM
temporal	JJ	I-PROBLEM
encephalomalacia	NN	I-PROBLEM
.	.	O

mr.	NN	O
pohl	NN	O
is	VBZ	O
a	DT	O
53	JJ	O
-	:	O
year-old	JJ	O
male	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
etoh	NN	O
,	,	O
hypertension	NN	B-PROBLEM
who	WP	O
presented	VBD	O
int	NN	O
he	PRP	O
emergency	NN	O
room	NN	O
with	IN	O
increased	JJ	B-PROBLEM
agitation	NN	I-PROBLEM
,	,	O
like	IN	O
secondary	JJ	O
to	TO	O
etoh	VB	B-PROBLEM
intoxication	NN	I-PROBLEM
and	CC	O
developed	VBD	O
subsequent	JJ	B-PROBLEM
hypotension	NN	I-PROBLEM
,	,	O
systolic	JJ	B-TEST
blood	NN	I-TEST
pressures	NNS	I-TEST
in	IN	O
the	DT	O
80	CD	O
's,	POS	O
status	NN	O
post	NN	O
ativan	NN	B-TREATMENT
and	CC	O
haldol	NN	B-TREATMENT
,	,	O
but	CC	O
was	VBD	O
responsive	JJ	O

to	TO	O
fluid	VB	B-TREATMENT
resuscitation	NN	I-TREATMENT
at	IN	O
4	CD	O
liters	NNS	O
and	CC	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
cmed	VBN	O
ccu	NN	O
for	IN	O
hemodynamic	JJ	B-TEST
monitoring	NN	I-TEST
.	.	O

plan	NN	O
for	IN	O
patient	JJ	O
regarding	VBG	O
cardiac	NN	O
,	,	O
unlike	IN	O
hypotension	NN	B-PROBLEM
of	IN	I-PROBLEM
cardiac	JJ	I-PROBLEM
origin	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
responded	VBD	O
well	RB	O
to	TO	O
fluid	VB	B-TREATMENT
resuscitation	NN	I-TREATMENT
.	.	O

elevated	VBN	B-PROBLEM
ck	NN	I-PROBLEM
on	IN	O
02-07	NN	O
is	VBZ	O
likely	JJ	O
secondary	JJ	O
to	TO	O
mild	VB	B-PROBLEM
rhabdomyolysis	NN	I-PROBLEM
.	.	O

we	PRP	O
decided	VBD	O
to	TO	O
discontinue	VB	O
telemetry	NN	B-TEST
and	CC	O
held	VBD	O
all	DT	B-TREATMENT
hypertension	NN	I-TREATMENT
medications	NNS	I-TREATMENT
including	VBG	O
lisinopril	NN	B-TREATMENT
,	,	O
mavik	NN	B-TREATMENT
,	,	O
hydrochlorothiazide	NN	B-TREATMENT
.	.	O

2.	CD	O
for	IN	O
pulmonary	NN	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
a	DT	O
good	JJ	O
o2	NN	B-TEST
saturations	NNS	I-TEST
on	IN	O
room	NN	O
air	NN	O
.	.	O

he	PRP	O
had	VBD	O
atelectasis	NN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	NN	I-PROBLEM
lower	RBR	I-PROBLEM
lobe	NN	I-PROBLEM
by	IN	O
chest	JJ	B-TEST
x-ray	NN	I-TEST
.	.	O

the	DT	O
patient	NN	O
on	IN	O
ranitidine	NN	B-TREATMENT
150	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O
for	IN	O
gastrointestinal	JJ	B-TREATMENT
prophylaxis	NN	I-TREATMENT
.	.	O

4.	CD	O
urology	NN	O
:	:	O
foley	NN	B-TREATMENT
was	VBD	O
discontinued	VBN	O
in	IN	O
the	DT	O
cmed	JJ	O
ccu	NN	O
at	IN	O
12	CD	O
p.m.	NN	O

the	DT	O
patient	NN	O
was	VBD	O
urinating	VBG	O
without	IN	O
difficulty	NN	B-PROBLEM
.	.	O

we	PRP	O
continued	VBD	O
iv	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
at	IN	O
100	CD	O
cc	NNS	O
per	IN	O
hour	NN	O
for	IN	O
one	CD	O
liter	NN	O
secondary	JJ	O
to	TO	O
a	DT	O
concern	NN	O
for	IN	O
rhabdomyolysis	NN	B-PROBLEM
plus	CC	O
kidney	NN	B-TREATMENT
protective	JJ	I-TREATMENT
effects	NNS	I-TREATMENT
.	.	O

k	NN	B-TEST
was	VBD	O
3.4	CD	O
,	,	O
repleted	VBN	O
,	,	O
potassium	NN	B-TREATMENT
chloride	NN	I-TREATMENT
40	CD	O
meq	NN	O
times	NNS	O
1	CD	O
dose	JJ	O
p.o.	NN	O

calcium	NN	B-TEST
with	IN	O
7.2	CD	O
corrected	VBD	O
to	TO	O
less	JJR	O
than	IN	O
8.0,	CD	O
completed	VBD	O
calcium	NN	B-TREATMENT
carbonate	NN	I-TREATMENT
at	IN	O
500	CD	O
mg	NNS	O
blood	NN	B-TEST
pressure.o.	NN	I-TEST
t.i.d.	NN	O
while	IN	O
in	IN	O
the	DT	O
hospital	NN	O
.	.	O

mag	NN	B-TEST
was	VBD	O
1.7	CD	O
,	,	O
repleted	VBN	O
with	IN	O
magnesium	NN	B-TREATMENT
oxide	NN	I-TREATMENT
with	IN	O
400	CD	O
mg	NN	O
p.o.	NN	O
times	NNS	O
one	CD	O
dose	NN	O
.	.	O

the	DT	O
patient	NN	O
seemed	VBD	O
notably	RB	B-PROBLEM
anxious	JJ	I-PROBLEM
and	CC	O
depressed	JJ	B-PROBLEM
.	.	O

it	PRP	O
is	VBZ	O
possible	JJ	O
that	IN	O
the	DT	O
patient	NN	O
is	VBZ	O
self	JJ	O
medicating	VBG	O
for	IN	O
underlying	VBG	B-PROBLEM
psychiatric	JJ	I-PROBLEM
disorder	NN	I-PROBLEM
.	.	O

we	PRP	O
will	MD	O
monitor	VB	B-TEST
for	IN	O
signs	NNS	O
of	IN	O
alcohol	NN	B-PROBLEM
withdrawal	NN	I-PROBLEM
according	VBG	O
to	TO	O
the	DT	B-TEST
ciwa	NN	I-TEST
scale	NN	I-TEST
.	.	O

we	PRP	O
will	MD	O
given	VBN	O
valium	VB	B-TREATMENT
5	CD	O
mg	NN	O
p.o.	NN	O
q.	VBD	O
3	CD	O
hours	NNS	O
for	IN	O
withdrawal	NN	B-PROBLEM
.	.	O

we	PRP	O
will	MD	O
consider	VB	O
psychiatry	NN	O
consult	NN	O
in	IN	O
the	DT	O
future	NN	O
to	TO	O
assess	VB	O
for	IN	O
underlying	VBG	B-PROBLEM
anxiety	NN	I-PROBLEM
disorder	NN	I-PROBLEM
or	CC	O
depression	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
may	MD	O
be	VB	O
discharge	JJ	O
harry	JJ	O
02-08	JJ	O
pending	VBG	O
observations	NNS	B-TEST
for	IN	O
delirium	NN	B-PROBLEM
tremens	NNS	I-PROBLEM
after	IN	O
discussion	NN	O
with	IN	O
primary	JJ	O
care	NN	O
physician	NN	O
,	,	O
dr.	JJ	O
blue	NN	O
who	WP	O
knows	VBZ	O
the	DT	O
patient	NN	O
well	RB	O
.	.	O

1.	CD	O
blood	NN	B-TEST
pressure	NN	I-TEST
:	:	O

the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
remained	VBD	O
stable	JJ	O
on	IN	O
hospital	JJ	O
day	NN	O
#2	NNP	O
through	IN	O
hospital	JJ	O
day	NN	O
#3	NNP	O
status	NN	O
post	NN	O
iv	NN	B-TREATMENT
hydration	NN	I-TREATMENT
with	IN	O
systolic	JJ	B-TEST
blood	NN	I-TEST
pressures	NNS	I-TEST
in	IN	O
the	DT	O
120	CD	O
's	POS	O
to	TO	O
130	CD	O
's.	NNS	O

we	PRP	O
continued	VBD	O
to	TO	O
hold	VB	O
the	DT	O
patient	NN	O
's	POS	O
home	NN	B-TREATMENT
blood	NN	I-TREATMENT
pressure	NN	I-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
asymptomatic	JJ	B-PROBLEM
without	IN	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
and	CC	O
no	DT	O
mental	JJ	B-PROBLEM
status	NN	I-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

on	IN	O
hospital	JJ	O
day	NN	O
#2	NNP	O
through	IN	O
hospital	JJ	O
day	NN	O
#3	NNP	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
mild	JJ	B-PROBLEM
tremor	NN	I-PROBLEM
on	IN	I-PROBLEM
hands	NNS	I-PROBLEM
,	,	O
but	CC	O
improved	VBD	O
over	IN	O
hospital	JJ	O
course	NN	O
.	.	O

the	DT	O
patient	NN	O
became	VBD	O
notably	RB	B-PROBLEM
less	RBR	I-PROBLEM
anxious	JJ	I-PROBLEM
throughout	IN	O
hospital	JJ	O
stay	NN	O
.	.	O

ciwa	NNS	B-TEST
scale	NN	I-TEST
over	IN	O
night	NN	O
was	VBD	O
1	CD	O
for	IN	O
tremor	NN	B-PROBLEM
and	CC	O
the	DT	O
patient	NN	O
did	VBD	O
not	RB	O
require	VB	O
any	DT	O
valium	NN	B-TREATMENT
for	IN	O
alcohol	NN	B-PROBLEM
withdrawal	NN	I-PROBLEM
.	.	O

calcium	NN	B-TREATMENT
carbonate	NN	I-TREATMENT
500	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O
,	,	O
mag	JJ	B-TREATMENT
oxide	IN	I-TREATMENT
400	CD	O
mg	NN	O
p.o.	NN	O
times	NNS	O
one	CD	O
dose	NN	O
,	,	O
potassium	NN	B-TREATMENT
chloride	NN	I-TREATMENT
repleted	VBD	O
40	CD	O
meq	NN	O
times	NNS	O
one	CD	O
dose	NN	O
.	.	O

1.	CD	O
etoh	JJ	B-PROBLEM
intoxication	NN	I-PROBLEM
.	.	O

2.	CD	O
hypertension	NN	B-PROBLEM
.	.	O

3.	CD	O
history	NN	O
of	IN	O
colonic	JJ	B-PROBLEM
polyp	NN	I-PROBLEM
times	NNS	O
3	CD	O
,	,	O
benign	NN	O
in	IN	O
2007	CD	O
,	,	O
repeat	NN	B-TEST
colonoscopy	NN	I-TEST
due	JJ	O
in	IN	O
2010	CD	O
.	.	O

4.	CD	O
history	NN	B-PROBLEM
of	IN	I-PROBLEM
right	JJ	I-PROBLEM
inguinal	JJ	I-PROBLEM
hernia	NN	I-PROBLEM
in	IN	O
2002	CD	O
.	.	O

return	NN	O
to	TO	O
home	NN	B-TREATMENT
medications	NNS	I-TREATMENT
:	:	O

1.	CD	O
lisinopril	JJ	B-TREATMENT
5	CD	O
mg	NN	O
p.o.q.d.	NN	O

2.	CD	O
mavik	NNS	B-TREATMENT
unknown	JJ	O
dosage	NN	O
.	.	O

3.	CD	O
hydrochlorothiazide	JJ	B-TREATMENT
unknown	JJ	O
dosage	NN	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
an	DT	O
82	CD	O
-	:	O
year-old	JJ	O
male	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
,	,	O
remote	VBP	O
tobacco	NN	O
abuse	NN	O
,	,	O
chronic	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
,	,	O
and	CC	O
a	DT	O
history	NN	O
of	IN	O
a	DT	B-PROBLEM
tia	NN	I-PROBLEM
who	WP	O
was	VBD	O
in	IN	O
his	PRP$	O
usual	JJ	O
state	NN	O
of	IN	O
health	NN	O
until	IN	O
five	CD	O
nights	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
when	WRB	O
he	PRP	O
awoke	VBD	O
at	IN	O
midnight	NN	O
with	IN	O
severe	JJ	B-PROBLEM
epigastric	JJ	I-PROBLEM
pain	NN	I-PROBLEM
radiating	NN	O
to	TO	O
both	DT	O
arms	NNS	O
.	.	O

he	PRP	O
also	RB	O
had	VBD	O
bilateral	JJ	B-PROBLEM
arm	NN	I-PROBLEM
numbness	NN	I-PROBLEM
.	.	O

the	DT	B-PROBLEM
symptoms	NNS	I-PROBLEM
were	VBD	O
associated	VBN	O
with	IN	O
diaphoresis	NN	B-PROBLEM
and	CC	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
but	CC	O
no	DT	O
nausea	NN	B-PROBLEM
or	CC	O
vomiting	NN	B-PROBLEM
.	.	O

after	IN	O
approximately	RB	O
one	CD	O
hour	NN	O
,	,	O
he	PRP	O
presented	VBD	O
to	TO	O
the	DT	O
bristol	JJ	O
county	NN	O
tuberculosis	NN	O
hospital	JJ	O
dana-farber	JJ	O
cancer	NN	O
institute	NN	O
campus	NN	O
where	WRB	O
he	PRP	O
ruled	VBD	O
in	IN	O
for	IN	O
a	DT	B-PROBLEM
non-st	JJ	I-PROBLEM
elevation	NN	I-PROBLEM
mi	NN	I-PROBLEM
with	IN	O
a	DT	B-TEST
ck	NN	I-TEST
of	IN	O
438	CD	O
with	IN	O
a	DT	B-TEST
peak	JJ	I-TEST
ck	NN	I-TEST
mb	NN	I-TEST
of	IN	O
19.8	CD	O
and	CC	O
troponin	VB	B-TEST
that	DT	O
peaked	VBD	O
at	IN	O
10.2	CD	O
.	.	O

he	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
nitrates	NNS	B-TREATMENT
there	RB	O
as	RB	O
well	RB	O
as	IN	O
heparin	NN	B-TREATMENT
and	CC	O
integrelin	NN	B-TREATMENT
and	CC	O
remained	VBD	O
pain-free	JJ	B-PROBLEM
.	.	O

he	PRP	O
denied	VBD	O
any	DT	O
history	NN	O
of	IN	O
similar	JJ	B-PROBLEM
symptoms	NNS	I-PROBLEM
in	IN	O
the	DT	O
past	NN	O
and	CC	O
has	VBZ	O
had	VBN	O
no	DT	O
prior	JJ	O
history	NN	O
of	IN	O
angina	NN	B-PROBLEM
or	CC	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
subsequently	RB	O
transferred	VBN	O
to	TO	O
youville	VB	O
hospital	NN	O
for	IN	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
.	.	O

at	IN	O
the	DT	O
time	NN	O
of	IN	O
transfer	NN	O
,	,	O
he	PRP	O
was	VBD	O
initially	RB	O
admitted	VBN	O
to	TO	O
the	DT	O
cmi	NN	O
service	NN	O
after	IN	O
undergoing	VBG	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
which	WDT	O
revealed	VBD	O
a	DT	B-PROBLEM
long	JJ	I-PROBLEM
lad	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
that	WDT	O
was	VBD	O
angioplastied	VBN	O
without	IN	O
stent	JJ	B-TREATMENT
placement	NN	I-TREATMENT
,	,	O
and	CC	O
a	DT	B-PROBLEM
total	JJ	I-PROBLEM
occlusion	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
rca	NN	I-PROBLEM
with	IN	O
collaterals	NNS	O
.	.	O

he	PRP	O
subsequently	RB	O
became	VBD	O
hypotensive	JJ	B-PROBLEM
and	CC	O
bradycardiac	NN	B-PROBLEM
in	IN	O
the	DT	O
catheterization	NN	O
laboratory	NN	O
which	WDT	O
responded	VBD	O
to	TO	O
iv	VB	B-TREATMENT
fluids	NNS	I-TREATMENT
,	,	O
dopamine	NN	B-TREATMENT
,	,	O
atropine	NN	B-TREATMENT
,	,	O
and	CC	O
he	PRP	O
was	VBD	O
then	RB	O
transferred	VBN	O
to	TO	O
the	DT	O
ccu	NN	O
for	IN	O
further	JJ	B-TEST
monitoring	NN	I-TEST
.	.	O

he	PRP	O
had	VBD	O
a	DT	B-TEST
bedside	JJ	I-TEST
transthoracic	NN	I-TEST
echocardiogram	NN	I-TEST
done	VBN	O
in	IN	O
the	DT	O
cardiac	JJ	O
catheterization	NN	O
laboratory	NN	O
without	IN	O
evidence	NN	O
of	IN	O
an	DT	B-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

a	DT	B-TREATMENT
swan	NN	I-TREATMENT
was	VBD	O
also	RB	O
placed	VBN	O
.	.	O

there	EX	O
were	VBD	O
no	DT	O
stents	NNS	B-TREATMENT
deployed	VBN	O
at	IN	O
all	DT	O
throughout	IN	O
the	DT	B-TEST
catheterization	NN	I-TEST
.	.	O

by	IN	O
the	DT	O
time	NN	O
he	PRP	O
was	VBD	O
admitted	VBN	O
,	,	O
he	PRP	O
was	VBD	O
off	IN	O
pressors	NNS	B-TREATMENT
and	CC	O
hemodynamically	RB	O
stable	JJ	O
and	CC	O
pain-free	JJ	B-PROBLEM
.	.	O

tia	NN	B-PROBLEM
in	IN	O
1998	CD	O
.	.	O

copd	NN	B-PROBLEM
with	IN	O
2	CD	O
liters	NNS	O
dependence	NN	O
of	IN	O
home	NN	B-TREATMENT
02	CD	I-TREATMENT
.	.	O

bph	NN	B-PROBLEM
.	.	O

chronic	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
.	.	O

gastritis	NN	B-PROBLEM
.	.	O

asthma	NN	B-PROBLEM
.	.	O

he	PRP	O
uses	VBZ	O
a	DT	B-TREATMENT
cane	NN	I-TREATMENT
p.r.n.	NN	O
for	IN	O
walking	NN	O
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

1.	CD	O
aspirin	JJ	B-TREATMENT
325	CD	O
mg	NN	O
q.d.	NN	O

2.	CD	O
metoprolol	JJ	B-TREATMENT
50	CD	O
mg	NN	O
b.i.d.	NN	O

3.	CD	O
lipitor	NN	B-TREATMENT
10	CD	O
mg	NN	O
q.d.	NN	O

4.	CD	O
mdi	NNS	B-TREATMENT
p.r.n.	NN	O

5.	CD	O
heparin	JJ	B-TREATMENT
drip	NN	I-TREATMENT
on	IN	O
transfer	NN	O
.	.	O

6.	CD	O
integrelin	JJ	B-TREATMENT
drip	NN	I-TREATMENT
on	IN	O
transfer	NN	O
.	.	O

vital	JJ	B-TEST
signs	NNS	I-TEST
:	:	O

heart	NN	B-TEST
rate	NN	I-TEST
91	CD	O
,	,	O
regular	JJ	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
169/81	CD	O
from	IN	O
a	DT	B-TREATMENT
right	JJ	I-TREATMENT
groin	NN	I-TREATMENT
a	DT	I-TREATMENT
line	NN	I-TREATMENT
,	,	O
respirations	NNS	B-TEST
12	CD	O
,	,	O
oxygen	JJR	B-TEST
saturation	NN	I-TEST
of	IN	O
97	CD	O
percent	NN	O
on	IN	O
2	CD	B-TREATMENT
liters	NNS	I-TREATMENT
nasal	JJ	I-TREATMENT
cannula	NN	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
a	DT	O
well	RB	O
appearing	VBG	O
male	NN	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

crusting	VBG	B-PROBLEM
around	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
eyelid	NN	I-PROBLEM
but	CC	O
the	DT	O
pupils	NNS	O
were	VBD	O
equal	JJ	O
,	,	O
round	NN	O
,	,	O
and	CC	O
reactive	JJ	O
to	TO	O
light	NN	O
.	.	O

he	PRP	O
was	VBD	O
edentulous	JJ	B-PROBLEM
.	.	O

the	DT	O
neck	NN	O
was	VBD	O
supple	RB	O
without	IN	O
lymphadenopathy	JJ	B-PROBLEM
or	CC	O
thyromegaly	NN	B-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
no	DT	O
murmurs	NNS	B-PROBLEM
,	,	O
rubs	NNS	B-PROBLEM
,	,	O
or	CC	O
gallops	NNS	B-PROBLEM
.	.	O

his	PRP$	O
lungs	NNS	O
were	VBD	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
anteriorly	RB	O
and	CC	O
laterally	RB	O
.	.	O

soft	JJ	O
,	,	O
obese	JJ	B-PROBLEM
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBN	B-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
normoactive	JJ	O
bowel	NN	B-TEST
sounds	NNS	I-TEST
.	.	O

there	EX	O
was	VBD	O
a	DT	B-TREATMENT
right	JJ	I-TREATMENT
groin	NN	I-TREATMENT
a	DT	I-TREATMENT
line	NN	I-TREATMENT
and	CC	O
a	DT	B-TREATMENT
left	JJ	I-TREATMENT
groin	NN	I-TREATMENT
venous	JJ	I-TREATMENT
sheath	NN	I-TREATMENT
with	IN	O
a	DT	B-TREATMENT
swan	NN	I-TREATMENT
.	.	O

he	PRP	O
had	VBD	O
no	DT	O
evident	JJ	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
2+	CD	O
dorsalis	NNS	B-TEST
pedis	NN	I-TEST
and	CC	O
posterior	JJ	B-TEST
tibial	JJ	I-TEST
pulses	NNS	I-TEST
bilaterally	RB	O
.	.	O

on	IN	O
admission	NN	O
,	,	O
the	DT	B-TEST
cbc	NN	I-TEST
revealed	VBD	O
a	DT	B-TEST
white	JJ	I-TEST
count	NN	I-TEST
of	IN	O
7.4	CD	O
,	,	O
hematocrit	NN	B-TEST
39.7	CD	O
,	,	O
and	CC	O
platelets	NNS	B-TEST
of	IN	O
217,000	CD	O
.	.	O

serum	NN	B-TEST
chemistries	NNS	I-TEST
revealed	VBD	O
a	DT	B-TEST
sodium	NN	I-TEST
of	IN	O
135,	CD	O
potassium	NN	B-TEST
4.0	CD	O
,	,	O
chloride	RB	B-TEST
102	CD	O
,	,	O
bicarbonate	NN	B-TEST
26	CD	O
,	,	O
bun	NN	B-TEST
29	CD	O
,	,	O
creatinine	NN	B-TEST
1.6	CD	O
,	,	O
and	CC	O
glucose	NN	B-TEST
of	IN	O
111	CD	O
.	.	O

the	DT	B-TEST
initial	JJ	I-TEST
ekg	NN	I-TEST
showed	VBD	O
normal	JJ	O
sinus	NN	B-TEST
rhythm	NN	I-TEST
at	IN	O
a	DT	B-TEST
rate	NN	I-TEST
of	IN	O
71	CD	O
with	IN	O
a	DT	O
normal	JJ	O
axis	NN	B-TEST
and	CC	O
evidence	NN	O
of	IN	O
first-degree	JJ	B-PROBLEM
av	NN	I-PROBLEM
block	NN	I-PROBLEM
with	IN	O
prolonged	JJ	B-PROBLEM
pr	NN	I-PROBLEM
interval	NN	I-PROBLEM
of	IN	O
238	CD	O
milliseconds	NNS	O
.	.	O

he	PRP	O
also	RB	O
had	VBD	O
a	DT	B-PROBLEM
widened	JJ	I-PROBLEM
qrs	NN	I-PROBLEM
of	IN	O
153	CD	O
milliseconds	NNS	O
,	,	O
an	DT	B-PROBLEM
old	JJ	I-PROBLEM
right	NN	I-PROBLEM
bundle	NN	I-PROBLEM
branch	NN	I-PROBLEM
block	NN	I-PROBLEM
,	,	O
and	CC	O
no	DT	O
acute	JJ	B-PROBLEM
st	NN	I-PROBLEM
or	CC	I-PROBLEM
t	NN	I-PROBLEM
wave	NN	I-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

the	DT	B-TEST
ekg	NN	I-TEST
was	VBD	O
prior	RB	O
to	TO	O
catheterization	NN	B-TEST
and	CC	O
the	DT	O
one	CD	O
post	NN	O
ptca	NN	B-TREATMENT
was	VBD	O
no	DT	O
different	JJ	O
.	.	O

he	PRP	O
had	VBD	O
a	DT	B-TEST
bedside	JJ	I-TEST
echocardiogram	NN	I-TEST
done	VBN	O
in	IN	O
the	DT	O
catheterization	NN	O
laboratory	NN	O
which	WDT	O
showed	VBD	O
normal	JJ	O
lv	NN	O
wall	NN	O
thickness	NN	O
and	CC	O
normal	JJ	O
lv	JJ	O
cavity	NN	O
size	NN	O
.	.	O

there	EX	O
was	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
effusion	NN	B-PROBLEM
.	.	O

cardiac	JJ	B-TEST
catheterization	NN	I-TEST
revealed	VBD	O
a	DT	B-PROBLEM
totally	RB	I-PROBLEM
occluded	JJ	I-PROBLEM
rca	NN	I-PROBLEM
with	IN	O
collaterals	NNS	O
,	,	O
an	DT	B-PROBLEM
80	CD	I-PROBLEM
percent	NN	I-PROBLEM
lad	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
extending	VBG	O
distally	RB	O
which	WDT	O
was	VBD	O
angioplastied	VBN	O
but	CC	O
no	DT	O
stent	NN	B-TREATMENT
was	VBD	O
placed	VBN	O
.	.	O

the	DT	B-TEST
right	JJ	I-TEST
heart	NN	I-TEST
catheterization	NN	I-TEST
revealed	VBD	O
pulmonary	JJ	B-TEST
capillary	JJ	I-TEST
wedge	NN	I-TEST
pressure	NN	I-TEST
of	IN	O
4	CD	O
,	,	O
cardiac	JJ	B-TEST
output	NN	I-TEST
of	IN	O
8	CD	O
,	,	O
and	CC	O
cardiac	JJ	B-TEST
index	NN	I-TEST
of	IN	O
3.8	CD	O
,	,	O
he	PRP	O
had	VBD	O
an	DT	B-TEST
ra	JJ	I-TEST
pressure	NN	I-TEST
of	IN	O
10	CD	O
,	,	O
rv	JJ	B-TEST
pressure	NN	I-TEST
of	IN	O
43/4	CD	O
,	,	O
pa	JJ	B-TEST
pressure	NN	I-TEST
of	IN	O
37/10	CD	O
.	.	O

this	DT	O
is	VBZ	O
an	DT	O
82	CD	O
-	:	O
year-old	JJ	O
male	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
prior	JJ	O
tobacco	NN	O
use	NN	O
,	,	O
hypertension	NN	B-PROBLEM
,	,	O
chronic	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
,	,	O
copd	NN	B-PROBLEM
,	,	O
gastritis	NN	B-PROBLEM
,	,	O
and	CC	O
tia	NN	B-PROBLEM
who	WP	O
initially	RB	O
presented	VBD	O
to	TO	O
braintree	VB	O
with	IN	O
a	DT	B-PROBLEM
non-st	JJ	I-PROBLEM
elevation	NN	I-PROBLEM
mi	NN	I-PROBLEM
and	CC	O
guaiac	JJ	B-PROBLEM
positive	JJ	I-PROBLEM
stools	NNS	I-PROBLEM
,	,	O
transferred	VBN	O
to	TO	O
st.	VB	O
margaret's	NN	O
center	NN	O
for	IN	O
women	NNS	O
&	CC	O
infants	NNS	O
for	IN	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
with	IN	O
ptca	NN	B-TREATMENT
to	TO	O
mid	VB	B-PROBLEM
lad	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
complicated	VBN	O
by	IN	O
hypotension	NN	B-PROBLEM
and	CC	O
bradycardia	NN	B-PROBLEM
requiring	VBG	O
atropine	NN	B-TREATMENT
,	,	O
iv	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
and	CC	O
transient	JJ	B-TREATMENT
dopamine	NN	I-TREATMENT
possibly	RB	O
secondary	JJ	O
to	TO	O
vagal	VB	B-PROBLEM
reaction	NN	I-PROBLEM
,	,	O
subsequently	RB	O
transferred	VBN	O
to	TO	O
ccu	VB	O
for	IN	O
close	JJ	B-TEST
monitoring	NN	I-TEST
,	,	O
hemodynamically	RB	O
stable	JJ	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
admission	NN	O
to	TO	O
the	DT	O
ccu	NN	O
.	.	O

as	IN	O
summarized	VBN	O
above	IN	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-PROBLEM
non-st	JJ	I-PROBLEM
elevation	NN	I-PROBLEM
mi	NN	I-PROBLEM
with	IN	O
evidence	NN	O
of	IN	O
an	DT	B-PROBLEM
80	CD	I-PROBLEM
percent	NN	I-PROBLEM
mid	NN	I-PROBLEM
lad	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
for	IN	O
which	WDT	O
he	PRP	O
underwent	VBD	O
angioplasty	RB	B-TREATMENT
without	IN	O
stent	JJ	B-TREATMENT
placement	NN	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
initially	RB	O
continued	VBN	O
on	IN	O
aspirin	NN	B-TREATMENT
,	,	O
plavix	NN	B-TREATMENT
,	,	O
beta	NN	B-TREATMENT
blocker	NN	I-TREATMENT
,	,	O
statin	NN	B-TREATMENT
,	,	O
and	CC	O
ace	NN	B-TREATMENT
inhibitor	NN	I-TREATMENT
.	.	O

at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
,	,	O
his	PRP$	B-TREATMENT
plavix	NN	I-TREATMENT
was	VBD	O
held	VBN	O
due	JJ	O
to	TO	O
guaiac	VB	B-PROBLEM
positive	JJ	I-PROBLEM
stools	NNS	I-PROBLEM
and	CC	O
hematocrit	NN	B-PROBLEM
drop	NN	I-PROBLEM
throughout	IN	O
admission	NN	O
.	.	O

he	PRP	O
had	VBD	O
a	DT	B-TEST
transthoracic	JJ	I-TEST
echocardiogram	NN	I-TEST
the	DT	O
day	NN	O
after	IN	O
admission	NN	O
showing	VBG	O
an	DT	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
of	IN	O
greater	JJR	O
than	IN	O
60	CD	O
percent	NN	O
.	.	O

no	DT	O
focal	JJ	B-PROBLEM
wall	NN	I-PROBLEM
motion	NN	I-PROBLEM
abnormalities	NNS	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
no	DT	O
recurrent	NN	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
or	CC	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
throughout	IN	O
admission	NN	O
.	.	O

in	IN	O
regards	NNS	O
to	TO	O
his	PRP$	O
rhythm	NN	O
,	,	O
he	PRP	O
has	VBZ	O
an	DT	B-PROBLEM
underlying	VBG	I-PROBLEM
right	JJ	I-PROBLEM
bundle	NN	I-PROBLEM
branch	NN	I-PROBLEM
block	NN	I-PROBLEM
and	CC	O
first-degree	JJ	B-PROBLEM
av	NN	I-PROBLEM
block	NN	I-PROBLEM
which	WDT	O
were	VBD	O
stable	JJ	O
throughout	IN	O
this	DT	O
admission	NN	O
.	.	O

he	PRP	O
had	VBD	O
a	DT	O
history	NN	O
of	IN	O
copd	NN	B-PROBLEM
for	IN	O
which	WDT	O
he	PRP	O
is	VBZ	O
on	IN	O
baseline	NN	O
2	CD	O
liters	NNS	O
of	IN	O
02	CD	B-TREATMENT
by	IN	O
nasal	JJ	B-TREATMENT
cannula	NN	I-TREATMENT
at	IN	O
home	NN	O
and	CC	O
albuterol	NN	B-TREATMENT
and	CC	O
atrovent	JJ	B-TREATMENT
mdi	NN	I-TREATMENT
s	NN	O
p.r.n.	NN	O
at	IN	O
home	NN	O
.	.	O

he	PRP	O
is	VBZ	O
also	RB	O
on	IN	O
flovent	JJ	B-TREATMENT
mdi	NN	I-TREATMENT
at	IN	O
home	NN	O
as	RB	O
well	RB	O
.	.	O

he	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
his	PRP$	B-TREATMENT
mdi	NN	I-TREATMENT
and	CC	O
was	VBD	O
at	IN	O
his	PRP$	B-PROBLEM
baseline	NN	I-PROBLEM
02	CD	I-PROBLEM
requirement	NN	I-PROBLEM
throughout	IN	O
admission	NN	O
.	.	O

he	PRP	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
chronic	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
likely	RB	O
secondary	JJ	O
to	TO	O
hypertension	NN	B-PROBLEM
and	CC	O
was	VBD	O
admitted	VBN	O
with	IN	O
a	DT	B-TEST
creatinine	NN	I-TEST
of	IN	O
1.6	CD	O
.	.	O

his	PRP$	B-TREATMENT
ace	NN	I-TREATMENT
inhibitor	NN	I-TREATMENT
post	NN	O
mi	NN	B-PROBLEM
was	VBD	O
initially	RB	O
held	VBN	O
due	JJ	O
to	TO	O
his	PRP$	B-TEST
creatinine	NN	I-TEST
.	.	O

however	RB	O
,	,	O
this	DT	O
responded	VBD	O
to	TO	O
iv	VB	B-TREATMENT
fluids	NNS	I-TREATMENT
and	CC	O
his	PRP$	B-TREATMENT
ace	NN	I-TREATMENT
inhibitor	NN	I-TREATMENT
was	VBD	O
restarted	VBN	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
.	.	O

he	PRP	O
will	MD	O
need	VB	O
close	JJ	B-TEST
monitoring	NN	I-TEST
of	IN	O
his	PRP$	B-TEST
creatinine	NN	I-TEST
post	NN	O
discharge	NN	O
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
reinstitution	NN	O
of	IN	O
his	PRP$	B-TREATMENT
ace	NN	I-TREATMENT
inhibitor	NN	I-TREATMENT
.	.	O

his	PRP$	O
stools	NNS	O
were	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
guaiac	JJ	B-PROBLEM
positive	JJ	I-PROBLEM
at	IN	O
the	DT	O
outside	JJ	O
hospital	NN	O
and	CC	O
there	EX	O
was	VBD	O
still	RB	O
concern	NN	O
for	IN	O
possible	JJ	O
gi	NN	B-PROBLEM
bleed	VBD	I-PROBLEM
given	VBN	O
continued	JJ	O
guaiac	JJ	B-PROBLEM
positive	JJ	I-PROBLEM
stools	NNS	I-PROBLEM
during	IN	O
this	DT	O
admission	NN	O
and	CC	O
a	DT	B-PROBLEM
slight	JJ	I-PROBLEM
drop	NN	I-PROBLEM
in	IN	I-PROBLEM
his	PRP$	I-PROBLEM
hematocrit	NN	I-PROBLEM
from	IN	O
39	CD	O
to	TO	O
33	CD	O
.	.	O

it	PRP	O
was	VBD	O
felt	VBN	O
most	JJS	O
appropriate	JJ	O
for	IN	O
him	PRP	O
to	TO	O
have	VB	O
an	DT	B-TEST
outpatient	JJ	I-TEST
gi	NN	I-TEST
workup	NN	I-TEST
,	,	O
and	CC	O
his	PRP$	O
pcp	NN	O
was	VBD	O
contacted	VBN	O
and	CC	O
will	MD	O
arrange	VB	O
for	IN	O
outpatient	JJ	B-TEST
colonoscopy	NN	I-TEST
.	.	O

his	PRP$	B-TREATMENT
plavix	NN	I-TREATMENT
was	VBD	O
held	VBN	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
due	JJ	O
to	TO	O
a	DT	O
question	NN	O
of	IN	O
gi	NN	B-PROBLEM
bleed	NN	I-PROBLEM
and	CC	O
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
not	RB	O
having	VBG	O
a	DT	B-TREATMENT
stent	NN	I-TREATMENT
placed	VBN	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
catheterization	NN	B-TEST
.	.	O

he	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
his	PRP$	B-TREATMENT
aspirin	NN	I-TREATMENT
,	,	O
however	RB	O
.	.	O

coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
non-st	JJ	B-PROBLEM
elevation	NN	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
with	IN	O
80	CD	B-PROBLEM
percent	NN	I-PROBLEM
mid	NN	I-PROBLEM
lad	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
,	,	O
now	RB	O
status	NN	O
post	NN	O
angioplasty	NN	B-TREATMENT
.	.	O

hypertension	NN	B-PROBLEM
.	.	O

chronic	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
.	.	O

chronic	JJ	B-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

guaiac	JJ	B-PROBLEM
positive	JJ	I-PROBLEM
stools	NNS	I-PROBLEM
.	.	O

anemia	NN	B-PROBLEM
.	.	O

1.	CD	O
lipitor	NN	B-TREATMENT
10	CD	O
mg	NN	O
q.d.	NN	O

2.	CD	O
lisinopril	JJ	B-TREATMENT
2.5	CD	O
mg	NN	O
q.d.	NN	O

3.	CD	O
flovent	JJ	B-TREATMENT
110	CD	O
micrograms	NNS	O
aerosol	RB	O
two	CD	O
puffs	NNS	O
b.i.d.	VBP	O

4.	CD	O
aspirin	JJ	B-TREATMENT
325	CD	O
mg	NN	O
q.d.	NN	O

5.	CD	O
combivent	NN	B-TREATMENT
mdi	NN	O
p.r.n.	NN	O

6.	CD	O
toprol	NN	B-TREATMENT
xl	VBD	I-TREATMENT
100	CD	O
mg	NN	O
q.d.	NN	O

at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
,	,	O
the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
vital	JJ	I-TEST
signs	NNS	I-TEST
were	VBD	O
stable	JJ	O
and	CC	O
he	PRP	O
was	VBD	O
without	IN	O
complaints	NNS	B-PROBLEM
.	.	O

it	PRP	O
was	VBD	O
discussed	VBN	O
with	IN	O
him	PRP	O
the	DT	O
need	NN	O
to	TO	O
schedule	VB	O
follow-up	NN	O
for	IN	O
colonoscopy	NN	B-TEST
with	IN	O
his	PRP$	O
pcp	NN	O
as	RB	O
well	RB	O
.	.	O

sulfa	NN	B-TREATMENT
(	(	I-TREATMENT
sulfonamides	NNS	I-TREATMENT
)	)	O
/	VBP	O
penicillins	NNS	B-TREATMENT
/	VBP	O
macrodantin	JJ	B-TREATMENT
/	NNP	O
ivp	NN	B-TREATMENT
dye	NN	I-TREATMENT
,	,	O
iodine	NN	B-TREATMENT
containing	NN	I-TREATMENT

just	RB	O
prior	RB	O
to	TO	O
discharge	VB	O
on	IN	O
11-14	JJ	O
,	,	O
pt	NN	B-TEST
's	POS	I-TEST
bp	NN	I-TEST
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
70/40	CD	O
p70	JJ	O
s	NN	O
just	RB	O
after	IN	O
receiving	VBG	O
her	PRP$	B-TREATMENT
am	VBP	I-TREATMENT
bp	JJ	I-TREATMENT
meds	NNS	I-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
asymptomatic	JJ	B-PROBLEM
.	.	O

1.	CD	O
hypotension	NN	B-PROBLEM
:	:	O
the	DT	B-TREATMENT
patient	NN	I-TREATMENT
'd	MD	I-TREATMENT
pm	VB	I-TREATMENT
bp	JJ	I-TREATMENT
meds	NNS	I-TREATMENT
were	VBD	O
held	VBN	O
11-14	JJ	O
and	CC	O
she	PRP	O
was	VBD	O
administered	VBN	O
1.5l	CD	O
ns	NN	B-TREATMENT
over	IN	O
the	DT	O
course	NN	O
of	IN	O
the	DT	O
day	NN	O
with	IN	O
subsequent	JJ	O
sbp	NN	B-TEST
s	NN	I-TEST
in	IN	O
the	DT	O
high	JJ	O
90	CD	O
s,	RB	O
low	JJ	O
100	CD	O
s,.	NN	O

the	DT	B-PROBLEM
hypotension	NN	I-PROBLEM
was	VBD	O
likely	JJ	O
due	JJ	O
to	TO	O
volume	NN	B-PROBLEM
depletion	NN	I-PROBLEM
caused	VBN	O
by	IN	O
her	PRP$	B-PROBLEM
diarrhea	NN	I-PROBLEM
/	NN	O
loose	JJ	B-PROBLEM
stools	NNS	I-PROBLEM
in	IN	O
addition	NN	O
to	TO	O
decreased	VBN	B-PROBLEM
po	NNS	I-PROBLEM
intake	VBP	I-PROBLEM
secondary	JJ	O
to	TO	O
her	PRP$	B-PROBLEM
gerd	NN	I-PROBLEM
and	CC	O
thrush	NN	B-PROBLEM
.	.	O

all	DT	O
of	IN	O
this	DT	O
occurred	VBN	O
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
aggressive	JJ	B-TREATMENT
bp	NN	I-TREATMENT
management	NN	I-TREATMENT
with	IN	O
metoprolol	JJ	B-TREATMENT
25	CD	O
bid	NN	O
,	,	O
hctz	NN	B-TREATMENT
/	NNP	O
triampterene	NN	B-TREATMENT
(	(	O
as	IN	O
a	DT	O
replacment	NN	O
for	IN	O
lasix	NN	B-TREATMENT
due	JJ	O
to	TO	O
recurrent	VB	B-PROBLEM
hypokalemia	NN	I-PROBLEM
),	NNP	O
benicar	NN	B-TREATMENT
20	CD	O
mg	NN	O
qd	NN	O
,	,	O
and	CC	O
imdur	RB	B-TREATMENT
30	CD	O
mg	NN	O
qd	NN	O
.	.	O

infection	NN	B-PROBLEM
/	FW	O
sepsis	NN	B-PROBLEM
was	VBD	O
not	RB	O
likely	JJ	O
given	VBN	O
she	PRP	O
was	VBD	O
afebrile	JJ	B-PROBLEM
and	CC	O
had	VBD	O
no	DT	O
localizing	VBG	B-PROBLEM
sx	NN	I-PROBLEM
with	IN	O
an	DT	O
improving	VBG	O
lung	NN	B-TEST
exam	NN	I-TEST
and	CC	O
02	CD	B-PROBLEM
requirement	NN	I-PROBLEM
.	.	O

given	VBN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
recent	JJ	I-PROBLEM
rp	NN	I-PROBLEM
bleed	NN	I-PROBLEM
,	,	O
there	EX	O
was	VBD	O
concern	NN	O
for	IN	O
a	DT	B-PROBLEM
recurrent	NN	I-PROBLEM
bleed	NN	I-PROBLEM
.	.	O

her	PRP$	B-TEST
groin	NN	I-TEST
exam	NN	I-TEST
was	VBD	O
unchanged	JJ	O
.	.	O

her	PRP$	B-TEST
hct	NN	I-TEST
dropped	VBD	O
from	IN	O
hct	JJ	B-TEST
38.9	CD	O
before	IN	O
fluids	NNS	B-TREATMENT
to	TO	O
35.5	CD	O
s/p	NNS	O
1.5l	CD	O
ns	NNS	B-TREATMENT
and	CC	O
was	VBD	O
thought	VBN	O
to	TO	O
be	VB	O
dilutional	JJ	O
.	.	O

repeat	NN	B-TEST
hcts	NNS	I-TEST
were	VBD	O
stable	JJ	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
kept	VBN	O
an	DT	O
additional	JJ	O
two	CD	O
days	NNS	O
to	TO	O
follow	VB	O
her	PRP$	B-TEST
hcts	NNS	I-TEST
and	CC	O
titrate	VB	O
her	PRP$	B-TREATMENT
bp	NN	I-TREATMENT
meds	NNS	I-TREATMENT
.	.	O

as	IN	O
volume	NN	B-PROBLEM
depletion	NN	I-PROBLEM
was	VBD	O
thought	VBN	O
to	TO	O
be	VB	O
the	DT	O
cause	NN	O
of	IN	O
her	PRP$	B-PROBLEM
low	JJ	I-PROBLEM
bp	NN	I-PROBLEM
,	,	O
only	RB	O
the	DT	B-TREATMENT
bblocker	NN	I-TREATMENT
was	VBD	O
restarted	VBN	O
.	.	O

she	PRP	O
was	VBD	O
also	RB	O
placed	VBN	O
on	IN	O
on	IN	O
low	JJ	B-TREATMENT
dose	JJ	I-TREATMENT
spironolactone	NN	I-TREATMENT
as	IN	O
a	DT	B-TREATMENT
k	NN	I-TREATMENT
sparing	VBG	I-TREATMENT
diuretic	JJ	I-TREATMENT
and	CC	O
for	IN	O
bp	NN	B-TREATMENT
control	NN	I-TREATMENT
in	IN	O
addition	NN	O
to	TO	O
toprol	VB	B-TREATMENT
xl	JJ	I-TREATMENT
25	CD	O
mg	NN	O
qd	NN	O
for	IN	O
her	PRP$	B-PROBLEM
coronary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

she	PRP	O
tolerated	VBD	O
these	DT	B-TREATMENT
meds	NNS	I-TREATMENT
with	IN	O
sbp	JJ	B-TEST
s	NN	I-TEST
in	IN	O
the	DT	O
high	JJ	O
90	CD	O
s	NN	O
to	TO	O
100	CD	O
s	NNS	O
and	CC	O
was	VBD	O
therefore	RB	O
discharged	VBN	O
on	IN	O
this	DT	B-TREATMENT
regimen	NNS	I-TREATMENT
.	.	O

she	PRP	O
will	MD	O
need	VB	O
follow	VB	O
up	RP	O
with	IN	O
her	PRP$	O
pcp	NN	O
within	IN	O
b	NN	O
week	NN	O
after	IN	O
discharge	NN	O
from	IN	O
the	DT	O
extended	VBN	O
care	NN	O
facility	NN	O
for	IN	O
further	JJ	B-TREATMENT
bp	NN	I-TREATMENT
titration	NN	I-TREATMENT
and	CC	O
monitoring	NN	B-TEST
of	IN	I-TEST
her	PRP$	I-TEST
electrolytes	NNS	I-TEST
.	.	O

2.	CD	O
thrush	NN	B-PROBLEM
:	:	O
this	DT	O
is	VBZ	O
likely	JJ	O
secondary	JJ	O
to	TO	O
her	PRP$	B-TREATMENT
steroid	JJ	I-TREATMENT
inhalers	NNS	I-TREATMENT
and	CC	O
po	VB	B-TREATMENT
prednisone	NN	I-TREATMENT
for	IN	O
copd	JJ	B-PROBLEM
exacerbation	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
nystatin	NN	B-TREATMENT
swish	JJ	O
and	CC	O
swallow	JJ	O
qid	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
encouraged	VBN	O
to	TO	O
take	VB	B-TREATMENT
po	NN	I-TREATMENT
liquids	NNS	I-TREATMENT
to	TO	O
prevent	VB	O
volume	NN	B-PROBLEM
depletion	NN	I-PROBLEM
.	.	O

3.	CD	O
diarrhea	NN	B-PROBLEM
:	:	O
the	DT	O
patient	NN	O
has	VBZ	O
been	VBN	O
having	VBG	O
loose	JJ	B-PROBLEM
stools	NNS	I-PROBLEM
at	IN	O
night	NN	O
and	CC	O
was	VBD	O
guiac	JJ	B-PROBLEM
pos	NN	I-PROBLEM
x	VBD	O
2	CD	O
.	.	O

stool	NN	B-TEST
for	IN	I-TEST
c.diff	NN	I-TEST
toxin	NN	I-TEST
was	VBD	O
sent	VBN	O
x	RB	O
1	CD	O
and	CC	O
was	VBD	O
negative	JJ	O
.	.	O

her	PRP$	B-TREATMENT
bowel	NN	I-TREATMENT
regimen	NN	I-TREATMENT
is	VBZ	O
prn	JJ	O
.	.	O

gastroenteritis	NN	B-PROBLEM
is	VBZ	O
possible	JJ	O
but	CC	O
she	PRP	O
has	VBZ	O
no	DT	O
vomiting	NN	B-PROBLEM
and	CC	O
only	RB	O
occ	JJ	B-PROBLEM
nausea	NN	I-PROBLEM
with	IN	O
meds	NNS	B-TREATMENT
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
evidence	NN	O
of	IN	O
obstruction	NN	B-PROBLEM
on	IN	O
axr	NN	B-TEST
.	.	O

therefore	RB	O
,	,	O
the	DT	O
cause	NN	O
of	IN	O
her	PRP$	B-PROBLEM
mild	JJ	I-PROBLEM
diarrhea	NN	I-PROBLEM
(	(	O
few	JJ	B-PROBLEM
loose	RB	I-PROBLEM
bm	JJ	I-PROBLEM
/	NNP	O
liquid	NN	B-PROBLEM
stool	NN	I-PROBLEM
/	NNP	O
night	NN	O
)	)	O
may	MD	O
be	VB	O
either	CC	O
viral	JJ	B-PROBLEM
or	CC	O
secondary	JJ	O
to	TO	O
resolving	VBG	B-PROBLEM
abdominal	JJ	I-PROBLEM
hematoma	NN	I-PROBLEM
with	IN	O
resultant	JJ	O
irritation	NN	B-PROBLEM
of	IN	I-PROBLEM
gi	NN	I-PROBLEM
system	NN	I-PROBLEM
.	.	O

we	PRP	O
have	VBP	O
advised	VBN	O
a	DT	B-TREATMENT
brat	NN	I-TREATMENT
diet	NN	I-TREATMENT
.	.	O

4.	CD	O
guiac	JJ	B-PROBLEM
pos	NN	I-PROBLEM
stool	NN	I-PROBLEM
:	:	O
given	VBN	O
the	DT	O
patient	NN	O
's	POS	O
sx	NN	O
of	IN	O
gerd	NN	B-PROBLEM
,	,	O
current	JJ	O
po	NN	B-TREATMENT
steroid	NN	I-TREATMENT
regimen	NNS	I-TREATMENT
,	,	O
and	CC	O
asa	NN	B-TREATMENT
for	IN	O
her	PRP$	B-TREATMENT
stents	NNS	I-TREATMENT
,	,	O
the	DT	O
ddx	NN	O
for	IN	O
her	PRP$	B-PROBLEM
guiac	JJ	I-PROBLEM
positive	JJ	I-PROBLEM
stools	NNS	I-PROBLEM
would	MD	O
include	VB	O
gastritis	NN	B-PROBLEM
/	NNP	O
gastric	JJ	B-PROBLEM
ulcer	NN	I-PROBLEM
in	IN	O
addition	NN	O
to	TO	O
lower	VB	B-PROBLEM
gi	NN	I-PROBLEM
pathology	NN	I-PROBLEM
.	.	O

however	RB	O
,	,	O
she	PRP	O
has	VBZ	O
no	DT	O
vomiting	NN	B-PROBLEM
and	CC	O
only	RB	B-PROBLEM
mild	JJ	I-PROBLEM
nausea	NN	I-PROBLEM
with	IN	O
medications	NNS	B-TREATMENT
.	.	O

she	PRP	O
also	RB	O
has	VBZ	O
no	DT	O
gross	JJ	B-PROBLEM
blood	NN	I-PROBLEM
per	IN	I-PROBLEM
rectum	NN	I-PROBLEM
and	CC	O
her	PRP$	B-TEST
hct	NN	I-TEST
is	VBZ	O
stable	JJ	O
.	.	O

upon	IN	O
discharge	PDT	O
the	DT	O
patient	NN	O
was	VBD	O
changed	VBN	O
to	TO	O
a	DT	B-TREATMENT
bid	NN	I-TREATMENT
protonix	NN	I-TREATMENT
regimen	NNS	I-TREATMENT
.	.	O

she	PRP	O
will	MD	O
need	VB	O
outpatient	NN	O
follow	VB	O
up	RP	O
for	IN	O
her	PRP$	B-PROBLEM
guiac	JJ	I-PROBLEM
pos	NN	I-PROBLEM
stools	NNS	I-PROBLEM
with	IN	O
endoscopy	JJ	B-TEST
vs	NNS	O
egd	VBP	B-TEST
+/-	JJ	O
h.pylori	NN	B-TEST
serologies	NNS	I-TEST
.	.	O

1.	CD	O
atorvastatin	JJ	B-TREATMENT
10	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

2.	CD	O
pantoprazole	JJ	B-TREATMENT
40	CD	O
mg	JJ	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

3.	CD	O
acetaminophen	JJ	B-TREATMENT
500	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
po	NN	O
q6h	NN	O
(	(	O
every	DT	O
6	CD	O
hours	NNS	O
).	VBP	O

4.	CD	O
oxycodone	NN	B-TREATMENT
5	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
q4h	NN	O
(	(	O
every	DT	O
4	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
pain	NN	B-PROBLEM
.	.	O

5.	CD	O
fluticasone	NN	B-TREATMENT
50	CD	O
mcg	NN	O
/	NNP	O
actuation	NN	O
aerosol	NN	O
,	,	O
spray	JJ	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
spray	NN	O
nasal	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

6.	CD	O
fluticasone	NN	B-TREATMENT
110	CD	O
mcg	NN	O
/	NNP	O
actuation	NN	O
aerosol	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
puff	NN	O
inhalation	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

7.	CD	O
tiotropium	NN	B-TREATMENT
bromide	NN	I-TREATMENT
18	CD	O
mcg	NN	O
capsule	NN	O
,	,	O
w/	JJ	O
inhalation	NN	O
device	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
cap	NN	O
inhalation	NN	O
daily	RB	O
(	(	O
daily	JJ	O
).	NN	O

8.	CD	O
clopidogrel	NN	B-TREATMENT
75	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

9.	CD	O
albuterol	NN	B-TREATMENT
sulfate	VB	I-TREATMENT
0.083	CD	O
%	NN	O
solution	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
puff	NN	O
inhalation	NN	O
q6h	NN	O
(	(	O
every	DT	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
or	CC	O
wheezing	NN	B-PROBLEM
.	.	O

10.	CD	O
aluminum	NN	B-TREATMENT
-	:	I-TREATMENT
magnesium	NN	I-TREATMENT
hydroxide	JJ	I-TREATMENT
225-200	JJ	O
mg	NN	O
/	$	O
5	CD	O
ml	JJ	O
suspension	NN	O
sig	NN	O
:	:	O
15-30	JJ	O
ml	NN	O
s	NN	O
po	NN	O
prn	NN	O
(	(	O
as	IN	O
needed	VBN	O
).	NN	O

11.	CD	O
senna	JJ	B-TREATMENT
8.6	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

12.	CD	O
prednisone	NN	B-TREATMENT
10	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
1-2	JJ	O
tablets	NNS	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
for	IN	O
4	CD	O
days	NNS	O
:	:	O
please	VB	O
take	VB	O
two	CD	O
pills	NNS	O
for	IN	O
one	CD	O
day	NN	O
starting	VBG	O
11-17	JJ	O
,	,	O
then	RB	O
take	VB	O
one	CD	O
pill	NN	O
for	IN	O
three	CD	O
days	NNS	O
.	.	O

13.	CD	O
oxygen	NN	B-TREATMENT
continue	VBP	O
02	CD	B-TREATMENT
at	IN	O
1l/min	CD	O
continuous	JJ	O
to	TO	O
keep	VB	O
sats	NNS	B-TEST
in	IN	O
90	CD	O
's.	NNS	O

14.	CD	O
spironolactone	NN	B-TREATMENT
25	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
0.5	CD	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

15.	CD	O
metoprolol	JJ	B-TREATMENT
succinate	NN	I-TREATMENT
25	CD	O
mg	NN	O
tablet	NN	O
sustained	VBD	O
release	NN	O
24hr	CD	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
sustained	VBD	O
release	NN	O
24hr	CD	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

16.	CD	O
nystatin	JJ	B-TREATMENT
100,000	CD	O
unit	NN	O
/	NNP	O
ml	NN	O
suspension	NN	O
sig	NN	O
:	:	O
ten	NN	O
(	(	O
10	CD	O
)	)	O
ml	NN	O
po	NN	O
qid	NN	O
(	(	O
4	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
for	IN	O
7	CD	O
days	NNS	O
.	.	O

17.	CD	O
aspirin	JJ	B-TREATMENT
325	CD	O
mg	JJ	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

1)	CD	O
rapid	JJ	B-PROBLEM
atrial	JJ	I-PROBLEM
fibrillation	NN	I-PROBLEM
with	IN	O
demand	NN	B-PROBLEM
ischemia	NN	I-PROBLEM

2)	CD	O
retroperitoneal	NN	B-PROBLEM
bleed	NN	I-PROBLEM

if	IN	O
you	PRP	O
experience	VBP	O
cp	NNS	B-PROBLEM
,	,	O
sob	NN	B-PROBLEM
,	,	O
dizzyness	NN	B-PROBLEM
,	,	O
or	CC	O
any	DT	B-PROBLEM
other	JJ	I-PROBLEM
symptoms	NNS	I-PROBLEM
that	IN	O
concern	NN	O
you	PRP	O
please	VBP	O
call	VB	O
your	PRP$	O
pcp	NN	O
or	CC	O
return	NN	O
to	TO	O
the	DT	O
er	NN	O
.	.	O

note	NN	O
:	:	O
you	PRP	O
have	VBP	O
had	VBN	O
a	DT	B-TREATMENT
cardiac	JJ	I-TREATMENT
stent	NN	I-TREATMENT
placed	VBD	O
during	IN	O
this	DT	O
admission	NN	O
.	.	O

you	PRP	O
must	MD	O
take	VB	O
your	PRP$	B-TREATMENT
aspirin	NN	I-TREATMENT
and	CC	O
plavix	JJ	B-TREATMENT
every	DT	O
day	NN	O
to	TO	O
prevent	VB	O
failure	NN	B-PROBLEM
of	IN	I-PROBLEM
these	DT	I-PROBLEM
stents	NNS	I-PROBLEM
which	WDT	O
could	MD	O
be	VB	O
life	NN	O
threatening	VBG	O
.	.	O

please	VB	O
take	VB	O
all	DT	B-TREATMENT
medications	NNS	I-TREATMENT
as	IN	O
prescribed	NN	O
.	.	O

2)	CD	O
you	PRP	O
are	VBP	O
scheduled	VBN	O
to	TO	O
have	VB	O
your	PRP$	B-TREATMENT
staples	NNS	I-TREATMENT
removed	VBN	O
on	IN	O
2013-11-20	JJ	O
3:00	CD	O
with	IN	O
provider	NN	O
:	:	O
leah	NN	O
,	,	O
paula	NN	O
g.	NN	O
wilson	NN	O
surgery	NN	O
(	(	O
nhb	NN	O
)	)	O

this	DT	O
is	VBZ	O
a	DT	O
55	CD	O
-	:	O
year-old	JJ	O
caucasian	JJ	O
speaking	VBG	O
male	NN	O
who	WP	O
is	VBZ	O
a	DT	O
smoker	NN	O
and	CC	O
has	VBZ	O
a	DT	O
family	NN	O
history	NN	O
of	IN	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
as	RB	O
well	RB	O
as	IN	O
a	DT	O
personal	JJ	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
,	,	O
who	WP	O
experienced	VBD	O
multiple	JJ	O
episodes	NNS	O
of	IN	O
10/10	CD	B-PROBLEM
substernal	JJ	I-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
radiating	VBG	O
down	RP	O
his	PRP$	O
left	JJ	O
arm	NN	O
last	JJ	O
night	NN	O
with	IN	O
his	PRP$	O
daily	JJ	O
activities	NNS	O
.	.	O

each	DT	B-PROBLEM
episode	NN	I-PROBLEM
lasted	VBD	O
approximately	RB	O
15	CD	O
minutes	NNS	O
in	IN	O
duration	NN	O
and	CC	O
resolved	VBN	O
on	IN	O
their	PRP$	O
own	JJ	O
.	.	O

this	DT	O
morning	NN	O
while	IN	O
landscaping	VBG	O
the	DT	O
patient	NN	O
had	VBD	O
unremitting	JJ	B-PROBLEM
12-05	JJ	I-PROBLEM
pain	NN	I-PROBLEM
with	IN	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
and	CC	O
diaphoresis	NN	B-PROBLEM
.	.	O

he	PRP	O
presented	VBD	O
to	TO	O
deaconess-nashoba	JJ	O
hospital	NN	O
hospital	NN	O
and	CC	O
the	DT	B-TEST
first	JJ	I-TEST
ekg	NN	I-TEST
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
st	JJ	B-PROBLEM
elevations	NNS	I-PROBLEM
in	IN	I-PROBLEM
v1-v3	NN	I-PROBLEM
of	IN	O
1-2	JJ	O
mm	NN	O
with	IN	O
t	JJ	B-PROBLEM
wave	VBP	I-PROBLEM
inversions	NNS	I-PROBLEM
in	IN	O
v4-6	NN	O
,	,	O
i	NN	O
and	CC	O
l	NN	O
,	,	O
which	WDT	O
progressed	VBD	O
to	TO	O
3-0167	JJ	O
w.	JJ	O
seventh	JJ	O
ave.	NN	O
elevations	NNS	O
within	IN	O
20	CD	O
minutes	NNS	O
.	.	O

heparin	NN	B-TREATMENT
and	CC	O
nitroglycerin	JJ	B-TREATMENT
drip	NN	I-TREATMENT
were	VBD	O
started	VBN	O
with	IN	O
10	CD	O
mg	NNS	O
of	IN	O
iv	JJ	B-TREATMENT
retavase	NN	I-TREATMENT
half	NN	O
dose	NN	O
.	.	O

he	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
north	JJ	O
adams	JJ	O
regional	JJ	O
hospital	NN	O
for	IN	O
catheterization	NN	B-TEST
.	.	O

once	RB	O
at	IN	O
hahnemann	JJ	O
general	JJ	O
hospital	NN	O
he	PRP	O
received	VBD	O
heparin	NN	B-TREATMENT
and	CC	O
integrilin	NN	B-TREATMENT
.	.	O

coronary	JJ	B-TEST
angiography	NN	I-TEST
revealed	VBD	O
left	VBD	O
main	JJ	O
,	,	O
left	VBD	O
circumflex	JJ	O
and	CC	O
rca	JJ	O
normal	JJ	O
and	CC	O
left	VBD	B-PROBLEM
lad	NN	I-PROBLEM
with	IN	I-PROBLEM
99%	CD	I-PROBLEM
midstenosis	NN	I-PROBLEM
.	.	O

a	DT	B-TREATMENT
hepacoat	NN	I-TREATMENT
stent	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
with	IN	O
no	DT	O
residuals	NNS	B-TEST
but	CC	O
good	JJ	O
flow	NN	O
after	IN	O
nitroglycerin	JJ	B-TREATMENT
and	CC	O
diltiazem	NN	B-TREATMENT
.	.	O

the	DT	B-PROBLEM
chest	JJS	I-PROBLEM
pain	NN	I-PROBLEM
persisted	VBD	O
afterwards	NNS	O
and	CC	O
a	DT	B-TEST
relook	NN	I-TEST
catheterization	NN	I-TEST
was	VBD	O
performed	VBN	O
that	IN	O
revealed	VBD	O
no	DT	O
occlusions	NNS	B-PROBLEM
.	.	O

the	DT	B-TEST
right	JJ	I-TEST
heart	NN	I-TEST
catheterization	NN	I-TEST
revealed	VBD	O
a	DT	B-TEST
cardiac	JJ	I-TEST
output	NN	I-TEST
index	NN	I-TEST
of	IN	O
4.11	CD	O
and	CC	O
2.15	CD	O
respectively	RB	O
.	.	O

ra	JJ	B-TEST
pressure	NN	I-TEST
was	VBD	O
13	CD	O
,	,	O
rv	JJ	B-TEST
pressure	NN	I-TEST
45/7	CD	O
,	,	O
wedge	NN	B-TEST
27	CD	O
and	CC	O
pa	JJ	B-TEST
pressures	NNS	I-TEST
of	IN	O
42/21	CD	O
.	.	O

he	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
cc	NN	O
for	IN	O
monitoring	NN	B-TEST
and	CC	O
he	PRP	O
denied	VBD	O
having	VBG	O
further	RB	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
or	CC	O
vomiting	NN	B-PROBLEM
.	.	O

at	IN	O
baseline	PDT	O
the	DT	O
patient	JJ	O
denies	VBZ	O
any	DT	O
previous	JJ	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
pressure	NN	B-PROBLEM
,	,	O
dyspnea	NN	B-PROBLEM
on	IN	O
exertion	NN	O
,	,	O
orthopnea	NN	B-PROBLEM
,	,	O
pnd	NN	B-PROBLEM
or	CC	O
palpitations	NNS	B-PROBLEM
.	.	O

only	RB	O
hypertension	NN	B-PROBLEM
.	.	O

antihypertensive	JJ	B-TREATMENT
medications	NNS	I-TREATMENT
that	IN	O
the	DT	O
patient	NN	O
could	MD	O
not	RB	O
identify	VB	O
.	.	O

the	DT	O
patient	NN	O
denies	VBZ	O
having	VBG	O
any	DT	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

significant	JJ	O
for	IN	O
a	DT	O
brother	NN	O
who	WP	O
had	VBD	O
an	DT	B-PROBLEM
mi	NN	I-PROBLEM
at	IN	O
age	NN	O
61	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
afebrile	RB	B-PROBLEM
.	.	O

blood	NN	B-TEST
pressure	NN	I-TEST
156/67	CD	O
,	,	O
pulse	RB	B-TEST
80	CD	O
and	CC	O
respiratory	JJ	B-TEST
rate	NN	I-TEST
14	CD	O
.	.	O

he	PRP	O
was	VBD	O
laying	VBG	O
flat	JJ	O
,	,	O
very	RB	B-PROBLEM
tense	JJ	I-PROBLEM
.	.	O

skin	NN	O
was	VBD	O
strong	JJ	O
build	NN	O
and	CC	O
was	VBD	O
in	IN	O
no	DT	O
apparent	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
anicteric	JJ	B-PROBLEM
with	IN	O
moist	JJ	O
mucous	JJ	O
membranes	NNS	O
.	.	O

no	DT	O
jvd	NN	B-PROBLEM
or	CC	O
increased	VBD	B-PROBLEM
jvp	NN	I-PROBLEM
was	VBD	O
appreciated	VBN	O
at	IN	O
0	CD	O
degrees	NNS	O
.	.	O

the	DT	O
patient	NN	O
did	VBD	O
not	RB	O
have	VB	O
any	DT	B-PROBLEM
carotid	JJ	I-PROBLEM
bruits	NNS	I-PROBLEM
,	,	O
abdominal	JJ	B-PROBLEM
bruits	NNS	I-PROBLEM
or	CC	O
femoral	JJ	B-PROBLEM
bruits	NNS	I-PROBLEM
.	.	O

his	PRP$	B-TEST
pmi	NN	I-TEST
was	VBD	O
two	CD	O
finger	JJR	B-TEST
breath	NN	I-TEST
width	NN	I-TEST
in	IN	O
the	DT	O
fifth	JJ	O
intercostal	JJ	O
space	NN	O
lateral	NN	O
to	TO	O
the	DT	O
midclavicular	JJ	O
line	NN	O
.	.	O

there	EX	O
were	VBD	O
no	DT	O
lifts	NNS	B-PROBLEM
or	CC	O
heaves	NNS	B-PROBLEM
on	IN	O
examination	NN	B-TEST
.	.	O

his	PRP$	O
heart	NN	O
was	VBD	O
regular	JJ	O
with	IN	O
no	DT	O
murmurs	NNS	B-PROBLEM
,	,	O
rubs	NNS	B-PROBLEM
or	CC	O
gallops	NNS	B-PROBLEM
and	CC	O
his	PRP$	B-TEST
radial	NN	I-TEST
and	CC	I-TEST
dp	NN	I-TEST
pulses	NNS	I-TEST
were	VBD	O
both	DT	O
2+	CD	O
bilaterally	RB	O
and	CC	O
equal	JJ	O
.	.	O

his	PRP$	O
lungs	NNS	O
were	VBD	O
clear	JJ	O
to	TO	O
auscultation	NN	B-TEST
.	.	O

his	PRP$	O
abdomen	NNS	O
was	VBD	O
scaphoid	JJ	B-PROBLEM
,	,	O
nondistended	JJ	B-PROBLEM
,	,	O
nontender	FW	B-PROBLEM
with	IN	O
positive	JJ	O
bowel	NN	O
sounds	NNS	O
.	.	O

his	PRP$	O
extremities	NNS	O
were	VBD	O
warm	JJ	O
,	,	O
pink	VB	O
with	IN	O
no	DT	O
edema	NN	B-PROBLEM
.	.	O

the	DT	O
right	JJ	O
calf	NN	O
site	NN	O
had	VBD	O
minimal	JJ	B-PROBLEM
ooze	NN	I-PROBLEM
and	CC	O
no	DT	O
hematomas	NN	B-PROBLEM
or	CC	O
bruits	NNS	B-PROBLEM
.	.	O

this	DT	O
is	VBZ	O
a	DT	O
54	JJ	O
-	:	O
year-old	JJ	O
man	NN	O
with	IN	O
significant	JJ	B-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
risk	NN	I-PROBLEM
factors	NNS	I-PROBLEM
,	,	O
positive	JJ	O
family	NN	O
history	NN	O
,	,	O
smoking	VBG	O
history	NN	O
,	,	O
hypertension	NN	B-PROBLEM
and	CC	O
gender	NN	O
who	WP	O
presented	VBD	O
with	IN	O
an	DT	B-PROBLEM
st	JJ	I-PROBLEM
elevation	NN	I-PROBLEM
mi	NN	I-PROBLEM
status	NN	O
post	NN	O
lad	JJ	B-TREATMENT
stent	NN	I-TREATMENT
,	,	O
complicated	VBN	O
by	IN	O
no	DT	O
residuals	NNS	B-PROBLEM
requiring	VBG	O
nitroglycerin	NN	B-TREATMENT
and	CC	O
diltiazem	NN	B-TREATMENT
for	IN	O
good	JJ	O
flow	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
pain	JJ	B-PROBLEM
free	JJ	O
and	CC	O
doing	VBG	O
well	RB	O
.	.	O

for	IN	O
his	PRP$	B-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
aspirin	NN	B-TREATMENT
was	VBD	O
started	VBN	O
at	IN	O
325	CD	O
.	.	O

plavix	NN	B-TREATMENT
was	VBD	O
started	VBN	O
at	IN	O
75	CD	O
mg	NNS	O
a	DT	O
day	NN	O
,	,	O
lipitor	NN	B-TREATMENT
20	CD	O
mg	NN	O
per	IN	O
day	NN	O
,	,	O
metoprolol	RB	B-TREATMENT
25	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
to	TO	O
be	VB	O
titrated	VBN	O
up	RP	O
as	IN	O
tolerated	VBN	O
and	CC	O
on	IN	O
day	NN	O
two	CD	O
of	IN	O
admission	NN	O
an	DT	B-TREATMENT
ace	NN	I-TREATMENT
inhibitor	NN	I-TREATMENT
was	VBD	O
started	VBN	O
.	.	O

captopril	NN	B-TREATMENT
6.2	CD	O
3	CD	O
x	NNS	O
a	DT	O
day	NN	O
and	CC	O
titrated	VBD	O
up	RP	O
.	.	O

a	DT	B-TEST
lipid	JJ	I-TEST
panel	NN	I-TEST
was	VBD	O
checked	VBN	O
and	CC	O
found	VBN	O
to	TO	O
be	VB	O
within	IN	O
normal	JJ	O
limits	NNS	O
,	,	O
although	IN	O
it	PRP	O
was	VBD	O
noted	VBN	O
this	DT	O
was	VBD	O
in	IN	O
the	DT	O
post	NN	O
mi	NN	O
setting	NN	O
and	CC	O
the	DT	B-TEST
lipid	JJ	I-TEST
panel	NN	I-TEST
could	MD	O
be	VB	O
falsely	RB	O
low	JJ	O
.	.	O

serial	JJ	B-TEST
ck	NN	I-TEST
s	NN	I-TEST
were	VBD	O
followed	VBN	O
with	IN	O
a	DT	B-TEST
ck	JJ	I-TEST
peak	NN	I-TEST
of	IN	O
433	CD	O
.	.	O

hypertension	NN	B-PROBLEM
was	VBD	O
managed	VBN	O
with	IN	O
beta	NN	B-TREATMENT
blocker	NN	I-TREATMENT
and	CC	O
ace	NN	B-TREATMENT
inhibitor	NN	I-TREATMENT
and	CC	O
integrilin	NN	B-TREATMENT
was	VBD	O
continued	VBN	O
post	NN	O
mi	NN	B-PROBLEM
for	IN	O
18	CD	O
hours	NNS	O
.	.	O

rhythm	NN	O
was	VBD	O
maintained	VBN	O
at	IN	O
normal	JJ	O
sinus	NN	O
,	,	O
monitored	VBD	O
on	IN	O
telemetry	NN	B-TEST
without	IN	O
ectopy	NN	B-PROBLEM
.	.	O

ekg	NN	B-TEST
s	NN	I-TEST
were	VBD	O
followed	VBN	O
for	IN	O
normalization	NN	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
an	DT	B-TEST
echocardiogram	NN	I-TEST
on	IN	O
day	NN	O
two	CD	O
of	IN	O
admission	NN	O
,	,	O
which	WDT	O
revealed	VBD	O
a	DT	B-PROBLEM
mildly	RB	I-PROBLEM
dilated	VBN	I-PROBLEM
left	JJ	I-PROBLEM
atrium	NN	I-PROBLEM
,	,	O
mild	JJ	B-PROBLEM
symmetric	JJ	I-PROBLEM
lvh	NN	I-PROBLEM
,	,	O
normal	JJ	O
lv	JJ	O
cavity	NN	O
size	NN	O
,	,	O
mild	JJ	B-PROBLEM
region	NN	I-PROBLEM
lv	VBZ	I-PROBLEM
systolic	JJ	I-PROBLEM
dysfunction	NN	I-PROBLEM
,	,	O
arresting	VBG	B-PROBLEM
regional	JJ	I-PROBLEM
wall	NN	I-PROBLEM
motion	NN	I-PROBLEM
abnormality	NN	I-PROBLEM
including	VBG	O
focal	JJ	B-PROBLEM
apical	JJ	I-PROBLEM
hypokinesis	NN	I-PROBLEM
,	,	O
a	DT	O
normal	JJ	O
right	JJ	O
ventricular	JJ	O
chamber	NN	O
size	NN	O
and	CC	O
free	JJ	O
wall	NN	O
motion	NN	O
,	,	O
a	DT	B-PROBLEM
moderately	RB	I-PROBLEM
dilated	VBN	I-PROBLEM
aortic	JJ	I-PROBLEM
root	NN	I-PROBLEM
,	,	O
a	DT	B-PROBLEM
mildly	RB	I-PROBLEM
dilated	JJ	I-PROBLEM
ascending	VBG	I-PROBLEM
aorta	NN	I-PROBLEM
,	,	O
normal	JJ	O
aortic	JJ	O
valve	NN	O
leaflet	NN	O
,	,	O
normal	JJ	O
mitral	JJ	O
valve	NN	O
leaflet	NN	O
and	CC	O
no	DT	O
pericardial	JJ	B-PROBLEM
effusions	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
normal	JJ	O
volume	NN	O
and	CC	O
displayed	VBD	O
no	DT	O
evidence	NN	O
chf	NN	B-PROBLEM
signs	NNS	I-PROBLEM
or	CC	I-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O

the	DT	B-PROBLEM
risk	NN	I-PROBLEM
factors	NNS	I-PROBLEM
were	VBD	O
addressed	VBN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
told	VBN	O
repeatedly	RB	O
that	IN	O
he	PRP	O
needed	VBD	O
to	TO	O
stop	VB	O
smoking	NN	O
and	CC	O
was	VBD	O
given	VBN	O
a	DT	B-TREATMENT
nicotine	JJ	I-TREATMENT
patch	NN	I-TREATMENT
and	CC	O
his	PRP$	O
primary	JJ	O
care	NN	O
provider	NN	O
was	VBD	O
called	VBN	O
to	TO	O
discuss	VB	O
outpatient	JJ	O
plans	NNS	O
to	TO	O
help	VB	O
the	DT	O
patient	NN	O
stop	NN	O
smoking	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
advised	VBN	O
to	TO	O
have	VB	O
a	DT	B-TREATMENT
low	JJ	I-TREATMENT
fat	JJ	I-TREATMENT
/	NN	I-TREATMENT
low	JJ	I-TREATMENT
cholesterol	NN	I-TREATMENT
diet	NN	I-TREATMENT
,	,	O
was	VBD	O
cleared	VBN	O
by	IN	O
pt	NN	O
and	CC	O
advised	VBD	O
to	TO	O
do	VB	O
cardiac	JJ	B-TREATMENT
rehabilitation	NN	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
advised	VBN	O
the	DT	O
importance	NN	O
of	IN	O
each	DT	O
of	IN	O
his	PRP$	O
and	CC	O
compliance	NN	O
with	IN	O
each	DT	O
of	IN	O
these	DT	B-TREATMENT
medications	NNS	I-TREATMENT
and	CC	O
was	VBD	O
told	VBN	O
he	PRP	O
needed	VBD	O
close	JJ	O
followup	NN	O
with	IN	O
a	DT	O
cardiologist	NN	O
.	.	O

for	IN	O
renal	JJ	O
,	,	O
his	PRP$	B-TEST
creatinine	NN	I-TEST
was	VBD	O
monitored	VBN	O
and	CC	O
the	DT	B-TEST
dye	NN	I-TEST
load	NN	I-TEST
and	CC	O
the	DT	B-TEST
catheterization	NN	I-TEST
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
a	DT	B-TREATMENT
low	JJ	I-TREATMENT
fat	JJ	I-TREATMENT
/	NN	I-TREATMENT
low	JJ	I-TREATMENT
cholesterol	NN	I-TREATMENT
diet	NN	I-TREATMENT
.	.	O

his	PRP$	B-TEST
electrolytes	NNS	I-TEST
were	VBD	O
monitored	VBN	O
and	CC	O
repleted	VBN	O
carefully	RB	O
.	.	O

he	PRP	O
had	VBD	O
normal	JJ	O
bowel	NN	O
movements	NNS	O
and	CC	O
had	VBD	O
gi	VBN	B-TREATMENT
prophylaxis	NN	I-TREATMENT
throughout	IN	O
his	PRP$	O
stay	NN	O
.	.	O

for	IN	O
hematology	NN	O
,	,	O
the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
hematocrit	NN	I-TEST
and	CC	O
platelets	NNS	B-TEST
were	VBD	O
monitored	VBN	O
after	IN	O
the	DT	B-TEST
catheterization	NN	I-TEST
.	.	O

they	PRP	O
were	VBD	O
normal	JJ	O
and	CC	O
did	VBD	O
not	RB	O
change	NN	O
and	CC	O
the	DT	O
patient	NN	O
received	VBD	O
pneumatic	JJ	B-TREATMENT
boots	NNS	I-TREATMENT
for	IN	O
dvt	NN	B-TREATMENT
prophylaxis	NN	I-TREATMENT
.	.	O

on	IN	O
day	NN	O
two	CD	O
of	IN	O
admission	NN	O
,	,	O
the	DT	O
patient	NN	O
ambulated	VBD	O
with	IN	O
pt	NN	B-TREATMENT
and	CC	O
was	VBD	O
moved	VBN	O
to	TO	O
the	DT	O
regular	JJ	O
floor	NN	O
.	.	O

he	PRP	O
denied	VBD	O
ever	RB	O
having	VBG	O
any	DT	B-PROBLEM
chest	JJS	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
chest	NN	B-PROBLEM
pressure	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
dyspnea	NN	B-PROBLEM
on	IN	O
exertion	NN	O
and	CC	O
he	PRP	O
was	VBD	O
discharged	VBN	O
to	TO	O
home	NN	O
.	.	O

he	PRP	O
was	VBD	O
told	VBN	O
to	TO	O
return	VB	O
to	TO	O
the	DT	O
emergency	NN	O
department	NN	O
if	IN	O
he	PRP	O
had	VBD	O
any	DT	B-PROBLEM
chest	JJS	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
pressure	NN	B-PROBLEM
,	,	O
difficulty	NN	B-PROBLEM
breathing	NN	I-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
,	,	O
light-headiness	JJ	B-PROBLEM
or	CC	O
dizziness	NN	B-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
advised	VBN	O
to	TO	O
take	VB	O
all	DT	O
of	IN	O
his	PRP$	B-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

1.	CD	O
st	JJ	B-PROBLEM
elevation	NN	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

2.	CD	O
hypertension	NN	B-PROBLEM
.	.	O

cardiac	JJ	B-TEST
catheterization	NN	I-TEST
and	CC	O
stent	JJ	B-TREATMENT
placement	NN	I-TREATMENT
in	IN	I-TREATMENT
the	DT	I-TREATMENT
mid	NN	I-TREATMENT
left	VBD	I-TREATMENT
anterior	JJ	I-TREATMENT
descending	VBG	I-TREATMENT
artery	NN	I-TREATMENT
.	.	O

aspirin	RB	B-TREATMENT
325	CD	O
mg	NN	O
q.d.	NN	O
,	,	O
plavix	VBP	B-TREATMENT
75	CD	O
mg	NN	O
q.d.	NN	O
,	,	O
lipitor	NN	B-TREATMENT
20	CD	O
mg	NN	O
q.d.	NN	O
,	,	O
nitroglycerin	RB	B-TREATMENT
0.3	CD	O
mg	NNS	O
sublingually	RB	O
p.r.n.	VBP	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
or	CC	O
pressure	NN	B-PROBLEM
or	CC	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
lisinopril	JJ	B-TREATMENT
hydrochlorothiazide	NN	B-TREATMENT
20	CD	O
/	NN	O
12.5	CD	O
mg	NN	O
q.d.	NN	O
,	,	O
atenolol	RB	B-TREATMENT
25	CD	O
mg	NNS	O
q.d.	NN	O

the	DT	O
patient	NN	O
was	VBD	O
told	VBN	O
he	PRP	O
could	MD	O
return	VB	O
to	TO	O
work	VB	O
after	IN	O
two	CD	O
weeks	NNS	O
of	IN	O
rest	NN	B-TREATMENT
,	,	O
given	VBN	O
that	IN	O
his	PRP$	O
work	NN	O
required	VBD	O
a	DT	O
high	JJ	O
level	NN	O
of	IN	O
exertion	NN	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
also	RB	O
given	VBN	O
a	DT	O
prescription	NN	O
for	IN	O
a	DT	B-TREATMENT
transdermal	JJ	I-TREATMENT
nicotine	JJ	I-TREATMENT
patch	NN	I-TREATMENT
14	CD	O
mg	VBD	O
the	DT	O
be	VB	O
used	VBN	O
for	IN	O
up	RB	O
to	TO	O
2	CD	O
weeks	NNS	O
until	IN	O
cravings	NNS	B-PROBLEM
remitted	VBN	O
.	.	O

